data_1jc2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jc2 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.411 ' OE1' ' HA ' ' A' ' 96' ' ' GLU . 5.4 tp10 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.24 0.543 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.8 -57.14 7.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.459 HD21 ' CD2' ' A' ' 155' ' ' LEU . 0.6 OUTLIER -50.11 -46.2 53.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.095 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -43.61 -58.55 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -53.6 -51.93 61.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -43.79 -30.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.403 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 30.6 t80 -42.79 -59.77 1.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -36.66 71.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 47.2 mm -57.24 -29.51 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.944 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.05 -54.18 6.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.949 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.404 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 3.8 t70 -67.61 87.04 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.966 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -84.87 -2.81 58.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.464 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 110' ' ' ASP . 2.1 p30 -131.28 153.09 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.136 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.68 89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 110.145 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 108' ' ' ASN . 60.9 t0 -142.29 -34.54 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 110.284 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.53 10.18 35.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 31.2 m-85 -153.52 147.06 25.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -1.175 . . . . 0.0 110.052 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.8 mt -90.99 114.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.336 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.87 179.9 4.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -66.66 -43.53 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.4 mm-40 -50.75 -45.5 58.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.822 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 7.9 mt-10 -65.02 -38.41 90.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.29 -38.53 77.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.118 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -47.75 -80.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -43.43 -54.15 4.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.323 -1.104 . . . . 0.0 110.743 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.501 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 14.0 mt -42.23 -61.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.71 -44.79 80.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -40.65 62.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.17 19.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.6 p -74.9 -169.33 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.11 56.57 0.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -116.83 -10.38 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 49.12 68.06 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.4 t -89.69 149.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.66 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' GLU . 18.0 pt -117.98 155.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.4 mt-10 -40.2 -50.1 2.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.33 -0.856 . . . . 0.0 110.887 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.4 -32.99 28.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 110.948 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -47.24 10.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.446 HD11 ' HA2' ' A' ' 119' ' ' GLY . 13.7 mt -58.2 -37.21 61.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.311 -0.868 . . . . 0.0 109.717 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HA ' HD13 ' A' ' 115' ' ' ILE . 4.5 mt-10 -57.4 -47.8 80.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.44 -43.65 71.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 0.0 110.112 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 134' ' ' ILE . 0.4 OUTLIER -53.61 -44.37 69.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.129 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.6 ttm -64.68 -41.77 95.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 0.0 110.261 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -56.25 22.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.38 -19.19 21.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 110.671 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.54 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -102.51 -61.5 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 0.0 110.736 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' SER . 59.5 t0 -39.38 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.402 -0.811 . . . . 0.0 110.852 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -92.67 -5.61 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.863 . . . . 0.0 110.142 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 1.1 m-80 -127.49 21.6 6.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.166 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 47.6 46.94 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -105.45 14.46 28.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 110.228 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.429 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 46.53 30.94 4.77 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 11.0 mtt180 -157.52 128.74 6.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -1.113 . . . . 0.0 110.363 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.54 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.2 mt -83.48 123.54 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.683 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 20.4 p-10 -96.33 -167.36 1.56 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.355 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 18.2 p90 -65.23 -43.3 91.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.222 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.587 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -64.32 -58.32 6.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.312 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.483 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 35.7 mt-10 -61.61 -42.83 99.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.521 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 17.4 t80 -56.49 -64.95 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 110.07 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.459 ' CD2' HD21 ' A' ' 98' ' ' LEU . 32.5 mt -44.94 -48.49 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.379 -0.826 . . . . 0.0 110.001 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -46.91 -46.53 21.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -0.881 . . . . 0.0 110.375 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.547 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -71.43 -53.29 14.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.949 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.547 ' N ' ' CG ' ' A' ' 157' ' ' MET . 5.3 mmt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.946 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.319 0.581 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.2 mt-10 -47.89 -65.2 0.6 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 110.846 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.496 HD21 ' CE1' ' A' ' 154' ' ' PHE . 0.1 OUTLIER -51.19 -55.22 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 110.639 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -44.87 -44.77 9.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.256 -0.902 . . . . 0.0 110.687 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 3.0 m-20 -50.77 -52.0 45.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.741 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 105' ' ' PHE . 0.8 OUTLIER -61.17 -16.67 47.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.17 -0.956 . . . . 0.0 110.977 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.473 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 34.7 t80 -47.88 -41.25 23.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -0.998 . . . . 0.0 110.844 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -73.87 -37.8 64.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.0 111.095 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.508 HD11 ' N ' ' A' ' 104' ' ' ILE . 1.7 mp -57.06 -35.63 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 110.474 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 101' ' ' CYS . 28.8 m-85 -80.83 -36.57 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 110.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -79.67 80.13 6.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.034 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.455 ' HB2' ' OE2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -54.46 -30.49 53.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.479 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -109.35 -151.7 0.48 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.081 -1.012 . . . . 0.0 110.33 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.06 47.75 1.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 9.2 p30 -83.14 -18.01 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 80.13 -5.0 64.27 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 110' ' ' ASP . 7.4 m-85 -145.5 135.79 23.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -1.184 . . . . 0.0 109.876 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 mt -82.84 120.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.04 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 6.9 p-10 -87.84 176.65 7.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.158 -0.964 . . . . 0.0 110.324 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -69.72 -40.62 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.126 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 11.7 mt-10 -54.29 -48.86 70.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.021 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 107' ' ' LYS . 3.5 mt-10 -53.3 -50.25 65.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.8 OUTLIER -58.28 -39.74 80.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.313 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.53 -73.99 0.34 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 14.5 pt-20 -54.85 -44.77 74.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.213 -1.169 . . . . 0.0 110.573 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.469 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 10.9 mt -53.01 -56.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 110.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.511 ' CD1' HD13 ' A' ' 134' ' ' ILE . 11.0 mt -63.84 -54.59 32.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -55.99 -39.67 72.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.05 -20.22 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.253 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 p -86.35 -1.95 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.12 81.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.481 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . 0.2 OUTLIER -79.32 0.5 28.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -1.112 . . . . 0.0 110.237 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 41.97 45.75 3.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.481 ' CG2' ' HB3' ' A' ' 127' ' ' GLU . 14.8 t -77.86 155.22 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.199 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 132' ' ' GLU . 20.7 pt -114.96 138.27 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 110.409 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ILE . 8.9 mt-10 -41.02 -43.44 2.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HB2' HG13 ' A' ' 130' ' ' ILE . 1.5 mm-40 -40.72 -38.53 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.303 -0.873 . . . . 0.0 110.6 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.84 -48.96 8.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.659 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 122' ' ' LEU . 13.3 mt -58.12 -39.45 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 4.5 tt0 -66.79 -41.6 87.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.589 -0.695 . . . . 0.0 110.021 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.81 -42.26 75.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.968 . . . . 0.0 110.086 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.43 78.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.505 ' CE ' HD13 ' A' ' 149' ' ' ILE . 31.2 tpp -61.64 -40.5 95.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.875 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -59.12 -49.42 77.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 110.104 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -68.19 -41.38 81.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.031 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.522 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -73.99 -63.97 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 9.7 t0 -45.41 97.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -82.14 -24.22 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.431 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 10.3 m-80 -107.76 14.78 25.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.887 . . . . 0.0 110.161 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.15 47.7 19.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 51.1 p30 -105.32 25.57 10.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 44.33 35.46 3.82 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 86.6 mtt180 -157.91 121.35 4.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.522 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.2 mt -83.62 118.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.432 ' OD2' ' OE2' ' A' ' 153' ' ' GLU . 41.0 p30 -97.18 -179.78 4.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 110.445 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -59.27 3.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.43 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -61.12 2.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.496 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 157' ' ' MET . 16.7 mt-10 -60.73 -39.95 90.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.366 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.51 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 21.5 t80 -59.68 -33.09 71.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -0.872 . . . . 0.0 110.975 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 25.1 mt -74.3 -46.45 40.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 110.974 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 157' ' ' MET . 63.5 mttt -66.67 -49.41 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -0.962 . . . . 0.0 110.834 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.73 -50.51 7.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.015 -1.053 . . . . 0.0 110.372 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.459 ' HB2' ' SD ' ' A' ' 157' ' ' MET . 9.8 ttm . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.318 0.58 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -49.8 -66.32 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.119 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.1 -45.62 52.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.81 -42.65 26.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 110.27 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.474 ' O ' HG12 ' A' ' 104' ' ' ILE . 42.4 m-20 -48.1 -46.19 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.5 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 m -78.21 -25.67 47.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 0.0 110.904 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.449 ' CD1' HD13 ' A' ' 113' ' ' ILE . 13.8 t80 -52.95 -62.65 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -0.999 . . . . 0.0 110.729 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -57.15 -27.98 62.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.897 . . . . 0.0 110.92 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 100' ' ' ASN . 45.6 mm -61.42 -26.3 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.026 -1.046 . . . . 0.0 110.464 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.13 -29.21 24.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -79.87 117.24 20.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.079 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 -11.47 15.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.289 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 109' ' ' ALA . 56.6 m-80 -116.34 16.11 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.302 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 43.98 79.42 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.17 -33.13 5.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 110.23 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.519 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 111.85 -14.35 26.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.519 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 18.7 m-85 -149.93 141.25 23.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -1.087 . . . . 0.0 109.826 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.449 HD13 ' CD1' ' A' ' 102' ' ' PHE . 44.4 mt -82.81 130.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 8.2 p30 -95.17 -176.87 3.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.1 tt -79.18 -44.98 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 110.508 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 117' ' ' GLU . 21.6 pt-20 -48.99 -35.13 14.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 116' ' ' GLU . 43.2 mt-10 -69.12 -42.31 76.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.46 HD23 HG23 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -57.36 -37.88 73.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.31 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.53 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -57.11 -72.95 0.5 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.4 pt-20 -53.95 -44.63 70.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -1.127 . . . . 0.0 110.701 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.2 mt -45.05 -56.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.009 . . . . 0.0 110.481 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.51 ' O ' ' CG2' ' A' ' 125' ' ' THR . 15.7 mt -66.24 -52.31 48.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.684 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -48.71 -30.93 6.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 110.681 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.45 -56.62 18.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.743 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 122' ' ' LEU . 2.3 t -63.2 -10.15 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.559 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 128' ' ' HIS . . . 111.52 -29.1 8.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 125' ' ' THR . 4.2 mm-40 -52.24 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' GLY . 8.1 m80 -67.32 76.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 109.975 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 122' ' ' LEU . 13.3 t -84.29 136.85 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.47 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 133' ' ' ASP . 17.2 pt -90.97 143.59 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -42.95 -46.96 5.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 110.454 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.408 ' HB3' HD12 ' A' ' 130' ' ' ILE . 3.8 tt0 -48.03 -27.23 2.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.458 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.46 ' HB2' HG13 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -89.68 -41.89 11.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.619 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.53 ' CD1' ' HA2' ' A' ' 119' ' ' GLY . 36.7 mt -65.64 -37.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.915 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.16 -48.46 73.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.91 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 12.8 t0 -55.57 -45.94 77.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -57.7 8.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.975 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 2.0 ttm -56.18 -20.88 19.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -72.89 -44.75 60.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 110.428 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -73.94 -34.48 64.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 110.716 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.528 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -74.04 -63.14 1.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.027 . . . . 0.0 110.547 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 138' ' ' MET . 23.2 m-20 -41.89 96.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.483 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -72.84 -3.81 27.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.31 22.57 2.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 48.94 86.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 110.337 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' OD1' ' CG ' ' A' ' 142' ' ' ASP . 17.6 p-10 -139.94 17.81 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 48.32 32.16 9.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 45.5 mtt180 -158.19 121.69 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.189 . . . . 0.0 110.454 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.528 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.8 mt -83.53 123.71 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.667 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.472 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 23.1 p30 -103.94 -177.44 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.617 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 155' ' ' LEU . 29.7 t80 -49.95 -62.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.629 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.83 -57.61 6.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.367 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.472 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 79.7 mt-10 -59.94 -39.63 86.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 109.989 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.478 ' O ' ' HG2' ' A' ' 157' ' ' MET . 33.0 t80 -63.34 -51.48 65.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.546 HD11 ' CE2' ' A' ' 151' ' ' PHE . 37.3 mt -47.53 -54.06 12.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.452 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -60.55 -51.2 70.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.609 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.506 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.1 ptm -48.75 -47.54 41.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.506 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.228 0.537 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.39 -62.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -47.78 -62.18 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 110.06 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -44.91 -47.37 11.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.877 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -50.88 -52.71 39.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -18.54 39.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 110.131 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 113' ' ' ILE . 16.0 t80 -55.06 -55.87 26.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -57.06 -42.89 81.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -0.885 . . . . 0.0 110.636 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 1.2 mp -57.21 -41.71 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.135 -0.978 . . . . 0.0 110.273 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -72.11 -43.64 64.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 0.0 110.486 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.64 102.58 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -84.14 -44.34 14.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 110.475 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -68.09 -8.04 34.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.226 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.47 24.77 1.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 4.0 p30 -68.16 -20.99 64.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 110.278 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.489 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 112.09 -15.77 25.52 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 9.7 m-85 -148.01 134.13 19.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -1.165 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.564 HD11 ' CE1' ' A' ' 102' ' ' PHE . 14.5 mt -82.5 133.78 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.297 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -107.28 -171.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 110.141 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.477 ' CD1' ' HG2' ' A' ' 135' ' ' GLU . 2.4 tt -72.51 -43.42 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 110.187 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.45 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -55.83 -35.6 66.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.131 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -74.97 -52.31 11.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 110.417 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -38.86 -30.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.46 -0.775 . . . . 0.0 111.065 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 117' ' ' GLU . . . -56.03 -43.76 88.18 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 11.4 pt-20 -49.28 -45.86 45.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.125 -1.22 . . . . 0.0 110.942 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.518 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 1.5 mp -60.26 -50.39 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.469 ' CD1' HD11 ' A' ' 118' ' ' LEU . 4.3 mp -69.08 -52.26 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.034 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 24.9 mtp180 -49.64 -36.93 26.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.32 23.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 0.0 110.324 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 59.8 p -61.14 -40.37 93.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.392 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.29 -3.97 9.58 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -92.66 133.47 35.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.26 60.21 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 110.136 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 38.6 t -45.48 166.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.456 HG21 HD13 ' A' ' 130' ' ' ILE . 31.9 pt -118.52 151.99 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.99 -48.44 3.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.382 -0.824 . . . . 0.0 110.78 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -48.88 -31.54 7.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.824 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.523 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -83.19 -43.95 15.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.2 mt -66.2 -38.15 81.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.506 -0.746 . . . . 0.0 109.822 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.477 ' HG2' ' CD1' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.98 -53.18 44.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 110.536 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -45.98 -51.31 13.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 0.0 110.45 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 137' ' ' LEU . 1.5 mm? -50.58 -41.27 54.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 20.9 tpp -67.97 -48.96 64.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -48.21 79.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.63 -32.42 69.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 143' ' ' LYS . 2.1 t -92.99 -38.06 11.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 138' ' ' MET . 1.4 m-20 -51.99 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 8.3 tptm -74.63 -18.19 60.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.911 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.434 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 1.6 m-80 -117.77 10.68 13.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.989 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 15.0 m120 55.31 46.13 24.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -0.881 . . . . 0.0 110.322 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -107.04 16.12 24.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 51.52 34.96 35.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 5.6 mtm180 -157.63 124.82 5.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -1.214 . . . . 0.0 110.223 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.483 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.2 mt -83.94 128.55 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 0.0 110.131 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.451 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 53.3 p-10 -108.73 -170.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 110.087 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -63.5 -37.87 88.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.93 -51.85 35.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.451 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 46.8 mt-10 -59.7 -45.41 92.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.566 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.449 ' CZ ' ' HE3' ' A' ' 158' ' ' MET . 1.9 t80 -50.61 -57.97 6.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.768 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.7 mt -39.92 -64.15 0.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.468 -0.77 . . . . 0.0 110.677 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -30.97 66.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.536 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -65.5 -40.31 92.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.536 ' N ' ' HG3' ' A' ' 157' ' ' MET . 2.5 mtt . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 0.0 110.169 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.247 0.546 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 1.9 mt-10 -59.71 -54.01 51.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.1 mt -50.78 -64.13 0.91 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 0.0 110.111 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.89 -46.01 10.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 67.7 m-20 -56.01 -48.29 76.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 73.8 m -45.33 -29.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -44.89 -62.97 1.02 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 109.82 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.39 -42.01 61.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 21.0 mm -61.28 -39.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.0 -51.96 48.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.865 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.447 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 21.0 t0 -53.42 129.37 31.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.517 -0.739 . . . . 0.0 110.418 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -98.29 -14.43 20.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.191 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -133.47 12.0 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.447 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 55.39 57.35 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 36.0 p30 -84.85 -14.57 47.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 94.07 -10.52 71.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 111' ' ' GLY . 46.7 m-85 -151.41 136.42 17.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -1.227 . . . . 0.0 110.635 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.9 mt -88.28 121.65 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.462 ' OD1' ' HG3' ' A' ' 117' ' ' GLU . 13.6 p30 -98.3 171.01 8.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.229 -0.919 . . . . 0.0 110.342 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -58.49 -36.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -51.03 -54.04 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.877 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 121' ' ' ILE . 51.6 mt-10 -56.38 -41.58 76.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -54.73 -43.56 72.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 134' ' ' ILE . . . -56.44 -75.47 0.25 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 16.1 pt-20 -42.35 -45.06 4.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -1.12 . . . . 0.0 110.479 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.482 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 41.5 mt -55.22 -55.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.453 ' O ' ' OG1' ' A' ' 125' ' ' THR . 0.2 OUTLIER -63.15 -53.67 49.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 110.442 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -48.82 -40.36 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.19 -34.39 22.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.286 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 36.4 p -70.01 -23.33 63.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.962 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.1 3.76 26.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -89.59 132.9 34.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.311 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -85.38 53.36 2.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.6 t -65.28 149.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.868 . . . . 0.0 110.518 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.419 HD12 ' HB2' ' A' ' 132' ' ' GLU . 6.2 pt -113.76 153.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.8 tt0 -41.71 -53.02 3.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -44.32 -36.45 2.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.72 -42.05 22.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 109.099 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 17.0 mt -67.18 -36.53 77.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.52 -0.737 . . . . 0.0 109.565 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 138' ' ' MET . 2.8 tm-20 -56.26 -32.47 64.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 109.838 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -49.83 -62.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 110.767 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.536 ' CD1' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pp -56.88 -27.97 61.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.987 . . . . 0.0 110.651 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.445 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 0.0 OUTLIER -67.01 -46.82 73.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.03 . . . . 0.0 110.046 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.84 72.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -59.9 -36.37 76.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.532 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -86.11 -59.06 2.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -43.44 92.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 110.597 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -92.3 -20.06 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 15.1 m-80 -104.74 6.4 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.03 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.0 OUTLIER 63.93 28.49 14.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 110.211 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -87.76 8.66 24.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.76 24.66 33.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.508 ' HD2' ' CB ' ' A' ' 112' ' ' PHE . 1.4 mtt-85 -147.69 142.58 26.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -1.155 . . . . 0.0 110.189 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 137' ' ' LEU . 19.4 mt -90.65 121.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.372 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 153' ' ' GLU . 36.4 p-10 -97.7 -156.32 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 0.0 109.907 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -71.18 -55.79 7.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.31 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.32 -60.21 4.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.908 . . . . 0.0 110.548 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.49 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 26.6 mt-10 -48.02 -37.74 15.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.316 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 50.9 t80 -60.37 -61.04 2.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 154' ' ' PHE . 91.4 mt -41.76 -39.03 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.435 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -58.42 -45.48 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 110.365 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.581 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -64.17 -51.2 64.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.826 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.581 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 110.572 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.236 0.541 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -67.88 -52.97 30.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.287 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.421 HD13 ' HE2' ' A' ' 158' ' ' MET . 0.1 OUTLIER -52.15 -53.39 43.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.97 44.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.95 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -77.02 -46.0 25.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -49.01 -27.26 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.967 . . . . 0.0 110.092 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.626 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 2.3 t80 -42.08 -56.54 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -56.93 -34.12 67.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.326 -0.859 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.61 -59.83 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.358 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.473 ' O ' ' CD1' ' A' ' 121' ' ' ILE . 3.0 m-85 -62.42 -38.37 89.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -85.76 62.24 7.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.229 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -35.43 10.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.182 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.434 ' HB3' ' OD2' ' A' ' 110' ' ' ASP . 1.5 t-20 -55.51 -21.26 15.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.02 47.18 25.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.434 ' OD2' ' HB3' ' A' ' 108' ' ' ASN . 33.1 m-20 -106.94 -13.86 15.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.542 ' C ' ' CD1' ' A' ' 112' ' ' PHE . . . 97.87 -2.43 60.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 111' ' ' GLY . 63.5 m-85 -150.57 119.42 6.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.24 . . . . 0.0 110.273 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.412 ' HA ' ' OE2' ' A' ' 117' ' ' GLU . 15.7 mt -83.79 116.39 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.34 -0.85 . . . . 0.0 110.112 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -92.59 175.28 6.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -57.05 -42.73 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.894 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.425 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.5 mt-10 -51.01 -45.87 61.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.093 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.4 mt-10 -58.47 -50.48 73.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.89 . . . . 0.0 110.127 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -52.1 -34.65 45.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.893 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 123' ' ' ARG . . . -70.28 -69.25 1.43 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.52 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -48.52 -45.24 37.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.237 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.52 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 47.3 mt -57.0 -50.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 125' ' ' THR . 12.9 mt -76.72 -53.98 7.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.965 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 119' ' ' GLY . 9.5 mtt180 -49.07 -32.24 9.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.098 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.15 -43.24 82.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.4 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 81.0 p -55.66 -43.57 76.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.26 -39.37 1.69 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -46.02 125.23 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.136 . . . . 0.0 110.321 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.56 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.3 OUTLIER -71.67 65.47 0.49 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.3 t -64.67 148.68 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.155 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.47 145.24 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.393 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLU . 15.7 mt-10 -43.86 -50.16 8.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.326 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -42.51 -32.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.366 -0.834 . . . . 0.0 109.992 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.76 -47.0 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.8 mt -59.69 -38.7 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 0.0 109.785 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -48.97 -48.79 42.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -51.24 -46.84 62.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.42 HD13 HD11 ' A' ' 118' ' ' LEU . 10.5 mt -53.48 -52.92 58.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 110.884 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 31.9 tpp -66.67 -52.35 45.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 0.0 110.167 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -60.7 2.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.45 -0.781 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.24 -37.67 67.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 0.0 110.666 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.523 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.68 -55.4 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 110.557 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 0.1 OUTLIER -46.74 91.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.593 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -80.81 -38.73 27.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.106 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.417 ' ND2' ' OD1' ' A' ' 146' ' ' ASP . 6.7 p30 -95.8 12.5 29.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.873 . . . . 0.0 110.082 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.4 m120 53.49 87.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 110.55 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 148' ' ' ARG . 6.8 p-10 -143.97 13.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 109.628 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 56.86 20.78 34.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.47 ' O ' ' OD2' ' A' ' 146' ' ' ASP . 30.7 mtt-85 -149.77 133.83 17.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.995 -1.297 . . . . 0.0 110.607 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.523 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.9 mt -84.29 132.85 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.812 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 24.4 p-10 -112.55 -170.01 1.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.458 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.626 ' CE1' ' CD2' ' A' ' 102' ' ' PHE . 3.3 m-85 -59.38 -56.58 20.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -59.17 4.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.225 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 157' ' ' MET . 54.2 mt-10 -57.39 -46.79 83.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.486 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 84.5 t80 -47.86 -32.24 5.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 110.233 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.532 ' O ' ' CE ' ' A' ' 158' ' ' MET . 27.7 mt -75.68 -50.64 14.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -49.42 74.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.184 -0.948 . . . . 0.0 110.954 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.77 -47.61 8.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 111.245 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 155' ' ' LEU . 6.2 ptp . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 0.0 110.616 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.273 0.558 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -47.54 -46.92 28.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.866 . . . . 0.0 109.919 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 98' ' ' LEU . 3.8 mm? -57.03 -48.54 78.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -49.08 -53.11 21.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.45 78.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.121 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -53.19 -19.2 2.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.524 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 44.3 t80 -50.5 -50.22 53.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 110.188 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -30.6 69.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.418 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 26.2 mm -56.89 -38.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -85.22 -11.85 53.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -91.24 106.6 18.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -9.29 33.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.338 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.466 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 66.4 m-80 -117.09 9.26 13.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.922 . . . . 0.0 110.312 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 44.02 43.49 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 10.8 m-20 -80.3 -22.43 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.36 -7.98 62.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 44.8 m-85 -151.81 125.06 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 149' ' ' ILE . 2.9 mp -83.31 112.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.955 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 15.2 p-10 -92.97 -173.24 3.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 1.3 tt -69.69 -41.9 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.867 . . . . 0.0 110.523 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.498 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.5 OUTLIER -53.81 -55.39 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 24.0 mt-10 -45.4 -55.05 6.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.355 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.456 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -48.77 -54.01 16.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.359 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -47.39 -77.06 0.12 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.9 pt-20 -42.67 -47.9 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.502 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 117' ' ' GLU . 8.0 mt -47.29 -55.43 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.011 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.437 ' O ' ' OG1' ' A' ' 125' ' ' THR . 2.4 mt -76.63 -54.86 6.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.211 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -49.06 -36.37 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.899 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.88 -39.66 26.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.052 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 69.9 p -66.76 -38.47 86.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.45 32.57 4.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 128' ' ' HIS . 8.6 mm-40 -97.02 7.08 47.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.319 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 127' ' ' GLU . 14.5 m-70 43.58 72.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.7 t -88.62 154.92 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.343 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.6 pt -103.38 145.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 110.177 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.1 mt-10 -49.85 -41.05 44.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.377 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.1 tm-20 -41.69 -33.38 0.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 110.357 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -44.78 12.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 0.0 109.418 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.421 HD11 ' HA2' ' A' ' 119' ' ' GLY . 26.9 mt -65.59 -38.95 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.505 -0.747 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 13.2 mm-40 -56.64 -50.52 71.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.47 -0.769 . . . . 0.0 110.277 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.93 -55.02 10.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.935 . . . . 0.0 110.408 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 45.3 mt -48.96 -52.95 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.496 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.485 ' HG3' ' HB2' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -71.08 -50.01 38.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.88 . . . . 0.0 110.418 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 14.1 mttm -56.53 -39.7 73.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.424 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.43 -40.66 61.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 143' ' ' LYS . 0.4 OUTLIER -83.86 -52.19 6.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 110.653 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.485 ' HB2' ' HG3' ' A' ' 138' ' ' MET . 29.5 t0 -46.45 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.401 -0.812 . . . . 0.0 111.01 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 30.3 tttt -77.71 -23.93 49.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -99.35 -5.61 29.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.69 . . . . 0.0 109.636 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.413 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 1.5 m-20 59.84 24.86 13.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 20.6 p30 -85.17 2.58 43.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 75.94 38.73 35.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 14.7 mtm180 -159.14 133.45 7.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.498 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 141' ' ' SER . 2.0 mt -97.81 123.89 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -105.48 -173.91 2.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 54.1 p90 -57.25 -43.49 83.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 110.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.603 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -63.75 -51.4 65.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.018 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 53.5 mt-10 -65.16 -52.51 54.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.089 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.524 ' CE2' ' HA ' ' A' ' 102' ' ' PHE . 5.9 t80 -46.72 -57.28 5.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' PHE . 71.3 mt -45.3 -63.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -60.69 -25.2 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 110.019 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.537 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -60.85 -38.03 84.13 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.262 -0.899 . . . . 0.0 109.148 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.537 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 109.985 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.151 0.5 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -49.69 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.472 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.3 mt -53.0 -43.06 66.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 110.274 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.31 -61.0 2.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -55.41 -49.72 71.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.522 ' SG ' ' CE2' ' A' ' 105' ' ' PHE . 42.5 t -59.93 -19.95 54.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.65 -57.47 11.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.054 -1.029 . . . . 0.0 110.177 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.79 -37.09 3.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 104' ' ' ILE . 2.0 mp -67.88 -53.06 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.522 ' CE2' ' SG ' ' A' ' 101' ' ' CYS . 11.9 m-85 -54.03 -31.21 50.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 110.028 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -87.2 91.52 8.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.906 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 -41.97 65.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.522 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 109' ' ' ALA . 32.8 m-80 -87.19 6.38 33.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 43.0 63.14 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -96.92 -11.79 24.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.301 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 90.78 -15.11 61.34 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 46.0 m-85 -147.35 125.02 11.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 110.074 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.84 131.13 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.95 -167.4 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.167 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -72.49 -41.02 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.932 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.506 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 1.6 tm-20 -57.03 -53.94 52.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.439 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 22.5 mt-10 -53.15 -38.2 62.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.33 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.421 ' CD2' HD13 ' A' ' 122' ' ' LEU . 0.9 OUTLIER -60.58 -51.35 69.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -50.1 -74.21 0.3 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -42.47 -54.61 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -1.141 . . . . 0.0 110.671 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.431 HG13 ' CD ' ' A' ' 120' ' ' GLU . 17.1 mt -49.13 -53.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 118' ' ' LEU . 36.3 mt -69.1 -46.23 68.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.355 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -39.4 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.92 -44.05 29.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.44 ' OG1' ' N ' ' A' ' 126' ' ' GLY . 32.9 p -55.55 -64.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.44 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . 142.32 37.76 0.08 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.75 154.85 24.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -1.131 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 128' ' ' HIS . 12.1 p-80 -90.01 63.5 5.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 110.645 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.2 t -82.49 135.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.976 . . . . 0.0 109.737 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.0 pt -102.78 145.07 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.508 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.2 mt-10 -42.74 -53.97 4.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.41 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -40.49 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.828 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -85.89 -51.24 6.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.77 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 134' ' ' ILE . 9.0 mt -60.82 -41.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 109.699 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.451 ' OE2' ' HB3' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -50.03 -50.99 45.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.89 -36.85 84.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 137' ' ' LEU . 2.0 tt -50.35 -44.36 54.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.611 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 ttm -67.11 -42.43 84.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.172 -0.955 . . . . 0.0 110.507 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -64.19 -44.34 92.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -68.53 -36.81 79.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.187 -0.945 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.532 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.0 t -80.78 -49.8 10.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 147' ' ' GLY . 38.5 t70 -60.55 90.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.63 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.47 49.12 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 73.5 m-80 -147.61 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.465 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.6 m-20 172.06 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.604 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 35.2 p-10 -41.54 -25.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 142' ' ' ASP . . . 76.64 51.54 6.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 2.5 mtm180 -158.13 153.66 26.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 110.35 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.532 HG12 ' CB ' ' A' ' 141' ' ' SER . 22.1 mt -88.97 114.17 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.901 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 26.5 p30 -105.9 -172.48 2.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 22.3 p90 -57.62 -37.07 72.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 110.757 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.612 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -70.44 -52.78 19.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 141' ' ' SER . 48.5 mt-10 -68.45 -43.74 76.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.927 . . . . 0.0 110.259 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.486 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 37.4 t80 -49.23 -33.88 13.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.538 ' O ' ' CE ' ' A' ' 158' ' ' MET . 94.8 mt -76.1 -42.02 48.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -69.15 -49.01 60.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.053 -1.029 . . . . 0.0 110.673 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -44.43 -48.24 9.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.213 -0.93 . . . . 0.0 111.056 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.538 ' CE ' ' O ' ' A' ' 155' ' ' LEU . 5.8 ptp . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.186 -0.946 . . . . 0.0 110.217 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.33 0.586 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -54.17 -55.74 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.292 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 12.7 mt -51.53 -47.1 63.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -41.82 -58.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 110.314 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -65.57 -26.96 68.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.912 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -74.89 -9.08 58.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -55.21 -47.62 75.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.019 -1.051 . . . . 0.0 110.013 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -60.43 -35.57 76.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 18.0 mm -59.67 -32.59 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.005 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 107' ' ' LYS . 3.0 m-85 -80.22 -59.0 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -58.32 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 109.932 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -53.39 -43.34 67.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.34 -0.85 . . . . 0.0 110.563 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -94.13 -159.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.35 60.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.57 -32.4 12.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.159 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.537 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 99.74 -3.73 57.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 36.2 m-85 -153.35 123.92 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 mp -83.58 122.38 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.309 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -95.77 178.47 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.1 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.2 tt -57.3 -42.7 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.027 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -51.82 -53.81 36.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.897 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.46 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 4.1 mt-10 -52.17 -47.21 65.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.959 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -54.77 -27.63 42.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 0.0 109.837 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.45 -68.71 1.51 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.543 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.3 pt-20 -49.89 -44.51 49.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.237 . . . . 0.0 110.177 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.543 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 20.2 mt -49.28 -61.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.46 ' O ' ' OG1' ' A' ' 125' ' ' THR . 1.0 OUTLIER -68.74 -43.7 75.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.012 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -50.77 -39.47 52.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.18 -44.19 75.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.0 110.381 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 45.6 p -60.89 -31.62 71.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.15 -0.969 . . . . 0.0 110.161 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.86 20.24 29.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 128' ' ' HIS . 2.2 mt-10 -88.9 23.13 2.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -1.162 . . . . 0.0 110.225 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.497 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 1.5 t60 56.94 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 128' ' ' HIS . 2.9 t 70.18 143.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.587 -0.696 . . . . 0.0 110.031 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.457 HG21 ' CE1' ' A' ' 128' ' ' HIS . 27.3 pt -123.18 146.85 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.137 -0.977 . . . . 0.0 110.491 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.64 -46.32 14.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 110.121 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.03 -28.93 1.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -48.98 6.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 22.6 mt -55.61 -39.29 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.074 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -58.28 -46.14 86.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.173 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -50.69 -52.11 43.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.6 OUTLIER -53.94 -43.27 69.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.089 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -71.08 -53.89 13.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.187 -0.946 . . . . 0.0 109.857 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -59.57 4.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -49.7 -40.51 40.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 110.202 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.54 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.2 t -77.12 -57.32 3.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER -61.15 75.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 110.551 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -79.66 4.12 17.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 179.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 144' ' ' ASN . 1.4 t30 -121.88 10.09 10.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.603 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.29 26.26 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -1.82 18.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.359 -0.838 . . . . 0.0 110.209 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.436 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 60.97 17.07 50.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.469 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 1.1 mtt-85 -158.34 143.39 16.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.33 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.54 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.7 mt -87.63 116.66 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.74 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 53.4 p-10 -101.42 -175.41 2.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -54.52 38.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.09 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.13 -62.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 110.367 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 68.1 mt-10 -57.21 -50.82 71.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.164 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 14.4 t80 -43.39 -56.18 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.869 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.72 -51.34 68.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -53.69 -50.56 65.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.501 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -50.93 -46.13 60.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.501 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.616 -0.678 . . . . 0.0 110.099 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.204 0.526 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 0.5 OUTLIER -48.98 -48.82 42.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.805 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 158' ' ' MET . 2.2 mm? -51.38 -61.45 2.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.039 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.11 -51.93 16.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.922 . . . . 0.0 110.228 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 71.6 m-20 -51.23 -34.04 30.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 110.143 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 97' ' ' GLU . 61.0 m -68.19 -15.09 63.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.215 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -56.24 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 100' ' ' ASN . 6.8 ptp180 -52.47 -37.67 57.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.289 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.427 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 13.0 mm -57.8 -45.76 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 110.261 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -53.95 34.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.21 146.52 54.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.509 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -125.49 -47.1 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.977 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -79.04 2.76 19.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.45 59.35 3.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.174 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.7 -21.52 20.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.23 -15.99 60.62 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 40.5 m-85 -153.09 130.06 11.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 110.043 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.468 HG21 ' CB ' ' A' ' 117' ' ' GLU . 3.2 mt -82.45 125.1 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.893 . . . . 0.0 110.626 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 7.6 p-10 -104.27 -157.81 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.825 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -75.5 -37.39 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.133 -0.98 . . . . 0.0 109.976 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.511 ' N ' HG21 ' A' ' 115' ' ' ILE . 57.1 mt-10 -55.71 -44.4 77.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.468 ' CB ' HG21 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -63.78 -44.46 93.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.76 -33.98 67.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -65.89 -74.21 0.54 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -42.12 -59.87 1.63 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.222 -1.163 . . . . 0.0 110.961 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 120' ' ' GLU . 4.2 mt -43.69 -50.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.001 -1.062 . . . . 0.0 109.974 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.1 mt -77.4 -42.45 36.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.398 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 44.6 mtt180 -55.68 -32.85 63.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.94 48.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.0 110.125 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.8 p -77.14 -157.66 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.92 58.12 0.69 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.06 164.48 26.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -1.137 . . . . 0.0 110.506 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.12 94.01 7.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.881 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.73 72.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.327 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 19.0 pt -62.57 159.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.2 tt0 -46.19 -49.5 16.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.481 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 2.4 mt-10 -40.99 -35.8 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.334 -0.854 . . . . 0.0 110.381 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.31 -47.46 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 17.6 mt -60.14 -41.03 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.423 ' CG ' ' HG2' ' A' ' 131' ' ' GLU . 4.9 mm-40 -57.6 -36.79 72.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.513 -0.742 . . . . 0.0 110.051 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -51.25 -50.32 59.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.845 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.1 OUTLIER -56.68 -43.91 80.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.516 ' CE ' HD13 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -68.24 -43.84 77.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 110.043 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -64.9 -43.46 92.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.42 -33.21 69.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 0.0 110.327 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.498 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.9 OUTLIER -86.03 -61.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.935 . . . . 0.0 110.394 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 60.6 t0 -41.14 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.559 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 143' ' ' LYS . 76.4 tttt -99.18 2.5 45.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.525 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 0.6 OUTLIER -134.41 16.85 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.662 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 8.9 m-20 48.01 51.53 14.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.443 -0.786 . . . . 0.0 110.341 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -104.61 4.57 32.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.88 11.18 60.22 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 6.0 mtp180 -147.56 146.43 29.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.142 -1.211 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.516 HD13 ' CE ' ' A' ' 138' ' ' MET . 4.7 mt -89.72 113.83 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.364 -0.835 . . . . 0.0 109.998 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.49 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 48.8 p30 -90.02 179.18 6.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.421 ' O ' ' HG ' ' A' ' 155' ' ' LEU . 16.8 m-85 -42.82 -59.19 2.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.349 -0.844 . . . . 0.0 110.28 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.94 -56.89 15.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.49 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 45.8 mt-10 -57.36 -46.9 82.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.517 ' HA ' ' CE ' ' A' ' 157' ' ' MET . 35.5 t80 -59.53 -56.36 22.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 151' ' ' PHE . 32.4 mt -45.74 -48.67 15.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 -57.92 6.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 0.0 110.081 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.57 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.3 ptp -47.45 -50.77 22.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.715 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.57 ' N ' ' CG ' ' A' ' 157' ' ' MET . 13.1 mmt . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.424 -0.798 . . . . 0.0 110.352 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.242 0.544 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -48.59 -60.14 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 110.342 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 99' ' ' ALA . 28.5 mt -58.96 -58.54 8.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.47 -40.39 2.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.144 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 90.8 m-20 -62.34 -35.63 79.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 98' ' ' LEU . 71.8 m -67.57 -36.54 81.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 43.0 t80 -42.67 -56.34 3.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 110.22 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -44.53 61.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 104' ' ' ILE . 1.7 mp -62.82 -54.55 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.339 -0.851 . . . . 0.0 109.913 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -58.63 -43.2 89.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 109.934 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.456 ' OD1' ' OE1' ' A' ' 117' ' ' GLU . 14.0 t0 -85.19 109.02 18.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -122.08 -28.92 4.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.449 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 5.6 p30 -97.15 -44.33 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -87.54 -42.24 12.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.887 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 7.6 m-20 47.93 23.96 0.55 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . -142.83 -36.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 76.7 m-85 -149.63 136.94 19.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -1.101 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.42 ' CD1' ' CD1' ' A' ' 154' ' ' PHE . 24.3 mt -82.56 131.5 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.101 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.444 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 28.4 p30 -119.11 -162.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -83.05 -42.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.508 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -52.49 -41.57 63.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' OE1' ' OD1' ' A' ' 106' ' ' ASP . 2.2 mt-10 -64.93 -37.93 89.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.49 ' CD1' HD13 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -65.82 -46.24 79.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.972 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -46.01 -75.66 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' GLY . 5.1 pt-20 -43.24 -47.76 6.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -1.125 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.94 -55.42 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 110.113 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.49 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -63.14 -43.16 99.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.986 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -38.92 64.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.274 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.81 -30.86 6.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -0.945 . . . . 0.0 110.265 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 44.2 p -73.85 -29.85 62.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.77 53.84 1.88 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' A' ' 127' ' ' GLU . 5.7 mm-40 -129.71 148.47 51.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -1.13 . . . . 0.0 110.214 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.502 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 23.2 p80 -71.3 58.34 0.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.13 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.459 ' O ' HG21 ' A' ' 130' ' ' ILE . 4.5 t -75.9 151.81 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 110.274 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.459 HG21 ' O ' ' A' ' 129' ' ' VAL . 28.0 pt -139.61 155.94 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.885 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.474 ' CA ' ' OE1' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -48.03 -47.88 33.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 3.6 mm-40 -42.11 -38.22 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -48.84 7.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 10.6 mt -61.46 -43.27 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -0.865 . . . . 0.0 109.748 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.514 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 3.5 mm-40 -53.11 -49.06 67.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 135' ' ' GLU . 12.5 t0 -43.75 -53.86 5.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.825 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.2 OUTLIER -50.66 -57.67 7.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.457 ' HE3' HD13 ' A' ' 149' ' ' ILE . 1.4 ttm -58.05 -34.86 70.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.178 -0.952 . . . . 0.0 109.583 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -70.56 -51.51 28.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.194 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -67.97 -40.36 83.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.372 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -57.69 -46.76 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 141' ' ' SER . 0.4 OUTLIER -44.36 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.235 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.6 OUTLIER -93.59 2.69 56.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.145 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 146' ' ' ASP . 4.2 m-80 -141.32 21.45 2.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.69 24.44 10.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.427 ' CG ' ' HB2' ' A' ' 144' ' ' ASN . 42.3 m-20 -69.95 -11.79 61.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 0.0 110.192 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.442 ' C ' ' HG3' ' A' ' 148' ' ' ARG . . . 79.6 -6.47 57.99 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.442 ' HG3' ' C ' ' A' ' 147' ' ' GLY . 45.3 mtt180 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.527 HG12 ' CB ' ' A' ' 141' ' ' SER . 20.3 mt -85.27 126.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.0 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 13.0 p-10 -109.01 -163.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.419 ' CZ ' HD13 ' A' ' 155' ' ' LEU . 56.2 t80 -57.81 -57.66 11.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 110.5 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -62.95 1.31 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.549 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.424 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 4.0 mt-10 -57.29 -43.93 83.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' MET . 82.6 t80 -48.41 -50.58 30.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.059 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 11.6 mt -57.25 -54.15 50.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.337 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -60.33 -40.1 89.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.304 -0.873 . . . . 0.0 110.735 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -49.98 -40.46 44.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 109.647 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.459 ' SD ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.558 -0.714 . . . . 0.0 110.543 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.253 0.549 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 19.3 mm-40 -52.23 -45.24 65.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.528 HD22 ' CD1' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -46.73 -61.78 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.277 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -41.55 -57.95 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -70.13 -53.78 15.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.46 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.1 m -47.99 -22.28 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.521 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 151' ' ' PHE . 59.2 t80 -51.7 -51.93 52.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -26.69 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.316 -0.865 . . . . 0.0 110.648 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 37.1 mm -68.13 -58.73 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.037 . . . . 0.0 110.332 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -51.31 -34.16 32.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 13.8 t0 -73.39 89.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.269 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -83.25 -20.38 34.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 7.9 p30 -114.47 -1.29 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' N ' ' OD1' ' A' ' 106' ' ' ASP . . . 66.73 69.77 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.327 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 4.3 p30 -108.72 -22.13 12.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.183 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.551 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 91.35 -3.64 79.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 6.9 m-85 -152.72 129.23 10.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.9 114.53 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.984 . . . . 0.0 109.8 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 116' ' ' GLU . 3.1 p30 -88.1 -176.16 5.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.582 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 1.9 tp -65.47 -40.78 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 110.09 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.503 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -54.71 -52.49 62.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 110.27 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 121' ' ' ILE . 52.2 mt-10 -51.91 -44.58 63.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.327 -0.858 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -53.11 -52.47 58.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.109 -0.994 . . . . 0.0 110.27 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.99 -66.69 2.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.8 pt-20 -48.06 -45.69 32.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 110.457 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.524 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 12.2 mt -52.97 -60.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.008 . . . . 0.0 109.973 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 125' ' ' THR . 16.8 mt -63.98 -38.67 91.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -64.4 -41.94 96.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.413 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 120' ' ' GLU . . . -55.1 -39.22 69.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 24.9 p -55.95 -19.75 13.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.325 -0.859 . . . . 0.0 110.301 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.21 30.42 7.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -119.9 167.46 12.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -1.16 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 128' ' ' HIS . 51.7 p-80 -113.03 75.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 110.301 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 122' ' ' LEU . 5.6 t -83.06 133.1 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.521 HD11 ' CB ' ' A' ' 132' ' ' GLU . 17.8 pt -85.42 152.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 2.3 mm-40 -52.53 -38.51 59.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.277 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.521 ' CB ' HD11 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.25 -38.04 0.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.377 -0.827 . . . . 0.0 110.686 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -45.66 9.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.123 -0.986 . . . . 0.0 109.636 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 40.1 mt -57.68 -38.36 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.798 . . . . 0.0 109.734 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 2.9 mt-10 -68.34 -36.33 79.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -58.51 -48.76 79.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.162 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.454 HD22 ' HE2' ' A' ' 157' ' ' MET . 97.2 mt -49.15 -44.38 42.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 0.0 110.199 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.51 ' O ' ' N ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -68.94 -48.64 62.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.063 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -55.32 -35.5 65.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.29 -27.4 59.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.324 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.537 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -106.37 -60.75 1.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.861 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 138' ' ' MET . 14.7 t0 -38.24 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.77 . . . . 0.0 110.79 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.0 OUTLIER -86.57 -40.53 15.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.633 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.475 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 13.9 m-80 -92.19 17.7 9.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 49.49 25.46 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 11.1 p-10 -78.66 2.8 18.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.132 -0.98 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.92 30.98 79.43 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -158.1 129.75 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.192 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' A' ' 141' ' ' SER . 1.2 mt -83.39 129.33 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.899 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 1.5 p-10 -100.45 -163.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.013 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.456 ' CE1' ' CZ ' ' A' ' 102' ' ' PHE . 73.9 m-85 -69.22 -51.1 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -50.12 70.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 110.632 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.54 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 72.9 mt-10 -56.92 -44.75 82.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.989 . . . . 0.0 110.533 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.528 ' CD1' HD22 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -52.97 -66.09 0.45 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.971 -1.081 . . . . 0.0 109.984 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.1 mt -43.87 -32.48 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.955 . . . . 0.0 109.626 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -28.98 55.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.415 -0.803 . . . . 0.0 109.928 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.551 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -61.85 -37.59 85.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.551 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 109.779 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.261 0.553 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -58.32 -36.03 72.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.708 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.454 ' CD2' HD21 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -84.52 -45.7 12.34 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.361 -0.837 . . . . 0.0 109.265 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.415 ' N ' ' HG ' ' A' ' 98' ' ' LEU . . . -47.43 -34.61 7.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.093 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.462 ' O ' HD11 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -47.61 -40.28 19.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.863 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -54.21 -21.4 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.993 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.45 -64.71 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.988 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -51.06 -39.2 55.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.77 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 100' ' ' ASN . 1.6 mp -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.289 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.571 ' CZ ' ' HE3' ' A' ' 158' ' ' MET . 4.7 m-85 -60.31 -52.06 66.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 109.546 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -67.61 87.53 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -88.79 -34.04 17.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.357 -0.839 . . . . 0.0 110.804 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 17.3 p30 -81.2 4.48 20.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.059 -1.026 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 84.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.456 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 2.3 p30 -128.1 -34.16 2.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.452 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 118.3 -24.47 8.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.501 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 67.3 m-85 -148.93 126.72 11.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -1.135 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.496 ' CD1' ' HB3' ' A' ' 105' ' ' PHE . 42.5 mt -83.58 126.96 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -105.05 -178.29 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.355 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 2.8 tp -56.09 -39.99 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.0 mm-40 -56.97 -58.12 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.442 ' OE1' HG12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -46.31 -34.98 4.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.201 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.468 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -70.59 -155.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' CA ' HD12 ' A' ' 134' ' ' ILE . . . 68.65 -80.72 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -51.04 -55.02 19.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.12 . . . . 0.0 110.428 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.431 ' C ' ' O ' ' A' ' 120' ' ' GLU . 10.4 mt -42.09 -44.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 110.43 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 118' ' ' LEU . 45.8 mt -72.28 -49.71 32.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -48.69 -35.78 14.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -0.889 . . . . 0.0 110.538 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.08 -42.29 60.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 32.1 p -68.03 -7.35 28.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.319 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.414 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 81.09 41.67 10.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -121.69 140.78 51.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.44 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 23.0 p80 -82.16 111.78 18.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.436 HG22 ' C ' ' A' ' 128' ' ' HIS . 10.6 t -126.12 156.18 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 12.9 pt -130.39 158.07 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.7 mt-10 -47.92 -49.77 29.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -42.65 -36.98 1.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.406 ' O ' HD11 ' A' ' 137' ' ' LEU . 0.4 OUTLIER -86.89 -48.07 8.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.29 179.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.459 HD12 HG22 ' A' ' 134' ' ' ILE . 22.9 mt -54.23 -36.45 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.482 -0.762 . . . . 0.0 109.694 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.528 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 51.8 mt-10 -60.89 -47.15 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.14 -39.52 56.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 133' ' ' ASP . 6.0 mp -61.74 -46.77 88.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 110.21 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.459 ' CE ' HD13 ' A' ' 149' ' ' ILE . 30.4 tpp -65.05 -48.21 74.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.88 85.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.943 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.89 -33.17 73.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.114 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.467 ' CB ' HG12 ' A' ' 149' ' ' ILE . 6.9 t -84.1 -56.02 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 15.0 m-20 -42.32 103.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 110.57 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.74 -16.49 55.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.706 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 2.1 p30 -124.82 14.84 8.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.872 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.17 73.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 147' ' ' GLY . 10.0 p-10 -128.28 22.58 6.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -0.834 . . . . 0.0 109.805 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.434 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 43.17 36.6 2.9 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -157.9 120.84 3.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -1.166 . . . . 0.0 110.474 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.467 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.1 mt -83.69 120.79 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.474 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 6.7 p-10 -90.06 -152.02 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -82.08 -39.51 23.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.329 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.18 -56.69 4.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 0.0 110.691 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.474 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 29.8 mt-10 -46.75 -36.07 6.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.495 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 157' ' ' MET . 32.6 t80 -56.2 -56.42 21.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 98' ' ' LEU . 2.6 mt -52.42 -54.07 36.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.401 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.34 -38.44 58.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -0.917 . . . . 0.0 110.475 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.512 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.2 ptm -65.88 -49.0 69.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.571 ' HE3' ' CZ ' ' A' ' 105' ' ' PHE . 3.9 mtt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.284 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.236 0.541 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.4 tp10 -58.91 -55.69 31.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 0.4 OUTLIER -61.85 -56.7 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 151' ' ' PHE . . . -45.24 -39.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.685 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -54.46 -46.31 73.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.884 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 98' ' ' LEU . 1.1 m -52.28 -41.01 62.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.326 -0.859 . . . . 0.0 109.88 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' CYS . 14.9 t80 -43.83 -51.73 7.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.758 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -60.66 -36.27 78.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.811 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 104' ' ' ILE . 47.8 mm -66.6 -43.58 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.569 ' CD2' HD12 ' A' ' 121' ' ' ILE . 1.3 m-85 -71.96 -40.06 68.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.873 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -79.19 88.38 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.85 68.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.37 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -70.47 -11.44 60.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 110.425 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.19 51.09 16.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.11 -27.19 22.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.48 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 128.53 -20.3 5.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 98.4 m-85 -151.21 134.15 15.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -1.178 . . . . 0.0 110.28 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.7 mt -82.75 149.46 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 -164.03 0.89 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.5 tt -77.38 -38.68 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.186 -0.946 . . . . 0.0 110.463 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 95.5 mt-10 -60.76 -61.43 2.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 121' ' ' ILE . 20.9 mt-10 -42.55 -38.97 2.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 110.409 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 3.5 tp -60.05 -31.12 69.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.464 ' O ' ' CG ' ' A' ' 123' ' ' ARG . . . -73.03 -72.17 1.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 12.7 pt-20 -42.49 -43.49 3.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.184 -1.186 . . . . 0.0 110.509 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.569 HD12 ' CD2' ' A' ' 105' ' ' PHE . 27.5 mt -57.93 -50.46 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.484 ' O ' ' CG2' ' A' ' 125' ' ' THR . 20.4 mt -67.74 -69.89 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.873 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 120' ' ' GLU . 2.4 ptm180 -49.88 -24.09 2.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.921 . . . . 0.0 110.651 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 120' ' ' GLU . . . -54.54 -44.19 72.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 110.008 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.486 ' CG2' ' HG3' ' A' ' 127' ' ' GLU . 1.8 t -80.91 9.34 6.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.468 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.2 17.7 58.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.486 ' HG3' ' CG2' ' A' ' 125' ' ' THR . 46.6 mt-10 -84.05 121.2 27.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -1.136 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 87.24 2.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.873 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 122' ' ' LEU . 3.4 t -109.61 146.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.44 HD11 HG21 ' A' ' 130' ' ' ILE . 31.7 pt -119.55 159.7 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.145 -0.972 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' ILE . 4.8 tt0 -41.43 -49.86 3.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.36 -28.91 13.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 0.0 110.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -43.38 11.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 134' ' ' ILE . 30.0 mt -67.92 -38.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.07 -36.87 82.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.39 -0.819 . . . . 0.0 110.421 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.83 -52.4 65.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 0.0 110.681 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.418 ' HB3' HD22 ' A' ' 118' ' ' LEU . 1.4 mp -49.86 -44.27 49.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.308 -0.87 . . . . 0.0 110.899 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.485 ' O ' ' N ' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -64.83 -48.04 75.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.056 -1.028 . . . . 0.0 110.053 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -60.1 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 110.62 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.47 -33.21 67.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -85.7 -62.47 1.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.146 -0.971 . . . . 0.0 110.717 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 138' ' ' MET . 0.5 OUTLIER -47.4 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.621 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 ttpp -89.4 -3.81 58.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.814 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -120.69 12.03 11.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 51.23 39.26 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.417 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 11.5 p30 -101.37 23.06 11.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 44.98 35.58 4.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 19.4 mtt180 -158.35 128.32 5.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -1.21 . . . . 0.0 110.458 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.527 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.5 mt -84.21 167.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.091 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 48.2 p30 -149.13 -163.68 1.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -64.6 -56.07 16.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.403 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -56.74 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.656 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 141' ' ' SER . 84.8 mt-10 -59.53 -44.53 93.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 110.515 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 21.6 t80 -54.62 -52.0 63.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.095 -1.003 . . . . 0.0 110.132 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 27.4 mt -57.34 -42.16 81.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -54.2 -60.29 3.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.6 OUTLIER -48.26 -52.81 19.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.025 -1.047 . . . . 0.0 109.551 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.411 -0.806 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.329 0.585 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.94 -58.56 6.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 0.0 110.58 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.455 HD11 ' SD ' ' A' ' 158' ' ' MET . 20.2 mt -50.97 -60.75 2.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.289 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.68 -50.74 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -55.15 -50.5 69.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.948 . . . . 0.0 110.246 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.92 -9.61 31.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.367 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 83.3 t80 -50.96 -61.69 2.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.514 ' HG3' ' N ' ' A' ' 104' ' ' ILE . 12.3 ptp180 -57.12 -36.04 70.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 110.458 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.514 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 1.0 OUTLIER -58.72 -34.06 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.665 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 107' ' ' LYS . 4.9 m-85 -83.65 -35.48 24.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.87 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 109' ' ' ALA . 48.1 t0 -67.78 59.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -46.6 -41.03 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 110' ' ' ASP . 46.8 t30 -69.51 -13.62 62.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.159 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 106' ' ' ASP . . . 45.49 54.98 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.857 . . . . 0.0 110.231 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.466 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 23.5 p-10 -108.65 -3.23 18.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.2 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.509 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 101.49 -19.4 50.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 95.8 m-85 -153.17 123.69 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -1.2 . . . . 0.0 110.434 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 117' ' ' GLU . 4.8 mt -82.87 132.28 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 110.304 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.71 -179.6 4.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.081 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.7 tt -59.94 -36.82 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.94 -52.69 39.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.443 ' HB2' HG23 ' A' ' 113' ' ' ILE . 15.3 mt-10 -57.66 -54.74 43.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -0.809 . . . . 0.0 110.311 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.549 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.1 mp -43.15 -39.78 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.464 ' HA2' HD12 ' A' ' 134' ' ' ILE . . . -59.75 -80.31 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.463 ' OE2' HG13 ' A' ' 121' ' ' ILE . 0.7 OUTLIER -48.3 -50.7 29.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -1.19 . . . . 0.0 110.297 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.463 HG13 ' OE2' ' A' ' 120' ' ' GLU . 10.3 mt -44.93 -55.07 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 110.137 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.1 mt -68.37 -62.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.51 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -48.76 -39.97 27.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 120' ' ' GLU . . . -52.84 -52.27 57.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.927 . . . . 0.0 110.212 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 121' ' ' ILE . 31.1 p -54.75 -32.44 59.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.59 -1.36 23.39 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -58.66 -17.02 18.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -1.164 . . . . 0.0 110.056 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 18.2 t-160 46.38 57.21 5.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.8 t -89.56 153.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.6 pt -98.06 154.85 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 132' ' ' GLU . 68.9 mt-10 -49.44 -51.41 35.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.539 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -41.81 -34.27 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.635 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -48.16 9.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.44 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.549 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 18.1 mt -55.52 -40.03 56.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.077 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -58.03 -53.89 53.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.626 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -45.03 37.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.962 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.454 HD21 ' HE3' ' A' ' 157' ' ' MET . 0.1 OUTLIER -55.67 -37.19 67.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.106 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.437 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 19.1 tpp -69.95 -44.76 68.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.394 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -51.27 62.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.396 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -55.34 -31.27 61.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.528 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -87.9 -51.2 5.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.374 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.7 OUTLIER -42.56 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.8 OUTLIER -76.2 -1.51 26.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.963 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.505 ' ND2' ' OD2' ' A' ' 146' ' ' ASP . 1.5 p30 -153.8 27.48 0.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 43.78 75.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 110.501 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.505 ' OD2' ' ND2' ' A' ' 144' ' ' ASN . 3.8 p30 -121.28 -0.29 9.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 70.88 24.16 77.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 5.4 mtt-85 -158.67 135.43 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.449 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.528 HG12 ' CB ' ' A' ' 141' ' ' SER . 16.6 mt -91.06 136.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.478 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 26.7 p-10 -112.44 -173.03 2.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.922 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 42.2 p90 -68.07 -28.41 67.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 110.392 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.428 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -78.14 -42.21 32.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.639 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.478 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 89.4 mt-10 -69.71 -37.15 76.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -0.986 . . . . 0.0 110.513 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.466 ' O ' ' HG2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.04 -33.29 51.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.964 . . . . 0.0 110.351 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.61 -62.56 1.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.4 mttm -53.4 -34.92 59.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.907 . . . . 0.0 110.566 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.536 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -53.79 -49.72 67.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.229 -0.919 . . . . 0.0 110.571 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.536 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.913 . . . . 0.0 110.447 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.177 0.513 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -60.46 -56.86 16.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 4.3 mm? -59.69 -51.44 69.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.34 -44.24 3.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -51.78 -47.16 64.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.106 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.81 -31.79 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 18.1 t80 -51.45 -42.07 61.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.933 . . . . 0.0 110.086 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -41.04 99.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.263 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 30.6 mm -59.0 -49.09 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 110.076 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -57.49 -35.48 70.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.756 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.91 113.14 25.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.661 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -109.12 6.33 24.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.408 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 2.5 p30 -131.41 22.61 4.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.435 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 108' ' ' ASN . . . 50.3 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.78 -37.39 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.434 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 92.21 -7.29 78.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 53.2 m-85 -153.13 125.62 8.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -1.152 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 2.7 mp -83.7 125.49 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -104.91 -176.04 2.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.052 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -63.46 -37.77 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.854 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.405 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 9.2 mm-40 -59.0 -56.3 23.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 109.982 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 15.9 mt-10 -45.5 -54.06 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HB3' HG22 ' A' ' 134' ' ' ILE . 1.2 tp -51.19 -27.94 10.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.32 -75.64 0.35 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.2 pt-20 -45.52 -44.39 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -1.183 . . . . 0.0 110.571 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.528 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 48.5 mt -48.43 -70.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.496 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.508 ' O ' ' CG2' ' A' ' 125' ' ' THR . 97.6 mt -48.76 -49.89 36.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 110.577 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -52.89 -38.41 61.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.977 . . . . 0.0 110.537 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.05 -59.97 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 110.528 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 126' ' ' GLY . 7.4 t -59.38 -26.06 64.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.396 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 125' ' ' THR . . . 92.02 37.54 5.98 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HG3' HG21 ' A' ' 125' ' ' THR . 2.1 mm-40 -86.79 -10.43 53.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -1.218 . . . . 0.0 110.029 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.71 82.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.11 166.14 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 131' ' ' GLU . 4.7 pt -117.13 146.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.102 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.9 pt-20 -39.57 -42.92 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 0.0 110.858 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -43.4 -40.08 3.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 110.328 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.44 -44.44 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 118' ' ' LEU . 66.8 mt -56.75 -35.72 46.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.674 0.75 . . . . 0.0 109.509 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.458 ' HA ' HD13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -68.6 -39.58 80.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.692 -0.63 . . . . 0.0 110.239 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.29 -50.29 72.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -45.63 -50.73 13.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.021 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.513 ' CE ' HD11 ' A' ' 149' ' ' ILE . 3.3 ttm -67.22 -46.6 73.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.923 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.31 -53.55 6.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.6 -49.98 73.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.529 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.1 t -69.72 -64.47 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.457 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 138' ' ' MET . 30.5 t0 -43.19 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 141' ' ' SER . 3.3 tptm -96.9 -13.64 22.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.467 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 6.2 m-80 -101.42 16.36 25.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 52.43 18.81 1.01 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 16.9 p30 -80.94 -0.18 38.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . 62.18 28.27 70.44 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 9.9 mtt180 -152.58 135.12 15.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.158 -1.201 . . . . 0.0 110.373 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 141' ' ' SER . 5.9 mt -83.65 116.3 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 0.0 109.86 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -97.77 -170.36 1.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -52.99 -58.78 5.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.366 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.06 -64.94 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.955 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.473 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 44.9 mt-10 -50.65 -51.98 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.481 ' O ' ' HG2' ' A' ' 157' ' ' MET . 42.0 t80 -50.53 -56.74 10.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 154' ' ' PHE . 46.9 mt -42.52 -51.31 5.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.345 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -62.2 -46.98 86.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 110.745 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.518 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.5 ptm -43.27 -46.5 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 109.85 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.518 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 110.195 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.216 0.531 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.65 -54.59 39.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.944 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 3.5 mm? -50.52 -49.38 55.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.881 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -53.55 -57.02 12.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 110.258 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -48.57 -50.16 33.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.82 -20.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 56.6 t80 -53.85 -51.24 64.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.486 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -29.19 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.163 -0.961 . . . . 0.0 110.489 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.5 -27.92 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.121 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -84.9 -55.73 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 110.336 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -50.82 131.62 26.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -0.817 . . . . 0.0 110.259 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -123.03 2.22 9.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 109' ' ' ALA . 73.5 m-20 -125.02 26.41 7.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.356 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.93 49.44 5.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -93.32 -31.75 14.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.382 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.473 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 96.41 -14.51 64.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.473 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 27.2 m-85 -147.7 131.7 17.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 mt -82.95 116.05 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 110.631 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 3.8 p-10 -100.87 175.9 5.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.808 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.48 ' N ' ' HE2' ' A' ' 138' ' ' MET . 1.2 tp -53.48 -41.56 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -51.48 -54.96 21.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 121' ' ' ILE . 31.8 mt-10 -56.8 -56.23 24.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.7 OUTLIER -44.1 -38.62 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.493 ' HA2' HD12 ' A' ' 134' ' ' ILE . . . -59.74 -78.29 0.15 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -51.21 -45.99 62.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 110.259 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.495 HD13 HG23 ' A' ' 121' ' ' ILE . 14.9 mt -42.55 -61.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 110.38 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.517 HD12 ' CD2' ' A' ' 118' ' ' LEU . 4.2 mt -59.34 -56.87 16.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.433 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -48.67 -34.58 12.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.085 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 121' ' ' ILE . . . -51.93 -40.83 61.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.7 p -66.59 -17.42 64.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 0.0 109.989 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.38 20.34 13.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.49 154.29 19.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -1.141 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -107.37 70.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 0.0 109.661 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 122' ' ' LEU . 15.6 t -79.27 123.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.522 -0.736 . . . . 0.0 110.703 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 132' ' ' GLU . 47.3 pt -75.33 159.71 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.28 -32.22 68.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.987 . . . . 0.0 110.556 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.46 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -48.75 -35.59 14.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 110.497 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.02 -51.2 6.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.652 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.548 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 7.3 mt -55.76 -43.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.508 -0.745 . . . . 0.0 109.472 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.433 ' HG2' HD12 ' A' ' 115' ' ' ILE . 2.9 mm-40 -62.05 -38.75 89.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.656 -0.652 . . . . 0.0 109.955 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.13 -51.88 66.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 110.208 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.2 mt -50.75 -42.09 57.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.48 ' HE2' ' N ' ' A' ' 115' ' ' ILE . 42.9 tpp -66.96 -49.07 66.6 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -59.09 -41.98 89.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.946 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -25.73 68.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.551 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -97.54 -33.58 11.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 110.234 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.2 t0 -59.43 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 109.931 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -76.25 0.58 18.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.328 -0.858 . . . . 0.0 110.994 -179.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.471 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -151.71 20.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.919 -1.113 . . . . 0.0 110.533 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.35 71.21 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.662 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 148' ' ' ARG . 7.6 p-10 -126.95 12.08 7.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.749 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 45.4 30.65 3.08 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.417 ' O ' ' OD2' ' A' ' 146' ' ' ASP . 3.7 mtt180 -158.69 131.12 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 110.701 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.551 HG12 ' CB ' ' A' ' 141' ' ' SER . 8.0 mt -88.89 133.42 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.73 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 2.8 p30 -113.54 -164.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.436 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.6 -57.67 9.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.88 -57.7 11.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.619 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.471 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 73.2 mt-10 -54.25 -50.16 67.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.463 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 155' ' ' LEU . 64.2 t80 -49.68 -59.0 4.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.027 -1.045 . . . . 0.0 110.237 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 154' ' ' PHE . 9.8 mt -41.79 -66.06 0.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -34.16 14.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.62 -37.97 73.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 109.854 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.52 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 110.63 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.355 0.598 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.5 tp10 -58.84 -41.31 86.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.66 -59.19 5.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.18 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.29 -43.64 10.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 22.0 m-20 -51.05 -45.98 61.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 102' ' ' PHE . 4.5 t -67.98 -22.86 64.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.003 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.501 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 14.1 t80 -42.31 -63.29 0.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 104' ' ' ILE . 4.7 ptt180 -62.23 -36.35 81.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.499 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 31.6 mm -59.65 -33.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.277 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -79.57 -65.98 0.93 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.906 . . . . 0.0 110.344 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 105' ' ' PHE . 48.3 t0 -42.58 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 105' ' ' PHE . 10.7 mttt -75.97 -10.25 59.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.213 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -102.14 -165.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 110.302 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.4 4.25 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.172 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.537 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 6.7 p-10 -66.37 -27.77 68.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.898 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 90.32 15.98 56.28 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 110' ' ' ASP . 38.0 m-85 -146.75 131.88 18.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.119 -1.224 . . . . 0.0 110.599 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.41 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 3.2 mt -83.16 131.74 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.406 -0.809 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 117' ' ' GLU . 24.3 p30 -100.52 -177.24 3.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 1.2 tt -64.93 -40.74 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 110.484 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.453 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -59.86 -52.02 67.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.038 . . . . 0.0 110.183 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 24.9 mt-10 -48.55 -42.85 34.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.911 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -58.35 -27.02 63.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 110.239 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -73.6 -72.87 0.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.4 pt-20 -41.91 -45.15 3.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.435 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.431 HD12 ' CD1' ' A' ' 105' ' ' PHE . 42.6 mt -57.44 -57.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.82 -44.31 56.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 110.61 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.22 -36.72 75.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 0.0 110.276 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.72 -40.44 20.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.011 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.0 p -56.17 -28.36 57.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 110.068 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.0 -31.52 6.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -49.99 125.78 12.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -1.097 . . . . 0.0 110.231 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.566 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -70.11 62.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.497 HG12 ' CG1' ' A' ' 134' ' ' ILE . 11.1 t -61.68 148.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 0.0 109.886 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 131' ' ' GLU . 5.8 pt -121.72 147.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 110.359 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -39.02 -36.67 0.31 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.576 -0.703 . . . . 0.0 110.761 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -35.43 62.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.687 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.06 -44.04 12.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.97 . . . . 0.0 109.697 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.497 ' CG1' HG12 ' A' ' 129' ' ' VAL . 15.9 mt -66.22 -36.96 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.387 -0.82 . . . . 0.0 110.138 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.17 -43.61 95.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -54.52 -53.38 55.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 141' ' ' SER . 2.1 mp -47.58 -41.31 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 110.509 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.477 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -71.69 -53.78 12.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 -57.07 4.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.754 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.27 -40.5 90.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.152 -0.967 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -75.26 -54.35 7.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 146' ' ' ASP . 0.3 OUTLIER -55.09 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 110.965 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -69.95 -46.29 65.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.049 -1.032 . . . . 0.0 109.466 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 9.0 p30 -82.78 -7.45 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 5.6 m120 63.39 82.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.43 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.513 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 10.7 p-10 -130.25 5.46 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 109.972 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 74.58 20.8 79.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 114' ' ' ASP . 35.5 mtm-85 -158.31 140.44 14.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -1.134 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.498 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.5 mt -90.46 137.64 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 109.79 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 150' ' ' ASP . 36.2 p-10 -110.01 -151.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.35 -55.51 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.589 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -54.7 43.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 110.461 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 142' ' ' ASP . 51.0 mt-10 -56.74 -53.48 57.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' GLU . 26.1 t80 -43.51 -51.54 6.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 0.0 110.396 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.13 -55.16 27.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -46.27 -41.48 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.985 . . . . 0.0 110.655 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.405 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.55 -46.81 62.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.808 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.405 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.252 0.549 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.75 -56.19 17.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 110.451 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 99' ' ' ALA . 6.3 mt -56.9 -58.8 6.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.554 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -40.84 -52.49 3.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -0.823 . . . . 0.0 110.529 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.41 -54.95 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 69.4 m -48.38 -24.16 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 110.715 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 47.0 t80 -45.23 -49.83 12.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.995 -1.066 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -57.16 -32.2 66.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 43.7 mm -59.47 -40.4 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -78.17 -38.41 43.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 110.427 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -79.25 84.7 5.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -1.0 . . . . 0.0 110.303 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -32.02 22.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 110.229 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.427 ' OD1' ' CG ' ' A' ' 110' ' ' ASP . 4.2 p30 -100.6 14.87 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.11 69.31 0.69 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.117 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.427 ' CG ' ' OD1' ' A' ' 108' ' ' ASN . 3.6 m-20 -97.47 -17.16 19.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 110.23 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.48 40.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -150.45 146.49 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.031 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 mt -82.64 116.12 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 110.366 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -97.2 -178.54 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.858 . . . . 0.0 110.014 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 3.8 tp -67.96 -39.43 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.425 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 5.8 mt-10 -55.1 -52.8 62.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.373 -0.829 . . . . 0.0 110.235 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 23.1 mt-10 -50.2 -45.3 53.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.398 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.5 OUTLIER -57.66 -34.18 69.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.574 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -66.54 -73.56 0.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -42.06 -49.44 4.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -1.122 . . . . 0.0 110.561 -179.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.444 HG13 ' CD ' ' A' ' 120' ' ' GLU . 66.4 mt -55.07 -51.94 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.441 HD11 HD22 ' A' ' 118' ' ' LEU . 16.5 mt -64.71 -55.5 19.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.271 -0.893 . . . . 0.0 110.561 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.18 -36.71 73.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.887 . . . . 0.0 110.659 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.84 -30.93 4.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.9 p -66.23 -29.62 69.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.76 26.8 2.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -116.7 170.1 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -1.161 . . . . 0.0 110.397 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.39 62.68 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.712 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.5 t -65.57 126.82 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.412 ' O ' HG13 ' A' ' 134' ' ' ILE . 15.3 pt -81.15 154.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -41.76 96.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 110.676 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -47.83 -33.56 7.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.256 -0.902 . . . . 0.0 110.781 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.23 -47.93 11.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 109.513 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.517 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 11.3 mt -58.26 -37.68 64.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.559 -0.713 . . . . 0.0 109.628 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 32.8 mt-10 -60.37 -34.72 74.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 110.591 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 14.5 t0 -56.33 -55.02 38.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -43.43 26.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.91 . . . . 0.0 111.023 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.6 tpp -65.06 -51.58 60.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.096 -1.003 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 139' ' ' LYS . 7.5 tmtm? -63.01 -39.25 94.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.4 -0.813 . . . . 0.0 109.953 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -67.27 -32.9 74.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.429 -0.794 . . . . 0.0 110.251 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 143' ' ' LYS . 2.6 t -82.28 -64.28 1.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 146' ' ' ASP . 45.6 t0 -44.36 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.48 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -89.26 -3.17 58.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.2 p30 -125.01 8.82 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.962 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 8.3 m120 59.26 39.27 22.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.465 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 19.3 p30 -72.85 -13.63 61.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 102.11 -11.77 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.495 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 70.9 mtt180 -158.43 177.94 10.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.152 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.521 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.6 mt -88.51 166.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 44.9 p-10 -144.35 -162.57 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.449 ' O ' ' CD1' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -73.26 -43.02 61.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.498 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -52.86 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.56 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 10.6 mt-10 -65.19 -39.98 93.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 3.5 t80 -54.75 -64.9 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.449 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.1 mt -42.22 -52.86 4.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -59.74 -37.12 78.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.487 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -62.01 -47.04 86.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.487 ' N ' ' CG ' ' A' ' 157' ' ' MET . 11.4 mmt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 110.43 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.258 0.551 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.36 -33.34 71.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.857 . . . . 0.0 110.264 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 0.2 OUTLIER -67.06 -49.56 64.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.458 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.06 25.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.994 -1.066 . . . . 0.0 110.164 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -50.96 -43.41 60.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.45 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -56.01 -16.22 4.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.343 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -54.0 -64.78 0.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 110.893 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -31.52 63.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.042 -1.036 . . . . 0.0 110.669 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 35.1 mm -57.18 -43.27 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.418 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.462 ' O ' HD13 ' A' ' 121' ' ' ILE . 5.4 m-85 -75.03 -31.84 61.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.97 98.81 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 110.119 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -95.17 -11.47 28.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.94 56.41 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.97 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.84 -12.9 29.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.46 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.517 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 117.06 -20.65 11.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.517 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 65.5 m-85 -152.54 127.14 9.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.104 -1.233 . . . . 0.0 110.502 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 12.6 mt -83.04 118.44 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.55 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 22.2 p30 -89.55 -172.88 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.708 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 4.1 tp -63.28 -42.56 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.523 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 1.6 mt-10 -53.1 -55.27 25.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.247 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 121' ' ' ILE . 23.7 mt-10 -50.6 -43.82 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -59.28 -29.27 67.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.58 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.463 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -78.02 -60.23 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.7 pt-20 -52.4 -44.63 65.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -1.141 . . . . 0.0 110.529 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.523 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 94.6 mt -53.42 -48.22 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.135 -0.978 . . . . 0.0 110.017 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.2 -48.85 16.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.81 -32.72 9.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.855 . . . . 0.0 110.342 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.14 -28.15 50.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.307 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 127' ' ' GLU . 27.9 p -86.74 21.49 2.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 62.86 21.11 62.95 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.456 ' HB2' ' OG1' ' A' ' 125' ' ' THR . 3.2 mt-10 -96.69 112.65 24.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.187 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -74.15 81.94 1.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.404 HG11 HG12 ' A' ' 134' ' ' ILE . 32.0 t -90.3 137.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 131' ' ' GLU . 28.4 pt -104.93 155.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 10.2 mt-10 -41.96 -46.67 4.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.6 mm-40 -41.0 -37.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 0.0 109.904 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.87 -47.33 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.422 -0.799 . . . . 0.0 109.43 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 118' ' ' LEU . 12.1 mt -58.94 -40.7 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.813 . . . . 0.0 109.726 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -59.11 -52.35 66.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.186 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -46.32 -45.9 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.229 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.44 HD11 ' N ' ' A' ' 137' ' ' LEU . 4.4 mp -60.87 -54.75 41.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 110.035 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.493 ' HA ' HD11 ' A' ' 149' ' ' ILE . 2.2 ttm -67.0 -43.83 81.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -60.14 -43.42 95.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.314 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -68.46 -34.1 75.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.279 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.504 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -87.17 -62.78 1.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.526 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 138' ' ' MET . 21.8 t0 -50.94 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.728 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -82.13 -25.35 34.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -0.977 . . . . 0.0 110.042 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.482 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 9.0 m-80 -90.16 16.17 8.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.18 38.02 3.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.936 . . . . 0.0 110.074 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -97.27 14.16 27.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . 51.46 37.92 41.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 6.6 mtt180 -158.68 125.9 4.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.163 -1.198 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 141' ' ' SER . 4.0 mt -87.28 129.27 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.201 -0.937 . . . . 0.0 109.214 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -110.58 -167.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.628 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -57.45 10.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.523 -0.735 . . . . 0.0 111.038 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.41 -64.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.191 -0.943 . . . . 0.0 111.335 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.482 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 65.4 mt-10 -47.29 -31.58 3.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.088 -1.007 . . . . 0.0 110.992 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 157' ' ' MET . 21.7 t80 -64.9 -59.02 4.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 0.0 110.533 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.7 mt -47.28 -54.5 10.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 110.272 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -24.9 58.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 109.922 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.03 -38.05 75.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.375 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.513 ' N ' ' HG3' ' A' ' 157' ' ' MET . 18.8 ttm . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.264 0.554 . . . . 0.0 109.624 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -55.34 22.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.613 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 99' ' ' ALA . 0.4 OUTLIER -64.18 -48.75 74.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.843 179.522 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.35 -53.43 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 109.759 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 96' ' ' GLU . 68.7 m-80 -52.21 -38.96 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.4 -0.813 . . . . 0.0 109.923 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -25.93 52.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.584 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -49.7 -58.16 5.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.486 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -66.9 -34.95 78.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.931 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.482 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 12.2 mm -68.33 -48.91 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 110.831 -179.341 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' LYS . 1.6 m-30 -71.27 -43.76 66.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.694 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -68.16 70.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.95 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' CD ' ' O ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -61.23 -35.63 77.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.298 -179.952 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 109' ' ' ALA . 13.4 t30 -75.9 -5.22 45.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.86 . . . . 0.0 110.036 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.29 76.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.3 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -124.08 -2.9 8.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.441 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 100.16 -21.96 42.21 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CG ' ' O ' ' A' ' 111' ' ' GLY . 92.6 m-85 -152.24 140.04 19.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -1.195 . . . . 0.0 110.375 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.452 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 29.5 mt -82.53 110.08 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.117 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -87.89 -175.47 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.348 -0.845 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.9 OUTLIER -66.12 -29.72 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.248 -0.908 . . . . 0.0 110.676 -179.667 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.53 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -63.41 -50.26 70.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.129 -0.982 . . . . 0.0 110.262 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 113' ' ' ILE . 8.4 mt-10 -57.55 -42.83 83.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.534 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.2 tp -52.67 -38.72 60.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.318 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.458 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -56.41 -72.84 0.51 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.3 pt-20 -51.76 -45.22 63.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -1.207 . . . . 0.0 110.785 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.519 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 40.9 mt -47.82 -46.79 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.97 -1.081 . . . . 0.0 110.23 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.0 mt -77.39 -51.87 10.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.923 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -48.45 -35.3 12.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.982 . . . . 0.0 109.488 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.61 -38.78 21.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.1 p -58.9 -55.29 37.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.44 ' C ' ' HG2' ' A' ' 127' ' ' GLU . . . 139.11 41.25 0.09 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.9 mt-10 -136.47 128.56 29.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.241 . . . . 0.0 110.072 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -65.74 66.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' GLU . 79.0 t -64.54 155.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.662 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.533 HD11 HG23 ' A' ' 130' ' ' ILE . 17.5 pt -123.94 145.68 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.839 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 4.4 mt-10 -43.74 -45.95 7.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.884 . . . . 0.0 110.581 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -41.59 -43.9 2.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 111.01 -179.546 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 -48.6 12.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.534 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 20.3 mt -53.21 -35.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.552 0.692 . . . . 0.0 109.651 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 64.0 mt-10 -55.9 -52.26 64.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.536 -0.728 . . . . 0.0 110.602 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 50.4 t0 -45.25 -49.16 12.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.474 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.3 -43.78 67.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.968 . . . . 0.0 110.393 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -40.31 68.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.398 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -60.06 -48.05 83.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.944 . . . . 0.0 110.843 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.9 -33.82 75.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.798 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.66 -35.66 57.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 146' ' ' ASP . 0.4 OUTLIER -55.25 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.544 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' SER . 5.9 tttt -67.69 -8.36 34.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.45 22.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.426 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 8.5 m-20 51.22 64.75 1.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.331 -0.855 . . . . 0.0 110.785 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 51.5 p-10 -112.72 5.77 17.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 60.0 24.92 61.22 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 13.6 mtt-85 -158.13 130.71 7.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -1.163 . . . . 0.0 110.533 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.527 HG12 ' CB ' ' A' ' 141' ' ' SER . 6.1 mt -85.72 121.29 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.362 -0.837 . . . . 0.0 109.94 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.18 -173.6 2.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 110.411 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -53.7 -57.43 10.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -55.17 16.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.505 -0.747 . . . . 0.0 110.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 157' ' ' MET . 88.0 mt-10 -64.01 -57.94 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.552 ' CZ ' ' HG3' ' A' ' 158' ' ' MET . 38.6 t80 -40.83 -59.72 1.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.654 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 154' ' ' PHE . 81.5 mt -42.3 -65.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.345 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.84 -38.09 77.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 110.431 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.534 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -66.97 -37.96 85.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.071 -179.639 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.552 ' HG3' ' CZ ' ' A' ' 154' ' ' PHE . 3.2 mmt . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.537 -0.727 . . . . 0.0 110.514 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.267 0.556 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.4 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 47.2 mm-40 -57.73 -32.07 67.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -51.07 9.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.509 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.07 50.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.133 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -66.15 -33.12 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.447 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.463 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.8 m -65.16 -22.08 66.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.829 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -49.25 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 110.391 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.53 -32.25 5.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.469 HD12 HG23 ' A' ' 104' ' ' ILE . 48.8 mm -68.33 -45.44 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 110.365 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.414 ' O ' HD13 ' A' ' 121' ' ' ILE . 17.0 m-85 -67.56 -24.94 65.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.25 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 23.3 t0 -90.07 84.96 6.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -67.69 -32.16 72.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 6.0 p30 -93.87 -12.25 29.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.497 ' N ' ' OD1' ' A' ' 106' ' ' ASP . . . 59.09 75.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.352 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 5.1 p30 -114.91 -6.39 12.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.269 -0.895 . . . . 0.0 110.091 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 86.28 -1.05 87.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 10.8 m-85 -146.8 124.01 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -1.142 . . . . 0.0 110.011 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.8 mt -85.83 124.59 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.261 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 116' ' ' GLU . 1.9 p30 -103.42 -176.19 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 134' ' ' ILE . 1.3 tp -75.97 -31.68 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.45 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 1.3 mt-10 -58.22 -45.06 88.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 121' ' ' ILE . 37.1 mt-10 -59.91 -48.67 80.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 110.423 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.452 ' HB3' HG22 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.8 -34.59 67.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.152 -0.968 . . . . 0.0 110.13 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -57.98 -71.99 0.66 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 18.7 pt-20 -57.35 -44.49 84.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -1.171 . . . . 0.0 110.299 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.0 mt -47.06 -57.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.975 . . . . 0.0 109.87 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 125' ' ' THR . 0.3 OUTLIER -69.09 -49.18 59.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -53.92 -37.2 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.435 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.16 60.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.307 -0.871 . . . . 0.0 110.868 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 61.5 p -54.65 -24.44 21.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.461 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.54 -27.4 6.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -75.79 134.05 40.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -1.122 . . . . 0.0 109.961 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -87.19 71.07 10.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.145 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.403 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 41.6 t -64.78 137.65 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.051 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' GLU . 9.4 pt -86.3 137.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 110.366 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 132' ' ' GLU . 8.9 mm-40 -42.75 -38.28 2.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -40.79 -39.46 1.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -0.822 . . . . 0.0 110.551 -179.837 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -84.31 -45.38 12.87 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.174 -0.954 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.452 HG22 ' HB3' ' A' ' 118' ' ' LEU . 23.6 mt -56.19 -35.67 43.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.493 -0.754 . . . . 0.0 109.535 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 1.1 mt-10 -65.66 -37.46 86.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.523 -0.736 . . . . 0.0 110.227 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 9.2 t70 -52.06 -54.6 28.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.3 mt -50.5 -39.57 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.418 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.527 ' CE ' HD11 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -65.18 -39.08 92.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.406 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -64.88 -52.31 57.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 110.571 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.2 -27.64 68.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 111.13 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.544 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -89.34 -65.05 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.018 . . . . 0.0 111.025 -179.292 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.448 ' OD1' ' OD1' ' A' ' 146' ' ' ASP . 18.5 t0 -41.69 98.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.895 . . . . 0.0 110.36 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.4 tppp? -94.51 -32.11 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 0.0 110.367 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.474 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 4.5 p30 -101.94 17.68 22.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.135 -0.978 . . . . 0.0 110.213 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.0 m-20 48.74 80.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.474 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 9.2 p-10 -134.77 11.1 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 62.1 14.51 46.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 72.1 mtt180 -146.94 143.95 28.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -1.158 . . . . 0.0 110.481 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.544 HG12 ' CB ' ' A' ' 141' ' ' SER . 1.2 mt -93.14 123.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 109.948 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 39.4 p30 -91.74 -165.06 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.805 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -54.93 15.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 110.393 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.26 -57.28 13.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 92.6 mt-10 -48.54 -46.29 38.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.577 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 1.5 t80 -54.16 -58.9 5.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.677 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 31.4 mt -51.46 -59.39 4.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.841 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -42.65 44.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.775 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.447 ' HE3' HG23 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -65.21 -45.17 85.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.509 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.422 ' HA ' ' HE2' ' A' ' 158' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.202 -0.937 . . . . 0.0 110.446 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.227 0.537 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -53.61 -56.48 16.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.887 . . . . 0.0 109.924 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mt -52.26 -57.83 8.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.95 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 102' ' ' PHE . . . -47.66 -41.96 23.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.46 -32.76 63.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -77.7 -7.2 56.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.577 -179.709 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 99' ' ' ALA . 2.5 t80 -60.86 -56.48 20.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.07 -1.019 . . . . 0.0 110.428 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -22.98 4.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.185 -0.947 . . . . 0.0 110.733 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 2.0 mp -74.28 -47.93 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.061 -1.025 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.12 -49.9 11.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.308 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 108' ' ' ASN . 52.7 t0 -67.48 74.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -46.43 -39.19 10.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.7 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 106' ' ' ASP . 17.3 m-80 -103.54 165.01 11.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 109.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.25 63.89 7.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 17.2 p30 -102.55 -18.43 15.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.072 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.575 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 74.91 5.81 76.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 52.8 m-85 -148.53 110.29 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -1.147 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.91 144.85 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 30.0 p30 -119.7 -163.78 1.02 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.519 ' CD1' ' HG2' ' A' ' 135' ' ' GLU . 1.2 tt -79.59 -45.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -0.841 . . . . 0.0 110.779 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.507 ' N ' HG21 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.41 -27.28 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 110.152 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.2 mt-10 -76.55 -48.93 17.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 109.86 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.85 -44.07 63.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 110.038 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -48.63 -83.91 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 10.6 pt-20 -42.42 -45.35 4.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -1.17 . . . . 0.0 110.493 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.0 mt -50.3 -54.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 109.679 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 125' ' ' THR . 19.6 mt -73.1 -47.48 43.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -49.89 -37.55 31.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.837 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.64 -31.56 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 43.0 p -69.25 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 110.154 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.97 38.21 2.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -113.0 -157.52 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -1.191 . . . . 0.0 110.331 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -145.11 53.72 1.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.034 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.507 HG11 ' CG1' ' A' ' 134' ' ' ILE . 46.8 t -61.18 162.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.832 . . . . 0.0 110.347 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 130' ' ' ILE . 13.7 pt -139.18 152.02 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.3 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -41.27 -53.62 3.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.993 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -43.44 -36.65 2.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -45.1 11.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.465 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.529 HG23 HD11 ' A' ' 134' ' ' ILE . 21.1 mt -62.81 -38.9 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 109.623 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.519 ' HG2' ' CD1' ' A' ' 115' ' ' ILE . 2.0 mm-40 -58.74 -45.05 90.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 110.12 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 4.8 t70 -44.0 -50.02 8.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.265 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 141' ' ' SER . 31.6 mt -58.4 -40.27 81.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.46 ' HE1' HD12 ' A' ' 149' ' ' ILE . 34.5 tpp -65.34 -48.44 73.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.609 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -64.8 -37.16 86.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.576 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 2.9 t0 -72.19 -36.98 69.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.469 -0.769 . . . . 0.0 109.974 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.535 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -85.43 -46.65 10.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 110.136 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 138' ' ' MET . 29.3 t0 -61.82 86.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.815 . . . . 0.0 110.45 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 -8.1 58.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -119.45 19.55 12.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.1 m120 46.97 41.9 11.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.111 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.9 -9.33 59.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.31 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.43 60.95 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' CD ' ' HB3' ' A' ' 114' ' ' ASP . 55.9 mtt180 -146.2 162.18 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -1.143 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.535 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.3 mt -84.38 118.77 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 2.9 p30 -94.39 -178.08 4.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.932 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.98 -61.26 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 110.051 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' CD ' ' HA ' ' A' ' 142' ' ' ASP . 94.1 mt-10 -59.42 -44.89 92.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 10.6 t80 -46.27 -66.98 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.957 . . . . 0.0 110.207 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 154' ' ' PHE . 10.0 mt -44.52 -56.86 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -37.52 72.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.0 ptm -54.76 -49.51 70.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.672 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.525 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 109.989 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.132 0.492 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.0 -51.15 71.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.719 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 4.1 mm? -46.68 -56.75 5.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -45.04 -55.13 5.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.225 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -52.1 -43.43 63.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.314 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.46 -24.52 60.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -53.83 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.98 . . . . 0.0 110.073 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -55.37 -38.01 68.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.142 -0.974 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.2 mm -62.5 -39.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 109.946 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -84.33 -46.08 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.173 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 6.7 t0 -82.42 96.24 7.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.335 -0.853 . . . . 0.0 109.838 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -105.83 -27.4 11.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 110.904 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.461 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 3.1 p30 -104.26 -45.19 4.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.014 -1.054 . . . . 0.0 110.77 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -86.12 -39.76 16.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.991 . . . . 0.0 110.016 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 2.9 m-20 45.3 27.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 109.962 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . -152.33 -36.99 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 20.9 m-85 -151.57 112.32 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.433 -1.039 . . . . 0.0 109.322 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.492 HG22 ' CB ' ' A' ' 117' ' ' GLU . 5.0 mt -82.77 118.84 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.681 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.473 ' OD2' ' N ' ' A' ' 116' ' ' GLU . 4.5 p-10 -92.66 -155.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 135' ' ' GLU . 3.0 tp -78.73 -33.63 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.0 110.248 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.473 ' N ' ' OD2' ' A' ' 114' ' ' ASP . 1.7 mm-40 -57.16 -59.32 5.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.305 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.492 ' CB ' HG22 ' A' ' 113' ' ' ILE . 1.9 mt-10 -44.23 -48.46 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.917 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.544 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -58.53 -31.98 68.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 110.103 179.811 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -60.44 -75.83 0.26 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 10.9 pt-20 -42.43 -45.58 4.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.258 -1.142 . . . . 0.0 110.44 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.453 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 45.7 mt -47.21 -53.66 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.142 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.451 ' O ' ' OG1' ' A' ' 125' ' ' THR . 72.1 mt -75.14 -36.87 61.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.328 -0.858 . . . . 0.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -62.96 -36.51 83.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 110.162 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.82 -40.43 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 67.2 p -61.96 -36.24 80.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.74 11.07 27.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -89.98 148.0 23.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.25 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -85.52 83.16 8.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 109.941 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.416 HG13 ' HB3' ' A' ' 133' ' ' ASP . 2.3 t -93.56 114.34 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 9.1 pt -73.28 146.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.05 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.7 mt-10 -41.13 -49.34 3.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 0.0 110.439 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.08 -26.68 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -81.02 -50.01 10.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.309 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.544 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 6.4 mt -66.22 -42.55 91.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 115' ' ' ILE . 8.3 mt-10 -45.81 -42.61 12.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.0 110.052 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.14 -51.78 68.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 110.246 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -48.63 -44.87 37.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.217 -0.927 . . . . 0.0 110.371 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.471 ' HE2' HD11 ' A' ' 149' ' ' ILE . 11.0 tpp -64.58 -45.96 84.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.759 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -46.21 74.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -0.835 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 110.561 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.494 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -89.48 -63.75 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.459 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 1.7 t0 -47.82 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.1 mttt -84.53 -26.02 28.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.162 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 11.6 m-80 -86.63 -3.94 59.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 109.744 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.3 OUTLIER 67.26 15.08 9.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -60.63 -15.79 32.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.1 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.15 -5.94 82.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.521 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -137.9 146.4 43.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.254 . . . . 0.0 110.486 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 141' ' ' SER . 5.8 mt -83.77 137.12 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 29.4 p-10 -121.15 -160.83 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 49.5 p90 -68.17 -41.83 80.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 1.0 OUTLIER -68.38 -56.88 6.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.499 -179.857 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 142' ' ' ASP . 59.1 mt-10 -58.35 -48.53 80.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 57.4 t80 -46.55 -54.42 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.927 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.501 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 6.2 mt -66.62 -47.06 73.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.984 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -55.78 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 110.143 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -58.28 -52.47 65.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 109.72 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.9 mtm . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.075 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.177 0.513 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.01 -55.93 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 mt -58.61 -53.28 60.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.335 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -49.17 -51.92 29.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.361 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -51.43 -50.61 59.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 102' ' ' PHE . 5.2 m -53.03 -42.08 65.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.713 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 87.3 t80 -42.28 -65.16 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 110.603 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -39.58 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.193 -0.942 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.455 HG22 HD12 ' A' ' 104' ' ' ILE . 36.0 mm -60.87 -32.78 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 110.581 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.1 -48.92 21.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.102 -0.999 . . . . 0.0 110.416 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.79 101.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -75.48 -45.88 35.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.201 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -69.43 -15.3 63.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 110.095 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.37 42.93 17.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.45 ' OD2' ' O ' ' A' ' 112' ' ' PHE . 6.7 p-10 -84.07 -16.56 43.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.085 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.483 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 113.23 -16.05 22.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 3.4 m-85 -148.37 135.46 20.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 110.404 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.446 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 22.9 mt -85.26 119.36 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.852 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 23.8 p-10 -90.98 -175.76 4.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 1.0 OUTLIER -68.25 -38.85 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.814 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.459 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 17.7 mt-10 -58.04 -55.2 38.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.332 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 113' ' ' ILE . 7.2 mt-10 -46.62 -40.36 12.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.818 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.51 ' HB3' HG21 ' A' ' 134' ' ' ILE . 1.1 tp -61.16 -49.03 78.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 110.063 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -51.94 -69.85 1.05 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -47.47 -45.96 26.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -1.189 . . . . 0.0 110.179 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.472 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 6.5 mt -48.28 -65.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.986 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 129' ' ' VAL . 44.4 mt -61.76 -44.83 96.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.467 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.506 ' NH1' ' HG2' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -55.21 -36.46 65.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.9 . . . . 0.0 110.731 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.55 -28.32 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 109.997 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.1 p -81.07 -47.31 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.32 35.51 1.45 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 5.1 mt-10 -99.88 16.6 23.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -1.204 . . . . 0.0 109.99 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 127' ' ' GLU . 44.5 p-80 38.24 43.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.627 -0.671 . . . . 0.0 110.49 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 122' ' ' LEU . 20.1 t -61.09 117.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.469 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.3 pt -77.74 148.63 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -45.34 -47.45 13.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 0.0 110.329 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.469 ' HB2' HG13 ' A' ' 130' ' ' ILE . 4.8 mt-10 -41.24 -36.32 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -0.863 . . . . 0.0 110.477 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -43.81 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.51 HG21 ' HB3' ' A' ' 118' ' ' LEU . 26.6 mt -64.11 -38.48 82.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.588 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -50.45 73.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.488 -0.757 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 136' ' ' ASP . 9.2 t0 -45.47 -49.29 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 tp -51.65 -38.89 56.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.163 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -73.02 -57.58 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 110.055 -179.993 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 138' ' ' MET . 2.9 mmtm -43.34 -63.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.01 -20.43 6.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.529 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -101.85 -62.32 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 110.424 -179.842 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 138' ' ' MET . 24.0 t70 -56.29 81.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -89.8 31.33 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 179.546 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -149.07 17.65 0.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.847 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 55.3 21.88 4.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.257 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 147' ' ' GLY . 1.4 t70 -85.58 4.57 35.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.855 . . . . 0.0 109.896 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . 41.57 38.97 2.34 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.414 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 12.3 mtt180 -158.31 124.55 4.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -1.211 . . . . 0.0 110.325 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 141' ' ' SER . 13.5 mt -83.76 106.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 44.8 p-10 -100.78 -140.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 110.37 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.46 -61.64 1.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 0.0 110.729 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.32 -56.02 13.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.654 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 148' ' ' ARG . 6.2 mt-10 -60.53 -53.54 56.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.676 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.495 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 44.9 t80 -43.98 -49.23 8.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.68 -36.55 84.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.203 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -46.37 69.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.887 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.531 ' HG2' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -61.08 -42.33 98.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.846 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.531 ' N ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 0.0 110.05 179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.187 0.517 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -55.97 -38.38 70.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 mt -57.14 -53.97 52.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.65 -65.61 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.845 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -52.07 -31.28 29.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.421 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -71.87 -9.85 58.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.208 -0.932 . . . . 0.0 110.378 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.99 -54.04 51.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.45 72.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.838 -179.378 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 mm -57.26 -29.31 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.125 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -80.53 -32.85 36.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.86 79.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -86.97 39.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.7 -179.878 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.42 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 27.9 t30 -128.96 -98.44 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 108' ' ' ASN . . . 174.8 27.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.984 -1.073 . . . . 0.0 111.041 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.4 p30 -113.45 -10.92 13.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.825 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.7 81.97 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.457 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 51.2 m-85 -141.6 139.75 33.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 110.6 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.453 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 51.0 mt -85.37 126.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.542 -0.724 . . . . 0.0 109.384 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.49 -179.23 3.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER -65.3 -44.31 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.64 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.541 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.6 mt-10 -60.17 -51.15 70.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.064 . . . . 0.0 109.907 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 113' ' ' ILE . 14.6 mt-10 -49.76 -36.53 26.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.486 ' CD2' HD23 ' A' ' 137' ' ' LEU . 5.0 tp -60.71 -51.24 70.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 0.0 110.531 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -42.43 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.2 pt-20 -42.08 -45.81 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -1.18 . . . . 0.0 110.628 -179.122 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.443 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 37.6 mt -56.23 -58.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.99 -1.069 . . . . 0.0 109.72 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.5 HD13 ' CD1' ' A' ' 134' ' ' ILE . 49.1 mt -60.7 -44.63 96.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 110.103 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.74 -37.77 79.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.126 -0.984 . . . . 0.0 110.264 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.87 64.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.987 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.8 p -62.74 -23.31 67.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.57 47.43 15.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.53 13.44 20.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -1.109 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 55.77 47.71 19.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.307 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.527 HG11 ' CG1' ' A' ' 134' ' ' ILE . 71.8 t -79.88 86.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' A' ' 132' ' ' GLU . 41.1 pt -57.79 149.86 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 132' ' ' GLU . 3.8 mm-40 -50.32 -44.54 54.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 111.142 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.446 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -39.43 -40.37 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.328 -0.857 . . . . 0.0 110.896 -179.474 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -47.3 21.6 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.307 -0.871 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.527 ' CG1' HG11 ' A' ' 129' ' ' VAL . 6.6 mt -59.71 -39.48 79.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.666 -0.646 . . . . 0.0 109.611 179.143 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.27 -42.33 73.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.03 -38.62 86.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 0.0 109.843 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.486 HD23 ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -49.69 -41.98 44.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 110.947 -179.505 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.2 tpp -70.36 -43.8 69.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.921 -1.112 . . . . 0.0 110.173 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -62.74 -43.83 97.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.88 -18.77 64.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -99.07 -63.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.573 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.2 m-20 -40.05 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.718 . . . . 0.0 110.798 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 141' ' ' SER . 15.2 tttt -79.66 3.88 17.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.046 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.3 p30 -141.51 8.38 1.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.935 . . . . 0.0 110.053 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 62.3 m-20 58.18 61.9 2.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.467 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 56.7 p30 -102.05 -5.03 25.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.936 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.466 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 87.71 -5.18 85.34 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.466 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 18.0 mtm-85 -152.35 157.03 40.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.311 . . . . 0.0 110.79 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.453 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.8 mt -89.28 144.87 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -121.01 -162.54 0.96 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.454 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.502 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 6.8 t80 -64.42 -52.92 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.977 . . . . 0.0 111.112 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.5 OUTLIER -60.2 -56.74 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 110.686 -179.397 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.02 -44.47 87.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.48 ' O ' ' HG2' ' A' ' 157' ' ' MET . 81.5 t80 -49.23 -54.99 14.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.208 -0.933 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 35.3 mt -51.81 -51.42 56.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 110.357 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -46.99 -58.17 4.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 110.739 -179.74 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.565 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -47.53 -51.66 20.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.335 -179.586 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.565 ' N ' ' CG ' ' A' ' 157' ' ' MET . 12.3 mmt . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.156 0.503 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -68.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.449 HD21 ' HB3' ' A' ' 158' ' ' MET . 7.6 mp -47.96 -61.92 1.72 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.01 -42.72 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.429 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -73.82 -57.9 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.595 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 62.9 m -48.93 -27.26 2.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.879 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -46.38 -50.32 16.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.989 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -56.55 -42.59 78.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 104' ' ' ILE . 20.0 mm -57.01 -43.3 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 110.635 -179.434 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -66.15 -38.45 88.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 110.175 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -67.19 89.74 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 0.0 110.091 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -62.78 -27.64 69.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 109.599 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.418 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 17.3 m-80 -104.78 -169.1 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.559 -0.713 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.14 65.41 0.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.365 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -114.44 -32.1 6.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 110.165 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.94 6.98 48.29 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 5.3 m-85 -152.09 128.88 10.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -1.203 . . . . 0.0 109.861 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.28 141.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 3.9 p30 -106.88 173.32 6.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.253 -0.904 . . . . 0.0 110.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 3.3 tt -56.4 -42.93 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.076 -1.015 . . . . 0.0 110.209 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.499 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.7 OUTLIER -55.2 -59.39 4.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.901 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.467 ' HB3' HD12 ' A' ' 121' ' ' ILE . 20.7 mt-10 -47.75 -43.93 27.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.668 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.552 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 2.5 tp -45.46 -31.23 1.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.612 -0.68 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -73.41 -74.5 0.81 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 5.5 pt-20 -42.05 -50.04 4.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -1.177 . . . . 0.0 110.476 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 117' ' ' GLU . 7.9 mt -48.33 -65.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 125' ' ' THR . 17.9 mt -59.67 -56.6 19.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -48.56 -30.99 5.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 110.453 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 120' ' ' GLU . . . -54.85 -53.78 50.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 122' ' ' LEU . 4.4 t -67.47 -139.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.973 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.437 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . -118.34 11.75 12.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.61 97.32 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -1.066 . . . . 0.0 111.046 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -66.06 93.25 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 122' ' ' LEU . 3.4 t -103.98 146.6 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.894 -178.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 131' ' ' GLU . 12.4 pt -112.71 159.0 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -42.89 -48.19 5.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.805 . . . . 0.0 110.914 -179.703 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -47.28 -32.53 4.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.309 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.446 ' O ' HD12 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -87.06 -48.3 8.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.463 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 22.8 mt -60.28 -42.74 91.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -59.01 -60.46 3.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.482 -0.762 . . . . 0.0 109.848 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -51.19 -45.39 61.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.217 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -48.25 -43.98 32.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.812 -179.79 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.476 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -62.27 -48.44 79.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.782 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.04 -36.02 69.52 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -0.791 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.85 -17.9 65.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.835 . . . . 0.0 110.412 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.502 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -102.77 -62.32 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.803 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.6 t0 -37.69 109.01 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.671 -0.643 . . . . 0.0 110.731 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -11.41 57.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.748 . . . . 0.0 109.86 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 1.7 p30 -132.08 4.69 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.151 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.9 m120 60.83 48.19 7.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.777 . . . . 0.0 110.772 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.442 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 45.9 p-10 -81.82 -10.2 59.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 179.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . 93.94 8.5 60.41 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.523 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 10.2 mtt180 -158.34 139.98 13.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -1.177 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' A' ' 141' ' ' SER . 3.6 mt -83.56 122.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -101.68 -174.24 2.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.32 -56.42 16.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -63.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.745 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.76 -36.57 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.932 -179.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -63.24 -55.56 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.914 -1.116 . . . . 0.0 109.977 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 12.8 mt -54.6 -41.83 70.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 110.388 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -58.93 -62.86 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.821 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -57.43 -50.83 71.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 0.0 110.832 -179.43 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' MET . 6.1 mmt . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.333 -0.854 . . . . 0.0 110.485 -179.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.261 0.553 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -48.2 -59.97 3.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.263 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.48 HD12 ' CD2' ' A' ' 155' ' ' LEU . 6.0 mt -57.99 -45.98 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -42.36 -59.29 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.242 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 101' ' ' CYS . 3.7 m120 -50.02 -54.11 22.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.45 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.2 m -43.6 -32.59 0.98 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.908 179.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 13.0 t80 -42.93 -63.93 0.71 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.345 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -63.68 -29.63 70.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 23.0 mm -60.84 -50.77 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.487 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.4 -13.7 14.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.409 ' OD1' ' OD2' ' A' ' 110' ' ' ASP . 25.9 t0 -89.42 118.49 29.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.09 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -110.66 -11.91 14.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -109.71 15.09 23.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 110.611 -179.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 45.25 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 110.239 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -126.55 -27.88 3.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.989 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.95 -19.47 49.33 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 62.0 m-85 -153.23 128.24 9.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -1.102 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -82.51 123.52 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 36.9 p-10 -102.21 -168.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.8 tt -65.14 -40.47 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 110.328 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.432 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.6 OUTLIER -51.38 -52.38 46.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.435 -179.693 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.432 ' OE1' HD13 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -56.97 -44.62 82.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.903 . . . . 0.0 110.28 -179.767 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -48.47 -34.19 10.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.171 -179.971 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -58.36 -85.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 15.7 pt-20 -42.43 -43.89 3.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.15 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.45 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.5 mt -52.61 -48.98 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.877 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.32 -47.1 62.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.097 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -51.96 -42.42 62.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.946 . . . . 0.0 110.208 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.04 -31.6 5.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.432 -0.793 . . . . 0.0 110.548 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 p -68.87 -35.91 77.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.363 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.91 49.24 2.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.45 -7.55 8.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.206 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 59.29 84.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 110.039 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 9.1 t -108.69 149.58 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.318 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 132' ' ' GLU . 16.2 pt -113.44 154.82 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.126 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 130' ' ' ILE . 10.2 mt-10 -39.41 -51.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.436 -0.79 . . . . 0.0 110.777 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.467 ' HB2' HD11 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 -179.991 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -88.37 -44.75 10.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.503 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.457 HG23 ' HB3' ' A' ' 118' ' ' LEU . 33.3 mt -63.26 -38.3 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.811 . . . . 0.0 109.894 179.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -54.04 -53.73 49.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.778 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -45.26 -48.73 12.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 134' ' ' ILE . 0.5 OUTLIER -53.09 -49.01 67.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 110.377 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 26.4 tpp -66.11 -50.43 64.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -41.83 93.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.398 -0.814 . . . . 0.0 110.093 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -66.77 -35.58 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.525 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -80.54 -48.83 12.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.4 OUTLIER -49.23 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.508 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 141' ' ' SER . 17.5 tttt -80.09 -19.21 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 0.2 OUTLIER -122.48 0.91 9.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.68 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 64.96 52.07 1.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.0 110.564 179.727 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 146' ' ' ASP . 50.7 p-10 -93.7 0.02 56.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 11.58 84.34 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -152.79 139.1 18.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.144 -1.21 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.525 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.2 mt -83.63 134.76 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.751 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 152' ' ' ASP . 2.1 p30 -118.6 -166.27 1.21 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 110.144 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 41.1 p90 -70.02 -34.98 73.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.594 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -66.0 -49.0 69.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.315 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 141' ' ' SER . 74.8 mt-10 -71.92 -56.61 5.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.38 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.464 ' HA ' ' HE2' ' A' ' 157' ' ' MET . 69.6 t80 -45.29 -45.17 11.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 0.0 110.117 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.48 ' CD2' HD12 ' A' ' 98' ' ' LEU . 13.1 mt -55.62 -40.93 72.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -55.11 36.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.56 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -47.17 -49.73 22.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 109.588 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.56 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.37 -0.831 . . . . 0.0 110.363 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.299 0.571 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -55.42 -60.1 3.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -0.894 . . . . 0.0 110.462 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.472 HD23 ' HE3' ' A' ' 158' ' ' MET . 0.2 OUTLIER -51.21 -54.79 22.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -41.32 -48.52 3.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 0.0 110.134 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.44 -43.65 71.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.064 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.8 m -63.9 -18.81 64.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.885 . . . . 0.0 110.192 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -53.15 -55.76 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 110.122 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -55.82 -33.75 64.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.03 -39.44 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -66.54 -51.51 55.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.099 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -72.56 123.77 23.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.165 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 19.6 mttp -93.99 17.19 12.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.416 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 50.3 m-80 -148.68 173.99 12.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 110.424 -179.485 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.5 40.6 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 p30 -88.13 -23.2 23.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.18 18.71 63.07 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -153.28 117.3 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -1.114 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 36.9 mt -84.1 132.05 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.32 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -107.34 -164.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -78.65 -43.93 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.085 -1.01 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.503 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 31.2 mt-10 -51.78 -53.07 43.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 109.826 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 76.2 mt-10 -57.37 -44.58 84.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.645 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.7 OUTLIER -50.48 -44.98 56.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 110.27 179.919 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.529 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -42.64 -83.39 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.459 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 11.7 pt-20 -47.06 -44.44 20.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -1.158 . . . . 0.0 110.33 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.508 HG23 HD12 ' A' ' 121' ' ' ILE . 17.8 mt -48.18 -57.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.916 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.432 ' O ' ' OG1' ' A' ' 125' ' ' THR . 18.2 mt -68.85 -47.63 65.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.95 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.32 -37.87 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 110.147 179.756 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -53.3 -31.33 43.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 65.7 p -52.9 -34.55 55.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.88 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.19 24.71 5.86 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -120.83 169.89 10.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 110.156 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -92.35 76.5 5.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.139 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.38 149.17 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' ' 131' ' ' GLU . 7.2 pt -133.26 149.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.085 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.1 mt-10 -41.55 -49.39 4.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.56 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 10.8 mt-10 -42.42 -40.39 2.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.037 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -47.92 10.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 109.175 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.529 ' CD1' ' HA2' ' A' ' 119' ' ' GLY . 10.4 mt -55.2 -39.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.4 -0.813 . . . . 0.0 109.272 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -54.59 -42.18 70.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.527 -0.733 . . . . 0.0 109.948 179.49 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -56.85 -50.72 71.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 110.245 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 137' ' ' LEU . 5.6 mp -54.63 -35.53 63.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.417 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 142' ' ' ASP . 2.1 ttm -74.64 -55.53 5.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 110.396 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -47.54 -55.54 8.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.61 -33.39 69.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.53 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.0 t -84.9 -62.34 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.344 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 138' ' ' MET . 3.4 t0 -40.44 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.406 -0.809 . . . . 0.0 110.694 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 mttt -76.66 -27.86 55.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.416 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 8.4 m-80 -104.24 1.44 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.796 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.39 17.57 7.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 110.314 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.23 -14.32 17.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.048 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.494 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 97.41 9.21 55.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.494 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 32.2 mtt85 -150.69 142.81 24.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.379 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.53 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.4 mt -83.7 137.62 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.048 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.74 -179.99 3.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 110.112 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.577 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 30.8 p90 -51.64 -42.49 62.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.577 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 1.9 m-20 -67.0 -58.48 4.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.885 . . . . 0.0 110.892 -179.434 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.416 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 39.6 mt-10 -59.46 -38.33 80.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.209 -0.932 . . . . 0.0 111.031 -179.321 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.488 ' CD2' ' SD ' ' A' ' 157' ' ' MET . 25.7 t80 -58.99 -57.38 13.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 110.619 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.46 ' O ' ' HE2' ' A' ' 158' ' ' MET . 64.6 mt -40.74 -50.07 3.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.317 -179.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -39.11 90.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.964 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.513 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -55.85 -46.52 78.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.362 -0.836 . . . . 0.0 109.869 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.513 ' N ' ' CG ' ' A' ' 157' ' ' MET . 1.7 tmm? . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.74 . . . . 0.0 110.158 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.206 0.527 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.49 -62.57 1.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.737 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 99' ' ' ALA . 16.0 mt -46.61 -53.75 10.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.45 -37.51 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.36 -42.74 53.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 110.623 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -55.17 -24.61 27.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.968 . . . . 0.0 110.544 -179.704 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 101' ' ' CYS . 15.6 t80 -42.82 -54.57 4.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -67.13 -37.51 83.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.194 -0.941 . . . . 0.0 110.0 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.7 mm -57.53 -39.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.29 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -83.59 -26.08 30.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -80.76 98.48 7.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.252 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 35.7 mmtt -75.81 0.94 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.289 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -132.27 167.53 19.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -0.858 . . . . 0.0 110.244 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.79 29.07 0.94 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.418 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 8.8 p30 -76.26 -24.0 54.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.538 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 80.03 7.46 88.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 38.7 m-85 -153.07 133.75 13.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -1.175 . . . . 0.0 110.241 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.33 129.48 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.345 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 35.4 p30 -101.99 -179.01 3.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.076 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -58.82 -43.47 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.064 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 19.3 mt-10 -52.21 -51.93 55.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.073 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.435 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.5 mm-40 -57.56 -39.19 76.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.9 OUTLIER -60.01 -50.95 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 110.537 -179.68 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.455 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -49.64 -74.45 0.27 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.435 ' CD ' ' HA ' ' A' ' 117' ' ' GLU . 5.6 pt-20 -42.31 -47.7 4.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.434 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.468 HG22 HD13 ' A' ' 121' ' ' ILE . 6.1 mt -51.86 -58.37 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 mt -60.67 -47.1 87.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.289 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -36.78 66.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.201 -0.937 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.13 -42.22 28.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -0.862 . . . . 0.0 110.497 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.2 p -54.86 -48.44 72.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.4 35.97 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.05 147.75 48.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -1.065 . . . . 0.0 110.129 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.574 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -82.96 59.94 5.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 110.301 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.9 t -61.7 156.81 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.407 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.4 pt -125.67 148.2 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.32 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLU . 4.3 mt-10 -45.99 -47.72 16.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.022 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' GLU . 1.9 mt-10 -42.58 -35.0 0.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.03 -43.63 12.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 14.1 mt -64.13 -40.04 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 109.633 179.36 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.8 -48.45 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.848 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -47.83 -53.79 14.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.76 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.434 HD23 ' HE3' ' A' ' 157' ' ' MET . 0.4 OUTLIER -50.76 -43.02 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.876 179.613 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -69.26 -53.69 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.615 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -53.76 46.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.079 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -57.59 -40.28 78.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 110.107 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.532 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.32 -59.03 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.207 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.1 m-20 -52.57 87.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.831 . . . . 0.0 110.533 -179.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.3 OUTLIER -68.25 -18.93 64.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.425 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -121.74 11.58 10.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.801 179.664 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 20.8 m-20 51.8 86.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -130.54 13.11 5.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 58.4 23.58 54.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.458 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 3.0 mtt85 -158.3 123.71 4.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 110.424 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.532 HG12 ' CB ' ' A' ' 141' ' ' SER . 5.7 mt -84.52 122.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 109.817 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -101.58 -175.09 2.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.995 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -49.26 -57.79 6.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 110.552 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -61.55 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.691 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.425 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 96.0 mt-10 -56.72 -33.15 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.645 -179.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.469 ' O ' ' HG2' ' A' ' 157' ' ' MET . 13.1 t80 -60.65 -64.34 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 110.614 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.1 mt -46.66 -58.07 4.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.443 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -47.11 -38.77 12.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.963 . . . . 0.0 110.409 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.524 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.9 OUTLIER -67.66 -48.71 65.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.881 . . . . 0.0 110.152 -179.957 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.524 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.3 tpp . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.369 -0.832 . . . . 0.0 110.411 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 4.3 mt-10 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.296 0.57 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER 65.07 150.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 110.298 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.19 150.69 23.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.42 -27.13 24.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 110.266 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . 76.49 -126.64 8.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 92' ' ' GLY . 8.0 mttt 42.13 -158.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -1.13 . . . . 0.0 110.173 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.5 161.06 2.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -51.16 -44.93 61.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.263 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 95' ' ' GLU . 5.4 tp10 -40.37 -63.76 0.59 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.43 -0.794 . . . . 0.0 110.503 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.8 -57.14 7.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.459 HD21 ' CD2' ' A' ' 155' ' ' LEU . 0.6 OUTLIER -50.11 -46.2 53.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.095 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -43.61 -58.55 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -53.6 -51.93 61.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -43.79 -30.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.403 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 30.6 t80 -42.79 -59.77 1.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -36.66 71.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 47.2 mm -57.24 -29.51 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.944 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.05 -54.18 6.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.949 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.404 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 3.8 t70 -67.61 87.04 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.966 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -84.87 -2.81 58.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.464 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 110' ' ' ASP . 2.1 p30 -131.28 153.09 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.136 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.68 89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 110.145 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 108' ' ' ASN . 60.9 t0 -142.29 -34.54 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 110.284 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.53 10.18 35.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 31.2 m-85 -153.52 147.06 25.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -1.175 . . . . 0.0 110.052 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.8 mt -90.99 114.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.336 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.87 179.9 4.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -66.66 -43.53 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.4 mm-40 -50.75 -45.5 58.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.822 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 7.9 mt-10 -65.02 -38.41 90.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.29 -38.53 77.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.118 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -47.75 -80.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -43.43 -54.15 4.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.323 -1.104 . . . . 0.0 110.743 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.501 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 14.0 mt -42.23 -61.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.71 -44.79 80.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -40.65 62.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.17 19.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.6 p -74.9 -169.33 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.11 56.57 0.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -116.83 -10.38 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 49.12 68.06 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.4 t -89.69 149.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.66 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' GLU . 18.0 pt -117.98 155.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.4 mt-10 -40.2 -50.1 2.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.33 -0.856 . . . . 0.0 110.887 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.4 -32.99 28.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 110.948 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -47.24 10.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.446 HD11 ' HA2' ' A' ' 119' ' ' GLY . 13.7 mt -58.2 -37.21 61.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.311 -0.868 . . . . 0.0 109.717 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HA ' HD13 ' A' ' 115' ' ' ILE . 4.5 mt-10 -57.4 -47.8 80.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.44 -43.65 71.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 0.0 110.112 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 134' ' ' ILE . 0.4 OUTLIER -53.61 -44.37 69.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.129 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.6 ttm -64.68 -41.77 95.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 0.0 110.261 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -56.25 22.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.38 -19.19 21.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 110.671 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.54 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -102.51 -61.5 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 0.0 110.736 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' SER . 59.5 t0 -39.38 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.402 -0.811 . . . . 0.0 110.852 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -92.67 -5.61 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.863 . . . . 0.0 110.142 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 1.1 m-80 -127.49 21.6 6.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.166 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 47.6 46.94 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -105.45 14.46 28.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 110.228 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.429 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 46.53 30.94 4.77 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 11.0 mtt180 -157.52 128.74 6.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -1.113 . . . . 0.0 110.363 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.54 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.2 mt -83.48 123.54 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.683 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 20.4 p-10 -96.33 -167.36 1.56 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.355 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 18.2 p90 -65.23 -43.3 91.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.222 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.587 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -64.32 -58.32 6.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.312 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.483 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 35.7 mt-10 -61.61 -42.83 99.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.521 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 17.4 t80 -56.49 -64.95 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 110.07 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.459 ' CD2' HD21 ' A' ' 98' ' ' LEU . 32.5 mt -44.94 -48.49 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.379 -0.826 . . . . 0.0 110.001 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -46.91 -46.53 21.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -0.881 . . . . 0.0 110.375 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.547 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -71.43 -53.29 14.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.949 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.547 ' N ' ' CG ' ' A' ' 157' ' ' MET . 5.3 mmt -45.3 -36.37 4.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.946 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -63.57 -40.98 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.016 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -116.27 62.8 0.37 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.5 t -48.39 143.2 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 110.438 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.258 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.261 0.553 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -160.21 168.9 24.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.157 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.1 6.82 2.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.947 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.83 109.24 1.38 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.77 -168.1 11.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.454 ' HG3' HD11 ' A' ' 98' ' ' LEU . 3.5 ptpp? -129.93 29.19 5.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.228 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.74 147.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 5.4 tm-20 -53.55 -42.44 67.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.858 . . . . 0.0 110.398 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 95' ' ' GLU . 2.4 tt0 -38.3 -66.84 0.23 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.468 -0.77 . . . . 0.0 111.056 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.2 mt-10 -47.89 -65.2 0.6 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 110.846 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.496 HD21 ' CE1' ' A' ' 154' ' ' PHE . 0.1 OUTLIER -51.19 -55.22 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 110.639 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 95' ' ' GLU . . . -44.87 -44.77 9.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.256 -0.902 . . . . 0.0 110.687 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 3.0 m-20 -50.77 -52.0 45.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.741 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 105' ' ' PHE . 0.8 OUTLIER -61.17 -16.67 47.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.17 -0.956 . . . . 0.0 110.977 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 34.7 t80 -47.88 -41.25 23.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -0.998 . . . . 0.0 110.844 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -73.87 -37.8 64.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.0 111.095 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.508 HD11 ' N ' ' A' ' 104' ' ' ILE . 1.7 mp -57.06 -35.63 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 110.474 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 101' ' ' CYS . 28.8 m-85 -80.83 -36.57 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 110.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -79.67 80.13 6.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.034 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.455 ' HB2' ' OE2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -54.46 -30.49 53.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.479 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -109.35 -151.7 0.48 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.081 -1.012 . . . . 0.0 110.33 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.06 47.75 1.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 9.2 p30 -83.14 -18.01 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 80.13 -5.0 64.27 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 110' ' ' ASP . 7.4 m-85 -145.5 135.79 23.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -1.184 . . . . 0.0 109.876 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 mt -82.84 120.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.04 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 6.9 p-10 -87.84 176.65 7.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.158 -0.964 . . . . 0.0 110.324 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -69.72 -40.62 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.126 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 11.7 mt-10 -54.29 -48.86 70.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.021 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 107' ' ' LYS . 3.5 mt-10 -53.3 -50.25 65.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.8 OUTLIER -58.28 -39.74 80.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.313 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.53 -73.99 0.34 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 14.5 pt-20 -54.85 -44.77 74.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.213 -1.169 . . . . 0.0 110.573 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.469 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 10.9 mt -53.01 -56.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 110.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.511 ' CD1' HD13 ' A' ' 134' ' ' ILE . 11.0 mt -63.84 -54.59 32.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -55.99 -39.67 72.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.05 -20.22 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.253 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 p -86.35 -1.95 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.12 81.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.481 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . 0.2 OUTLIER -79.32 0.5 28.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -1.112 . . . . 0.0 110.237 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 41.97 45.75 3.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.481 ' CG2' ' HB3' ' A' ' 127' ' ' GLU . 14.8 t -77.86 155.22 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.199 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 132' ' ' GLU . 20.7 pt -114.96 138.27 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 110.409 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ILE . 8.9 mt-10 -41.02 -43.44 2.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HB2' HG13 ' A' ' 130' ' ' ILE . 1.5 mm-40 -40.72 -38.53 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.303 -0.873 . . . . 0.0 110.6 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.84 -48.96 8.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.659 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 122' ' ' LEU . 13.3 mt -58.12 -39.45 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 4.5 tt0 -66.79 -41.6 87.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.589 -0.695 . . . . 0.0 110.021 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.81 -42.26 75.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.968 . . . . 0.0 110.086 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.43 78.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.505 ' CE ' HD13 ' A' ' 149' ' ' ILE . 31.2 tpp -61.64 -40.5 95.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.875 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -59.12 -49.42 77.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 110.104 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -68.19 -41.38 81.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.031 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.522 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -73.99 -63.97 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 9.7 t0 -45.41 97.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -82.14 -24.22 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.431 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 10.3 m-80 -107.76 14.78 25.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.887 . . . . 0.0 110.161 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.15 47.7 19.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 51.1 p30 -105.32 25.57 10.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 44.33 35.46 3.82 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 86.6 mtt180 -157.91 121.35 4.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.522 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.2 mt -83.62 118.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.432 ' OD2' ' OE2' ' A' ' 153' ' ' GLU . 41.0 p30 -97.18 -179.78 4.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 110.445 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -59.27 3.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.43 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -61.12 2.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.496 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 157' ' ' MET . 16.7 mt-10 -60.73 -39.95 90.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.366 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.51 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 21.5 t80 -59.68 -33.09 71.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -0.872 . . . . 0.0 110.975 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 25.1 mt -74.3 -46.45 40.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 110.974 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 157' ' ' MET . 63.5 mttt -66.67 -49.41 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -0.962 . . . . 0.0 110.834 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.73 -50.51 7.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.015 -1.053 . . . . 0.0 110.372 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.459 ' HB2' ' SD ' ' A' ' 157' ' ' MET . 9.8 ttm -101.04 64.07 1.03 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.43 75.44 8.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 110.35 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.68 -47.66 2.78 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 161' ' ' VAL . 12.2 p -49.61 122.9 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -1.146 . . . . 0.0 110.295 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.198 179.865 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.222 0.534 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 90' ' ' ALA . 12.4 t70 -110.51 -16.45 13.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.22 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 89' ' ' ASP . . . 66.7 114.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.387 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -116.09 48.44 1.24 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.0 110.065 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.27 -47.52 1.01 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -92.89 107.71 19.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 110.085 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -59.72 139.56 57.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.889 . . . . 0.0 110.524 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 94' ' ' SER . 17.8 tt0 -43.61 -46.47 7.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.946 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -50.42 -39.25 46.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.356 -0.84 . . . . 0.0 109.941 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.423 ' HG2' ' HG3' ' A' ' 93' ' ' LYS . 6.3 tp10 -49.8 -66.32 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.119 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.1 -45.62 52.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.81 -42.65 26.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 110.27 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.474 ' O ' HG12 ' A' ' 104' ' ' ILE . 42.4 m-20 -48.1 -46.19 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.5 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 m -78.21 -25.67 47.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 0.0 110.904 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.449 ' CD1' HD13 ' A' ' 113' ' ' ILE . 13.8 t80 -52.95 -62.65 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -0.999 . . . . 0.0 110.729 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -57.15 -27.98 62.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.897 . . . . 0.0 110.92 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 100' ' ' ASN . 45.6 mm -61.42 -26.3 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.026 -1.046 . . . . 0.0 110.464 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.13 -29.21 24.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -79.87 117.24 20.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.079 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 -11.47 15.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.289 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 109' ' ' ALA . 56.6 m-80 -116.34 16.11 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.302 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 43.98 79.42 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.17 -33.13 5.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 110.23 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.519 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 111.85 -14.35 26.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.519 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 18.7 m-85 -149.93 141.25 23.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -1.087 . . . . 0.0 109.826 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.449 HD13 ' CD1' ' A' ' 102' ' ' PHE . 44.4 mt -82.81 130.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 8.2 p30 -95.17 -176.87 3.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.1 tt -79.18 -44.98 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 110.508 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 117' ' ' GLU . 21.6 pt-20 -48.99 -35.13 14.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 116' ' ' GLU . 43.2 mt-10 -69.12 -42.31 76.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.46 HD23 HG23 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -57.36 -37.88 73.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.31 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.53 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -57.11 -72.95 0.5 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.4 pt-20 -53.95 -44.63 70.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -1.127 . . . . 0.0 110.701 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.2 mt -45.05 -56.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.009 . . . . 0.0 110.481 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.51 ' O ' ' CG2' ' A' ' 125' ' ' THR . 15.7 mt -66.24 -52.31 48.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.684 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -48.71 -30.93 6.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 110.681 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.45 -56.62 18.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.743 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 122' ' ' LEU . 2.3 t -63.2 -10.15 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.559 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 128' ' ' HIS . . . 111.52 -29.1 8.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 125' ' ' THR . 4.2 mm-40 -52.24 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' GLY . 8.1 m80 -67.32 76.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 109.975 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 122' ' ' LEU . 13.3 t -84.29 136.85 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.47 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 133' ' ' ASP . 17.2 pt -90.97 143.59 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -42.95 -46.96 5.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 110.454 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.408 ' HB3' HD12 ' A' ' 130' ' ' ILE . 3.8 tt0 -48.03 -27.23 2.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.458 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.46 ' HB2' HG13 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -89.68 -41.89 11.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.619 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.53 ' CD1' ' HA2' ' A' ' 119' ' ' GLY . 36.7 mt -65.64 -37.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.915 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.16 -48.46 73.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.91 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 12.8 t0 -55.57 -45.94 77.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -57.7 8.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.975 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 2.0 ttm -56.18 -20.88 19.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -72.89 -44.75 60.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 110.428 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -73.94 -34.48 64.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 110.716 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.528 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -74.04 -63.14 1.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.027 . . . . 0.0 110.547 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 138' ' ' MET . 23.2 m-20 -41.89 96.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.483 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -72.84 -3.81 27.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.31 22.57 2.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 48.94 86.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 110.337 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' OD1' ' CG ' ' A' ' 142' ' ' ASP . 17.6 p-10 -139.94 17.81 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 48.32 32.16 9.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 45.5 mtt180 -158.19 121.69 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.189 . . . . 0.0 110.454 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.528 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.8 mt -83.53 123.71 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.667 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.472 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 23.1 p30 -103.94 -177.44 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.617 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 155' ' ' LEU . 29.7 t80 -49.95 -62.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.629 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.83 -57.61 6.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.367 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.472 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 79.7 mt-10 -59.94 -39.63 86.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 109.989 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.478 ' O ' ' HG2' ' A' ' 157' ' ' MET . 33.0 t80 -63.34 -51.48 65.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.546 HD11 ' CE2' ' A' ' 151' ' ' PHE . 37.3 mt -47.53 -54.06 12.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.452 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -60.55 -51.2 70.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.609 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.506 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.1 ptm -48.75 -47.54 41.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.506 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -95.66 32.91 1.73 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -76.7 126.01 30.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.875 . . . . 0.0 110.262 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.63 50.67 6.4 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 158' ' ' MET . 58.7 t -59.99 138.13 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -1.139 . . . . 0.0 110.222 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.2 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.224 0.535 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -132.12 -77.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.218 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 91' ' ' LYS . . . -178.21 158.47 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 110.412 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -177.62 142.46 0.32 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.033 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.63 -22.06 56.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -71.23 130.81 42.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -1.193 . . . . 0.0 110.306 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 95' ' ' GLU . 4.1 m -94.92 150.35 20.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.232 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 94' ' ' SER . 3.2 tm-20 -42.34 -38.53 1.86 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.872 . . . . 0.0 110.196 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 95' ' ' GLU . 3.4 mt-10 -41.7 -61.76 1.03 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.308 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.39 -62.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -47.78 -62.18 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 110.06 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -44.91 -47.37 11.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.877 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -50.88 -52.71 39.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -18.54 39.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 110.131 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 113' ' ' ILE . 16.0 t80 -55.06 -55.87 26.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -57.06 -42.89 81.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -0.885 . . . . 0.0 110.636 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 1.2 mp -57.21 -41.71 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.135 -0.978 . . . . 0.0 110.273 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -72.11 -43.64 64.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 0.0 110.486 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.64 102.58 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -84.14 -44.34 14.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 110.475 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -68.09 -8.04 34.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.226 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.47 24.77 1.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 4.0 p30 -68.16 -20.99 64.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 110.278 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.489 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 112.09 -15.77 25.52 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 9.7 m-85 -148.01 134.13 19.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -1.165 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.564 HD11 ' CE1' ' A' ' 102' ' ' PHE . 14.5 mt -82.5 133.78 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.297 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -107.28 -171.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 110.141 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.477 ' CD1' ' HG2' ' A' ' 135' ' ' GLU . 2.4 tt -72.51 -43.42 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 110.187 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.45 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -55.83 -35.6 66.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.131 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -74.97 -52.31 11.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 110.417 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -38.86 -30.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.46 -0.775 . . . . 0.0 111.065 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 117' ' ' GLU . . . -56.03 -43.76 88.18 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 11.4 pt-20 -49.28 -45.86 45.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.125 -1.22 . . . . 0.0 110.942 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.518 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 1.5 mp -60.26 -50.39 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.469 ' CD1' HD11 ' A' ' 118' ' ' LEU . 4.3 mp -69.08 -52.26 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.034 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 24.9 mtp180 -49.64 -36.93 26.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.32 23.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 0.0 110.324 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 59.8 p -61.14 -40.37 93.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.392 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.29 -3.97 9.58 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -92.66 133.47 35.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.26 60.21 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 110.136 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 38.6 t -45.48 166.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.456 HG21 HD13 ' A' ' 130' ' ' ILE . 31.9 pt -118.52 151.99 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.99 -48.44 3.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.382 -0.824 . . . . 0.0 110.78 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -48.88 -31.54 7.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.824 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.523 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -83.19 -43.95 15.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.2 mt -66.2 -38.15 81.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.506 -0.746 . . . . 0.0 109.822 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.477 ' HG2' ' CD1' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.98 -53.18 44.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 110.536 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -45.98 -51.31 13.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 0.0 110.45 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 137' ' ' LEU . 1.5 mm? -50.58 -41.27 54.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.476 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 20.9 tpp -67.97 -48.96 64.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -48.21 79.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.63 -32.42 69.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 143' ' ' LYS . 2.1 t -92.99 -38.06 11.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 138' ' ' MET . 1.4 m-20 -51.99 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 8.3 tptm -74.63 -18.19 60.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.911 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.434 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 1.6 m-80 -117.77 10.68 13.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.989 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 15.0 m120 55.31 46.13 24.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -0.881 . . . . 0.0 110.322 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -107.04 16.12 24.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 51.52 34.96 35.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 5.6 mtm180 -157.63 124.82 5.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -1.214 . . . . 0.0 110.223 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.483 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.2 mt -83.94 128.55 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 0.0 110.131 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.451 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 53.3 p-10 -108.73 -170.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 110.087 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -63.5 -37.87 88.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.93 -51.85 35.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.451 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 46.8 mt-10 -59.7 -45.41 92.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.566 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.449 ' CZ ' ' HE3' ' A' ' 158' ' ' MET . 1.9 t80 -50.61 -57.97 6.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.768 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.7 mt -39.92 -64.15 0.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.468 -0.77 . . . . 0.0 110.677 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -30.97 66.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.536 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -65.5 -40.31 92.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.536 ' N ' ' HG3' ' A' ' 157' ' ' MET . 2.5 mtt -109.06 48.92 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 0.0 110.169 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -87.11 8.44 23.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 0.0 110.318 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -161.48 39.0 0.4 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 162' ' ' GLN . 15.0 t -120.99 158.17 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.235 . . . . 0.0 110.179 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 161' ' ' VAL . 3.2 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.247 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.231 0.539 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 45.1 p-10 -102.28 148.14 25.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.38 37.14 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.9 59.43 1.7 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.323 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.42 -82.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HE2' HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -168.16 93.92 0.37 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -1.137 . . . . 0.0 110.163 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -97.82 -178.25 4.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -0.833 . . . . 0.0 110.202 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' HG3' HD21 ' A' ' 155' ' ' LEU . 2.7 mp0 -44.33 -52.11 7.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.185 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -49.63 -55.95 11.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 1.9 mt-10 -59.71 -54.01 51.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.456 HD22 ' HE2' ' A' ' 93' ' ' LYS . 14.1 mt -50.78 -64.13 0.91 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.89 -46.01 10.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 67.7 m-20 -56.01 -48.29 76.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 73.8 m -45.33 -29.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -44.89 -62.97 1.02 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 109.82 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.39 -42.01 61.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 21.0 mm -61.28 -39.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.0 -51.96 48.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.865 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.447 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 21.0 t0 -53.42 129.37 31.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.517 -0.739 . . . . 0.0 110.418 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -98.29 -14.43 20.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.191 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -133.47 12.0 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.447 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 55.39 57.35 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 36.0 p30 -84.85 -14.57 47.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 94.07 -10.52 71.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 111' ' ' GLY . 46.7 m-85 -151.41 136.42 17.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -1.227 . . . . 0.0 110.635 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.9 mt -88.28 121.65 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.462 ' OD1' ' HG3' ' A' ' 117' ' ' GLU . 13.6 p30 -98.3 171.01 8.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.229 -0.919 . . . . 0.0 110.342 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -58.49 -36.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -51.03 -54.04 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.877 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 121' ' ' ILE . 51.6 mt-10 -56.38 -41.58 76.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -54.73 -43.56 72.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 134' ' ' ILE . . . -56.44 -75.47 0.25 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 16.1 pt-20 -42.35 -45.06 4.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -1.12 . . . . 0.0 110.479 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.482 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 41.5 mt -55.22 -55.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.453 ' O ' ' OG1' ' A' ' 125' ' ' THR . 0.2 OUTLIER -63.15 -53.67 49.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 110.442 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -48.82 -40.36 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.19 -34.39 22.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.286 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 36.4 p -70.01 -23.33 63.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.962 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.1 3.76 26.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -89.59 132.9 34.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.311 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -85.38 53.36 2.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.6 t -65.28 149.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.868 . . . . 0.0 110.518 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.419 HD12 ' HB2' ' A' ' 132' ' ' GLU . 6.2 pt -113.76 153.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.8 tt0 -41.71 -53.02 3.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -44.32 -36.45 2.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.72 -42.05 22.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 109.099 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 17.0 mt -67.18 -36.53 77.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.52 -0.737 . . . . 0.0 109.565 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 138' ' ' MET . 2.8 tm-20 -56.26 -32.47 64.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 109.838 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -49.83 -62.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 110.767 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.536 ' CD1' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pp -56.88 -27.97 61.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.987 . . . . 0.0 110.651 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.445 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 0.0 OUTLIER -67.01 -46.82 73.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.03 . . . . 0.0 110.046 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.84 72.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -59.9 -36.37 76.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.532 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -86.11 -59.06 2.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -43.44 92.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 110.597 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -92.3 -20.06 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 15.1 m-80 -104.74 6.4 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.03 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.0 OUTLIER 63.93 28.49 14.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 110.211 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -87.76 8.66 24.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.76 24.66 33.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.508 ' HD2' ' CB ' ' A' ' 112' ' ' PHE . 1.4 mtt-85 -147.69 142.58 26.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -1.155 . . . . 0.0 110.189 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 137' ' ' LEU . 19.4 mt -90.65 121.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.372 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 153' ' ' GLU . 36.4 p-10 -97.7 -156.32 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 0.0 109.907 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -71.18 -55.79 7.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.31 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.32 -60.21 4.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.908 . . . . 0.0 110.548 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.49 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 26.6 mt-10 -48.02 -37.74 15.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.316 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 50.9 t80 -60.37 -61.04 2.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' A' ' 95' ' ' GLU . 91.4 mt -41.76 -39.03 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.435 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -58.42 -45.48 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 110.365 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.581 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -64.17 -51.2 64.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.826 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.581 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -96.88 50.93 1.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 110.572 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.63 -20.2 17.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.098 -1.001 . . . . 0.0 110.349 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -88.14 -31.13 15.05 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 161' ' ' VAL . 13.8 p -50.09 133.07 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.178 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.252 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.201 0.524 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -150.11 67.88 0.98 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 110.249 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.19 81.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 110.23 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.69 -151.16 0.48 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 93' ' ' LYS . . . -86.78 144.04 19.37 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 92' ' ' GLY . 36.4 mmtt 54.95 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.316 -1.108 . . . . 0.0 110.246 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -101.21 -178.4 3.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.935 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.13 -40.88 64.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 110.236 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.12 -49.85 72.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.313 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -67.88 -52.97 30.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.287 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.421 HD13 ' HE2' ' A' ' 158' ' ' MET . 0.1 OUTLIER -52.15 -53.39 43.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.97 44.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.95 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -77.02 -46.0 25.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -49.01 -27.26 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.967 . . . . 0.0 110.092 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.626 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 2.3 t80 -42.08 -56.54 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -56.93 -34.12 67.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.326 -0.859 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.61 -59.83 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.358 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.473 ' O ' ' CD1' ' A' ' 121' ' ' ILE . 3.0 m-85 -62.42 -38.37 89.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -85.76 62.24 7.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.229 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -35.43 10.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.182 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.434 ' HB3' ' OD2' ' A' ' 110' ' ' ASP . 1.5 t-20 -55.51 -21.26 15.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.02 47.18 25.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.434 ' OD2' ' HB3' ' A' ' 108' ' ' ASN . 33.1 m-20 -106.94 -13.86 15.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.542 ' C ' ' CD1' ' A' ' 112' ' ' PHE . . . 97.87 -2.43 60.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 111' ' ' GLY . 63.5 m-85 -150.57 119.42 6.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.24 . . . . 0.0 110.273 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.412 ' HA ' ' OE2' ' A' ' 117' ' ' GLU . 15.7 mt -83.79 116.39 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.34 -0.85 . . . . 0.0 110.112 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -92.59 175.28 6.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -57.05 -42.73 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.894 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.425 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.5 mt-10 -51.01 -45.87 61.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.093 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.4 mt-10 -58.47 -50.48 73.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.89 . . . . 0.0 110.127 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -52.1 -34.65 45.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.893 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 123' ' ' ARG . . . -70.28 -69.25 1.43 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.52 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -48.52 -45.24 37.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.237 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.52 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 47.3 mt -57.0 -50.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 125' ' ' THR . 12.9 mt -76.72 -53.98 7.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.965 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 119' ' ' GLY . 9.5 mtt180 -49.07 -32.24 9.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.098 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.15 -43.24 82.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.4 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 81.0 p -55.66 -43.57 76.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.26 -39.37 1.69 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -46.02 125.23 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.136 . . . . 0.0 110.321 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.56 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.3 OUTLIER -71.67 65.47 0.49 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.3 t -64.67 148.68 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.155 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.47 145.24 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.393 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLU . 15.7 mt-10 -43.86 -50.16 8.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.326 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -42.51 -32.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.366 -0.834 . . . . 0.0 109.992 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.76 -47.0 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.8 mt -59.69 -38.7 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 0.0 109.785 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -48.97 -48.79 42.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -51.24 -46.84 62.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.42 HD13 HD11 ' A' ' 118' ' ' LEU . 10.5 mt -53.48 -52.92 58.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 110.884 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 31.9 tpp -66.67 -52.35 45.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 0.0 110.167 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -60.7 2.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.45 -0.781 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.24 -37.67 67.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 0.0 110.666 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.523 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.68 -55.4 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 110.557 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.471 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 0.1 OUTLIER -46.74 91.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.593 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -80.81 -38.73 27.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.106 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -95.8 12.5 29.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.873 . . . . 0.0 110.082 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.4 m120 53.49 87.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 110.55 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 148' ' ' ARG . 6.8 p-10 -143.97 13.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 109.628 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 56.86 20.78 34.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.47 ' O ' ' OD2' ' A' ' 146' ' ' ASP . 30.7 mtt-85 -149.77 133.83 17.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.995 -1.297 . . . . 0.0 110.607 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.523 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.9 mt -84.29 132.85 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.812 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 24.4 p-10 -112.55 -170.01 1.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.458 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.626 ' CE1' ' CD2' ' A' ' 102' ' ' PHE . 3.3 m-85 -59.38 -56.58 20.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -59.17 4.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.225 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 157' ' ' MET . 54.2 mt-10 -57.39 -46.79 83.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.486 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 84.5 t80 -47.86 -32.24 5.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 110.233 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.532 ' O ' ' CE ' ' A' ' 158' ' ' MET . 27.7 mt -75.68 -50.64 14.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -49.42 74.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.184 -0.948 . . . . 0.0 110.954 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.77 -47.61 8.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 111.245 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 155' ' ' LEU . 6.2 ptp -39.06 -29.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 0.0 110.616 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 157' ' ' MET . 9.6 mm-40 -51.46 146.16 7.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.96 . . . . 0.0 110.004 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.34 14.1 56.28 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.8 t -113.72 115.3 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -1.134 . . . . 0.0 110.235 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.204 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.204 0.526 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.46 -162.86 0.61 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.089 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -98.29 46.81 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.937 . . . . 0.0 110.12 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -71.86 -49.79 35.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 141.74 -121.59 1.86 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HG3' ' HB3' ' A' ' 97' ' ' GLU . 2.2 tppt? -142.8 165.6 26.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.99 169.31 9.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -0.862 . . . . 0.0 110.035 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -42.43 -44.05 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.948 . . . . 0.0 110.203 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -50.92 71.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 110.483 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.431 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 2.8 tp10 -47.54 -46.92 28.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.866 . . . . 0.0 109.919 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 98' ' ' LEU . 3.8 mm? -57.03 -48.54 78.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -49.08 -53.11 21.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.45 78.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.121 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -53.19 -19.2 2.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.524 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 44.3 t80 -50.5 -50.22 53.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 110.188 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -30.6 69.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.418 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 26.2 mm -56.89 -38.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -85.22 -11.85 53.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -91.24 106.6 18.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -9.29 33.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.338 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.466 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 66.4 m-80 -117.09 9.26 13.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.922 . . . . 0.0 110.312 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 44.02 43.49 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 10.8 m-20 -80.3 -22.43 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.36 -7.98 62.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 44.8 m-85 -151.81 125.06 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 149' ' ' ILE . 2.9 mp -83.31 112.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.955 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 15.2 p-10 -92.97 -173.24 3.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 1.3 tt -69.69 -41.9 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.867 . . . . 0.0 110.523 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.498 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.5 OUTLIER -53.81 -55.39 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 24.0 mt-10 -45.4 -55.05 6.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.355 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.456 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -48.77 -54.01 16.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.359 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -47.39 -77.06 0.12 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.9 pt-20 -42.67 -47.9 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.502 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 117' ' ' GLU . 8.0 mt -47.29 -55.43 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.011 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.437 ' O ' ' OG1' ' A' ' 125' ' ' THR . 2.4 mt -76.63 -54.86 6.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.211 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -49.06 -36.37 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.899 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.88 -39.66 26.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.052 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 69.9 p -66.76 -38.47 86.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.45 32.57 4.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 128' ' ' HIS . 8.6 mm-40 -97.02 7.08 47.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.319 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 127' ' ' GLU . 14.5 m-70 43.58 72.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 57.7 t -88.62 154.92 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.343 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.6 pt -103.38 145.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 110.177 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.1 mt-10 -49.85 -41.05 44.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.377 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.1 tm-20 -41.69 -33.38 0.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 110.357 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -44.78 12.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 0.0 109.418 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.421 HD11 ' HA2' ' A' ' 119' ' ' GLY . 26.9 mt -65.59 -38.95 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.505 -0.747 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 13.2 mm-40 -56.64 -50.52 71.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.47 -0.769 . . . . 0.0 110.277 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.93 -55.02 10.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.935 . . . . 0.0 110.408 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 45.3 mt -48.96 -52.95 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.496 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.485 ' HG3' ' HB2' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -71.08 -50.01 38.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.88 . . . . 0.0 110.418 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 14.1 mttm -56.53 -39.7 73.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.424 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.43 -40.66 61.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 143' ' ' LYS . 0.4 OUTLIER -83.86 -52.19 6.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 110.653 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.485 ' HB2' ' HG3' ' A' ' 138' ' ' MET . 29.5 t0 -46.45 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.401 -0.812 . . . . 0.0 111.01 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 30.3 tttt -77.71 -23.93 49.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -99.35 -5.61 29.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.69 . . . . 0.0 109.636 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.413 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 1.5 m-20 59.84 24.86 13.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 20.6 p30 -85.17 2.58 43.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 75.94 38.73 35.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 14.7 mtm180 -159.14 133.45 7.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.498 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 141' ' ' SER . 2.0 mt -97.81 123.89 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -105.48 -173.91 2.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 54.1 p90 -57.25 -43.49 83.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 110.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.603 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -63.75 -51.4 65.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.018 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 53.5 mt-10 -65.16 -52.51 54.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.089 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.524 ' CE2' ' HA ' ' A' ' 102' ' ' PHE . 5.9 t80 -46.72 -57.28 5.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' PHE . 71.3 mt -45.3 -63.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -60.69 -25.2 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 110.019 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.537 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -60.85 -38.03 84.13 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.262 -0.899 . . . . 0.0 109.148 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.537 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.2 OUTLIER -103.11 4.47 37.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 109.985 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -89.84 -33.45 16.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -0.852 . . . . 0.0 110.157 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -134.92 48.8 0.92 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.3 t -52.06 130.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -1.069 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.059 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.193 0.52 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 15.1 p30 -136.47 58.91 1.72 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.27 -0.894 . . . . 0.0 110.267 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 58.35 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.895 . . . . 0.0 110.221 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -168.56 1.65 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . -113.47 22.63 14.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 10.5 mttp 43.45 68.52 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.174 -1.192 . . . . 0.0 110.035 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -51.11 163.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.3 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 94' ' ' SER . 21.3 tt0 -42.9 -47.45 5.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 110.424 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.71 -41.58 74.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.285 -0.884 . . . . 0.0 110.692 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -52.25 -49.69 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.472 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.3 mt -53.0 -43.06 66.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 110.274 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.31 -61.0 2.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -55.41 -49.72 71.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.522 ' SG ' ' CE2' ' A' ' 105' ' ' PHE . 42.5 t -59.93 -19.95 54.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.65 -57.47 11.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.054 -1.029 . . . . 0.0 110.177 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.79 -37.09 3.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 104' ' ' ILE . 2.0 mp -67.88 -53.06 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.522 ' CE2' ' SG ' ' A' ' 101' ' ' CYS . 11.9 m-85 -54.03 -31.21 50.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 110.028 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -87.2 91.52 8.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.906 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 -41.97 65.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.522 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 109' ' ' ALA . 32.8 m-80 -87.19 6.38 33.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 43.0 63.14 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -96.92 -11.79 24.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.301 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 90.78 -15.11 61.34 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 46.0 m-85 -147.35 125.02 11.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 110.074 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.84 131.13 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.95 -167.4 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.167 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -72.49 -41.02 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.932 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.506 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 1.6 tm-20 -57.03 -53.94 52.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.439 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 22.5 mt-10 -53.15 -38.2 62.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.33 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.421 ' CD2' HD13 ' A' ' 122' ' ' LEU . 0.9 OUTLIER -60.58 -51.35 69.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -50.1 -74.21 0.3 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -42.47 -54.61 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -1.141 . . . . 0.0 110.671 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.431 HG13 ' CD ' ' A' ' 120' ' ' GLU . 17.1 mt -49.13 -53.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 118' ' ' LEU . 36.3 mt -69.1 -46.23 68.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.355 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -39.4 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.92 -44.05 29.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.44 ' OG1' ' N ' ' A' ' 126' ' ' GLY . 32.9 p -55.55 -64.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.44 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . 142.32 37.76 0.08 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.75 154.85 24.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -1.131 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 128' ' ' HIS . 12.1 p-80 -90.01 63.5 5.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 110.645 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.2 t -82.49 135.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.976 . . . . 0.0 109.737 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.0 pt -102.78 145.07 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.508 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.2 mt-10 -42.74 -53.97 4.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.41 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -40.49 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.828 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -85.89 -51.24 6.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.77 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 134' ' ' ILE . 9.0 mt -60.82 -41.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 109.699 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.451 ' OE2' ' HB3' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -50.03 -50.99 45.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.89 -36.85 84.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 137' ' ' LEU . 2.0 tt -50.35 -44.36 54.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.611 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 ttm -67.11 -42.43 84.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.172 -0.955 . . . . 0.0 110.507 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -64.19 -44.34 92.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -68.53 -36.81 79.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.187 -0.945 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.532 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.0 t -80.78 -49.8 10.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.47 ' OD2' ' HA2' ' A' ' 147' ' ' GLY . 38.5 t70 -60.55 90.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.63 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.47 49.12 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 73.5 m-80 -147.61 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.465 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.6 m-20 172.06 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.604 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 35.2 p-10 -41.54 -25.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.47 ' HA2' ' OD2' ' A' ' 142' ' ' ASP . . . 76.64 51.54 6.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 2.5 mtm180 -158.13 153.66 26.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 110.35 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.532 HG12 ' CB ' ' A' ' 141' ' ' SER . 22.1 mt -88.97 114.17 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.901 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 26.5 p30 -105.9 -172.48 2.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 22.3 p90 -57.62 -37.07 72.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 110.757 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.612 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -70.44 -52.78 19.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 141' ' ' SER . 48.5 mt-10 -68.45 -43.74 76.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.927 . . . . 0.0 110.259 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.486 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 37.4 t80 -49.23 -33.88 13.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.538 ' O ' ' CE ' ' A' ' 158' ' ' MET . 94.8 mt -76.1 -42.02 48.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -69.15 -49.01 60.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.053 -1.029 . . . . 0.0 110.673 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -44.43 -48.24 9.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.213 -0.93 . . . . 0.0 111.056 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.538 ' CE ' ' O ' ' A' ' 155' ' ' LEU . 5.8 ptp -41.74 -27.33 0.1 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.186 -0.946 . . . . 0.0 110.217 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 157' ' ' MET . 0.8 OUTLIER -103.06 87.65 2.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 110.203 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 124.8 10.8 4.67 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 161' ' ' VAL . 9.9 p -111.97 125.83 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.26 -1.141 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.167 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.247 0.546 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 0.2 OUTLIER 65.37 148.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.862 . . . . 0.0 110.214 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 89' ' ' ASP . . . 64.14 81.17 0.21 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 110.299 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.8 -161.32 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -0.883 . . . . 0.0 110.239 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.48 129.47 5.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.64 133.02 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -90.97 161.93 14.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -0.936 . . . . 0.0 110.355 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' HG2' HD22 ' A' ' 155' ' ' LEU . 7.6 tt0 -42.92 -52.61 5.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.361 -0.837 . . . . 0.0 110.271 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -49.33 -58.26 5.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.053 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -54.17 -55.74 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.292 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 12.7 mt -51.53 -47.1 63.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -41.82 -58.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 110.314 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -65.57 -26.96 68.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.912 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -74.89 -9.08 58.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -55.21 -47.62 75.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.019 -1.051 . . . . 0.0 110.013 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -60.43 -35.57 76.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 18.0 mm -59.67 -32.59 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.005 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 107' ' ' LYS . 3.0 m-85 -80.22 -59.0 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -58.32 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 109.932 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -53.39 -43.34 67.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.34 -0.85 . . . . 0.0 110.563 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -94.13 -159.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.35 60.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.57 -32.4 12.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.159 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.537 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 99.74 -3.73 57.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 36.2 m-85 -153.35 123.92 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 mp -83.58 122.38 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.309 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -95.77 178.47 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.1 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.2 tt -57.3 -42.7 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.027 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -51.82 -53.81 36.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.897 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 4.1 mt-10 -52.17 -47.21 65.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.959 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -54.77 -27.63 42.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 0.0 109.837 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.45 -68.71 1.51 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.543 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.3 pt-20 -49.89 -44.51 49.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.237 . . . . 0.0 110.177 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.543 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 20.2 mt -49.28 -61.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' O ' ' OG1' ' A' ' 125' ' ' THR . 1.0 OUTLIER -68.74 -43.7 75.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.012 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -50.77 -39.47 52.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.18 -44.19 75.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.0 110.381 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 45.6 p -60.89 -31.62 71.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.15 -0.969 . . . . 0.0 110.161 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.86 20.24 29.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 128' ' ' HIS . 2.2 mt-10 -88.9 23.13 2.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -1.162 . . . . 0.0 110.225 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.497 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 1.5 t60 56.94 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 128' ' ' HIS . 2.9 t 70.18 143.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.587 -0.696 . . . . 0.0 110.031 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.457 HG21 ' CE1' ' A' ' 128' ' ' HIS . 27.3 pt -123.18 146.85 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.137 -0.977 . . . . 0.0 110.491 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.64 -46.32 14.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 110.121 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.03 -28.93 1.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -48.98 6.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 22.6 mt -55.61 -39.29 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.074 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -58.28 -46.14 86.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.173 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -50.69 -52.11 43.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.6 OUTLIER -53.94 -43.27 69.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.089 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -71.08 -53.89 13.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.187 -0.946 . . . . 0.0 109.857 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -59.57 4.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -49.7 -40.51 40.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 110.202 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.54 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.2 t -77.12 -57.32 3.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER -61.15 75.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 110.551 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -79.66 4.12 17.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 179.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 144' ' ' ASN . 1.4 t30 -121.88 10.09 10.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.603 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.29 26.26 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -1.82 18.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.359 -0.838 . . . . 0.0 110.209 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.436 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 60.97 17.07 50.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.469 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 1.1 mtt-85 -158.34 143.39 16.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.33 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.54 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.7 mt -87.63 116.66 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.74 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 53.4 p-10 -101.42 -175.41 2.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -54.52 38.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.09 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.13 -62.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 110.367 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 68.1 mt-10 -57.21 -50.82 71.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.164 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 14.4 t80 -43.39 -56.18 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.869 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 159' ' ' GLU . 96.0 mt -61.72 -51.34 68.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . 7.1 mmtt -53.69 -50.56 65.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.501 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -50.93 -46.13 60.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.501 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -105.61 43.91 1.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.616 -0.678 . . . . 0.0 110.099 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -112.82 159.72 18.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.229 -0.92 . . . . 0.0 110.218 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.94 56.51 6.41 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.69 138.87 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -1.186 . . . . 0.0 110.067 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.171 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.219 0.533 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.51 151.08 19.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.125 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 91' ' ' LYS . . . -65.62 -144.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 110.017 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 90' ' ' ALA . 8.4 mttt -43.98 118.37 1.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.053 -1.03 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.481 ' O ' ' CG ' ' A' ' 93' ' ' LYS . . . -63.26 152.11 47.48 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER 37.94 -156.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.642 -0.916 . . . . 0.0 110.776 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -177.01 176.62 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.431 -0.793 . . . . 0.0 110.01 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -54.19 -35.44 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 110.108 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -42.45 -71.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.241 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 0.5 OUTLIER -48.98 -48.82 42.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.805 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 158' ' ' MET . 2.2 mm? -51.38 -61.45 2.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.039 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.11 -51.93 16.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.922 . . . . 0.0 110.228 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 71.6 m-20 -51.23 -34.04 30.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 110.143 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 97' ' ' GLU . 61.0 m -68.19 -15.09 63.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.215 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -56.24 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 100' ' ' ASN . 6.8 ptp180 -52.47 -37.67 57.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.289 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.427 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 13.0 mm -57.8 -45.76 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 110.261 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -53.95 34.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.21 146.52 54.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.509 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -125.49 -47.1 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.977 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -79.04 2.76 19.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.45 59.35 3.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.174 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.7 -21.52 20.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.23 -15.99 60.62 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 40.5 m-85 -153.09 130.06 11.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 110.043 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.468 HG21 ' CB ' ' A' ' 117' ' ' GLU . 3.2 mt -82.45 125.1 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.893 . . . . 0.0 110.626 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 7.6 p-10 -104.27 -157.81 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.825 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -75.5 -37.39 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.133 -0.98 . . . . 0.0 109.976 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.511 ' N ' HG21 ' A' ' 115' ' ' ILE . 57.1 mt-10 -55.71 -44.4 77.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.468 ' CB ' HG21 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -63.78 -44.46 93.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.76 -33.98 67.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -65.89 -74.21 0.54 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -42.12 -59.87 1.63 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.222 -1.163 . . . . 0.0 110.961 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 120' ' ' GLU . 4.2 mt -43.69 -50.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.001 -1.062 . . . . 0.0 109.974 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.1 mt -77.4 -42.45 36.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.398 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 44.6 mtt180 -55.68 -32.85 63.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.94 48.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.0 110.125 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.8 p -77.14 -157.66 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.92 58.12 0.69 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.06 164.48 26.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -1.137 . . . . 0.0 110.506 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.12 94.01 7.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.881 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.73 72.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.327 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 19.0 pt -62.57 159.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.2 tt0 -46.19 -49.5 16.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.481 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 2.4 mt-10 -40.99 -35.8 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.334 -0.854 . . . . 0.0 110.381 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.31 -47.46 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 17.6 mt -60.14 -41.03 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.423 ' CG ' ' HG2' ' A' ' 131' ' ' GLU . 4.9 mm-40 -57.6 -36.79 72.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.513 -0.742 . . . . 0.0 110.051 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -51.25 -50.32 59.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.845 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.1 OUTLIER -56.68 -43.91 80.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.516 ' CE ' HD13 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -68.24 -43.84 77.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 110.043 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -64.9 -43.46 92.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.42 -33.21 69.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 0.0 110.327 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.498 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.9 OUTLIER -86.03 -61.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.935 . . . . 0.0 110.394 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 60.6 t0 -41.14 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.559 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 143' ' ' LYS . 76.4 tttt -99.18 2.5 45.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.525 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 0.6 OUTLIER -134.41 16.85 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.662 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 8.9 m-20 48.01 51.53 14.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.443 -0.786 . . . . 0.0 110.341 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -104.61 4.57 32.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.88 11.18 60.22 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 6.0 mtp180 -147.56 146.43 29.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.142 -1.211 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.516 HD13 ' CE ' ' A' ' 138' ' ' MET . 4.7 mt -89.72 113.83 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.364 -0.835 . . . . 0.0 109.998 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.49 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 48.8 p30 -90.02 179.18 6.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.421 ' O ' ' HG ' ' A' ' 155' ' ' LEU . 16.8 m-85 -42.82 -59.19 2.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.349 -0.844 . . . . 0.0 110.28 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.94 -56.89 15.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.49 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 45.8 mt-10 -57.36 -46.9 82.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.517 ' HA ' ' CE ' ' A' ' 157' ' ' MET . 35.5 t80 -59.53 -56.36 22.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 151' ' ' PHE . 32.4 mt -45.74 -48.67 15.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 -57.92 6.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 0.0 110.081 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.57 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.3 ptp -47.45 -50.77 22.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.715 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.57 ' N ' ' CG ' ' A' ' 157' ' ' MET . 13.1 mmt -66.88 -32.19 73.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.424 -0.798 . . . . 0.0 110.352 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 160' ' ' GLY . 9.0 tt0 -86.99 157.66 19.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.045 -1.034 . . . . 0.0 110.085 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' GLU . . . 45.05 56.37 6.0 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 158' ' ' MET . 20.4 t -84.11 143.37 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -1.133 . . . . 0.0 110.245 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.246 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.193 0.521 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -93.78 -49.81 5.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.158 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.14 -168.97 3.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.094 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -124.01 52.19 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . -97.66 104.31 2.98 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.434 ' O ' ' OG ' ' A' ' 94' ' ' SER . 0.0 OUTLIER 44.23 -157.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -1.174 . . . . 0.0 110.049 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 93' ' ' LYS . 1.3 m 179.8 157.65 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.98 . . . . 0.0 110.444 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.407 ' HG2' HD23 ' A' ' 155' ' ' LEU . 1.3 tt0 -50.03 -49.26 51.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 110.071 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.12 -51.05 34.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 110.229 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -48.59 -60.14 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 110.342 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 99' ' ' ALA . 28.5 mt -58.96 -58.54 8.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.47 -40.39 2.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.144 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 90.8 m-20 -62.34 -35.63 79.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 98' ' ' LEU . 71.8 m -67.57 -36.54 81.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 43.0 t80 -42.67 -56.34 3.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 110.22 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -44.53 61.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 104' ' ' ILE . 1.7 mp -62.82 -54.55 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.339 -0.851 . . . . 0.0 109.913 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -58.63 -43.2 89.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 109.934 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.456 ' OD1' ' OE1' ' A' ' 117' ' ' GLU . 14.0 t0 -85.19 109.02 18.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -122.08 -28.92 4.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.449 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 5.6 p30 -97.15 -44.33 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -87.54 -42.24 12.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.887 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 7.6 m-20 47.93 23.96 0.55 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . -142.83 -36.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 76.7 m-85 -149.63 136.94 19.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -1.101 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.42 ' CD1' ' CD1' ' A' ' 154' ' ' PHE . 24.3 mt -82.56 131.5 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.101 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.444 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 28.4 p30 -119.11 -162.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -83.05 -42.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.508 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -52.49 -41.57 63.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' OE1' ' OD1' ' A' ' 106' ' ' ASP . 2.2 mt-10 -64.93 -37.93 89.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.49 ' CD1' HD13 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -65.82 -46.24 79.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.972 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -46.01 -75.66 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' GLY . 5.1 pt-20 -43.24 -47.76 6.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -1.125 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.94 -55.42 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 110.113 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.49 HD13 ' CD1' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -63.14 -43.16 99.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.986 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -38.92 64.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.274 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.81 -30.86 6.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -0.945 . . . . 0.0 110.265 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 44.2 p -73.85 -29.85 62.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.77 53.84 1.88 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' A' ' 127' ' ' GLU . 5.7 mm-40 -129.71 148.47 51.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -1.13 . . . . 0.0 110.214 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.502 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 23.2 p80 -71.3 58.34 0.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.13 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.459 ' O ' HG21 ' A' ' 130' ' ' ILE . 4.5 t -75.9 151.81 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 110.274 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.459 HG21 ' O ' ' A' ' 129' ' ' VAL . 28.0 pt -139.61 155.94 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.885 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.474 ' CA ' ' OE1' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -48.03 -47.88 33.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 3.6 mm-40 -42.11 -38.22 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -48.84 7.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 10.6 mt -61.46 -43.27 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -0.865 . . . . 0.0 109.748 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.514 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 3.5 mm-40 -53.11 -49.06 67.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 135' ' ' GLU . 12.5 t0 -43.75 -53.86 5.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.825 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.2 OUTLIER -50.66 -57.67 7.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.457 ' HE3' HD13 ' A' ' 149' ' ' ILE . 1.4 ttm -58.05 -34.86 70.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.178 -0.952 . . . . 0.0 109.583 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -70.56 -51.51 28.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.194 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -67.97 -40.36 83.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.372 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -57.69 -46.76 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 141' ' ' SER . 0.4 OUTLIER -44.36 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.235 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.6 OUTLIER -93.59 2.69 56.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.145 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 146' ' ' ASP . 4.2 m-80 -141.32 21.45 2.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.69 24.44 10.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' CG ' ' HB2' ' A' ' 144' ' ' ASN . 42.3 m-20 -69.95 -11.79 61.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 0.0 110.192 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.442 ' C ' ' HG3' ' A' ' 148' ' ' ARG . . . 79.6 -6.47 57.99 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.442 ' HG3' ' C ' ' A' ' 147' ' ' GLY . 45.3 mtt180 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.527 HG12 ' CB ' ' A' ' 141' ' ' SER . 20.3 mt -85.27 126.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.0 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 13.0 p-10 -109.01 -163.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.419 ' CZ ' HD13 ' A' ' 155' ' ' LEU . 56.2 t80 -57.81 -57.66 11.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 110.5 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -62.95 1.31 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.549 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.424 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 4.0 mt-10 -57.29 -43.93 83.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' MET . 82.6 t80 -48.41 -50.58 30.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.059 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 161' ' ' VAL . 11.6 mt -57.25 -54.15 50.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.337 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -60.33 -40.1 89.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.304 -0.873 . . . . 0.0 110.735 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -49.98 -40.46 44.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 109.647 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.528 ' HB3' ' CG2' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -64.21 -6.95 7.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.558 -0.714 . . . . 0.0 110.543 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 158' ' ' MET . 1.2 mt-10 59.28 139.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.357 -0.839 . . . . 0.0 110.428 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.41 25.07 69.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 158' ' ' MET . 42.5 t -106.88 155.06 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -1.102 . . . . 0.0 110.268 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.28 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.303 0.573 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 90' ' ' ALA . 12.3 m-20 53.95 -166.2 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -0.953 . . . . 0.0 110.081 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 89' ' ' ASP . . . 44.3 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.241 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -43.05 123.61 2.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.293 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 142.63 145.62 4.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.434 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 17.4 pttm -166.66 157.76 12.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -1.123 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.9 175.14 6.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.268 -0.895 . . . . 0.0 110.37 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.03 -54.18 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.341 -0.85 . . . . 0.0 110.2 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.83 -65.82 0.46 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 110.147 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 19.3 mm-40 -52.23 -45.24 65.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.528 HD22 ' CD1' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -46.73 -61.78 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.277 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -41.55 -57.95 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -70.13 -53.78 15.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.46 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.1 m -47.99 -22.28 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.521 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 151' ' ' PHE . 59.2 t80 -51.7 -51.93 52.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -26.69 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.316 -0.865 . . . . 0.0 110.648 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 37.1 mm -68.13 -58.73 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.037 . . . . 0.0 110.332 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -51.31 -34.16 32.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 13.8 t0 -73.39 89.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.269 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -83.25 -20.38 34.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 7.9 p30 -114.47 -1.29 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' N ' ' OD1' ' A' ' 106' ' ' ASP . . . 66.73 69.77 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.327 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 4.3 p30 -108.72 -22.13 12.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.183 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.551 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 91.35 -3.64 79.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 6.9 m-85 -152.72 129.23 10.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.9 114.53 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.984 . . . . 0.0 109.8 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 116' ' ' GLU . 3.1 p30 -88.1 -176.16 5.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.582 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 1.9 tp -65.47 -40.78 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 110.09 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.503 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -54.71 -52.49 62.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 110.27 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 121' ' ' ILE . 52.2 mt-10 -51.91 -44.58 63.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.327 -0.858 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -53.11 -52.47 58.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.109 -0.994 . . . . 0.0 110.27 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.99 -66.69 2.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.8 pt-20 -48.06 -45.69 32.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 110.457 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.524 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 12.2 mt -52.97 -60.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.008 . . . . 0.0 109.973 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 125' ' ' THR . 16.8 mt -63.98 -38.67 91.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -64.4 -41.94 96.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.413 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 120' ' ' GLU . . . -55.1 -39.22 69.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 24.9 p -55.95 -19.75 13.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.325 -0.859 . . . . 0.0 110.301 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.21 30.42 7.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -119.9 167.46 12.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -1.16 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 128' ' ' HIS . 51.7 p-80 -113.03 75.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 110.301 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 122' ' ' LEU . 5.6 t -83.06 133.1 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.521 HD11 ' CB ' ' A' ' 132' ' ' GLU . 17.8 pt -85.42 152.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 2.3 mm-40 -52.53 -38.51 59.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.277 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.521 ' CB ' HD11 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.25 -38.04 0.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.377 -0.827 . . . . 0.0 110.686 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -45.66 9.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.123 -0.986 . . . . 0.0 109.636 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 40.1 mt -57.68 -38.36 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.798 . . . . 0.0 109.734 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 2.9 mt-10 -68.34 -36.33 79.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -58.51 -48.76 79.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.162 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.454 HD22 ' HE2' ' A' ' 157' ' ' MET . 97.2 mt -49.15 -44.38 42.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 0.0 110.199 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.51 ' O ' ' N ' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -68.94 -48.64 62.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.063 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -55.32 -35.5 65.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.29 -27.4 59.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.324 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.537 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -106.37 -60.75 1.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.861 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 138' ' ' MET . 14.7 t0 -38.24 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.77 . . . . 0.0 110.79 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.0 OUTLIER -86.57 -40.53 15.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.633 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.475 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 13.9 m-80 -92.19 17.7 9.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 49.49 25.46 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 11.1 p-10 -78.66 2.8 18.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.132 -0.98 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.92 30.98 79.43 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -158.1 129.75 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.192 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' A' ' 141' ' ' SER . 1.2 mt -83.39 129.33 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.899 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 1.5 p-10 -100.45 -163.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.013 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.456 ' CE1' ' CZ ' ' A' ' 102' ' ' PHE . 73.9 m-85 -69.22 -51.1 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -50.12 70.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 110.632 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.54 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 72.9 mt-10 -56.92 -44.75 82.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.989 . . . . 0.0 110.533 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.528 ' CD1' HD22 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -52.97 -66.09 0.45 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.971 -1.081 . . . . 0.0 109.984 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.1 mt -43.87 -32.48 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.955 . . . . 0.0 109.626 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -28.98 55.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.415 -0.803 . . . . 0.0 109.928 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.551 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -61.85 -37.59 85.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.551 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.0 OUTLIER -109.01 43.35 1.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 109.779 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -104.23 -38.27 6.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 110.547 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.34 17.01 29.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 161' ' ' VAL . 8.6 p -62.95 144.27 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -1.141 . . . . 0.0 110.188 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.241 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 88' ' ' GLU . 2.0 mp0 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.235 0.541 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' GLU . 2.3 p30 -55.59 -164.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.87 . . . . 0.0 110.092 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.29 117.65 26.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.02 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.32 -34.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.258 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.35 104.12 2.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 45.99 83.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -1.139 . . . . 0.0 110.43 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.506 ' N ' ' HB2' ' A' ' 97' ' ' GLU . 0.3 OUTLIER -63.08 162.53 11.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.995 . . . . 0.0 109.974 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 8.7 mt-10 -46.32 -52.44 12.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 110.161 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -68.44 -42.05 79.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 109.751 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.506 ' HB2' ' N ' ' A' ' 94' ' ' SER . 58.9 mm-40 -58.32 -36.03 72.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.708 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.454 ' CD2' HD21 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -84.52 -45.7 12.34 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.361 -0.837 . . . . 0.0 109.265 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 95' ' ' GLU . . . -47.43 -34.61 7.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.093 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.462 ' O ' HD11 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -47.61 -40.28 19.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.863 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -54.21 -21.4 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.993 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.45 -64.71 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.988 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -51.06 -39.2 55.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.77 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 100' ' ' ASN . 1.6 mp -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.289 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.571 ' CZ ' ' HE3' ' A' ' 158' ' ' MET . 4.7 m-85 -60.31 -52.06 66.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 109.546 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -67.61 87.53 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -88.79 -34.04 17.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.357 -0.839 . . . . 0.0 110.804 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 17.3 p30 -81.2 4.48 20.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.059 -1.026 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 84.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.456 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 2.3 p30 -128.1 -34.16 2.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.452 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 118.3 -24.47 8.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.501 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 67.3 m-85 -148.93 126.72 11.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -1.135 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.496 ' CD1' ' HB3' ' A' ' 105' ' ' PHE . 42.5 mt -83.58 126.96 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -105.05 -178.29 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.355 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 2.8 tp -56.09 -39.99 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.0 mm-40 -56.97 -58.12 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.442 ' OE1' HG12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -46.31 -34.98 4.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.201 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.468 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 0.6 OUTLIER -70.59 -155.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' CA ' HD12 ' A' ' 134' ' ' ILE . . . 68.65 -80.72 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -51.04 -55.02 19.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.12 . . . . 0.0 110.428 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.431 ' C ' ' O ' ' A' ' 120' ' ' GLU . 10.4 mt -42.09 -44.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 110.43 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 118' ' ' LEU . 45.8 mt -72.28 -49.71 32.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -48.69 -35.78 14.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -0.889 . . . . 0.0 110.538 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.08 -42.29 60.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 32.1 p -68.03 -7.35 28.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.319 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 81.09 41.67 10.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -121.69 140.78 51.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.44 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 23.0 p80 -82.16 111.78 18.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.436 HG22 ' C ' ' A' ' 128' ' ' HIS . 10.6 t -126.12 156.18 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 12.9 pt -130.39 158.07 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.7 mt-10 -47.92 -49.77 29.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -42.65 -36.98 1.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' O ' HD11 ' A' ' 137' ' ' LEU . 0.4 OUTLIER -86.89 -48.07 8.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.29 179.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.459 HD12 HG22 ' A' ' 134' ' ' ILE . 22.9 mt -54.23 -36.45 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.482 -0.762 . . . . 0.0 109.694 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.528 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 51.8 mt-10 -60.89 -47.15 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.14 -39.52 56.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 133' ' ' ASP . 6.0 mp -61.74 -46.77 88.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 110.21 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.459 ' CE ' HD13 ' A' ' 149' ' ' ILE . 30.4 tpp -65.05 -48.21 74.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.88 85.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.943 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.89 -33.17 73.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.114 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.467 ' CB ' HG12 ' A' ' 149' ' ' ILE . 6.9 t -84.1 -56.02 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 15.0 m-20 -42.32 103.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 110.57 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.74 -16.49 55.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.706 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 2.1 p30 -124.82 14.84 8.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.872 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.17 73.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 147' ' ' GLY . 10.0 p-10 -128.28 22.58 6.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -0.834 . . . . 0.0 109.805 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.434 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 43.17 36.6 2.9 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -157.9 120.84 3.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -1.166 . . . . 0.0 110.474 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.467 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.1 mt -83.69 120.79 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.474 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 6.7 p-10 -90.06 -152.02 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -82.08 -39.51 23.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.329 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.18 -56.69 4.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 0.0 110.691 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.474 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 29.8 mt-10 -46.75 -36.07 6.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.495 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 157' ' ' MET . 32.6 t80 -56.2 -56.42 21.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 98' ' ' LEU . 2.6 mt -52.42 -54.07 36.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.401 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.34 -38.44 58.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -0.917 . . . . 0.0 110.475 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.512 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.2 ptm -65.88 -49.0 69.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.571 ' HE3' ' CZ ' ' A' ' 105' ' ' PHE . 3.9 mtt -95.62 37.06 1.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.284 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -95.73 -34.16 12.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 109.759 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.13 38.56 2.28 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 12.5 p -57.75 152.57 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -1.109 . . . . 0.0 110.595 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.229 0.538 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -96.92 42.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 110.189 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.42 110.56 1.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 110.294 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.28 17.36 2.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 110.237 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.64 -142.08 15.41 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HB3' HD13 ' A' ' 98' ' ' LEU . 3.2 mmtt -72.65 82.94 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -1.135 . . . . 0.0 110.295 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.71 162.75 27.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.151 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -51.55 -50.4 60.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.913 . . . . 0.0 110.264 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -47.95 -46.57 32.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.127 -0.983 . . . . 0.0 110.125 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.4 tp10 -58.91 -55.69 31.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -61.85 -56.7 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 151' ' ' PHE . . . -45.24 -39.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.685 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -54.46 -46.31 73.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.884 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 98' ' ' LEU . 1.1 m -52.28 -41.01 62.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.326 -0.859 . . . . 0.0 109.88 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' CYS . 14.9 t80 -43.83 -51.73 7.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.758 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -60.66 -36.27 78.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.811 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 104' ' ' ILE . 47.8 mm -66.6 -43.58 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.569 ' CD2' HD12 ' A' ' 121' ' ' ILE . 1.3 m-85 -71.96 -40.06 68.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.873 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -79.19 88.38 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.85 68.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.37 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -70.47 -11.44 60.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 110.425 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.19 51.09 16.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.11 -27.19 22.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.48 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 128.53 -20.3 5.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 98.4 m-85 -151.21 134.15 15.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -1.178 . . . . 0.0 110.28 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.7 mt -82.75 149.46 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 -164.03 0.89 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.5 tt -77.38 -38.68 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.186 -0.946 . . . . 0.0 110.463 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 95.5 mt-10 -60.76 -61.43 2.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 121' ' ' ILE . 20.9 mt-10 -42.55 -38.97 2.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 110.409 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 3.5 tp -60.05 -31.12 69.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.464 ' O ' ' CG ' ' A' ' 123' ' ' ARG . . . -73.03 -72.17 1.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 12.7 pt-20 -42.49 -43.49 3.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.184 -1.186 . . . . 0.0 110.509 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.569 HD12 ' CD2' ' A' ' 105' ' ' PHE . 27.5 mt -57.93 -50.46 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.484 ' O ' ' CG2' ' A' ' 125' ' ' THR . 20.4 mt -67.74 -69.89 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.873 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 120' ' ' GLU . 2.4 ptm180 -49.88 -24.09 2.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.921 . . . . 0.0 110.651 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 120' ' ' GLU . . . -54.54 -44.19 72.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 110.008 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.486 ' CG2' ' HG3' ' A' ' 127' ' ' GLU . 1.8 t -80.91 9.34 6.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.468 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.2 17.7 58.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.486 ' HG3' ' CG2' ' A' ' 125' ' ' THR . 46.6 mt-10 -84.05 121.2 27.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -1.136 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 87.24 2.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.873 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 122' ' ' LEU . 3.4 t -109.61 146.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.44 HD11 HG21 ' A' ' 130' ' ' ILE . 31.7 pt -119.55 159.7 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.145 -0.972 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' ILE . 4.8 tt0 -41.43 -49.86 3.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.36 -28.91 13.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 0.0 110.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -43.38 11.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 134' ' ' ILE . 30.0 mt -67.92 -38.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.07 -36.87 82.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.39 -0.819 . . . . 0.0 110.421 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.83 -52.4 65.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 0.0 110.681 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.418 ' HB3' HD22 ' A' ' 118' ' ' LEU . 1.4 mp -49.86 -44.27 49.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.308 -0.87 . . . . 0.0 110.899 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.485 ' O ' ' N ' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -64.83 -48.04 75.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.056 -1.028 . . . . 0.0 110.053 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -60.1 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 110.62 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.47 -33.21 67.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -85.7 -62.47 1.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.146 -0.971 . . . . 0.0 110.717 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 138' ' ' MET . 0.5 OUTLIER -47.4 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.621 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 ttpp -89.4 -3.81 58.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.814 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -120.69 12.03 11.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 51.23 39.26 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.417 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -101.37 23.06 11.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 44.98 35.58 4.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 19.4 mtt180 -158.35 128.32 5.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -1.21 . . . . 0.0 110.458 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.527 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.5 mt -84.21 167.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.091 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 48.2 p30 -149.13 -163.68 1.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -64.6 -56.07 16.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.403 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -56.74 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.656 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 141' ' ' SER . 84.8 mt-10 -59.53 -44.53 93.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 110.515 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 21.6 t80 -54.62 -52.0 63.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.095 -1.003 . . . . 0.0 110.132 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 159' ' ' GLU . 27.4 mt -57.34 -42.16 81.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -54.2 -60.29 3.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.6 OUTLIER -48.26 -52.81 19.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.025 -1.047 . . . . 0.0 109.551 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -104.72 52.97 0.74 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.411 -0.806 . . . . 0.0 110.227 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 4.5 tp10 -92.34 -53.82 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -103.09 32.99 6.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.81 149.22 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -1.167 . . . . 0.0 110.121 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.263 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.284 0.564 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.29 -49.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -104.72 152.15 22.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -68.08 111.83 4.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.087 -1.008 . . . . 0.0 110.298 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.63 -139.85 5.26 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -173.74 31.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.243 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -46.63 167.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.141 -0.974 . . . . 0.0 110.121 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.456 ' HA ' HD23 ' A' ' 155' ' ' LEU . 0.4 OUTLIER -42.62 -45.19 4.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.895 . . . . 0.0 110.326 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -49.25 -54.31 17.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 110.224 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.94 -58.56 6.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 0.0 110.58 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.455 HD11 ' SD ' ' A' ' 158' ' ' MET . 20.2 mt -50.97 -60.75 2.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.289 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.68 -50.74 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -55.15 -50.5 69.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.948 . . . . 0.0 110.246 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.92 -9.61 31.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.367 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 83.3 t80 -50.96 -61.69 2.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.514 ' HG3' ' N ' ' A' ' 104' ' ' ILE . 12.3 ptp180 -57.12 -36.04 70.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 110.458 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.514 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 1.0 OUTLIER -58.72 -34.06 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.665 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 107' ' ' LYS . 4.9 m-85 -83.65 -35.48 24.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.87 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 109' ' ' ALA . 48.1 t0 -67.78 59.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -46.6 -41.03 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 110' ' ' ASP . 46.8 t30 -69.51 -13.62 62.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.159 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 106' ' ' ASP . . . 45.49 54.98 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.857 . . . . 0.0 110.231 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.466 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 23.5 p-10 -108.65 -3.23 18.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.2 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.509 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 101.49 -19.4 50.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 95.8 m-85 -153.17 123.69 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -1.2 . . . . 0.0 110.434 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 117' ' ' GLU . 4.8 mt -82.87 132.28 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 110.304 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.71 -179.6 4.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.081 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.7 tt -59.94 -36.82 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.94 -52.69 39.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.443 ' HB2' HG23 ' A' ' 113' ' ' ILE . 15.3 mt-10 -57.66 -54.74 43.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -0.809 . . . . 0.0 110.311 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.549 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.1 mp -43.15 -39.78 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.464 ' HA2' HD12 ' A' ' 134' ' ' ILE . . . -59.75 -80.31 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.463 ' OE2' HG13 ' A' ' 121' ' ' ILE . 0.7 OUTLIER -48.3 -50.7 29.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -1.19 . . . . 0.0 110.297 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.463 HG13 ' OE2' ' A' ' 120' ' ' GLU . 10.3 mt -44.93 -55.07 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 110.137 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.1 mt -68.37 -62.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.51 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -48.76 -39.97 27.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 120' ' ' GLU . . . -52.84 -52.27 57.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.927 . . . . 0.0 110.212 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 121' ' ' ILE . 31.1 p -54.75 -32.44 59.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.59 -1.36 23.39 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -58.66 -17.02 18.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -1.164 . . . . 0.0 110.056 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 18.2 t-160 46.38 57.21 5.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.8 t -89.56 153.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.6 pt -98.06 154.85 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 110.2 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 132' ' ' GLU . 68.9 mt-10 -49.44 -51.41 35.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.539 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -41.81 -34.27 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.635 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -48.16 9.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.44 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.549 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 18.1 mt -55.52 -40.03 56.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.077 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -58.03 -53.89 53.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.626 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -45.03 37.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.962 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.454 HD21 ' HE3' ' A' ' 157' ' ' MET . 0.1 OUTLIER -55.67 -37.19 67.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.106 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.437 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 19.1 tpp -69.95 -44.76 68.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.394 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -51.27 62.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.396 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -55.34 -31.27 61.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.528 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -87.9 -51.2 5.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.374 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.7 OUTLIER -42.56 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.8 OUTLIER -76.2 -1.51 26.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.963 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.505 ' ND2' ' OD2' ' A' ' 146' ' ' ASP . 1.5 p30 -153.8 27.48 0.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 43.78 75.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 110.501 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.505 ' OD2' ' ND2' ' A' ' 144' ' ' ASN . 3.8 p30 -121.28 -0.29 9.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 70.88 24.16 77.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 5.4 mtt-85 -158.67 135.43 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.449 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.528 HG12 ' CB ' ' A' ' 141' ' ' SER . 16.6 mt -91.06 136.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.478 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 26.7 p-10 -112.44 -173.03 2.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.922 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 42.2 p90 -68.07 -28.41 67.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 110.392 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.428 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -78.14 -42.21 32.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.639 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.478 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 89.4 mt-10 -69.71 -37.15 76.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -0.986 . . . . 0.0 110.513 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.466 ' O ' ' HG2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.04 -33.29 51.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.964 . . . . 0.0 110.351 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 95' ' ' GLU . 81.8 mt -70.61 -62.56 1.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 159' ' ' GLU . 21.4 mttm -53.4 -34.92 59.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.907 . . . . 0.0 110.566 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.536 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -53.79 -49.72 67.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.229 -0.919 . . . . 0.0 110.571 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.536 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -99.37 -9.95 22.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.913 . . . . 0.0 110.447 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -43.09 129.58 4.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 0.0 110.318 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 159' ' ' GLU . . . 43.28 63.84 1.96 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 161' ' ' VAL . 11.0 p -82.96 150.97 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -1.125 . . . . 0.0 110.305 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.097 179.95 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.202 0.525 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -157.49 137.31 12.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.491 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 89' ' ' ASP . . . 69.95 162.88 0.24 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.877 . . . . 0.0 110.75 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.74 133.53 47.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.227 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . -99.72 159.37 19.68 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.471 ' CG ' ' OE2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 44.08 81.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -1.141 . . . . 0.0 110.25 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 93' ' ' LYS . 6.5 m -43.46 146.06 0.54 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.167 -0.958 . . . . 0.0 110.023 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 96' ' ' GLU . 58.1 mm-40 -40.86 -40.35 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 110.456 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' GLU . 30.0 mm-40 -42.01 -40.45 2.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 110.385 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.471 ' OE2' ' CG ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -60.46 -56.86 16.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 4.3 mm? -59.69 -51.44 69.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.34 -44.24 3.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -51.78 -47.16 64.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.106 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.81 -31.79 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 113' ' ' ILE . 18.1 t80 -51.45 -42.07 61.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.933 . . . . 0.0 110.086 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -41.04 99.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.263 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 30.6 mm -59.0 -49.09 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 110.076 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -57.49 -35.48 70.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.756 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.91 113.14 25.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.661 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -109.12 6.33 24.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.408 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 2.5 p30 -131.41 22.61 4.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.435 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 108' ' ' ASN . . . 50.3 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.78 -37.39 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.434 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 92.21 -7.29 78.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 53.2 m-85 -153.13 125.62 8.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -1.152 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 2.7 mp -83.7 125.49 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -104.91 -176.04 2.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.052 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -63.46 -37.77 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.854 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.405 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 9.2 mm-40 -59.0 -56.3 23.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 109.982 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 15.9 mt-10 -45.5 -54.06 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.434 ' HB3' HG22 ' A' ' 134' ' ' ILE . 1.2 tp -51.19 -27.94 10.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.32 -75.64 0.35 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.2 pt-20 -45.52 -44.39 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -1.183 . . . . 0.0 110.571 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.528 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 48.5 mt -48.43 -70.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.496 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.508 ' O ' ' CG2' ' A' ' 125' ' ' THR . 97.6 mt -48.76 -49.89 36.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 110.577 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -52.89 -38.41 61.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.977 . . . . 0.0 110.537 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.05 -59.97 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 110.528 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 126' ' ' GLY . 7.4 t -59.38 -26.06 64.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.396 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 125' ' ' THR . . . 92.02 37.54 5.98 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HG3' HG21 ' A' ' 125' ' ' THR . 2.1 mm-40 -86.79 -10.43 53.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -1.218 . . . . 0.0 110.029 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.71 82.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.11 166.14 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 131' ' ' GLU . 4.7 pt -117.13 146.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.102 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.9 pt-20 -39.57 -42.92 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 0.0 110.858 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -43.4 -40.08 3.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 110.328 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.44 -44.44 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 118' ' ' LEU . 66.8 mt -56.75 -35.72 46.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.674 0.75 . . . . 0.0 109.509 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.458 ' HA ' HD13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -68.6 -39.58 80.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.692 -0.63 . . . . 0.0 110.239 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.29 -50.29 72.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -45.63 -50.73 13.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.021 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.513 ' CE ' HD11 ' A' ' 149' ' ' ILE . 3.3 ttm -67.22 -46.6 73.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.923 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.31 -53.55 6.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.6 -49.98 73.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.529 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.1 t -69.72 -64.47 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.457 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 138' ' ' MET . 30.5 t0 -43.19 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 141' ' ' SER . 3.3 tptm -96.9 -13.64 22.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.467 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 6.2 m-80 -101.42 16.36 25.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 52.43 18.81 1.01 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 16.9 p30 -80.94 -0.18 38.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . 62.18 28.27 70.44 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 9.9 mtt180 -152.58 135.12 15.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.158 -1.201 . . . . 0.0 110.373 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 141' ' ' SER . 5.9 mt -83.65 116.3 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 0.0 109.86 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -97.77 -170.36 1.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -52.99 -58.78 5.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.366 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.06 -64.94 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.955 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.473 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 44.9 mt-10 -50.65 -51.98 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.481 ' O ' ' HG2' ' A' ' 157' ' ' MET . 42.0 t80 -50.53 -56.74 10.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 154' ' ' PHE . 46.9 mt -42.52 -51.31 5.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.345 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -62.2 -46.98 86.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 110.745 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.518 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.5 ptm -43.27 -46.5 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 109.85 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.518 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.8 OUTLIER -92.93 47.89 1.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 110.195 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -98.35 118.63 35.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.69 11.27 80.59 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.49 155.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -1.181 . . . . 0.0 110.117 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.229 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 89' ' ' ASP . 1.9 m-20 -89.65 55.85 3.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.42 -136.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 110.061 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.95 -17.56 27.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 0.0 110.361 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.98 70.64 1.28 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' HD2' ' OE2' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -64.42 126.06 26.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -1.173 . . . . 0.0 110.36 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.66 172.87 6.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.95 . . . . 0.0 110.21 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -49.51 -48.96 47.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 110.138 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -43.72 -49.38 7.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.955 . . . . 0.0 109.894 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.411 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 0.8 OUTLIER -54.65 -54.59 39.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.944 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 3.5 mm? -50.52 -49.38 55.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.881 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -53.55 -57.02 12.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 110.258 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -48.57 -50.16 33.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.82 -20.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 56.6 t80 -53.85 -51.24 64.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.486 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -29.19 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.163 -0.961 . . . . 0.0 110.489 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.5 -27.92 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.121 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -84.9 -55.73 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 110.336 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -50.82 131.62 26.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -0.817 . . . . 0.0 110.259 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -123.03 2.22 9.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 109' ' ' ALA . 73.5 m-20 -125.02 26.41 7.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.356 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.93 49.44 5.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -93.32 -31.75 14.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.382 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.473 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 96.41 -14.51 64.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.473 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 27.2 m-85 -147.7 131.7 17.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 mt -82.95 116.05 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 110.631 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 3.8 p-10 -100.87 175.9 5.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.808 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.48 ' N ' ' HE2' ' A' ' 138' ' ' MET . 1.2 tp -53.48 -41.56 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -51.48 -54.96 21.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 121' ' ' ILE . 31.8 mt-10 -56.8 -56.23 24.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.7 OUTLIER -44.1 -38.62 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.493 ' HA2' HD12 ' A' ' 134' ' ' ILE . . . -59.74 -78.29 0.15 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -51.21 -45.99 62.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 110.259 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.495 HD13 HG23 ' A' ' 121' ' ' ILE . 14.9 mt -42.55 -61.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 110.38 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.517 HD12 ' CD2' ' A' ' 118' ' ' LEU . 4.2 mt -59.34 -56.87 16.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.433 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -48.67 -34.58 12.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.085 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 121' ' ' ILE . . . -51.93 -40.83 61.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.7 p -66.59 -17.42 64.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 0.0 109.989 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.38 20.34 13.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.49 154.29 19.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -1.141 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -107.37 70.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 0.0 109.661 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 122' ' ' LEU . 15.6 t -79.27 123.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.522 -0.736 . . . . 0.0 110.703 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 132' ' ' GLU . 47.3 pt -75.33 159.71 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.28 -32.22 68.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.987 . . . . 0.0 110.556 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.46 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -48.75 -35.59 14.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 110.497 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.02 -51.2 6.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.652 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.548 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 7.3 mt -55.76 -43.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.508 -0.745 . . . . 0.0 109.472 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.433 ' HG2' HD12 ' A' ' 115' ' ' ILE . 2.9 mm-40 -62.05 -38.75 89.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.656 -0.652 . . . . 0.0 109.955 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.13 -51.88 66.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 110.208 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.2 mt -50.75 -42.09 57.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.48 ' HE2' ' N ' ' A' ' 115' ' ' ILE . 42.9 tpp -66.96 -49.07 66.6 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -59.09 -41.98 89.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.946 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -25.73 68.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.551 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -97.54 -33.58 11.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 110.234 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.2 t0 -59.43 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 109.931 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -76.25 0.58 18.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.328 -0.858 . . . . 0.0 110.994 -179.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.471 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -151.71 20.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.919 -1.113 . . . . 0.0 110.533 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.35 71.21 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.662 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 148' ' ' ARG . 7.6 p-10 -126.95 12.08 7.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.749 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 45.4 30.65 3.08 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.417 ' O ' ' OD2' ' A' ' 146' ' ' ASP . 3.7 mtt180 -158.69 131.12 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 110.701 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.551 HG12 ' CB ' ' A' ' 141' ' ' SER . 8.0 mt -88.89 133.42 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.73 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 2.8 p30 -113.54 -164.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.436 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.6 -57.67 9.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.88 -57.7 11.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.619 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.471 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 73.2 mt-10 -54.25 -50.16 67.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.463 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 155' ' ' LEU . 64.2 t80 -49.68 -59.0 4.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.027 -1.045 . . . . 0.0 110.237 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 154' ' ' PHE . 9.8 mt -41.79 -66.06 0.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -34.16 14.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.62 -37.97 73.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 109.854 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.52 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.4 OUTLIER -112.21 27.05 9.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 110.63 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 155' ' ' LEU . 1.6 mt-10 -90.45 -172.82 3.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 0.0 110.007 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.07 40.46 82.92 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.2 t -129.96 157.52 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -1.168 . . . . 0.0 110.466 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.031 179.698 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.257 0.551 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.68 93.3 9.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.99 105.34 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.103 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -166.51 131.72 2.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.313 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.59 153.39 23.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -129.67 57.62 1.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -1.165 . . . . 0.0 110.27 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -45.12 153.1 0.21 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 110.167 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 94' ' ' SER . 6.4 tt0 -42.9 -45.94 5.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -64.1 -48.32 76.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.965 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.5 tp10 -58.84 -41.31 86.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 25.1 mt -61.66 -59.19 5.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.29 -43.64 10.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 22.0 m-20 -51.05 -45.98 61.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 102' ' ' PHE . 4.5 t -67.98 -22.86 64.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.003 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.501 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 14.1 t80 -42.31 -63.29 0.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 104' ' ' ILE . 4.7 ptt180 -62.23 -36.35 81.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.499 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 31.6 mm -59.65 -33.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.277 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -79.57 -65.98 0.93 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.906 . . . . 0.0 110.344 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 105' ' ' PHE . 48.3 t0 -42.58 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 105' ' ' PHE . 10.7 mttt -75.97 -10.25 59.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.213 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -102.14 -165.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 110.302 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.4 4.25 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.172 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.537 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 6.7 p-10 -66.37 -27.77 68.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.898 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 90.32 15.98 56.28 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 110' ' ' ASP . 38.0 m-85 -146.75 131.88 18.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.119 -1.224 . . . . 0.0 110.599 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.41 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 3.2 mt -83.16 131.74 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.406 -0.809 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 117' ' ' GLU . 24.3 p30 -100.52 -177.24 3.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 1.2 tt -64.93 -40.74 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 110.484 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.453 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -59.86 -52.02 67.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.038 . . . . 0.0 110.183 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 24.9 mt-10 -48.55 -42.85 34.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.911 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -58.35 -27.02 63.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 110.239 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -73.6 -72.87 0.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.4 pt-20 -41.91 -45.15 3.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.435 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.431 HD12 ' CD1' ' A' ' 105' ' ' PHE . 42.6 mt -57.44 -57.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.82 -44.31 56.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 110.61 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.22 -36.72 75.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 0.0 110.276 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.72 -40.44 20.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.011 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.0 p -56.17 -28.36 57.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 110.068 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.0 -31.52 6.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -49.99 125.78 12.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -1.097 . . . . 0.0 110.231 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.566 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -70.11 62.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.497 HG12 ' CG1' ' A' ' 134' ' ' ILE . 11.1 t -61.68 148.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 0.0 109.886 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 131' ' ' GLU . 5.8 pt -121.72 147.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 110.359 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -39.02 -36.67 0.31 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.576 -0.703 . . . . 0.0 110.761 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -35.43 62.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.687 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.06 -44.04 12.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.97 . . . . 0.0 109.697 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.497 ' CG1' HG12 ' A' ' 129' ' ' VAL . 15.9 mt -66.22 -36.96 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.387 -0.82 . . . . 0.0 110.138 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.17 -43.61 95.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -54.52 -53.38 55.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 141' ' ' SER . 2.1 mp -47.58 -41.31 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 110.509 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.477 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -71.69 -53.78 12.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 -57.07 4.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.754 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.27 -40.5 90.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.152 -0.967 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -75.26 -54.35 7.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 146' ' ' ASP . 0.3 OUTLIER -55.09 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 110.965 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -69.95 -46.29 65.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.049 -1.032 . . . . 0.0 109.466 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 9.0 p30 -82.78 -7.45 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 5.6 m120 63.39 82.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.43 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.513 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 10.7 p-10 -130.25 5.46 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 109.972 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 74.58 20.8 79.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 114' ' ' ASP . 35.5 mtm-85 -158.31 140.44 14.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -1.134 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.498 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.5 mt -90.46 137.64 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 109.79 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 150' ' ' ASP . 36.2 p-10 -110.01 -151.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.35 -55.51 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.589 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -54.7 43.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 110.461 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 142' ' ' ASP . 51.0 mt-10 -56.74 -53.48 57.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' GLU . 26.1 t80 -43.51 -51.54 6.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 0.0 110.396 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.13 -55.16 27.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -46.27 -41.48 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.985 . . . . 0.0 110.655 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.405 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.55 -46.81 62.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.808 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.405 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -99.47 42.33 1.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.71 133.3 41.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.124 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.86 30.65 75.77 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 162' ' ' GLN . 70.5 t -45.58 140.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -1.097 . . . . 0.0 110.498 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 161' ' ' VAL . 51.3 mt-30 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.422 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.322 0.582 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 25.9 t0 -50.62 -51.46 48.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.359 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 89' ' ' ASP . . . 60.44 -173.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 110.298 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 74.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.4 -51.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -144.96 140.25 28.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -1.149 . . . . 0.0 110.241 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.73 163.89 13.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HG3' ' CD2' ' A' ' 155' ' ' LEU . 33.9 tt0 -51.24 -43.48 61.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 110.276 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -44.59 -56.11 4.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.75 -56.19 17.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 110.451 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 99' ' ' ALA . 6.3 mt -56.9 -58.8 6.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.554 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -40.84 -52.49 3.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -0.823 . . . . 0.0 110.529 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.41 -54.95 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 69.4 m -48.38 -24.16 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 110.715 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 47.0 t80 -45.23 -49.83 12.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.995 -1.066 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -57.16 -32.2 66.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 43.7 mm -59.47 -40.4 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -78.17 -38.41 43.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 110.427 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -79.25 84.7 5.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -1.0 . . . . 0.0 110.303 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -32.02 22.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 110.229 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.427 ' OD1' ' CG ' ' A' ' 110' ' ' ASP . 4.2 p30 -100.6 14.87 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.11 69.31 0.69 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.117 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.427 ' CG ' ' OD1' ' A' ' 108' ' ' ASN . 3.6 m-20 -97.47 -17.16 19.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 110.23 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.48 40.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -150.45 146.49 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.031 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 mt -82.64 116.12 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 110.366 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -97.2 -178.54 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.858 . . . . 0.0 110.014 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 3.8 tp -67.96 -39.43 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.425 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 5.8 mt-10 -55.1 -52.8 62.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.373 -0.829 . . . . 0.0 110.235 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 23.1 mt-10 -50.2 -45.3 53.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.398 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.5 OUTLIER -57.66 -34.18 69.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.574 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -66.54 -73.56 0.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -42.06 -49.44 4.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -1.122 . . . . 0.0 110.561 -179.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.444 HG13 ' CD ' ' A' ' 120' ' ' GLU . 66.4 mt -55.07 -51.94 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.441 HD11 HD22 ' A' ' 118' ' ' LEU . 16.5 mt -64.71 -55.5 19.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.271 -0.893 . . . . 0.0 110.561 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.18 -36.71 73.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.887 . . . . 0.0 110.659 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.84 -30.93 4.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.9 p -66.23 -29.62 69.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.76 26.8 2.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -116.7 170.1 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -1.161 . . . . 0.0 110.397 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.39 62.68 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.712 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 5.5 t -65.57 126.82 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.412 ' O ' HG13 ' A' ' 134' ' ' ILE . 15.3 pt -81.15 154.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -41.76 96.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 110.676 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -47.83 -33.56 7.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.256 -0.902 . . . . 0.0 110.781 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.23 -47.93 11.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 109.513 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.517 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 11.3 mt -58.26 -37.68 64.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.559 -0.713 . . . . 0.0 109.628 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 32.8 mt-10 -60.37 -34.72 74.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 110.591 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 14.5 t0 -56.33 -55.02 38.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -43.43 26.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.91 . . . . 0.0 111.023 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.6 tpp -65.06 -51.58 60.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.096 -1.003 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 139' ' ' LYS . 7.5 tmtm? -63.01 -39.25 94.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.4 -0.813 . . . . 0.0 109.953 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -67.27 -32.9 74.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.429 -0.794 . . . . 0.0 110.251 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 143' ' ' LYS . 2.6 t -82.28 -64.28 1.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -44.36 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.48 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -89.26 -3.17 58.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.2 p30 -125.01 8.82 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.962 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 8.3 m120 59.26 39.27 22.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.465 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 19.3 p30 -72.85 -13.63 61.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 102.11 -11.77 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.495 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 70.9 mtt180 -158.43 177.94 10.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.152 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.521 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.6 mt -88.51 166.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 44.9 p-10 -144.35 -162.57 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.449 ' O ' ' CD1' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -73.26 -43.02 61.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.498 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -52.86 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.56 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 10.6 mt-10 -65.19 -39.98 93.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 3.5 t80 -54.75 -64.9 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.449 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.1 mt -42.22 -52.86 4.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -59.74 -37.12 78.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.487 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -62.01 -47.04 86.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.487 ' N ' ' CG ' ' A' ' 157' ' ' MET . 11.4 mmt -81.02 -41.79 22.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 110.43 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 38.0 mt-10 -50.17 101.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.136 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.71 25.49 29.81 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.55 135.63 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -1.114 . . . . 0.0 110.368 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.196 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.318 0.58 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -111.15 -61.34 1.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.873 . . . . 0.0 110.183 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.74 84.03 4.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 110.398 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -152.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.099 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.73 -156.95 8.34 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -169.46 -179.37 3.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -1.115 . . . . 0.0 110.113 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.57 -175.67 3.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 0.0 109.922 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 17.7 mp0 -56.74 -37.43 71.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.964 . . . . 0.0 109.88 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 95' ' ' GLU . 10.8 tt0 -43.03 -62.62 0.98 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.953 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.36 -33.34 71.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.857 . . . . 0.0 110.264 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 0.2 OUTLIER -67.06 -49.56 64.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.458 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.06 25.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.994 -1.066 . . . . 0.0 110.164 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -50.96 -43.41 60.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.45 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -56.01 -16.22 4.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.343 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -54.0 -64.78 0.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 110.893 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -31.52 63.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.042 -1.036 . . . . 0.0 110.669 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 35.1 mm -57.18 -43.27 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.418 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.462 ' O ' HD13 ' A' ' 121' ' ' ILE . 5.4 m-85 -75.03 -31.84 61.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.97 98.81 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 110.119 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -95.17 -11.47 28.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.94 56.41 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.97 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.84 -12.9 29.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.46 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.517 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 117.06 -20.65 11.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.517 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 65.5 m-85 -152.54 127.14 9.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.104 -1.233 . . . . 0.0 110.502 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 12.6 mt -83.04 118.44 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.55 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 22.2 p30 -89.55 -172.88 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.708 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 4.1 tp -63.28 -42.56 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.523 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 1.6 mt-10 -53.1 -55.27 25.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.247 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 121' ' ' ILE . 23.7 mt-10 -50.6 -43.82 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -59.28 -29.27 67.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.58 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.463 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -78.02 -60.23 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.7 pt-20 -52.4 -44.63 65.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -1.141 . . . . 0.0 110.529 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.523 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 94.6 mt -53.42 -48.22 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.135 -0.978 . . . . 0.0 110.017 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.2 -48.85 16.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.81 -32.72 9.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.855 . . . . 0.0 110.342 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.14 -28.15 50.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.307 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 127' ' ' GLU . 27.9 p -86.74 21.49 2.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 62.86 21.11 62.95 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.456 ' HB2' ' OG1' ' A' ' 125' ' ' THR . 3.2 mt-10 -96.69 112.65 24.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.187 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -74.15 81.94 1.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.404 HG11 HG12 ' A' ' 134' ' ' ILE . 32.0 t -90.3 137.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 131' ' ' GLU . 28.4 pt -104.93 155.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 10.2 mt-10 -41.96 -46.67 4.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.6 mm-40 -41.0 -37.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 0.0 109.904 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.87 -47.33 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.422 -0.799 . . . . 0.0 109.43 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 118' ' ' LEU . 12.1 mt -58.94 -40.7 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.813 . . . . 0.0 109.726 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -59.11 -52.35 66.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.186 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -46.32 -45.9 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.229 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.44 HD11 ' N ' ' A' ' 137' ' ' LEU . 4.4 mp -60.87 -54.75 41.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 110.035 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.493 ' HA ' HD11 ' A' ' 149' ' ' ILE . 2.2 ttm -67.0 -43.83 81.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -60.14 -43.42 95.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.314 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -68.46 -34.1 75.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.279 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.504 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -87.17 -62.78 1.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.526 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 138' ' ' MET . 21.8 t0 -50.94 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.728 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -82.13 -25.35 34.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -0.977 . . . . 0.0 110.042 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.482 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 9.0 m-80 -90.16 16.17 8.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.18 38.02 3.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.936 . . . . 0.0 110.074 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -97.27 14.16 27.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 114' ' ' ASP . . . 51.46 37.92 41.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 6.6 mtt180 -158.68 125.9 4.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.163 -1.198 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 141' ' ' SER . 4.0 mt -87.28 129.27 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.201 -0.937 . . . . 0.0 109.214 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -110.58 -167.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.628 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -57.45 10.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.523 -0.735 . . . . 0.0 111.038 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.41 -64.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.191 -0.943 . . . . 0.0 111.335 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.482 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 65.4 mt-10 -47.29 -31.58 3.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.088 -1.007 . . . . 0.0 110.992 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 157' ' ' MET . 21.7 t80 -64.9 -59.02 4.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 0.0 110.533 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.7 mt -47.28 -54.5 10.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 110.272 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -24.9 58.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 109.922 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.03 -38.05 75.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.375 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.513 ' N ' ' HG3' ' A' ' 157' ' ' MET . 18.8 ttm -103.94 40.63 1.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.93 70.09 0.98 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 110.024 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 146.0 -20.75 1.77 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.6 p -112.97 144.1 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.982 . . . . 0.0 109.967 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.278 -179.953 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.092 0.472 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -121.15 131.25 54.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.46 75.89 1.66 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 110.319 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -63.12 106.24 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 110.404 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.48 -37.44 0.49 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HE2' HD13 ' A' ' 98' ' ' LEU . 3.6 mtpt -151.6 139.68 20.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -1.098 . . . . 0.0 109.84 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 95' ' ' GLU . 2.0 m -126.22 160.69 29.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 110.562 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 99' ' ' ALA . 4.9 tt0 -44.28 -46.29 9.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.75 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -47.75 -53.31 15.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.917 . . . . 0.0 109.624 179.526 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -55.34 22.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.613 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.455 HD13 ' HE2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -64.18 -48.75 74.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.843 179.522 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 95' ' ' GLU . . . -42.35 -53.43 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 109.759 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 96' ' ' GLU . 68.7 m-80 -52.21 -38.96 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.4 -0.813 . . . . 0.0 109.923 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -25.93 52.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.584 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -49.7 -58.16 5.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.486 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -66.9 -34.95 78.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.931 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.482 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 12.2 mm -68.33 -48.91 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 110.831 -179.341 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' LYS . 1.6 m-30 -71.27 -43.76 66.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.694 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -68.16 70.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.95 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' CD ' ' O ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -61.23 -35.63 77.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.298 -179.952 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 109' ' ' ALA . 13.4 t30 -75.9 -5.22 45.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.86 . . . . 0.0 110.036 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.29 76.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.3 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -124.08 -2.9 8.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.441 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 100.16 -21.96 42.21 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CG ' ' O ' ' A' ' 111' ' ' GLY . 92.6 m-85 -152.24 140.04 19.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -1.195 . . . . 0.0 110.375 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.452 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 29.5 mt -82.53 110.08 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.117 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -87.89 -175.47 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.348 -0.845 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.9 OUTLIER -66.12 -29.72 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.248 -0.908 . . . . 0.0 110.676 -179.667 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.53 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -63.41 -50.26 70.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.129 -0.982 . . . . 0.0 110.262 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' A' ' 113' ' ' ILE . 8.4 mt-10 -57.55 -42.83 83.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.534 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.2 tp -52.67 -38.72 60.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.318 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.458 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -56.41 -72.84 0.51 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.3 pt-20 -51.76 -45.22 63.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -1.207 . . . . 0.0 110.785 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.519 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 40.9 mt -47.82 -46.79 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.97 -1.081 . . . . 0.0 110.23 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.0 mt -77.39 -51.87 10.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.923 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -48.45 -35.3 12.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.982 . . . . 0.0 109.488 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.61 -38.78 21.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.1 p -58.9 -55.29 37.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.44 ' C ' ' HG2' ' A' ' 127' ' ' GLU . . . 139.11 41.25 0.09 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.9 mt-10 -136.47 128.56 29.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.241 . . . . 0.0 110.072 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -65.74 66.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' GLU . 79.0 t -64.54 155.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.662 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.533 HD11 HG23 ' A' ' 130' ' ' ILE . 17.5 pt -123.94 145.68 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.839 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 4.4 mt-10 -43.74 -45.95 7.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.884 . . . . 0.0 110.581 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -41.59 -43.9 2.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 111.01 -179.546 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 -48.6 12.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.534 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 20.3 mt -53.21 -35.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.552 0.692 . . . . 0.0 109.651 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 64.0 mt-10 -55.9 -52.26 64.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.536 -0.728 . . . . 0.0 110.602 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 50.4 t0 -45.25 -49.16 12.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.474 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.3 -43.78 67.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.968 . . . . 0.0 110.393 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -40.31 68.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.398 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -60.06 -48.05 83.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.944 . . . . 0.0 110.843 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.9 -33.82 75.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.798 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.66 -35.66 57.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 146' ' ' ASP . 0.4 OUTLIER -55.25 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.544 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' SER . 5.9 tttt -67.69 -8.36 34.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.45 22.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.426 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 8.5 m-20 51.22 64.75 1.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.331 -0.855 . . . . 0.0 110.785 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 51.5 p-10 -112.72 5.77 17.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 60.0 24.92 61.22 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 13.6 mtt-85 -158.13 130.71 7.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -1.163 . . . . 0.0 110.533 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.527 HG12 ' CB ' ' A' ' 141' ' ' SER . 6.1 mt -85.72 121.29 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.362 -0.837 . . . . 0.0 109.94 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.18 -173.6 2.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 110.411 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -53.7 -57.43 10.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -55.17 16.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.505 -0.747 . . . . 0.0 110.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 157' ' ' MET . 88.0 mt-10 -64.01 -57.94 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.552 ' CZ ' ' HG3' ' A' ' 158' ' ' MET . 38.6 t80 -40.83 -59.72 1.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.654 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 154' ' ' PHE . 81.5 mt -42.3 -65.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.345 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.84 -38.09 77.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 110.431 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.534 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -66.97 -37.96 85.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.071 -179.639 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.552 ' HG3' ' CZ ' ' A' ' 154' ' ' PHE . 3.2 mmt -83.81 13.76 4.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.537 -0.727 . . . . 0.0 110.514 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -111.51 143.58 42.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.032 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.55 -17.1 59.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.76 145.42 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.398 -1.06 . . . . 0.0 110.192 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.289 -179.912 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.162 0.506 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.44 179.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.439 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 49.68 70.7 0.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 110.371 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -94.8 107.35 19.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.127 179.865 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.62 137.25 6.45 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.49 157.25 21.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -1.131 . . . . 0.0 110.344 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -103.76 150.28 24.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.951 179.621 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 94' ' ' SER . 2.5 mt-10 -42.19 -49.33 4.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -44.79 -56.35 4.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.278 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.4 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 47.2 mm-40 -57.73 -32.07 67.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -51.07 9.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.509 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.07 50.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.133 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -66.15 -33.12 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.447 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.463 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.8 m -65.16 -22.08 66.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.829 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -49.25 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 110.391 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.53 -32.25 5.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.469 HD12 HG23 ' A' ' 104' ' ' ILE . 48.8 mm -68.33 -45.44 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 110.365 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.414 ' O ' HD13 ' A' ' 121' ' ' ILE . 17.0 m-85 -67.56 -24.94 65.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.25 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 23.3 t0 -90.07 84.96 6.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -67.69 -32.16 72.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 6.0 p30 -93.87 -12.25 29.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.497 ' N ' ' OD1' ' A' ' 106' ' ' ASP . . . 59.09 75.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.352 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 5.1 p30 -114.91 -6.39 12.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.269 -0.895 . . . . 0.0 110.091 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 86.28 -1.05 87.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 10.8 m-85 -146.8 124.01 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -1.142 . . . . 0.0 110.011 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 40.8 mt -85.83 124.59 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.261 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 116' ' ' GLU . 1.9 p30 -103.42 -176.19 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 134' ' ' ILE . 1.3 tp -75.97 -31.68 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.45 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 1.3 mt-10 -58.22 -45.06 88.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 121' ' ' ILE . 37.1 mt-10 -59.91 -48.67 80.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 110.423 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.452 ' HB3' HG22 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.8 -34.59 67.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.152 -0.968 . . . . 0.0 110.13 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -57.98 -71.99 0.66 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 18.7 pt-20 -57.35 -44.49 84.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -1.171 . . . . 0.0 110.299 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.0 mt -47.06 -57.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.975 . . . . 0.0 109.87 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 125' ' ' THR . 0.3 OUTLIER -69.09 -49.18 59.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -53.92 -37.2 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.435 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.16 60.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.307 -0.871 . . . . 0.0 110.868 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 61.5 p -54.65 -24.44 21.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.461 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.54 -27.4 6.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -75.79 134.05 40.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -1.122 . . . . 0.0 109.961 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -87.19 71.07 10.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.145 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.403 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 41.6 t -64.78 137.65 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.051 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' GLU . 9.4 pt -86.3 137.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 110.366 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 132' ' ' GLU . 8.9 mm-40 -42.75 -38.28 2.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -40.79 -39.46 1.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -0.822 . . . . 0.0 110.551 -179.837 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -84.31 -45.38 12.87 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.174 -0.954 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.452 HG22 ' HB3' ' A' ' 118' ' ' LEU . 23.6 mt -56.19 -35.67 43.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.493 -0.754 . . . . 0.0 109.535 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 1.1 mt-10 -65.66 -37.46 86.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.523 -0.736 . . . . 0.0 110.227 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 9.2 t70 -52.06 -54.6 28.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.3 mt -50.5 -39.57 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.418 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.527 ' CE ' HD11 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -65.18 -39.08 92.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.406 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -64.88 -52.31 57.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 110.571 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.2 -27.64 68.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 111.13 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.544 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -89.34 -65.05 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.018 . . . . 0.0 111.025 -179.292 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' SER . 18.5 t0 -41.69 98.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.895 . . . . 0.0 110.36 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.4 tppp? -94.51 -32.11 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 0.0 110.367 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.474 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 4.5 p30 -101.94 17.68 22.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.135 -0.978 . . . . 0.0 110.213 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.0 m-20 48.74 80.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.474 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 9.2 p-10 -134.77 11.1 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 62.1 14.51 46.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 72.1 mtt180 -146.94 143.95 28.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -1.158 . . . . 0.0 110.481 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.544 HG12 ' CB ' ' A' ' 141' ' ' SER . 1.2 mt -93.14 123.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 109.948 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 39.4 p30 -91.74 -165.06 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.805 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -54.93 15.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 110.393 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.26 -57.28 13.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 92.6 mt-10 -48.54 -46.29 38.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.577 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 1.5 t80 -54.16 -58.9 5.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.677 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 31.4 mt -51.46 -59.39 4.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.841 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -42.65 44.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.775 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.447 ' HE3' HG23 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -65.21 -45.17 85.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.509 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.466 ' HA ' HG21 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -86.57 3.44 44.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.202 -0.937 . . . . 0.0 110.446 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -79.0 142.83 36.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 0.0 110.317 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.57 31.67 80.84 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.466 HG21 ' HA ' ' A' ' 158' ' ' MET . 70.0 t -101.27 67.46 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.149 -1.207 . . . . 0.0 110.111 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.237 -179.767 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.315 0.579 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.55 102.24 13.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 110.281 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.04 159.88 4.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -133.87 124.45 26.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 110.104 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.63 -150.46 5.95 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -106.63 -169.9 1.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -1.13 . . . . 0.0 110.174 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -64.55 -13.73 54.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 110.351 -179.967 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 94' ' ' SER . 0.2 OUTLIER 73.88 -49.15 0.68 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.388 -0.82 . . . . 0.0 110.546 -179.571 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -42.81 -48.93 5.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.085 -1.009 . . . . 0.0 110.092 -179.929 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -53.61 -56.48 16.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.887 . . . . 0.0 109.924 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 95' ' ' GLU . 3.1 mt -52.26 -57.83 8.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.95 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 102' ' ' PHE . . . -47.66 -41.96 23.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.46 -32.76 63.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -77.7 -7.2 56.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.577 -179.709 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 99' ' ' ALA . 2.5 t80 -60.86 -56.48 20.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.07 -1.019 . . . . 0.0 110.428 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -22.98 4.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.185 -0.947 . . . . 0.0 110.733 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 2.0 mp -74.28 -47.93 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.061 -1.025 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.12 -49.9 11.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.308 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 108' ' ' ASN . 52.7 t0 -67.48 74.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -46.43 -39.19 10.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.7 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 106' ' ' ASP . 17.3 m-80 -103.54 165.01 11.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 109.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.25 63.89 7.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 17.2 p30 -102.55 -18.43 15.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.072 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.575 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 74.91 5.81 76.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 52.8 m-85 -148.53 110.29 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -1.147 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.91 144.85 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 30.0 p30 -119.7 -163.78 1.02 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.519 ' CD1' ' HG2' ' A' ' 135' ' ' GLU . 1.2 tt -79.59 -45.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -0.841 . . . . 0.0 110.779 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.507 ' N ' HG21 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.41 -27.28 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 110.152 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 121' ' ' ILE . 9.2 mt-10 -76.55 -48.93 17.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 109.86 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.85 -44.07 63.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 110.038 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -48.63 -83.91 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 10.6 pt-20 -42.42 -45.35 4.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -1.17 . . . . 0.0 110.493 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.0 mt -50.3 -54.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 109.679 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 125' ' ' THR . 19.6 mt -73.1 -47.48 43.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -49.89 -37.55 31.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.837 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.64 -31.56 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 43.0 p -69.25 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 110.154 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.97 38.21 2.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -113.0 -157.52 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -1.191 . . . . 0.0 110.331 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -145.11 53.72 1.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.034 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.507 HG11 ' CG1' ' A' ' 134' ' ' ILE . 46.8 t -61.18 162.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.832 . . . . 0.0 110.347 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 130' ' ' ILE . 13.7 pt -139.18 152.02 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.3 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -41.27 -53.62 3.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.993 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -43.44 -36.65 2.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -45.1 11.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.465 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.529 HG23 HD11 ' A' ' 134' ' ' ILE . 21.1 mt -62.81 -38.9 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 109.623 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.519 ' HG2' ' CD1' ' A' ' 115' ' ' ILE . 2.0 mm-40 -58.74 -45.05 90.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 110.12 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 4.8 t70 -44.0 -50.02 8.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.265 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 141' ' ' SER . 31.6 mt -58.4 -40.27 81.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.46 ' HE1' HD12 ' A' ' 149' ' ' ILE . 34.5 tpp -65.34 -48.44 73.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.609 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -64.8 -37.16 86.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.576 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 2.9 t0 -72.19 -36.98 69.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.469 -0.769 . . . . 0.0 109.974 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.535 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -85.43 -46.65 10.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 110.136 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 138' ' ' MET . 29.3 t0 -61.82 86.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.815 . . . . 0.0 110.45 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 -8.1 58.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -119.45 19.55 12.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.1 m120 46.97 41.9 11.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.111 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.9 -9.33 59.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.31 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.43 60.95 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' CD ' ' HB3' ' A' ' 114' ' ' ASP . 55.9 mtt180 -146.2 162.18 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -1.143 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.535 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.3 mt -84.38 118.77 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 2.9 p30 -94.39 -178.08 4.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.932 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.98 -61.26 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 110.051 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' CD ' ' HA ' ' A' ' 142' ' ' ASP . 94.1 mt-10 -59.42 -44.89 92.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 10.6 t80 -46.27 -66.98 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.957 . . . . 0.0 110.207 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.466 HD23 ' HG2' ' A' ' 95' ' ' GLU . 10.0 mt -44.52 -56.86 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -37.52 72.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.0 ptm -54.76 -49.51 70.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.672 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.525 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -63.61 -17.33 62.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 109.989 179.818 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.39 106.76 4.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.331 -0.856 . . . . 0.0 110.104 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 117.28 -25.69 8.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.49 159.0 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 110.19 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.152 -179.965 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.278 0.561 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.53 -54.14 3.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 110.298 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.71 132.88 9.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.391 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -108.7 2.31 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.139 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.89 -151.04 49.79 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 175.08 8.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.149 -1.207 . . . . 0.0 109.949 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 95' ' ' GLU . 72.6 m -95.42 142.38 27.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 110.327 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' SER . 3.5 mt-10 -43.38 -40.52 3.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.36 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -43.48 -45.51 6.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.711 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.0 -51.15 71.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.719 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 4.1 mm? -46.68 -56.75 5.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -45.04 -55.13 5.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.225 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -52.1 -43.43 63.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.314 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.46 -24.52 60.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -53.83 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.98 . . . . 0.0 110.073 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -55.37 -38.01 68.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.142 -0.974 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.2 mm -62.5 -39.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 109.946 179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -84.33 -46.08 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.173 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 6.7 t0 -82.42 96.24 7.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.335 -0.853 . . . . 0.0 109.838 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -105.83 -27.4 11.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 110.904 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.461 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 3.1 p30 -104.26 -45.19 4.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.014 -1.054 . . . . 0.0 110.77 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -86.12 -39.76 16.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.991 . . . . 0.0 110.016 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 2.9 m-20 45.3 27.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 109.962 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . -152.33 -36.99 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 20.9 m-85 -151.57 112.32 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.433 -1.039 . . . . 0.0 109.322 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.492 HG22 ' CB ' ' A' ' 117' ' ' GLU . 5.0 mt -82.77 118.84 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.681 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.473 ' OD2' ' N ' ' A' ' 116' ' ' GLU . 4.5 p-10 -92.66 -155.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 135' ' ' GLU . 3.0 tp -78.73 -33.63 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.0 110.248 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.473 ' N ' ' OD2' ' A' ' 114' ' ' ASP . 1.7 mm-40 -57.16 -59.32 5.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.305 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.492 ' CB ' HG22 ' A' ' 113' ' ' ILE . 1.9 mt-10 -44.23 -48.46 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.917 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.544 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.3 OUTLIER -58.53 -31.98 68.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 110.103 179.811 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -60.44 -75.83 0.26 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 10.9 pt-20 -42.43 -45.58 4.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.258 -1.142 . . . . 0.0 110.44 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.453 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 45.7 mt -47.21 -53.66 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.142 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.451 ' O ' ' OG1' ' A' ' 125' ' ' THR . 72.1 mt -75.14 -36.87 61.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.328 -0.858 . . . . 0.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -62.96 -36.51 83.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 110.162 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.82 -40.43 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 67.2 p -61.96 -36.24 80.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.74 11.07 27.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -89.98 148.0 23.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.25 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -85.52 83.16 8.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 109.941 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.416 HG13 ' HB3' ' A' ' 133' ' ' ASP . 2.3 t -93.56 114.34 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 9.1 pt -73.28 146.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.05 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.7 mt-10 -41.13 -49.34 3.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 0.0 110.439 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.08 -26.68 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -81.02 -50.01 10.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.309 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.544 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 6.4 mt -66.22 -42.55 91.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 115' ' ' ILE . 8.3 mt-10 -45.81 -42.61 12.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.0 110.052 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.14 -51.78 68.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 110.246 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -48.63 -44.87 37.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.217 -0.927 . . . . 0.0 110.371 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.471 ' HE2' HD11 ' A' ' 149' ' ' ILE . 11.0 tpp -64.58 -45.96 84.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.759 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -46.21 74.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -0.835 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 110.561 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.494 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -89.48 -63.75 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.459 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 1.7 t0 -47.82 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.1 mttt -84.53 -26.02 28.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.162 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 11.6 m-80 -86.63 -3.94 59.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 109.744 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.3 OUTLIER 67.26 15.08 9.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -60.63 -15.79 32.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.1 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.15 -5.94 82.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.521 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -137.9 146.4 43.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.254 . . . . 0.0 110.486 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 141' ' ' SER . 5.8 mt -83.77 137.12 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 29.4 p-10 -121.15 -160.83 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 49.5 p90 -68.17 -41.83 80.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 1.0 OUTLIER -68.38 -56.88 6.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.499 -179.857 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 142' ' ' ASP . 59.1 mt-10 -58.35 -48.53 80.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 57.4 t80 -46.55 -54.42 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.927 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.501 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 6.2 mt -66.62 -47.06 73.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.984 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -48.32 -55.78 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 110.143 179.927 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -58.28 -52.47 65.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 109.72 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.9 mtm -89.96 39.81 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.075 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 4.8 tt0 -96.96 105.15 17.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 110.265 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 44.07 55.49 5.67 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 162' ' ' GLN . 60.6 t -53.99 168.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -1.137 . . . . 0.0 110.306 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.494 ' N ' HG12 ' A' ' 161' ' ' VAL . 5.8 mt-30 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.144 0.497 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -166.65 93.69 0.49 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.563 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.55 -176.98 6.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 109.706 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 54.14 2.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.022 -1.049 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -165.11 127.45 1.63 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' CD ' HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.87 162.52 41.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -1.104 . . . . 0.0 109.97 179.916 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.14 -169.22 1.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.807 -179.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -53.07 -46.11 68.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.453 -0.779 . . . . 0.0 110.844 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 95' ' ' GLU . 1.5 tt0 -38.31 -64.37 0.42 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -0.781 . . . . 0.0 110.819 -179.409 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.01 -55.93 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.432 HD13 ' CD ' ' A' ' 93' ' ' LYS . 3.0 mt -58.61 -53.28 60.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.335 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -49.17 -51.92 29.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.361 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -51.43 -50.61 59.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 102' ' ' PHE . 5.2 m -53.03 -42.08 65.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.713 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 87.3 t80 -42.28 -65.16 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 110.603 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -39.58 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.193 -0.942 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.455 HG22 HD12 ' A' ' 104' ' ' ILE . 36.0 mm -60.87 -32.78 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 110.581 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.1 -48.92 21.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.102 -0.999 . . . . 0.0 110.416 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.79 101.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -75.48 -45.88 35.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.201 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -69.43 -15.3 63.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 110.095 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.37 42.93 17.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.45 ' OD2' ' O ' ' A' ' 112' ' ' PHE . 6.7 p-10 -84.07 -16.56 43.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.085 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.483 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 113.23 -16.05 22.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 3.4 m-85 -148.37 135.46 20.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 110.404 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.446 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 22.9 mt -85.26 119.36 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.852 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 23.8 p-10 -90.98 -175.76 4.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 1.0 OUTLIER -68.25 -38.85 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.814 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.459 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 17.7 mt-10 -58.04 -55.2 38.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.332 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 113' ' ' ILE . 7.2 mt-10 -46.62 -40.36 12.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.818 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.51 ' HB3' HG21 ' A' ' 134' ' ' ILE . 1.1 tp -61.16 -49.03 78.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 110.063 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -51.94 -69.85 1.05 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -47.47 -45.96 26.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -1.189 . . . . 0.0 110.179 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.472 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 6.5 mt -48.28 -65.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.986 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 129' ' ' VAL . 44.4 mt -61.76 -44.83 96.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.467 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.506 ' NH1' ' HG2' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -55.21 -36.46 65.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.9 . . . . 0.0 110.731 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.55 -28.32 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 109.997 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.1 p -81.07 -47.31 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.32 35.51 1.45 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 5.1 mt-10 -99.88 16.6 23.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -1.204 . . . . 0.0 109.99 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 127' ' ' GLU . 44.5 p-80 38.24 43.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.627 -0.671 . . . . 0.0 110.49 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 122' ' ' LEU . 20.1 t -61.09 117.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.469 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.3 pt -77.74 148.63 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -45.34 -47.45 13.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 0.0 110.329 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.469 ' HB2' HG13 ' A' ' 130' ' ' ILE . 4.8 mt-10 -41.24 -36.32 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -0.863 . . . . 0.0 110.477 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -43.81 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.51 HG21 ' HB3' ' A' ' 118' ' ' LEU . 26.6 mt -64.11 -38.48 82.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.588 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -50.45 73.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.488 -0.757 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 136' ' ' ASP . 9.2 t0 -45.47 -49.29 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 tp -51.65 -38.89 56.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.163 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -73.02 -57.58 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 110.055 -179.993 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 138' ' ' MET . 2.9 mmtm -43.34 -63.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.01 -20.43 6.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.529 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -101.85 -62.32 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 110.424 -179.842 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 138' ' ' MET . 24.0 t70 -56.29 81.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -89.8 31.33 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 179.546 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -149.07 17.65 0.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.847 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 55.3 21.88 4.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.257 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 147' ' ' GLY . 1.4 t70 -85.58 4.57 35.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.855 . . . . 0.0 109.896 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . 41.57 38.97 2.34 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -158.31 124.55 4.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -1.211 . . . . 0.0 110.325 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 141' ' ' SER . 13.5 mt -83.76 106.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 44.8 p-10 -100.78 -140.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 110.37 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.46 -61.64 1.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 0.0 110.729 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.32 -56.02 13.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.654 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -60.53 -53.54 56.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.676 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.495 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 44.9 t80 -43.98 -49.23 8.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.68 -36.55 84.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.203 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -46.37 69.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.887 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.531 ' HG2' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -61.08 -42.33 98.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.846 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.531 ' N ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER -109.03 42.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 0.0 110.05 179.77 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.77 94.43 9.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.338 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 44.82 41.94 7.5 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' A' ' 158' ' ' MET . 23.1 t -47.17 133.94 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -1.169 . . . . 0.0 110.187 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 162' ' ' GLN . 3.1 mm100 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.287 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.394 0.616 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 54.0 t0 -143.53 60.57 1.39 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -102.44 60.82 0.83 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.388 -0.82 . . . . 0.0 110.893 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 10.7 tttt -178.47 175.68 1.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.129 -0.982 . . . . 0.0 110.74 179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' LYS . . . 60.64 144.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -76.1 0.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.413 -1.051 . . . . 0.0 109.878 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER 57.82 160.38 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.461 -0.774 . . . . 0.0 110.91 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 94' ' ' SER . 16.1 mt-10 -39.26 -40.26 0.73 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.485 -0.759 . . . . 0.0 110.745 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -45.71 -71.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 110.532 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -55.97 -38.38 70.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 mt -57.14 -53.97 52.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.65 -65.61 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.845 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -52.07 -31.28 29.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.421 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -71.87 -9.85 58.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.208 -0.932 . . . . 0.0 110.378 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.99 -54.04 51.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.45 72.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.838 -179.378 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 mm -57.26 -29.31 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.125 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -80.53 -32.85 36.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.86 79.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -86.97 39.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.7 -179.878 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.42 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 27.9 t30 -128.96 -98.44 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 108' ' ' ASN . . . 174.8 27.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.984 -1.073 . . . . 0.0 111.041 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.4 p30 -113.45 -10.92 13.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.825 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.7 81.97 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.457 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 51.2 m-85 -141.6 139.75 33.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 110.6 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.453 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 51.0 mt -85.37 126.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.542 -0.724 . . . . 0.0 109.384 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.49 -179.23 3.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.6 OUTLIER -65.3 -44.31 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.64 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.541 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.6 mt-10 -60.17 -51.15 70.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.064 . . . . 0.0 109.907 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 113' ' ' ILE . 14.6 mt-10 -49.76 -36.53 26.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.486 ' CD2' HD23 ' A' ' 137' ' ' LEU . 5.0 tp -60.71 -51.24 70.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 0.0 110.531 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -42.43 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.2 pt-20 -42.08 -45.81 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -1.18 . . . . 0.0 110.628 -179.122 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.443 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 37.6 mt -56.23 -58.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.99 -1.069 . . . . 0.0 109.72 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.5 HD13 ' CD1' ' A' ' 134' ' ' ILE . 49.1 mt -60.7 -44.63 96.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 110.103 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.74 -37.77 79.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.126 -0.984 . . . . 0.0 110.264 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.87 64.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.987 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.8 p -62.74 -23.31 67.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.57 47.43 15.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.53 13.44 20.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -1.109 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 55.77 47.71 19.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.307 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.527 HG11 ' CG1' ' A' ' 134' ' ' ILE . 71.8 t -79.88 86.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' A' ' 132' ' ' GLU . 41.1 pt -57.79 149.86 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 132' ' ' GLU . 3.8 mm-40 -50.32 -44.54 54.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 111.142 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.446 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -39.43 -40.37 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.328 -0.857 . . . . 0.0 110.896 -179.474 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -47.3 21.6 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.307 -0.871 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.527 ' CG1' HG11 ' A' ' 129' ' ' VAL . 6.6 mt -59.71 -39.48 79.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.666 -0.646 . . . . 0.0 109.611 179.143 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.27 -42.33 73.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.03 -38.62 86.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 0.0 109.843 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.486 HD23 ' CD2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -49.69 -41.98 44.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 110.947 -179.505 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.2 tpp -70.36 -43.8 69.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.921 -1.112 . . . . 0.0 110.173 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -62.74 -43.83 97.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.88 -18.77 64.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -99.07 -63.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.573 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.2 m-20 -40.05 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.718 . . . . 0.0 110.798 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 141' ' ' SER . 15.2 tttt -79.66 3.88 17.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.046 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.3 p30 -141.51 8.38 1.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.935 . . . . 0.0 110.053 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 62.3 m-20 58.18 61.9 2.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.467 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 56.7 p30 -102.05 -5.03 25.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.936 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.466 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 87.71 -5.18 85.34 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.466 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 18.0 mtm-85 -152.35 157.03 40.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.311 . . . . 0.0 110.79 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.453 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.8 mt -89.28 144.87 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -121.01 -162.54 0.96 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.454 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.502 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 6.8 t80 -64.42 -52.92 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.977 . . . . 0.0 111.112 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.5 OUTLIER -60.2 -56.74 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 110.686 -179.397 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.02 -44.47 87.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.48 ' O ' ' HG2' ' A' ' 157' ' ' MET . 81.5 t80 -49.23 -54.99 14.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.208 -0.933 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 35.3 mt -51.81 -51.42 56.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 110.357 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -46.99 -58.17 4.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 110.739 -179.74 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.565 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -47.53 -51.66 20.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.335 -179.586 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.565 ' N ' ' CG ' ' A' ' 157' ' ' MET . 12.3 mmt -60.83 -36.38 78.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 158' ' ' MET . 0.0 OUTLIER 39.85 36.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.327 -0.858 . . . . 0.0 111.335 179.334 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 159' ' ' GLU . . . 42.44 41.71 4.19 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.439 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 158' ' ' MET . 59.7 t -55.49 125.3 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -1.11 . . . . 0.0 110.478 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 161' ' ' VAL . 25.7 mt-30 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.49 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.209 0.528 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.5 136.82 15.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 110.29 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.15 -164.47 1.44 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.301 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.85 125.5 47.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 110.048 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.8 56.9 3.19 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.23 135.88 36.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -1.174 . . . . 0.0 110.595 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 m -76.59 138.91 40.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.671 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -47.62 -32.85 5.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.925 . . . . 0.0 110.284 -179.654 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -42.26 -52.12 4.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 110.302 -179.909 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -68.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.449 HD21 ' HB3' ' A' ' 158' ' ' MET . 7.6 mp -47.96 -61.92 1.72 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.01 -42.72 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.429 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -73.82 -57.9 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.595 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 62.9 m -48.93 -27.26 2.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.879 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -46.38 -50.32 16.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.989 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -56.55 -42.59 78.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 104' ' ' ILE . 20.0 mm -57.01 -43.3 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 110.635 -179.434 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -66.15 -38.45 88.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 110.175 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -67.19 89.74 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 0.0 110.091 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -62.78 -27.64 69.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 109.599 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.418 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 17.3 m-80 -104.78 -169.1 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.559 -0.713 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.14 65.41 0.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.365 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -114.44 -32.1 6.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 110.165 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.94 6.98 48.29 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 5.3 m-85 -152.09 128.88 10.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -1.203 . . . . 0.0 109.861 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.28 141.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 3.9 p30 -106.88 173.32 6.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.253 -0.904 . . . . 0.0 110.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 3.3 tt -56.4 -42.93 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.076 -1.015 . . . . 0.0 110.209 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.499 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.7 OUTLIER -55.2 -59.39 4.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.901 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.467 ' HB3' HD12 ' A' ' 121' ' ' ILE . 20.7 mt-10 -47.75 -43.93 27.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.668 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.552 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 2.5 tp -45.46 -31.23 1.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.612 -0.68 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -73.41 -74.5 0.81 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 5.5 pt-20 -42.05 -50.04 4.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -1.177 . . . . 0.0 110.476 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 117' ' ' GLU . 7.9 mt -48.33 -65.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 125' ' ' THR . 17.9 mt -59.67 -56.6 19.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -48.56 -30.99 5.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 110.453 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 120' ' ' GLU . . . -54.85 -53.78 50.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 122' ' ' LEU . 4.4 t -67.47 -139.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.973 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.437 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . -118.34 11.75 12.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.61 97.32 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -1.066 . . . . 0.0 111.046 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -66.06 93.25 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 122' ' ' LEU . 3.4 t -103.98 146.6 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.894 -178.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 131' ' ' GLU . 12.4 pt -112.71 159.0 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -42.89 -48.19 5.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.805 . . . . 0.0 110.914 -179.703 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -47.28 -32.53 4.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.309 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.446 ' O ' HD12 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -87.06 -48.3 8.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.463 -179.937 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 22.8 mt -60.28 -42.74 91.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -59.01 -60.46 3.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.482 -0.762 . . . . 0.0 109.848 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -51.19 -45.39 61.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.217 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -48.25 -43.98 32.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.812 -179.79 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.476 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -62.27 -48.44 79.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.782 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.04 -36.02 69.52 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -0.791 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.85 -17.9 65.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.835 . . . . 0.0 110.412 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.502 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -102.77 -62.32 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.803 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.6 t0 -37.69 109.01 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.671 -0.643 . . . . 0.0 110.731 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -11.41 57.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.748 . . . . 0.0 109.86 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 1.7 p30 -132.08 4.69 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.151 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.9 m120 60.83 48.19 7.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.777 . . . . 0.0 110.772 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.442 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 45.9 p-10 -81.82 -10.2 59.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 179.557 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . 93.94 8.5 60.41 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.523 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 10.2 mtt180 -158.34 139.98 13.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -1.177 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' A' ' 141' ' ' SER . 3.6 mt -83.56 122.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -101.68 -174.24 2.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.32 -56.42 16.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -63.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.745 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.76 -36.57 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.932 -179.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -63.24 -55.56 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.914 -1.116 . . . . 0.0 109.977 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 159' ' ' GLU . 12.8 mt -54.6 -41.83 70.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 110.388 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -58.93 -62.86 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.821 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -57.43 -50.83 71.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 0.0 110.832 -179.43 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' MET . 6.1 mmt -62.09 -31.08 71.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.333 -0.854 . . . . 0.0 110.485 -179.722 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 38.6 tt0 -66.72 76.97 0.11 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.458 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 110.47 36.01 1.99 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.72 163.14 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -1.041 . . . . 0.0 110.785 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.259 179.939 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.245 0.545 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.39 125.13 47.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.117 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -174.87 -179.33 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 0.0 110.462 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 6.1 ttmt 63.89 88.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.317 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.83 -141.63 7.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HE2' ' HG2' ' A' ' 97' ' ' GLU . 0.7 OUTLIER -93.4 120.82 34.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -1.139 . . . . 0.0 110.093 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -92.0 157.36 16.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.261 -0.899 . . . . 0.0 110.28 -179.826 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 94' ' ' SER . 0.4 OUTLIER -43.66 -50.34 7.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 110.205 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -44.95 -57.35 3.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 110.244 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.444 ' HG2' ' HE2' ' A' ' 93' ' ' LYS . 5.9 tp10 -48.2 -59.97 3.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.263 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.48 HD12 ' CD2' ' A' ' 155' ' ' LEU . 6.0 mt -57.99 -45.98 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -42.36 -59.29 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.242 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 101' ' ' CYS . 3.7 m120 -50.02 -54.11 22.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.45 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.2 m -43.6 -32.59 0.98 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.908 179.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 13.0 t80 -42.93 -63.93 0.71 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.345 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -63.68 -29.63 70.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 23.0 mm -60.84 -50.77 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.487 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.4 -13.7 14.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -89.42 118.49 29.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.09 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -110.66 -11.91 14.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -109.71 15.09 23.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 110.611 -179.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 45.25 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 110.239 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -126.55 -27.88 3.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.989 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.95 -19.47 49.33 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 62.0 m-85 -153.23 128.24 9.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -1.102 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -82.51 123.52 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 36.9 p-10 -102.21 -168.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.8 tt -65.14 -40.47 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 110.328 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.432 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.6 OUTLIER -51.38 -52.38 46.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.435 -179.693 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.432 ' OE1' HD13 ' A' ' 121' ' ' ILE . 0.1 OUTLIER -56.97 -44.62 82.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.903 . . . . 0.0 110.28 -179.767 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -48.47 -34.19 10.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.171 -179.971 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -58.36 -85.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 15.7 pt-20 -42.43 -43.89 3.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.15 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.45 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.5 mt -52.61 -48.98 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.877 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.32 -47.1 62.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.097 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -51.96 -42.42 62.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.946 . . . . 0.0 110.208 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.04 -31.6 5.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.432 -0.793 . . . . 0.0 110.548 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 p -68.87 -35.91 77.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.363 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.91 49.24 2.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.45 -7.55 8.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.206 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 59.29 84.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 110.039 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 9.1 t -108.69 149.58 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.318 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 132' ' ' GLU . 16.2 pt -113.44 154.82 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.126 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 130' ' ' ILE . 10.2 mt-10 -39.41 -51.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.436 -0.79 . . . . 0.0 110.777 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.467 ' HB2' HD11 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 -179.991 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -88.37 -44.75 10.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.503 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.457 HG23 ' HB3' ' A' ' 118' ' ' LEU . 33.3 mt -63.26 -38.3 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.811 . . . . 0.0 109.894 179.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -54.04 -53.73 49.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.778 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -45.26 -48.73 12.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 134' ' ' ILE . 0.5 OUTLIER -53.09 -49.01 67.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 110.377 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 26.4 tpp -66.11 -50.43 64.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -41.83 93.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.398 -0.814 . . . . 0.0 110.093 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -66.77 -35.58 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.525 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -80.54 -48.83 12.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.4 OUTLIER -49.23 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.508 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 141' ' ' SER . 17.5 tttt -80.09 -19.21 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 0.2 OUTLIER -122.48 0.91 9.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.68 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 64.96 52.07 1.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.0 110.564 179.727 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 146' ' ' ASP . 50.7 p-10 -93.7 0.02 56.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 11.58 84.34 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -152.79 139.1 18.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.144 -1.21 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.525 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.2 mt -83.63 134.76 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.751 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 152' ' ' ASP . 2.1 p30 -118.6 -166.27 1.21 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 110.144 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 41.1 p90 -70.02 -34.98 73.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.594 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -66.0 -49.0 69.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.315 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 141' ' ' SER . 74.8 mt-10 -71.92 -56.61 5.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.38 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.464 ' HA ' ' HE2' ' A' ' 157' ' ' MET . 69.6 t80 -45.29 -45.17 11.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 0.0 110.117 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.48 ' CD2' HD12 ' A' ' 98' ' ' LEU . 13.1 mt -55.62 -40.93 72.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -55.11 36.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.56 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -47.17 -49.73 22.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 109.588 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.56 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -66.77 -29.89 69.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.37 -0.831 . . . . 0.0 110.363 179.947 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 158' ' ' MET . 0.4 OUTLIER 42.82 -148.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.994 . . . . 0.0 110.277 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.23 38.52 3.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.7 p -46.09 151.31 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -1.13 . . . . 0.0 110.271 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.244 -179.954 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.189 0.518 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.73 171.77 11.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.354 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -123.4 34.67 5.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 110.262 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 3.6 tptp 70.11 69.18 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.264 -0.897 . . . . 0.0 110.56 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 93' ' ' LYS . . . 107.86 64.54 0.58 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER 64.64 113.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 110.376 179.608 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 95' ' ' GLU . 1.5 p -74.7 142.18 44.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.942 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 94' ' ' SER . 4.7 mt-10 -41.14 -44.91 2.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.79 -44.59 28.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.062 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.411 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 3.0 mt-10 -55.42 -60.1 3.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -0.894 . . . . 0.0 110.462 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.472 HD23 ' HE3' ' A' ' 158' ' ' MET . 0.2 OUTLIER -51.21 -54.79 22.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -41.32 -48.52 3.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 0.0 110.134 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.44 -43.65 71.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.064 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.8 m -63.9 -18.81 64.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.885 . . . . 0.0 110.192 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -53.15 -55.76 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 110.122 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -55.82 -33.75 64.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.03 -39.44 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -66.54 -51.51 55.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.099 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -72.56 123.77 23.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.165 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 19.6 mttp -93.99 17.19 12.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.416 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 50.3 m-80 -148.68 173.99 12.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 110.424 -179.485 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.5 40.6 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 p30 -88.13 -23.2 23.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.18 18.71 63.07 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -153.28 117.3 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -1.114 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 36.9 mt -84.1 132.05 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.32 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -107.34 -164.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -78.65 -43.93 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.085 -1.01 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.503 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 31.2 mt-10 -51.78 -53.07 43.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 109.826 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 76.2 mt-10 -57.37 -44.58 84.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.645 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.7 OUTLIER -50.48 -44.98 56.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 110.27 179.919 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.529 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -42.64 -83.39 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.459 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 11.7 pt-20 -47.06 -44.44 20.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -1.158 . . . . 0.0 110.33 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.508 HG23 HD12 ' A' ' 121' ' ' ILE . 17.8 mt -48.18 -57.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.916 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.432 ' O ' ' OG1' ' A' ' 125' ' ' THR . 18.2 mt -68.85 -47.63 65.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.95 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.32 -37.87 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 110.147 179.756 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -53.3 -31.33 43.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 65.7 p -52.9 -34.55 55.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.88 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.19 24.71 5.86 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -120.83 169.89 10.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 110.156 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -92.35 76.5 5.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.139 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.38 149.17 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' ' 131' ' ' GLU . 7.2 pt -133.26 149.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.085 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.1 mt-10 -41.55 -49.39 4.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.56 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 10.8 mt-10 -42.42 -40.39 2.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.037 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -47.92 10.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 109.175 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.529 ' CD1' ' HA2' ' A' ' 119' ' ' GLY . 10.4 mt -55.2 -39.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.4 -0.813 . . . . 0.0 109.272 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -54.59 -42.18 70.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.527 -0.733 . . . . 0.0 109.948 179.49 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -56.85 -50.72 71.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 110.245 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 137' ' ' LEU . 5.6 mp -54.63 -35.53 63.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.417 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 142' ' ' ASP . 2.1 ttm -74.64 -55.53 5.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 110.396 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -47.54 -55.54 8.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.61 -33.39 69.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.53 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.0 t -84.9 -62.34 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.344 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 138' ' ' MET . 3.4 t0 -40.44 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.406 -0.809 . . . . 0.0 110.694 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 mttt -76.66 -27.86 55.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.416 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 8.4 m-80 -104.24 1.44 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.796 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.39 17.57 7.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 110.314 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.23 -14.32 17.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.048 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.494 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 97.41 9.21 55.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.494 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 32.2 mtt85 -150.69 142.81 24.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.379 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.53 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.4 mt -83.7 137.62 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.048 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.74 -179.99 3.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 110.112 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.577 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 30.8 p90 -51.64 -42.49 62.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.577 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 1.9 m-20 -67.0 -58.48 4.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.885 . . . . 0.0 110.892 -179.434 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.416 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 39.6 mt-10 -59.46 -38.33 80.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.209 -0.932 . . . . 0.0 111.031 -179.321 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.488 ' CD2' ' SD ' ' A' ' 157' ' ' MET . 25.7 t80 -58.99 -57.38 13.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 110.619 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.46 ' O ' ' HE2' ' A' ' 158' ' ' MET . 64.6 mt -40.74 -50.07 3.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.317 -179.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -39.11 90.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.964 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.513 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -55.85 -46.52 78.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.362 -0.836 . . . . 0.0 109.869 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.513 ' N ' ' CG ' ' A' ' 157' ' ' MET . 1.7 tmm? -69.09 -14.74 63.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.74 . . . . 0.0 110.158 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.03 -24.14 30.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.89 45.24 1.09 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 87.7 t -52.57 111.09 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 0.0 110.128 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.435 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.219 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.228 0.537 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.09 134.53 35.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 0.0 110.168 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.88 34.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.063 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 40.33 1.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 110.153 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -137.81 -178.64 16.22 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -101.67 101.25 11.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -1.132 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -76.35 158.36 31.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 110.118 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -41.93 -44.38 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 110.298 -179.961 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -59.62 -44.11 93.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -0.906 . . . . 0.0 110.52 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.49 -62.57 1.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.737 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 99' ' ' ALA . 16.0 mt -46.61 -53.75 10.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.45 -37.51 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.36 -42.74 53.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 110.623 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -55.17 -24.61 27.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.968 . . . . 0.0 110.544 -179.704 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 101' ' ' CYS . 15.6 t80 -42.82 -54.57 4.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -67.13 -37.51 83.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.194 -0.941 . . . . 0.0 110.0 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.7 mm -57.53 -39.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.29 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -83.59 -26.08 30.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -80.76 98.48 7.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.252 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 35.7 mmtt -75.81 0.94 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.289 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -132.27 167.53 19.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -0.858 . . . . 0.0 110.244 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.79 29.07 0.94 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.418 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 8.8 p30 -76.26 -24.0 54.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.538 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 80.03 7.46 88.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 38.7 m-85 -153.07 133.75 13.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -1.175 . . . . 0.0 110.241 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.33 129.48 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.345 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 35.4 p30 -101.99 -179.01 3.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.076 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -58.82 -43.47 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.064 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 19.3 mt-10 -52.21 -51.93 55.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.073 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.435 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.5 mm-40 -57.56 -39.19 76.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.9 OUTLIER -60.01 -50.95 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 110.537 -179.68 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.455 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -49.64 -74.45 0.27 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.435 ' CD ' ' HA ' ' A' ' 117' ' ' GLU . 5.6 pt-20 -42.31 -47.7 4.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.434 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.468 HG22 HD13 ' A' ' 121' ' ' ILE . 6.1 mt -51.86 -58.37 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 mt -60.67 -47.1 87.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.289 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -36.78 66.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.201 -0.937 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.13 -42.22 28.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -0.862 . . . . 0.0 110.497 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.2 p -54.86 -48.44 72.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.4 35.97 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.05 147.75 48.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -1.065 . . . . 0.0 110.129 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.574 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -82.96 59.94 5.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 110.301 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.9 t -61.7 156.81 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.407 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.4 pt -125.67 148.2 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.32 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLU . 4.3 mt-10 -45.99 -47.72 16.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.022 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' GLU . 1.9 mt-10 -42.58 -35.0 0.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.03 -43.63 12.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 14.1 mt -64.13 -40.04 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 109.633 179.36 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.8 -48.45 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.848 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -47.83 -53.79 14.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.76 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.434 HD23 ' HE3' ' A' ' 157' ' ' MET . 0.4 OUTLIER -50.76 -43.02 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.876 179.613 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -69.26 -53.69 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.615 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -53.76 46.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.079 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -57.59 -40.28 78.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 110.107 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.532 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.32 -59.03 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.207 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.1 m-20 -52.57 87.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.831 . . . . 0.0 110.533 -179.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.3 OUTLIER -68.25 -18.93 64.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.425 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -121.74 11.58 10.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.801 179.664 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 20.8 m-20 51.8 86.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -130.54 13.11 5.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 58.4 23.58 54.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.458 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 3.0 mtt85 -158.3 123.71 4.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 110.424 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.532 HG12 ' CB ' ' A' ' 141' ' ' SER . 5.7 mt -84.52 122.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 109.817 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -101.58 -175.09 2.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.995 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -49.26 -57.79 6.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 110.552 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -61.55 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.691 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.425 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 96.0 mt-10 -56.72 -33.15 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.645 -179.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.469 ' O ' ' HG2' ' A' ' 157' ' ' MET . 13.1 t80 -60.65 -64.34 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 110.614 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.1 mt -46.66 -58.07 4.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.443 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -47.11 -38.77 12.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.963 . . . . 0.0 110.409 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.524 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.9 OUTLIER -67.66 -48.71 65.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.881 . . . . 0.0 110.152 -179.957 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.524 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.3 tpp -87.73 21.0 2.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.369 -0.832 . . . . 0.0 110.411 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.99 125.17 41.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 110.132 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.76 55.8 4.8 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.7 t -76.28 129.13 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -1.19 . . . . 0.0 110.367 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.152 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 5.4 tp10 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.24 0.543 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.8 -57.14 7.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.556 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.6 OUTLIER -50.11 -46.2 53.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.095 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -43.61 -58.55 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -53.6 -51.93 61.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -43.79 -30.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.403 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 30.6 t80 -42.79 -59.77 1.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -36.66 71.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 47.2 mm -57.24 -29.51 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.944 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.05 -54.18 6.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.949 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 3.8 t70 -67.61 87.04 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.966 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -84.87 -2.81 58.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.464 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 110' ' ' ASP . 2.1 p30 -131.28 153.09 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.136 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.68 89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 110.145 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 108' ' ' ASN . 60.9 t0 -142.29 -34.54 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 110.284 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.53 10.18 35.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.46 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 31.2 m-85 -153.52 147.06 25.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -1.175 . . . . 0.0 110.052 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 149' ' ' ILE . 32.8 mt -90.99 114.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.336 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.87 179.9 4.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.566 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -66.66 -43.53 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 115' ' ' ILE . 2.4 mm-40 -50.75 -45.5 58.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.822 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 7.9 mt-10 -65.02 -38.41 90.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.9 OUTLIER -58.29 -38.53 77.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.118 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.413 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -47.75 -80.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -43.43 -54.15 4.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.323 -1.104 . . . . 0.0 110.743 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.501 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 14.0 mt -42.23 -61.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.71 -44.79 80.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -40.65 62.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.17 19.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.6 p -74.9 -169.33 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.11 56.57 0.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -116.83 -10.38 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 49.12 68.06 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.4 t -89.69 149.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.66 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' GLU . 18.0 pt -117.98 155.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.4 mt-10 -40.2 -50.1 2.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.33 -0.856 . . . . 0.0 110.887 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.4 -32.99 28.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 110.948 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -47.24 10.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 13.7 mt -58.2 -37.21 61.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.311 -0.868 . . . . 0.0 109.717 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.495 ' HA ' HD11 ' A' ' 115' ' ' ILE . 4.5 mt-10 -57.4 -47.8 80.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.44 -43.65 71.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 0.0 110.112 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.61 -44.37 69.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.129 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.6 ttm -64.68 -41.77 95.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 0.0 110.261 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -56.25 22.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.38 -19.19 21.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 110.671 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.559 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -102.51 -61.5 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 0.0 110.736 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' SER . 59.5 t0 -39.38 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.402 -0.811 . . . . 0.0 110.852 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -92.67 -5.61 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.863 . . . . 0.0 110.142 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -127.49 21.6 6.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.166 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 47.6 46.94 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -105.45 14.46 28.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 110.228 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.429 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 46.53 30.94 4.77 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 11.0 mtt180 -157.52 128.74 6.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -1.113 . . . . 0.0 110.363 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.559 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.2 mt -83.48 123.54 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.683 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 20.4 p-10 -96.33 -167.36 1.56 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.355 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 18.2 p90 -65.23 -43.3 91.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.222 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.587 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -64.32 -58.32 6.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.312 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 143' ' ' LYS . 35.7 mt-10 -61.61 -42.83 99.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.521 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 17.4 t80 -56.49 -64.95 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 110.07 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 155' ' ' LEU . 32.5 mt -44.94 -48.49 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.379 -0.826 . . . . 0.0 110.001 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -46.91 -46.53 21.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -0.881 . . . . 0.0 110.375 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.547 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -71.43 -53.29 14.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.949 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.556 ' HB3' HD21 ' A' ' 98' ' ' LEU . 5.3 mmt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.946 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.319 0.581 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.2 mt-10 -47.89 -65.2 0.6 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 110.846 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' A' ' 154' ' ' PHE . 0.1 OUTLIER -51.19 -55.22 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 110.639 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -44.87 -44.77 9.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.256 -0.902 . . . . 0.0 110.687 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 3.0 m-20 -50.77 -52.0 45.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.741 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 105' ' ' PHE . 0.8 OUTLIER -61.17 -16.67 47.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.17 -0.956 . . . . 0.0 110.977 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 34.7 t80 -47.88 -41.25 23.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -0.998 . . . . 0.0 110.844 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -73.87 -37.8 64.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.0 111.095 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -57.06 -35.63 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 110.474 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 101' ' ' CYS . 28.8 m-85 -80.83 -36.57 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 110.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -79.67 80.13 6.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.034 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.456 ' HB2' ' OE2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -54.46 -30.49 53.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.479 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -109.35 -151.7 0.48 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.081 -1.012 . . . . 0.0 110.33 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.06 47.75 1.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 9.2 p30 -83.14 -18.01 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 80.13 -5.0 64.27 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 110' ' ' ASP . 7.4 m-85 -145.5 135.79 23.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -1.184 . . . . 0.0 109.876 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 mt -82.84 120.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.04 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 6.9 p-10 -87.84 176.65 7.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.158 -0.964 . . . . 0.0 110.324 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -69.72 -40.62 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.126 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 11.7 mt-10 -54.29 -48.86 70.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.021 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' OE2' ' HB2' ' A' ' 107' ' ' LYS . 3.5 mt-10 -53.3 -50.25 65.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.687 HD23 HG23 ' A' ' 134' ' ' ILE . 0.8 OUTLIER -58.28 -39.74 80.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.313 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.53 -73.99 0.34 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 14.5 pt-20 -54.85 -44.77 74.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.213 -1.169 . . . . 0.0 110.573 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 125' ' ' THR . 10.9 mt -53.01 -56.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 110.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.84 -54.59 32.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -55.99 -39.67 72.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -53.05 -20.22 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.253 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 121' ' ' ILE . 12.2 p -86.35 -1.95 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.12 81.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . 0.2 OUTLIER -79.32 0.5 28.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -1.112 . . . . 0.0 110.237 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 41.97 45.75 3.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 127' ' ' GLU . 14.8 t -77.86 155.22 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.199 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 130' ' ' ILE . 20.7 pt -114.96 138.27 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 110.409 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ILE . 8.9 mt-10 -41.02 -43.44 2.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HB2' HG13 ' A' ' 130' ' ' ILE . 1.5 mm-40 -40.72 -38.53 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.303 -0.873 . . . . 0.0 110.6 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.84 -48.96 8.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.659 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.687 HG23 HD23 ' A' ' 118' ' ' LEU . 13.3 mt -58.12 -39.45 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.863 ' HA ' HD11 ' A' ' 115' ' ' ILE . 4.5 tt0 -66.79 -41.6 87.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.589 -0.695 . . . . 0.0 110.021 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.81 -42.26 75.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.968 . . . . 0.0 110.086 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.43 78.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 31.2 tpp -61.64 -40.5 95.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.875 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -59.12 -49.42 77.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 110.104 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -68.19 -41.38 81.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.031 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.54 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -73.99 -63.97 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 138' ' ' MET . 9.7 t0 -45.41 97.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -82.14 -24.22 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.431 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 10.3 m-80 -107.76 14.78 25.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.887 . . . . 0.0 110.161 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.15 47.7 19.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 51.1 p30 -105.32 25.57 10.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 44.33 35.46 3.82 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 86.6 mtt180 -157.91 121.35 4.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.54 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.2 mt -83.62 118.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.432 ' OD2' ' OE2' ' A' ' 153' ' ' GLU . 41.0 p30 -97.18 -179.78 4.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 110.445 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -59.27 3.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.43 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -61.12 2.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.496 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 157' ' ' MET . 16.7 mt-10 -60.73 -39.95 90.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.366 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' A' ' 98' ' ' LEU . 21.5 t80 -59.68 -33.09 71.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -0.872 . . . . 0.0 110.975 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 155' ' ' LEU . 25.1 mt -74.3 -46.45 40.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 110.974 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 157' ' ' MET . 63.5 mttt -66.67 -49.41 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -0.962 . . . . 0.0 110.834 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.73 -50.51 7.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.015 -1.053 . . . . 0.0 110.372 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.467 ' HB2' ' SD ' ' A' ' 157' ' ' MET . 9.8 ttm . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 1.1 tp10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.318 0.58 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -49.8 -66.32 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.119 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.3 OUTLIER -50.1 -45.62 52.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -47.81 -42.65 26.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 110.27 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 104' ' ' ILE . 42.4 m-20 -48.1 -46.19 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.5 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 m -78.21 -25.67 47.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 0.0 110.904 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -52.95 -62.65 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -0.999 . . . . 0.0 110.729 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -57.15 -27.98 62.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.897 . . . . 0.0 110.92 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 100' ' ' ASN . 45.6 mm -61.42 -26.3 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.026 -1.046 . . . . 0.0 110.464 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.13 -29.21 24.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -79.87 117.24 20.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.079 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 -11.47 15.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.289 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 109' ' ' ALA . 56.6 m-80 -116.34 16.11 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.302 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 43.98 79.42 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.17 -33.13 5.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 110.23 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.519 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 111.85 -14.35 26.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.519 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 18.7 m-85 -149.93 141.25 23.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -1.087 . . . . 0.0 109.826 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 44.4 mt -82.81 130.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 8.2 p30 -95.17 -176.87 3.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.1 tt -79.18 -44.98 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 110.508 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.605 ' N ' HG23 ' A' ' 115' ' ' ILE . 21.6 pt-20 -48.99 -35.13 14.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 116' ' ' GLU . 43.2 mt-10 -69.12 -42.31 76.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.622 HD23 HG23 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -57.36 -37.88 73.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.31 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -57.11 -72.95 0.5 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.4 pt-20 -53.95 -44.63 70.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -1.127 . . . . 0.0 110.701 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.2 mt -45.05 -56.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.009 . . . . 0.0 110.481 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.716 ' O ' HG22 ' A' ' 125' ' ' THR . 15.7 mt -66.24 -52.31 48.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.684 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -48.71 -30.93 6.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 110.681 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.45 -56.62 18.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.743 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.716 HG22 ' O ' ' A' ' 122' ' ' LEU . 2.3 t -63.2 -10.15 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.559 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 128' ' ' HIS . . . 111.52 -29.1 8.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 129' ' ' VAL . 4.2 mm-40 -52.24 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' GLY . 8.1 m80 -67.32 76.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 109.975 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 127' ' ' GLU . 13.3 t -84.29 136.85 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.47 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 ' HB2' ' A' ' 133' ' ' ASP . 17.2 pt -90.97 143.59 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -42.95 -46.96 5.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 110.454 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -48.03 -27.23 2.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.458 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.486 ' HB2' HG13 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -89.68 -41.89 11.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.619 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.622 HG23 HD23 ' A' ' 118' ' ' LEU . 36.7 mt -65.64 -37.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.915 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.16 -48.46 73.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.91 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 12.8 t0 -55.57 -45.94 77.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -57.7 8.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.975 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 2.0 ttm -56.18 -20.88 19.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -72.89 -44.75 60.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 110.428 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -73.94 -34.48 64.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 110.716 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -74.04 -63.14 1.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.027 . . . . 0.0 110.547 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 138' ' ' MET . 23.2 m-20 -41.89 96.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.483 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -72.84 -3.81 27.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.31 22.57 2.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 48.94 86.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 110.337 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' OD1' ' CG ' ' A' ' 142' ' ' ASP . 17.6 p-10 -139.94 17.81 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 48.32 32.16 9.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 45.5 mtt180 -158.19 121.69 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.189 . . . . 0.0 110.454 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.8 mt -83.53 123.71 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.667 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 23.1 p30 -103.94 -177.44 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.617 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.89 ' CE2' HD11 ' A' ' 155' ' ' LEU . 29.7 t80 -49.95 -62.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.629 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.512 ' HA ' HD12 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -48.83 -57.61 6.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.367 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.472 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 79.7 mt-10 -59.94 -39.63 86.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 109.989 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 33.0 t80 -63.34 -51.48 65.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.89 HD11 ' CE2' ' A' ' 151' ' ' PHE . 37.3 mt -47.53 -54.06 12.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.452 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -60.55 -51.2 70.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.609 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.506 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.1 ptm -48.75 -47.54 41.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.595 ' HB3' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.228 0.537 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -51.39 -62.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 110.079 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -47.78 -62.18 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 110.06 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -44.91 -47.37 11.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.877 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 1.8 m-20 -50.88 -52.71 39.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -18.54 39.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 110.131 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 16.0 t80 -55.06 -55.87 26.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -57.06 -42.89 81.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -0.885 . . . . 0.0 110.636 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 1.2 mp -57.21 -41.71 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.135 -0.978 . . . . 0.0 110.273 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.455 ' CE2' ' HE3' ' A' ' 158' ' ' MET . 10.9 m-85 -72.11 -43.64 64.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 0.0 110.486 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.64 102.58 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -84.14 -44.34 14.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 110.475 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -68.09 -8.04 34.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.226 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.47 24.77 1.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 112' ' ' PHE . 4.0 p30 -68.16 -20.99 64.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 110.278 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.489 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 112.09 -15.77 25.52 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 9.7 m-85 -148.01 134.13 19.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -1.165 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.5 mt -82.5 133.78 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.297 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 6.4 p-10 -107.28 -171.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 110.141 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.4 tt -72.51 -43.42 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 110.187 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.587 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -55.83 -35.6 66.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.131 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -74.97 -52.31 11.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 110.417 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -38.86 -30.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.46 -0.775 . . . . 0.0 111.065 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 117' ' ' GLU . . . -56.03 -43.76 88.18 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 11.4 pt-20 -49.28 -45.86 45.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.125 -1.22 . . . . 0.0 110.942 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.518 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 1.5 mp -60.26 -50.39 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.677 HD12 ' O ' ' A' ' 118' ' ' LEU . 4.3 mp -69.08 -52.26 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.034 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 24.9 mtp180 -49.64 -36.93 26.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.32 23.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 0.0 110.324 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.8 p -61.14 -40.37 93.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.392 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.29 -3.97 9.58 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -92.66 133.47 35.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.26 60.21 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 110.136 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.545 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 38.6 t -45.48 166.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.442 ' N ' HG12 ' A' ' 129' ' ' VAL . 31.9 pt -118.52 151.99 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.99 -48.44 3.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.382 -0.824 . . . . 0.0 110.78 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -48.88 -31.54 7.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.824 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.545 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -83.19 -43.95 15.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.2 mt -66.2 -38.15 81.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.506 -0.746 . . . . 0.0 109.822 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.498 ' HA ' HD12 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.98 -53.18 44.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 110.536 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -45.98 -51.31 13.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 0.0 110.45 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.56 HD12 ' HE3' ' A' ' 157' ' ' MET . 1.5 mm? -50.58 -41.27 54.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.553 ' HE2' HD12 ' A' ' 149' ' ' ILE . 20.9 tpp -67.97 -48.96 64.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -48.21 79.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.63 -32.42 69.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 143' ' ' LYS . 2.1 t -92.99 -38.06 11.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' MET . 1.4 m-20 -51.99 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 8.3 tptm -74.63 -18.19 60.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.911 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.77 10.68 13.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.989 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.0 m120 55.31 46.13 24.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -0.881 . . . . 0.0 110.322 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -107.04 16.12 24.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 51.52 34.96 35.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 5.6 mtm180 -157.63 124.82 5.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -1.214 . . . . 0.0 110.223 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.553 HD12 ' HE2' ' A' ' 138' ' ' MET . 4.2 mt -83.94 128.55 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 0.0 110.131 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.451 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 53.3 p-10 -108.73 -170.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 110.087 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -63.5 -37.87 88.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.93 -51.85 35.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.451 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 46.8 mt-10 -59.7 -45.41 92.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.566 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 155' ' ' LEU . 1.9 t80 -50.61 -57.97 6.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.768 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.7 mt -39.92 -64.15 0.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.468 -0.77 . . . . 0.0 110.677 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -30.97 66.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.56 ' HE3' HD12 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -65.5 -40.31 92.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.53 ' N ' ' HG3' ' A' ' 157' ' ' MET . 2.5 mtt . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 0.0 110.169 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.247 0.546 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 1.9 mt-10 -59.71 -54.01 51.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.701 HD22 ' HE1' ' A' ' 154' ' ' PHE . 14.1 mt -50.78 -64.13 0.91 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.89 -46.01 10.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 67.7 m-20 -56.01 -48.29 76.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 73.8 m -45.33 -29.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -44.89 -62.97 1.02 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 109.82 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.39 -42.01 61.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 21.0 mm -61.28 -39.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.0 -51.96 48.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.865 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 21.0 t0 -53.42 129.37 31.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.517 -0.739 . . . . 0.0 110.418 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -98.29 -14.43 20.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.191 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 4.3 p30 -133.47 12.0 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 55.39 57.35 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 36.0 p30 -84.85 -14.57 47.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 94.07 -10.52 71.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CB ' ' HD2' ' A' ' 148' ' ' ARG . 46.7 m-85 -151.41 136.42 17.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -1.227 . . . . 0.0 110.635 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.9 mt -88.28 121.65 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' HG3' ' A' ' 117' ' ' GLU . 13.6 p30 -98.3 171.01 8.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.229 -0.919 . . . . 0.0 110.342 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -58.49 -36.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.451 ' N ' HG23 ' A' ' 115' ' ' ILE . 70.8 mm-40 -51.03 -54.04 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.877 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 51.6 mt-10 -56.38 -41.58 76.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.787 ' HG ' HD21 ' A' ' 137' ' ' LEU . 0.3 OUTLIER -54.73 -43.56 72.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -56.44 -75.47 0.25 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 16.1 pt-20 -42.35 -45.06 4.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -1.12 . . . . 0.0 110.479 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.497 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 41.5 mt -55.22 -55.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.722 HD22 HG21 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -63.15 -53.67 49.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 110.442 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -48.82 -40.36 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.19 -34.39 22.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.286 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 36.4 p -70.01 -23.33 63.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.962 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.1 3.76 26.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HB3' HG23 ' A' ' 129' ' ' VAL . 11.9 mt-10 -89.59 132.9 34.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.311 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -85.38 53.36 2.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.722 HG21 HD22 ' A' ' 122' ' ' LEU . 22.6 t -65.28 149.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.868 . . . . 0.0 110.518 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 132' ' ' GLU . 6.2 pt -113.76 153.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.8 tt0 -41.71 -53.02 3.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.536 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -44.32 -36.45 2.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.72 -42.05 22.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 109.099 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 17.0 mt -67.18 -36.53 77.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.52 -0.737 . . . . 0.0 109.565 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 138' ' ' MET . 2.8 tm-20 -56.26 -32.47 64.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 109.838 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -49.83 -62.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 110.767 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.904 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.1 pp -56.88 -27.97 61.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.987 . . . . 0.0 110.651 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.436 ' N ' HD12 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -67.01 -46.82 73.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.03 . . . . 0.0 110.046 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.84 72.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -59.9 -36.37 76.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.552 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -86.11 -59.06 2.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 145' ' ' ASN . 53.9 t0 -43.44 92.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -92.3 -20.06 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 15.1 m-80 -104.74 6.4 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.03 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.0 OUTLIER 63.93 28.49 14.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 110.211 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -87.76 8.66 24.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.76 24.66 33.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.538 ' HD2' ' CB ' ' A' ' 112' ' ' PHE . 1.4 mtt-85 -147.69 142.58 26.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -1.155 . . . . 0.0 110.189 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.904 HD11 ' CD1' ' A' ' 137' ' ' LEU . 19.4 mt -90.65 121.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.372 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 36.4 p-10 -97.7 -156.32 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 0.0 109.907 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -71.18 -55.79 7.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.31 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -59.32 -60.21 4.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.908 . . . . 0.0 110.548 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.49 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 26.6 mt-10 -48.02 -37.74 15.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.316 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.701 ' HE1' HD22 ' A' ' 98' ' ' LEU . 50.9 t80 -60.37 -61.04 2.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 154' ' ' PHE . 91.4 mt -41.76 -39.03 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.435 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 152' ' ' ASP . 8.8 mttm -58.42 -45.48 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 110.365 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.863 ' HE1' HD13 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -64.17 -51.2 64.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.826 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.581 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 110.572 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.236 0.541 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -67.88 -52.97 30.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.287 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.509 HD22 ' HE2' ' A' ' 158' ' ' MET . 0.1 OUTLIER -52.15 -53.39 43.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.97 44.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.95 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -77.02 -46.0 25.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -49.01 -27.26 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.967 . . . . 0.0 110.092 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.626 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 2.3 t80 -42.08 -56.54 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -56.93 -34.12 67.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.326 -0.859 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.61 -59.83 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.358 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.675 ' O ' HD11 ' A' ' 121' ' ' ILE . 3.0 m-85 -62.42 -38.37 89.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -85.76 62.24 7.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.229 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -35.43 10.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.182 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.424 ' HB3' ' OD2' ' A' ' 110' ' ' ASP . 1.5 t-20 -55.51 -21.26 15.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.02 47.18 25.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 108' ' ' ASN . 33.1 m-20 -106.94 -13.86 15.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.542 ' C ' ' CD1' ' A' ' 112' ' ' PHE . . . 97.87 -2.43 60.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 111' ' ' GLY . 63.5 m-85 -150.57 119.42 6.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.24 . . . . 0.0 110.273 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.409 ' HA ' ' OE2' ' A' ' 117' ' ' GLU . 15.7 mt -83.79 116.39 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.34 -0.85 . . . . 0.0 110.112 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -92.59 175.28 6.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.578 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -57.05 -42.73 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.894 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.578 ' N ' HG23 ' A' ' 115' ' ' ILE . 4.5 mt-10 -51.01 -45.87 61.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.093 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.4 mt-10 -58.47 -50.48 73.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.89 . . . . 0.0 110.127 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 137' ' ' LEU . 0.3 OUTLIER -52.1 -34.65 45.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.893 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -70.28 -69.25 1.43 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -48.52 -45.24 37.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.237 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.675 HD11 ' O ' ' A' ' 105' ' ' PHE . 47.3 mt -57.0 -50.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 122' ' ' LEU . 12.9 mt -76.72 -53.98 7.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.965 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 9.5 mtt180 -49.07 -32.24 9.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.098 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -57.15 -43.24 82.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.4 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 81.0 p -55.66 -43.57 76.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.26 -39.37 1.69 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 129' ' ' VAL . 1.9 mt-10 -46.02 125.23 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.136 . . . . 0.0 110.321 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.56 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 2.6 p-80 -71.67 65.47 0.49 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 127' ' ' GLU . 5.3 t -64.67 148.68 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.155 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.47 145.24 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.393 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLU . 15.7 mt-10 -43.86 -50.16 8.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.326 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -42.51 -32.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.366 -0.834 . . . . 0.0 109.992 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.76 -47.0 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.8 mt -59.69 -38.7 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 0.0 109.785 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -48.97 -48.79 42.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -51.24 -46.84 62.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 118' ' ' LEU . 10.5 mt -53.48 -52.92 58.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 110.884 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 31.9 tpp -66.67 -52.35 45.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 0.0 110.167 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -60.7 2.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.45 -0.781 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.24 -37.67 67.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 0.0 110.666 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.544 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.68 -55.4 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 110.557 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -46.74 91.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.593 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -80.81 -38.73 27.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.106 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.417 ' ND2' ' OD1' ' A' ' 146' ' ' ASP . 6.7 p30 -95.8 12.5 29.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.873 . . . . 0.0 110.082 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.4 m120 53.49 87.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 110.55 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 148' ' ' ARG . 6.8 p-10 -143.97 13.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 109.628 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 56.86 20.78 34.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HG3' ' C ' ' A' ' 147' ' ' GLY . 30.7 mtt-85 -149.77 133.83 17.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.995 -1.297 . . . . 0.0 110.607 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.544 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.9 mt -84.29 132.85 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.812 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 24.4 p-10 -112.55 -170.01 1.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.458 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.626 ' CE1' ' CD2' ' A' ' 102' ' ' PHE . 3.3 m-85 -59.38 -56.58 20.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.411 ' HA ' HD12 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -52.33 -59.17 4.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.225 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 157' ' ' MET . 54.2 mt-10 -57.39 -46.79 83.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.539 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 84.5 t80 -47.86 -32.24 5.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 110.233 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.532 ' O ' ' CE ' ' A' ' 158' ' ' MET . 27.7 mt -75.68 -50.64 14.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -49.42 74.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.184 -0.948 . . . . 0.0 110.954 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.77 -47.61 8.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 111.245 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 155' ' ' LEU . 6.2 ptp . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 0.0 110.616 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.273 0.558 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -47.54 -46.92 28.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.866 . . . . 0.0 109.919 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 3.8 mm? -57.03 -48.54 78.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -49.08 -53.11 21.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.45 78.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.121 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -53.19 -19.2 2.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 44.3 t80 -50.5 -50.22 53.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 110.188 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -30.6 69.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.418 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 26.2 mm -56.89 -38.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -85.22 -11.85 53.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -91.24 106.6 18.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -9.29 33.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.338 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.488 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 66.4 m-80 -117.09 9.26 13.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.922 . . . . 0.0 110.312 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 44.02 43.49 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 10.8 m-20 -80.3 -22.43 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.36 -7.98 62.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 44.8 m-85 -151.81 125.06 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 149' ' ' ILE . 2.9 mp -83.31 112.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.955 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 15.2 p-10 -92.97 -173.24 3.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.3 tt -69.69 -41.9 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.867 . . . . 0.0 110.523 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -53.81 -55.39 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 24.0 mt-10 -45.4 -55.05 6.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.355 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.746 HD23 HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -48.77 -54.01 16.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.359 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -47.39 -77.06 0.12 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.9 pt-20 -42.67 -47.9 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.502 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 118' ' ' LEU . 8.0 mt -47.29 -55.43 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.011 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.746 HD12 HD23 ' A' ' 118' ' ' LEU . 2.4 mt -76.63 -54.86 6.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.211 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -49.06 -36.37 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.899 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -48.88 -39.66 26.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.052 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 69.9 p -66.76 -38.47 86.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.45 32.57 4.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 128' ' ' HIS . 8.6 mm-40 -97.02 7.08 47.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.319 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 127' ' ' GLU . 8.2 m80 43.58 72.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 122' ' ' LEU . 57.7 t -88.62 154.92 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.343 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 130' ' ' ILE . 17.6 pt -103.38 145.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 110.177 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.1 mt-10 -49.85 -41.05 44.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.377 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.1 tm-20 -41.69 -33.38 0.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 110.357 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -44.78 12.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 0.0 109.418 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.634 HG23 HD22 ' A' ' 118' ' ' LEU . 26.9 mt -65.59 -38.95 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.505 -0.747 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 13.2 mm-40 -56.64 -50.52 71.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.47 -0.769 . . . . 0.0 110.277 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.93 -55.02 10.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.935 . . . . 0.0 110.408 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.464 HD13 HD21 ' A' ' 118' ' ' LEU . 45.3 mt -48.96 -52.95 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.496 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.513 ' HG3' ' HB2' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -71.08 -50.01 38.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.88 . . . . 0.0 110.418 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 14.1 mttm -56.53 -39.7 73.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.424 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.43 -40.66 61.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.538 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -83.86 -52.19 6.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 110.653 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.513 ' HB2' ' HG3' ' A' ' 138' ' ' MET . 29.5 t0 -46.45 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.401 -0.812 . . . . 0.0 111.01 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 30.3 tttt -77.71 -23.93 49.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -99.35 -5.61 29.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.69 . . . . 0.0 109.636 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.469 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 1.5 m-20 59.84 24.86 13.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 20.6 p30 -85.17 2.58 43.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 75.94 38.73 35.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 14.7 mtm180 -159.14 133.45 7.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.498 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 141' ' ' SER . 2.0 mt -97.81 123.89 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -105.48 -173.91 2.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 54.1 p90 -57.25 -43.49 83.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 110.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.603 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -63.75 -51.4 65.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.018 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 53.5 mt-10 -65.16 -52.51 54.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.089 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 102' ' ' PHE . 5.9 t80 -46.72 -57.28 5.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' PHE . 71.3 mt -45.3 -63.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -60.69 -25.2 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 110.019 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.525 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -60.85 -38.03 84.13 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.262 -0.899 . . . . 0.0 109.148 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.525 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 109.985 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.151 0.5 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -49.69 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.472 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.635 HD12 ' CE ' ' A' ' 158' ' ' MET . 21.3 mt -53.0 -43.06 66.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 110.274 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.31 -61.0 2.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -55.41 -49.72 71.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.498 ' SG ' ' CE2' ' A' ' 105' ' ' PHE . 42.5 t -59.93 -19.95 54.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.65 -57.47 11.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.054 -1.029 . . . . 0.0 110.177 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.79 -37.09 3.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 104' ' ' ILE . 2.0 mp -67.88 -53.06 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.498 ' CE2' ' SG ' ' A' ' 101' ' ' CYS . 11.9 m-85 -54.03 -31.21 50.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 110.028 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 18.7 t0 -87.2 91.52 8.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.906 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 -41.97 65.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.522 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 109' ' ' ALA . 32.8 m-80 -87.19 6.38 33.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 43.0 63.14 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -96.92 -11.79 24.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.301 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 90.78 -15.11 61.34 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 46.0 m-85 -147.35 125.02 11.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 110.074 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.84 131.13 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.95 -167.4 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.167 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.798 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -72.49 -41.02 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.932 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.506 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 1.6 tm-20 -57.03 -53.94 52.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.475 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 22.5 mt-10 -53.15 -38.2 62.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.33 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.461 HD11 HD22 ' A' ' 137' ' ' LEU . 0.9 OUTLIER -60.58 -51.35 69.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -50.1 -74.21 0.3 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.475 ' OE2' ' HA ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -42.47 -54.61 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -1.141 . . . . 0.0 110.671 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.441 HG13 ' CD ' ' A' ' 120' ' ' GLU . 17.1 mt -49.13 -53.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 122' ' ' LEU . 36.3 mt -69.1 -46.23 68.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.355 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -39.4 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.92 -44.05 29.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 126' ' ' GLY . 32.9 p -55.55 -64.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.455 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . 142.32 37.76 0.08 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.75 154.85 24.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -1.131 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.451 ' H ' ' CD2' ' A' ' 128' ' ' HIS . 23.3 p80 -90.01 63.5 5.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 110.645 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.2 t -82.49 135.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.976 . . . . 0.0 109.737 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.0 pt -102.78 145.07 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.508 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.2 mt-10 -42.74 -53.97 4.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.41 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -40.49 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.828 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -85.89 -51.24 6.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.77 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.0 mt -60.82 -41.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 109.699 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.798 ' HA ' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -50.03 -50.99 45.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.89 -36.85 84.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 118' ' ' LEU . 2.0 tt -50.35 -44.36 54.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.611 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 ttm -67.11 -42.43 84.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.172 -0.955 . . . . 0.0 110.507 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -64.19 -44.34 92.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -68.53 -36.81 79.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.187 -0.945 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.552 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.0 t -80.78 -49.8 10.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.505 ' HA ' ' OE2' ' A' ' 153' ' ' GLU . 38.5 t70 -60.55 90.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.63 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.47 49.12 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 73.5 m-80 -147.61 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.465 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.6 m-20 172.06 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.604 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 35.2 p-10 -41.54 -25.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 76.64 51.54 6.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 2.5 mtm180 -158.13 153.66 26.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 110.35 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.552 HG12 ' CB ' ' A' ' 141' ' ' SER . 22.1 mt -88.97 114.17 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.901 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 26.5 p30 -105.9 -172.48 2.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 22.3 p90 -57.62 -37.07 72.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 110.757 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.612 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -70.44 -52.78 19.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' HA ' ' A' ' 142' ' ' ASP . 48.5 mt-10 -68.45 -43.74 76.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.927 . . . . 0.0 110.259 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.537 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 37.4 t80 -49.23 -33.88 13.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.538 ' O ' ' CE ' ' A' ' 158' ' ' MET . 94.8 mt -76.1 -42.02 48.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -69.15 -49.01 60.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.053 -1.029 . . . . 0.0 110.673 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.537 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -44.43 -48.24 9.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.213 -0.93 . . . . 0.0 111.056 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.635 ' CE ' HD12 ' A' ' 98' ' ' LEU . 5.8 ptp . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.186 -0.946 . . . . 0.0 110.217 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 1.6 mt-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.33 0.586 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -54.17 -55.74 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.292 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 12.7 mt -51.53 -47.1 63.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -41.82 -58.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 110.314 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -65.57 -26.96 68.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.912 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -74.89 -9.08 58.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -55.21 -47.62 75.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.019 -1.051 . . . . 0.0 110.013 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -60.43 -35.57 76.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 18.0 mm -59.67 -32.59 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.005 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 107' ' ' LYS . 3.0 m-85 -80.22 -59.0 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -58.32 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 109.932 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -53.39 -43.34 67.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.34 -0.85 . . . . 0.0 110.563 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -94.13 -159.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.35 60.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.57 -32.4 12.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.159 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.537 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 99.74 -3.73 57.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 36.2 m-85 -153.35 123.92 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 113' ' ' ILE . 3.8 mp -83.58 122.38 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.309 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -95.77 178.47 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.1 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.636 HD11 ' HG2' ' A' ' 135' ' ' GLU . 2.2 tt -57.3 -42.7 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.027 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -51.82 -53.81 36.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.897 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 4.1 mt-10 -52.17 -47.21 65.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.959 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.566 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -54.77 -27.63 42.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 0.0 109.837 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.45 -68.71 1.51 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.3 pt-20 -49.89 -44.51 49.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.237 . . . . 0.0 110.177 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.566 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 20.2 mt -49.28 -61.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' A' ' 129' ' ' VAL . 1.0 OUTLIER -68.74 -43.7 75.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.012 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -50.77 -39.47 52.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.18 -44.19 75.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.0 110.381 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 p -60.89 -31.62 71.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.15 -0.969 . . . . 0.0 110.161 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.86 20.24 29.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 128' ' ' HIS . 2.2 mt-10 -88.9 23.13 2.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -1.162 . . . . 0.0 110.225 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.583 ' C ' HG23 ' A' ' 129' ' ' VAL . 1.5 t60 56.94 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 122' ' ' LEU . 2.9 t 70.18 143.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.587 -0.696 . . . . 0.0 110.031 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.3 pt -123.18 146.85 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.137 -0.977 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.64 -46.32 14.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 110.121 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.03 -28.93 1.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' O ' HD12 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -92.7 -48.98 6.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 118' ' ' LEU . 22.6 mt -55.61 -39.29 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.074 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.636 ' HG2' HD11 ' A' ' 115' ' ' ILE . 7.0 mt-10 -58.28 -46.14 86.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -50.69 -52.11 43.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.6 OUTLIER -53.94 -43.27 69.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.089 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -71.08 -53.89 13.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.187 -0.946 . . . . 0.0 109.857 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -59.57 4.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -49.7 -40.51 40.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 110.202 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.554 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.2 t -77.12 -57.32 3.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER -61.15 75.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 110.551 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -79.66 4.12 17.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 179.365 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 144' ' ' ASN . 1.4 t30 -121.88 10.09 10.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.603 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.29 26.26 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -1.82 18.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.359 -0.838 . . . . 0.0 110.209 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.436 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 60.97 17.07 50.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.469 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 1.1 mtt-85 -158.34 143.39 16.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.33 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.554 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.7 mt -87.63 116.66 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.74 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 154' ' ' PHE . 53.4 p-10 -101.42 -175.41 2.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -54.52 38.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.09 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.13 -62.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 110.367 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 154' ' ' PHE . 68.1 mt-10 -57.21 -50.82 71.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.164 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 14.4 t80 -43.39 -56.18 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.869 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.72 -51.34 68.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -53.69 -50.56 65.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.501 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -50.93 -46.13 60.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.501 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.616 -0.678 . . . . 0.0 110.099 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.204 0.526 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.98 -48.82 42.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.805 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.536 ' CD1' ' HB3' ' A' ' 158' ' ' MET . 2.2 mm? -51.38 -61.45 2.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.039 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.11 -51.93 16.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.922 . . . . 0.0 110.228 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 71.6 m-20 -51.23 -34.04 30.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 110.143 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.41 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 61.0 m -68.19 -15.09 63.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.215 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -56.24 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 100' ' ' ASN . 6.8 ptp180 -52.47 -37.67 57.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.289 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 13.0 mm -57.8 -45.76 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 110.261 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -53.95 34.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.21 146.52 54.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.509 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -125.49 -47.1 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.977 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 66.2 m-20 -79.04 2.76 19.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 56.45 59.35 3.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.174 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.7 -21.52 20.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.23 -15.99 60.62 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 40.5 m-85 -153.09 130.06 11.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 110.043 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.45 125.1 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.893 . . . . 0.0 110.626 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -104.27 -157.81 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.825 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.458 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -75.5 -37.39 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.133 -0.98 . . . . 0.0 109.976 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.458 ' N ' HG23 ' A' ' 115' ' ' ILE . 57.1 mt-10 -55.71 -44.4 77.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -63.78 -44.46 93.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.668 HD12 HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -56.76 -33.98 67.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -65.89 -74.21 0.54 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -42.12 -59.87 1.63 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.222 -1.163 . . . . 0.0 110.961 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 120' ' ' GLU . 4.2 mt -43.69 -50.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.001 -1.062 . . . . 0.0 109.974 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.845 HD13 HG11 ' A' ' 129' ' ' VAL . 11.1 mt -77.4 -42.45 36.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.398 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 44.6 mtt180 -55.68 -32.85 63.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.94 48.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.0 110.125 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.8 p -77.14 -157.66 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.92 58.12 0.69 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.06 164.48 26.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -1.137 . . . . 0.0 110.506 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.12 94.01 7.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.881 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.845 HG11 HD13 ' A' ' 122' ' ' LEU . 4.0 t -109.73 72.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.327 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 19.0 pt -62.57 159.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.2 tt0 -46.19 -49.5 16.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.503 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 2.4 mt-10 -40.99 -35.8 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.334 -0.854 . . . . 0.0 110.381 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.31 -47.46 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.661 ' CG1' HG12 ' A' ' 129' ' ' VAL . 17.6 mt -60.14 -41.03 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HG2' ' HG2' ' A' ' 131' ' ' GLU . 4.9 mm-40 -57.6 -36.79 72.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.513 -0.742 . . . . 0.0 110.051 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -51.25 -50.32 59.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.845 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.1 OUTLIER -56.68 -43.91 80.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.405 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -68.24 -43.84 77.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 110.043 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -64.9 -43.46 92.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.42 -33.21 69.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 0.0 110.327 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.523 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.9 OUTLIER -86.03 -61.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.935 . . . . 0.0 110.394 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 60.6 t0 -41.14 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.559 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 143' ' ' LYS . 76.4 tttt -99.18 2.5 45.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -134.41 16.85 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.662 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 8.9 m-20 48.01 51.53 14.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.443 -0.786 . . . . 0.0 110.341 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -104.61 4.57 32.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.88 11.18 60.22 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 6.0 mtp180 -147.56 146.43 29.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.142 -1.211 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.678 HG21 ' CE ' ' A' ' 157' ' ' MET . 4.7 mt -89.72 113.83 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.364 -0.835 . . . . 0.0 109.998 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.49 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 48.8 p30 -90.02 179.18 6.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.422 ' O ' ' HG ' ' A' ' 155' ' ' LEU . 16.8 m-85 -42.82 -59.19 2.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.349 -0.844 . . . . 0.0 110.28 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.94 -56.89 15.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.49 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 45.8 mt-10 -57.36 -46.9 82.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.901 ' HA ' ' HE3' ' A' ' 157' ' ' MET . 35.5 t80 -59.53 -56.36 22.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 151' ' ' PHE . 32.4 mt -45.74 -48.67 15.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 -57.92 6.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 0.0 110.081 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.901 ' HE3' ' HA ' ' A' ' 154' ' ' PHE . 1.3 ptp -47.45 -50.77 22.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.715 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.57 ' N ' ' CG ' ' A' ' 157' ' ' MET . 13.1 mmt . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.424 -0.798 . . . . 0.0 110.352 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.242 0.544 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -48.59 -60.14 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 110.342 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 99' ' ' ALA . 28.5 mt -58.96 -58.54 8.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -42.47 -40.39 2.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.144 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 90.8 m-20 -62.34 -35.63 79.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 98' ' ' LEU . 71.8 m -67.57 -36.54 81.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 43.0 t80 -42.67 -56.34 3.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 110.22 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -44.53 61.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -62.82 -54.55 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.339 -0.851 . . . . 0.0 109.913 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -58.63 -43.2 89.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 109.934 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.456 ' OD1' ' OE1' ' A' ' 117' ' ' GLU . 14.0 t0 -85.19 109.02 18.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -122.08 -28.92 4.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.449 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 2.7 p-10 -97.15 -44.33 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -87.54 -42.24 12.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.887 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 7.6 m-20 47.93 23.96 0.55 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . -142.83 -36.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 76.7 m-85 -149.63 136.94 19.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -1.101 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.42 ' CD1' ' CD1' ' A' ' 154' ' ' PHE . 24.3 mt -82.56 131.5 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.101 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.48 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 28.4 p30 -119.11 -162.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -83.05 -42.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.577 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -52.49 -41.57 63.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' OE1' ' OD1' ' A' ' 106' ' ' ASP . 2.2 mt-10 -64.93 -37.93 89.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -65.82 -46.24 79.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.972 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -46.01 -75.66 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' GLY . 5.1 pt-20 -43.24 -47.76 6.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -1.125 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.94 -55.42 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 110.113 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.69 HD22 HG11 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -63.14 -43.16 99.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.986 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -38.92 64.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.274 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.81 -30.86 6.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -0.945 . . . . 0.0 110.265 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.2 p -73.85 -29.85 62.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.77 53.84 1.88 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.7 mm-40 -129.71 148.47 51.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -1.13 . . . . 0.0 110.214 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.502 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 23.2 p80 -71.3 58.34 0.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.13 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 122' ' ' LEU . 4.5 t -75.9 151.81 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 110.274 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.0 pt -139.61 155.94 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.885 . . . . 0.0 110.138 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.474 ' CA ' ' OE1' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -48.03 -47.88 33.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 3.6 mm-40 -42.11 -38.22 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -48.84 7.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 10.6 mt -61.46 -43.27 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -0.865 . . . . 0.0 109.748 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.623 ' HG2' HD11 ' A' ' 115' ' ' ILE . 3.5 mm-40 -53.11 -49.06 67.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 135' ' ' GLU . 12.5 t0 -43.75 -53.86 5.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.825 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.2 OUTLIER -50.66 -57.67 7.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.48 ' HE1' ' HA ' ' A' ' 114' ' ' ASP . 1.4 ttm -58.05 -34.86 70.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.178 -0.952 . . . . 0.0 109.583 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -70.56 -51.51 28.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.194 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -67.97 -40.36 83.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.372 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -57.69 -46.76 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 141' ' ' SER . 0.4 OUTLIER -44.36 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.235 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.6 OUTLIER -93.59 2.69 56.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.145 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.441 ' HB2' ' CG ' ' A' ' 146' ' ' ASP . 4.2 m-80 -141.32 21.45 2.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.69 24.44 10.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 144' ' ' ASN . 42.3 m-20 -69.95 -11.79 61.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 0.0 110.192 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.456 ' C ' ' HG3' ' A' ' 148' ' ' ARG . . . 79.6 -6.47 57.99 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.456 ' HG3' ' C ' ' A' ' 147' ' ' GLY . 45.3 mtt180 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 141' ' ' SER . 20.3 mt -85.27 126.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.0 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.462 ' N ' ' OE1' ' A' ' 153' ' ' GLU . 13.0 p-10 -109.01 -163.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CZ ' HD11 ' A' ' 155' ' ' LEU . 56.2 t80 -57.81 -57.66 11.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 110.5 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -62.95 1.31 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.549 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' A' ' 150' ' ' ASP . 4.0 mt-10 -57.29 -43.93 83.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.458 ' O ' ' HG2' ' A' ' 157' ' ' MET . 82.6 t80 -48.41 -50.58 30.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.059 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.459 HD11 ' CZ ' ' A' ' 151' ' ' PHE . 11.6 mt -57.25 -54.15 50.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.337 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -60.33 -40.1 89.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.304 -0.873 . . . . 0.0 110.735 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG2' ' SD ' ' A' ' 158' ' ' MET . 0.6 OUTLIER -49.98 -40.46 44.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 109.647 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.484 ' SD ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.558 -0.714 . . . . 0.0 110.543 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.253 0.549 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 19.3 mm-40 -52.23 -45.24 65.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -46.73 -61.78 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.277 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -41.55 -57.95 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -70.13 -53.78 15.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.1 m -47.99 -22.28 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.521 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 151' ' ' PHE . 59.2 t80 -51.7 -51.93 52.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -26.69 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.316 -0.865 . . . . 0.0 110.648 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 37.1 mm -68.13 -58.73 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.037 . . . . 0.0 110.332 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -51.31 -34.16 32.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 13.8 t0 -73.39 89.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.269 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -83.25 -20.38 34.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.683 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 7.9 p30 -114.47 -1.29 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 66.73 69.77 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.327 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 4.3 p30 -108.72 -22.13 12.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.183 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.551 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 91.35 -3.64 79.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 6.9 m-85 -152.72 129.23 10.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 113' ' ' ILE . 3.4 mp -82.9 114.53 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.984 . . . . 0.0 109.8 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 116' ' ' GLU . 3.1 p30 -88.1 -176.16 5.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.582 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.9 tp -65.47 -40.78 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 110.09 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.543 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -54.71 -52.49 62.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 110.27 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 52.2 mt-10 -51.91 -44.58 63.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.327 -0.858 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.727 HD12 HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -53.11 -52.47 58.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.109 -0.994 . . . . 0.0 110.27 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.538 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -58.99 -66.69 2.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.8 pt-20 -48.06 -45.69 32.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 110.457 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.542 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 12.2 mt -52.97 -60.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.008 . . . . 0.0 109.973 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.651 HD13 HG11 ' A' ' 129' ' ' VAL . 16.8 mt -63.98 -38.67 91.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -64.4 -41.94 96.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.413 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.22 69.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 121' ' ' ILE . 24.9 p -55.95 -19.75 13.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.325 -0.859 . . . . 0.0 110.301 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.21 30.42 7.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -119.9 167.46 12.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -1.16 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 128' ' ' HIS . 51.7 p-80 -113.03 75.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 110.301 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.651 HG11 HD13 ' A' ' 122' ' ' LEU . 5.6 t -83.06 133.1 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.84 HD12 ' HB2' ' A' ' 132' ' ' GLU . 17.8 pt -85.42 152.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 2.3 mm-40 -52.53 -38.51 59.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.277 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.84 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.25 -38.04 0.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.377 -0.827 . . . . 0.0 110.686 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -45.66 9.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.123 -0.986 . . . . 0.0 109.636 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.727 HG23 HD12 ' A' ' 118' ' ' LEU . 40.1 mt -57.68 -38.36 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.798 . . . . 0.0 109.734 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 2.9 mt-10 -68.34 -36.33 79.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -58.51 -48.76 79.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.162 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 118' ' ' LEU . 97.2 mt -49.15 -44.38 42.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 0.0 110.199 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.629 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -68.94 -48.64 62.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.063 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -55.32 -35.5 65.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.29 -27.4 59.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.324 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.558 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -106.37 -60.75 1.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.861 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 138' ' ' MET . 14.7 t0 -38.24 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.77 . . . . 0.0 110.79 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.0 OUTLIER -86.57 -40.53 15.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.633 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.475 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 13.9 m-80 -92.19 17.7 9.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 49.49 25.46 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 11.1 p-10 -78.66 2.8 18.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.132 -0.98 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.92 30.98 79.43 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.1 129.75 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.192 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.629 HD12 ' CE ' ' A' ' 138' ' ' MET . 1.2 mt -83.39 129.33 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.899 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 1.5 p-10 -100.45 -163.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.013 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.456 ' CE1' ' CZ ' ' A' ' 102' ' ' PHE . 73.9 m-85 -69.22 -51.1 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -50.12 70.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 110.632 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.54 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 72.9 mt-10 -56.92 -44.75 82.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.989 . . . . 0.0 110.533 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -52.97 -66.09 0.45 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.971 -1.081 . . . . 0.0 109.984 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.1 mt -43.87 -32.48 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.955 . . . . 0.0 109.626 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -28.98 55.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.415 -0.803 . . . . 0.0 109.928 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.548 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -61.85 -37.59 85.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.548 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 109.779 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.261 0.553 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -58.32 -36.03 72.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.708 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.868 ' CD2' HD23 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -84.52 -45.7 12.34 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.361 -0.837 . . . . 0.0 109.265 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 151' ' ' PHE . . . -47.43 -34.61 7.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.093 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.61 -40.28 19.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.863 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.51 ' HG ' ' HE1' ' A' ' 105' ' ' PHE . 0.7 OUTLIER -54.21 -21.4 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.993 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.45 -64.71 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.988 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -51.06 -39.2 55.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.77 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.6 mp -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.289 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.797 ' HB3' HD13 ' A' ' 113' ' ' ILE . 4.7 m-85 -60.31 -52.06 66.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 109.546 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -67.61 87.53 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -88.79 -34.04 17.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.357 -0.839 . . . . 0.0 110.804 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 17.3 p30 -81.2 4.48 20.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.059 -1.026 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 84.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.456 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 2.3 p30 -128.1 -34.16 2.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.452 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 118.3 -24.47 8.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.501 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 67.3 m-85 -148.93 126.72 11.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -1.135 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.797 HD13 ' HB3' ' A' ' 105' ' ' PHE . 42.5 mt -83.58 126.96 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -105.05 -178.29 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.355 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 2.8 tp -56.09 -39.99 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.0 mm-40 -56.97 -58.12 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.599 ' OE1' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -46.31 -34.98 4.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.201 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.628 HD13 HG23 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -70.59 -155.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 68.65 -80.72 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -51.04 -55.02 19.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.12 . . . . 0.0 110.428 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.431 ' C ' ' O ' ' A' ' 120' ' ' GLU . 10.4 mt -42.09 -44.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 110.43 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 122' ' ' LEU . 45.8 mt -72.28 -49.71 32.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -48.69 -35.78 14.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -0.889 . . . . 0.0 110.538 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.08 -42.29 60.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 32.1 p -68.03 -7.35 28.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.319 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.414 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 81.09 41.67 10.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -121.69 140.78 51.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.479 ' H ' ' CD2' ' A' ' 128' ' ' HIS . 23.0 p80 -82.16 111.78 18.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.6 t -126.12 156.18 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 12.9 pt -130.39 158.07 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.428 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 2.7 mt-10 -47.92 -49.77 29.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -42.65 -36.98 1.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.89 -48.07 8.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.29 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.628 HG23 HD13 ' A' ' 118' ' ' LEU . 22.9 mt -54.23 -36.45 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.482 -0.762 . . . . 0.0 109.694 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.497 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 51.8 mt-10 -60.89 -47.15 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.14 -39.52 56.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.0 mp -61.74 -46.77 88.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 110.21 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.486 ' CE ' HD12 ' A' ' 149' ' ' ILE . 30.4 tpp -65.05 -48.21 74.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.88 85.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.943 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.89 -33.17 73.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.114 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.483 ' CB ' HG12 ' A' ' 149' ' ' ILE . 6.9 t -84.1 -56.02 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 15.0 m-20 -42.32 103.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 110.57 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.74 -16.49 55.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.706 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 2.1 p30 -124.82 14.84 8.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.872 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.17 73.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 147' ' ' GLY . 10.0 p-10 -128.28 22.58 6.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -0.834 . . . . 0.0 109.805 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.434 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 43.17 36.6 2.9 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -157.9 120.84 3.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -1.166 . . . . 0.0 110.474 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.486 HD12 ' CE ' ' A' ' 138' ' ' MET . 7.1 mt -83.69 120.79 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.474 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 6.7 p-10 -90.06 -152.02 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.426 ' CZ ' ' HB1' ' A' ' 99' ' ' ALA . 49.5 t80 -82.08 -39.51 23.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.329 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.18 -56.69 4.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 0.0 110.691 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.474 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 29.8 mt-10 -46.75 -36.07 6.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.495 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.454 ' O ' ' HG2' ' A' ' 157' ' ' MET . 32.6 t80 -56.2 -56.42 21.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.868 HD23 ' CD2' ' A' ' 98' ' ' LEU . 2.6 mt -52.42 -54.07 36.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.401 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.34 -38.44 58.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -0.917 . . . . 0.0 110.475 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.512 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.2 ptm -65.88 -49.0 69.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.512 ' N ' ' CG ' ' A' ' 157' ' ' MET . 3.9 mtt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.284 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.236 0.541 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.4 tp10 -58.91 -55.69 31.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 0.4 OUTLIER -61.85 -56.7 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -45.24 -39.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.685 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -54.46 -46.31 73.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.884 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 98' ' ' LEU . 1.1 m -52.28 -41.01 62.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.326 -0.859 . . . . 0.0 109.88 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' CYS . 14.9 t80 -43.83 -51.73 7.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.758 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -60.66 -36.27 78.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.811 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.6 -43.58 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.832 ' CD2' HD13 ' A' ' 121' ' ' ILE . 1.3 m-85 -71.96 -40.06 68.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.873 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -79.19 88.38 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.85 68.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.37 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -70.47 -11.44 60.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 110.425 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.19 51.09 16.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.11 -27.19 22.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.48 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 128.53 -20.3 5.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 98.4 m-85 -151.21 134.15 15.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -1.178 . . . . 0.0 110.28 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.7 mt -82.75 149.46 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 -164.03 0.89 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.5 tt -77.38 -38.68 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.186 -0.946 . . . . 0.0 110.463 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 95.5 mt-10 -60.76 -61.43 2.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.72 ' O ' HD12 ' A' ' 121' ' ' ILE . 20.9 mt-10 -42.55 -38.97 2.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 110.409 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.824 ' HB3' HG23 ' A' ' 134' ' ' ILE . 3.5 tp -60.05 -31.12 69.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 123' ' ' ARG . . . -73.03 -72.17 1.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.867 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 12.7 pt-20 -42.49 -43.49 3.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.184 -1.186 . . . . 0.0 110.509 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.832 HD13 ' CD2' ' A' ' 105' ' ' PHE . 27.5 mt -57.93 -50.46 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.852 ' HB3' HG21 ' A' ' 129' ' ' VAL . 20.4 mt -67.74 -69.89 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.873 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 119' ' ' GLY . 2.4 ptm180 -49.88 -24.09 2.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.921 . . . . 0.0 110.651 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.54 -44.19 72.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 110.008 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.789 HG23 ' HG3' ' A' ' 127' ' ' GLU . 1.8 t -80.91 9.34 6.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.468 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.2 17.7 58.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.789 ' HG3' HG23 ' A' ' 125' ' ' THR . 46.6 mt-10 -84.05 121.2 27.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -1.136 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 87.24 2.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.873 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.852 HG21 ' HB3' ' A' ' 122' ' ' LEU . 3.4 t -109.61 146.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' GLU . 31.7 pt -119.55 159.7 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.145 -0.972 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' ILE . 4.8 tt0 -41.43 -49.86 3.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.36 -28.91 13.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 0.0 110.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -43.38 11.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.824 HG23 ' HB3' ' A' ' 118' ' ' LEU . 30.0 mt -67.92 -38.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.07 -36.87 82.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.39 -0.819 . . . . 0.0 110.421 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.83 -52.4 65.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 0.0 110.681 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.635 ' HB3' HD21 ' A' ' 118' ' ' LEU . 1.4 mp -49.86 -44.27 49.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.308 -0.87 . . . . 0.0 110.899 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.485 ' O ' ' N ' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -64.83 -48.04 75.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.056 -1.028 . . . . 0.0 110.053 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -60.1 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 110.62 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.47 -33.21 67.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.547 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -85.7 -62.47 1.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.146 -0.971 . . . . 0.0 110.717 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 138' ' ' MET . 0.5 OUTLIER -47.4 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.621 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 ttpp -89.4 -3.81 58.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.814 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -120.69 12.03 11.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 51.23 39.26 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.417 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 11.5 p30 -101.37 23.06 11.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 44.98 35.58 4.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 19.4 mtt180 -158.35 128.32 5.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -1.21 . . . . 0.0 110.458 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.547 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.5 mt -84.21 167.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.091 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 48.2 p30 -149.13 -163.68 1.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -56.07 16.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.403 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -56.74 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.656 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 141' ' ' SER . 84.8 mt-10 -59.53 -44.53 93.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 110.515 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 21.6 t80 -54.62 -52.0 63.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.095 -1.003 . . . . 0.0 110.132 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 27.4 mt -57.34 -42.16 81.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -54.2 -60.29 3.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.6 OUTLIER -48.26 -52.81 19.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.025 -1.047 . . . . 0.0 109.551 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.411 -0.806 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.329 0.585 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.94 -58.56 6.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 0.0 110.58 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.593 HD11 ' SD ' ' A' ' 158' ' ' MET . 20.2 mt -50.97 -60.75 2.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.289 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.68 -50.74 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -55.15 -50.5 69.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.948 . . . . 0.0 110.246 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.92 -9.61 31.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.367 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 83.3 t80 -50.96 -61.69 2.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.57 ' CG ' HD12 ' A' ' 104' ' ' ILE . 12.3 ptp180 -57.12 -36.04 70.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 110.458 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.57 HD12 ' CG ' ' A' ' 103' ' ' ARG . 1.0 OUTLIER -58.72 -34.06 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.665 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 107' ' ' LYS . 4.9 m-85 -83.65 -35.48 24.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.87 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 48.1 t0 -67.78 59.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -46.6 -41.03 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 110' ' ' ASP . 46.8 t30 -69.51 -13.62 62.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.159 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 45.49 54.98 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.857 . . . . 0.0 110.231 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.473 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 23.5 p-10 -108.65 -3.23 18.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.2 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.509 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 101.49 -19.4 50.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 95.8 m-85 -153.17 123.69 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -1.2 . . . . 0.0 110.434 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.87 132.28 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 110.304 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.71 -179.6 4.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.081 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.7 tt -59.94 -36.82 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.195 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -50.94 -52.69 39.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.442 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 15.3 mt-10 -57.66 -54.74 43.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -0.809 . . . . 0.0 110.311 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.561 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.1 mp -43.15 -39.78 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.515 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -59.75 -80.31 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.482 ' OE2' HG13 ' A' ' 121' ' ' ILE . 0.7 OUTLIER -48.3 -50.7 29.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -1.19 . . . . 0.0 110.297 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 125' ' ' THR . 10.3 mt -44.93 -55.07 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 110.137 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.1 mt -68.37 -62.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.51 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -48.76 -39.97 27.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.84 -52.27 57.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.927 . . . . 0.0 110.212 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 121' ' ' ILE . 31.1 p -54.75 -32.44 59.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.59 -1.36 23.39 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . 23.4 mm-40 -58.66 -17.02 18.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -1.164 . . . . 0.0 110.056 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.7 OUTLIER 46.38 57.21 5.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 127' ' ' GLU . 14.8 t -89.56 153.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 132' ' ' GLU . 19.6 pt -98.06 154.85 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 110.2 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 132' ' ' GLU . 68.9 mt-10 -49.44 -51.41 35.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.539 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -41.81 -34.27 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.635 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -48.16 9.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.44 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 18.1 mt -55.52 -40.03 56.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.077 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -58.03 -53.89 53.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.626 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -45.03 37.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.962 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -37.19 67.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.106 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 19.1 tpp -69.95 -44.76 68.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.394 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -51.27 62.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.396 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -55.34 -31.27 61.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.543 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -87.9 -51.2 5.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.374 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.7 OUTLIER -42.56 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.8 OUTLIER -76.2 -1.51 26.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.963 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.505 ' ND2' ' OD2' ' A' ' 146' ' ' ASP . 1.5 p30 -153.8 27.48 0.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 43.78 75.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 110.501 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.505 ' OD2' ' ND2' ' A' ' 144' ' ' ASN . 3.8 p30 -121.28 -0.29 9.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 70.88 24.16 77.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 5.4 mtt-85 -158.67 135.43 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.449 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 141' ' ' SER . 16.6 mt -91.06 136.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.478 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 26.7 p-10 -112.44 -173.03 2.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.922 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 42.2 p90 -68.07 -28.41 67.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 110.392 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.428 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -78.14 -42.21 32.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.639 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.513 ' OE1' ' HA ' ' A' ' 149' ' ' ILE . 89.4 mt-10 -69.71 -37.15 76.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -0.986 . . . . 0.0 110.513 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.462 ' O ' ' HG2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.04 -33.29 51.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.964 . . . . 0.0 110.351 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.61 -62.56 1.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.401 ' HD2' ' HD2' ' A' ' 143' ' ' LYS . 21.4 mttm -53.4 -34.92 59.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.907 . . . . 0.0 110.566 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.536 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -53.79 -49.72 67.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.229 -0.919 . . . . 0.0 110.571 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.593 ' SD ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.913 . . . . 0.0 110.447 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.177 0.513 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -60.46 -56.86 16.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 4.3 mm? -59.69 -51.44 69.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.34 -44.24 3.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -51.78 -47.16 64.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.106 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.81 -31.79 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CZ ' HD12 ' A' ' 113' ' ' ILE . 18.1 t80 -51.45 -42.07 61.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.933 . . . . 0.0 110.086 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -41.04 99.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.263 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 104' ' ' ILE . 30.6 mm -59.0 -49.09 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 110.076 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -57.49 -35.48 70.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.756 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.91 113.14 25.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.661 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -109.12 6.33 24.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.408 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 2.5 p30 -131.41 22.61 4.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.435 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 108' ' ' ASN . . . 50.3 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.78 -37.39 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.434 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 92.21 -7.29 78.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 53.2 m-85 -153.13 125.62 8.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -1.152 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 2.7 mp -83.7 125.49 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -104.91 -176.04 2.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.052 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -63.46 -37.77 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.854 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.405 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 9.2 mm-40 -59.0 -56.3 23.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 109.982 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 15.9 mt-10 -45.5 -54.06 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.734 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.2 tp -51.19 -27.94 10.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.32 -75.64 0.35 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.2 pt-20 -45.52 -44.39 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -1.183 . . . . 0.0 110.571 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.546 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 48.5 mt -48.43 -70.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.496 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.833 ' O ' HG22 ' A' ' 125' ' ' THR . 97.6 mt -48.76 -49.89 36.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 110.577 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -52.89 -38.41 61.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.977 . . . . 0.0 110.537 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -48.05 -59.97 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 110.528 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.833 HG22 ' O ' ' A' ' 122' ' ' LEU . 7.4 t -59.38 -26.06 64.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.396 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.02 37.54 5.98 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -86.79 -10.43 53.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -1.218 . . . . 0.0 110.029 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.71 82.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.11 166.14 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 132' ' ' GLU . 4.7 pt -117.13 146.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.102 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.474 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 2.9 pt-20 -39.57 -42.92 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 0.0 110.858 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.481 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -43.4 -40.08 3.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 110.328 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.44 -44.44 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 118' ' ' LEU . 66.8 mt -56.75 -35.72 46.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.674 0.75 . . . . 0.0 109.509 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.835 ' HA ' HD11 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -68.6 -39.58 80.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.692 -0.63 . . . . 0.0 110.239 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.29 -50.29 72.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.451 ' HB3' HD21 ' A' ' 118' ' ' LEU . 1.3 mm? -45.63 -50.73 13.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.021 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.552 ' CE ' HD12 ' A' ' 149' ' ' ILE . 3.3 ttm -67.22 -46.6 73.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.923 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.31 -53.55 6.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.6 -49.98 73.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.551 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.1 t -69.72 -64.47 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.457 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.491 ' HB2' ' HG3' ' A' ' 138' ' ' MET . 30.5 t0 -43.19 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 141' ' ' SER . 3.3 tptm -96.9 -13.64 22.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -101.42 16.36 25.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 52.43 18.81 1.01 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 16.9 p30 -80.94 -0.18 38.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . 62.18 28.27 70.44 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 9.9 mtt180 -152.58 135.12 15.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.158 -1.201 . . . . 0.0 110.373 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.552 HD12 ' CE ' ' A' ' 138' ' ' MET . 5.9 mt -83.65 116.3 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 0.0 109.86 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -97.77 -170.36 1.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -52.99 -58.78 5.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.366 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.06 -64.94 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.955 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.473 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 44.9 mt-10 -50.65 -51.98 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.472 ' O ' ' HG2' ' A' ' 157' ' ' MET . 42.0 t80 -50.53 -56.74 10.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 154' ' ' PHE . 46.9 mt -42.52 -51.31 5.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.345 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -62.2 -46.98 86.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 110.745 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.518 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.5 ptm -43.27 -46.5 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 109.85 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.518 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 110.195 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.216 0.531 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.65 -54.59 39.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.944 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 3.5 mm? -50.52 -49.38 55.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.881 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -53.55 -57.02 12.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 110.258 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -48.57 -50.16 33.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.82 -20.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 56.6 t80 -53.85 -51.24 64.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.486 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -29.19 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.163 -0.961 . . . . 0.0 110.489 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.5 -27.92 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.121 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.475 ' HD1' HD13 ' A' ' 121' ' ' ILE . 2.5 m-85 -84.9 -55.73 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 110.336 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -50.82 131.62 26.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -0.817 . . . . 0.0 110.259 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -123.03 2.22 9.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 109' ' ' ALA . 73.5 m-20 -125.02 26.41 7.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.356 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.93 49.44 5.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -93.32 -31.75 14.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.382 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.473 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 96.41 -14.51 64.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.473 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 27.2 m-85 -147.7 131.7 17.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 mt -82.95 116.05 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 110.631 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 3.8 p-10 -100.87 175.9 5.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.808 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.2 tp -53.48 -41.56 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.56 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -51.48 -54.96 21.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 31.8 mt-10 -56.8 -56.23 24.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -44.1 -38.62 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.506 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -59.74 -78.29 0.15 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -51.21 -45.99 62.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 110.259 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.55 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 14.9 mt -42.55 -61.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 110.38 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.855 HD22 HG21 ' A' ' 129' ' ' VAL . 4.2 mt -59.34 -56.87 16.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.433 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -48.67 -34.58 12.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.085 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -51.93 -40.83 61.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.7 p -66.59 -17.42 64.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 0.0 109.989 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.38 20.34 13.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.49 154.29 19.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -1.141 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -107.37 70.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 0.0 109.661 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.855 HG21 HD22 ' A' ' 122' ' ' LEU . 15.6 t -79.27 123.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.522 -0.736 . . . . 0.0 110.703 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 132' ' ' GLU . 47.3 pt -75.33 159.71 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.28 -32.22 68.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.987 . . . . 0.0 110.556 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.506 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -48.75 -35.59 14.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 110.497 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.02 -51.2 6.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.652 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 118' ' ' LEU . 7.3 mt -55.76 -43.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.508 -0.745 . . . . 0.0 109.472 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HG2' HD11 ' A' ' 115' ' ' ILE . 2.9 mm-40 -62.05 -38.75 89.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.656 -0.652 . . . . 0.0 109.955 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.13 -51.88 66.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 110.208 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.2 mt -50.75 -42.09 57.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 42.9 tpp -66.96 -49.07 66.6 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -59.09 -41.98 89.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.946 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -25.73 68.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.571 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -97.54 -33.58 11.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 110.234 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.2 t0 -59.43 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 109.931 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -76.25 0.58 18.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.328 -0.858 . . . . 0.0 110.994 -179.338 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.429 HD22 ' HB3' ' A' ' 146' ' ' ASP . 7.4 p-10 -151.71 20.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.919 -1.113 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.35 71.21 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.662 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.429 ' HB3' HD22 ' A' ' 144' ' ' ASN . 7.6 p-10 -126.95 12.08 7.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.749 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 45.4 30.65 3.08 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' CD ' ' HB2' ' A' ' 112' ' ' PHE . 3.7 mtt180 -158.69 131.12 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 110.701 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.571 HG12 ' CB ' ' A' ' 141' ' ' SER . 8.0 mt -88.89 133.42 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.73 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 2.8 p30 -113.54 -164.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.436 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.6 -57.67 9.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.88 -57.7 11.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.619 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.447 ' HG2' ' HB2' ' A' ' 143' ' ' LYS . 73.2 mt-10 -54.25 -50.16 67.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.463 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 155' ' ' LEU . 64.2 t80 -49.68 -59.0 4.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.027 -1.045 . . . . 0.0 110.237 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 154' ' ' PHE . 9.8 mt -41.79 -66.06 0.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -34.16 14.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.62 -37.97 73.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 109.854 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.513 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 110.63 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.355 0.598 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.5 tp10 -58.84 -41.31 86.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.66 -59.19 5.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.18 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.29 -43.64 10.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 22.0 m-20 -51.05 -45.98 61.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 102' ' ' PHE . 4.5 t -67.98 -22.86 64.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.003 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.501 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 14.1 t80 -42.31 -63.29 0.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.515 ' HG3' ' N ' ' A' ' 104' ' ' ILE . 4.7 ptt180 -62.23 -36.35 81.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.515 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 31.6 mm -59.65 -33.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.277 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -79.57 -65.98 0.93 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.906 . . . . 0.0 110.344 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 105' ' ' PHE . 48.3 t0 -42.58 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 105' ' ' PHE . 10.7 mttt -75.97 -10.25 59.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.213 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -102.14 -165.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 110.302 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.4 4.25 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.172 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.537 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 6.7 p-10 -66.37 -27.77 68.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.898 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 90.32 15.98 56.28 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 110' ' ' ASP . 38.0 m-85 -146.75 131.88 18.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.119 -1.224 . . . . 0.0 110.599 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.468 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 3.2 mt -83.16 131.74 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.406 -0.809 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 117' ' ' GLU . 24.3 p30 -100.52 -177.24 3.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.2 tt -64.93 -40.74 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 110.484 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.554 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -59.86 -52.02 67.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.038 . . . . 0.0 110.183 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 24.9 mt-10 -48.55 -42.85 34.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.911 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.578 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -58.35 -27.02 63.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 110.239 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -73.6 -72.87 0.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.4 pt-20 -41.91 -45.15 3.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.435 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 117' ' ' GLU . 42.6 mt -57.44 -57.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -73.82 -44.31 56.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 110.61 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.22 -36.72 75.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 0.0 110.276 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -47.72 -40.44 20.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.011 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.419 ' H ' HG23 ' A' ' 125' ' ' THR . 52.0 p -56.17 -28.36 57.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 110.068 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.0 -31.52 6.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 129' ' ' VAL . 6.7 mt-10 -49.99 125.78 12.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -1.097 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.566 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -70.11 62.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 127' ' ' GLU . 11.1 t -61.68 148.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 0.0 109.886 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 131' ' ' GLU . 5.8 pt -121.72 147.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 110.359 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -39.02 -36.67 0.31 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.576 -0.703 . . . . 0.0 110.761 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -35.43 62.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.687 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.06 -44.04 12.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.97 . . . . 0.0 109.697 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.578 HG23 ' HB3' ' A' ' 118' ' ' LEU . 15.9 mt -66.22 -36.96 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.387 -0.82 . . . . 0.0 110.138 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.17 -43.61 95.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -54.52 -53.38 55.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 141' ' ' SER . 2.1 mp -47.58 -41.31 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 110.509 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -71.69 -53.78 12.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 -57.07 4.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.754 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.27 -40.5 90.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.152 -0.967 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.515 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -75.26 -54.35 7.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 146' ' ' ASP . 0.3 OUTLIER -55.09 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 110.965 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -69.95 -46.29 65.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.049 -1.032 . . . . 0.0 109.466 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 9.0 p30 -82.78 -7.45 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 17.3 m-20 63.39 82.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.43 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.513 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 10.7 p-10 -130.25 5.46 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 109.972 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 74.58 20.8 79.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 35.5 mtm-85 -158.31 140.44 14.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -1.134 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.515 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.5 mt -90.46 137.64 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 109.79 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 150' ' ' ASP . 36.2 p-10 -110.01 -151.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.761 ' O ' HD12 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -75.35 -55.51 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.589 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -54.7 43.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 110.461 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.464 ' OE1' ' HA ' ' A' ' 142' ' ' ASP . 51.0 mt-10 -56.74 -53.48 57.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' GLU . 26.1 t80 -43.51 -51.54 6.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 0.0 110.396 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 151' ' ' PHE . 4.6 mt -63.13 -55.16 27.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -46.27 -41.48 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.985 . . . . 0.0 110.655 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.405 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.55 -46.81 62.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.808 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.405 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.252 0.549 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.75 -56.19 17.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 110.451 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 99' ' ' ALA . 6.3 mt -56.9 -58.8 6.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.554 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -40.84 -52.49 3.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -0.823 . . . . 0.0 110.529 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.41 -54.95 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 69.4 m -48.38 -24.16 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 110.715 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.497 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 47.0 t80 -45.23 -49.83 12.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.995 -1.066 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -57.16 -32.2 66.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 43.7 mm -59.47 -40.4 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -78.17 -38.41 43.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 110.427 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -79.25 84.7 5.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -1.0 . . . . 0.0 110.303 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -32.02 22.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 110.229 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.427 ' OD1' ' CG ' ' A' ' 110' ' ' ASP . 4.2 p30 -100.6 14.87 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.11 69.31 0.69 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.117 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.427 ' CG ' ' OD1' ' A' ' 108' ' ' ASN . 3.6 m-20 -97.47 -17.16 19.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 110.23 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.48 40.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -150.45 146.49 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.031 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 mt -82.64 116.12 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 110.366 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -97.2 -178.54 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.858 . . . . 0.0 110.014 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.547 HG23 ' N ' ' A' ' 116' ' ' GLU . 3.8 tp -67.96 -39.43 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.547 ' N ' HG23 ' A' ' 115' ' ' ILE . 5.8 mt-10 -55.1 -52.8 62.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.373 -0.829 . . . . 0.0 110.235 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 23.1 mt-10 -50.2 -45.3 53.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.398 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.563 HD22 HG23 ' A' ' 134' ' ' ILE . 0.5 OUTLIER -57.66 -34.18 69.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.574 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -66.54 -73.56 0.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.46 ' CD ' HG13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -42.06 -49.44 4.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -1.122 . . . . 0.0 110.561 -179.597 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.46 HG13 ' CD ' ' A' ' 120' ' ' GLU . 66.4 mt -55.07 -51.94 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.639 ' HB3' HG21 ' A' ' 129' ' ' VAL . 16.5 mt -64.71 -55.5 19.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.271 -0.893 . . . . 0.0 110.561 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.18 -36.71 73.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.887 . . . . 0.0 110.659 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.84 -30.93 4.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.428 ' H ' HG23 ' A' ' 125' ' ' THR . 30.9 p -66.23 -29.62 69.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.76 26.8 2.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -116.7 170.1 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -1.161 . . . . 0.0 110.397 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.39 62.68 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.712 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 122' ' ' LEU . 5.5 t -65.57 126.82 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 134' ' ' ILE . 15.3 pt -81.15 154.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -41.76 96.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 110.676 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -47.83 -33.56 7.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.256 -0.902 . . . . 0.0 110.781 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -83.23 -47.93 11.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 109.513 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.563 HG23 HD22 ' A' ' 118' ' ' LEU . 11.3 mt -58.26 -37.68 64.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.559 -0.713 . . . . 0.0 109.628 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.509 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 32.8 mt-10 -60.37 -34.72 74.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 110.591 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 14.5 t0 -56.33 -55.02 38.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -43.43 26.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.91 . . . . 0.0 111.023 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.6 tpp -65.06 -51.58 60.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.096 -1.003 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 139' ' ' LYS . 7.5 tmtm? -63.01 -39.25 94.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.4 -0.813 . . . . 0.0 109.953 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -67.27 -32.9 74.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.429 -0.794 . . . . 0.0 110.251 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.538 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.6 t -82.28 -64.28 1.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 146' ' ' ASP . 45.6 t0 -44.36 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.48 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -89.26 -3.17 58.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.2 p30 -125.01 8.82 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.962 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.426 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 8.3 m120 59.26 39.27 22.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 19.3 p30 -72.85 -13.63 61.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 102.11 -11.77 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.495 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 70.9 mtt180 -158.43 177.94 10.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.152 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.538 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.6 mt -88.51 166.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 44.9 p-10 -144.35 -162.57 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.74 ' O ' HD12 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -73.26 -43.02 61.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.498 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -52.86 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.56 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 10.6 mt-10 -65.19 -39.98 93.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 3.5 t80 -54.75 -64.9 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 151' ' ' PHE . 8.1 mt -42.22 -52.86 4.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -59.74 -37.12 78.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.487 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -62.01 -47.04 86.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.487 ' N ' ' CG ' ' A' ' 157' ' ' MET . 11.4 mmt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 110.43 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.258 0.551 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.36 -33.34 71.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.857 . . . . 0.0 110.264 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.677 HD22 HD23 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -67.06 -49.56 64.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.458 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.06 25.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.994 -1.066 . . . . 0.0 110.164 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -50.96 -43.41 60.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -56.01 -16.22 4.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.343 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -54.0 -64.78 0.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 110.893 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -31.52 63.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.042 -1.036 . . . . 0.0 110.669 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 35.1 mm -57.18 -43.27 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.418 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.754 ' O ' HD11 ' A' ' 121' ' ' ILE . 5.4 m-85 -75.03 -31.84 61.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.97 98.81 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 110.119 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 69.9 m-80 -95.17 -11.47 28.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 53.94 56.41 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.97 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.84 -12.9 29.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.46 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.517 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 117.06 -20.65 11.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.517 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 65.5 m-85 -152.54 127.14 9.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.104 -1.233 . . . . 0.0 110.502 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 117' ' ' GLU . 12.6 mt -83.04 118.44 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.55 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 22.2 p30 -89.55 -172.88 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.708 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 116' ' ' GLU . 4.1 tp -63.28 -42.56 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.579 ' N ' HG23 ' A' ' 115' ' ' ILE . 1.6 mt-10 -53.1 -55.27 25.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.247 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.585 ' HB3' HG23 ' A' ' 113' ' ' ILE . 23.7 mt-10 -50.6 -43.82 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -59.28 -29.27 67.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.58 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.02 -60.23 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.7 pt-20 -52.4 -44.63 65.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -1.141 . . . . 0.0 110.529 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.754 HD11 ' O ' ' A' ' 105' ' ' PHE . 94.6 mt -53.42 -48.22 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.135 -0.978 . . . . 0.0 110.017 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.2 -48.85 16.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.81 -32.72 9.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.855 . . . . 0.0 110.342 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.14 -28.15 50.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.307 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 127' ' ' GLU . 27.9 p -86.74 21.49 2.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 62.86 21.11 62.95 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 125' ' ' THR . 3.2 mt-10 -96.69 112.65 24.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.187 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -74.15 81.94 1.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 134' ' ' ILE . 32.0 t -90.3 137.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 131' ' ' GLU . 28.4 pt -104.93 155.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 10.2 mt-10 -41.96 -46.67 4.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.6 mm-40 -41.0 -37.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 0.0 109.904 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.87 -47.33 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.422 -0.799 . . . . 0.0 109.43 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 118' ' ' LEU . 12.1 mt -58.94 -40.7 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.813 . . . . 0.0 109.726 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -59.11 -52.35 66.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.186 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -46.32 -45.9 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.229 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.4 mp -60.87 -54.75 41.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 110.035 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.646 ' CE ' HD12 ' A' ' 149' ' ' ILE . 2.2 ttm -67.0 -43.83 81.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -60.14 -43.42 95.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.314 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -68.46 -34.1 75.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.279 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.544 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -87.17 -62.78 1.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.526 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 138' ' ' MET . 21.8 t0 -50.94 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.728 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -82.13 -25.35 34.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -0.977 . . . . 0.0 110.042 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.482 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 9.0 m-80 -90.16 16.17 8.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.18 38.02 3.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.936 . . . . 0.0 110.074 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -97.27 14.16 27.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 51.46 37.92 41.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 6.6 mtt180 -158.68 125.9 4.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.163 -1.198 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.646 HD12 ' CE ' ' A' ' 138' ' ' MET . 4.0 mt -87.28 129.27 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.201 -0.937 . . . . 0.0 109.214 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -110.58 -167.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.628 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -57.45 10.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.523 -0.735 . . . . 0.0 111.038 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.41 -64.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.191 -0.943 . . . . 0.0 111.335 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.482 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 65.4 mt-10 -47.29 -31.58 3.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.088 -1.007 . . . . 0.0 110.992 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.402 ' O ' ' HB3' ' A' ' 157' ' ' MET . 21.7 t80 -64.9 -59.02 4.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 0.0 110.533 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.677 HD23 HD22 ' A' ' 98' ' ' LEU . 3.7 mt -47.28 -54.5 10.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 110.272 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -24.9 58.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 109.922 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.03 -38.05 75.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.375 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.495 ' N ' ' HG3' ' A' ' 157' ' ' MET . 18.8 ttm . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.264 0.554 . . . . 0.0 109.624 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -55.34 22.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.613 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.4 OUTLIER -64.18 -48.75 74.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.843 179.522 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.35 -53.43 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 109.759 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 96' ' ' GLU . 68.7 m-80 -52.21 -38.96 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.4 -0.813 . . . . 0.0 109.923 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -25.93 52.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.584 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 9.8 t80 -49.7 -58.16 5.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.486 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -66.9 -34.95 78.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.931 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.482 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 12.2 mm -68.33 -48.91 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 110.831 -179.341 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' LYS . 1.6 m-30 -71.27 -43.76 66.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.694 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -68.16 70.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.95 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' CD ' ' O ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -61.23 -35.63 77.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.298 -179.952 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 109' ' ' ALA . 13.4 t30 -75.9 -5.22 45.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.86 . . . . 0.0 110.036 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.29 76.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.3 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -124.08 -2.9 8.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.441 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 100.16 -21.96 42.21 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CG ' ' O ' ' A' ' 111' ' ' GLY . 92.6 m-85 -152.24 140.04 19.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -1.195 . . . . 0.0 110.375 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.446 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 29.5 mt -82.53 110.08 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.117 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -87.89 -175.47 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.348 -0.845 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.12 -29.72 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.248 -0.908 . . . . 0.0 110.676 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -50.26 70.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.129 -0.982 . . . . 0.0 110.262 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.501 ' C ' HD12 ' A' ' 121' ' ' ILE . 8.4 mt-10 -57.55 -42.83 83.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.549 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.2 tp -52.67 -38.72 60.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.318 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.583 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -56.41 -72.84 0.51 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.3 pt-20 -51.76 -45.22 63.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -1.207 . . . . 0.0 110.785 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.539 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 40.9 mt -47.82 -46.79 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.97 -1.081 . . . . 0.0 110.23 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.0 mt -77.39 -51.87 10.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.923 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -48.45 -35.3 12.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.982 . . . . 0.0 109.488 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.61 -38.78 21.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.1 p -58.9 -55.29 37.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.452 ' C ' ' HG2' ' A' ' 127' ' ' GLU . . . 139.11 41.25 0.09 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.9 mt-10 -136.47 128.56 29.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.241 . . . . 0.0 110.072 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -65.74 66.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' GLU . 79.0 t -64.54 155.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.662 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 131' ' ' GLU . 17.5 pt -123.94 145.68 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.839 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 4.4 mt-10 -43.74 -45.95 7.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.884 . . . . 0.0 110.581 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -41.59 -43.9 2.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 111.01 -179.546 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 -48.6 12.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.583 HD13 ' HA2' ' A' ' 119' ' ' GLY . 20.3 mt -53.21 -35.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.552 0.692 . . . . 0.0 109.651 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.455 ' OE1' ' HA ' ' A' ' 132' ' ' GLU . 64.0 mt-10 -55.9 -52.26 64.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.536 -0.728 . . . . 0.0 110.602 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 50.4 t0 -45.25 -49.16 12.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.474 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.515 HD23 ' HE1' ' A' ' 157' ' ' MET . 0.1 OUTLIER -53.3 -43.78 67.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.968 . . . . 0.0 110.393 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -40.31 68.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.398 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -60.06 -48.05 83.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.944 . . . . 0.0 110.843 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.9 -33.82 75.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.798 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.55 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.66 -35.66 57.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER -55.25 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.544 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' SER . 5.9 tttt -67.69 -8.36 34.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.45 22.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 8.5 m-20 51.22 64.75 1.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.331 -0.855 . . . . 0.0 110.785 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 51.5 p-10 -112.72 5.77 17.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 60.0 24.92 61.22 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 13.6 mtt-85 -158.13 130.71 7.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -1.163 . . . . 0.0 110.533 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.55 HG12 ' CB ' ' A' ' 141' ' ' SER . 6.1 mt -85.72 121.29 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.362 -0.837 . . . . 0.0 109.94 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.18 -173.6 2.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 110.411 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -53.7 -57.43 10.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -55.17 16.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.505 -0.747 . . . . 0.0 110.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 157' ' ' MET . 88.0 mt-10 -64.01 -57.94 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.572 ' CZ ' ' HG3' ' A' ' 158' ' ' MET . 38.6 t80 -40.83 -59.72 1.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.654 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 154' ' ' PHE . 81.5 mt -42.3 -65.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.345 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.84 -38.09 77.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 110.431 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -66.97 -37.96 85.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.071 -179.639 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.73 ' HB3' HD21 ' A' ' 98' ' ' LEU . 3.2 mmt . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.537 -0.727 . . . . 0.0 110.514 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.267 0.556 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -57.73 -32.07 67.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -51.07 9.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.509 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.07 50.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.133 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -66.15 -33.12 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.447 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.8 m -65.16 -22.08 66.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.829 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE1' HD11 ' A' ' 113' ' ' ILE . 71.7 t80 -49.25 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 110.391 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.53 -32.25 5.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 48.8 mm -68.33 -45.44 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 110.365 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.412 ' O ' HD11 ' A' ' 121' ' ' ILE . 17.0 m-85 -67.56 -24.94 65.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.25 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 23.3 t0 -90.07 84.96 6.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -67.69 -32.16 72.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 6.0 p30 -93.87 -12.25 29.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 59.09 75.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.352 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 5.1 p30 -114.91 -6.39 12.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.269 -0.895 . . . . 0.0 110.091 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 86.28 -1.05 87.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 10.8 m-85 -146.8 124.01 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -1.142 . . . . 0.0 110.011 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.488 HD11 ' CE1' ' A' ' 102' ' ' PHE . 40.8 mt -85.83 124.59 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.261 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 116' ' ' GLU . 1.9 p30 -103.42 -176.19 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.3 tp -75.97 -31.68 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.452 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 1.3 mt-10 -58.22 -45.06 88.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 121' ' ' ILE . 37.1 mt-10 -59.91 -48.67 80.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 110.423 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.59 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.8 -34.59 67.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.152 -0.968 . . . . 0.0 110.13 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -57.98 -71.99 0.66 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 18.7 pt-20 -57.35 -44.49 84.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -1.171 . . . . 0.0 110.299 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.0 mt -47.06 -57.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.975 . . . . 0.0 109.87 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 125' ' ' THR . 0.3 OUTLIER -69.09 -49.18 59.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -53.92 -37.2 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.435 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.16 60.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.307 -0.871 . . . . 0.0 110.868 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 61.5 p -54.65 -24.44 21.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.461 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.54 -27.4 6.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -75.79 134.05 40.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -1.122 . . . . 0.0 109.961 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -87.19 71.07 10.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.145 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.403 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 41.6 t -64.78 137.65 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.051 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' GLU . 9.4 pt -86.3 137.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 110.366 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.801 ' OE1' HD12 ' A' ' 134' ' ' ILE . 8.9 mm-40 -42.75 -38.28 2.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -40.79 -39.46 1.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -0.822 . . . . 0.0 110.551 -179.837 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -84.31 -45.38 12.87 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.174 -0.954 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.801 HD12 ' OE1' ' A' ' 131' ' ' GLU . 23.6 mt -56.19 -35.67 43.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.493 -0.754 . . . . 0.0 109.535 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 1.1 mt-10 -65.66 -37.46 86.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.523 -0.736 . . . . 0.0 110.227 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 9.2 t70 -52.06 -54.6 28.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 137' ' ' LEU . 25.3 mt -50.5 -39.57 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.418 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.668 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -65.18 -39.08 92.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.406 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -64.88 -52.31 57.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 110.571 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.2 -27.64 68.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 111.13 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.568 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -89.34 -65.05 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.018 . . . . 0.0 111.025 -179.292 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.448 ' OD1' ' OD1' ' A' ' 146' ' ' ASP . 18.5 t0 -41.69 98.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.895 . . . . 0.0 110.36 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.4 tppp? -94.51 -32.11 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 0.0 110.367 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 4.5 p30 -101.94 17.68 22.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.135 -0.978 . . . . 0.0 110.213 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.0 m-20 48.74 80.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.486 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 9.2 p-10 -134.77 11.1 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 62.1 14.51 46.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 72.1 mtt180 -146.94 143.95 28.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -1.158 . . . . 0.0 110.481 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.668 HD12 ' CE ' ' A' ' 138' ' ' MET . 1.2 mt -93.14 123.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 109.948 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 39.4 p30 -91.74 -165.06 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.805 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -54.93 15.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 110.393 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.26 -57.28 13.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 92.6 mt-10 -48.54 -46.29 38.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.577 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 1.5 t80 -54.16 -58.9 5.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.677 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 155' ' ' LEU . 31.4 mt -51.46 -59.39 4.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.841 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -42.65 44.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.775 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.474 ' HE1' HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -65.21 -45.17 85.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.509 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.549 ' HA ' ' HE3' ' A' ' 158' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.202 -0.937 . . . . 0.0 110.446 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.227 0.537 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 21.3 mp0 -53.61 -56.48 16.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.887 . . . . 0.0 109.924 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mt -52.26 -57.83 8.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.95 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 102' ' ' PHE . . . -47.66 -41.96 23.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -55.46 -32.76 63.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.686 ' HA ' HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -77.7 -7.2 56.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.577 -179.709 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 99' ' ' ALA . 2.5 t80 -60.86 -56.48 20.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.07 -1.019 . . . . 0.0 110.428 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.524 ' HG2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -52.16 -22.98 4.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.185 -0.947 . . . . 0.0 110.733 -179.764 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.686 HD13 ' HA ' ' A' ' 101' ' ' CYS . 2.0 mp -74.28 -47.93 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.061 -1.025 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.12 -49.9 11.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.308 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 108' ' ' ASN . 52.7 t0 -67.48 74.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -46.43 -39.19 10.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.7 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 106' ' ' ASP . 17.3 m-80 -103.54 165.01 11.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 109.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.25 63.89 7.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 17.2 p30 -102.55 -18.43 15.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.072 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.575 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 74.91 5.81 76.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 52.8 m-85 -148.53 110.29 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -1.147 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.91 144.85 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.46 ' CG ' ' HG3' ' A' ' 116' ' ' GLU . 30.0 p30 -119.7 -163.78 1.02 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' A' ' 135' ' ' GLU . 1.2 tt -79.59 -45.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -0.841 . . . . 0.0 110.779 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.603 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.41 -27.28 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 110.152 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 9.2 mt-10 -76.55 -48.93 17.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 109.86 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.472 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -51.85 -44.07 63.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 110.038 179.783 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -48.63 -83.91 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 10.6 pt-20 -42.42 -45.35 4.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -1.17 . . . . 0.0 110.493 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.0 mt -50.3 -54.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 109.679 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 122' ' ' LEU . 19.6 mt -73.1 -47.48 43.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -49.89 -37.55 31.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.837 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.64 -31.56 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 43.0 p -69.25 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 110.154 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.97 38.21 2.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -113.0 -157.52 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -1.191 . . . . 0.0 110.331 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -145.11 53.72 1.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.034 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 134' ' ' ILE . 46.8 t -61.18 162.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.832 . . . . 0.0 110.347 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 131' ' ' GLU . 13.7 pt -139.18 152.02 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.3 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -41.27 -53.62 3.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.993 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -43.44 -36.65 2.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -45.1 11.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.465 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 118' ' ' LEU . 21.1 mt -62.81 -38.9 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 109.623 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.608 ' HG2' HD11 ' A' ' 115' ' ' ILE . 2.0 mm-40 -58.74 -45.05 90.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 110.12 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 4.8 t70 -44.0 -50.02 8.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.265 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 141' ' ' SER . 31.6 mt -58.4 -40.27 81.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.444 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 34.5 tpp -65.34 -48.44 73.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.609 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -64.8 -37.16 86.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.576 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 2.9 t0 -72.19 -36.98 69.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.469 -0.769 . . . . 0.0 109.974 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.558 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -85.43 -46.65 10.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 110.136 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.454 ' HA ' ' CD ' ' A' ' 153' ' ' GLU . 29.3 t0 -61.82 86.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.815 . . . . 0.0 110.45 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 -8.1 58.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -119.45 19.55 12.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.429 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 34.1 m120 46.97 41.9 11.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.111 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.9 -9.33 59.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.31 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.43 60.95 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.436 ' CD ' ' HB3' ' A' ' 114' ' ' ASP . 55.9 mtt180 -146.2 162.18 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -1.143 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.558 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.3 mt -84.38 118.77 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 2.9 p30 -94.39 -178.08 4.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.932 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.98 -61.26 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 110.051 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.454 ' CD ' ' HA ' ' A' ' 142' ' ' ASP . 94.1 mt-10 -59.42 -44.89 92.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 10.6 t80 -46.27 -66.98 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.957 . . . . 0.0 110.207 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 154' ' ' PHE . 10.0 mt -44.52 -56.86 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -37.52 72.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.0 ptm -54.76 -49.51 70.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.672 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.525 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 109.989 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.132 0.492 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.0 -51.15 71.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.719 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 4.1 mm? -46.68 -56.75 5.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -45.04 -55.13 5.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.225 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -52.1 -43.43 63.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.314 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.46 -24.52 60.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -53.83 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.98 . . . . 0.0 110.073 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -55.37 -38.01 68.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.142 -0.974 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.468 ' HA ' HD13 ' A' ' 104' ' ' ILE . 12.2 mm -62.5 -39.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 109.946 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.417 ' CE2' HD13 ' A' ' 121' ' ' ILE . 1.4 m-30 -84.33 -46.08 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.173 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 6.7 t0 -82.42 96.24 7.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.335 -0.853 . . . . 0.0 109.838 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -105.83 -27.4 11.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 110.904 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.461 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 2.4 p-10 -104.26 -45.19 4.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.014 -1.054 . . . . 0.0 110.77 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -86.12 -39.76 16.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.991 . . . . 0.0 110.016 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 2.9 m-20 45.3 27.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 109.962 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . -152.33 -36.99 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 20.9 m-85 -151.57 112.32 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.433 -1.039 . . . . 0.0 109.322 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.429 HG23 ' CB ' ' A' ' 117' ' ' GLU . 5.0 mt -82.77 118.84 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.681 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.473 ' OD2' ' N ' ' A' ' 116' ' ' GLU . 4.5 p-10 -92.66 -155.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' A' ' 135' ' ' GLU . 3.0 tp -78.73 -33.63 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.0 110.248 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.473 ' N ' ' OD2' ' A' ' 114' ' ' ASP . 1.7 mm-40 -57.16 -59.32 5.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.305 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 1.9 mt-10 -44.23 -48.46 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.917 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.571 ' HA ' HD12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -58.53 -31.98 68.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 110.103 179.811 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -60.44 -75.83 0.26 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 10.9 pt-20 -42.43 -45.58 4.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.258 -1.142 . . . . 0.0 110.44 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 118' ' ' LEU . 45.7 mt -47.21 -53.66 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.142 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.409 HD12 HG12 ' A' ' 134' ' ' ILE . 72.1 mt -75.14 -36.87 61.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.328 -0.858 . . . . 0.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 120' ' ' GLU . 6.6 mtm180 -62.96 -36.51 83.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 110.162 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.82 -40.43 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.2 p -61.96 -36.24 80.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.74 11.07 27.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -89.98 148.0 23.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.25 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -85.52 83.16 8.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 109.941 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' A' ' 133' ' ' ASP . 2.3 t -93.56 114.34 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 9.1 pt -73.28 146.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.05 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.7 mt-10 -41.13 -49.34 3.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 0.0 110.439 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.08 -26.68 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB3' HG12 ' A' ' 129' ' ' VAL . 0.1 OUTLIER -81.02 -50.01 10.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.309 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.557 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 6.4 mt -66.22 -42.55 91.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.492 ' HA ' HD11 ' A' ' 115' ' ' ILE . 8.3 mt-10 -45.81 -42.61 12.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.0 110.052 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.14 -51.78 68.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 110.246 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.478 ' HA ' HD13 ' A' ' 137' ' ' LEU . 2.7 mm? -48.63 -44.87 37.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.217 -0.927 . . . . 0.0 110.371 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 11.0 tpp -64.58 -45.96 84.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.759 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -46.21 74.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -0.835 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 110.561 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.531 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -89.48 -63.75 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.459 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 1.7 t0 -47.82 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.1 mttt -84.53 -26.02 28.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.162 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 11.6 m-80 -86.63 -3.94 59.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 109.744 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.3 OUTLIER 67.26 15.08 9.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -60.63 -15.79 32.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.1 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.15 -5.94 82.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.521 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -137.9 146.4 43.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.254 . . . . 0.0 110.486 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 141' ' ' SER . 5.8 mt -83.77 137.12 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 29.4 p-10 -121.15 -160.83 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.864 ' O ' HD12 ' A' ' 155' ' ' LEU . 49.5 p90 -68.17 -41.83 80.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 1.0 OUTLIER -68.38 -56.88 6.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.499 -179.857 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' HA ' ' A' ' 142' ' ' ASP . 59.1 mt-10 -58.35 -48.53 80.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 57.4 t80 -46.55 -54.42 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.927 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.864 HD12 ' O ' ' A' ' 151' ' ' PHE . 6.2 mt -66.62 -47.06 73.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.984 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -55.78 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 110.143 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -58.28 -52.47 65.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 109.72 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.9 mtm . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.075 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.177 0.513 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.01 -55.93 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 mt -58.61 -53.28 60.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.335 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -49.17 -51.92 29.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.361 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -51.43 -50.61 59.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 102' ' ' PHE . 5.2 m -53.03 -42.08 65.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.713 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 87.3 t80 -42.28 -65.16 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 110.603 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -39.58 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.193 -0.942 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 mm -60.87 -32.78 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 110.581 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.1 -48.92 21.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.102 -0.999 . . . . 0.0 110.416 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.79 101.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -75.48 -45.88 35.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.201 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 69.3 m-80 -69.43 -15.3 63.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 110.095 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 59.37 42.93 17.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.45 ' OD2' ' O ' ' A' ' 112' ' ' PHE . 6.7 p-10 -84.07 -16.56 43.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.085 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.483 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 113.23 -16.05 22.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 3.4 m-85 -148.37 135.46 20.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 110.404 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 22.9 mt -85.26 119.36 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.852 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 23.8 p-10 -90.98 -175.76 4.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.0 OUTLIER -68.25 -38.85 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.814 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.492 ' N ' HG23 ' A' ' 115' ' ' ILE . 17.7 mt-10 -58.04 -55.2 38.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.332 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 113' ' ' ILE . 7.2 mt-10 -46.62 -40.36 12.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.818 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.515 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.1 tp -61.16 -49.03 78.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 110.063 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -51.94 -69.85 1.05 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -47.47 -45.96 26.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -1.189 . . . . 0.0 110.179 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 122' ' ' LEU . 6.5 mt -48.28 -65.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.986 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.699 ' HB3' HG21 ' A' ' 129' ' ' VAL . 44.4 mt -61.76 -44.83 96.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.467 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.495 ' NH1' ' HG2' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -55.21 -36.46 65.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.9 . . . . 0.0 110.731 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.55 -28.32 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 109.997 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.1 p -81.07 -47.31 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.32 35.51 1.45 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 5.1 mt-10 -99.88 16.6 23.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -1.204 . . . . 0.0 109.99 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 127' ' ' GLU . 44.5 p-80 38.24 43.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.627 -0.671 . . . . 0.0 110.49 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 122' ' ' LEU . 20.1 t -61.09 117.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.472 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.3 pt -77.74 148.63 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -45.34 -47.45 13.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 0.0 110.329 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB2' HG13 ' A' ' 130' ' ' ILE . 4.8 mt-10 -41.24 -36.32 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -0.863 . . . . 0.0 110.477 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -43.81 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.673 HD13 ' HA2' ' A' ' 119' ' ' GLY . 26.6 mt -64.11 -38.48 82.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.588 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -50.45 73.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.488 -0.757 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 136' ' ' ASP . 9.2 t0 -45.47 -49.29 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 141' ' ' SER . 1.7 tp -51.65 -38.89 56.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.163 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -73.02 -57.58 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 110.055 -179.993 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 138' ' ' MET . 2.9 mmtm -43.34 -63.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.01 -20.43 6.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.547 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -101.85 -62.32 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 110.424 -179.842 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 138' ' ' MET . 24.0 t70 -56.29 81.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -89.8 31.33 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 179.546 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -149.07 17.65 0.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.847 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 55.3 21.88 4.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.257 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 147' ' ' GLY . 1.4 t70 -85.58 4.57 35.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.855 . . . . 0.0 109.896 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . 41.57 38.97 2.34 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.414 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 12.3 mtt180 -158.31 124.55 4.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -1.211 . . . . 0.0 110.325 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.547 HG12 ' CB ' ' A' ' 141' ' ' SER . 13.5 mt -83.76 106.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 44.8 p-10 -100.78 -140.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 110.37 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.46 -61.64 1.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 0.0 110.729 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.32 -56.02 13.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.654 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 148' ' ' ARG . 6.2 mt-10 -60.53 -53.54 56.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.676 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.495 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 44.9 t80 -43.98 -49.23 8.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.68 -36.55 84.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.203 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -46.37 69.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.887 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.551 ' HG2' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -61.08 -42.33 98.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.846 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.551 ' N ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 0.0 110.05 179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.187 0.517 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -55.97 -38.38 70.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 98' ' ' LEU . 9.5 mt -57.14 -53.97 52.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.65 -65.61 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.845 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -52.07 -31.28 29.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.421 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -71.87 -9.85 58.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.208 -0.932 . . . . 0.0 110.378 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.99 -54.04 51.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.45 72.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.838 -179.378 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 mm -57.26 -29.31 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.125 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -80.53 -32.85 36.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.86 79.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -86.97 39.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.7 -179.878 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 27.9 t30 -128.96 -98.44 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 108' ' ' ASN . . . 174.8 27.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.984 -1.073 . . . . 0.0 111.041 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.4 p30 -113.45 -10.92 13.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.825 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.7 81.97 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.457 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 51.2 m-85 -141.6 139.75 33.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 110.6 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.478 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 51.0 mt -85.37 126.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.542 -0.724 . . . . 0.0 109.384 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.49 -179.23 3.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.205 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -65.3 -44.31 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.64 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.541 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.6 mt-10 -60.17 -51.15 70.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.064 . . . . 0.0 109.907 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.534 ' O ' HD12 ' A' ' 121' ' ' ILE . 14.6 mt-10 -49.76 -36.53 26.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.607 HD23 HG23 ' A' ' 134' ' ' ILE . 5.0 tp -60.71 -51.24 70.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 0.0 110.531 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -42.43 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.2 pt-20 -42.08 -45.81 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -1.18 . . . . 0.0 110.628 -179.122 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 117' ' ' GLU . 37.6 mt -56.23 -58.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.99 -1.069 . . . . 0.0 109.72 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.033 HD13 HG11 ' A' ' 129' ' ' VAL . 49.1 mt -60.7 -44.63 96.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 110.103 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.74 -37.77 79.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.126 -0.984 . . . . 0.0 110.264 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.87 64.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.987 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.8 p -62.74 -23.31 67.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.57 47.43 15.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.53 13.44 20.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -1.109 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 55.77 47.71 19.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.307 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.033 HG11 HD13 ' A' ' 122' ' ' LEU . 71.8 t -79.88 86.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.1 pt -57.79 149.86 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 132' ' ' GLU . 3.8 mm-40 -50.32 -44.54 54.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 111.142 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -39.43 -40.37 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.328 -0.857 . . . . 0.0 110.896 -179.474 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -47.3 21.6 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.307 -0.871 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.607 HG23 HD23 ' A' ' 118' ' ' LEU . 6.6 mt -59.71 -39.48 79.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.666 -0.646 . . . . 0.0 109.611 179.143 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.63 ' HA ' HD11 ' A' ' 115' ' ' ILE . 1.3 mm-40 -55.27 -42.33 73.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.03 -38.62 86.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 0.0 109.843 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 134' ' ' ILE . 0.6 OUTLIER -49.69 -41.98 44.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 110.947 -179.505 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.477 ' CE ' HD12 ' A' ' 149' ' ' ILE . 49.2 tpp -70.36 -43.8 69.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.921 -1.112 . . . . 0.0 110.173 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -62.74 -43.83 97.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.88 -18.77 64.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -99.07 -63.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.573 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.2 m-20 -40.05 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.718 . . . . 0.0 110.798 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 141' ' ' SER . 15.2 tttt -79.66 3.88 17.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.046 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.3 p30 -141.51 8.38 1.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.935 . . . . 0.0 110.053 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 62.3 m-20 58.18 61.9 2.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 56.7 p30 -102.05 -5.03 25.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.936 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.466 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 87.71 -5.18 85.34 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.466 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 18.0 mtm-85 -152.35 157.03 40.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.311 . . . . 0.0 110.79 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.477 HD12 ' CE ' ' A' ' 138' ' ' MET . 3.8 mt -89.28 144.87 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -121.01 -162.54 0.96 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.454 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.502 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 6.8 t80 -64.42 -52.92 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.977 . . . . 0.0 111.112 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.5 OUTLIER -60.2 -56.74 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 110.686 -179.397 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.02 -44.47 87.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.49 ' O ' ' HG2' ' A' ' 157' ' ' MET . 81.5 t80 -49.23 -54.99 14.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.208 -0.933 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 155' ' ' LEU . 35.3 mt -51.81 -51.42 56.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 110.357 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -46.99 -58.17 4.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 110.739 -179.74 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.565 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -47.53 -51.66 20.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.335 -179.586 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.565 ' N ' ' CG ' ' A' ' 157' ' ' MET . 12.3 mmt . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.156 0.503 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -68.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 99' ' ' ALA . 7.6 mp -47.96 -61.92 1.72 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.01 -42.72 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.429 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -73.82 -57.9 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.595 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 62.9 m -48.93 -27.26 2.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.879 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -46.38 -50.32 16.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.989 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -56.55 -42.59 78.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.425 HD12 HG23 ' A' ' 104' ' ' ILE . 20.0 mm -57.01 -43.3 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 110.635 -179.434 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -66.15 -38.45 88.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 110.175 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -67.19 89.74 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 0.0 110.091 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -62.78 -27.64 69.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 109.599 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.439 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 12.8 m120 -104.78 -169.1 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.559 -0.713 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.14 65.41 0.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.365 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -114.44 -32.1 6.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 110.165 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.94 6.98 48.29 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.582 ' HB2' ' HD3' ' A' ' 148' ' ' ARG . 5.3 m-85 -152.09 128.88 10.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -1.203 . . . . 0.0 109.861 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.28 141.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 3.9 p30 -106.88 173.32 6.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.253 -0.904 . . . . 0.0 110.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 116' ' ' GLU . 3.3 tt -56.4 -42.93 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.076 -1.015 . . . . 0.0 110.209 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.595 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.7 OUTLIER -55.2 -59.39 4.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.901 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.598 ' C ' HD12 ' A' ' 121' ' ' ILE . 20.7 mt-10 -47.75 -43.93 27.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.668 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.762 ' HB3' HG23 ' A' ' 134' ' ' ILE . 2.5 tp -45.46 -31.23 1.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.612 -0.68 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -73.41 -74.5 0.81 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 5.5 pt-20 -42.05 -50.04 4.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -1.177 . . . . 0.0 110.476 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.598 HD12 ' C ' ' A' ' 117' ' ' GLU . 7.9 mt -48.33 -65.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.825 ' O ' HG22 ' A' ' 125' ' ' THR . 17.9 mt -59.67 -56.6 19.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -48.56 -30.99 5.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 110.453 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -54.85 -53.78 50.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 122' ' ' LEU . 4.4 t -67.47 -139.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.973 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.448 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . -118.34 11.75 12.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.828 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.3 mm-40 -81.61 97.32 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -1.066 . . . . 0.0 111.046 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -66.06 93.25 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 127' ' ' GLU . 3.4 t -103.98 146.6 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.894 -178.826 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 131' ' ' GLU . 12.4 pt -112.71 159.0 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -42.89 -48.19 5.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.805 . . . . 0.0 110.914 -179.703 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -47.28 -32.53 4.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.309 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.06 -48.3 8.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.463 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.762 HG23 ' HB3' ' A' ' 118' ' ' LEU . 22.8 mt -60.28 -42.74 91.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -59.01 -60.46 3.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.482 -0.762 . . . . 0.0 109.848 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -51.19 -45.39 61.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.217 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -48.25 -43.98 32.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.812 -179.79 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.594 ' HA ' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -62.27 -48.44 79.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.782 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.04 -36.02 69.52 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -0.791 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.85 -17.9 65.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.835 . . . . 0.0 110.412 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.549 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -102.77 -62.32 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.803 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.6 t0 -37.69 109.01 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.671 -0.643 . . . . 0.0 110.731 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -83.51 -11.41 57.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.748 . . . . 0.0 109.86 179.843 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 1.7 p30 -132.08 4.69 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.151 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.9 m120 60.83 48.19 7.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.777 . . . . 0.0 110.772 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.45 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 45.9 p-10 -81.82 -10.2 59.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 179.557 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . 93.94 8.5 60.41 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.582 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 10.2 mtt180 -158.34 139.98 13.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -1.177 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 138' ' ' MET . 3.6 mt -83.56 122.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -101.68 -174.24 2.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.32 -56.42 16.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -63.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.745 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 143' ' ' LYS . 21.1 mt-10 -55.76 -36.57 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.932 -179.392 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -63.24 -55.56 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.914 -1.116 . . . . 0.0 109.977 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 12.8 mt -54.6 -41.83 70.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 110.388 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -58.93 -62.86 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.821 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -57.43 -50.83 71.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 0.0 110.832 -179.43 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' MET . 6.1 mmt . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.333 -0.854 . . . . 0.0 110.485 -179.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 4.5 mp0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.261 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -48.2 -59.97 3.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.263 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 155' ' ' LEU . 6.0 mt -57.99 -45.98 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -42.36 -59.29 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.242 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 101' ' ' CYS . 3.7 m120 -50.02 -54.11 22.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.457 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.2 m -43.6 -32.59 0.98 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.908 179.716 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 13.0 t80 -42.93 -63.93 0.71 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.345 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -63.68 -29.63 70.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 23.0 mm -60.84 -50.77 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.487 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.4 -13.7 14.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.409 ' OD1' ' OD2' ' A' ' 110' ' ' ASP . 25.9 t0 -89.42 118.49 29.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.09 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -110.66 -11.91 14.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -109.71 15.09 23.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 110.611 -179.243 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 45.25 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 110.239 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -126.55 -27.88 3.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.989 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.95 -19.47 49.33 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 62.0 m-85 -153.23 128.24 9.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -1.102 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.499 HG23 ' OE1' ' A' ' 117' ' ' GLU . 1.4 mp -82.51 123.52 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -102.21 -168.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.249 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.8 tt -65.14 -40.47 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 110.328 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.555 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -51.38 -52.38 46.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.435 -179.693 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.499 ' OE1' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -56.97 -44.62 82.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.903 . . . . 0.0 110.28 -179.767 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.631 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -48.47 -34.19 10.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.171 -179.971 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -58.36 -85.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 15.7 pt-20 -42.43 -43.89 3.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.15 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.45 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.5 mt -52.61 -48.98 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.877 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 122' ' ' LEU . 10.8 mt -70.32 -47.1 62.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.097 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -51.96 -42.42 62.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.946 . . . . 0.0 110.208 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.04 -31.6 5.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.432 -0.793 . . . . 0.0 110.548 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 p -68.87 -35.91 77.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.363 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.91 49.24 2.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.45 -7.55 8.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.206 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 59.29 84.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 110.039 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 9.1 t -108.69 149.58 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.318 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' O ' ' C ' ' A' ' 131' ' ' GLU . 16.2 pt -113.44 154.82 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.126 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 130' ' ' ILE . 10.2 mt-10 -39.41 -51.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.436 -0.79 . . . . 0.0 110.777 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 -179.991 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -88.37 -44.75 10.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.503 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 118' ' ' LEU . 33.3 mt -63.26 -38.3 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.811 . . . . 0.0 109.894 179.515 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -54.04 -53.73 49.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.778 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -45.26 -48.73 12.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.575 HD22 HD21 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -53.09 -49.01 67.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 110.377 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 26.4 tpp -66.11 -50.43 64.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -41.83 93.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.398 -0.814 . . . . 0.0 110.093 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -66.77 -35.58 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.539 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -80.54 -48.83 12.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.4 OUTLIER -49.23 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.508 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 141' ' ' SER . 17.5 tttt -80.09 -19.21 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 1.5 p30 -122.48 0.91 9.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 64.96 52.07 1.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.0 110.564 179.727 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 146' ' ' ASP . 50.7 p-10 -93.7 0.02 56.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 11.58 84.34 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -152.79 139.1 18.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.144 -1.21 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.2 mt -83.63 134.76 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.751 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 152' ' ' ASP . 2.1 p30 -118.6 -166.27 1.21 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 110.144 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 41.1 p90 -70.02 -34.98 73.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.594 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -66.0 -49.0 69.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.315 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 141' ' ' SER . 74.8 mt-10 -71.92 -56.61 5.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.38 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.446 ' O ' ' HG2' ' A' ' 157' ' ' MET . 69.6 t80 -45.29 -45.17 11.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 0.0 110.117 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 98' ' ' LEU . 13.1 mt -55.62 -40.93 72.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -55.11 36.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.56 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -47.17 -49.73 22.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 109.588 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.56 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.37 -0.831 . . . . 0.0 110.363 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.299 0.571 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -55.42 -60.1 3.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -0.894 . . . . 0.0 110.462 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.652 HD13 ' HE1' ' A' ' 158' ' ' MET . 0.2 OUTLIER -51.21 -54.79 22.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -41.32 -48.52 3.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 0.0 110.134 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.44 -43.65 71.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.064 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.8 m -63.9 -18.81 64.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.885 . . . . 0.0 110.192 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -53.15 -55.76 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 110.122 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -55.82 -33.75 64.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.03 -39.44 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -66.54 -51.51 55.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.099 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -72.56 123.77 23.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.165 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.471 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 19.6 mttp -93.99 17.19 12.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.424 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 50.3 m-80 -148.68 173.99 12.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 110.424 -179.485 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.5 40.6 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 p30 -88.13 -23.2 23.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.18 18.71 63.07 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -153.28 117.3 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -1.114 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 36.9 mt -84.1 132.05 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.32 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -107.34 -164.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -78.65 -43.93 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.085 -1.01 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.585 ' N ' HG23 ' A' ' 115' ' ' ILE . 31.2 mt-10 -51.78 -53.07 43.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 109.826 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 76.2 mt-10 -57.37 -44.58 84.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.645 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -50.48 -44.98 56.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 110.27 179.919 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.535 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -42.64 -83.39 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.471 ' OE2' ' NZ ' ' A' ' 107' ' ' LYS . 11.7 pt-20 -47.06 -44.44 20.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -1.158 . . . . 0.0 110.33 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.459 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 17.8 mt -48.18 -57.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.916 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 125' ' ' THR . 18.2 mt -68.85 -47.63 65.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.95 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.32 -37.87 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 110.147 179.756 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.3 -31.33 43.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 122' ' ' LEU . 65.7 p -52.9 -34.55 55.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.88 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.19 24.71 5.86 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -120.83 169.89 10.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 110.156 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -92.35 76.5 5.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.139 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.38 149.17 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' ' 131' ' ' GLU . 7.2 pt -133.26 149.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.085 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.1 mt-10 -41.55 -49.39 4.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.56 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 10.8 mt-10 -42.42 -40.39 2.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.037 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -47.92 10.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 109.175 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.64 HG23 HD13 ' A' ' 118' ' ' LEU . 10.4 mt -55.2 -39.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.4 -0.813 . . . . 0.0 109.272 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -54.59 -42.18 70.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.527 -0.733 . . . . 0.0 109.948 179.49 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -56.85 -50.72 71.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 110.245 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.6 mp -54.63 -35.53 63.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.417 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 142' ' ' ASP . 2.1 ttm -74.64 -55.53 5.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 110.396 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -47.54 -55.54 8.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.61 -33.39 69.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.0 t -84.9 -62.34 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.344 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 138' ' ' MET . 3.4 t0 -40.44 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.406 -0.809 . . . . 0.0 110.694 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 mttt -76.66 -27.86 55.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.416 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 8.4 m-80 -104.24 1.44 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.796 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.39 17.57 7.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 110.314 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.23 -14.32 17.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.048 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.494 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 97.41 9.21 55.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.494 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 32.2 mtt85 -150.69 142.81 24.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.379 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.4 mt -83.7 137.62 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.048 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.74 -179.99 3.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 110.112 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.577 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 30.8 p90 -51.64 -42.49 62.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.577 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 1.9 m-20 -67.0 -58.48 4.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.885 . . . . 0.0 110.892 -179.434 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.416 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 39.6 mt-10 -59.46 -38.33 80.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.209 -0.932 . . . . 0.0 111.031 -179.321 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.488 ' CD2' ' SD ' ' A' ' 157' ' ' MET . 25.7 t80 -58.99 -57.38 13.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 110.619 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.469 ' O ' ' HE3' ' A' ' 158' ' ' MET . 64.6 mt -40.74 -50.07 3.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.317 -179.741 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -39.11 90.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.964 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.513 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -55.85 -46.52 78.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.362 -0.836 . . . . 0.0 109.869 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.652 ' HE1' HD13 ' A' ' 98' ' ' LEU . 1.7 tmm? . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.74 . . . . 0.0 110.158 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.206 0.527 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.49 -62.57 1.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.737 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.514 HD21 ' HG2' ' A' ' 158' ' ' MET . 16.0 mt -46.61 -53.75 10.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.45 -37.51 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.36 -42.74 53.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 110.623 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -55.17 -24.61 27.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.968 . . . . 0.0 110.544 -179.704 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 101' ' ' CYS . 15.6 t80 -42.82 -54.57 4.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -67.13 -37.51 83.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.194 -0.941 . . . . 0.0 110.0 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.7 mm -57.53 -39.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.29 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.676 ' CD2' HD13 ' A' ' 121' ' ' ILE . 2.4 m-85 -83.59 -26.08 30.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -80.76 98.48 7.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.252 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -75.81 0.94 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.289 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -132.27 167.53 19.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -0.858 . . . . 0.0 110.244 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.79 29.07 0.94 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.418 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 8.8 p30 -76.26 -24.0 54.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.538 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 80.03 7.46 88.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 38.7 m-85 -153.07 133.75 13.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -1.175 . . . . 0.0 110.241 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.33 129.48 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.345 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 117' ' ' GLU . 35.4 p30 -101.99 -179.01 3.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.076 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -58.82 -43.47 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.064 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.563 ' N ' HG23 ' A' ' 115' ' ' ILE . 19.3 mt-10 -52.21 -51.93 55.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.073 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.5 mm-40 -57.56 -39.19 76.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.511 HD22 HD11 ' A' ' 122' ' ' LEU . 0.9 OUTLIER -60.01 -50.95 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 110.537 -179.68 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.498 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -49.64 -74.45 0.27 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' CD ' ' HA ' ' A' ' 117' ' ' GLU . 5.6 pt-20 -42.31 -47.7 4.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.434 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.676 HD13 ' CD2' ' A' ' 105' ' ' PHE . 6.1 mt -51.86 -58.37 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.511 HD11 HD22 ' A' ' 118' ' ' LEU . 64.7 mt -60.67 -47.1 87.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.289 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -36.78 66.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.201 -0.937 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.13 -42.22 28.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -0.862 . . . . 0.0 110.497 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.2 p -54.86 -48.44 72.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.4 35.97 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.05 147.75 48.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -1.065 . . . . 0.0 110.129 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.574 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -82.96 59.94 5.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 110.301 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 122' ' ' LEU . 7.9 t -61.7 156.81 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.407 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.4 pt -125.67 148.2 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.32 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLU . 4.3 mt-10 -45.99 -47.72 16.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.022 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' GLU . 1.9 mt-10 -42.58 -35.0 0.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.03 -43.63 12.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.498 HD13 ' HA2' ' A' ' 119' ' ' GLY . 14.1 mt -64.13 -40.04 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 109.633 179.36 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.8 -48.45 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.848 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -47.83 -53.79 14.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.76 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.537 ' HG ' ' HE2' ' A' ' 157' ' ' MET . 0.4 OUTLIER -50.76 -43.02 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.876 179.613 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -69.26 -53.69 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.615 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -53.76 46.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.079 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -57.59 -40.28 78.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 110.107 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.32 -59.03 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.207 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.1 m-20 -52.57 87.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.831 . . . . 0.0 110.533 -179.683 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.3 OUTLIER -68.25 -18.93 64.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.74 11.58 10.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.801 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 20.8 m-20 51.8 86.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -130.54 13.11 5.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 58.4 23.58 54.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 3.0 mtt85 -158.3 123.71 4.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 110.424 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 5.7 mt -84.52 122.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 109.817 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -101.58 -175.09 2.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.995 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -49.26 -57.79 6.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 110.552 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -61.55 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.691 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.72 -33.15 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.645 -179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 157' ' ' MET . 13.1 t80 -60.65 -64.34 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 110.614 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.1 mt -46.66 -58.07 4.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.443 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -47.11 -38.77 12.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.963 . . . . 0.0 110.409 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.537 ' HE2' ' HG ' ' A' ' 137' ' ' LEU . 0.9 OUTLIER -67.66 -48.71 65.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.881 . . . . 0.0 110.152 -179.957 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.524 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.3 tpp . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.369 -0.832 . . . . 0.0 110.411 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 4.3 mt-10 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.296 0.57 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER 65.07 150.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 110.298 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.19 150.69 23.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.42 -27.13 24.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 110.266 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . 76.49 -126.64 8.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 92' ' ' GLY . 8.0 mttt 42.13 -158.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -1.13 . . . . 0.0 110.173 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.5 161.06 2.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -51.16 -44.93 61.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.263 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 5.4 tp10 -40.37 -63.76 0.59 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.43 -0.794 . . . . 0.0 110.503 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.8 -57.14 7.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.556 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.6 OUTLIER -50.11 -46.2 53.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.095 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -43.61 -58.55 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -53.6 -51.93 61.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -43.79 -30.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.403 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 30.6 t80 -42.79 -59.77 1.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -36.66 71.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 47.2 mm -57.24 -29.51 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.944 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.05 -54.18 6.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.949 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 3.8 t70 -67.61 87.04 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.966 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -84.87 -2.81 58.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.464 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 110' ' ' ASP . 2.1 p30 -131.28 153.09 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.136 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.68 89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 110.145 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 108' ' ' ASN . 60.9 t0 -142.29 -34.54 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 110.284 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.53 10.18 35.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.46 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 31.2 m-85 -153.52 147.06 25.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -1.175 . . . . 0.0 110.052 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 149' ' ' ILE . 32.8 mt -90.99 114.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.336 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.87 179.9 4.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.566 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -66.66 -43.53 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 115' ' ' ILE . 2.4 mm-40 -50.75 -45.5 58.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.822 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 7.9 mt-10 -65.02 -38.41 90.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.9 OUTLIER -58.29 -38.53 77.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.118 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.413 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -47.75 -80.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -43.43 -54.15 4.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.323 -1.104 . . . . 0.0 110.743 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.501 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 14.0 mt -42.23 -61.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.71 -44.79 80.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -40.65 62.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.17 19.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.6 p -74.9 -169.33 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.11 56.57 0.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -116.83 -10.38 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 49.12 68.06 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.4 t -89.69 149.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.66 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' GLU . 18.0 pt -117.98 155.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.4 mt-10 -40.2 -50.1 2.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.33 -0.856 . . . . 0.0 110.887 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.4 -32.99 28.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 110.948 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -47.24 10.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 13.7 mt -58.2 -37.21 61.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.311 -0.868 . . . . 0.0 109.717 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.495 ' HA ' HD11 ' A' ' 115' ' ' ILE . 4.5 mt-10 -57.4 -47.8 80.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.44 -43.65 71.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 0.0 110.112 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.61 -44.37 69.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.129 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.6 ttm -64.68 -41.77 95.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 0.0 110.261 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -56.25 22.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.38 -19.19 21.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 110.671 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.559 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -102.51 -61.5 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 0.0 110.736 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' SER . 59.5 t0 -39.38 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.402 -0.811 . . . . 0.0 110.852 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -92.67 -5.61 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.863 . . . . 0.0 110.142 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -127.49 21.6 6.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.166 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 47.6 46.94 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -105.45 14.46 28.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 110.228 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.429 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 46.53 30.94 4.77 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 11.0 mtt180 -157.52 128.74 6.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -1.113 . . . . 0.0 110.363 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.559 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.2 mt -83.48 123.54 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.683 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 20.4 p-10 -96.33 -167.36 1.56 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.355 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 18.2 p90 -65.23 -43.3 91.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.222 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.587 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -64.32 -58.32 6.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.312 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 143' ' ' LYS . 35.7 mt-10 -61.61 -42.83 99.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.521 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 17.4 t80 -56.49 -64.95 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 110.07 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 155' ' ' LEU . 32.5 mt -44.94 -48.49 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.379 -0.826 . . . . 0.0 110.001 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -46.91 -46.53 21.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -0.881 . . . . 0.0 110.375 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.547 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -71.43 -53.29 14.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.949 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.556 ' HB3' HD21 ' A' ' 98' ' ' LEU . 5.3 mmt -45.3 -36.37 4.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.946 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -63.57 -40.98 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.016 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -116.27 62.8 0.37 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 158' ' ' MET . 70.5 t -48.39 143.2 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 110.438 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.258 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.261 0.553 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -160.21 168.9 24.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.157 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.1 6.82 2.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.947 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.83 109.24 1.38 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.77 -168.1 11.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.509 ' HG3' HD12 ' A' ' 98' ' ' LEU . 3.5 ptpp? -129.93 29.19 5.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.228 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.74 147.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 96' ' ' GLU . 5.4 tm-20 -53.55 -42.44 67.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.858 . . . . 0.0 110.398 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 95' ' ' GLU . 2.4 tt0 -38.3 -66.84 0.23 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.468 -0.77 . . . . 0.0 111.056 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.2 mt-10 -47.89 -65.2 0.6 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 110.846 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' A' ' 154' ' ' PHE . 0.1 OUTLIER -51.19 -55.22 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 110.639 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -44.87 -44.77 9.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.256 -0.902 . . . . 0.0 110.687 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 3.0 m-20 -50.77 -52.0 45.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.741 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 105' ' ' PHE . 0.8 OUTLIER -61.17 -16.67 47.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.17 -0.956 . . . . 0.0 110.977 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 34.7 t80 -47.88 -41.25 23.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -0.998 . . . . 0.0 110.844 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -73.87 -37.8 64.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.0 111.095 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -57.06 -35.63 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 110.474 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 101' ' ' CYS . 28.8 m-85 -80.83 -36.57 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 110.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -79.67 80.13 6.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.034 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.456 ' HB2' ' OE2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -54.46 -30.49 53.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.479 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -109.35 -151.7 0.48 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.081 -1.012 . . . . 0.0 110.33 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.06 47.75 1.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 9.2 p30 -83.14 -18.01 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 80.13 -5.0 64.27 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 110' ' ' ASP . 7.4 m-85 -145.5 135.79 23.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -1.184 . . . . 0.0 109.876 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 mt -82.84 120.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.04 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 6.9 p-10 -87.84 176.65 7.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.158 -0.964 . . . . 0.0 110.324 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -69.72 -40.62 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.126 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 11.7 mt-10 -54.29 -48.86 70.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.021 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' OE2' ' HB2' ' A' ' 107' ' ' LYS . 3.5 mt-10 -53.3 -50.25 65.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.687 HD23 HG23 ' A' ' 134' ' ' ILE . 0.8 OUTLIER -58.28 -39.74 80.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.313 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.53 -73.99 0.34 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 14.5 pt-20 -54.85 -44.77 74.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.213 -1.169 . . . . 0.0 110.573 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 125' ' ' THR . 10.9 mt -53.01 -56.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 110.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.84 -54.59 32.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -55.99 -39.67 72.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -53.05 -20.22 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.253 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 121' ' ' ILE . 12.2 p -86.35 -1.95 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.12 81.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . 0.2 OUTLIER -79.32 0.5 28.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -1.112 . . . . 0.0 110.237 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 41.97 45.75 3.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 127' ' ' GLU . 14.8 t -77.86 155.22 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.199 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 130' ' ' ILE . 20.7 pt -114.96 138.27 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 110.409 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ILE . 8.9 mt-10 -41.02 -43.44 2.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HB2' HG13 ' A' ' 130' ' ' ILE . 1.5 mm-40 -40.72 -38.53 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.303 -0.873 . . . . 0.0 110.6 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.84 -48.96 8.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.659 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.687 HG23 HD23 ' A' ' 118' ' ' LEU . 13.3 mt -58.12 -39.45 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.863 ' HA ' HD11 ' A' ' 115' ' ' ILE . 4.5 tt0 -66.79 -41.6 87.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.589 -0.695 . . . . 0.0 110.021 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.81 -42.26 75.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.968 . . . . 0.0 110.086 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.43 78.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 31.2 tpp -61.64 -40.5 95.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.875 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -59.12 -49.42 77.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 110.104 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -68.19 -41.38 81.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.031 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.54 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -73.99 -63.97 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 138' ' ' MET . 9.7 t0 -45.41 97.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -82.14 -24.22 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.431 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 10.3 m-80 -107.76 14.78 25.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.887 . . . . 0.0 110.161 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.15 47.7 19.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 51.1 p30 -105.32 25.57 10.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 44.33 35.46 3.82 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 86.6 mtt180 -157.91 121.35 4.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.54 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.2 mt -83.62 118.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.432 ' OD2' ' OE2' ' A' ' 153' ' ' GLU . 41.0 p30 -97.18 -179.78 4.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 110.445 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -59.27 3.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.43 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -61.12 2.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.496 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 157' ' ' MET . 16.7 mt-10 -60.73 -39.95 90.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.366 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' A' ' 98' ' ' LEU . 21.5 t80 -59.68 -33.09 71.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -0.872 . . . . 0.0 110.975 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 155' ' ' LEU . 25.1 mt -74.3 -46.45 40.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 110.974 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 157' ' ' MET . 63.5 mttt -66.67 -49.41 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -0.962 . . . . 0.0 110.834 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.73 -50.51 7.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.015 -1.053 . . . . 0.0 110.372 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.467 ' HB2' ' SD ' ' A' ' 157' ' ' MET . 9.8 ttm -101.04 64.07 1.03 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.43 75.44 8.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 110.35 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.68 -47.66 2.78 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.696 HG22 ' HG2' ' A' ' 162' ' ' GLN . 12.2 p -49.61 122.9 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -1.146 . . . . 0.0 110.295 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.696 ' HG2' HG22 ' A' ' 161' ' ' VAL . 81.4 mm-40 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.198 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.222 0.534 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 12.4 t70 -110.51 -16.45 13.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.22 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 66.7 114.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.387 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -116.09 48.44 1.24 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.0 110.065 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.27 -47.52 1.01 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' HG3' ' HG2' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -92.89 107.71 19.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 110.085 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -59.72 139.56 57.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.889 . . . . 0.0 110.524 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 94' ' ' SER . 17.8 tt0 -43.61 -46.47 7.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.946 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 1.1 tp10 -50.42 -39.25 46.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.356 -0.84 . . . . 0.0 109.941 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HG2' ' HG3' ' A' ' 93' ' ' LYS . 6.3 tp10 -49.8 -66.32 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.119 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.3 OUTLIER -50.1 -45.62 52.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -47.81 -42.65 26.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 110.27 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 104' ' ' ILE . 42.4 m-20 -48.1 -46.19 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.5 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 m -78.21 -25.67 47.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 0.0 110.904 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -52.95 -62.65 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -0.999 . . . . 0.0 110.729 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -57.15 -27.98 62.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.897 . . . . 0.0 110.92 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 100' ' ' ASN . 45.6 mm -61.42 -26.3 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.026 -1.046 . . . . 0.0 110.464 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.13 -29.21 24.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -79.87 117.24 20.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.079 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 -11.47 15.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.289 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 109' ' ' ALA . 56.6 m-80 -116.34 16.11 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.302 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 43.98 79.42 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.17 -33.13 5.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 110.23 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.519 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 111.85 -14.35 26.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.519 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 18.7 m-85 -149.93 141.25 23.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -1.087 . . . . 0.0 109.826 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 44.4 mt -82.81 130.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 8.2 p30 -95.17 -176.87 3.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.1 tt -79.18 -44.98 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 110.508 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.605 ' N ' HG23 ' A' ' 115' ' ' ILE . 21.6 pt-20 -48.99 -35.13 14.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 116' ' ' GLU . 43.2 mt-10 -69.12 -42.31 76.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.622 HD23 HG23 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -57.36 -37.88 73.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.31 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -57.11 -72.95 0.5 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.4 pt-20 -53.95 -44.63 70.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -1.127 . . . . 0.0 110.701 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.2 mt -45.05 -56.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.009 . . . . 0.0 110.481 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.716 ' O ' HG22 ' A' ' 125' ' ' THR . 15.7 mt -66.24 -52.31 48.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.684 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -48.71 -30.93 6.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 110.681 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.45 -56.62 18.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.743 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.716 HG22 ' O ' ' A' ' 122' ' ' LEU . 2.3 t -63.2 -10.15 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.559 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 128' ' ' HIS . . . 111.52 -29.1 8.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 129' ' ' VAL . 4.2 mm-40 -52.24 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' GLY . 8.1 m80 -67.32 76.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 109.975 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 127' ' ' GLU . 13.3 t -84.29 136.85 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.47 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 ' HB2' ' A' ' 133' ' ' ASP . 17.2 pt -90.97 143.59 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -42.95 -46.96 5.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 110.454 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -48.03 -27.23 2.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.458 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.486 ' HB2' HG13 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -89.68 -41.89 11.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.619 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.622 HG23 HD23 ' A' ' 118' ' ' LEU . 36.7 mt -65.64 -37.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.915 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.16 -48.46 73.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.91 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 12.8 t0 -55.57 -45.94 77.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -57.7 8.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.975 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 2.0 ttm -56.18 -20.88 19.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -72.89 -44.75 60.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 110.428 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -73.94 -34.48 64.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 110.716 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -74.04 -63.14 1.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.027 . . . . 0.0 110.547 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 138' ' ' MET . 23.2 m-20 -41.89 96.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.483 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -72.84 -3.81 27.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.31 22.57 2.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 48.94 86.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 110.337 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' OD1' ' CG ' ' A' ' 142' ' ' ASP . 17.6 p-10 -139.94 17.81 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 48.32 32.16 9.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 45.5 mtt180 -158.19 121.69 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.189 . . . . 0.0 110.454 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.8 mt -83.53 123.71 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.667 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 23.1 p30 -103.94 -177.44 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.617 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.89 ' CE2' HD11 ' A' ' 155' ' ' LEU . 29.7 t80 -49.95 -62.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.629 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.512 ' HA ' HD12 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -48.83 -57.61 6.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.367 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.472 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 79.7 mt-10 -59.94 -39.63 86.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 109.989 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 33.0 t80 -63.34 -51.48 65.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.89 HD11 ' CE2' ' A' ' 151' ' ' PHE . 37.3 mt -47.53 -54.06 12.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.452 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . 31.7 mttt -60.55 -51.2 70.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.609 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.506 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.1 ptm -48.75 -47.54 41.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.595 ' HB3' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -95.66 32.91 1.73 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 156' ' ' LYS . 5.3 tp10 -76.7 126.01 30.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.875 . . . . 0.0 110.262 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.63 50.67 6.4 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -59.99 138.13 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -1.139 . . . . 0.0 110.222 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.2 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.224 0.535 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 52.9 m-20 -132.12 -77.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.218 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 89' ' ' ASP . . . -178.21 158.47 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 110.412 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -177.62 142.46 0.32 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.033 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.63 -22.06 56.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -71.23 130.81 42.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -1.193 . . . . 0.0 110.306 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 95' ' ' GLU . 4.1 m -94.92 150.35 20.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.232 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 94' ' ' SER . 3.2 tm-20 -42.34 -38.53 1.86 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.872 . . . . 0.0 110.196 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 95' ' ' GLU . 3.4 mt-10 -41.7 -61.76 1.03 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.308 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -51.39 -62.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 110.079 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -47.78 -62.18 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 110.06 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -44.91 -47.37 11.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.877 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 1.8 m-20 -50.88 -52.71 39.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -18.54 39.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 110.131 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 16.0 t80 -55.06 -55.87 26.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -57.06 -42.89 81.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -0.885 . . . . 0.0 110.636 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 1.2 mp -57.21 -41.71 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.135 -0.978 . . . . 0.0 110.273 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.455 ' CE2' ' HE3' ' A' ' 158' ' ' MET . 10.9 m-85 -72.11 -43.64 64.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 0.0 110.486 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.64 102.58 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -84.14 -44.34 14.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 110.475 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -68.09 -8.04 34.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.226 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.47 24.77 1.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 112' ' ' PHE . 4.0 p30 -68.16 -20.99 64.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 110.278 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.489 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 112.09 -15.77 25.52 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 9.7 m-85 -148.01 134.13 19.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -1.165 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.5 mt -82.5 133.78 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.297 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 6.4 p-10 -107.28 -171.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 110.141 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.4 tt -72.51 -43.42 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 110.187 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.587 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -55.83 -35.6 66.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.131 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -74.97 -52.31 11.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 110.417 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -38.86 -30.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.46 -0.775 . . . . 0.0 111.065 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 117' ' ' GLU . . . -56.03 -43.76 88.18 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 11.4 pt-20 -49.28 -45.86 45.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.125 -1.22 . . . . 0.0 110.942 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.518 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 1.5 mp -60.26 -50.39 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.677 HD12 ' O ' ' A' ' 118' ' ' LEU . 4.3 mp -69.08 -52.26 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.034 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 24.9 mtp180 -49.64 -36.93 26.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.32 23.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 0.0 110.324 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.8 p -61.14 -40.37 93.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.392 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.29 -3.97 9.58 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -92.66 133.47 35.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.26 60.21 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 110.136 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.545 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 38.6 t -45.48 166.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.442 ' N ' HG12 ' A' ' 129' ' ' VAL . 31.9 pt -118.52 151.99 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.99 -48.44 3.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.382 -0.824 . . . . 0.0 110.78 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -48.88 -31.54 7.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.824 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.545 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -83.19 -43.95 15.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.2 mt -66.2 -38.15 81.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.506 -0.746 . . . . 0.0 109.822 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.498 ' HA ' HD12 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.98 -53.18 44.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 110.536 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -45.98 -51.31 13.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 0.0 110.45 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.56 HD12 ' HE3' ' A' ' 157' ' ' MET . 1.5 mm? -50.58 -41.27 54.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.553 ' HE2' HD12 ' A' ' 149' ' ' ILE . 20.9 tpp -67.97 -48.96 64.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -48.21 79.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.63 -32.42 69.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 143' ' ' LYS . 2.1 t -92.99 -38.06 11.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' MET . 1.4 m-20 -51.99 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 8.3 tptm -74.63 -18.19 60.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.911 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -117.77 10.68 13.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.989 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.0 m120 55.31 46.13 24.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -0.881 . . . . 0.0 110.322 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -107.04 16.12 24.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 51.52 34.96 35.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 5.6 mtm180 -157.63 124.82 5.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -1.214 . . . . 0.0 110.223 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.553 HD12 ' HE2' ' A' ' 138' ' ' MET . 4.2 mt -83.94 128.55 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 0.0 110.131 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.451 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 53.3 p-10 -108.73 -170.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 110.087 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -63.5 -37.87 88.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.93 -51.85 35.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.451 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 46.8 mt-10 -59.7 -45.41 92.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.566 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 155' ' ' LEU . 1.9 t80 -50.61 -57.97 6.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.768 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.7 mt -39.92 -64.15 0.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.468 -0.77 . . . . 0.0 110.677 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -30.97 66.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.56 ' HE3' HD12 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -65.5 -40.31 92.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.53 ' N ' ' HG3' ' A' ' 157' ' ' MET . 2.5 mtt -109.06 48.92 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 0.0 110.169 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -87.11 8.44 23.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 0.0 110.318 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -161.48 39.0 0.4 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 162' ' ' GLN . 15.0 t -120.99 158.17 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.235 . . . . 0.0 110.179 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 161' ' ' VAL . 3.2 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.247 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.231 0.539 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 45.1 p-10 -102.28 148.14 25.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.38 37.14 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.9 59.43 1.7 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.323 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.42 -82.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.422 ' CG ' ' HG ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -168.16 93.92 0.37 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -1.137 . . . . 0.0 110.163 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -97.82 -178.25 4.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -0.833 . . . . 0.0 110.202 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 94' ' ' SER . 2.7 mp0 -44.33 -52.11 7.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.185 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -49.63 -55.95 11.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 1.9 mt-10 -59.71 -54.01 51.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.701 HD22 ' HE1' ' A' ' 154' ' ' PHE . 14.1 mt -50.78 -64.13 0.91 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.89 -46.01 10.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 67.7 m-20 -56.01 -48.29 76.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 73.8 m -45.33 -29.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -44.89 -62.97 1.02 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 109.82 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.39 -42.01 61.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 21.0 mm -61.28 -39.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.0 -51.96 48.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.865 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 21.0 t0 -53.42 129.37 31.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.517 -0.739 . . . . 0.0 110.418 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -98.29 -14.43 20.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.191 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 4.3 p30 -133.47 12.0 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 55.39 57.35 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 36.0 p30 -84.85 -14.57 47.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 94.07 -10.52 71.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CB ' ' HD2' ' A' ' 148' ' ' ARG . 46.7 m-85 -151.41 136.42 17.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -1.227 . . . . 0.0 110.635 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.9 mt -88.28 121.65 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' HG3' ' A' ' 117' ' ' GLU . 13.6 p30 -98.3 171.01 8.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.229 -0.919 . . . . 0.0 110.342 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -58.49 -36.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.451 ' N ' HG23 ' A' ' 115' ' ' ILE . 70.8 mm-40 -51.03 -54.04 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.877 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 51.6 mt-10 -56.38 -41.58 76.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.787 ' HG ' HD21 ' A' ' 137' ' ' LEU . 0.3 OUTLIER -54.73 -43.56 72.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -56.44 -75.47 0.25 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 16.1 pt-20 -42.35 -45.06 4.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -1.12 . . . . 0.0 110.479 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.497 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 41.5 mt -55.22 -55.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.722 HD22 HG21 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -63.15 -53.67 49.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 110.442 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -48.82 -40.36 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.19 -34.39 22.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.286 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 36.4 p -70.01 -23.33 63.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.962 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.1 3.76 26.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HB3' HG23 ' A' ' 129' ' ' VAL . 11.9 mt-10 -89.59 132.9 34.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.311 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -85.38 53.36 2.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.722 HG21 HD22 ' A' ' 122' ' ' LEU . 22.6 t -65.28 149.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.868 . . . . 0.0 110.518 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 132' ' ' GLU . 6.2 pt -113.76 153.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.8 tt0 -41.71 -53.02 3.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.536 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -44.32 -36.45 2.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.72 -42.05 22.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 109.099 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 17.0 mt -67.18 -36.53 77.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.52 -0.737 . . . . 0.0 109.565 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 138' ' ' MET . 2.8 tm-20 -56.26 -32.47 64.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 109.838 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -49.83 -62.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 110.767 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.904 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.1 pp -56.88 -27.97 61.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.987 . . . . 0.0 110.651 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.436 ' N ' HD12 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -67.01 -46.82 73.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.03 . . . . 0.0 110.046 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.84 72.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -59.9 -36.37 76.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.552 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -86.11 -59.06 2.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 145' ' ' ASN . 53.9 t0 -43.44 92.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -92.3 -20.06 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 15.1 m-80 -104.74 6.4 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.03 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.0 OUTLIER 63.93 28.49 14.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 110.211 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -87.76 8.66 24.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.76 24.66 33.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.538 ' HD2' ' CB ' ' A' ' 112' ' ' PHE . 1.4 mtt-85 -147.69 142.58 26.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -1.155 . . . . 0.0 110.189 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.904 HD11 ' CD1' ' A' ' 137' ' ' LEU . 19.4 mt -90.65 121.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.372 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 36.4 p-10 -97.7 -156.32 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 0.0 109.907 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -71.18 -55.79 7.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.31 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -59.32 -60.21 4.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.908 . . . . 0.0 110.548 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.49 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 26.6 mt-10 -48.02 -37.74 15.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.316 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.701 ' HE1' HD22 ' A' ' 98' ' ' LEU . 50.9 t80 -60.37 -61.04 2.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 154' ' ' PHE . 91.4 mt -41.76 -39.03 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.435 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 152' ' ' ASP . 8.8 mttm -58.42 -45.48 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 110.365 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.863 ' HE1' HD13 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -64.17 -51.2 64.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.826 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.581 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -96.88 50.93 1.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 110.572 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.63 -20.2 17.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.098 -1.001 . . . . 0.0 110.349 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -88.14 -31.13 15.05 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 161' ' ' VAL . 13.8 p -50.09 133.07 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.178 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.252 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.201 0.524 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -150.11 67.88 0.98 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 110.249 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.19 81.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 110.23 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.69 -151.16 0.48 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 93' ' ' LYS . . . -86.78 144.04 19.37 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 92' ' ' GLY . 36.4 mmtt 54.95 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.316 -1.108 . . . . 0.0 110.246 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -101.21 -178.4 3.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.935 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.13 -40.88 64.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 110.236 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.12 -49.85 72.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.313 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -67.88 -52.97 30.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.287 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.509 HD22 ' HE2' ' A' ' 158' ' ' MET . 0.1 OUTLIER -52.15 -53.39 43.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.97 44.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.95 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -77.02 -46.0 25.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -49.01 -27.26 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.967 . . . . 0.0 110.092 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.626 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 2.3 t80 -42.08 -56.54 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -56.93 -34.12 67.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.326 -0.859 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.61 -59.83 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.358 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.675 ' O ' HD11 ' A' ' 121' ' ' ILE . 3.0 m-85 -62.42 -38.37 89.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -85.76 62.24 7.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.229 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -35.43 10.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.182 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.424 ' HB3' ' OD2' ' A' ' 110' ' ' ASP . 1.5 t-20 -55.51 -21.26 15.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.02 47.18 25.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 108' ' ' ASN . 33.1 m-20 -106.94 -13.86 15.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.542 ' C ' ' CD1' ' A' ' 112' ' ' PHE . . . 97.87 -2.43 60.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 111' ' ' GLY . 63.5 m-85 -150.57 119.42 6.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.24 . . . . 0.0 110.273 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.409 ' HA ' ' OE2' ' A' ' 117' ' ' GLU . 15.7 mt -83.79 116.39 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.34 -0.85 . . . . 0.0 110.112 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -92.59 175.28 6.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.578 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -57.05 -42.73 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.894 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.578 ' N ' HG23 ' A' ' 115' ' ' ILE . 4.5 mt-10 -51.01 -45.87 61.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.093 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.4 mt-10 -58.47 -50.48 73.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.89 . . . . 0.0 110.127 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 137' ' ' LEU . 0.3 OUTLIER -52.1 -34.65 45.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.893 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -70.28 -69.25 1.43 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -48.52 -45.24 37.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.237 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.675 HD11 ' O ' ' A' ' 105' ' ' PHE . 47.3 mt -57.0 -50.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 122' ' ' LEU . 12.9 mt -76.72 -53.98 7.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.965 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 9.5 mtt180 -49.07 -32.24 9.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.098 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -57.15 -43.24 82.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.4 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 81.0 p -55.66 -43.57 76.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.26 -39.37 1.69 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 129' ' ' VAL . 1.9 mt-10 -46.02 125.23 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.136 . . . . 0.0 110.321 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.56 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 2.6 p-80 -71.67 65.47 0.49 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 127' ' ' GLU . 5.3 t -64.67 148.68 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.155 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.47 145.24 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.393 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLU . 15.7 mt-10 -43.86 -50.16 8.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.326 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -42.51 -32.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.366 -0.834 . . . . 0.0 109.992 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.76 -47.0 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.8 mt -59.69 -38.7 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 0.0 109.785 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -48.97 -48.79 42.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -51.24 -46.84 62.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 118' ' ' LEU . 10.5 mt -53.48 -52.92 58.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 110.884 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 31.9 tpp -66.67 -52.35 45.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 0.0 110.167 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -60.7 2.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.45 -0.781 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.24 -37.67 67.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 0.0 110.666 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.544 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.68 -55.4 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 110.557 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -46.74 91.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.593 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -80.81 -38.73 27.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.106 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -95.8 12.5 29.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.873 . . . . 0.0 110.082 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.4 m120 53.49 87.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 110.55 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 148' ' ' ARG . 6.8 p-10 -143.97 13.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 109.628 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 56.86 20.78 34.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HG3' ' C ' ' A' ' 147' ' ' GLY . 30.7 mtt-85 -149.77 133.83 17.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.995 -1.297 . . . . 0.0 110.607 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.544 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.9 mt -84.29 132.85 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.812 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 24.4 p-10 -112.55 -170.01 1.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.458 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.626 ' CE1' ' CD2' ' A' ' 102' ' ' PHE . 3.3 m-85 -59.38 -56.58 20.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.411 ' HA ' HD12 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -52.33 -59.17 4.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.225 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 157' ' ' MET . 54.2 mt-10 -57.39 -46.79 83.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.539 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 84.5 t80 -47.86 -32.24 5.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 110.233 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.532 ' O ' ' CE ' ' A' ' 158' ' ' MET . 27.7 mt -75.68 -50.64 14.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -49.42 74.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.184 -0.948 . . . . 0.0 110.954 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.77 -47.61 8.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 111.245 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 155' ' ' LEU . 6.2 ptp -39.06 -29.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 0.0 110.616 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 157' ' ' MET . 9.6 mm-40 -51.46 146.16 7.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.96 . . . . 0.0 110.004 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.34 14.1 56.28 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.8 t -113.72 115.3 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -1.134 . . . . 0.0 110.235 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.204 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.204 0.526 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.46 -162.86 0.61 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.089 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -98.29 46.81 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.937 . . . . 0.0 110.12 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -71.86 -49.79 35.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 141.74 -121.59 1.86 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 97' ' ' GLU . 2.2 tppt? -142.8 165.6 26.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.99 169.31 9.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -0.862 . . . . 0.0 110.035 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -42.43 -44.05 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.948 . . . . 0.0 110.203 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -50.92 71.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 110.483 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.461 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 2.8 tp10 -47.54 -46.92 28.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.866 . . . . 0.0 109.919 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 3.8 mm? -57.03 -48.54 78.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -49.08 -53.11 21.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.45 78.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.121 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -53.19 -19.2 2.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 44.3 t80 -50.5 -50.22 53.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 110.188 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -30.6 69.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.418 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 26.2 mm -56.89 -38.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -85.22 -11.85 53.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -91.24 106.6 18.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -9.29 33.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.338 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.488 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 66.4 m-80 -117.09 9.26 13.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.922 . . . . 0.0 110.312 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 44.02 43.49 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 10.8 m-20 -80.3 -22.43 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.36 -7.98 62.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 44.8 m-85 -151.81 125.06 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 149' ' ' ILE . 2.9 mp -83.31 112.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.955 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 15.2 p-10 -92.97 -173.24 3.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.3 tt -69.69 -41.9 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.867 . . . . 0.0 110.523 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -53.81 -55.39 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 24.0 mt-10 -45.4 -55.05 6.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.355 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.746 HD23 HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -48.77 -54.01 16.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.359 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -47.39 -77.06 0.12 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.9 pt-20 -42.67 -47.9 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.502 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 118' ' ' LEU . 8.0 mt -47.29 -55.43 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.011 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.746 HD12 HD23 ' A' ' 118' ' ' LEU . 2.4 mt -76.63 -54.86 6.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.211 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -49.06 -36.37 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.899 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -48.88 -39.66 26.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.052 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 69.9 p -66.76 -38.47 86.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.45 32.57 4.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 128' ' ' HIS . 8.6 mm-40 -97.02 7.08 47.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.319 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 127' ' ' GLU . 8.2 m80 43.58 72.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 122' ' ' LEU . 57.7 t -88.62 154.92 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.343 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 130' ' ' ILE . 17.6 pt -103.38 145.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 110.177 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.1 mt-10 -49.85 -41.05 44.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.377 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.1 tm-20 -41.69 -33.38 0.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 110.357 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -44.78 12.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 0.0 109.418 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.634 HG23 HD22 ' A' ' 118' ' ' LEU . 26.9 mt -65.59 -38.95 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.505 -0.747 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 13.2 mm-40 -56.64 -50.52 71.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.47 -0.769 . . . . 0.0 110.277 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.93 -55.02 10.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.935 . . . . 0.0 110.408 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.464 HD13 HD21 ' A' ' 118' ' ' LEU . 45.3 mt -48.96 -52.95 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.496 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.513 ' HG3' ' HB2' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -71.08 -50.01 38.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.88 . . . . 0.0 110.418 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 14.1 mttm -56.53 -39.7 73.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.424 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.43 -40.66 61.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.538 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -83.86 -52.19 6.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 110.653 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.513 ' HB2' ' HG3' ' A' ' 138' ' ' MET . 29.5 t0 -46.45 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.401 -0.812 . . . . 0.0 111.01 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 30.3 tttt -77.71 -23.93 49.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -99.35 -5.61 29.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.69 . . . . 0.0 109.636 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.469 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 1.5 m-20 59.84 24.86 13.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 20.6 p30 -85.17 2.58 43.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 75.94 38.73 35.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 14.7 mtm180 -159.14 133.45 7.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.498 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 141' ' ' SER . 2.0 mt -97.81 123.89 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -105.48 -173.91 2.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 54.1 p90 -57.25 -43.49 83.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 110.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.603 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -63.75 -51.4 65.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.018 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 53.5 mt-10 -65.16 -52.51 54.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.089 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 102' ' ' PHE . 5.9 t80 -46.72 -57.28 5.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' PHE . 71.3 mt -45.3 -63.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -60.69 -25.2 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 110.019 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.525 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -60.85 -38.03 84.13 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.262 -0.899 . . . . 0.0 109.148 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.525 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.2 OUTLIER -103.11 4.47 37.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 109.985 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -89.84 -33.45 16.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -0.852 . . . . 0.0 110.157 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -134.92 48.8 0.92 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.3 t -52.06 130.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -1.069 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.059 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.193 0.52 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 15.1 p30 -136.47 58.91 1.72 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.27 -0.894 . . . . 0.0 110.267 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 58.35 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.895 . . . . 0.0 110.221 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -168.56 1.65 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . -113.47 22.63 14.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.461 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 10.5 mttp 43.45 68.52 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.174 -1.192 . . . . 0.0 110.035 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -51.11 163.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.3 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 94' ' ' SER . 21.3 tt0 -42.9 -47.45 5.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 110.424 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.71 -41.58 74.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.285 -0.884 . . . . 0.0 110.692 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -52.25 -49.69 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.472 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.635 HD12 ' CE ' ' A' ' 158' ' ' MET . 21.3 mt -53.0 -43.06 66.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 110.274 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.31 -61.0 2.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -55.41 -49.72 71.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.498 ' SG ' ' CE2' ' A' ' 105' ' ' PHE . 42.5 t -59.93 -19.95 54.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.65 -57.47 11.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.054 -1.029 . . . . 0.0 110.177 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.79 -37.09 3.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 104' ' ' ILE . 2.0 mp -67.88 -53.06 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.498 ' CE2' ' SG ' ' A' ' 101' ' ' CYS . 11.9 m-85 -54.03 -31.21 50.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 110.028 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 18.7 t0 -87.2 91.52 8.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.906 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 -41.97 65.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.522 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 109' ' ' ALA . 32.8 m-80 -87.19 6.38 33.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 43.0 63.14 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -96.92 -11.79 24.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.301 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 90.78 -15.11 61.34 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 46.0 m-85 -147.35 125.02 11.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 110.074 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.84 131.13 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.95 -167.4 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.167 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.798 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -72.49 -41.02 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.932 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.506 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 1.6 tm-20 -57.03 -53.94 52.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.475 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 22.5 mt-10 -53.15 -38.2 62.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.33 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.461 HD11 HD22 ' A' ' 137' ' ' LEU . 0.9 OUTLIER -60.58 -51.35 69.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -50.1 -74.21 0.3 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.475 ' OE2' ' HA ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -42.47 -54.61 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -1.141 . . . . 0.0 110.671 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.441 HG13 ' CD ' ' A' ' 120' ' ' GLU . 17.1 mt -49.13 -53.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 122' ' ' LEU . 36.3 mt -69.1 -46.23 68.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.355 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -39.4 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.92 -44.05 29.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 126' ' ' GLY . 32.9 p -55.55 -64.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.455 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . 142.32 37.76 0.08 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.75 154.85 24.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -1.131 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.451 ' H ' ' CD2' ' A' ' 128' ' ' HIS . 23.3 p80 -90.01 63.5 5.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 110.645 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.2 t -82.49 135.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.976 . . . . 0.0 109.737 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.0 pt -102.78 145.07 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.508 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.2 mt-10 -42.74 -53.97 4.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.41 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -40.49 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.828 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -85.89 -51.24 6.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.77 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.0 mt -60.82 -41.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 109.699 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.798 ' HA ' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -50.03 -50.99 45.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.89 -36.85 84.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 118' ' ' LEU . 2.0 tt -50.35 -44.36 54.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.611 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 ttm -67.11 -42.43 84.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.172 -0.955 . . . . 0.0 110.507 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -64.19 -44.34 92.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -68.53 -36.81 79.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.187 -0.945 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.552 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.0 t -80.78 -49.8 10.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.505 ' HA ' ' OE2' ' A' ' 153' ' ' GLU . 38.5 t70 -60.55 90.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.63 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.47 49.12 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 73.5 m-80 -147.61 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.465 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.6 m-20 172.06 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.604 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 35.2 p-10 -41.54 -25.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 76.64 51.54 6.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 2.5 mtm180 -158.13 153.66 26.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 110.35 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.552 HG12 ' CB ' ' A' ' 141' ' ' SER . 22.1 mt -88.97 114.17 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.901 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 26.5 p30 -105.9 -172.48 2.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 22.3 p90 -57.62 -37.07 72.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 110.757 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.612 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -70.44 -52.78 19.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' HA ' ' A' ' 142' ' ' ASP . 48.5 mt-10 -68.45 -43.74 76.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.927 . . . . 0.0 110.259 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.537 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 37.4 t80 -49.23 -33.88 13.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.538 ' O ' ' CE ' ' A' ' 158' ' ' MET . 94.8 mt -76.1 -42.02 48.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -69.15 -49.01 60.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.053 -1.029 . . . . 0.0 110.673 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.537 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -44.43 -48.24 9.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.213 -0.93 . . . . 0.0 111.056 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.635 ' CE ' HD12 ' A' ' 98' ' ' LEU . 5.8 ptp -41.74 -27.33 0.1 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.186 -0.946 . . . . 0.0 110.217 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 157' ' ' MET . 0.8 OUTLIER -103.06 87.65 2.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 110.203 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 124.8 10.8 4.67 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.657 HG22 ' OE1' ' A' ' 162' ' ' GLN . 9.9 p -111.97 125.83 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.26 -1.141 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.657 ' OE1' HG22 ' A' ' 161' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.167 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.247 0.546 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.633 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER 65.37 148.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.862 . . . . 0.0 110.214 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 64.14 81.17 0.21 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 110.299 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.8 -161.32 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -0.883 . . . . 0.0 110.239 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.48 129.47 5.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.64 133.02 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -90.97 161.93 14.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -0.936 . . . . 0.0 110.355 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.861 ' HG2' HD22 ' A' ' 155' ' ' LEU . 7.6 tt0 -42.92 -52.61 5.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.361 -0.837 . . . . 0.0 110.271 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 1.6 mt-10 -49.33 -58.26 5.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.053 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -54.17 -55.74 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.292 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 12.7 mt -51.53 -47.1 63.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -41.82 -58.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 110.314 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -65.57 -26.96 68.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.912 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -74.89 -9.08 58.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -55.21 -47.62 75.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.019 -1.051 . . . . 0.0 110.013 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -60.43 -35.57 76.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 18.0 mm -59.67 -32.59 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.005 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 107' ' ' LYS . 3.0 m-85 -80.22 -59.0 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -58.32 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 109.932 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -53.39 -43.34 67.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.34 -0.85 . . . . 0.0 110.563 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -94.13 -159.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.35 60.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.57 -32.4 12.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.159 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.537 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 99.74 -3.73 57.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 36.2 m-85 -153.35 123.92 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 113' ' ' ILE . 3.8 mp -83.58 122.38 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.309 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -95.77 178.47 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.1 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.636 HD11 ' HG2' ' A' ' 135' ' ' GLU . 2.2 tt -57.3 -42.7 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.027 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -51.82 -53.81 36.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.897 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 4.1 mt-10 -52.17 -47.21 65.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.959 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.566 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -54.77 -27.63 42.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 0.0 109.837 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.45 -68.71 1.51 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.3 pt-20 -49.89 -44.51 49.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.237 . . . . 0.0 110.177 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.566 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 20.2 mt -49.28 -61.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' A' ' 129' ' ' VAL . 1.0 OUTLIER -68.74 -43.7 75.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.012 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -50.77 -39.47 52.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.18 -44.19 75.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.0 110.381 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 p -60.89 -31.62 71.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.15 -0.969 . . . . 0.0 110.161 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.86 20.24 29.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 128' ' ' HIS . 2.2 mt-10 -88.9 23.13 2.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -1.162 . . . . 0.0 110.225 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.583 ' C ' HG23 ' A' ' 129' ' ' VAL . 1.5 t60 56.94 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 122' ' ' LEU . 2.9 t 70.18 143.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.587 -0.696 . . . . 0.0 110.031 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.3 pt -123.18 146.85 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.137 -0.977 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.64 -46.32 14.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 110.121 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.03 -28.93 1.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.437 ' O ' HD12 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -92.7 -48.98 6.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 118' ' ' LEU . 22.6 mt -55.61 -39.29 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.074 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.636 ' HG2' HD11 ' A' ' 115' ' ' ILE . 7.0 mt-10 -58.28 -46.14 86.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -50.69 -52.11 43.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.6 OUTLIER -53.94 -43.27 69.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.089 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -71.08 -53.89 13.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.187 -0.946 . . . . 0.0 109.857 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -59.57 4.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -49.7 -40.51 40.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 110.202 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.554 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.2 t -77.12 -57.32 3.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER -61.15 75.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 110.551 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -79.66 4.12 17.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 179.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.452 ' O ' ' CG ' ' A' ' 144' ' ' ASN . 1.4 t30 -121.88 10.09 10.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.603 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.29 26.26 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -1.82 18.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.359 -0.838 . . . . 0.0 110.209 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.436 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 60.97 17.07 50.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.469 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 1.1 mtt-85 -158.34 143.39 16.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.33 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.554 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.7 mt -87.63 116.66 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.74 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 154' ' ' PHE . 53.4 p-10 -101.42 -175.41 2.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -54.52 38.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.09 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.13 -62.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 110.367 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 154' ' ' PHE . 68.1 mt-10 -57.21 -50.82 71.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.164 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 14.4 t80 -43.39 -56.18 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.869 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.861 HD22 ' HG2' ' A' ' 95' ' ' GLU . 96.0 mt -61.72 -51.34 68.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . 7.1 mmtt -53.69 -50.56 65.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.501 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -50.93 -46.13 60.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.501 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -105.61 43.91 1.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.616 -0.678 . . . . 0.0 110.099 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -112.82 159.72 18.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.229 -0.92 . . . . 0.0 110.218 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.94 56.51 6.41 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.69 138.87 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -1.186 . . . . 0.0 110.067 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.171 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.219 0.533 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.51 151.08 19.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.125 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 91' ' ' LYS . . . -65.62 -144.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 110.017 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 90' ' ' ALA . 8.4 mttt -43.98 118.37 1.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.053 -1.03 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 93' ' ' LYS . . . -63.26 152.11 47.48 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER 37.94 -156.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.642 -0.916 . . . . 0.0 110.776 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -177.01 176.62 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.431 -0.793 . . . . 0.0 110.01 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -54.19 -35.44 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 110.108 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -42.45 -71.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.241 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.98 -48.82 42.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.805 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.536 ' CD1' ' HB3' ' A' ' 158' ' ' MET . 2.2 mm? -51.38 -61.45 2.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.039 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.11 -51.93 16.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.922 . . . . 0.0 110.228 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 71.6 m-20 -51.23 -34.04 30.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 110.143 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.41 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 61.0 m -68.19 -15.09 63.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.215 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -56.24 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 100' ' ' ASN . 6.8 ptp180 -52.47 -37.67 57.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.289 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 13.0 mm -57.8 -45.76 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 110.261 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -53.95 34.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.21 146.52 54.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.509 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -125.49 -47.1 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.977 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 66.2 m-20 -79.04 2.76 19.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 56.45 59.35 3.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.174 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.7 -21.52 20.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.23 -15.99 60.62 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 40.5 m-85 -153.09 130.06 11.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 110.043 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.45 125.1 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.893 . . . . 0.0 110.626 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -104.27 -157.81 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.825 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.458 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -75.5 -37.39 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.133 -0.98 . . . . 0.0 109.976 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.458 ' N ' HG23 ' A' ' 115' ' ' ILE . 57.1 mt-10 -55.71 -44.4 77.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -63.78 -44.46 93.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.668 HD12 HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -56.76 -33.98 67.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -65.89 -74.21 0.54 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -42.12 -59.87 1.63 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.222 -1.163 . . . . 0.0 110.961 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 120' ' ' GLU . 4.2 mt -43.69 -50.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.001 -1.062 . . . . 0.0 109.974 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.845 HD13 HG11 ' A' ' 129' ' ' VAL . 11.1 mt -77.4 -42.45 36.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.398 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 44.6 mtt180 -55.68 -32.85 63.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.94 48.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.0 110.125 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.8 p -77.14 -157.66 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.92 58.12 0.69 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.06 164.48 26.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -1.137 . . . . 0.0 110.506 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.12 94.01 7.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.881 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.845 HG11 HD13 ' A' ' 122' ' ' LEU . 4.0 t -109.73 72.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.327 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 19.0 pt -62.57 159.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.2 tt0 -46.19 -49.5 16.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.503 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 2.4 mt-10 -40.99 -35.8 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.334 -0.854 . . . . 0.0 110.381 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.31 -47.46 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.661 ' CG1' HG12 ' A' ' 129' ' ' VAL . 17.6 mt -60.14 -41.03 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HG2' ' HG2' ' A' ' 131' ' ' GLU . 4.9 mm-40 -57.6 -36.79 72.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.513 -0.742 . . . . 0.0 110.051 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -51.25 -50.32 59.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.845 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.1 OUTLIER -56.68 -43.91 80.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.405 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -68.24 -43.84 77.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 110.043 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -64.9 -43.46 92.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.42 -33.21 69.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 0.0 110.327 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.523 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.9 OUTLIER -86.03 -61.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.935 . . . . 0.0 110.394 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 60.6 t0 -41.14 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.559 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 143' ' ' LYS . 76.4 tttt -99.18 2.5 45.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -134.41 16.85 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.662 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 8.9 m-20 48.01 51.53 14.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.443 -0.786 . . . . 0.0 110.341 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -104.61 4.57 32.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.88 11.18 60.22 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 6.0 mtp180 -147.56 146.43 29.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.142 -1.211 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.678 HG21 ' CE ' ' A' ' 157' ' ' MET . 4.7 mt -89.72 113.83 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.364 -0.835 . . . . 0.0 109.998 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.49 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 48.8 p30 -90.02 179.18 6.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.422 ' O ' ' HG ' ' A' ' 155' ' ' LEU . 16.8 m-85 -42.82 -59.19 2.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.349 -0.844 . . . . 0.0 110.28 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.94 -56.89 15.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.49 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 45.8 mt-10 -57.36 -46.9 82.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.901 ' HA ' ' HE3' ' A' ' 157' ' ' MET . 35.5 t80 -59.53 -56.36 22.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 151' ' ' PHE . 32.4 mt -45.74 -48.67 15.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 -57.92 6.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 0.0 110.081 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.901 ' HE3' ' HA ' ' A' ' 154' ' ' PHE . 1.3 ptp -47.45 -50.77 22.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.715 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.57 ' N ' ' CG ' ' A' ' 157' ' ' MET . 13.1 mmt -66.88 -32.19 73.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.424 -0.798 . . . . 0.0 110.352 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 160' ' ' GLY . 9.0 tt0 -86.99 157.66 19.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.045 -1.034 . . . . 0.0 110.085 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' GLU . . . 45.05 56.37 6.0 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 158' ' ' MET . 20.4 t -84.11 143.37 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -1.133 . . . . 0.0 110.245 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.246 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.193 0.521 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -93.78 -49.81 5.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.158 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.14 -168.97 3.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.094 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -124.01 52.19 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . -97.66 104.31 2.98 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER 44.23 -157.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -1.174 . . . . 0.0 110.049 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m 179.8 157.65 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.98 . . . . 0.0 110.444 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' HG2' HD21 ' A' ' 155' ' ' LEU . 1.3 tt0 -50.03 -49.26 51.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 110.071 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.12 -51.05 34.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 110.229 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -48.59 -60.14 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 110.342 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.556 HD12 HG13 ' A' ' 161' ' ' VAL . 28.5 mt -58.96 -58.54 8.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -42.47 -40.39 2.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.144 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 90.8 m-20 -62.34 -35.63 79.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 98' ' ' LEU . 71.8 m -67.57 -36.54 81.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 43.0 t80 -42.67 -56.34 3.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 110.22 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -44.53 61.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -62.82 -54.55 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.339 -0.851 . . . . 0.0 109.913 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -58.63 -43.2 89.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 109.934 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.456 ' OD1' ' OE1' ' A' ' 117' ' ' GLU . 14.0 t0 -85.19 109.02 18.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -122.08 -28.92 4.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.449 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 2.7 p-10 -97.15 -44.33 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -87.54 -42.24 12.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.887 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 7.6 m-20 47.93 23.96 0.55 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . -142.83 -36.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 76.7 m-85 -149.63 136.94 19.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -1.101 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.42 ' CD1' ' CD1' ' A' ' 154' ' ' PHE . 24.3 mt -82.56 131.5 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.101 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.48 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 28.4 p30 -119.11 -162.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -83.05 -42.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.577 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -52.49 -41.57 63.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' OE1' ' OD1' ' A' ' 106' ' ' ASP . 2.2 mt-10 -64.93 -37.93 89.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -65.82 -46.24 79.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.972 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -46.01 -75.66 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' GLY . 5.1 pt-20 -43.24 -47.76 6.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -1.125 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.94 -55.42 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 110.113 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.69 HD22 HG11 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -63.14 -43.16 99.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.986 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -38.92 64.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.274 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.81 -30.86 6.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -0.945 . . . . 0.0 110.265 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.2 p -73.85 -29.85 62.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.77 53.84 1.88 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.7 mm-40 -129.71 148.47 51.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -1.13 . . . . 0.0 110.214 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.502 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 23.2 p80 -71.3 58.34 0.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.13 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 122' ' ' LEU . 4.5 t -75.9 151.81 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 110.274 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.0 pt -139.61 155.94 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.885 . . . . 0.0 110.138 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.474 ' CA ' ' OE1' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -48.03 -47.88 33.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 3.6 mm-40 -42.11 -38.22 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -48.84 7.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 10.6 mt -61.46 -43.27 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -0.865 . . . . 0.0 109.748 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.623 ' HG2' HD11 ' A' ' 115' ' ' ILE . 3.5 mm-40 -53.11 -49.06 67.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 135' ' ' GLU . 12.5 t0 -43.75 -53.86 5.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.825 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.2 OUTLIER -50.66 -57.67 7.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.48 ' HE1' ' HA ' ' A' ' 114' ' ' ASP . 1.4 ttm -58.05 -34.86 70.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.178 -0.952 . . . . 0.0 109.583 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -70.56 -51.51 28.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.194 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -67.97 -40.36 83.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.372 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -57.69 -46.76 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 141' ' ' SER . 0.4 OUTLIER -44.36 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.235 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.6 OUTLIER -93.59 2.69 56.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.145 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.441 ' HB2' ' CG ' ' A' ' 146' ' ' ASP . 4.2 m-80 -141.32 21.45 2.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.69 24.44 10.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 144' ' ' ASN . 42.3 m-20 -69.95 -11.79 61.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 0.0 110.192 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.456 ' C ' ' HG3' ' A' ' 148' ' ' ARG . . . 79.6 -6.47 57.99 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.456 ' HG3' ' C ' ' A' ' 147' ' ' GLY . 45.3 mtt180 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 141' ' ' SER . 20.3 mt -85.27 126.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.0 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.462 ' N ' ' OE1' ' A' ' 153' ' ' GLU . 13.0 p-10 -109.01 -163.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CZ ' HD11 ' A' ' 155' ' ' LEU . 56.2 t80 -57.81 -57.66 11.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 110.5 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -62.95 1.31 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.549 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' A' ' 150' ' ' ASP . 4.0 mt-10 -57.29 -43.93 83.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.458 ' O ' ' HG2' ' A' ' 157' ' ' MET . 82.6 t80 -48.41 -50.58 30.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.059 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 95' ' ' GLU . 11.6 mt -57.25 -54.15 50.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.337 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -60.33 -40.1 89.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.304 -0.873 . . . . 0.0 110.735 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG2' ' SD ' ' A' ' 158' ' ' MET . 0.6 OUTLIER -49.98 -40.46 44.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 109.647 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.801 ' CB ' HG21 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -64.21 -6.95 7.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.558 -0.714 . . . . 0.0 110.543 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 158' ' ' MET . 1.2 mt-10 59.28 139.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.357 -0.839 . . . . 0.0 110.428 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.41 25.07 69.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.801 HG21 ' CB ' ' A' ' 158' ' ' MET . 42.5 t -106.88 155.06 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -1.102 . . . . 0.0 110.268 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.28 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.303 0.573 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 90' ' ' ALA . 12.3 m-20 53.95 -166.2 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -0.953 . . . . 0.0 110.081 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 89' ' ' ASP . . . 44.3 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.241 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -43.05 123.61 2.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.293 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 142.63 145.62 4.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 17.4 pttm -166.66 157.76 12.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -1.123 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.9 175.14 6.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.268 -0.895 . . . . 0.0 110.37 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.03 -54.18 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.341 -0.85 . . . . 0.0 110.2 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.83 -65.82 0.46 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 110.147 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 93' ' ' LYS . 19.3 mm-40 -52.23 -45.24 65.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.466 ' HG ' ' HE2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -46.73 -61.78 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.277 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -41.55 -57.95 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -70.13 -53.78 15.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.1 m -47.99 -22.28 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.521 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 151' ' ' PHE . 59.2 t80 -51.7 -51.93 52.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -26.69 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.316 -0.865 . . . . 0.0 110.648 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 37.1 mm -68.13 -58.73 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.037 . . . . 0.0 110.332 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -51.31 -34.16 32.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 13.8 t0 -73.39 89.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.269 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -83.25 -20.38 34.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.683 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 7.9 p30 -114.47 -1.29 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 66.73 69.77 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.327 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 4.3 p30 -108.72 -22.13 12.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.183 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.551 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 91.35 -3.64 79.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 6.9 m-85 -152.72 129.23 10.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 113' ' ' ILE . 3.4 mp -82.9 114.53 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.984 . . . . 0.0 109.8 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 116' ' ' GLU . 3.1 p30 -88.1 -176.16 5.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.582 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.9 tp -65.47 -40.78 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 110.09 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.543 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -54.71 -52.49 62.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 110.27 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 52.2 mt-10 -51.91 -44.58 63.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.327 -0.858 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.727 HD12 HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -53.11 -52.47 58.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.109 -0.994 . . . . 0.0 110.27 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.538 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -58.99 -66.69 2.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.8 pt-20 -48.06 -45.69 32.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 110.457 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.542 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 12.2 mt -52.97 -60.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.008 . . . . 0.0 109.973 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.651 HD13 HG11 ' A' ' 129' ' ' VAL . 16.8 mt -63.98 -38.67 91.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -64.4 -41.94 96.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.413 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.22 69.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 121' ' ' ILE . 24.9 p -55.95 -19.75 13.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.325 -0.859 . . . . 0.0 110.301 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.21 30.42 7.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -119.9 167.46 12.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -1.16 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 128' ' ' HIS . 51.7 p-80 -113.03 75.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 110.301 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.651 HG11 HD13 ' A' ' 122' ' ' LEU . 5.6 t -83.06 133.1 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.84 HD12 ' HB2' ' A' ' 132' ' ' GLU . 17.8 pt -85.42 152.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 2.3 mm-40 -52.53 -38.51 59.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.277 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.84 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.25 -38.04 0.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.377 -0.827 . . . . 0.0 110.686 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -45.66 9.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.123 -0.986 . . . . 0.0 109.636 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.727 HG23 HD12 ' A' ' 118' ' ' LEU . 40.1 mt -57.68 -38.36 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.798 . . . . 0.0 109.734 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 2.9 mt-10 -68.34 -36.33 79.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -58.51 -48.76 79.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.162 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 118' ' ' LEU . 97.2 mt -49.15 -44.38 42.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 0.0 110.199 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.629 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -68.94 -48.64 62.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.063 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -55.32 -35.5 65.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.29 -27.4 59.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.324 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.558 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -106.37 -60.75 1.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.861 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 138' ' ' MET . 14.7 t0 -38.24 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.77 . . . . 0.0 110.79 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.0 OUTLIER -86.57 -40.53 15.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.633 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.475 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 13.9 m-80 -92.19 17.7 9.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 49.49 25.46 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 11.1 p-10 -78.66 2.8 18.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.132 -0.98 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.92 30.98 79.43 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.1 129.75 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.192 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.629 HD12 ' CE ' ' A' ' 138' ' ' MET . 1.2 mt -83.39 129.33 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.899 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 1.5 p-10 -100.45 -163.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.013 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.456 ' CE1' ' CZ ' ' A' ' 102' ' ' PHE . 73.9 m-85 -69.22 -51.1 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -50.12 70.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 110.632 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.54 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 72.9 mt-10 -56.92 -44.75 82.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.989 . . . . 0.0 110.533 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -52.97 -66.09 0.45 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.971 -1.081 . . . . 0.0 109.984 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.1 mt -43.87 -32.48 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.955 . . . . 0.0 109.626 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -28.98 55.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.415 -0.803 . . . . 0.0 109.928 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.548 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -61.85 -37.59 85.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.548 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.0 OUTLIER -109.01 43.35 1.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 109.779 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -104.23 -38.27 6.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 110.547 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.34 17.01 29.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.95 144.27 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -1.141 . . . . 0.0 110.188 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.241 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 88' ' ' GLU . 2.0 mp0 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.235 0.541 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' GLU . 2.3 p30 -55.59 -164.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.87 . . . . 0.0 110.092 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.29 117.65 26.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.02 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.32 -34.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.258 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.35 104.12 2.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 45.99 83.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -1.139 . . . . 0.0 110.43 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.52 ' N ' ' HB2' ' A' ' 97' ' ' GLU . 0.3 OUTLIER -63.08 162.53 11.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.995 . . . . 0.0 109.974 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' O ' HD21 ' A' ' 155' ' ' LEU . 8.7 mt-10 -46.32 -52.44 12.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 110.161 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -68.44 -42.05 79.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 109.751 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.52 ' HB2' ' N ' ' A' ' 94' ' ' SER . 58.9 mm-40 -58.32 -36.03 72.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.708 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.868 ' CD2' HD23 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -84.52 -45.7 12.34 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.361 -0.837 . . . . 0.0 109.265 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 151' ' ' PHE . . . -47.43 -34.61 7.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.093 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.61 -40.28 19.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.863 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.51 ' HG ' ' HE1' ' A' ' 105' ' ' PHE . 0.7 OUTLIER -54.21 -21.4 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.993 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.45 -64.71 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.988 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -51.06 -39.2 55.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.77 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.6 mp -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.289 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.797 ' HB3' HD13 ' A' ' 113' ' ' ILE . 4.7 m-85 -60.31 -52.06 66.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 109.546 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -67.61 87.53 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -88.79 -34.04 17.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.357 -0.839 . . . . 0.0 110.804 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 17.3 p30 -81.2 4.48 20.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.059 -1.026 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 84.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.456 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 2.3 p30 -128.1 -34.16 2.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.452 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 118.3 -24.47 8.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.501 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 67.3 m-85 -148.93 126.72 11.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -1.135 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.797 HD13 ' HB3' ' A' ' 105' ' ' PHE . 42.5 mt -83.58 126.96 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -105.05 -178.29 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.355 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 2.8 tp -56.09 -39.99 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.0 mm-40 -56.97 -58.12 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.599 ' OE1' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -46.31 -34.98 4.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.201 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.628 HD13 HG23 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -70.59 -155.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 68.65 -80.72 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -51.04 -55.02 19.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.12 . . . . 0.0 110.428 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.431 ' C ' ' O ' ' A' ' 120' ' ' GLU . 10.4 mt -42.09 -44.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 110.43 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 122' ' ' LEU . 45.8 mt -72.28 -49.71 32.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -48.69 -35.78 14.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -0.889 . . . . 0.0 110.538 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.08 -42.29 60.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 32.1 p -68.03 -7.35 28.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.319 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 81.09 41.67 10.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -121.69 140.78 51.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.479 ' H ' ' CD2' ' A' ' 128' ' ' HIS . 23.0 p80 -82.16 111.78 18.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.6 t -126.12 156.18 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 12.9 pt -130.39 158.07 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.428 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 2.7 mt-10 -47.92 -49.77 29.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -42.65 -36.98 1.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.89 -48.07 8.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.29 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.628 HG23 HD13 ' A' ' 118' ' ' LEU . 22.9 mt -54.23 -36.45 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.482 -0.762 . . . . 0.0 109.694 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.497 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 51.8 mt-10 -60.89 -47.15 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.14 -39.52 56.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.0 mp -61.74 -46.77 88.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 110.21 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.486 ' CE ' HD12 ' A' ' 149' ' ' ILE . 30.4 tpp -65.05 -48.21 74.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.88 85.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.943 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.89 -33.17 73.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.114 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.483 ' CB ' HG12 ' A' ' 149' ' ' ILE . 6.9 t -84.1 -56.02 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 15.0 m-20 -42.32 103.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 110.57 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.74 -16.49 55.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.706 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 2.1 p30 -124.82 14.84 8.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.872 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.17 73.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 147' ' ' GLY . 10.0 p-10 -128.28 22.58 6.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -0.834 . . . . 0.0 109.805 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.434 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 43.17 36.6 2.9 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -157.9 120.84 3.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -1.166 . . . . 0.0 110.474 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.486 HD12 ' CE ' ' A' ' 138' ' ' MET . 7.1 mt -83.69 120.79 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.474 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 6.7 p-10 -90.06 -152.02 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.426 ' CZ ' ' HB1' ' A' ' 99' ' ' ALA . 49.5 t80 -82.08 -39.51 23.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.329 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.18 -56.69 4.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 0.0 110.691 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.474 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 29.8 mt-10 -46.75 -36.07 6.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.495 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.454 ' O ' ' HG2' ' A' ' 157' ' ' MET . 32.6 t80 -56.2 -56.42 21.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.868 HD23 ' CD2' ' A' ' 98' ' ' LEU . 2.6 mt -52.42 -54.07 36.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.401 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.34 -38.44 58.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -0.917 . . . . 0.0 110.475 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.512 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.2 ptm -65.88 -49.0 69.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.512 ' N ' ' CG ' ' A' ' 157' ' ' MET . 3.9 mtt -95.62 37.06 1.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.284 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -95.73 -34.16 12.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 109.759 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.13 38.56 2.28 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 12.5 p -57.75 152.57 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -1.109 . . . . 0.0 110.595 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.229 0.538 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -96.92 42.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 110.189 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.42 110.56 1.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 110.294 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.28 17.36 2.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 110.237 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.64 -142.08 15.41 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -72.65 82.94 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -1.135 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.71 162.75 27.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.151 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -51.55 -50.4 60.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.913 . . . . 0.0 110.264 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -47.95 -46.57 32.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.127 -0.983 . . . . 0.0 110.125 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.4 tp10 -58.91 -55.69 31.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 0.4 OUTLIER -61.85 -56.7 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -45.24 -39.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.685 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -54.46 -46.31 73.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.884 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 98' ' ' LEU . 1.1 m -52.28 -41.01 62.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.326 -0.859 . . . . 0.0 109.88 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' CYS . 14.9 t80 -43.83 -51.73 7.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.758 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -60.66 -36.27 78.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.811 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.6 -43.58 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.832 ' CD2' HD13 ' A' ' 121' ' ' ILE . 1.3 m-85 -71.96 -40.06 68.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.873 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -79.19 88.38 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.85 68.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.37 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -70.47 -11.44 60.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 110.425 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.19 51.09 16.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.11 -27.19 22.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.48 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 128.53 -20.3 5.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 98.4 m-85 -151.21 134.15 15.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -1.178 . . . . 0.0 110.28 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.7 mt -82.75 149.46 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 -164.03 0.89 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.5 tt -77.38 -38.68 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.186 -0.946 . . . . 0.0 110.463 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 95.5 mt-10 -60.76 -61.43 2.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.72 ' O ' HD12 ' A' ' 121' ' ' ILE . 20.9 mt-10 -42.55 -38.97 2.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 110.409 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.824 ' HB3' HG23 ' A' ' 134' ' ' ILE . 3.5 tp -60.05 -31.12 69.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 123' ' ' ARG . . . -73.03 -72.17 1.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.867 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 12.7 pt-20 -42.49 -43.49 3.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.184 -1.186 . . . . 0.0 110.509 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.832 HD13 ' CD2' ' A' ' 105' ' ' PHE . 27.5 mt -57.93 -50.46 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.852 ' HB3' HG21 ' A' ' 129' ' ' VAL . 20.4 mt -67.74 -69.89 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.873 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 119' ' ' GLY . 2.4 ptm180 -49.88 -24.09 2.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.921 . . . . 0.0 110.651 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.54 -44.19 72.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 110.008 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.789 HG23 ' HG3' ' A' ' 127' ' ' GLU . 1.8 t -80.91 9.34 6.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.468 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.2 17.7 58.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.789 ' HG3' HG23 ' A' ' 125' ' ' THR . 46.6 mt-10 -84.05 121.2 27.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -1.136 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 87.24 2.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.873 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.852 HG21 ' HB3' ' A' ' 122' ' ' LEU . 3.4 t -109.61 146.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' GLU . 31.7 pt -119.55 159.7 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.145 -0.972 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' ILE . 4.8 tt0 -41.43 -49.86 3.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.36 -28.91 13.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 0.0 110.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -43.38 11.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.824 HG23 ' HB3' ' A' ' 118' ' ' LEU . 30.0 mt -67.92 -38.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.07 -36.87 82.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.39 -0.819 . . . . 0.0 110.421 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.83 -52.4 65.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 0.0 110.681 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.635 ' HB3' HD21 ' A' ' 118' ' ' LEU . 1.4 mp -49.86 -44.27 49.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.308 -0.87 . . . . 0.0 110.899 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.485 ' O ' ' N ' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -64.83 -48.04 75.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.056 -1.028 . . . . 0.0 110.053 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -60.1 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 110.62 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.47 -33.21 67.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.547 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -85.7 -62.47 1.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.146 -0.971 . . . . 0.0 110.717 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 138' ' ' MET . 0.5 OUTLIER -47.4 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.621 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 ttpp -89.4 -3.81 58.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.814 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -120.69 12.03 11.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 51.23 39.26 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.417 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -101.37 23.06 11.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 44.98 35.58 4.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 19.4 mtt180 -158.35 128.32 5.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -1.21 . . . . 0.0 110.458 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.547 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.5 mt -84.21 167.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.091 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 48.2 p30 -149.13 -163.68 1.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -56.07 16.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.403 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -56.74 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.656 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 141' ' ' SER . 84.8 mt-10 -59.53 -44.53 93.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 110.515 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 21.6 t80 -54.62 -52.0 63.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.095 -1.003 . . . . 0.0 110.132 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 159' ' ' GLU . 27.4 mt -57.34 -42.16 81.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -54.2 -60.29 3.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.6 OUTLIER -48.26 -52.81 19.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.025 -1.047 . . . . 0.0 109.551 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -104.72 52.97 0.74 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.411 -0.806 . . . . 0.0 110.227 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 4.5 tp10 -92.34 -53.82 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -103.09 32.99 6.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.81 149.22 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -1.167 . . . . 0.0 110.121 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.263 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.284 0.564 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.29 -49.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -104.72 152.15 22.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -68.08 111.83 4.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.087 -1.008 . . . . 0.0 110.298 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.63 -139.85 5.26 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -173.74 31.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.243 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -46.63 167.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.141 -0.974 . . . . 0.0 110.121 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.546 ' HA ' HD22 ' A' ' 155' ' ' LEU . 0.4 OUTLIER -42.62 -45.19 4.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.895 . . . . 0.0 110.326 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -49.25 -54.31 17.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 110.224 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 93' ' ' LYS . 4.8 mm-40 -52.94 -58.56 6.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 0.0 110.58 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD11 ' SD ' ' A' ' 158' ' ' MET . 20.2 mt -50.97 -60.75 2.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.289 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.68 -50.74 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -55.15 -50.5 69.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.948 . . . . 0.0 110.246 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.92 -9.61 31.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.367 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 83.3 t80 -50.96 -61.69 2.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.57 ' CG ' HD12 ' A' ' 104' ' ' ILE . 12.3 ptp180 -57.12 -36.04 70.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 110.458 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.57 HD12 ' CG ' ' A' ' 103' ' ' ARG . 1.0 OUTLIER -58.72 -34.06 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.665 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 107' ' ' LYS . 4.9 m-85 -83.65 -35.48 24.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.87 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 48.1 t0 -67.78 59.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -46.6 -41.03 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 110' ' ' ASP . 46.8 t30 -69.51 -13.62 62.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.159 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 45.49 54.98 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.857 . . . . 0.0 110.231 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.473 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 23.5 p-10 -108.65 -3.23 18.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.2 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.509 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 101.49 -19.4 50.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 95.8 m-85 -153.17 123.69 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -1.2 . . . . 0.0 110.434 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.87 132.28 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 110.304 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.71 -179.6 4.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.081 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.7 tt -59.94 -36.82 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.195 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -50.94 -52.69 39.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.442 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 15.3 mt-10 -57.66 -54.74 43.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -0.809 . . . . 0.0 110.311 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.561 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.1 mp -43.15 -39.78 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.515 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -59.75 -80.31 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.482 ' OE2' HG13 ' A' ' 121' ' ' ILE . 0.7 OUTLIER -48.3 -50.7 29.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -1.19 . . . . 0.0 110.297 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 125' ' ' THR . 10.3 mt -44.93 -55.07 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 110.137 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.1 mt -68.37 -62.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.51 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -48.76 -39.97 27.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.84 -52.27 57.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.927 . . . . 0.0 110.212 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 121' ' ' ILE . 31.1 p -54.75 -32.44 59.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.59 -1.36 23.39 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . 23.4 mm-40 -58.66 -17.02 18.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -1.164 . . . . 0.0 110.056 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.7 OUTLIER 46.38 57.21 5.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 127' ' ' GLU . 14.8 t -89.56 153.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 132' ' ' GLU . 19.6 pt -98.06 154.85 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 110.2 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 132' ' ' GLU . 68.9 mt-10 -49.44 -51.41 35.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.539 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -41.81 -34.27 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.635 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -48.16 9.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.44 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 18.1 mt -55.52 -40.03 56.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.077 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -58.03 -53.89 53.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.626 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -45.03 37.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.962 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -37.19 67.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.106 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 19.1 tpp -69.95 -44.76 68.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.394 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -51.27 62.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.396 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -55.34 -31.27 61.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.543 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -87.9 -51.2 5.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.374 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.7 OUTLIER -42.56 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.8 OUTLIER -76.2 -1.51 26.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.963 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.505 ' ND2' ' OD2' ' A' ' 146' ' ' ASP . 1.5 p30 -153.8 27.48 0.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 43.78 75.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 110.501 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.505 ' OD2' ' ND2' ' A' ' 144' ' ' ASN . 3.8 p30 -121.28 -0.29 9.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 70.88 24.16 77.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 5.4 mtt-85 -158.67 135.43 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.449 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 141' ' ' SER . 16.6 mt -91.06 136.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.478 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 26.7 p-10 -112.44 -173.03 2.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.922 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 42.2 p90 -68.07 -28.41 67.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 110.392 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.428 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -78.14 -42.21 32.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.639 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.513 ' OE1' ' HA ' ' A' ' 149' ' ' ILE . 89.4 mt-10 -69.71 -37.15 76.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -0.986 . . . . 0.0 110.513 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.462 ' O ' ' HG2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.04 -33.29 51.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.964 . . . . 0.0 110.351 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 95' ' ' GLU . 81.8 mt -70.61 -62.56 1.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.509 ' HA ' ' HG2' ' A' ' 159' ' ' GLU . 21.4 mttm -53.4 -34.92 59.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.907 . . . . 0.0 110.566 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.536 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -53.79 -49.72 67.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.229 -0.919 . . . . 0.0 110.571 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.593 ' SD ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -99.37 -9.95 22.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.913 . . . . 0.0 110.447 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.509 ' HG2' ' HA ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -43.09 129.58 4.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 0.0 110.318 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 159' ' ' GLU . . . 43.28 63.84 1.96 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.0 p -82.96 150.97 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -1.125 . . . . 0.0 110.305 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.097 179.95 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.202 0.525 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.727 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -157.49 137.31 12.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.491 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 69.95 162.88 0.24 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.877 . . . . 0.0 110.75 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.74 133.53 47.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.227 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . -99.72 159.37 19.68 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HG2' ' OE2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 44.08 81.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -1.141 . . . . 0.0 110.25 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 93' ' ' LYS . 6.5 m -43.46 146.06 0.54 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.167 -0.958 . . . . 0.0 110.023 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.66 ' OE1' HD22 ' A' ' 155' ' ' LEU . 58.1 mm-40 -40.86 -40.35 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 110.456 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' GLU . 30.0 mm-40 -42.01 -40.45 2.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 110.385 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.474 ' OE2' ' HG2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -60.46 -56.86 16.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 4.3 mm? -59.69 -51.44 69.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.34 -44.24 3.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -51.78 -47.16 64.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.106 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.81 -31.79 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CZ ' HD12 ' A' ' 113' ' ' ILE . 18.1 t80 -51.45 -42.07 61.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.933 . . . . 0.0 110.086 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -41.04 99.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.263 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 104' ' ' ILE . 30.6 mm -59.0 -49.09 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 110.076 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -57.49 -35.48 70.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.756 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.91 113.14 25.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.661 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -109.12 6.33 24.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.408 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 2.5 p30 -131.41 22.61 4.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.435 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 108' ' ' ASN . . . 50.3 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.78 -37.39 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.434 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 92.21 -7.29 78.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 53.2 m-85 -153.13 125.62 8.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -1.152 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 2.7 mp -83.7 125.49 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -104.91 -176.04 2.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.052 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -63.46 -37.77 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.854 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.405 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 9.2 mm-40 -59.0 -56.3 23.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 109.982 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 15.9 mt-10 -45.5 -54.06 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.734 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.2 tp -51.19 -27.94 10.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.32 -75.64 0.35 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.2 pt-20 -45.52 -44.39 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -1.183 . . . . 0.0 110.571 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.546 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 48.5 mt -48.43 -70.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.496 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.833 ' O ' HG22 ' A' ' 125' ' ' THR . 97.6 mt -48.76 -49.89 36.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 110.577 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -52.89 -38.41 61.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.977 . . . . 0.0 110.537 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -48.05 -59.97 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 110.528 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.833 HG22 ' O ' ' A' ' 122' ' ' LEU . 7.4 t -59.38 -26.06 64.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.396 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.02 37.54 5.98 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -86.79 -10.43 53.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -1.218 . . . . 0.0 110.029 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.71 82.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.11 166.14 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 132' ' ' GLU . 4.7 pt -117.13 146.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.102 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.474 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 2.9 pt-20 -39.57 -42.92 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 0.0 110.858 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.481 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -43.4 -40.08 3.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 110.328 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.44 -44.44 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 118' ' ' LEU . 66.8 mt -56.75 -35.72 46.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.674 0.75 . . . . 0.0 109.509 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.835 ' HA ' HD11 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -68.6 -39.58 80.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.692 -0.63 . . . . 0.0 110.239 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.29 -50.29 72.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.451 ' HB3' HD21 ' A' ' 118' ' ' LEU . 1.3 mm? -45.63 -50.73 13.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.021 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.552 ' CE ' HD12 ' A' ' 149' ' ' ILE . 3.3 ttm -67.22 -46.6 73.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.923 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.31 -53.55 6.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.6 -49.98 73.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.551 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.1 t -69.72 -64.47 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.457 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.491 ' HB2' ' HG3' ' A' ' 138' ' ' MET . 30.5 t0 -43.19 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 141' ' ' SER . 3.3 tptm -96.9 -13.64 22.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -101.42 16.36 25.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 52.43 18.81 1.01 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 16.9 p30 -80.94 -0.18 38.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . 62.18 28.27 70.44 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 9.9 mtt180 -152.58 135.12 15.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.158 -1.201 . . . . 0.0 110.373 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.552 HD12 ' CE ' ' A' ' 138' ' ' MET . 5.9 mt -83.65 116.3 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 0.0 109.86 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -97.77 -170.36 1.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -52.99 -58.78 5.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.366 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.06 -64.94 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.955 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.473 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 44.9 mt-10 -50.65 -51.98 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.472 ' O ' ' HG2' ' A' ' 157' ' ' MET . 42.0 t80 -50.53 -56.74 10.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.66 HD22 ' OE1' ' A' ' 95' ' ' GLU . 46.9 mt -42.52 -51.31 5.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.345 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -62.2 -46.98 86.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 110.745 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.518 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.5 ptm -43.27 -46.5 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 109.85 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.518 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.8 OUTLIER -92.93 47.89 1.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 110.195 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -98.35 118.63 35.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.69 11.27 80.59 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.49 155.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -1.181 . . . . 0.0 110.117 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.229 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 89' ' ' ASP . 1.9 m-20 -89.65 55.85 3.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.42 -136.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 110.061 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.95 -17.56 27.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 0.0 110.361 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.98 70.64 1.28 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HG3' ' CD ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -64.42 126.06 26.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -1.173 . . . . 0.0 110.36 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.66 172.87 6.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.95 . . . . 0.0 110.21 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -49.51 -48.96 47.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 110.138 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -43.72 -49.38 7.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.955 . . . . 0.0 109.894 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.417 ' CD ' ' HG3' ' A' ' 93' ' ' LYS . 0.8 OUTLIER -54.65 -54.59 39.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.944 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 3.5 mm? -50.52 -49.38 55.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.881 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -53.55 -57.02 12.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 110.258 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -48.57 -50.16 33.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.82 -20.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 56.6 t80 -53.85 -51.24 64.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.486 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -29.19 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.163 -0.961 . . . . 0.0 110.489 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.5 -27.92 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.121 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.475 ' HD1' HD13 ' A' ' 121' ' ' ILE . 2.5 m-85 -84.9 -55.73 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 110.336 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -50.82 131.62 26.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -0.817 . . . . 0.0 110.259 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -123.03 2.22 9.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 109' ' ' ALA . 73.5 m-20 -125.02 26.41 7.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.356 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.93 49.44 5.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -93.32 -31.75 14.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.382 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.473 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 96.41 -14.51 64.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.473 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 27.2 m-85 -147.7 131.7 17.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 mt -82.95 116.05 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 110.631 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 3.8 p-10 -100.87 175.9 5.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.808 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.2 tp -53.48 -41.56 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.56 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -51.48 -54.96 21.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 31.8 mt-10 -56.8 -56.23 24.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -44.1 -38.62 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.506 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -59.74 -78.29 0.15 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -51.21 -45.99 62.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 110.259 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.55 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 14.9 mt -42.55 -61.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 110.38 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.855 HD22 HG21 ' A' ' 129' ' ' VAL . 4.2 mt -59.34 -56.87 16.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.433 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -48.67 -34.58 12.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.085 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -51.93 -40.83 61.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.7 p -66.59 -17.42 64.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 0.0 109.989 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.38 20.34 13.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.49 154.29 19.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -1.141 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -107.37 70.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 0.0 109.661 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.855 HG21 HD22 ' A' ' 122' ' ' LEU . 15.6 t -79.27 123.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.522 -0.736 . . . . 0.0 110.703 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 132' ' ' GLU . 47.3 pt -75.33 159.71 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.28 -32.22 68.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.987 . . . . 0.0 110.556 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.506 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -48.75 -35.59 14.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 110.497 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.02 -51.2 6.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.652 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 118' ' ' LEU . 7.3 mt -55.76 -43.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.508 -0.745 . . . . 0.0 109.472 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HG2' HD11 ' A' ' 115' ' ' ILE . 2.9 mm-40 -62.05 -38.75 89.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.656 -0.652 . . . . 0.0 109.955 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.13 -51.88 66.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 110.208 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.2 mt -50.75 -42.09 57.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 42.9 tpp -66.96 -49.07 66.6 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -59.09 -41.98 89.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.946 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -25.73 68.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.571 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -97.54 -33.58 11.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 110.234 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.2 t0 -59.43 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 109.931 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -76.25 0.58 18.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.328 -0.858 . . . . 0.0 110.994 -179.338 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.429 HD22 ' HB3' ' A' ' 146' ' ' ASP . 7.4 p-10 -151.71 20.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.919 -1.113 . . . . 0.0 110.533 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.35 71.21 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.662 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.429 ' HB3' HD22 ' A' ' 144' ' ' ASN . 7.6 p-10 -126.95 12.08 7.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.749 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 45.4 30.65 3.08 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' CD ' ' HB2' ' A' ' 112' ' ' PHE . 3.7 mtt180 -158.69 131.12 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 110.701 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.571 HG12 ' CB ' ' A' ' 141' ' ' SER . 8.0 mt -88.89 133.42 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.73 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 2.8 p30 -113.54 -164.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.436 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.6 -57.67 9.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.88 -57.7 11.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.619 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.447 ' HG2' ' HB2' ' A' ' 143' ' ' LYS . 73.2 mt-10 -54.25 -50.16 67.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.463 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 155' ' ' LEU . 64.2 t80 -49.68 -59.0 4.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.027 -1.045 . . . . 0.0 110.237 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 154' ' ' PHE . 9.8 mt -41.79 -66.06 0.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -34.16 14.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.62 -37.97 73.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 109.854 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.513 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.4 OUTLIER -112.21 27.05 9.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 110.63 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.781 ' O ' HG23 ' A' ' 161' ' ' VAL . 1.6 mt-10 -90.45 -172.82 3.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 0.0 110.007 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.07 40.46 82.92 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 159' ' ' GLU . 19.2 t -129.96 157.52 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -1.168 . . . . 0.0 110.466 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.031 179.698 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.257 0.551 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.68 93.3 9.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.99 105.34 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.103 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -166.51 131.72 2.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.313 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.59 153.39 23.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -129.67 57.62 1.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -1.165 . . . . 0.0 110.27 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -45.12 153.1 0.21 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 110.167 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 94' ' ' SER . 6.4 tt0 -42.9 -45.94 5.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -64.1 -48.32 76.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.965 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.5 tp10 -58.84 -41.31 86.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 25.1 mt -61.66 -59.19 5.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.29 -43.64 10.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 22.0 m-20 -51.05 -45.98 61.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 102' ' ' PHE . 4.5 t -67.98 -22.86 64.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.003 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.501 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 14.1 t80 -42.31 -63.29 0.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.515 ' HG3' ' N ' ' A' ' 104' ' ' ILE . 4.7 ptt180 -62.23 -36.35 81.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.515 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 31.6 mm -59.65 -33.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.277 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -79.57 -65.98 0.93 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.906 . . . . 0.0 110.344 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 105' ' ' PHE . 48.3 t0 -42.58 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 105' ' ' PHE . 10.7 mttt -75.97 -10.25 59.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.213 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -102.14 -165.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 110.302 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.4 4.25 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.172 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.537 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 6.7 p-10 -66.37 -27.77 68.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.898 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 90.32 15.98 56.28 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 110' ' ' ASP . 38.0 m-85 -146.75 131.88 18.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.119 -1.224 . . . . 0.0 110.599 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.468 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 3.2 mt -83.16 131.74 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.406 -0.809 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 117' ' ' GLU . 24.3 p30 -100.52 -177.24 3.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.2 tt -64.93 -40.74 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 110.484 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.554 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -59.86 -52.02 67.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.038 . . . . 0.0 110.183 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 24.9 mt-10 -48.55 -42.85 34.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.911 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.578 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -58.35 -27.02 63.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 110.239 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -73.6 -72.87 0.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.4 pt-20 -41.91 -45.15 3.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.435 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 117' ' ' GLU . 42.6 mt -57.44 -57.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -73.82 -44.31 56.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 110.61 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.22 -36.72 75.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 0.0 110.276 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -47.72 -40.44 20.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.011 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.419 ' H ' HG23 ' A' ' 125' ' ' THR . 52.0 p -56.17 -28.36 57.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 110.068 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.0 -31.52 6.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 129' ' ' VAL . 6.7 mt-10 -49.99 125.78 12.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -1.097 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.566 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -70.11 62.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 127' ' ' GLU . 11.1 t -61.68 148.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 0.0 109.886 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 131' ' ' GLU . 5.8 pt -121.72 147.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 110.359 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -39.02 -36.67 0.31 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.576 -0.703 . . . . 0.0 110.761 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -35.43 62.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.687 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.06 -44.04 12.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.97 . . . . 0.0 109.697 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.578 HG23 ' HB3' ' A' ' 118' ' ' LEU . 15.9 mt -66.22 -36.96 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.387 -0.82 . . . . 0.0 110.138 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.17 -43.61 95.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -54.52 -53.38 55.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 141' ' ' SER . 2.1 mp -47.58 -41.31 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 110.509 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -71.69 -53.78 12.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 -57.07 4.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.754 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.27 -40.5 90.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.152 -0.967 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.515 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -75.26 -54.35 7.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 146' ' ' ASP . 0.3 OUTLIER -55.09 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 110.965 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -69.95 -46.29 65.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.049 -1.032 . . . . 0.0 109.466 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 9.0 p30 -82.78 -7.45 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 17.3 m-20 63.39 82.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.43 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.513 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 10.7 p-10 -130.25 5.46 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 109.972 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 74.58 20.8 79.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 35.5 mtm-85 -158.31 140.44 14.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -1.134 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.515 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.5 mt -90.46 137.64 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 109.79 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 150' ' ' ASP . 36.2 p-10 -110.01 -151.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.761 ' O ' HD12 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -75.35 -55.51 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.589 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -54.7 43.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 110.461 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.464 ' OE1' ' HA ' ' A' ' 142' ' ' ASP . 51.0 mt-10 -56.74 -53.48 57.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' GLU . 26.1 t80 -43.51 -51.54 6.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 0.0 110.396 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 151' ' ' PHE . 4.6 mt -63.13 -55.16 27.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -46.27 -41.48 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.985 . . . . 0.0 110.655 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.405 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.55 -46.81 62.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.808 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.405 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -99.47 42.33 1.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.71 133.3 41.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.124 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.86 30.65 75.77 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 162' ' ' GLN . 70.5 t -45.58 140.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -1.097 . . . . 0.0 110.498 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 161' ' ' VAL . 51.3 mt-30 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.422 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.322 0.582 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 25.9 t0 -50.62 -51.46 48.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.359 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 60.44 -173.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 110.298 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 74.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.4 -51.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -144.96 140.25 28.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -1.149 . . . . 0.0 110.241 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.73 163.89 13.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HG3' ' CD2' ' A' ' 155' ' ' LEU . 33.9 tt0 -51.24 -43.48 61.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 110.276 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -44.59 -56.11 4.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.75 -56.19 17.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 110.451 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 99' ' ' ALA . 6.3 mt -56.9 -58.8 6.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.554 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -40.84 -52.49 3.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -0.823 . . . . 0.0 110.529 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.41 -54.95 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 69.4 m -48.38 -24.16 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 110.715 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.497 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 47.0 t80 -45.23 -49.83 12.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.995 -1.066 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -57.16 -32.2 66.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 43.7 mm -59.47 -40.4 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -78.17 -38.41 43.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 110.427 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -79.25 84.7 5.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -1.0 . . . . 0.0 110.303 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -32.02 22.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 110.229 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.427 ' OD1' ' CG ' ' A' ' 110' ' ' ASP . 4.2 p30 -100.6 14.87 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.11 69.31 0.69 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.117 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.427 ' CG ' ' OD1' ' A' ' 108' ' ' ASN . 3.6 m-20 -97.47 -17.16 19.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 110.23 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.48 40.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -150.45 146.49 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.031 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 mt -82.64 116.12 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 110.366 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -97.2 -178.54 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.858 . . . . 0.0 110.014 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.547 HG23 ' N ' ' A' ' 116' ' ' GLU . 3.8 tp -67.96 -39.43 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.547 ' N ' HG23 ' A' ' 115' ' ' ILE . 5.8 mt-10 -55.1 -52.8 62.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.373 -0.829 . . . . 0.0 110.235 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 23.1 mt-10 -50.2 -45.3 53.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.398 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.563 HD22 HG23 ' A' ' 134' ' ' ILE . 0.5 OUTLIER -57.66 -34.18 69.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.574 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -66.54 -73.56 0.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' CD ' HG13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -42.06 -49.44 4.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -1.122 . . . . 0.0 110.561 -179.597 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.46 HG13 ' CD ' ' A' ' 120' ' ' GLU . 66.4 mt -55.07 -51.94 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.639 ' HB3' HG21 ' A' ' 129' ' ' VAL . 16.5 mt -64.71 -55.5 19.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.271 -0.893 . . . . 0.0 110.561 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.18 -36.71 73.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.887 . . . . 0.0 110.659 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.84 -30.93 4.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.428 ' H ' HG23 ' A' ' 125' ' ' THR . 30.9 p -66.23 -29.62 69.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.76 26.8 2.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -116.7 170.1 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -1.161 . . . . 0.0 110.397 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.39 62.68 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.712 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 122' ' ' LEU . 5.5 t -65.57 126.82 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 134' ' ' ILE . 15.3 pt -81.15 154.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -41.76 96.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 110.676 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -47.83 -33.56 7.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.256 -0.902 . . . . 0.0 110.781 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -83.23 -47.93 11.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 109.513 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.563 HG23 HD22 ' A' ' 118' ' ' LEU . 11.3 mt -58.26 -37.68 64.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.559 -0.713 . . . . 0.0 109.628 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.509 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 32.8 mt-10 -60.37 -34.72 74.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 110.591 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 14.5 t0 -56.33 -55.02 38.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -43.43 26.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.91 . . . . 0.0 111.023 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.6 tpp -65.06 -51.58 60.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.096 -1.003 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 139' ' ' LYS . 7.5 tmtm? -63.01 -39.25 94.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.4 -0.813 . . . . 0.0 109.953 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -67.27 -32.9 74.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.429 -0.794 . . . . 0.0 110.251 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.538 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.6 t -82.28 -64.28 1.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.426 ' OD2' ' HA ' ' A' ' 145' ' ' ASN . 45.6 t0 -44.36 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.48 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -89.26 -3.17 58.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.2 p30 -125.01 8.82 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.962 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.426 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 8.3 m120 59.26 39.27 22.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.459 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 19.3 p30 -72.85 -13.63 61.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 102.11 -11.77 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.495 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 70.9 mtt180 -158.43 177.94 10.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.152 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.538 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.6 mt -88.51 166.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 44.9 p-10 -144.35 -162.57 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.74 ' O ' HD12 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -73.26 -43.02 61.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.498 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -52.86 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.56 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 10.6 mt-10 -65.19 -39.98 93.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 3.5 t80 -54.75 -64.9 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 151' ' ' PHE . 8.1 mt -42.22 -52.86 4.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -59.74 -37.12 78.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.487 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -62.01 -47.04 86.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.487 ' N ' ' CG ' ' A' ' 157' ' ' MET . 11.4 mmt -81.02 -41.79 22.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 110.43 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 38.0 mt-10 -50.17 101.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.136 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.71 25.49 29.81 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 161' ' ' VAL . 8.6 p -62.55 135.63 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -1.114 . . . . 0.0 110.368 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.196 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.318 0.58 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -111.15 -61.34 1.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.873 . . . . 0.0 110.183 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.74 84.03 4.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 110.398 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -152.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.099 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.73 -156.95 8.34 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -169.46 -179.37 3.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -1.115 . . . . 0.0 110.113 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.498 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -129.57 -175.67 3.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 0.0 109.922 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 17.7 mp0 -56.74 -37.43 71.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.964 . . . . 0.0 109.88 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 95' ' ' GLU . 10.8 tt0 -43.03 -62.62 0.98 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.953 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.36 -33.34 71.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.857 . . . . 0.0 110.264 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.677 HD22 HD23 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -67.06 -49.56 64.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.458 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.06 25.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.994 -1.066 . . . . 0.0 110.164 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -50.96 -43.41 60.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -56.01 -16.22 4.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.343 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -54.0 -64.78 0.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 110.893 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -31.52 63.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.042 -1.036 . . . . 0.0 110.669 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 35.1 mm -57.18 -43.27 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.418 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.754 ' O ' HD11 ' A' ' 121' ' ' ILE . 5.4 m-85 -75.03 -31.84 61.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.97 98.81 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 110.119 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 69.9 m-80 -95.17 -11.47 28.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 53.94 56.41 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.97 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.84 -12.9 29.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.46 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.517 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 117.06 -20.65 11.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.517 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 65.5 m-85 -152.54 127.14 9.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.104 -1.233 . . . . 0.0 110.502 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 117' ' ' GLU . 12.6 mt -83.04 118.44 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.55 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 22.2 p30 -89.55 -172.88 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.708 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 116' ' ' GLU . 4.1 tp -63.28 -42.56 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.579 ' N ' HG23 ' A' ' 115' ' ' ILE . 1.6 mt-10 -53.1 -55.27 25.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.247 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.585 ' HB3' HG23 ' A' ' 113' ' ' ILE . 23.7 mt-10 -50.6 -43.82 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -59.28 -29.27 67.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.58 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.02 -60.23 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.7 pt-20 -52.4 -44.63 65.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -1.141 . . . . 0.0 110.529 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.754 HD11 ' O ' ' A' ' 105' ' ' PHE . 94.6 mt -53.42 -48.22 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.135 -0.978 . . . . 0.0 110.017 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.2 -48.85 16.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.81 -32.72 9.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.855 . . . . 0.0 110.342 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.14 -28.15 50.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.307 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 127' ' ' GLU . 27.9 p -86.74 21.49 2.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 62.86 21.11 62.95 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 125' ' ' THR . 3.2 mt-10 -96.69 112.65 24.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.187 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -74.15 81.94 1.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 134' ' ' ILE . 32.0 t -90.3 137.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 131' ' ' GLU . 28.4 pt -104.93 155.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 10.2 mt-10 -41.96 -46.67 4.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.6 mm-40 -41.0 -37.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 0.0 109.904 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.87 -47.33 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.422 -0.799 . . . . 0.0 109.43 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 118' ' ' LEU . 12.1 mt -58.94 -40.7 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.813 . . . . 0.0 109.726 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -59.11 -52.35 66.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.186 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -46.32 -45.9 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.229 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.4 mp -60.87 -54.75 41.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 110.035 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.646 ' CE ' HD12 ' A' ' 149' ' ' ILE . 2.2 ttm -67.0 -43.83 81.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -60.14 -43.42 95.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.314 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -68.46 -34.1 75.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.279 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.544 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -87.17 -62.78 1.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.526 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 138' ' ' MET . 21.8 t0 -50.94 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.728 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -82.13 -25.35 34.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -0.977 . . . . 0.0 110.042 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.482 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 9.0 m-80 -90.16 16.17 8.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.18 38.02 3.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.936 . . . . 0.0 110.074 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -97.27 14.16 27.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 51.46 37.92 41.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 6.6 mtt180 -158.68 125.9 4.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.163 -1.198 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.646 HD12 ' CE ' ' A' ' 138' ' ' MET . 4.0 mt -87.28 129.27 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.201 -0.937 . . . . 0.0 109.214 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -110.58 -167.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.628 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -57.45 10.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.523 -0.735 . . . . 0.0 111.038 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.41 -64.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.191 -0.943 . . . . 0.0 111.335 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.482 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 65.4 mt-10 -47.29 -31.58 3.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.088 -1.007 . . . . 0.0 110.992 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.402 ' O ' ' HB3' ' A' ' 157' ' ' MET . 21.7 t80 -64.9 -59.02 4.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 0.0 110.533 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.677 HD23 HD22 ' A' ' 98' ' ' LEU . 3.7 mt -47.28 -54.5 10.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 110.272 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -24.9 58.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 109.922 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.03 -38.05 75.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.375 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.495 ' N ' ' HG3' ' A' ' 157' ' ' MET . 18.8 ttm -103.94 40.63 1.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.93 70.09 0.98 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 110.024 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 146.0 -20.75 1.77 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.435 ' H ' HG12 ' A' ' 161' ' ' VAL . 4.6 p -112.97 144.1 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.982 . . . . 0.0 109.967 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.278 -179.953 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.092 0.472 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -121.15 131.25 54.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.46 75.89 1.66 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 110.319 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -63.12 106.24 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 110.404 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.48 -37.44 0.49 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -151.6 139.68 20.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -1.098 . . . . 0.0 109.84 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 95' ' ' GLU . 2.0 m -126.22 160.69 29.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 110.562 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 94' ' ' SER . 4.9 tt0 -44.28 -46.29 9.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.75 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -47.75 -53.31 15.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.917 . . . . 0.0 109.624 179.526 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -55.34 22.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.613 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.4 OUTLIER -64.18 -48.75 74.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.843 179.522 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.35 -53.43 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 109.759 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 96' ' ' GLU . 68.7 m-80 -52.21 -38.96 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.4 -0.813 . . . . 0.0 109.923 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -25.93 52.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.584 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 9.8 t80 -49.7 -58.16 5.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.486 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -66.9 -34.95 78.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.931 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.482 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 12.2 mm -68.33 -48.91 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 110.831 -179.341 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' LYS . 1.6 m-30 -71.27 -43.76 66.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.694 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -68.16 70.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.95 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' CD ' ' O ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -61.23 -35.63 77.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.298 -179.952 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 109' ' ' ALA . 13.4 t30 -75.9 -5.22 45.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.86 . . . . 0.0 110.036 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.29 76.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.3 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -124.08 -2.9 8.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.441 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 100.16 -21.96 42.21 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CG ' ' O ' ' A' ' 111' ' ' GLY . 92.6 m-85 -152.24 140.04 19.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -1.195 . . . . 0.0 110.375 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.446 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 29.5 mt -82.53 110.08 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.117 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -87.89 -175.47 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.348 -0.845 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.12 -29.72 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.248 -0.908 . . . . 0.0 110.676 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -50.26 70.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.129 -0.982 . . . . 0.0 110.262 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.501 ' C ' HD12 ' A' ' 121' ' ' ILE . 8.4 mt-10 -57.55 -42.83 83.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.549 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.2 tp -52.67 -38.72 60.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.318 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.583 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -56.41 -72.84 0.51 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.3 pt-20 -51.76 -45.22 63.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -1.207 . . . . 0.0 110.785 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.539 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 40.9 mt -47.82 -46.79 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.97 -1.081 . . . . 0.0 110.23 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.0 mt -77.39 -51.87 10.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.923 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -48.45 -35.3 12.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.982 . . . . 0.0 109.488 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.61 -38.78 21.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.1 p -58.9 -55.29 37.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.452 ' C ' ' HG2' ' A' ' 127' ' ' GLU . . . 139.11 41.25 0.09 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.9 mt-10 -136.47 128.56 29.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.241 . . . . 0.0 110.072 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -65.74 66.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' GLU . 79.0 t -64.54 155.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.662 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 131' ' ' GLU . 17.5 pt -123.94 145.68 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.839 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 4.4 mt-10 -43.74 -45.95 7.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.884 . . . . 0.0 110.581 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -41.59 -43.9 2.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 111.01 -179.546 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 -48.6 12.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.583 HD13 ' HA2' ' A' ' 119' ' ' GLY . 20.3 mt -53.21 -35.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.552 0.692 . . . . 0.0 109.651 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.455 ' OE1' ' HA ' ' A' ' 132' ' ' GLU . 64.0 mt-10 -55.9 -52.26 64.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.536 -0.728 . . . . 0.0 110.602 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 50.4 t0 -45.25 -49.16 12.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.474 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.515 HD23 ' HE1' ' A' ' 157' ' ' MET . 0.1 OUTLIER -53.3 -43.78 67.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.968 . . . . 0.0 110.393 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -40.31 68.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.398 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -60.06 -48.05 83.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.944 . . . . 0.0 110.843 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.9 -33.82 75.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.798 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.55 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.66 -35.66 57.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER -55.25 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.544 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' SER . 5.9 tttt -67.69 -8.36 34.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.45 22.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 8.5 m-20 51.22 64.75 1.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.331 -0.855 . . . . 0.0 110.785 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 51.5 p-10 -112.72 5.77 17.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 60.0 24.92 61.22 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 13.6 mtt-85 -158.13 130.71 7.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -1.163 . . . . 0.0 110.533 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.55 HG12 ' CB ' ' A' ' 141' ' ' SER . 6.1 mt -85.72 121.29 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.362 -0.837 . . . . 0.0 109.94 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.18 -173.6 2.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 110.411 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -53.7 -57.43 10.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -55.17 16.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.505 -0.747 . . . . 0.0 110.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 157' ' ' MET . 88.0 mt-10 -64.01 -57.94 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.572 ' CZ ' ' HG3' ' A' ' 158' ' ' MET . 38.6 t80 -40.83 -59.72 1.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.654 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 154' ' ' PHE . 81.5 mt -42.3 -65.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.345 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.84 -38.09 77.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 110.431 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -66.97 -37.96 85.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.071 -179.639 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.73 ' HB3' HD21 ' A' ' 98' ' ' LEU . 3.2 mmt -83.81 13.76 4.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.537 -0.727 . . . . 0.0 110.514 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -111.51 143.58 42.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.032 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.55 -17.1 59.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 161' ' ' VAL . 7.7 p -84.76 145.42 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.398 -1.06 . . . . 0.0 110.192 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.289 -179.912 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.162 0.506 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.44 179.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.439 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 49.68 70.7 0.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 110.371 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.8 107.35 19.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.127 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.62 137.25 6.45 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.49 157.25 21.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -1.131 . . . . 0.0 110.344 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -103.76 150.28 24.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.951 179.621 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 94' ' ' SER . 2.5 mt-10 -42.19 -49.33 4.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -44.79 -56.35 4.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.278 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -57.73 -32.07 67.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -51.07 9.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.509 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.07 50.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.133 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -66.15 -33.12 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.447 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.8 m -65.16 -22.08 66.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.829 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE1' HD11 ' A' ' 113' ' ' ILE . 71.7 t80 -49.25 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 110.391 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.53 -32.25 5.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 48.8 mm -68.33 -45.44 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 110.365 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.412 ' O ' HD11 ' A' ' 121' ' ' ILE . 17.0 m-85 -67.56 -24.94 65.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.25 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 23.3 t0 -90.07 84.96 6.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -67.69 -32.16 72.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 6.0 p30 -93.87 -12.25 29.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 59.09 75.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.352 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 5.1 p30 -114.91 -6.39 12.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.269 -0.895 . . . . 0.0 110.091 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 86.28 -1.05 87.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 10.8 m-85 -146.8 124.01 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -1.142 . . . . 0.0 110.011 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.488 HD11 ' CE1' ' A' ' 102' ' ' PHE . 40.8 mt -85.83 124.59 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.261 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 116' ' ' GLU . 1.9 p30 -103.42 -176.19 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.3 tp -75.97 -31.68 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.452 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 1.3 mt-10 -58.22 -45.06 88.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 121' ' ' ILE . 37.1 mt-10 -59.91 -48.67 80.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 110.423 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.59 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.8 -34.59 67.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.152 -0.968 . . . . 0.0 110.13 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -57.98 -71.99 0.66 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 18.7 pt-20 -57.35 -44.49 84.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -1.171 . . . . 0.0 110.299 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.0 mt -47.06 -57.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.975 . . . . 0.0 109.87 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 125' ' ' THR . 0.3 OUTLIER -69.09 -49.18 59.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -53.92 -37.2 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.435 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.16 60.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.307 -0.871 . . . . 0.0 110.868 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 61.5 p -54.65 -24.44 21.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.461 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.54 -27.4 6.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -75.79 134.05 40.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -1.122 . . . . 0.0 109.961 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -87.19 71.07 10.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.145 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.403 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 41.6 t -64.78 137.65 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.051 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' GLU . 9.4 pt -86.3 137.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 110.366 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.801 ' OE1' HD12 ' A' ' 134' ' ' ILE . 8.9 mm-40 -42.75 -38.28 2.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -40.79 -39.46 1.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -0.822 . . . . 0.0 110.551 -179.837 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -84.31 -45.38 12.87 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.174 -0.954 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.801 HD12 ' OE1' ' A' ' 131' ' ' GLU . 23.6 mt -56.19 -35.67 43.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.493 -0.754 . . . . 0.0 109.535 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 1.1 mt-10 -65.66 -37.46 86.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.523 -0.736 . . . . 0.0 110.227 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 9.2 t70 -52.06 -54.6 28.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 137' ' ' LEU . 25.3 mt -50.5 -39.57 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.418 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.668 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -65.18 -39.08 92.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.406 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -64.88 -52.31 57.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 110.571 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.2 -27.64 68.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 111.13 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.568 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -89.34 -65.05 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.018 . . . . 0.0 111.025 -179.292 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' SER . 18.5 t0 -41.69 98.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.895 . . . . 0.0 110.36 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.4 tppp? -94.51 -32.11 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 0.0 110.367 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 4.5 p30 -101.94 17.68 22.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.135 -0.978 . . . . 0.0 110.213 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.0 m-20 48.74 80.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.486 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 9.2 p-10 -134.77 11.1 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 62.1 14.51 46.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 72.1 mtt180 -146.94 143.95 28.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -1.158 . . . . 0.0 110.481 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.668 HD12 ' CE ' ' A' ' 138' ' ' MET . 1.2 mt -93.14 123.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 109.948 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 39.4 p30 -91.74 -165.06 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.805 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -54.93 15.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 110.393 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.26 -57.28 13.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 92.6 mt-10 -48.54 -46.29 38.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.577 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 1.5 t80 -54.16 -58.9 5.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.677 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 155' ' ' LEU . 31.4 mt -51.46 -59.39 4.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.841 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -42.65 44.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.775 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.474 ' HE1' HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -65.21 -45.17 85.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.509 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.527 ' HA ' HG21 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -86.57 3.44 44.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.202 -0.937 . . . . 0.0 110.446 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -79.0 142.83 36.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 0.0 110.317 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.57 31.67 80.84 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 161' ' ' VAL . 70.0 t -101.27 67.46 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.149 -1.207 . . . . 0.0 110.111 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.237 -179.767 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.315 0.579 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.55 102.24 13.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 110.281 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.04 159.88 4.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -133.87 124.45 26.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 110.104 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.63 -150.46 5.95 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -106.63 -169.9 1.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -1.13 . . . . 0.0 110.174 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -64.55 -13.73 54.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 110.351 -179.967 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 94' ' ' SER . 0.2 OUTLIER 73.88 -49.15 0.68 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.388 -0.82 . . . . 0.0 110.546 -179.571 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -42.81 -48.93 5.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.085 -1.009 . . . . 0.0 110.092 -179.929 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 21.3 mp0 -53.61 -56.48 16.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.887 . . . . 0.0 109.924 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 95' ' ' GLU . 3.1 mt -52.26 -57.83 8.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.95 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 102' ' ' PHE . . . -47.66 -41.96 23.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -55.46 -32.76 63.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.686 ' HA ' HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -77.7 -7.2 56.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.577 -179.709 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 99' ' ' ALA . 2.5 t80 -60.86 -56.48 20.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.07 -1.019 . . . . 0.0 110.428 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.524 ' HG2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -52.16 -22.98 4.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.185 -0.947 . . . . 0.0 110.733 -179.764 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.686 HD13 ' HA ' ' A' ' 101' ' ' CYS . 2.0 mp -74.28 -47.93 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.061 -1.025 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.12 -49.9 11.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.308 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 108' ' ' ASN . 52.7 t0 -67.48 74.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -46.43 -39.19 10.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.7 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 106' ' ' ASP . 17.3 m-80 -103.54 165.01 11.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 109.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.25 63.89 7.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 17.2 p30 -102.55 -18.43 15.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.072 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.575 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 74.91 5.81 76.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 52.8 m-85 -148.53 110.29 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -1.147 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.91 144.85 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.46 ' CG ' ' HG3' ' A' ' 116' ' ' GLU . 30.0 p30 -119.7 -163.78 1.02 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' A' ' 135' ' ' GLU . 1.2 tt -79.59 -45.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -0.841 . . . . 0.0 110.779 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.603 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.41 -27.28 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 110.152 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 9.2 mt-10 -76.55 -48.93 17.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 109.86 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.472 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -51.85 -44.07 63.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 110.038 179.783 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -48.63 -83.91 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 10.6 pt-20 -42.42 -45.35 4.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -1.17 . . . . 0.0 110.493 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.0 mt -50.3 -54.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 109.679 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 122' ' ' LEU . 19.6 mt -73.1 -47.48 43.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -49.89 -37.55 31.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.837 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.64 -31.56 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 43.0 p -69.25 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 110.154 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.97 38.21 2.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -113.0 -157.52 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -1.191 . . . . 0.0 110.331 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -145.11 53.72 1.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.034 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 134' ' ' ILE . 46.8 t -61.18 162.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.832 . . . . 0.0 110.347 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 131' ' ' GLU . 13.7 pt -139.18 152.02 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.3 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -41.27 -53.62 3.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.993 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -43.44 -36.65 2.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -45.1 11.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.465 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 118' ' ' LEU . 21.1 mt -62.81 -38.9 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 109.623 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.608 ' HG2' HD11 ' A' ' 115' ' ' ILE . 2.0 mm-40 -58.74 -45.05 90.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 110.12 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 4.8 t70 -44.0 -50.02 8.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.265 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 141' ' ' SER . 31.6 mt -58.4 -40.27 81.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.444 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 34.5 tpp -65.34 -48.44 73.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.609 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -64.8 -37.16 86.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.576 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 2.9 t0 -72.19 -36.98 69.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.469 -0.769 . . . . 0.0 109.974 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.558 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -85.43 -46.65 10.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 110.136 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.454 ' HA ' ' CD ' ' A' ' 153' ' ' GLU . 29.3 t0 -61.82 86.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.815 . . . . 0.0 110.45 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 -8.1 58.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -119.45 19.55 12.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.429 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 34.1 m120 46.97 41.9 11.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.111 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.9 -9.33 59.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.31 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.43 60.95 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.436 ' CD ' ' HB3' ' A' ' 114' ' ' ASP . 55.9 mtt180 -146.2 162.18 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -1.143 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.558 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.3 mt -84.38 118.77 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 2.9 p30 -94.39 -178.08 4.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.932 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.98 -61.26 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 110.051 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.454 ' CD ' ' HA ' ' A' ' 142' ' ' ASP . 94.1 mt-10 -59.42 -44.89 92.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 10.6 t80 -46.27 -66.98 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.957 . . . . 0.0 110.207 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 154' ' ' PHE . 10.0 mt -44.52 -56.86 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -37.52 72.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.0 ptm -54.76 -49.51 70.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.672 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.525 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -63.61 -17.33 62.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 109.989 179.818 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.39 106.76 4.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.331 -0.856 . . . . 0.0 110.104 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 117.28 -25.69 8.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.49 159.0 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 110.19 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.152 -179.965 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.278 0.561 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.53 -54.14 3.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 110.298 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.71 132.88 9.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.391 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -108.7 2.31 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.139 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.89 -151.04 49.79 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 175.08 8.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.149 -1.207 . . . . 0.0 109.949 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 95' ' ' GLU . 72.6 m -95.42 142.38 27.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 110.327 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' SER . 3.5 mt-10 -43.38 -40.52 3.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.36 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -43.48 -45.51 6.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.711 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.0 -51.15 71.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.719 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 4.1 mm? -46.68 -56.75 5.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -45.04 -55.13 5.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.225 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -52.1 -43.43 63.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.314 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.46 -24.52 60.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -53.83 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.98 . . . . 0.0 110.073 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -55.37 -38.01 68.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.142 -0.974 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.468 ' HA ' HD13 ' A' ' 104' ' ' ILE . 12.2 mm -62.5 -39.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 109.946 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.417 ' CE2' HD13 ' A' ' 121' ' ' ILE . 1.4 m-30 -84.33 -46.08 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.173 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 6.7 t0 -82.42 96.24 7.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.335 -0.853 . . . . 0.0 109.838 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -105.83 -27.4 11.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 110.904 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.461 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 2.4 p-10 -104.26 -45.19 4.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.014 -1.054 . . . . 0.0 110.77 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -86.12 -39.76 16.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.991 . . . . 0.0 110.016 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 2.9 m-20 45.3 27.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 109.962 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . -152.33 -36.99 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 20.9 m-85 -151.57 112.32 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.433 -1.039 . . . . 0.0 109.322 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.429 HG23 ' CB ' ' A' ' 117' ' ' GLU . 5.0 mt -82.77 118.84 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.681 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.473 ' OD2' ' N ' ' A' ' 116' ' ' GLU . 4.5 p-10 -92.66 -155.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' A' ' 135' ' ' GLU . 3.0 tp -78.73 -33.63 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.0 110.248 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.473 ' N ' ' OD2' ' A' ' 114' ' ' ASP . 1.7 mm-40 -57.16 -59.32 5.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.305 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 1.9 mt-10 -44.23 -48.46 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.917 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.571 ' HA ' HD12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -58.53 -31.98 68.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 110.103 179.811 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -60.44 -75.83 0.26 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 10.9 pt-20 -42.43 -45.58 4.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.258 -1.142 . . . . 0.0 110.44 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 118' ' ' LEU . 45.7 mt -47.21 -53.66 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.142 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.409 HD12 HG12 ' A' ' 134' ' ' ILE . 72.1 mt -75.14 -36.87 61.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.328 -0.858 . . . . 0.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 120' ' ' GLU . 6.6 mtm180 -62.96 -36.51 83.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 110.162 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.82 -40.43 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.2 p -61.96 -36.24 80.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.74 11.07 27.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -89.98 148.0 23.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.25 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -85.52 83.16 8.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 109.941 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' A' ' 133' ' ' ASP . 2.3 t -93.56 114.34 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 9.1 pt -73.28 146.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.05 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.7 mt-10 -41.13 -49.34 3.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 0.0 110.439 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.08 -26.68 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB3' HG12 ' A' ' 129' ' ' VAL . 0.1 OUTLIER -81.02 -50.01 10.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.309 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.557 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 6.4 mt -66.22 -42.55 91.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.492 ' HA ' HD11 ' A' ' 115' ' ' ILE . 8.3 mt-10 -45.81 -42.61 12.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.0 110.052 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.14 -51.78 68.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 110.246 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.478 ' HA ' HD13 ' A' ' 137' ' ' LEU . 2.7 mm? -48.63 -44.87 37.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.217 -0.927 . . . . 0.0 110.371 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 11.0 tpp -64.58 -45.96 84.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.759 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -46.21 74.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -0.835 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 110.561 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.531 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -89.48 -63.75 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.459 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 1.7 t0 -47.82 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.1 mttt -84.53 -26.02 28.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.162 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 11.6 m-80 -86.63 -3.94 59.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 109.744 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.3 OUTLIER 67.26 15.08 9.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -60.63 -15.79 32.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.1 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.15 -5.94 82.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.521 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -137.9 146.4 43.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.254 . . . . 0.0 110.486 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 141' ' ' SER . 5.8 mt -83.77 137.12 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 29.4 p-10 -121.15 -160.83 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.864 ' O ' HD12 ' A' ' 155' ' ' LEU . 49.5 p90 -68.17 -41.83 80.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 1.0 OUTLIER -68.38 -56.88 6.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.499 -179.857 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' HA ' ' A' ' 142' ' ' ASP . 59.1 mt-10 -58.35 -48.53 80.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 57.4 t80 -46.55 -54.42 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.927 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.864 HD12 ' O ' ' A' ' 151' ' ' PHE . 6.2 mt -66.62 -47.06 73.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.984 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -48.32 -55.78 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 110.143 179.927 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -58.28 -52.47 65.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 109.72 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.9 mtm -89.96 39.81 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.075 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 4.8 tt0 -96.96 105.15 17.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 110.265 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 44.07 55.49 5.67 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 162' ' ' GLN . 60.6 t -53.99 168.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -1.137 . . . . 0.0 110.306 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.511 ' N ' HG12 ' A' ' 161' ' ' VAL . 5.8 mt-30 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.144 0.497 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -166.65 93.69 0.49 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.563 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.55 -176.98 6.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 109.706 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 54.14 2.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.022 -1.049 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -165.11 127.45 1.63 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -152.87 162.52 41.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -1.104 . . . . 0.0 109.97 179.916 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.552 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -107.14 -169.22 1.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.807 -179.354 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -53.07 -46.11 68.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.453 -0.779 . . . . 0.0 110.844 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 95' ' ' GLU . 1.5 tt0 -38.31 -64.37 0.42 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -0.781 . . . . 0.0 110.819 -179.409 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.01 -55.93 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 94' ' ' SER . 3.0 mt -58.61 -53.28 60.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.335 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -49.17 -51.92 29.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.361 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -51.43 -50.61 59.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 102' ' ' PHE . 5.2 m -53.03 -42.08 65.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.713 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 87.3 t80 -42.28 -65.16 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 110.603 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -39.58 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.193 -0.942 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 mm -60.87 -32.78 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 110.581 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.1 -48.92 21.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.102 -0.999 . . . . 0.0 110.416 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.79 101.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -75.48 -45.88 35.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.201 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 69.3 m-80 -69.43 -15.3 63.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 110.095 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 59.37 42.93 17.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.45 ' OD2' ' O ' ' A' ' 112' ' ' PHE . 6.7 p-10 -84.07 -16.56 43.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.085 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.483 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 113.23 -16.05 22.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 3.4 m-85 -148.37 135.46 20.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 110.404 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 22.9 mt -85.26 119.36 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.852 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 23.8 p-10 -90.98 -175.76 4.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.0 OUTLIER -68.25 -38.85 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.814 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.492 ' N ' HG23 ' A' ' 115' ' ' ILE . 17.7 mt-10 -58.04 -55.2 38.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.332 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 113' ' ' ILE . 7.2 mt-10 -46.62 -40.36 12.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.818 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.515 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.1 tp -61.16 -49.03 78.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 110.063 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -51.94 -69.85 1.05 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -47.47 -45.96 26.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -1.189 . . . . 0.0 110.179 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 122' ' ' LEU . 6.5 mt -48.28 -65.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.986 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.699 ' HB3' HG21 ' A' ' 129' ' ' VAL . 44.4 mt -61.76 -44.83 96.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.467 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.495 ' NH1' ' HG2' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -55.21 -36.46 65.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.9 . . . . 0.0 110.731 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.55 -28.32 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 109.997 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.1 p -81.07 -47.31 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.32 35.51 1.45 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 5.1 mt-10 -99.88 16.6 23.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -1.204 . . . . 0.0 109.99 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 127' ' ' GLU . 44.5 p-80 38.24 43.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.627 -0.671 . . . . 0.0 110.49 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 122' ' ' LEU . 20.1 t -61.09 117.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.472 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.3 pt -77.74 148.63 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -45.34 -47.45 13.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 0.0 110.329 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB2' HG13 ' A' ' 130' ' ' ILE . 4.8 mt-10 -41.24 -36.32 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -0.863 . . . . 0.0 110.477 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -43.81 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.673 HD13 ' HA2' ' A' ' 119' ' ' GLY . 26.6 mt -64.11 -38.48 82.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.588 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -50.45 73.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.488 -0.757 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 136' ' ' ASP . 9.2 t0 -45.47 -49.29 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 141' ' ' SER . 1.7 tp -51.65 -38.89 56.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.163 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -73.02 -57.58 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 110.055 -179.993 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 138' ' ' MET . 2.9 mmtm -43.34 -63.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.01 -20.43 6.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.547 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -101.85 -62.32 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 110.424 -179.842 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 138' ' ' MET . 24.0 t70 -56.29 81.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -89.8 31.33 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 179.546 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -149.07 17.65 0.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.847 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 55.3 21.88 4.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.257 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 147' ' ' GLY . 1.4 t70 -85.58 4.57 35.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.855 . . . . 0.0 109.896 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . 41.57 38.97 2.34 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -158.31 124.55 4.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -1.211 . . . . 0.0 110.325 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.547 HG12 ' CB ' ' A' ' 141' ' ' SER . 13.5 mt -83.76 106.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 44.8 p-10 -100.78 -140.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 110.37 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.46 -61.64 1.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 0.0 110.729 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.32 -56.02 13.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.654 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -60.53 -53.54 56.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.676 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.495 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 44.9 t80 -43.98 -49.23 8.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.68 -36.55 84.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.203 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -46.37 69.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.887 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.551 ' HG2' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -61.08 -42.33 98.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.846 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.551 ' N ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER -109.03 42.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 0.0 110.05 179.77 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.77 94.43 9.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.338 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 44.82 41.94 7.5 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 162' ' ' GLN . 23.1 t -47.17 133.94 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -1.169 . . . . 0.0 110.187 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 161' ' ' VAL . 3.1 mm100 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.287 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.394 0.616 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 89' ' ' ASP . 54.0 t0 -143.53 60.57 1.39 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -102.44 60.82 0.83 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.388 -0.82 . . . . 0.0 110.893 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 10.7 tttt -178.47 175.68 1.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.129 -0.982 . . . . 0.0 110.74 179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' LYS . . . 60.64 144.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -76.1 0.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.413 -1.051 . . . . 0.0 109.878 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER 57.82 160.38 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.461 -0.774 . . . . 0.0 110.91 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 94' ' ' SER . 16.1 mt-10 -39.26 -40.26 0.73 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.485 -0.759 . . . . 0.0 110.745 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -45.71 -71.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 110.532 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -55.97 -38.38 70.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 98' ' ' LEU . 9.5 mt -57.14 -53.97 52.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.65 -65.61 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.845 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -52.07 -31.28 29.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.421 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -71.87 -9.85 58.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.208 -0.932 . . . . 0.0 110.378 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.99 -54.04 51.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.45 72.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.838 -179.378 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 mm -57.26 -29.31 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.125 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -80.53 -32.85 36.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.86 79.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -86.97 39.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.7 -179.878 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 27.9 t30 -128.96 -98.44 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 108' ' ' ASN . . . 174.8 27.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.984 -1.073 . . . . 0.0 111.041 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.4 p30 -113.45 -10.92 13.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.825 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.7 81.97 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.457 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 51.2 m-85 -141.6 139.75 33.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 110.6 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.478 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 51.0 mt -85.37 126.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.542 -0.724 . . . . 0.0 109.384 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.49 -179.23 3.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.205 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -65.3 -44.31 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.64 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.541 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.6 mt-10 -60.17 -51.15 70.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.064 . . . . 0.0 109.907 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.534 ' O ' HD12 ' A' ' 121' ' ' ILE . 14.6 mt-10 -49.76 -36.53 26.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.607 HD23 HG23 ' A' ' 134' ' ' ILE . 5.0 tp -60.71 -51.24 70.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 0.0 110.531 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -42.43 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.2 pt-20 -42.08 -45.81 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -1.18 . . . . 0.0 110.628 -179.122 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 117' ' ' GLU . 37.6 mt -56.23 -58.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.99 -1.069 . . . . 0.0 109.72 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.033 HD13 HG11 ' A' ' 129' ' ' VAL . 49.1 mt -60.7 -44.63 96.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 110.103 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.74 -37.77 79.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.126 -0.984 . . . . 0.0 110.264 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.87 64.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.987 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.8 p -62.74 -23.31 67.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.57 47.43 15.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.53 13.44 20.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -1.109 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 55.77 47.71 19.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.307 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.033 HG11 HD13 ' A' ' 122' ' ' LEU . 71.8 t -79.88 86.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.1 pt -57.79 149.86 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 132' ' ' GLU . 3.8 mm-40 -50.32 -44.54 54.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 111.142 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -39.43 -40.37 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.328 -0.857 . . . . 0.0 110.896 -179.474 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -47.3 21.6 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.307 -0.871 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.607 HG23 HD23 ' A' ' 118' ' ' LEU . 6.6 mt -59.71 -39.48 79.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.666 -0.646 . . . . 0.0 109.611 179.143 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.63 ' HA ' HD11 ' A' ' 115' ' ' ILE . 1.3 mm-40 -55.27 -42.33 73.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.03 -38.62 86.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 0.0 109.843 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 134' ' ' ILE . 0.6 OUTLIER -49.69 -41.98 44.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 110.947 -179.505 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.477 ' CE ' HD12 ' A' ' 149' ' ' ILE . 49.2 tpp -70.36 -43.8 69.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.921 -1.112 . . . . 0.0 110.173 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -62.74 -43.83 97.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.88 -18.77 64.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -99.07 -63.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.573 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.2 m-20 -40.05 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.718 . . . . 0.0 110.798 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 141' ' ' SER . 15.2 tttt -79.66 3.88 17.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.046 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.3 p30 -141.51 8.38 1.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.935 . . . . 0.0 110.053 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 62.3 m-20 58.18 61.9 2.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 56.7 p30 -102.05 -5.03 25.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.936 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.466 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 87.71 -5.18 85.34 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.466 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 18.0 mtm-85 -152.35 157.03 40.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.311 . . . . 0.0 110.79 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.477 HD12 ' CE ' ' A' ' 138' ' ' MET . 3.8 mt -89.28 144.87 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -121.01 -162.54 0.96 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.454 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.502 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 6.8 t80 -64.42 -52.92 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.977 . . . . 0.0 111.112 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.5 OUTLIER -60.2 -56.74 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 110.686 -179.397 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.02 -44.47 87.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.49 ' O ' ' HG2' ' A' ' 157' ' ' MET . 81.5 t80 -49.23 -54.99 14.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.208 -0.933 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 155' ' ' LEU . 35.3 mt -51.81 -51.42 56.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 110.357 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -46.99 -58.17 4.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 110.739 -179.74 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.565 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -47.53 -51.66 20.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.335 -179.586 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 158' ' ' MET . . . . . 1.073 ' O ' HG23 ' A' ' 161' ' ' VAL . 12.3 mmt -60.83 -36.38 78.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 158' ' ' MET . 0.0 OUTLIER 39.85 36.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.327 -0.858 . . . . 0.0 111.335 179.334 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 159' ' ' GLU . . . 42.44 41.71 4.19 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.439 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 158' ' ' MET . 59.7 t -55.49 125.3 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -1.11 . . . . 0.0 110.478 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 161' ' ' VAL . 25.7 mt-30 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.49 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.209 0.528 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.5 136.82 15.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 110.29 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.15 -164.47 1.44 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.301 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.85 125.5 47.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 110.048 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.8 56.9 3.19 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.23 135.88 36.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -1.174 . . . . 0.0 110.595 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 m -76.59 138.91 40.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.671 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -47.62 -32.85 5.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.925 . . . . 0.0 110.284 -179.654 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -42.26 -52.12 4.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 110.302 -179.909 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -68.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 99' ' ' ALA . 7.6 mp -47.96 -61.92 1.72 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.01 -42.72 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.429 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -73.82 -57.9 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.595 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 62.9 m -48.93 -27.26 2.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.879 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -46.38 -50.32 16.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.989 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -56.55 -42.59 78.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.425 HD12 HG23 ' A' ' 104' ' ' ILE . 20.0 mm -57.01 -43.3 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 110.635 -179.434 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -66.15 -38.45 88.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 110.175 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -67.19 89.74 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 0.0 110.091 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -62.78 -27.64 69.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 109.599 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.439 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 12.8 m120 -104.78 -169.1 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.559 -0.713 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.14 65.41 0.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.365 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -114.44 -32.1 6.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 110.165 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.94 6.98 48.29 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.582 ' HB2' ' HD3' ' A' ' 148' ' ' ARG . 5.3 m-85 -152.09 128.88 10.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -1.203 . . . . 0.0 109.861 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.28 141.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 3.9 p30 -106.88 173.32 6.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.253 -0.904 . . . . 0.0 110.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 116' ' ' GLU . 3.3 tt -56.4 -42.93 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.076 -1.015 . . . . 0.0 110.209 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.595 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.7 OUTLIER -55.2 -59.39 4.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.901 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.598 ' C ' HD12 ' A' ' 121' ' ' ILE . 20.7 mt-10 -47.75 -43.93 27.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.668 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.762 ' HB3' HG23 ' A' ' 134' ' ' ILE . 2.5 tp -45.46 -31.23 1.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.612 -0.68 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -73.41 -74.5 0.81 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 5.5 pt-20 -42.05 -50.04 4.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -1.177 . . . . 0.0 110.476 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.598 HD12 ' C ' ' A' ' 117' ' ' GLU . 7.9 mt -48.33 -65.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.825 ' O ' HG22 ' A' ' 125' ' ' THR . 17.9 mt -59.67 -56.6 19.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -48.56 -30.99 5.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 110.453 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -54.85 -53.78 50.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 122' ' ' LEU . 4.4 t -67.47 -139.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.973 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.448 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . -118.34 11.75 12.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.828 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.3 mm-40 -81.61 97.32 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -1.066 . . . . 0.0 111.046 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -66.06 93.25 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 127' ' ' GLU . 3.4 t -103.98 146.6 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.894 -178.826 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 131' ' ' GLU . 12.4 pt -112.71 159.0 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -42.89 -48.19 5.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.805 . . . . 0.0 110.914 -179.703 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -47.28 -32.53 4.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.309 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.06 -48.3 8.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.463 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.762 HG23 ' HB3' ' A' ' 118' ' ' LEU . 22.8 mt -60.28 -42.74 91.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -59.01 -60.46 3.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.482 -0.762 . . . . 0.0 109.848 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -51.19 -45.39 61.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.217 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -48.25 -43.98 32.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.812 -179.79 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.594 ' HA ' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -62.27 -48.44 79.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.782 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.04 -36.02 69.52 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -0.791 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.85 -17.9 65.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.835 . . . . 0.0 110.412 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.549 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -102.77 -62.32 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.803 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.6 t0 -37.69 109.01 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.671 -0.643 . . . . 0.0 110.731 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -83.51 -11.41 57.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.748 . . . . 0.0 109.86 179.843 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 1.7 p30 -132.08 4.69 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.151 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 145' ' ' ASN . 2.9 m120 60.83 48.19 7.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.777 . . . . 0.0 110.772 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.45 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 45.9 p-10 -81.82 -10.2 59.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 179.557 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . 93.94 8.5 60.41 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.582 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 10.2 mtt180 -158.34 139.98 13.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -1.177 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 138' ' ' MET . 3.6 mt -83.56 122.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -101.68 -174.24 2.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.32 -56.42 16.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -63.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.745 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 143' ' ' LYS . 21.1 mt-10 -55.76 -36.57 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.932 -179.392 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -63.24 -55.56 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.914 -1.116 . . . . 0.0 109.977 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 159' ' ' GLU . 12.8 mt -54.6 -41.83 70.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 110.388 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -58.93 -62.86 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.821 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -57.43 -50.83 71.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 0.0 110.832 -179.43 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' MET . 6.1 mmt -62.09 -31.08 71.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.333 -0.854 . . . . 0.0 110.485 -179.722 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 38.6 tt0 -66.72 76.97 0.11 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.458 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 110.47 36.01 1.99 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 162' ' ' GLN . 6.1 p -72.72 163.14 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -1.041 . . . . 0.0 110.785 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.445 ' N ' HG22 ' A' ' 161' ' ' VAL . 1.8 mt-30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.259 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.245 0.545 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.39 125.13 47.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.117 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -174.87 -179.33 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 0.0 110.462 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 6.1 ttmt 63.89 88.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.317 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.83 -141.63 7.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.439 ' HE2' ' HG2' ' A' ' 97' ' ' GLU . 0.7 OUTLIER -93.4 120.82 34.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -1.139 . . . . 0.0 110.093 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -92.0 157.36 16.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.261 -0.899 . . . . 0.0 110.28 -179.826 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 94' ' ' SER . 0.4 OUTLIER -43.66 -50.34 7.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 110.205 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 4.5 mp0 -44.95 -57.35 3.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 110.244 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' HG2' ' HE2' ' A' ' 93' ' ' LYS . 5.9 tp10 -48.2 -59.97 3.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.263 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 155' ' ' LEU . 6.0 mt -57.99 -45.98 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -42.36 -59.29 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.242 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 101' ' ' CYS . 3.7 m120 -50.02 -54.11 22.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.457 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.2 m -43.6 -32.59 0.98 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.908 179.716 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 13.0 t80 -42.93 -63.93 0.71 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.345 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -63.68 -29.63 70.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 23.0 mm -60.84 -50.77 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.487 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.4 -13.7 14.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -89.42 118.49 29.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.09 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -110.66 -11.91 14.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -109.71 15.09 23.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 110.611 -179.243 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 45.25 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 110.239 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -126.55 -27.88 3.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.989 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.95 -19.47 49.33 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 62.0 m-85 -153.23 128.24 9.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -1.102 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.499 HG23 ' OE1' ' A' ' 117' ' ' GLU . 1.4 mp -82.51 123.52 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -102.21 -168.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.249 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.8 tt -65.14 -40.47 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 110.328 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.555 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -51.38 -52.38 46.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.435 -179.693 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.499 ' OE1' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -56.97 -44.62 82.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.903 . . . . 0.0 110.28 -179.767 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.631 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -48.47 -34.19 10.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.171 -179.971 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -58.36 -85.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 15.7 pt-20 -42.43 -43.89 3.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.15 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.45 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.5 mt -52.61 -48.98 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.877 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 122' ' ' LEU . 10.8 mt -70.32 -47.1 62.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.097 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -51.96 -42.42 62.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.946 . . . . 0.0 110.208 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.04 -31.6 5.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.432 -0.793 . . . . 0.0 110.548 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 p -68.87 -35.91 77.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.363 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.91 49.24 2.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.45 -7.55 8.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.206 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 59.29 84.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 110.039 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 9.1 t -108.69 149.58 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.318 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' O ' ' C ' ' A' ' 131' ' ' GLU . 16.2 pt -113.44 154.82 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.126 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 130' ' ' ILE . 10.2 mt-10 -39.41 -51.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.436 -0.79 . . . . 0.0 110.777 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 -179.991 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -88.37 -44.75 10.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.503 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 118' ' ' LEU . 33.3 mt -63.26 -38.3 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.811 . . . . 0.0 109.894 179.515 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -54.04 -53.73 49.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.778 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -45.26 -48.73 12.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.575 HD22 HD21 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -53.09 -49.01 67.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 110.377 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 26.4 tpp -66.11 -50.43 64.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -41.83 93.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.398 -0.814 . . . . 0.0 110.093 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -66.77 -35.58 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.539 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -80.54 -48.83 12.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.4 OUTLIER -49.23 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.508 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 141' ' ' SER . 17.5 tttt -80.09 -19.21 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 1.5 p30 -122.48 0.91 9.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 64.96 52.07 1.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.0 110.564 179.727 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 146' ' ' ASP . 50.7 p-10 -93.7 0.02 56.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 11.58 84.34 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -152.79 139.1 18.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.144 -1.21 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.2 mt -83.63 134.76 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.751 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 152' ' ' ASP . 2.1 p30 -118.6 -166.27 1.21 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 110.144 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 41.1 p90 -70.02 -34.98 73.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.594 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -66.0 -49.0 69.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.315 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 141' ' ' SER . 74.8 mt-10 -71.92 -56.61 5.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.38 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.446 ' O ' ' HG2' ' A' ' 157' ' ' MET . 69.6 t80 -45.29 -45.17 11.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 0.0 110.117 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 98' ' ' LEU . 13.1 mt -55.62 -40.93 72.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -55.11 36.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.56 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -47.17 -49.73 22.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 109.588 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.56 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -66.77 -29.89 69.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.37 -0.831 . . . . 0.0 110.363 179.947 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 158' ' ' MET . 0.4 OUTLIER 42.82 -148.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.994 . . . . 0.0 110.277 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.23 38.52 3.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.7 p -46.09 151.31 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -1.13 . . . . 0.0 110.271 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.244 -179.954 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.189 0.518 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.73 171.77 11.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.354 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -123.4 34.67 5.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 110.262 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 3.6 tptp 70.11 69.18 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.264 -0.897 . . . . 0.0 110.56 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 93' ' ' LYS . . . 107.86 64.54 0.58 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.526 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER 64.64 113.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 110.376 179.608 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 95' ' ' GLU . 1.5 p -74.7 142.18 44.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.942 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.697 ' HG2' HD22 ' A' ' 155' ' ' LEU . 4.7 mt-10 -41.14 -44.91 2.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.79 -44.59 28.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.062 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.433 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 3.0 mt-10 -55.42 -60.1 3.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -0.894 . . . . 0.0 110.462 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.652 HD13 ' HE1' ' A' ' 158' ' ' MET . 0.2 OUTLIER -51.21 -54.79 22.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -41.32 -48.52 3.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 0.0 110.134 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.44 -43.65 71.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.064 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.8 m -63.9 -18.81 64.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.885 . . . . 0.0 110.192 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -53.15 -55.76 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 110.122 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -55.82 -33.75 64.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.03 -39.44 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -66.54 -51.51 55.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.099 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -72.56 123.77 23.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.165 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.471 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 19.6 mttp -93.99 17.19 12.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.424 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 50.3 m-80 -148.68 173.99 12.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 110.424 -179.485 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.5 40.6 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 p30 -88.13 -23.2 23.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.18 18.71 63.07 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -153.28 117.3 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -1.114 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 36.9 mt -84.1 132.05 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.32 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -107.34 -164.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -78.65 -43.93 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.085 -1.01 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.585 ' N ' HG23 ' A' ' 115' ' ' ILE . 31.2 mt-10 -51.78 -53.07 43.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 109.826 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 76.2 mt-10 -57.37 -44.58 84.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.645 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -50.48 -44.98 56.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 110.27 179.919 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.535 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -42.64 -83.39 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.757 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.471 ' OE2' ' NZ ' ' A' ' 107' ' ' LYS . 11.7 pt-20 -47.06 -44.44 20.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -1.158 . . . . 0.0 110.33 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.459 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 17.8 mt -48.18 -57.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.916 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 125' ' ' THR . 18.2 mt -68.85 -47.63 65.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.95 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.32 -37.87 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 110.147 179.756 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.3 -31.33 43.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 122' ' ' LEU . 65.7 p -52.9 -34.55 55.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.88 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.19 24.71 5.86 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -120.83 169.89 10.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 110.156 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -92.35 76.5 5.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.139 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.38 149.17 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' ' 131' ' ' GLU . 7.2 pt -133.26 149.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.085 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.1 mt-10 -41.55 -49.39 4.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.56 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 10.8 mt-10 -42.42 -40.39 2.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.037 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -47.92 10.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 109.175 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.64 HG23 HD13 ' A' ' 118' ' ' LEU . 10.4 mt -55.2 -39.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.4 -0.813 . . . . 0.0 109.272 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -54.59 -42.18 70.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.527 -0.733 . . . . 0.0 109.948 179.49 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -56.85 -50.72 71.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 110.245 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.6 mp -54.63 -35.53 63.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.417 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 142' ' ' ASP . 2.1 ttm -74.64 -55.53 5.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 110.396 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -47.54 -55.54 8.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.61 -33.39 69.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.0 t -84.9 -62.34 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.344 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 138' ' ' MET . 3.4 t0 -40.44 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.406 -0.809 . . . . 0.0 110.694 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 mttt -76.66 -27.86 55.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.416 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 8.4 m-80 -104.24 1.44 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.796 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.39 17.57 7.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 110.314 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.23 -14.32 17.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.048 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.494 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 97.41 9.21 55.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.494 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 32.2 mtt85 -150.69 142.81 24.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.379 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.4 mt -83.7 137.62 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.048 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.74 -179.99 3.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 110.112 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.577 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 30.8 p90 -51.64 -42.49 62.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.577 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 1.9 m-20 -67.0 -58.48 4.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.885 . . . . 0.0 110.892 -179.434 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.416 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 39.6 mt-10 -59.46 -38.33 80.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.209 -0.932 . . . . 0.0 111.031 -179.321 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.488 ' CD2' ' SD ' ' A' ' 157' ' ' MET . 25.7 t80 -58.99 -57.38 13.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 110.619 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.697 HD22 ' HG2' ' A' ' 95' ' ' GLU . 64.6 mt -40.74 -50.07 3.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.317 -179.741 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -39.11 90.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.964 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.513 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -55.85 -46.52 78.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.362 -0.836 . . . . 0.0 109.869 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.652 ' HE1' HD13 ' A' ' 98' ' ' LEU . 1.7 tmm? -69.09 -14.74 63.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.74 . . . . 0.0 110.158 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.03 -24.14 30.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.89 45.24 1.09 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 87.7 t -52.57 111.09 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 0.0 110.128 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.435 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.219 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.228 0.537 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.09 134.53 35.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 0.0 110.168 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.88 34.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.063 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 40.33 1.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 110.153 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -137.81 -178.64 16.22 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -101.67 101.25 11.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -1.132 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -76.35 158.36 31.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 110.118 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -41.93 -44.38 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 110.298 -179.961 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -59.62 -44.11 93.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -0.906 . . . . 0.0 110.52 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.49 -62.57 1.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.737 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.514 HD21 ' HG2' ' A' ' 158' ' ' MET . 16.0 mt -46.61 -53.75 10.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.45 -37.51 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.36 -42.74 53.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 110.623 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -55.17 -24.61 27.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.968 . . . . 0.0 110.544 -179.704 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 101' ' ' CYS . 15.6 t80 -42.82 -54.57 4.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -67.13 -37.51 83.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.194 -0.941 . . . . 0.0 110.0 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.7 mm -57.53 -39.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.29 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.676 ' CD2' HD13 ' A' ' 121' ' ' ILE . 2.4 m-85 -83.59 -26.08 30.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -80.76 98.48 7.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.252 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -75.81 0.94 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.289 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -132.27 167.53 19.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -0.858 . . . . 0.0 110.244 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.79 29.07 0.94 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.418 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 8.8 p30 -76.26 -24.0 54.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.538 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 80.03 7.46 88.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 38.7 m-85 -153.07 133.75 13.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -1.175 . . . . 0.0 110.241 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.33 129.48 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.345 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 117' ' ' GLU . 35.4 p30 -101.99 -179.01 3.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.076 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -58.82 -43.47 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.064 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.563 ' N ' HG23 ' A' ' 115' ' ' ILE . 19.3 mt-10 -52.21 -51.93 55.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.073 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.5 mm-40 -57.56 -39.19 76.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.511 HD22 HD11 ' A' ' 122' ' ' LEU . 0.9 OUTLIER -60.01 -50.95 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 110.537 -179.68 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.498 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -49.64 -74.45 0.27 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' CD ' ' HA ' ' A' ' 117' ' ' GLU . 5.6 pt-20 -42.31 -47.7 4.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.434 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.676 HD13 ' CD2' ' A' ' 105' ' ' PHE . 6.1 mt -51.86 -58.37 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.511 HD11 HD22 ' A' ' 118' ' ' LEU . 64.7 mt -60.67 -47.1 87.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.289 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -36.78 66.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.201 -0.937 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.13 -42.22 28.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -0.862 . . . . 0.0 110.497 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.2 p -54.86 -48.44 72.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.4 35.97 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.05 147.75 48.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -1.065 . . . . 0.0 110.129 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.574 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -82.96 59.94 5.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 110.301 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 122' ' ' LEU . 7.9 t -61.7 156.81 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.407 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.4 pt -125.67 148.2 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.32 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLU . 4.3 mt-10 -45.99 -47.72 16.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.022 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' GLU . 1.9 mt-10 -42.58 -35.0 0.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.03 -43.63 12.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.498 HD13 ' HA2' ' A' ' 119' ' ' GLY . 14.1 mt -64.13 -40.04 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 109.633 179.36 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.8 -48.45 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.848 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -47.83 -53.79 14.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.76 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.537 ' HG ' ' HE2' ' A' ' 157' ' ' MET . 0.4 OUTLIER -50.76 -43.02 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.876 179.613 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -69.26 -53.69 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.615 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -53.76 46.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.079 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -57.59 -40.28 78.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 110.107 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.32 -59.03 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.207 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.1 m-20 -52.57 87.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.831 . . . . 0.0 110.533 -179.683 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.3 OUTLIER -68.25 -18.93 64.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.74 11.58 10.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.801 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 20.8 m-20 51.8 86.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -130.54 13.11 5.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 58.4 23.58 54.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 3.0 mtt85 -158.3 123.71 4.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 110.424 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 5.7 mt -84.52 122.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 109.817 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -101.58 -175.09 2.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.995 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -49.26 -57.79 6.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 110.552 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -61.55 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.691 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.72 -33.15 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.645 -179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 157' ' ' MET . 13.1 t80 -60.65 -64.34 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 110.614 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.1 mt -46.66 -58.07 4.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.443 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -47.11 -38.77 12.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.963 . . . . 0.0 110.409 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.537 ' HE2' ' HG ' ' A' ' 137' ' ' LEU . 0.9 OUTLIER -67.66 -48.71 65.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.881 . . . . 0.0 110.152 -179.957 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.524 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.3 tpp -87.73 21.0 2.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.369 -0.832 . . . . 0.0 110.411 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.99 125.17 41.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 110.132 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.76 55.8 4.8 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.7 t -76.28 129.13 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -1.19 . . . . 0.0 110.367 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.152 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 5.4 tp10 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.24 0.543 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.8 -57.14 7.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.556 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.6 OUTLIER -50.11 -46.2 53.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.095 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -43.61 -58.55 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -53.6 -51.93 61.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -43.79 -30.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.403 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 30.6 t80 -42.79 -59.77 1.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -36.66 71.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 47.2 mm -57.24 -29.51 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.944 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.05 -54.18 6.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.949 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 3.8 t70 -67.61 87.04 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.966 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -84.87 -2.81 58.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.464 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 110' ' ' ASP . 2.1 p30 -131.28 153.09 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.136 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.68 89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 110.145 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 108' ' ' ASN . 60.9 t0 -142.29 -34.54 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 110.284 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.53 10.18 35.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.46 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 31.2 m-85 -153.52 147.06 25.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -1.175 . . . . 0.0 110.052 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 149' ' ' ILE . 32.8 mt -90.99 114.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.336 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.87 179.9 4.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.566 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -66.66 -43.53 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 115' ' ' ILE . 2.4 mm-40 -50.75 -45.5 58.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.822 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 7.9 mt-10 -65.02 -38.41 90.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.9 OUTLIER -58.29 -38.53 77.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.118 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.413 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -47.75 -80.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -43.43 -54.15 4.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.323 -1.104 . . . . 0.0 110.743 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.501 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 14.0 mt -42.23 -61.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.71 -44.79 80.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -40.65 62.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.17 19.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.6 p -74.9 -169.33 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.11 56.57 0.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -116.83 -10.38 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 49.12 68.06 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.4 t -89.69 149.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.66 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' GLU . 18.0 pt -117.98 155.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.4 mt-10 -40.2 -50.1 2.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.33 -0.856 . . . . 0.0 110.887 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.4 -32.99 28.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 110.948 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -47.24 10.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 13.7 mt -58.2 -37.21 61.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.311 -0.868 . . . . 0.0 109.717 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.495 ' HA ' HD11 ' A' ' 115' ' ' ILE . 4.5 mt-10 -57.4 -47.8 80.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.44 -43.65 71.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 0.0 110.112 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.61 -44.37 69.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.129 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.6 ttm -64.68 -41.77 95.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 0.0 110.261 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -56.25 22.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.38 -19.19 21.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 110.671 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.559 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -102.51 -61.5 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 0.0 110.736 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' SER . 59.5 t0 -39.38 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.402 -0.811 . . . . 0.0 110.852 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -92.67 -5.61 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.863 . . . . 0.0 110.142 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 1.1 m-80 -127.49 21.6 6.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.166 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 47.6 46.94 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -105.45 14.46 28.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 110.228 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.429 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 46.53 30.94 4.77 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 11.0 mtt180 -157.52 128.74 6.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -1.113 . . . . 0.0 110.363 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.559 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.2 mt -83.48 123.54 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.683 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 20.4 p-10 -96.33 -167.36 1.56 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.355 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 18.2 p90 -65.23 -43.3 91.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.222 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.587 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -64.32 -58.32 6.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.312 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 143' ' ' LYS . 35.7 mt-10 -61.61 -42.83 99.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.521 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 17.4 t80 -56.49 -64.95 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 110.07 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 155' ' ' LEU . 32.5 mt -44.94 -48.49 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.379 -0.826 . . . . 0.0 110.001 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -46.91 -46.53 21.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -0.881 . . . . 0.0 110.375 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.547 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -71.43 -53.29 14.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.949 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.556 ' HB3' HD21 ' A' ' 98' ' ' LEU . 5.3 mmt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.946 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.319 0.581 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.2 mt-10 -47.89 -65.2 0.6 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 110.846 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' A' ' 154' ' ' PHE . 0.1 OUTLIER -51.19 -55.22 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 110.639 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -44.87 -44.77 9.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.256 -0.902 . . . . 0.0 110.687 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 3.0 m-20 -50.77 -52.0 45.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.741 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 105' ' ' PHE . 0.8 OUTLIER -61.17 -16.67 47.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.17 -0.956 . . . . 0.0 110.977 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 34.7 t80 -47.88 -41.25 23.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -0.998 . . . . 0.0 110.844 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -73.87 -37.8 64.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.0 111.095 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -57.06 -35.63 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 110.474 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 101' ' ' CYS . 28.8 m-85 -80.83 -36.57 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 110.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -79.67 80.13 6.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.034 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.456 ' HB2' ' OE2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -54.46 -30.49 53.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.479 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -109.35 -151.7 0.48 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.081 -1.012 . . . . 0.0 110.33 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.06 47.75 1.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 9.2 p30 -83.14 -18.01 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 80.13 -5.0 64.27 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 110' ' ' ASP . 7.4 m-85 -145.5 135.79 23.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -1.184 . . . . 0.0 109.876 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 mt -82.84 120.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.04 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 6.9 p-10 -87.84 176.65 7.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.158 -0.964 . . . . 0.0 110.324 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -69.72 -40.62 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.126 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 11.7 mt-10 -54.29 -48.86 70.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.021 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' OE2' ' HB2' ' A' ' 107' ' ' LYS . 3.5 mt-10 -53.3 -50.25 65.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.687 HD23 HG23 ' A' ' 134' ' ' ILE . 0.8 OUTLIER -58.28 -39.74 80.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.313 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.53 -73.99 0.34 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 14.5 pt-20 -54.85 -44.77 74.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.213 -1.169 . . . . 0.0 110.573 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 125' ' ' THR . 10.9 mt -53.01 -56.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 110.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.84 -54.59 32.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -55.99 -39.67 72.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -53.05 -20.22 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.253 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 121' ' ' ILE . 12.2 p -86.35 -1.95 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.12 81.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . 0.2 OUTLIER -79.32 0.5 28.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -1.112 . . . . 0.0 110.237 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 41.97 45.75 3.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 127' ' ' GLU . 14.8 t -77.86 155.22 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.199 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 130' ' ' ILE . 20.7 pt -114.96 138.27 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 110.409 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ILE . 8.9 mt-10 -41.02 -43.44 2.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HB2' HG13 ' A' ' 130' ' ' ILE . 1.5 mm-40 -40.72 -38.53 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.303 -0.873 . . . . 0.0 110.6 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.84 -48.96 8.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.659 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.687 HG23 HD23 ' A' ' 118' ' ' LEU . 13.3 mt -58.12 -39.45 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.863 ' HA ' HD11 ' A' ' 115' ' ' ILE . 4.5 tt0 -66.79 -41.6 87.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.589 -0.695 . . . . 0.0 110.021 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.81 -42.26 75.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.968 . . . . 0.0 110.086 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.43 78.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 31.2 tpp -61.64 -40.5 95.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.875 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -59.12 -49.42 77.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 110.104 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -68.19 -41.38 81.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.031 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.54 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -73.99 -63.97 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 138' ' ' MET . 9.7 t0 -45.41 97.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -82.14 -24.22 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.431 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 10.3 m-80 -107.76 14.78 25.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.887 . . . . 0.0 110.161 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.15 47.7 19.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 51.1 p30 -105.32 25.57 10.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 44.33 35.46 3.82 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 86.6 mtt180 -157.91 121.35 4.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.54 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.2 mt -83.62 118.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.432 ' OD2' ' OE2' ' A' ' 153' ' ' GLU . 41.0 p30 -97.18 -179.78 4.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 110.445 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -59.27 3.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.43 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -61.12 2.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.496 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 157' ' ' MET . 16.7 mt-10 -60.73 -39.95 90.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.366 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' A' ' 98' ' ' LEU . 21.5 t80 -59.68 -33.09 71.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -0.872 . . . . 0.0 110.975 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 155' ' ' LEU . 25.1 mt -74.3 -46.45 40.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 110.974 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 157' ' ' MET . 63.5 mttt -66.67 -49.41 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -0.962 . . . . 0.0 110.834 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.73 -50.51 7.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.015 -1.053 . . . . 0.0 110.372 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.467 ' HB2' ' SD ' ' A' ' 157' ' ' MET . 9.8 ttm . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 1.1 tp10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.318 0.58 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -49.8 -66.32 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.119 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.3 OUTLIER -50.1 -45.62 52.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -47.81 -42.65 26.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 110.27 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 104' ' ' ILE . 42.4 m-20 -48.1 -46.19 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.5 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 m -78.21 -25.67 47.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 0.0 110.904 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -52.95 -62.65 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -0.999 . . . . 0.0 110.729 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -57.15 -27.98 62.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.897 . . . . 0.0 110.92 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 100' ' ' ASN . 45.6 mm -61.42 -26.3 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.026 -1.046 . . . . 0.0 110.464 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.13 -29.21 24.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -79.87 117.24 20.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.079 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 -11.47 15.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.289 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 109' ' ' ALA . 56.6 m-80 -116.34 16.11 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.302 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 43.98 79.42 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.17 -33.13 5.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 110.23 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.519 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 111.85 -14.35 26.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.519 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 18.7 m-85 -149.93 141.25 23.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -1.087 . . . . 0.0 109.826 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 44.4 mt -82.81 130.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 8.2 p30 -95.17 -176.87 3.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.1 tt -79.18 -44.98 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 110.508 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.605 ' N ' HG23 ' A' ' 115' ' ' ILE . 21.6 pt-20 -48.99 -35.13 14.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 116' ' ' GLU . 43.2 mt-10 -69.12 -42.31 76.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.622 HD23 HG23 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -57.36 -37.88 73.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.31 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -57.11 -72.95 0.5 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.4 pt-20 -53.95 -44.63 70.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -1.127 . . . . 0.0 110.701 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.2 mt -45.05 -56.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.009 . . . . 0.0 110.481 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.716 ' O ' HG22 ' A' ' 125' ' ' THR . 15.7 mt -66.24 -52.31 48.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.684 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -48.71 -30.93 6.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 110.681 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.45 -56.62 18.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.743 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.716 HG22 ' O ' ' A' ' 122' ' ' LEU . 2.3 t -63.2 -10.15 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.559 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 128' ' ' HIS . . . 111.52 -29.1 8.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 129' ' ' VAL . 4.2 mm-40 -52.24 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' GLY . 8.1 m80 -67.32 76.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 109.975 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 127' ' ' GLU . 13.3 t -84.29 136.85 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.47 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 ' HB2' ' A' ' 133' ' ' ASP . 17.2 pt -90.97 143.59 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -42.95 -46.96 5.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 110.454 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -48.03 -27.23 2.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.458 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.486 ' HB2' HG13 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -89.68 -41.89 11.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.619 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.622 HG23 HD23 ' A' ' 118' ' ' LEU . 36.7 mt -65.64 -37.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.915 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.16 -48.46 73.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.91 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 12.8 t0 -55.57 -45.94 77.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -57.7 8.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.975 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 2.0 ttm -56.18 -20.88 19.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -72.89 -44.75 60.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 110.428 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -73.94 -34.48 64.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 110.716 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -74.04 -63.14 1.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.027 . . . . 0.0 110.547 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 138' ' ' MET . 23.2 m-20 -41.89 96.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.483 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -72.84 -3.81 27.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.31 22.57 2.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 48.94 86.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 110.337 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' OD1' ' CG ' ' A' ' 142' ' ' ASP . 17.6 p-10 -139.94 17.81 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 48.32 32.16 9.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 45.5 mtt180 -158.19 121.69 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.189 . . . . 0.0 110.454 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.8 mt -83.53 123.71 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.667 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 23.1 p30 -103.94 -177.44 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.617 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.89 ' CE2' HD11 ' A' ' 155' ' ' LEU . 29.7 t80 -49.95 -62.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.629 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.512 ' HA ' HD12 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -48.83 -57.61 6.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.367 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.472 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 79.7 mt-10 -59.94 -39.63 86.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 109.989 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 33.0 t80 -63.34 -51.48 65.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.89 HD11 ' CE2' ' A' ' 151' ' ' PHE . 37.3 mt -47.53 -54.06 12.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.452 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -60.55 -51.2 70.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.609 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.506 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.1 ptm -48.75 -47.54 41.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.595 ' HB3' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.228 0.537 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -51.39 -62.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 110.079 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -47.78 -62.18 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 110.06 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -44.91 -47.37 11.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.877 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 1.8 m-20 -50.88 -52.71 39.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -18.54 39.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 110.131 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 16.0 t80 -55.06 -55.87 26.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -57.06 -42.89 81.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -0.885 . . . . 0.0 110.636 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 1.2 mp -57.21 -41.71 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.135 -0.978 . . . . 0.0 110.273 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.455 ' CE2' ' HE3' ' A' ' 158' ' ' MET . 10.9 m-85 -72.11 -43.64 64.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 0.0 110.486 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.64 102.58 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -84.14 -44.34 14.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 110.475 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -68.09 -8.04 34.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.226 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.47 24.77 1.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 112' ' ' PHE . 4.0 p30 -68.16 -20.99 64.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 110.278 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.489 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 112.09 -15.77 25.52 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 9.7 m-85 -148.01 134.13 19.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -1.165 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.5 mt -82.5 133.78 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.297 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 6.4 p-10 -107.28 -171.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 110.141 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.4 tt -72.51 -43.42 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 110.187 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.587 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -55.83 -35.6 66.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.131 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -74.97 -52.31 11.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 110.417 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -38.86 -30.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.46 -0.775 . . . . 0.0 111.065 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 117' ' ' GLU . . . -56.03 -43.76 88.18 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 11.4 pt-20 -49.28 -45.86 45.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.125 -1.22 . . . . 0.0 110.942 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.518 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 1.5 mp -60.26 -50.39 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.677 HD12 ' O ' ' A' ' 118' ' ' LEU . 4.3 mp -69.08 -52.26 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.034 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 24.9 mtp180 -49.64 -36.93 26.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.32 23.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 0.0 110.324 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.8 p -61.14 -40.37 93.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.392 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.29 -3.97 9.58 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -92.66 133.47 35.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.26 60.21 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 110.136 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.545 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 38.6 t -45.48 166.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.442 ' N ' HG12 ' A' ' 129' ' ' VAL . 31.9 pt -118.52 151.99 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.99 -48.44 3.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.382 -0.824 . . . . 0.0 110.78 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -48.88 -31.54 7.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.824 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.545 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -83.19 -43.95 15.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.2 mt -66.2 -38.15 81.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.506 -0.746 . . . . 0.0 109.822 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.498 ' HA ' HD12 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.98 -53.18 44.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 110.536 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -45.98 -51.31 13.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 0.0 110.45 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.56 HD12 ' HE3' ' A' ' 157' ' ' MET . 1.5 mm? -50.58 -41.27 54.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.553 ' HE2' HD12 ' A' ' 149' ' ' ILE . 20.9 tpp -67.97 -48.96 64.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -48.21 79.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.63 -32.42 69.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 143' ' ' LYS . 2.1 t -92.99 -38.06 11.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' MET . 1.4 m-20 -51.99 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 8.3 tptm -74.63 -18.19 60.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.911 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 1.6 m-80 -117.77 10.68 13.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.989 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.0 m120 55.31 46.13 24.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -0.881 . . . . 0.0 110.322 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -107.04 16.12 24.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 51.52 34.96 35.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 5.6 mtm180 -157.63 124.82 5.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -1.214 . . . . 0.0 110.223 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.553 HD12 ' HE2' ' A' ' 138' ' ' MET . 4.2 mt -83.94 128.55 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 0.0 110.131 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.451 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 53.3 p-10 -108.73 -170.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 110.087 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -63.5 -37.87 88.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.93 -51.85 35.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.451 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 46.8 mt-10 -59.7 -45.41 92.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.566 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 155' ' ' LEU . 1.9 t80 -50.61 -57.97 6.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.768 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.7 mt -39.92 -64.15 0.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.468 -0.77 . . . . 0.0 110.677 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -30.97 66.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.56 ' HE3' HD12 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -65.5 -40.31 92.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.53 ' N ' ' HG3' ' A' ' 157' ' ' MET . 2.5 mtt . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 0.0 110.169 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.247 0.546 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 1.9 mt-10 -59.71 -54.01 51.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.701 HD22 ' HE1' ' A' ' 154' ' ' PHE . 14.1 mt -50.78 -64.13 0.91 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.89 -46.01 10.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 67.7 m-20 -56.01 -48.29 76.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 73.8 m -45.33 -29.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -44.89 -62.97 1.02 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 109.82 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.39 -42.01 61.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 21.0 mm -61.28 -39.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.0 -51.96 48.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.865 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 21.0 t0 -53.42 129.37 31.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.517 -0.739 . . . . 0.0 110.418 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -98.29 -14.43 20.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.191 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 4.3 p30 -133.47 12.0 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 55.39 57.35 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 36.0 p30 -84.85 -14.57 47.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 94.07 -10.52 71.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CB ' ' HD2' ' A' ' 148' ' ' ARG . 46.7 m-85 -151.41 136.42 17.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -1.227 . . . . 0.0 110.635 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.9 mt -88.28 121.65 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' HG3' ' A' ' 117' ' ' GLU . 13.6 p30 -98.3 171.01 8.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.229 -0.919 . . . . 0.0 110.342 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -58.49 -36.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.451 ' N ' HG23 ' A' ' 115' ' ' ILE . 70.8 mm-40 -51.03 -54.04 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.877 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 51.6 mt-10 -56.38 -41.58 76.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.787 ' HG ' HD21 ' A' ' 137' ' ' LEU . 0.3 OUTLIER -54.73 -43.56 72.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -56.44 -75.47 0.25 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 16.1 pt-20 -42.35 -45.06 4.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -1.12 . . . . 0.0 110.479 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.497 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 41.5 mt -55.22 -55.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.722 HD22 HG21 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -63.15 -53.67 49.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 110.442 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -48.82 -40.36 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.19 -34.39 22.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.286 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 36.4 p -70.01 -23.33 63.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.962 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.1 3.76 26.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HB3' HG23 ' A' ' 129' ' ' VAL . 11.9 mt-10 -89.59 132.9 34.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.311 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -85.38 53.36 2.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.722 HG21 HD22 ' A' ' 122' ' ' LEU . 22.6 t -65.28 149.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.868 . . . . 0.0 110.518 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 132' ' ' GLU . 6.2 pt -113.76 153.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.8 tt0 -41.71 -53.02 3.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.536 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -44.32 -36.45 2.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.72 -42.05 22.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 109.099 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 17.0 mt -67.18 -36.53 77.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.52 -0.737 . . . . 0.0 109.565 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 138' ' ' MET . 2.8 tm-20 -56.26 -32.47 64.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 109.838 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -49.83 -62.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 110.767 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.904 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.1 pp -56.88 -27.97 61.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.987 . . . . 0.0 110.651 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.436 ' N ' HD12 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -67.01 -46.82 73.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.03 . . . . 0.0 110.046 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.84 72.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -59.9 -36.37 76.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.552 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -86.11 -59.06 2.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 145' ' ' ASN . 53.9 t0 -43.44 92.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -92.3 -20.06 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 15.1 m-80 -104.74 6.4 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.03 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.0 OUTLIER 63.93 28.49 14.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 110.211 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -87.76 8.66 24.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.76 24.66 33.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.538 ' HD2' ' CB ' ' A' ' 112' ' ' PHE . 1.4 mtt-85 -147.69 142.58 26.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -1.155 . . . . 0.0 110.189 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.904 HD11 ' CD1' ' A' ' 137' ' ' LEU . 19.4 mt -90.65 121.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.372 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 36.4 p-10 -97.7 -156.32 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 0.0 109.907 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -71.18 -55.79 7.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.31 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -59.32 -60.21 4.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.908 . . . . 0.0 110.548 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.49 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 26.6 mt-10 -48.02 -37.74 15.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.316 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.701 ' HE1' HD22 ' A' ' 98' ' ' LEU . 50.9 t80 -60.37 -61.04 2.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 154' ' ' PHE . 91.4 mt -41.76 -39.03 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.435 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 152' ' ' ASP . 8.8 mttm -58.42 -45.48 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 110.365 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.863 ' HE1' HD13 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -64.17 -51.2 64.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.826 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.581 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 110.572 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.236 0.541 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -67.88 -52.97 30.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.287 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.509 HD22 ' HE2' ' A' ' 158' ' ' MET . 0.1 OUTLIER -52.15 -53.39 43.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.97 44.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.95 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -77.02 -46.0 25.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -49.01 -27.26 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.967 . . . . 0.0 110.092 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.626 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 2.3 t80 -42.08 -56.54 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -56.93 -34.12 67.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.326 -0.859 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.61 -59.83 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.358 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.675 ' O ' HD11 ' A' ' 121' ' ' ILE . 3.0 m-85 -62.42 -38.37 89.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -85.76 62.24 7.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.229 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -35.43 10.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.182 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.424 ' HB3' ' OD2' ' A' ' 110' ' ' ASP . 1.5 t-20 -55.51 -21.26 15.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.02 47.18 25.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 108' ' ' ASN . 33.1 m-20 -106.94 -13.86 15.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.542 ' C ' ' CD1' ' A' ' 112' ' ' PHE . . . 97.87 -2.43 60.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 111' ' ' GLY . 63.5 m-85 -150.57 119.42 6.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.24 . . . . 0.0 110.273 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.409 ' HA ' ' OE2' ' A' ' 117' ' ' GLU . 15.7 mt -83.79 116.39 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.34 -0.85 . . . . 0.0 110.112 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -92.59 175.28 6.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.578 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -57.05 -42.73 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.894 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.578 ' N ' HG23 ' A' ' 115' ' ' ILE . 4.5 mt-10 -51.01 -45.87 61.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.093 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.4 mt-10 -58.47 -50.48 73.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.89 . . . . 0.0 110.127 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 137' ' ' LEU . 0.3 OUTLIER -52.1 -34.65 45.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.893 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -70.28 -69.25 1.43 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -48.52 -45.24 37.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.237 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.675 HD11 ' O ' ' A' ' 105' ' ' PHE . 47.3 mt -57.0 -50.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 122' ' ' LEU . 12.9 mt -76.72 -53.98 7.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.965 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 9.5 mtt180 -49.07 -32.24 9.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.098 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -57.15 -43.24 82.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.4 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 81.0 p -55.66 -43.57 76.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.26 -39.37 1.69 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 129' ' ' VAL . 1.9 mt-10 -46.02 125.23 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.136 . . . . 0.0 110.321 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.56 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.3 OUTLIER -71.67 65.47 0.49 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 127' ' ' GLU . 5.3 t -64.67 148.68 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.155 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.47 145.24 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.393 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLU . 15.7 mt-10 -43.86 -50.16 8.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.326 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -42.51 -32.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.366 -0.834 . . . . 0.0 109.992 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.76 -47.0 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.8 mt -59.69 -38.7 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 0.0 109.785 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -48.97 -48.79 42.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -51.24 -46.84 62.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 118' ' ' LEU . 10.5 mt -53.48 -52.92 58.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 110.884 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 31.9 tpp -66.67 -52.35 45.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 0.0 110.167 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -60.7 2.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.45 -0.781 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.24 -37.67 67.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 0.0 110.666 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.544 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.68 -55.4 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 110.557 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -46.74 91.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.593 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -80.81 -38.73 27.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.106 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.417 ' ND2' ' OD1' ' A' ' 146' ' ' ASP . 6.7 p30 -95.8 12.5 29.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.873 . . . . 0.0 110.082 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 2.4 m120 53.49 87.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 110.55 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 148' ' ' ARG . 6.8 p-10 -143.97 13.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 109.628 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 56.86 20.78 34.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HG3' ' C ' ' A' ' 147' ' ' GLY . 30.7 mtt-85 -149.77 133.83 17.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.995 -1.297 . . . . 0.0 110.607 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.544 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.9 mt -84.29 132.85 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.812 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 24.4 p-10 -112.55 -170.01 1.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.458 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.626 ' CE1' ' CD2' ' A' ' 102' ' ' PHE . 3.3 m-85 -59.38 -56.58 20.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.411 ' HA ' HD12 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -52.33 -59.17 4.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.225 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 157' ' ' MET . 54.2 mt-10 -57.39 -46.79 83.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.539 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 84.5 t80 -47.86 -32.24 5.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 110.233 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.532 ' O ' ' CE ' ' A' ' 158' ' ' MET . 27.7 mt -75.68 -50.64 14.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -49.42 74.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.184 -0.948 . . . . 0.0 110.954 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.77 -47.61 8.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 111.245 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 155' ' ' LEU . 6.2 ptp . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 0.0 110.616 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.273 0.558 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -47.54 -46.92 28.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.866 . . . . 0.0 109.919 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.501 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 3.8 mm? -57.03 -48.54 78.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -49.08 -53.11 21.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.45 78.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.121 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -53.19 -19.2 2.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 44.3 t80 -50.5 -50.22 53.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 110.188 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -30.6 69.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.418 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 26.2 mm -56.89 -38.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -85.22 -11.85 53.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -91.24 106.6 18.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -9.29 33.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.338 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.488 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 66.4 m-80 -117.09 9.26 13.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.922 . . . . 0.0 110.312 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 44.02 43.49 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 10.8 m-20 -80.3 -22.43 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.36 -7.98 62.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 44.8 m-85 -151.81 125.06 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 149' ' ' ILE . 2.9 mp -83.31 112.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.955 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 15.2 p-10 -92.97 -173.24 3.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.3 tt -69.69 -41.9 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.867 . . . . 0.0 110.523 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -53.81 -55.39 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 24.0 mt-10 -45.4 -55.05 6.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.355 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.746 HD23 HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -48.77 -54.01 16.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.359 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -47.39 -77.06 0.12 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.9 pt-20 -42.67 -47.9 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.502 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 117' ' ' GLU . 8.0 mt -47.29 -55.43 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.011 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.746 HD12 HD23 ' A' ' 118' ' ' LEU . 2.4 mt -76.63 -54.86 6.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.211 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -49.06 -36.37 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.899 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -48.88 -39.66 26.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.052 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 69.9 p -66.76 -38.47 86.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.45 32.57 4.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 128' ' ' HIS . 8.6 mm-40 -97.02 7.08 47.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.319 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 127' ' ' GLU . 14.5 m-70 43.58 72.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 122' ' ' LEU . 57.7 t -88.62 154.92 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.343 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 130' ' ' ILE . 17.6 pt -103.38 145.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 110.177 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.1 mt-10 -49.85 -41.05 44.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.377 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.1 tm-20 -41.69 -33.38 0.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 110.357 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -44.78 12.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 0.0 109.418 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.634 HG23 HD22 ' A' ' 118' ' ' LEU . 26.9 mt -65.59 -38.95 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.505 -0.747 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 13.2 mm-40 -56.64 -50.52 71.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.47 -0.769 . . . . 0.0 110.277 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.93 -55.02 10.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.935 . . . . 0.0 110.408 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.464 HD13 HD21 ' A' ' 118' ' ' LEU . 45.3 mt -48.96 -52.95 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.496 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.513 ' HG3' ' HB2' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -71.08 -50.01 38.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.88 . . . . 0.0 110.418 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 14.1 mttm -56.53 -39.7 73.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.424 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.43 -40.66 61.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.538 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -83.86 -52.19 6.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 110.653 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.513 ' HB2' ' HG3' ' A' ' 138' ' ' MET . 29.5 t0 -46.45 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.401 -0.812 . . . . 0.0 111.01 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 30.3 tttt -77.71 -23.93 49.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -99.35 -5.61 29.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.69 . . . . 0.0 109.636 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.469 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 1.5 m-20 59.84 24.86 13.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 20.6 p30 -85.17 2.58 43.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 75.94 38.73 35.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 14.7 mtm180 -159.14 133.45 7.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.498 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 141' ' ' SER . 2.0 mt -97.81 123.89 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -105.48 -173.91 2.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 54.1 p90 -57.25 -43.49 83.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 110.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.603 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -63.75 -51.4 65.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.018 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 53.5 mt-10 -65.16 -52.51 54.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.089 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 102' ' ' PHE . 5.9 t80 -46.72 -57.28 5.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' PHE . 71.3 mt -45.3 -63.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -60.69 -25.2 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 110.019 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.525 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -60.85 -38.03 84.13 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.262 -0.899 . . . . 0.0 109.148 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.525 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 109.985 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.151 0.5 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -49.69 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.472 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.635 HD12 ' CE ' ' A' ' 158' ' ' MET . 21.3 mt -53.0 -43.06 66.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 110.274 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.31 -61.0 2.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -55.41 -49.72 71.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.498 ' SG ' ' CE2' ' A' ' 105' ' ' PHE . 42.5 t -59.93 -19.95 54.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.65 -57.47 11.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.054 -1.029 . . . . 0.0 110.177 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.79 -37.09 3.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 104' ' ' ILE . 2.0 mp -67.88 -53.06 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.498 ' CE2' ' SG ' ' A' ' 101' ' ' CYS . 11.9 m-85 -54.03 -31.21 50.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 110.028 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 18.7 t0 -87.2 91.52 8.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.906 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 -41.97 65.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.522 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 109' ' ' ALA . 32.8 m-80 -87.19 6.38 33.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 43.0 63.14 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -96.92 -11.79 24.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.301 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 90.78 -15.11 61.34 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 46.0 m-85 -147.35 125.02 11.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 110.074 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.84 131.13 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.95 -167.4 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.167 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.798 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -72.49 -41.02 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.932 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.506 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 1.6 tm-20 -57.03 -53.94 52.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.475 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 22.5 mt-10 -53.15 -38.2 62.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.33 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.461 HD11 HD22 ' A' ' 137' ' ' LEU . 0.9 OUTLIER -60.58 -51.35 69.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -50.1 -74.21 0.3 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.475 ' OE2' ' HA ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -42.47 -54.61 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -1.141 . . . . 0.0 110.671 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.441 HG13 ' CD ' ' A' ' 120' ' ' GLU . 17.1 mt -49.13 -53.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 122' ' ' LEU . 36.3 mt -69.1 -46.23 68.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.355 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -39.4 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.92 -44.05 29.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 126' ' ' GLY . 32.9 p -55.55 -64.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.455 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . 142.32 37.76 0.08 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.75 154.85 24.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -1.131 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 128' ' ' HIS . 12.1 p-80 -90.01 63.5 5.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 110.645 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.2 t -82.49 135.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.976 . . . . 0.0 109.737 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.0 pt -102.78 145.07 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.508 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.2 mt-10 -42.74 -53.97 4.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.41 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -40.49 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.828 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -85.89 -51.24 6.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.77 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.0 mt -60.82 -41.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 109.699 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.798 ' HA ' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -50.03 -50.99 45.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.89 -36.85 84.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 118' ' ' LEU . 2.0 tt -50.35 -44.36 54.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.611 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 ttm -67.11 -42.43 84.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.172 -0.955 . . . . 0.0 110.507 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -64.19 -44.34 92.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -68.53 -36.81 79.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.187 -0.945 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.552 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.0 t -80.78 -49.8 10.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.505 ' HA ' ' OE2' ' A' ' 153' ' ' GLU . 38.5 t70 -60.55 90.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.63 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.47 49.12 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 73.5 m-80 -147.61 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.465 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.6 m-20 172.06 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.604 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 35.2 p-10 -41.54 -25.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 76.64 51.54 6.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 2.5 mtm180 -158.13 153.66 26.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 110.35 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.552 HG12 ' CB ' ' A' ' 141' ' ' SER . 22.1 mt -88.97 114.17 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.901 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 26.5 p30 -105.9 -172.48 2.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 22.3 p90 -57.62 -37.07 72.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 110.757 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.612 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -70.44 -52.78 19.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' HA ' ' A' ' 142' ' ' ASP . 48.5 mt-10 -68.45 -43.74 76.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.927 . . . . 0.0 110.259 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.537 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 37.4 t80 -49.23 -33.88 13.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.538 ' O ' ' CE ' ' A' ' 158' ' ' MET . 94.8 mt -76.1 -42.02 48.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -69.15 -49.01 60.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.053 -1.029 . . . . 0.0 110.673 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.537 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -44.43 -48.24 9.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.213 -0.93 . . . . 0.0 111.056 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.635 ' CE ' HD12 ' A' ' 98' ' ' LEU . 5.8 ptp . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.186 -0.946 . . . . 0.0 110.217 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 1.6 mt-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.33 0.586 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -54.17 -55.74 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.292 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 12.7 mt -51.53 -47.1 63.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -41.82 -58.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 110.314 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -65.57 -26.96 68.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.912 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -74.89 -9.08 58.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -55.21 -47.62 75.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.019 -1.051 . . . . 0.0 110.013 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -60.43 -35.57 76.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 18.0 mm -59.67 -32.59 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.005 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 107' ' ' LYS . 3.0 m-85 -80.22 -59.0 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -58.32 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 109.932 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -53.39 -43.34 67.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.34 -0.85 . . . . 0.0 110.563 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -94.13 -159.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.35 60.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.57 -32.4 12.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.159 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.537 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 99.74 -3.73 57.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 36.2 m-85 -153.35 123.92 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 113' ' ' ILE . 3.8 mp -83.58 122.38 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.309 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -95.77 178.47 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.1 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.636 HD11 ' HG2' ' A' ' 135' ' ' GLU . 2.2 tt -57.3 -42.7 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.027 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -51.82 -53.81 36.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.897 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 4.1 mt-10 -52.17 -47.21 65.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.959 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.566 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -54.77 -27.63 42.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 0.0 109.837 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.45 -68.71 1.51 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.3 pt-20 -49.89 -44.51 49.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.237 . . . . 0.0 110.177 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.566 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 20.2 mt -49.28 -61.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' A' ' 129' ' ' VAL . 1.0 OUTLIER -68.74 -43.7 75.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.012 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -50.77 -39.47 52.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.18 -44.19 75.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.0 110.381 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 p -60.89 -31.62 71.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.15 -0.969 . . . . 0.0 110.161 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.86 20.24 29.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 128' ' ' HIS . 2.2 mt-10 -88.9 23.13 2.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -1.162 . . . . 0.0 110.225 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.583 ' C ' HG23 ' A' ' 129' ' ' VAL . 1.5 t60 56.94 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 122' ' ' LEU . 2.9 t 70.18 143.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.587 -0.696 . . . . 0.0 110.031 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.3 pt -123.18 146.85 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.137 -0.977 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.64 -46.32 14.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 110.121 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.03 -28.93 1.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' O ' HD12 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -92.7 -48.98 6.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 118' ' ' LEU . 22.6 mt -55.61 -39.29 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.074 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.636 ' HG2' HD11 ' A' ' 115' ' ' ILE . 7.0 mt-10 -58.28 -46.14 86.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -50.69 -52.11 43.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.6 OUTLIER -53.94 -43.27 69.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.089 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -71.08 -53.89 13.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.187 -0.946 . . . . 0.0 109.857 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -59.57 4.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -49.7 -40.51 40.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 110.202 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.554 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.2 t -77.12 -57.32 3.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER -61.15 75.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 110.551 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -79.66 4.12 17.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 179.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 144' ' ' ASN . 1.4 t30 -121.88 10.09 10.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.603 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.29 26.26 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -1.82 18.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.359 -0.838 . . . . 0.0 110.209 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.436 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 60.97 17.07 50.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.469 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 1.1 mtt-85 -158.34 143.39 16.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.33 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.554 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.7 mt -87.63 116.66 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.74 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 154' ' ' PHE . 53.4 p-10 -101.42 -175.41 2.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -54.52 38.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.09 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.13 -62.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 110.367 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 154' ' ' PHE . 68.1 mt-10 -57.21 -50.82 71.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.164 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 14.4 t80 -43.39 -56.18 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.869 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.72 -51.34 68.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -53.69 -50.56 65.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.501 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -50.93 -46.13 60.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.501 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.616 -0.678 . . . . 0.0 110.099 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.204 0.526 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.98 -48.82 42.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.805 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.536 ' CD1' ' HB3' ' A' ' 158' ' ' MET . 2.2 mm? -51.38 -61.45 2.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.039 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.11 -51.93 16.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.922 . . . . 0.0 110.228 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 71.6 m-20 -51.23 -34.04 30.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 110.143 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.41 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 61.0 m -68.19 -15.09 63.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.215 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -56.24 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 100' ' ' ASN . 6.8 ptp180 -52.47 -37.67 57.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.289 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 13.0 mm -57.8 -45.76 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 110.261 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -53.95 34.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.21 146.52 54.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.509 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -125.49 -47.1 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.977 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 66.2 m-20 -79.04 2.76 19.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 56.45 59.35 3.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.174 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.7 -21.52 20.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.23 -15.99 60.62 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 40.5 m-85 -153.09 130.06 11.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 110.043 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.45 125.1 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.893 . . . . 0.0 110.626 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -104.27 -157.81 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.825 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.458 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -75.5 -37.39 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.133 -0.98 . . . . 0.0 109.976 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.458 ' N ' HG23 ' A' ' 115' ' ' ILE . 57.1 mt-10 -55.71 -44.4 77.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -63.78 -44.46 93.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.668 HD12 HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -56.76 -33.98 67.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -65.89 -74.21 0.54 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -42.12 -59.87 1.63 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.222 -1.163 . . . . 0.0 110.961 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 120' ' ' GLU . 4.2 mt -43.69 -50.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.001 -1.062 . . . . 0.0 109.974 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.845 HD13 HG11 ' A' ' 129' ' ' VAL . 11.1 mt -77.4 -42.45 36.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.398 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 44.6 mtt180 -55.68 -32.85 63.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.94 48.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.0 110.125 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.8 p -77.14 -157.66 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.92 58.12 0.69 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.06 164.48 26.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -1.137 . . . . 0.0 110.506 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.12 94.01 7.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.881 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.845 HG11 HD13 ' A' ' 122' ' ' LEU . 4.0 t -109.73 72.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.327 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 19.0 pt -62.57 159.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.2 tt0 -46.19 -49.5 16.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.503 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 2.4 mt-10 -40.99 -35.8 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.334 -0.854 . . . . 0.0 110.381 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.31 -47.46 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.661 ' CG1' HG12 ' A' ' 129' ' ' VAL . 17.6 mt -60.14 -41.03 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HG2' ' HG2' ' A' ' 131' ' ' GLU . 4.9 mm-40 -57.6 -36.79 72.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.513 -0.742 . . . . 0.0 110.051 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -51.25 -50.32 59.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.845 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.1 OUTLIER -56.68 -43.91 80.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.405 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -68.24 -43.84 77.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 110.043 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -64.9 -43.46 92.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.42 -33.21 69.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 0.0 110.327 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.523 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.9 OUTLIER -86.03 -61.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.935 . . . . 0.0 110.394 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 60.6 t0 -41.14 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.559 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 76.4 tttt -99.18 2.5 45.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.525 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 0.6 OUTLIER -134.41 16.85 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.662 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 8.9 m-20 48.01 51.53 14.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.443 -0.786 . . . . 0.0 110.341 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -104.61 4.57 32.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.88 11.18 60.22 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 6.0 mtp180 -147.56 146.43 29.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.142 -1.211 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.678 HG21 ' CE ' ' A' ' 157' ' ' MET . 4.7 mt -89.72 113.83 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.364 -0.835 . . . . 0.0 109.998 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.49 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 48.8 p30 -90.02 179.18 6.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.422 ' O ' ' HG ' ' A' ' 155' ' ' LEU . 16.8 m-85 -42.82 -59.19 2.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.349 -0.844 . . . . 0.0 110.28 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.94 -56.89 15.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.49 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 45.8 mt-10 -57.36 -46.9 82.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.901 ' HA ' ' HE3' ' A' ' 157' ' ' MET . 35.5 t80 -59.53 -56.36 22.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 151' ' ' PHE . 32.4 mt -45.74 -48.67 15.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 -57.92 6.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 0.0 110.081 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.901 ' HE3' ' HA ' ' A' ' 154' ' ' PHE . 1.3 ptp -47.45 -50.77 22.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.715 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.57 ' N ' ' CG ' ' A' ' 157' ' ' MET . 13.1 mmt . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.424 -0.798 . . . . 0.0 110.352 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.242 0.544 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -48.59 -60.14 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 110.342 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 99' ' ' ALA . 28.5 mt -58.96 -58.54 8.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -42.47 -40.39 2.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.144 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 90.8 m-20 -62.34 -35.63 79.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 98' ' ' LEU . 71.8 m -67.57 -36.54 81.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 43.0 t80 -42.67 -56.34 3.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 110.22 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -44.53 61.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -62.82 -54.55 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.339 -0.851 . . . . 0.0 109.913 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -58.63 -43.2 89.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 109.934 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.456 ' OD1' ' OE1' ' A' ' 117' ' ' GLU . 14.0 t0 -85.19 109.02 18.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -122.08 -28.92 4.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.449 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 5.6 p30 -97.15 -44.33 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -87.54 -42.24 12.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.887 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 7.6 m-20 47.93 23.96 0.55 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . -142.83 -36.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 76.7 m-85 -149.63 136.94 19.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -1.101 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.42 ' CD1' ' CD1' ' A' ' 154' ' ' PHE . 24.3 mt -82.56 131.5 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.101 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.48 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 28.4 p30 -119.11 -162.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -83.05 -42.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.577 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -52.49 -41.57 63.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' OE1' ' OD1' ' A' ' 106' ' ' ASP . 2.2 mt-10 -64.93 -37.93 89.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -65.82 -46.24 79.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.972 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -46.01 -75.66 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' GLY . 5.1 pt-20 -43.24 -47.76 6.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -1.125 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.94 -55.42 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 110.113 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.69 HD22 HG11 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -63.14 -43.16 99.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.986 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -38.92 64.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.274 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.81 -30.86 6.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -0.945 . . . . 0.0 110.265 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.2 p -73.85 -29.85 62.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.77 53.84 1.88 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.7 mm-40 -129.71 148.47 51.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -1.13 . . . . 0.0 110.214 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 128' ' ' HIS . 23.2 p80 -71.3 58.34 0.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.13 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 122' ' ' LEU . 4.5 t -75.9 151.81 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 110.274 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.0 pt -139.61 155.94 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.885 . . . . 0.0 110.138 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.474 ' CA ' ' OE1' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -48.03 -47.88 33.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 3.6 mm-40 -42.11 -38.22 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -48.84 7.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 10.6 mt -61.46 -43.27 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -0.865 . . . . 0.0 109.748 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.623 ' HG2' HD11 ' A' ' 115' ' ' ILE . 3.5 mm-40 -53.11 -49.06 67.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 135' ' ' GLU . 12.5 t0 -43.75 -53.86 5.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.825 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.2 OUTLIER -50.66 -57.67 7.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.48 ' HE1' ' HA ' ' A' ' 114' ' ' ASP . 1.4 ttm -58.05 -34.86 70.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.178 -0.952 . . . . 0.0 109.583 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -70.56 -51.51 28.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.194 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -67.97 -40.36 83.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.372 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -57.69 -46.76 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 141' ' ' SER . 0.4 OUTLIER -44.36 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.235 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.6 OUTLIER -93.59 2.69 56.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.145 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.441 ' HB2' ' CG ' ' A' ' 146' ' ' ASP . 4.2 m-80 -141.32 21.45 2.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.69 24.44 10.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 144' ' ' ASN . 42.3 m-20 -69.95 -11.79 61.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 0.0 110.192 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.456 ' C ' ' HG3' ' A' ' 148' ' ' ARG . . . 79.6 -6.47 57.99 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.456 ' HG3' ' C ' ' A' ' 147' ' ' GLY . 45.3 mtt180 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 141' ' ' SER . 20.3 mt -85.27 126.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.0 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.462 ' N ' ' OE1' ' A' ' 153' ' ' GLU . 13.0 p-10 -109.01 -163.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CZ ' HD11 ' A' ' 155' ' ' LEU . 56.2 t80 -57.81 -57.66 11.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 110.5 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -62.95 1.31 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.549 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' A' ' 150' ' ' ASP . 4.0 mt-10 -57.29 -43.93 83.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.458 ' O ' ' HG2' ' A' ' 157' ' ' MET . 82.6 t80 -48.41 -50.58 30.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.059 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.459 HD11 ' CZ ' ' A' ' 151' ' ' PHE . 11.6 mt -57.25 -54.15 50.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.337 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -60.33 -40.1 89.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.304 -0.873 . . . . 0.0 110.735 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG2' ' SD ' ' A' ' 158' ' ' MET . 0.6 OUTLIER -49.98 -40.46 44.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 109.647 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.484 ' SD ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.558 -0.714 . . . . 0.0 110.543 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.253 0.549 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 19.3 mm-40 -52.23 -45.24 65.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -46.73 -61.78 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.277 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -41.55 -57.95 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -70.13 -53.78 15.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.1 m -47.99 -22.28 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.521 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 151' ' ' PHE . 59.2 t80 -51.7 -51.93 52.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -26.69 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.316 -0.865 . . . . 0.0 110.648 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 37.1 mm -68.13 -58.73 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.037 . . . . 0.0 110.332 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -51.31 -34.16 32.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 13.8 t0 -73.39 89.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.269 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -83.25 -20.38 34.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.683 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 7.9 p30 -114.47 -1.29 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 66.73 69.77 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.327 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 4.3 p30 -108.72 -22.13 12.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.183 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.551 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 91.35 -3.64 79.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 6.9 m-85 -152.72 129.23 10.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 113' ' ' ILE . 3.4 mp -82.9 114.53 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.984 . . . . 0.0 109.8 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 116' ' ' GLU . 3.1 p30 -88.1 -176.16 5.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.582 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.9 tp -65.47 -40.78 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 110.09 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.543 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -54.71 -52.49 62.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 110.27 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 52.2 mt-10 -51.91 -44.58 63.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.327 -0.858 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.727 HD12 HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -53.11 -52.47 58.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.109 -0.994 . . . . 0.0 110.27 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.538 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -58.99 -66.69 2.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.8 pt-20 -48.06 -45.69 32.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 110.457 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.542 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 12.2 mt -52.97 -60.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.008 . . . . 0.0 109.973 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.651 HD13 HG11 ' A' ' 129' ' ' VAL . 16.8 mt -63.98 -38.67 91.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -64.4 -41.94 96.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.413 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.22 69.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 121' ' ' ILE . 24.9 p -55.95 -19.75 13.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.325 -0.859 . . . . 0.0 110.301 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.21 30.42 7.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -119.9 167.46 12.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -1.16 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 128' ' ' HIS . 51.7 p-80 -113.03 75.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 110.301 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.651 HG11 HD13 ' A' ' 122' ' ' LEU . 5.6 t -83.06 133.1 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.84 HD12 ' HB2' ' A' ' 132' ' ' GLU . 17.8 pt -85.42 152.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 2.3 mm-40 -52.53 -38.51 59.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.277 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.84 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.25 -38.04 0.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.377 -0.827 . . . . 0.0 110.686 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -45.66 9.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.123 -0.986 . . . . 0.0 109.636 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.727 HG23 HD12 ' A' ' 118' ' ' LEU . 40.1 mt -57.68 -38.36 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.798 . . . . 0.0 109.734 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 2.9 mt-10 -68.34 -36.33 79.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -58.51 -48.76 79.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.162 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 118' ' ' LEU . 97.2 mt -49.15 -44.38 42.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 0.0 110.199 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.629 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -68.94 -48.64 62.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.063 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -55.32 -35.5 65.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.29 -27.4 59.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.324 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.558 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -106.37 -60.75 1.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.861 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 138' ' ' MET . 14.7 t0 -38.24 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.77 . . . . 0.0 110.79 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.0 OUTLIER -86.57 -40.53 15.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.633 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.475 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 13.9 m-80 -92.19 17.7 9.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 49.49 25.46 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 11.1 p-10 -78.66 2.8 18.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.132 -0.98 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.92 30.98 79.43 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.1 129.75 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.192 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.629 HD12 ' CE ' ' A' ' 138' ' ' MET . 1.2 mt -83.39 129.33 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.899 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 1.5 p-10 -100.45 -163.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.013 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.456 ' CE1' ' CZ ' ' A' ' 102' ' ' PHE . 73.9 m-85 -69.22 -51.1 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -50.12 70.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 110.632 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.54 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 72.9 mt-10 -56.92 -44.75 82.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.989 . . . . 0.0 110.533 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -52.97 -66.09 0.45 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.971 -1.081 . . . . 0.0 109.984 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.1 mt -43.87 -32.48 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.955 . . . . 0.0 109.626 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -28.98 55.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.415 -0.803 . . . . 0.0 109.928 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.548 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -61.85 -37.59 85.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.548 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 109.779 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.261 0.553 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -58.32 -36.03 72.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.708 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.868 ' CD2' HD23 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -84.52 -45.7 12.34 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.361 -0.837 . . . . 0.0 109.265 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 151' ' ' PHE . . . -47.43 -34.61 7.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.093 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.61 -40.28 19.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.863 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.51 ' HG ' ' HE1' ' A' ' 105' ' ' PHE . 0.7 OUTLIER -54.21 -21.4 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.993 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.45 -64.71 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.988 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -51.06 -39.2 55.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.77 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.6 mp -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.289 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.797 ' HB3' HD13 ' A' ' 113' ' ' ILE . 4.7 m-85 -60.31 -52.06 66.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 109.546 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -67.61 87.53 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -88.79 -34.04 17.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.357 -0.839 . . . . 0.0 110.804 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 17.3 p30 -81.2 4.48 20.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.059 -1.026 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 84.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.456 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 2.3 p30 -128.1 -34.16 2.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.452 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 118.3 -24.47 8.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.501 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 67.3 m-85 -148.93 126.72 11.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -1.135 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.797 HD13 ' HB3' ' A' ' 105' ' ' PHE . 42.5 mt -83.58 126.96 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -105.05 -178.29 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.355 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 2.8 tp -56.09 -39.99 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.0 mm-40 -56.97 -58.12 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.599 ' OE1' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -46.31 -34.98 4.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.201 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.628 HD13 HG23 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -70.59 -155.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 68.65 -80.72 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -51.04 -55.02 19.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.12 . . . . 0.0 110.428 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.431 ' C ' ' O ' ' A' ' 120' ' ' GLU . 10.4 mt -42.09 -44.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 110.43 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 122' ' ' LEU . 45.8 mt -72.28 -49.71 32.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -48.69 -35.78 14.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -0.889 . . . . 0.0 110.538 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.08 -42.29 60.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 32.1 p -68.03 -7.35 28.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.319 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.414 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 81.09 41.67 10.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -121.69 140.78 51.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.479 ' H ' ' CD2' ' A' ' 128' ' ' HIS . 23.0 p80 -82.16 111.78 18.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.6 t -126.12 156.18 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 12.9 pt -130.39 158.07 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.428 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 2.7 mt-10 -47.92 -49.77 29.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -42.65 -36.98 1.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.89 -48.07 8.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.29 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.628 HG23 HD13 ' A' ' 118' ' ' LEU . 22.9 mt -54.23 -36.45 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.482 -0.762 . . . . 0.0 109.694 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.497 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 51.8 mt-10 -60.89 -47.15 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.14 -39.52 56.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.0 mp -61.74 -46.77 88.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 110.21 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.486 ' CE ' HD12 ' A' ' 149' ' ' ILE . 30.4 tpp -65.05 -48.21 74.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.88 85.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.943 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.89 -33.17 73.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.114 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.483 ' CB ' HG12 ' A' ' 149' ' ' ILE . 6.9 t -84.1 -56.02 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 15.0 m-20 -42.32 103.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 110.57 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.74 -16.49 55.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.706 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 2.1 p30 -124.82 14.84 8.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.872 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.17 73.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 147' ' ' GLY . 10.0 p-10 -128.28 22.58 6.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -0.834 . . . . 0.0 109.805 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.434 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 43.17 36.6 2.9 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -157.9 120.84 3.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -1.166 . . . . 0.0 110.474 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.486 HD12 ' CE ' ' A' ' 138' ' ' MET . 7.1 mt -83.69 120.79 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.474 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 6.7 p-10 -90.06 -152.02 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.426 ' CZ ' ' HB1' ' A' ' 99' ' ' ALA . 49.5 t80 -82.08 -39.51 23.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.329 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.18 -56.69 4.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 0.0 110.691 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.474 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 29.8 mt-10 -46.75 -36.07 6.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.495 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.454 ' O ' ' HG2' ' A' ' 157' ' ' MET . 32.6 t80 -56.2 -56.42 21.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.868 HD23 ' CD2' ' A' ' 98' ' ' LEU . 2.6 mt -52.42 -54.07 36.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.401 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.34 -38.44 58.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -0.917 . . . . 0.0 110.475 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.512 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.2 ptm -65.88 -49.0 69.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.512 ' N ' ' CG ' ' A' ' 157' ' ' MET . 3.9 mtt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.284 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.236 0.541 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.4 tp10 -58.91 -55.69 31.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 0.4 OUTLIER -61.85 -56.7 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -45.24 -39.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.685 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -54.46 -46.31 73.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.884 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 98' ' ' LEU . 1.1 m -52.28 -41.01 62.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.326 -0.859 . . . . 0.0 109.88 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' CYS . 14.9 t80 -43.83 -51.73 7.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.758 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -60.66 -36.27 78.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.811 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.6 -43.58 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.832 ' CD2' HD13 ' A' ' 121' ' ' ILE . 1.3 m-85 -71.96 -40.06 68.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.873 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -79.19 88.38 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.85 68.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.37 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -70.47 -11.44 60.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 110.425 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.19 51.09 16.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.11 -27.19 22.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.48 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 128.53 -20.3 5.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 98.4 m-85 -151.21 134.15 15.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -1.178 . . . . 0.0 110.28 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.7 mt -82.75 149.46 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 -164.03 0.89 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.5 tt -77.38 -38.68 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.186 -0.946 . . . . 0.0 110.463 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 95.5 mt-10 -60.76 -61.43 2.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.72 ' O ' HD12 ' A' ' 121' ' ' ILE . 20.9 mt-10 -42.55 -38.97 2.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 110.409 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.824 ' HB3' HG23 ' A' ' 134' ' ' ILE . 3.5 tp -60.05 -31.12 69.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 123' ' ' ARG . . . -73.03 -72.17 1.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.867 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 12.7 pt-20 -42.49 -43.49 3.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.184 -1.186 . . . . 0.0 110.509 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.832 HD13 ' CD2' ' A' ' 105' ' ' PHE . 27.5 mt -57.93 -50.46 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.852 ' HB3' HG21 ' A' ' 129' ' ' VAL . 20.4 mt -67.74 -69.89 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.873 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 119' ' ' GLY . 2.4 ptm180 -49.88 -24.09 2.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.921 . . . . 0.0 110.651 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.54 -44.19 72.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 110.008 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.789 HG23 ' HG3' ' A' ' 127' ' ' GLU . 1.8 t -80.91 9.34 6.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.468 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.2 17.7 58.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.789 ' HG3' HG23 ' A' ' 125' ' ' THR . 46.6 mt-10 -84.05 121.2 27.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -1.136 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 87.24 2.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.873 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.852 HG21 ' HB3' ' A' ' 122' ' ' LEU . 3.4 t -109.61 146.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' GLU . 31.7 pt -119.55 159.7 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.145 -0.972 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' ILE . 4.8 tt0 -41.43 -49.86 3.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.36 -28.91 13.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 0.0 110.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -43.38 11.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.824 HG23 ' HB3' ' A' ' 118' ' ' LEU . 30.0 mt -67.92 -38.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.07 -36.87 82.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.39 -0.819 . . . . 0.0 110.421 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.83 -52.4 65.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 0.0 110.681 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.635 ' HB3' HD21 ' A' ' 118' ' ' LEU . 1.4 mp -49.86 -44.27 49.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.308 -0.87 . . . . 0.0 110.899 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.485 ' O ' ' N ' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -64.83 -48.04 75.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.056 -1.028 . . . . 0.0 110.053 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -60.1 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 110.62 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.47 -33.21 67.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.547 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -85.7 -62.47 1.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.146 -0.971 . . . . 0.0 110.717 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 138' ' ' MET . 0.5 OUTLIER -47.4 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.621 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 ttpp -89.4 -3.81 58.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.814 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -120.69 12.03 11.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 51.23 39.26 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.417 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.467 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 11.5 p30 -101.37 23.06 11.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 44.98 35.58 4.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 19.4 mtt180 -158.35 128.32 5.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -1.21 . . . . 0.0 110.458 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.547 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.5 mt -84.21 167.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.091 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 48.2 p30 -149.13 -163.68 1.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -56.07 16.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.403 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -56.74 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.656 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 141' ' ' SER . 84.8 mt-10 -59.53 -44.53 93.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 110.515 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 21.6 t80 -54.62 -52.0 63.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.095 -1.003 . . . . 0.0 110.132 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 27.4 mt -57.34 -42.16 81.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -54.2 -60.29 3.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.6 OUTLIER -48.26 -52.81 19.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.025 -1.047 . . . . 0.0 109.551 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.411 -0.806 . . . . 0.0 110.227 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.329 0.585 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.94 -58.56 6.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 0.0 110.58 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.593 HD11 ' SD ' ' A' ' 158' ' ' MET . 20.2 mt -50.97 -60.75 2.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.289 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.68 -50.74 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -55.15 -50.5 69.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.948 . . . . 0.0 110.246 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.92 -9.61 31.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.367 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 83.3 t80 -50.96 -61.69 2.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.57 ' CG ' HD12 ' A' ' 104' ' ' ILE . 12.3 ptp180 -57.12 -36.04 70.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 110.458 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.57 HD12 ' CG ' ' A' ' 103' ' ' ARG . 1.0 OUTLIER -58.72 -34.06 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.665 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 107' ' ' LYS . 4.9 m-85 -83.65 -35.48 24.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.87 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 48.1 t0 -67.78 59.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -46.6 -41.03 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 110' ' ' ASP . 46.8 t30 -69.51 -13.62 62.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.159 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 45.49 54.98 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.857 . . . . 0.0 110.231 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.473 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 23.5 p-10 -108.65 -3.23 18.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.2 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.509 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 101.49 -19.4 50.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 95.8 m-85 -153.17 123.69 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -1.2 . . . . 0.0 110.434 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.87 132.28 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 110.304 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.71 -179.6 4.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.081 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.7 tt -59.94 -36.82 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.195 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -50.94 -52.69 39.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.442 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 15.3 mt-10 -57.66 -54.74 43.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -0.809 . . . . 0.0 110.311 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.561 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.1 mp -43.15 -39.78 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.515 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -59.75 -80.31 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.482 ' OE2' HG13 ' A' ' 121' ' ' ILE . 0.7 OUTLIER -48.3 -50.7 29.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -1.19 . . . . 0.0 110.297 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 125' ' ' THR . 10.3 mt -44.93 -55.07 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 110.137 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.1 mt -68.37 -62.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.51 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -48.76 -39.97 27.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.84 -52.27 57.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.927 . . . . 0.0 110.212 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 121' ' ' ILE . 31.1 p -54.75 -32.44 59.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.59 -1.36 23.39 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . 23.4 mm-40 -58.66 -17.02 18.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -1.164 . . . . 0.0 110.056 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 18.2 t-160 46.38 57.21 5.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 127' ' ' GLU . 14.8 t -89.56 153.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 132' ' ' GLU . 19.6 pt -98.06 154.85 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 110.2 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 132' ' ' GLU . 68.9 mt-10 -49.44 -51.41 35.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.539 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -41.81 -34.27 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.635 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -48.16 9.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.44 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 18.1 mt -55.52 -40.03 56.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.077 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -58.03 -53.89 53.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.626 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -45.03 37.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.962 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -37.19 67.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.106 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 19.1 tpp -69.95 -44.76 68.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.394 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -51.27 62.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.396 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -55.34 -31.27 61.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.543 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -87.9 -51.2 5.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.374 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.7 OUTLIER -42.56 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.8 OUTLIER -76.2 -1.51 26.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.963 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.505 ' ND2' ' OD2' ' A' ' 146' ' ' ASP . 1.5 p30 -153.8 27.48 0.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 43.78 75.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 110.501 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.505 ' OD2' ' ND2' ' A' ' 144' ' ' ASN . 3.8 p30 -121.28 -0.29 9.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 70.88 24.16 77.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 5.4 mtt-85 -158.67 135.43 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.449 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 141' ' ' SER . 16.6 mt -91.06 136.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.478 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 26.7 p-10 -112.44 -173.03 2.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.922 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 42.2 p90 -68.07 -28.41 67.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 110.392 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.428 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -78.14 -42.21 32.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.639 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.513 ' OE1' ' HA ' ' A' ' 149' ' ' ILE . 89.4 mt-10 -69.71 -37.15 76.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -0.986 . . . . 0.0 110.513 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.462 ' O ' ' HG2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.04 -33.29 51.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.964 . . . . 0.0 110.351 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.61 -62.56 1.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.401 ' HD2' ' HD2' ' A' ' 143' ' ' LYS . 21.4 mttm -53.4 -34.92 59.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.907 . . . . 0.0 110.566 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.536 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -53.79 -49.72 67.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.229 -0.919 . . . . 0.0 110.571 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.593 ' SD ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.913 . . . . 0.0 110.447 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.177 0.513 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -60.46 -56.86 16.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 4.3 mm? -59.69 -51.44 69.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.34 -44.24 3.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -51.78 -47.16 64.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.106 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.81 -31.79 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CZ ' HD12 ' A' ' 113' ' ' ILE . 18.1 t80 -51.45 -42.07 61.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.933 . . . . 0.0 110.086 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -41.04 99.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.263 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 104' ' ' ILE . 30.6 mm -59.0 -49.09 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 110.076 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -57.49 -35.48 70.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.756 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.91 113.14 25.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.661 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -109.12 6.33 24.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.408 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 2.5 p30 -131.41 22.61 4.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.435 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 108' ' ' ASN . . . 50.3 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.78 -37.39 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.434 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 92.21 -7.29 78.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 53.2 m-85 -153.13 125.62 8.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -1.152 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 2.7 mp -83.7 125.49 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -104.91 -176.04 2.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.052 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -63.46 -37.77 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.854 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.405 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 9.2 mm-40 -59.0 -56.3 23.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 109.982 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 15.9 mt-10 -45.5 -54.06 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.734 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.2 tp -51.19 -27.94 10.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.32 -75.64 0.35 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.2 pt-20 -45.52 -44.39 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -1.183 . . . . 0.0 110.571 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.546 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 48.5 mt -48.43 -70.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.496 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.833 ' O ' HG22 ' A' ' 125' ' ' THR . 97.6 mt -48.76 -49.89 36.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 110.577 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -52.89 -38.41 61.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.977 . . . . 0.0 110.537 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -48.05 -59.97 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 110.528 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.833 HG22 ' O ' ' A' ' 122' ' ' LEU . 7.4 t -59.38 -26.06 64.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.396 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.02 37.54 5.98 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -86.79 -10.43 53.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -1.218 . . . . 0.0 110.029 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.71 82.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.11 166.14 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 132' ' ' GLU . 4.7 pt -117.13 146.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.102 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.474 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 2.9 pt-20 -39.57 -42.92 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 0.0 110.858 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.481 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -43.4 -40.08 3.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 110.328 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.44 -44.44 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 118' ' ' LEU . 66.8 mt -56.75 -35.72 46.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.674 0.75 . . . . 0.0 109.509 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.835 ' HA ' HD11 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -68.6 -39.58 80.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.692 -0.63 . . . . 0.0 110.239 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.29 -50.29 72.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.451 ' HB3' HD21 ' A' ' 118' ' ' LEU . 1.3 mm? -45.63 -50.73 13.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.021 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.552 ' CE ' HD12 ' A' ' 149' ' ' ILE . 3.3 ttm -67.22 -46.6 73.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.923 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.31 -53.55 6.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.6 -49.98 73.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.551 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.1 t -69.72 -64.47 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.457 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.491 ' HB2' ' HG3' ' A' ' 138' ' ' MET . 30.5 t0 -43.19 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 141' ' ' SER . 3.3 tptm -96.9 -13.64 22.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.467 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 6.2 m-80 -101.42 16.36 25.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 52.43 18.81 1.01 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 16.9 p30 -80.94 -0.18 38.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . 62.18 28.27 70.44 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 9.9 mtt180 -152.58 135.12 15.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.158 -1.201 . . . . 0.0 110.373 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.552 HD12 ' CE ' ' A' ' 138' ' ' MET . 5.9 mt -83.65 116.3 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 0.0 109.86 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -97.77 -170.36 1.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -52.99 -58.78 5.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.366 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.06 -64.94 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.955 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.473 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 44.9 mt-10 -50.65 -51.98 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.472 ' O ' ' HG2' ' A' ' 157' ' ' MET . 42.0 t80 -50.53 -56.74 10.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 154' ' ' PHE . 46.9 mt -42.52 -51.31 5.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.345 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -62.2 -46.98 86.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 110.745 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.518 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.5 ptm -43.27 -46.5 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 109.85 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.518 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 110.195 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.216 0.531 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.65 -54.59 39.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.944 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 3.5 mm? -50.52 -49.38 55.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.881 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -53.55 -57.02 12.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 110.258 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -48.57 -50.16 33.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.82 -20.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 56.6 t80 -53.85 -51.24 64.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.486 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -29.19 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.163 -0.961 . . . . 0.0 110.489 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.5 -27.92 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.121 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.475 ' HD1' HD13 ' A' ' 121' ' ' ILE . 2.5 m-85 -84.9 -55.73 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 110.336 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -50.82 131.62 26.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -0.817 . . . . 0.0 110.259 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -123.03 2.22 9.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 109' ' ' ALA . 73.5 m-20 -125.02 26.41 7.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.356 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.93 49.44 5.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -93.32 -31.75 14.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.382 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.473 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 96.41 -14.51 64.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.473 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 27.2 m-85 -147.7 131.7 17.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 mt -82.95 116.05 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 110.631 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 3.8 p-10 -100.87 175.9 5.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.808 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.2 tp -53.48 -41.56 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.56 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -51.48 -54.96 21.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 121' ' ' ILE . 31.8 mt-10 -56.8 -56.23 24.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -44.1 -38.62 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.506 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -59.74 -78.29 0.15 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -51.21 -45.99 62.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 110.259 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.55 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 14.9 mt -42.55 -61.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 110.38 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.855 HD22 HG21 ' A' ' 129' ' ' VAL . 4.2 mt -59.34 -56.87 16.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.433 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -48.67 -34.58 12.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.085 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -51.93 -40.83 61.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.7 p -66.59 -17.42 64.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 0.0 109.989 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.38 20.34 13.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.49 154.29 19.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -1.141 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -107.37 70.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 0.0 109.661 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.855 HG21 HD22 ' A' ' 122' ' ' LEU . 15.6 t -79.27 123.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.522 -0.736 . . . . 0.0 110.703 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 132' ' ' GLU . 47.3 pt -75.33 159.71 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.28 -32.22 68.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.987 . . . . 0.0 110.556 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.506 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -48.75 -35.59 14.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 110.497 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.02 -51.2 6.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.652 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 118' ' ' LEU . 7.3 mt -55.76 -43.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.508 -0.745 . . . . 0.0 109.472 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HG2' HD11 ' A' ' 115' ' ' ILE . 2.9 mm-40 -62.05 -38.75 89.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.656 -0.652 . . . . 0.0 109.955 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.13 -51.88 66.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 110.208 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.2 mt -50.75 -42.09 57.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 42.9 tpp -66.96 -49.07 66.6 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -59.09 -41.98 89.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.946 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -25.73 68.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.571 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -97.54 -33.58 11.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 110.234 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.2 t0 -59.43 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 109.931 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -76.25 0.58 18.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.328 -0.858 . . . . 0.0 110.994 -179.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.471 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -151.71 20.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.919 -1.113 . . . . 0.0 110.533 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.35 71.21 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.662 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 7.6 p-10 -126.95 12.08 7.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.749 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 45.4 30.65 3.08 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' CD ' ' HB2' ' A' ' 112' ' ' PHE . 3.7 mtt180 -158.69 131.12 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 110.701 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.571 HG12 ' CB ' ' A' ' 141' ' ' SER . 8.0 mt -88.89 133.42 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.73 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 2.8 p30 -113.54 -164.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.436 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.6 -57.67 9.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.88 -57.7 11.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.619 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.471 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 73.2 mt-10 -54.25 -50.16 67.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.463 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 155' ' ' LEU . 64.2 t80 -49.68 -59.0 4.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.027 -1.045 . . . . 0.0 110.237 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 154' ' ' PHE . 9.8 mt -41.79 -66.06 0.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -34.16 14.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.62 -37.97 73.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 109.854 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.513 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 110.63 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.355 0.598 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.5 tp10 -58.84 -41.31 86.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.66 -59.19 5.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.18 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.29 -43.64 10.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 22.0 m-20 -51.05 -45.98 61.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 102' ' ' PHE . 4.5 t -67.98 -22.86 64.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.003 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.501 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 14.1 t80 -42.31 -63.29 0.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.515 ' HG3' ' N ' ' A' ' 104' ' ' ILE . 4.7 ptt180 -62.23 -36.35 81.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.515 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 31.6 mm -59.65 -33.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.277 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -79.57 -65.98 0.93 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.906 . . . . 0.0 110.344 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 105' ' ' PHE . 48.3 t0 -42.58 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 105' ' ' PHE . 10.7 mttt -75.97 -10.25 59.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.213 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -102.14 -165.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 110.302 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.4 4.25 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.172 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.537 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 6.7 p-10 -66.37 -27.77 68.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.898 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 90.32 15.98 56.28 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 110' ' ' ASP . 38.0 m-85 -146.75 131.88 18.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.119 -1.224 . . . . 0.0 110.599 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.468 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 3.2 mt -83.16 131.74 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.406 -0.809 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 117' ' ' GLU . 24.3 p30 -100.52 -177.24 3.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.2 tt -64.93 -40.74 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 110.484 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.554 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -59.86 -52.02 67.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.038 . . . . 0.0 110.183 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 24.9 mt-10 -48.55 -42.85 34.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.911 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.578 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -58.35 -27.02 63.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 110.239 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -73.6 -72.87 0.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.4 pt-20 -41.91 -45.15 3.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.435 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 117' ' ' GLU . 42.6 mt -57.44 -57.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -73.82 -44.31 56.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 110.61 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.22 -36.72 75.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 0.0 110.276 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -47.72 -40.44 20.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.011 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.419 ' H ' HG23 ' A' ' 125' ' ' THR . 52.0 p -56.17 -28.36 57.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 110.068 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.0 -31.52 6.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 129' ' ' VAL . 6.7 mt-10 -49.99 125.78 12.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -1.097 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.566 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -70.11 62.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 127' ' ' GLU . 11.1 t -61.68 148.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 0.0 109.886 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 131' ' ' GLU . 5.8 pt -121.72 147.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 110.359 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -39.02 -36.67 0.31 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.576 -0.703 . . . . 0.0 110.761 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -35.43 62.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.687 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.06 -44.04 12.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.97 . . . . 0.0 109.697 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.578 HG23 ' HB3' ' A' ' 118' ' ' LEU . 15.9 mt -66.22 -36.96 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.387 -0.82 . . . . 0.0 110.138 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.17 -43.61 95.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -54.52 -53.38 55.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 141' ' ' SER . 2.1 mp -47.58 -41.31 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 110.509 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -71.69 -53.78 12.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 -57.07 4.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.754 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.27 -40.5 90.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.152 -0.967 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.515 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -75.26 -54.35 7.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 146' ' ' ASP . 0.3 OUTLIER -55.09 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 110.965 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -69.95 -46.29 65.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.049 -1.032 . . . . 0.0 109.466 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 9.0 p30 -82.78 -7.45 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 5.6 m120 63.39 82.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.43 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.513 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 10.7 p-10 -130.25 5.46 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 109.972 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 74.58 20.8 79.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 35.5 mtm-85 -158.31 140.44 14.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -1.134 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.515 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.5 mt -90.46 137.64 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 109.79 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 150' ' ' ASP . 36.2 p-10 -110.01 -151.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.761 ' O ' HD12 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -75.35 -55.51 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.589 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -54.7 43.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 110.461 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.464 ' OE1' ' HA ' ' A' ' 142' ' ' ASP . 51.0 mt-10 -56.74 -53.48 57.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' GLU . 26.1 t80 -43.51 -51.54 6.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 0.0 110.396 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 151' ' ' PHE . 4.6 mt -63.13 -55.16 27.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -46.27 -41.48 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.985 . . . . 0.0 110.655 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.405 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.55 -46.81 62.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.808 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.405 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.252 0.549 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.75 -56.19 17.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 110.451 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 99' ' ' ALA . 6.3 mt -56.9 -58.8 6.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.554 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -40.84 -52.49 3.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -0.823 . . . . 0.0 110.529 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.41 -54.95 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 69.4 m -48.38 -24.16 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 110.715 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.497 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 47.0 t80 -45.23 -49.83 12.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.995 -1.066 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -57.16 -32.2 66.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 43.7 mm -59.47 -40.4 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -78.17 -38.41 43.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 110.427 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -79.25 84.7 5.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -1.0 . . . . 0.0 110.303 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -32.02 22.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 110.229 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.427 ' OD1' ' CG ' ' A' ' 110' ' ' ASP . 4.2 p30 -100.6 14.87 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.11 69.31 0.69 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.117 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.427 ' CG ' ' OD1' ' A' ' 108' ' ' ASN . 3.6 m-20 -97.47 -17.16 19.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 110.23 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.48 40.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -150.45 146.49 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.031 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 mt -82.64 116.12 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 110.366 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -97.2 -178.54 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.858 . . . . 0.0 110.014 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.547 HG23 ' N ' ' A' ' 116' ' ' GLU . 3.8 tp -67.96 -39.43 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.547 ' N ' HG23 ' A' ' 115' ' ' ILE . 5.8 mt-10 -55.1 -52.8 62.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.373 -0.829 . . . . 0.0 110.235 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 23.1 mt-10 -50.2 -45.3 53.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.398 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.563 HD22 HG23 ' A' ' 134' ' ' ILE . 0.5 OUTLIER -57.66 -34.18 69.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.574 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -66.54 -73.56 0.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.46 ' CD ' HG13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -42.06 -49.44 4.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -1.122 . . . . 0.0 110.561 -179.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.46 HG13 ' CD ' ' A' ' 120' ' ' GLU . 66.4 mt -55.07 -51.94 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.639 ' HB3' HG21 ' A' ' 129' ' ' VAL . 16.5 mt -64.71 -55.5 19.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.271 -0.893 . . . . 0.0 110.561 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.18 -36.71 73.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.887 . . . . 0.0 110.659 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.84 -30.93 4.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.428 ' H ' HG23 ' A' ' 125' ' ' THR . 30.9 p -66.23 -29.62 69.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.76 26.8 2.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -116.7 170.1 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -1.161 . . . . 0.0 110.397 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.39 62.68 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.712 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 122' ' ' LEU . 5.5 t -65.57 126.82 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 134' ' ' ILE . 15.3 pt -81.15 154.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -41.76 96.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 110.676 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -47.83 -33.56 7.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.256 -0.902 . . . . 0.0 110.781 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -83.23 -47.93 11.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 109.513 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.563 HG23 HD22 ' A' ' 118' ' ' LEU . 11.3 mt -58.26 -37.68 64.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.559 -0.713 . . . . 0.0 109.628 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.509 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 32.8 mt-10 -60.37 -34.72 74.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 110.591 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 14.5 t0 -56.33 -55.02 38.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -43.43 26.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.91 . . . . 0.0 111.023 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.6 tpp -65.06 -51.58 60.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.096 -1.003 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 139' ' ' LYS . 7.5 tmtm? -63.01 -39.25 94.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.4 -0.813 . . . . 0.0 109.953 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -67.27 -32.9 74.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.429 -0.794 . . . . 0.0 110.251 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.538 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.6 t -82.28 -64.28 1.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.459 ' OD1' ' OD1' ' A' ' 146' ' ' ASP . 45.6 t0 -44.36 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.48 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -89.26 -3.17 58.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.2 p30 -125.01 8.82 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.962 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.426 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 8.3 m120 59.26 39.27 22.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.459 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 19.3 p30 -72.85 -13.63 61.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 102.11 -11.77 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.495 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 70.9 mtt180 -158.43 177.94 10.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.152 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.538 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.6 mt -88.51 166.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 44.9 p-10 -144.35 -162.57 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.74 ' O ' HD12 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -73.26 -43.02 61.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.498 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -52.86 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.56 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 10.6 mt-10 -65.19 -39.98 93.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 3.5 t80 -54.75 -64.9 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 151' ' ' PHE . 8.1 mt -42.22 -52.86 4.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -59.74 -37.12 78.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.487 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -62.01 -47.04 86.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.487 ' N ' ' CG ' ' A' ' 157' ' ' MET . 11.4 mmt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 110.43 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.258 0.551 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.36 -33.34 71.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.857 . . . . 0.0 110.264 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.677 HD22 HD23 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -67.06 -49.56 64.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.458 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.06 25.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.994 -1.066 . . . . 0.0 110.164 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -50.96 -43.41 60.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -56.01 -16.22 4.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.343 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -54.0 -64.78 0.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 110.893 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -31.52 63.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.042 -1.036 . . . . 0.0 110.669 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 35.1 mm -57.18 -43.27 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.418 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.754 ' O ' HD11 ' A' ' 121' ' ' ILE . 5.4 m-85 -75.03 -31.84 61.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.97 98.81 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 110.119 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 69.9 m-80 -95.17 -11.47 28.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 53.94 56.41 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.97 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.84 -12.9 29.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.46 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.517 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 117.06 -20.65 11.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.517 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 65.5 m-85 -152.54 127.14 9.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.104 -1.233 . . . . 0.0 110.502 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 117' ' ' GLU . 12.6 mt -83.04 118.44 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.55 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 22.2 p30 -89.55 -172.88 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.708 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 116' ' ' GLU . 4.1 tp -63.28 -42.56 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.579 ' N ' HG23 ' A' ' 115' ' ' ILE . 1.6 mt-10 -53.1 -55.27 25.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.247 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.585 ' HB3' HG23 ' A' ' 113' ' ' ILE . 23.7 mt-10 -50.6 -43.82 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -59.28 -29.27 67.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.58 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.02 -60.23 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.7 pt-20 -52.4 -44.63 65.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -1.141 . . . . 0.0 110.529 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.754 HD11 ' O ' ' A' ' 105' ' ' PHE . 94.6 mt -53.42 -48.22 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.135 -0.978 . . . . 0.0 110.017 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.2 -48.85 16.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.81 -32.72 9.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.855 . . . . 0.0 110.342 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.14 -28.15 50.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.307 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 127' ' ' GLU . 27.9 p -86.74 21.49 2.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 62.86 21.11 62.95 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 125' ' ' THR . 3.2 mt-10 -96.69 112.65 24.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.187 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -74.15 81.94 1.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 134' ' ' ILE . 32.0 t -90.3 137.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 131' ' ' GLU . 28.4 pt -104.93 155.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 10.2 mt-10 -41.96 -46.67 4.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.6 mm-40 -41.0 -37.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 0.0 109.904 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.87 -47.33 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.422 -0.799 . . . . 0.0 109.43 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 118' ' ' LEU . 12.1 mt -58.94 -40.7 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.813 . . . . 0.0 109.726 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -59.11 -52.35 66.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.186 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -46.32 -45.9 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.229 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.4 mp -60.87 -54.75 41.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 110.035 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.646 ' CE ' HD12 ' A' ' 149' ' ' ILE . 2.2 ttm -67.0 -43.83 81.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -60.14 -43.42 95.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.314 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -68.46 -34.1 75.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.279 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.544 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -87.17 -62.78 1.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.526 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 138' ' ' MET . 21.8 t0 -50.94 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.728 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -82.13 -25.35 34.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -0.977 . . . . 0.0 110.042 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.482 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 9.0 m-80 -90.16 16.17 8.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.18 38.02 3.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.936 . . . . 0.0 110.074 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -97.27 14.16 27.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 51.46 37.92 41.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 6.6 mtt180 -158.68 125.9 4.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.163 -1.198 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.646 HD12 ' CE ' ' A' ' 138' ' ' MET . 4.0 mt -87.28 129.27 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.201 -0.937 . . . . 0.0 109.214 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -110.58 -167.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.628 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -57.45 10.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.523 -0.735 . . . . 0.0 111.038 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.41 -64.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.191 -0.943 . . . . 0.0 111.335 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.482 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 65.4 mt-10 -47.29 -31.58 3.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.088 -1.007 . . . . 0.0 110.992 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.402 ' O ' ' HB3' ' A' ' 157' ' ' MET . 21.7 t80 -64.9 -59.02 4.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 0.0 110.533 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.677 HD23 HD22 ' A' ' 98' ' ' LEU . 3.7 mt -47.28 -54.5 10.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 110.272 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -24.9 58.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 109.922 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.03 -38.05 75.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.375 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.495 ' N ' ' HG3' ' A' ' 157' ' ' MET . 18.8 ttm . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.264 0.554 . . . . 0.0 109.624 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -55.34 22.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.613 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.4 OUTLIER -64.18 -48.75 74.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.843 179.522 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.35 -53.43 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 109.759 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 96' ' ' GLU . 68.7 m-80 -52.21 -38.96 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.4 -0.813 . . . . 0.0 109.923 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -25.93 52.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.584 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 9.8 t80 -49.7 -58.16 5.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.486 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -66.9 -34.95 78.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.931 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.482 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 12.2 mm -68.33 -48.91 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 110.831 -179.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' LYS . 1.6 m-30 -71.27 -43.76 66.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.694 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -68.16 70.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.95 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.482 ' CD ' ' O ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -61.23 -35.63 77.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.298 -179.952 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 109' ' ' ALA . 13.4 t30 -75.9 -5.22 45.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.86 . . . . 0.0 110.036 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.29 76.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.3 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -124.08 -2.9 8.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.441 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 100.16 -21.96 42.21 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CG ' ' O ' ' A' ' 111' ' ' GLY . 92.6 m-85 -152.24 140.04 19.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -1.195 . . . . 0.0 110.375 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.446 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 29.5 mt -82.53 110.08 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.117 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -87.89 -175.47 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.348 -0.845 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.12 -29.72 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.248 -0.908 . . . . 0.0 110.676 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -50.26 70.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.129 -0.982 . . . . 0.0 110.262 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.501 ' C ' HD12 ' A' ' 121' ' ' ILE . 8.4 mt-10 -57.55 -42.83 83.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.549 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.2 tp -52.67 -38.72 60.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.318 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.583 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -56.41 -72.84 0.51 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.3 pt-20 -51.76 -45.22 63.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -1.207 . . . . 0.0 110.785 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.539 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 40.9 mt -47.82 -46.79 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.97 -1.081 . . . . 0.0 110.23 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.0 mt -77.39 -51.87 10.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.923 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -48.45 -35.3 12.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.982 . . . . 0.0 109.488 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.61 -38.78 21.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.1 p -58.9 -55.29 37.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.452 ' C ' ' HG2' ' A' ' 127' ' ' GLU . . . 139.11 41.25 0.09 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.9 mt-10 -136.47 128.56 29.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.241 . . . . 0.0 110.072 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -65.74 66.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' GLU . 79.0 t -64.54 155.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.662 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 131' ' ' GLU . 17.5 pt -123.94 145.68 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.839 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 4.4 mt-10 -43.74 -45.95 7.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.884 . . . . 0.0 110.581 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -41.59 -43.9 2.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 111.01 -179.546 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 -48.6 12.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.583 HD13 ' HA2' ' A' ' 119' ' ' GLY . 20.3 mt -53.21 -35.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.552 0.692 . . . . 0.0 109.651 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.455 ' OE1' ' HA ' ' A' ' 132' ' ' GLU . 64.0 mt-10 -55.9 -52.26 64.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.536 -0.728 . . . . 0.0 110.602 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 50.4 t0 -45.25 -49.16 12.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.474 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.515 HD23 ' HE1' ' A' ' 157' ' ' MET . 0.1 OUTLIER -53.3 -43.78 67.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.968 . . . . 0.0 110.393 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -40.31 68.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.398 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -60.06 -48.05 83.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.944 . . . . 0.0 110.843 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.9 -33.82 75.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.798 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.55 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.66 -35.66 57.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER -55.25 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.544 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' SER . 5.9 tttt -67.69 -8.36 34.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.45 22.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 8.5 m-20 51.22 64.75 1.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.331 -0.855 . . . . 0.0 110.785 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 51.5 p-10 -112.72 5.77 17.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 60.0 24.92 61.22 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 13.6 mtt-85 -158.13 130.71 7.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -1.163 . . . . 0.0 110.533 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.55 HG12 ' CB ' ' A' ' 141' ' ' SER . 6.1 mt -85.72 121.29 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.362 -0.837 . . . . 0.0 109.94 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.18 -173.6 2.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 110.411 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -53.7 -57.43 10.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -55.17 16.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.505 -0.747 . . . . 0.0 110.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 157' ' ' MET . 88.0 mt-10 -64.01 -57.94 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.572 ' CZ ' ' HG3' ' A' ' 158' ' ' MET . 38.6 t80 -40.83 -59.72 1.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.654 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 154' ' ' PHE . 81.5 mt -42.3 -65.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.345 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.84 -38.09 77.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 110.431 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -66.97 -37.96 85.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.071 -179.639 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.73 ' HB3' HD21 ' A' ' 98' ' ' LEU . 3.2 mmt . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.537 -0.727 . . . . 0.0 110.514 -179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.267 0.556 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -57.73 -32.07 67.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -51.07 9.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.509 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.07 50.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.133 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -66.15 -33.12 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.447 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.8 m -65.16 -22.08 66.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.829 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE1' HD11 ' A' ' 113' ' ' ILE . 71.7 t80 -49.25 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 110.391 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.53 -32.25 5.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 48.8 mm -68.33 -45.44 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 110.365 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.412 ' O ' HD11 ' A' ' 121' ' ' ILE . 17.0 m-85 -67.56 -24.94 65.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.25 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 23.3 t0 -90.07 84.96 6.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -67.69 -32.16 72.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 6.0 p30 -93.87 -12.25 29.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 59.09 75.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.352 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 5.1 p30 -114.91 -6.39 12.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.269 -0.895 . . . . 0.0 110.091 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 86.28 -1.05 87.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 10.8 m-85 -146.8 124.01 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -1.142 . . . . 0.0 110.011 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.488 HD11 ' CE1' ' A' ' 102' ' ' PHE . 40.8 mt -85.83 124.59 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.261 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 116' ' ' GLU . 1.9 p30 -103.42 -176.19 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.3 tp -75.97 -31.68 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.452 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 1.3 mt-10 -58.22 -45.06 88.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 121' ' ' ILE . 37.1 mt-10 -59.91 -48.67 80.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 110.423 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.59 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.8 -34.59 67.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.152 -0.968 . . . . 0.0 110.13 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -57.98 -71.99 0.66 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 18.7 pt-20 -57.35 -44.49 84.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -1.171 . . . . 0.0 110.299 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.0 mt -47.06 -57.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.975 . . . . 0.0 109.87 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 125' ' ' THR . 0.3 OUTLIER -69.09 -49.18 59.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -53.92 -37.2 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.435 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.16 60.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.307 -0.871 . . . . 0.0 110.868 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 61.5 p -54.65 -24.44 21.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.461 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.54 -27.4 6.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -75.79 134.05 40.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -1.122 . . . . 0.0 109.961 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -87.19 71.07 10.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.145 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.403 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 41.6 t -64.78 137.65 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.051 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' GLU . 9.4 pt -86.3 137.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 110.366 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.801 ' OE1' HD12 ' A' ' 134' ' ' ILE . 8.9 mm-40 -42.75 -38.28 2.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -40.79 -39.46 1.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -0.822 . . . . 0.0 110.551 -179.837 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -84.31 -45.38 12.87 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.174 -0.954 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.801 HD12 ' OE1' ' A' ' 131' ' ' GLU . 23.6 mt -56.19 -35.67 43.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.493 -0.754 . . . . 0.0 109.535 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 1.1 mt-10 -65.66 -37.46 86.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.523 -0.736 . . . . 0.0 110.227 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 9.2 t70 -52.06 -54.6 28.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 137' ' ' LEU . 25.3 mt -50.5 -39.57 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.418 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.668 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -65.18 -39.08 92.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.406 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -64.88 -52.31 57.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 110.571 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.2 -27.64 68.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 111.13 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.568 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -89.34 -65.05 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.018 . . . . 0.0 111.025 -179.292 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.448 ' OD1' ' OD1' ' A' ' 146' ' ' ASP . 18.5 t0 -41.69 98.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.895 . . . . 0.0 110.36 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.4 tppp? -94.51 -32.11 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 0.0 110.367 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 4.5 p30 -101.94 17.68 22.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.135 -0.978 . . . . 0.0 110.213 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 2.0 m-20 48.74 80.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.486 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 9.2 p-10 -134.77 11.1 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 62.1 14.51 46.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 72.1 mtt180 -146.94 143.95 28.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -1.158 . . . . 0.0 110.481 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.668 HD12 ' CE ' ' A' ' 138' ' ' MET . 1.2 mt -93.14 123.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 109.948 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 39.4 p30 -91.74 -165.06 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.805 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -54.93 15.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 110.393 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.26 -57.28 13.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 92.6 mt-10 -48.54 -46.29 38.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.577 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 1.5 t80 -54.16 -58.9 5.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.677 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 155' ' ' LEU . 31.4 mt -51.46 -59.39 4.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.841 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -42.65 44.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.775 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.474 ' HE1' HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -65.21 -45.17 85.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.509 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.549 ' HA ' ' HE3' ' A' ' 158' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.202 -0.937 . . . . 0.0 110.446 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.227 0.537 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 21.3 mp0 -53.61 -56.48 16.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.887 . . . . 0.0 109.924 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mt -52.26 -57.83 8.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.95 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 102' ' ' PHE . . . -47.66 -41.96 23.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -55.46 -32.76 63.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.686 ' HA ' HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -77.7 -7.2 56.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.577 -179.709 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 99' ' ' ALA . 2.5 t80 -60.86 -56.48 20.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.07 -1.019 . . . . 0.0 110.428 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.524 ' HG2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -52.16 -22.98 4.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.185 -0.947 . . . . 0.0 110.733 -179.764 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.686 HD13 ' HA ' ' A' ' 101' ' ' CYS . 2.0 mp -74.28 -47.93 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.061 -1.025 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.12 -49.9 11.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.308 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 108' ' ' ASN . 52.7 t0 -67.48 74.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -46.43 -39.19 10.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.7 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 106' ' ' ASP . 17.3 m-80 -103.54 165.01 11.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 109.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.25 63.89 7.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 17.2 p30 -102.55 -18.43 15.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.072 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.575 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 74.91 5.81 76.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 52.8 m-85 -148.53 110.29 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -1.147 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.91 144.85 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.46 ' CG ' ' HG3' ' A' ' 116' ' ' GLU . 30.0 p30 -119.7 -163.78 1.02 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' A' ' 135' ' ' GLU . 1.2 tt -79.59 -45.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -0.841 . . . . 0.0 110.779 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.603 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.41 -27.28 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 110.152 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 9.2 mt-10 -76.55 -48.93 17.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 109.86 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.472 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -51.85 -44.07 63.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 110.038 179.783 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -48.63 -83.91 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 10.6 pt-20 -42.42 -45.35 4.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -1.17 . . . . 0.0 110.493 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.0 mt -50.3 -54.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 109.679 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 122' ' ' LEU . 19.6 mt -73.1 -47.48 43.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -49.89 -37.55 31.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.837 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.64 -31.56 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 43.0 p -69.25 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 110.154 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.97 38.21 2.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -113.0 -157.52 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -1.191 . . . . 0.0 110.331 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -145.11 53.72 1.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.034 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 134' ' ' ILE . 46.8 t -61.18 162.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.832 . . . . 0.0 110.347 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 131' ' ' GLU . 13.7 pt -139.18 152.02 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.3 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -41.27 -53.62 3.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.993 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -43.44 -36.65 2.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -45.1 11.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.465 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 118' ' ' LEU . 21.1 mt -62.81 -38.9 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 109.623 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.608 ' HG2' HD11 ' A' ' 115' ' ' ILE . 2.0 mm-40 -58.74 -45.05 90.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 110.12 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 4.8 t70 -44.0 -50.02 8.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.265 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 141' ' ' SER . 31.6 mt -58.4 -40.27 81.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.444 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 34.5 tpp -65.34 -48.44 73.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.609 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -64.8 -37.16 86.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.576 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 2.9 t0 -72.19 -36.98 69.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.469 -0.769 . . . . 0.0 109.974 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.558 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -85.43 -46.65 10.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 110.136 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.454 ' HA ' ' CD ' ' A' ' 153' ' ' GLU . 29.3 t0 -61.82 86.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.815 . . . . 0.0 110.45 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 -8.1 58.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -119.45 19.55 12.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.429 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 34.1 m120 46.97 41.9 11.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.111 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.9 -9.33 59.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.31 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.43 60.95 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.436 ' CD ' ' HB3' ' A' ' 114' ' ' ASP . 55.9 mtt180 -146.2 162.18 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -1.143 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.558 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.3 mt -84.38 118.77 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 2.9 p30 -94.39 -178.08 4.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.932 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.98 -61.26 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 110.051 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.454 ' CD ' ' HA ' ' A' ' 142' ' ' ASP . 94.1 mt-10 -59.42 -44.89 92.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 10.6 t80 -46.27 -66.98 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.957 . . . . 0.0 110.207 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 154' ' ' PHE . 10.0 mt -44.52 -56.86 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -37.52 72.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.0 ptm -54.76 -49.51 70.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.672 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.525 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 109.989 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.132 0.492 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.0 -51.15 71.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.719 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 4.1 mm? -46.68 -56.75 5.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -45.04 -55.13 5.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.225 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -52.1 -43.43 63.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.314 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.46 -24.52 60.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -53.83 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.98 . . . . 0.0 110.073 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -55.37 -38.01 68.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.142 -0.974 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.468 ' HA ' HD13 ' A' ' 104' ' ' ILE . 12.2 mm -62.5 -39.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 109.946 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.417 ' CE2' HD13 ' A' ' 121' ' ' ILE . 1.4 m-30 -84.33 -46.08 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.173 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 6.7 t0 -82.42 96.24 7.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.335 -0.853 . . . . 0.0 109.838 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -105.83 -27.4 11.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 110.904 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.461 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 3.1 p30 -104.26 -45.19 4.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.014 -1.054 . . . . 0.0 110.77 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -86.12 -39.76 16.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.991 . . . . 0.0 110.016 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 2.9 m-20 45.3 27.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 109.962 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . -152.33 -36.99 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 20.9 m-85 -151.57 112.32 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.433 -1.039 . . . . 0.0 109.322 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.429 HG23 ' CB ' ' A' ' 117' ' ' GLU . 5.0 mt -82.77 118.84 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.681 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.473 ' OD2' ' N ' ' A' ' 116' ' ' GLU . 4.5 p-10 -92.66 -155.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' A' ' 135' ' ' GLU . 3.0 tp -78.73 -33.63 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.0 110.248 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.473 ' N ' ' OD2' ' A' ' 114' ' ' ASP . 1.7 mm-40 -57.16 -59.32 5.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.305 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 1.9 mt-10 -44.23 -48.46 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.917 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.571 ' HA ' HD12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -58.53 -31.98 68.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 110.103 179.811 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -60.44 -75.83 0.26 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 10.9 pt-20 -42.43 -45.58 4.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.258 -1.142 . . . . 0.0 110.44 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 118' ' ' LEU . 45.7 mt -47.21 -53.66 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.142 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.409 HD12 HG12 ' A' ' 134' ' ' ILE . 72.1 mt -75.14 -36.87 61.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.328 -0.858 . . . . 0.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 120' ' ' GLU . 6.6 mtm180 -62.96 -36.51 83.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 110.162 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.82 -40.43 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.2 p -61.96 -36.24 80.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.74 11.07 27.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -89.98 148.0 23.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.25 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -85.52 83.16 8.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 109.941 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' A' ' 133' ' ' ASP . 2.3 t -93.56 114.34 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 9.1 pt -73.28 146.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.05 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.7 mt-10 -41.13 -49.34 3.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 0.0 110.439 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.08 -26.68 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB3' HG12 ' A' ' 129' ' ' VAL . 0.1 OUTLIER -81.02 -50.01 10.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.309 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.557 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 6.4 mt -66.22 -42.55 91.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.492 ' HA ' HD11 ' A' ' 115' ' ' ILE . 8.3 mt-10 -45.81 -42.61 12.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.0 110.052 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.14 -51.78 68.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 110.246 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' A' ' 137' ' ' LEU . 2.7 mm? -48.63 -44.87 37.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.217 -0.927 . . . . 0.0 110.371 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 11.0 tpp -64.58 -45.96 84.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.759 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -46.21 74.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -0.835 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 110.561 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.531 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -89.48 -63.75 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.459 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 1.7 t0 -47.82 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.1 mttt -84.53 -26.02 28.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.162 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 11.6 m-80 -86.63 -3.94 59.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 109.744 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.3 OUTLIER 67.26 15.08 9.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -60.63 -15.79 32.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.1 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.15 -5.94 82.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.521 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -137.9 146.4 43.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.254 . . . . 0.0 110.486 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 141' ' ' SER . 5.8 mt -83.77 137.12 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 29.4 p-10 -121.15 -160.83 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.864 ' O ' HD12 ' A' ' 155' ' ' LEU . 49.5 p90 -68.17 -41.83 80.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 1.0 OUTLIER -68.38 -56.88 6.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.499 -179.857 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' HA ' ' A' ' 142' ' ' ASP . 59.1 mt-10 -58.35 -48.53 80.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 57.4 t80 -46.55 -54.42 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.927 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.864 HD12 ' O ' ' A' ' 151' ' ' PHE . 6.2 mt -66.62 -47.06 73.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.984 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -55.78 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 110.143 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -58.28 -52.47 65.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 109.72 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.9 mtm . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.075 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.177 0.513 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.01 -55.93 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 mt -58.61 -53.28 60.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.335 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -49.17 -51.92 29.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.361 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -51.43 -50.61 59.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 102' ' ' PHE . 5.2 m -53.03 -42.08 65.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.713 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 87.3 t80 -42.28 -65.16 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 110.603 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -39.58 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.193 -0.942 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 mm -60.87 -32.78 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 110.581 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.1 -48.92 21.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.102 -0.999 . . . . 0.0 110.416 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.79 101.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -75.48 -45.88 35.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.201 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 69.3 m-80 -69.43 -15.3 63.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 110.095 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 59.37 42.93 17.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.45 ' OD2' ' O ' ' A' ' 112' ' ' PHE . 6.7 p-10 -84.07 -16.56 43.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.085 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.483 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 113.23 -16.05 22.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 3.4 m-85 -148.37 135.46 20.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 110.404 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 22.9 mt -85.26 119.36 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.852 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 23.8 p-10 -90.98 -175.76 4.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.0 OUTLIER -68.25 -38.85 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.814 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.492 ' N ' HG23 ' A' ' 115' ' ' ILE . 17.7 mt-10 -58.04 -55.2 38.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.332 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 113' ' ' ILE . 7.2 mt-10 -46.62 -40.36 12.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.818 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.515 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.1 tp -61.16 -49.03 78.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 110.063 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -51.94 -69.85 1.05 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -47.47 -45.96 26.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -1.189 . . . . 0.0 110.179 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 122' ' ' LEU . 6.5 mt -48.28 -65.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.986 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.699 ' HB3' HG21 ' A' ' 129' ' ' VAL . 44.4 mt -61.76 -44.83 96.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.467 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.495 ' HG2' ' NH1' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -55.21 -36.46 65.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.9 . . . . 0.0 110.731 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.55 -28.32 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 109.997 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.1 p -81.07 -47.31 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.32 35.51 1.45 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 5.1 mt-10 -99.88 16.6 23.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -1.204 . . . . 0.0 109.99 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 127' ' ' GLU . 44.5 p-80 38.24 43.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.627 -0.671 . . . . 0.0 110.49 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 122' ' ' LEU . 20.1 t -61.09 117.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.472 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.3 pt -77.74 148.63 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -45.34 -47.45 13.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 0.0 110.329 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB2' HG13 ' A' ' 130' ' ' ILE . 4.8 mt-10 -41.24 -36.32 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -0.863 . . . . 0.0 110.477 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -43.81 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.673 HD13 ' HA2' ' A' ' 119' ' ' GLY . 26.6 mt -64.11 -38.48 82.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.588 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -50.45 73.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.488 -0.757 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 136' ' ' ASP . 9.2 t0 -45.47 -49.29 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 141' ' ' SER . 1.7 tp -51.65 -38.89 56.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.163 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -73.02 -57.58 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 110.055 -179.993 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 138' ' ' MET . 2.9 mmtm -43.34 -63.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.01 -20.43 6.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.547 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -101.85 -62.32 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 110.424 -179.842 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 138' ' ' MET . 24.0 t70 -56.29 81.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -89.8 31.33 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 179.546 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -149.07 17.65 0.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.847 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 55.3 21.88 4.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.257 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 147' ' ' GLY . 1.4 t70 -85.58 4.57 35.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.855 . . . . 0.0 109.896 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . 41.57 38.97 2.34 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.414 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 12.3 mtt180 -158.31 124.55 4.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -1.211 . . . . 0.0 110.325 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.547 HG12 ' CB ' ' A' ' 141' ' ' SER . 13.5 mt -83.76 106.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 44.8 p-10 -100.78 -140.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 110.37 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.46 -61.64 1.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 0.0 110.729 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.32 -56.02 13.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.654 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 148' ' ' ARG . 6.2 mt-10 -60.53 -53.54 56.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.676 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.495 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 44.9 t80 -43.98 -49.23 8.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.68 -36.55 84.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.203 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -46.37 69.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.887 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.551 ' HG2' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -61.08 -42.33 98.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.846 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.551 ' N ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 0.0 110.05 179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.187 0.517 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -55.97 -38.38 70.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.511 ' HA ' HD23 ' A' ' 98' ' ' LEU . 9.5 mt -57.14 -53.97 52.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.65 -65.61 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.845 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -52.07 -31.28 29.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.421 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -71.87 -9.85 58.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.208 -0.932 . . . . 0.0 110.378 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.99 -54.04 51.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.45 72.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.838 -179.378 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 mm -57.26 -29.31 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.125 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -80.53 -32.85 36.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.86 79.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -86.97 39.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.7 -179.878 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 27.9 t30 -128.96 -98.44 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 108' ' ' ASN . . . 174.8 27.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.984 -1.073 . . . . 0.0 111.041 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.4 p30 -113.45 -10.92 13.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.825 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.7 81.97 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.457 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 51.2 m-85 -141.6 139.75 33.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 110.6 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.478 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 51.0 mt -85.37 126.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.542 -0.724 . . . . 0.0 109.384 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.49 -179.23 3.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -65.3 -44.31 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.64 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.541 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.6 mt-10 -60.17 -51.15 70.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.064 . . . . 0.0 109.907 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.534 ' O ' HD12 ' A' ' 121' ' ' ILE . 14.6 mt-10 -49.76 -36.53 26.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.607 HD23 HG23 ' A' ' 134' ' ' ILE . 5.0 tp -60.71 -51.24 70.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 0.0 110.531 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -42.43 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.2 pt-20 -42.08 -45.81 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -1.18 . . . . 0.0 110.628 -179.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 117' ' ' GLU . 37.6 mt -56.23 -58.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.99 -1.069 . . . . 0.0 109.72 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.033 HD13 HG11 ' A' ' 129' ' ' VAL . 49.1 mt -60.7 -44.63 96.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 110.103 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.74 -37.77 79.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.126 -0.984 . . . . 0.0 110.264 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.87 64.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.987 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.8 p -62.74 -23.31 67.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.57 47.43 15.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.53 13.44 20.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -1.109 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 55.77 47.71 19.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.307 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.033 HG11 HD13 ' A' ' 122' ' ' LEU . 71.8 t -79.88 86.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.1 pt -57.79 149.86 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 132' ' ' GLU . 3.8 mm-40 -50.32 -44.54 54.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 111.142 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -39.43 -40.37 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.328 -0.857 . . . . 0.0 110.896 -179.474 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -47.3 21.6 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.307 -0.871 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.607 HG23 HD23 ' A' ' 118' ' ' LEU . 6.6 mt -59.71 -39.48 79.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.666 -0.646 . . . . 0.0 109.611 179.143 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.63 ' HA ' HD11 ' A' ' 115' ' ' ILE . 1.3 mm-40 -55.27 -42.33 73.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.03 -38.62 86.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 0.0 109.843 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 134' ' ' ILE . 0.6 OUTLIER -49.69 -41.98 44.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 110.947 -179.505 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.477 ' CE ' HD12 ' A' ' 149' ' ' ILE . 49.2 tpp -70.36 -43.8 69.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.921 -1.112 . . . . 0.0 110.173 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -62.74 -43.83 97.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.88 -18.77 64.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -99.07 -63.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.573 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.2 m-20 -40.05 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.718 . . . . 0.0 110.798 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 141' ' ' SER . 15.2 tttt -79.66 3.88 17.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.046 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.3 p30 -141.51 8.38 1.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.935 . . . . 0.0 110.053 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 62.3 m-20 58.18 61.9 2.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 56.7 p30 -102.05 -5.03 25.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.936 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.466 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 87.71 -5.18 85.34 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.466 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 18.0 mtm-85 -152.35 157.03 40.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.311 . . . . 0.0 110.79 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.477 HD12 ' CE ' ' A' ' 138' ' ' MET . 3.8 mt -89.28 144.87 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -121.01 -162.54 0.96 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.454 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.502 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 6.8 t80 -64.42 -52.92 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.977 . . . . 0.0 111.112 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.5 OUTLIER -60.2 -56.74 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 110.686 -179.397 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.02 -44.47 87.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.49 ' O ' ' HG2' ' A' ' 157' ' ' MET . 81.5 t80 -49.23 -54.99 14.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.208 -0.933 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 155' ' ' LEU . 35.3 mt -51.81 -51.42 56.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 110.357 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -46.99 -58.17 4.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 110.739 -179.74 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.565 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -47.53 -51.66 20.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.335 -179.586 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.565 ' N ' ' CG ' ' A' ' 157' ' ' MET . 12.3 mmt . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.156 0.503 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -68.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 99' ' ' ALA . 7.6 mp -47.96 -61.92 1.72 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.01 -42.72 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.429 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -73.82 -57.9 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.595 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 62.9 m -48.93 -27.26 2.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.879 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -46.38 -50.32 16.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.989 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -56.55 -42.59 78.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.425 HD12 HG23 ' A' ' 104' ' ' ILE . 20.0 mm -57.01 -43.3 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 110.635 -179.434 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -66.15 -38.45 88.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 110.175 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -67.19 89.74 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 0.0 110.091 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -62.78 -27.64 69.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 109.599 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.439 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 17.3 m-80 -104.78 -169.1 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.559 -0.713 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.14 65.41 0.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.365 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -114.44 -32.1 6.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 110.165 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.94 6.98 48.29 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.582 ' HB2' ' HD3' ' A' ' 148' ' ' ARG . 5.3 m-85 -152.09 128.88 10.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -1.203 . . . . 0.0 109.861 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.28 141.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 3.9 p30 -106.88 173.32 6.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.253 -0.904 . . . . 0.0 110.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 116' ' ' GLU . 3.3 tt -56.4 -42.93 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.076 -1.015 . . . . 0.0 110.209 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.595 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.7 OUTLIER -55.2 -59.39 4.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.901 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.598 ' C ' HD12 ' A' ' 121' ' ' ILE . 20.7 mt-10 -47.75 -43.93 27.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.668 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.762 ' HB3' HG23 ' A' ' 134' ' ' ILE . 2.5 tp -45.46 -31.23 1.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.612 -0.68 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -73.41 -74.5 0.81 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 5.5 pt-20 -42.05 -50.04 4.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -1.177 . . . . 0.0 110.476 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.598 HD12 ' C ' ' A' ' 117' ' ' GLU . 7.9 mt -48.33 -65.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.825 ' O ' HG22 ' A' ' 125' ' ' THR . 17.9 mt -59.67 -56.6 19.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -48.56 -30.99 5.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 110.453 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -54.85 -53.78 50.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 122' ' ' LEU . 4.4 t -67.47 -139.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.973 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.448 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . -118.34 11.75 12.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.828 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.3 mm-40 -81.61 97.32 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -1.066 . . . . 0.0 111.046 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -66.06 93.25 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 127' ' ' GLU . 3.4 t -103.98 146.6 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.894 -178.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 131' ' ' GLU . 12.4 pt -112.71 159.0 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -42.89 -48.19 5.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.805 . . . . 0.0 110.914 -179.703 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -47.28 -32.53 4.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.309 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.06 -48.3 8.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.463 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.762 HG23 ' HB3' ' A' ' 118' ' ' LEU . 22.8 mt -60.28 -42.74 91.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -59.01 -60.46 3.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.482 -0.762 . . . . 0.0 109.848 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -51.19 -45.39 61.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.217 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -48.25 -43.98 32.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.812 -179.79 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.594 ' HA ' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -62.27 -48.44 79.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.782 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.04 -36.02 69.52 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -0.791 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.85 -17.9 65.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.835 . . . . 0.0 110.412 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.549 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -102.77 -62.32 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.803 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.6 t0 -37.69 109.01 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.671 -0.643 . . . . 0.0 110.731 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -83.51 -11.41 57.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.748 . . . . 0.0 109.86 179.843 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 1.7 p30 -132.08 4.69 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.151 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 2.9 m120 60.83 48.19 7.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.777 . . . . 0.0 110.772 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.45 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 45.9 p-10 -81.82 -10.2 59.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 179.557 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . 93.94 8.5 60.41 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.582 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 10.2 mtt180 -158.34 139.98 13.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -1.177 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 138' ' ' MET . 3.6 mt -83.56 122.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -101.68 -174.24 2.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.32 -56.42 16.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -63.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.745 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 143' ' ' LYS . 21.1 mt-10 -55.76 -36.57 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.932 -179.392 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -63.24 -55.56 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.914 -1.116 . . . . 0.0 109.977 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 12.8 mt -54.6 -41.83 70.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 110.388 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -58.93 -62.86 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.821 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -57.43 -50.83 71.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 0.0 110.832 -179.43 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' MET . 6.1 mmt . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.333 -0.854 . . . . 0.0 110.485 -179.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 4.5 mp0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.261 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -48.2 -59.97 3.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.263 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 155' ' ' LEU . 6.0 mt -57.99 -45.98 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -42.36 -59.29 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.242 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 101' ' ' CYS . 3.7 m120 -50.02 -54.11 22.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.457 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.2 m -43.6 -32.59 0.98 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.908 179.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 13.0 t80 -42.93 -63.93 0.71 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.345 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -63.68 -29.63 70.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 23.0 mm -60.84 -50.77 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.487 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.4 -13.7 14.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.409 ' OD1' ' OD2' ' A' ' 110' ' ' ASP . 25.9 t0 -89.42 118.49 29.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.09 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -110.66 -11.91 14.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -109.71 15.09 23.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 110.611 -179.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 45.25 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 110.239 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -126.55 -27.88 3.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.989 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.95 -19.47 49.33 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 62.0 m-85 -153.23 128.24 9.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -1.102 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.499 HG23 ' OE1' ' A' ' 117' ' ' GLU . 1.4 mp -82.51 123.52 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -102.21 -168.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.249 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.8 tt -65.14 -40.47 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 110.328 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.555 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -51.38 -52.38 46.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.435 -179.693 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.499 ' OE1' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -56.97 -44.62 82.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.903 . . . . 0.0 110.28 -179.767 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.631 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -48.47 -34.19 10.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.171 -179.971 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -58.36 -85.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 15.7 pt-20 -42.43 -43.89 3.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.15 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.45 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.5 mt -52.61 -48.98 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.877 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 122' ' ' LEU . 10.8 mt -70.32 -47.1 62.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.097 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -51.96 -42.42 62.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.946 . . . . 0.0 110.208 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.04 -31.6 5.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.432 -0.793 . . . . 0.0 110.548 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 p -68.87 -35.91 77.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.363 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.91 49.24 2.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.45 -7.55 8.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.206 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 59.29 84.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 110.039 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 9.1 t -108.69 149.58 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.318 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' O ' ' C ' ' A' ' 131' ' ' GLU . 16.2 pt -113.44 154.82 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.126 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 130' ' ' ILE . 10.2 mt-10 -39.41 -51.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.436 -0.79 . . . . 0.0 110.777 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 -179.991 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -88.37 -44.75 10.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.503 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 118' ' ' LEU . 33.3 mt -63.26 -38.3 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.811 . . . . 0.0 109.894 179.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -54.04 -53.73 49.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.778 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -45.26 -48.73 12.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.575 HD22 HD21 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -53.09 -49.01 67.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 110.377 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 26.4 tpp -66.11 -50.43 64.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -41.83 93.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.398 -0.814 . . . . 0.0 110.093 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -66.77 -35.58 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.539 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -80.54 -48.83 12.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.4 OUTLIER -49.23 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.508 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 141' ' ' SER . 17.5 tttt -80.09 -19.21 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 0.2 OUTLIER -122.48 0.91 9.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.68 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 64.96 52.07 1.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.0 110.564 179.727 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 146' ' ' ASP . 50.7 p-10 -93.7 0.02 56.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 11.58 84.34 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -152.79 139.1 18.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.144 -1.21 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.2 mt -83.63 134.76 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.751 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 152' ' ' ASP . 2.1 p30 -118.6 -166.27 1.21 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 110.144 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 41.1 p90 -70.02 -34.98 73.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.594 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -66.0 -49.0 69.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.315 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 141' ' ' SER . 74.8 mt-10 -71.92 -56.61 5.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.38 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.446 ' O ' ' HG2' ' A' ' 157' ' ' MET . 69.6 t80 -45.29 -45.17 11.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 0.0 110.117 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 98' ' ' LEU . 13.1 mt -55.62 -40.93 72.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -55.11 36.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.56 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -47.17 -49.73 22.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 109.588 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.56 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.37 -0.831 . . . . 0.0 110.363 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.299 0.571 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -55.42 -60.1 3.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -0.894 . . . . 0.0 110.462 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.652 HD13 ' HE1' ' A' ' 158' ' ' MET . 0.2 OUTLIER -51.21 -54.79 22.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -41.32 -48.52 3.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 0.0 110.134 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.44 -43.65 71.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.064 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.8 m -63.9 -18.81 64.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.885 . . . . 0.0 110.192 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -53.15 -55.76 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 110.122 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -55.82 -33.75 64.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.03 -39.44 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -66.54 -51.51 55.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.099 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -72.56 123.77 23.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.165 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.471 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 19.6 mttp -93.99 17.19 12.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.424 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 50.3 m-80 -148.68 173.99 12.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 110.424 -179.485 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.5 40.6 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 p30 -88.13 -23.2 23.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.18 18.71 63.07 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -153.28 117.3 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -1.114 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 36.9 mt -84.1 132.05 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.32 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -107.34 -164.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -78.65 -43.93 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.085 -1.01 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.585 ' N ' HG23 ' A' ' 115' ' ' ILE . 31.2 mt-10 -51.78 -53.07 43.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 109.826 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 76.2 mt-10 -57.37 -44.58 84.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -50.48 -44.98 56.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 110.27 179.919 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.535 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -42.64 -83.39 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.471 ' OE2' ' NZ ' ' A' ' 107' ' ' LYS . 11.7 pt-20 -47.06 -44.44 20.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -1.158 . . . . 0.0 110.33 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.459 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 17.8 mt -48.18 -57.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.916 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 125' ' ' THR . 18.2 mt -68.85 -47.63 65.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.95 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.32 -37.87 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 110.147 179.756 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.3 -31.33 43.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 122' ' ' LEU . 65.7 p -52.9 -34.55 55.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.88 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.19 24.71 5.86 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -120.83 169.89 10.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 110.156 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -92.35 76.5 5.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.139 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.38 149.17 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' ' 131' ' ' GLU . 7.2 pt -133.26 149.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.085 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.1 mt-10 -41.55 -49.39 4.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.56 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 10.8 mt-10 -42.42 -40.39 2.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.037 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -47.92 10.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 109.175 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.64 HG23 HD13 ' A' ' 118' ' ' LEU . 10.4 mt -55.2 -39.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.4 -0.813 . . . . 0.0 109.272 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -54.59 -42.18 70.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.527 -0.733 . . . . 0.0 109.948 179.49 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -56.85 -50.72 71.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 110.245 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.6 mp -54.63 -35.53 63.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.417 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 142' ' ' ASP . 2.1 ttm -74.64 -55.53 5.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 110.396 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -47.54 -55.54 8.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.61 -33.39 69.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.0 t -84.9 -62.34 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.344 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 138' ' ' MET . 3.4 t0 -40.44 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.406 -0.809 . . . . 0.0 110.694 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 mttt -76.66 -27.86 55.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.416 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 8.4 m-80 -104.24 1.44 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.796 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.39 17.57 7.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 110.314 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.23 -14.32 17.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.048 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.494 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 97.41 9.21 55.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.494 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 32.2 mtt85 -150.69 142.81 24.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.379 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.4 mt -83.7 137.62 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.048 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.74 -179.99 3.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 110.112 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.577 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 30.8 p90 -51.64 -42.49 62.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.577 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 1.9 m-20 -67.0 -58.48 4.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.885 . . . . 0.0 110.892 -179.434 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.416 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 39.6 mt-10 -59.46 -38.33 80.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.209 -0.932 . . . . 0.0 111.031 -179.321 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.488 ' CD2' ' SD ' ' A' ' 157' ' ' MET . 25.7 t80 -58.99 -57.38 13.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 110.619 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.469 ' O ' ' HE3' ' A' ' 158' ' ' MET . 64.6 mt -40.74 -50.07 3.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.317 -179.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -39.11 90.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.964 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.513 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -55.85 -46.52 78.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.362 -0.836 . . . . 0.0 109.869 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.652 ' HE1' HD13 ' A' ' 98' ' ' LEU . 1.7 tmm? . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.74 . . . . 0.0 110.158 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.206 0.527 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.49 -62.57 1.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.737 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.514 HD21 ' HG2' ' A' ' 158' ' ' MET . 16.0 mt -46.61 -53.75 10.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.45 -37.51 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.36 -42.74 53.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 110.623 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -55.17 -24.61 27.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.968 . . . . 0.0 110.544 -179.704 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 101' ' ' CYS . 15.6 t80 -42.82 -54.57 4.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -67.13 -37.51 83.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.194 -0.941 . . . . 0.0 110.0 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.7 mm -57.53 -39.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.29 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.676 ' CD2' HD13 ' A' ' 121' ' ' ILE . 2.4 m-85 -83.59 -26.08 30.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -80.76 98.48 7.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.252 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -75.81 0.94 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.289 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -132.27 167.53 19.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -0.858 . . . . 0.0 110.244 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.79 29.07 0.94 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.418 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 8.8 p30 -76.26 -24.0 54.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.538 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 80.03 7.46 88.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 38.7 m-85 -153.07 133.75 13.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -1.175 . . . . 0.0 110.241 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.33 129.48 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.345 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 117' ' ' GLU . 35.4 p30 -101.99 -179.01 3.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.076 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -58.82 -43.47 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.064 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.563 ' N ' HG23 ' A' ' 115' ' ' ILE . 19.3 mt-10 -52.21 -51.93 55.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.073 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.5 mm-40 -57.56 -39.19 76.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.511 HD22 HD11 ' A' ' 122' ' ' LEU . 0.9 OUTLIER -60.01 -50.95 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 110.537 -179.68 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.498 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -49.64 -74.45 0.27 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' CD ' ' HA ' ' A' ' 117' ' ' GLU . 5.6 pt-20 -42.31 -47.7 4.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.434 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.676 HD13 ' CD2' ' A' ' 105' ' ' PHE . 6.1 mt -51.86 -58.37 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.511 HD11 HD22 ' A' ' 118' ' ' LEU . 64.7 mt -60.67 -47.1 87.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.289 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -36.78 66.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.201 -0.937 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.13 -42.22 28.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -0.862 . . . . 0.0 110.497 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.2 p -54.86 -48.44 72.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.4 35.97 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.05 147.75 48.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -1.065 . . . . 0.0 110.129 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.574 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -82.96 59.94 5.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 110.301 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 122' ' ' LEU . 7.9 t -61.7 156.81 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.407 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.4 pt -125.67 148.2 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.32 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLU . 4.3 mt-10 -45.99 -47.72 16.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.022 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' GLU . 1.9 mt-10 -42.58 -35.0 0.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.03 -43.63 12.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.498 HD13 ' HA2' ' A' ' 119' ' ' GLY . 14.1 mt -64.13 -40.04 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 109.633 179.36 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.8 -48.45 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.848 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -47.83 -53.79 14.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.76 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.537 ' HG ' ' HE2' ' A' ' 157' ' ' MET . 0.4 OUTLIER -50.76 -43.02 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.876 179.613 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -69.26 -53.69 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.615 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -53.76 46.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.079 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -57.59 -40.28 78.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 110.107 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.32 -59.03 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.207 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.1 m-20 -52.57 87.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.831 . . . . 0.0 110.533 -179.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.3 OUTLIER -68.25 -18.93 64.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.425 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -121.74 11.58 10.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.801 179.664 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 20.8 m-20 51.8 86.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -130.54 13.11 5.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 58.4 23.58 54.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 3.0 mtt85 -158.3 123.71 4.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 110.424 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 5.7 mt -84.52 122.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 109.817 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -101.58 -175.09 2.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.995 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -49.26 -57.79 6.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 110.552 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -61.55 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.691 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.425 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 96.0 mt-10 -56.72 -33.15 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.645 -179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 157' ' ' MET . 13.1 t80 -60.65 -64.34 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 110.614 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.1 mt -46.66 -58.07 4.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.443 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -47.11 -38.77 12.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.963 . . . . 0.0 110.409 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.537 ' HE2' ' HG ' ' A' ' 137' ' ' LEU . 0.9 OUTLIER -67.66 -48.71 65.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.881 . . . . 0.0 110.152 -179.957 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.524 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.3 tpp . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.369 -0.832 . . . . 0.0 110.411 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 4.3 mt-10 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.296 0.57 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER 65.07 150.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 110.298 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.19 150.69 23.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 110.14 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.42 -27.13 24.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 110.266 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . 76.49 -126.64 8.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 92' ' ' GLY . 8.0 mttt 42.13 -158.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -1.13 . . . . 0.0 110.173 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.5 161.06 2.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -0.961 . . . . 0.0 110.302 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.5 OUTLIER -51.16 -44.93 61.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -0.91 . . . . 0.0 110.263 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 5.4 tp10 -40.37 -63.76 0.59 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.43 -0.794 . . . . 0.0 110.503 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.8 -57.14 7.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.556 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.6 OUTLIER -50.11 -46.2 53.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 0.0 110.095 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -43.61 -58.55 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -53.6 -51.93 61.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -43.79 -30.26 0.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.403 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 30.6 t80 -42.79 -59.77 1.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.425 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.4 -36.66 71.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.226 -0.921 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 47.2 mm -57.24 -29.51 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.944 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -78.05 -54.18 6.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.949 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 3.8 t70 -67.61 87.04 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.966 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -84.87 -2.81 58.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.908 . . . . 0.0 110.464 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 110' ' ' ASP . 2.1 p30 -131.28 153.09 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.136 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.68 89.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 110.145 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 108' ' ' ASN . 60.9 t0 -142.29 -34.54 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 110.284 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.53 10.18 35.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.46 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 31.2 m-85 -153.52 147.06 25.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -1.175 . . . . 0.0 110.052 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 149' ' ' ILE . 32.8 mt -90.99 114.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 110.336 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -98.87 179.9 4.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 110.177 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.566 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -66.66 -43.53 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.986 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.566 ' N ' HG23 ' A' ' 115' ' ' ILE . 2.4 mm-40 -50.75 -45.5 58.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 109.822 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 7.9 mt-10 -65.02 -38.41 90.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 0.9 OUTLIER -58.29 -38.53 77.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 110.118 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.413 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -47.75 -80.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -43.43 -54.15 4.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.323 -1.104 . . . . 0.0 110.743 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.501 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 14.0 mt -42.23 -61.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.14 -0.975 . . . . 0.0 110.342 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 74.5 mt -66.71 -44.79 80.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.37 -40.65 62.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.342 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.17 19.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.6 p -74.9 -169.33 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.344 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.11 56.57 0.46 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -116.83 -10.38 11.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 110.201 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 49.12 68.06 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.4 t -89.69 149.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.955 . . . . 0.0 110.66 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 131' ' ' GLU . 18.0 pt -117.98 155.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.949 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.4 mt-10 -40.2 -50.1 2.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.33 -0.856 . . . . 0.0 110.887 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.4 -32.99 28.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 110.948 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -47.24 10.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.089 -1.007 . . . . 0.0 109.585 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 13.7 mt -58.2 -37.21 61.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.311 -0.868 . . . . 0.0 109.717 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.495 ' HA ' HD11 ' A' ' 115' ' ' ILE . 4.5 mt-10 -57.4 -47.8 80.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.44 -43.65 71.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 0.0 110.112 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.61 -44.37 69.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.255 -0.903 . . . . 0.0 110.129 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.6 ttm -64.68 -41.77 95.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.356 -0.84 . . . . 0.0 110.261 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -56.25 22.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.369 -0.832 . . . . 0.0 110.634 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -57.38 -19.19 21.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 110.671 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.559 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -102.51 -61.5 1.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 0.0 110.736 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 141' ' ' SER . 59.5 t0 -39.38 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.402 -0.811 . . . . 0.0 110.852 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -92.67 -5.61 51.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.863 . . . . 0.0 110.142 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 1.1 m-80 -127.49 21.6 6.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.166 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 47.6 46.94 17.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -105.45 14.46 28.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 110.228 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.429 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 46.53 30.94 4.77 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 11.0 mtt180 -157.52 128.74 6.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -1.113 . . . . 0.0 110.363 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.559 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.2 mt -83.48 123.54 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.258 -0.901 . . . . 0.0 109.683 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 20.4 p-10 -96.33 -167.36 1.56 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.355 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.587 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 18.2 p90 -65.23 -43.3 91.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.222 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.587 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -64.32 -58.32 6.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.312 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.486 ' HG2' ' HB2' ' A' ' 143' ' ' LYS . 35.7 mt-10 -61.61 -42.83 99.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.176 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.521 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 17.4 t80 -56.49 -64.95 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.148 -0.97 . . . . 0.0 110.07 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 155' ' ' LEU . 32.5 mt -44.94 -48.49 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.379 -0.826 . . . . 0.0 110.001 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -46.91 -46.53 21.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.291 -0.881 . . . . 0.0 110.375 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.547 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -71.43 -53.29 14.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.949 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.556 ' HB3' HD21 ' A' ' 98' ' ' LEU . 5.3 mmt -45.3 -36.37 4.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.946 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -63.57 -40.98 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 110.016 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -116.27 62.8 0.37 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 158' ' ' MET . 70.5 t -48.39 143.2 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 110.438 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.258 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.261 0.553 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -160.21 168.9 24.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.157 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.1 6.82 2.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.947 . . . . 0.0 110.242 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.83 109.24 1.38 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 0.0 110.254 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.77 -168.1 11.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.509 ' HG3' HD12 ' A' ' 98' ' ' LEU . 3.5 ptpp? -129.93 29.19 5.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.228 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.74 147.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 110.266 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 96' ' ' GLU . 5.4 tm-20 -53.55 -42.44 67.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.328 -0.858 . . . . 0.0 110.398 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 95' ' ' GLU . 2.4 tt0 -38.3 -66.84 0.23 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.468 -0.77 . . . . 0.0 111.056 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.2 mt-10 -47.89 -65.2 0.6 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 110.846 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' A' ' 154' ' ' PHE . 0.1 OUTLIER -51.19 -55.22 19.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.145 -0.972 . . . . 0.0 110.639 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -44.87 -44.77 9.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.256 -0.902 . . . . 0.0 110.687 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 3.0 m-20 -50.77 -52.0 45.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.741 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 105' ' ' PHE . 0.8 OUTLIER -61.17 -16.67 47.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.17 -0.956 . . . . 0.0 110.977 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 34.7 t80 -47.88 -41.25 23.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.103 -0.998 . . . . 0.0 110.844 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -73.87 -37.8 64.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.0 111.095 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -57.06 -35.63 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 110.474 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 101' ' ' CYS . 28.8 m-85 -80.83 -36.57 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 110.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -79.67 80.13 6.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.034 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.456 ' HB2' ' OE2' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -54.46 -30.49 53.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -0.831 . . . . 0.0 110.479 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -109.35 -151.7 0.48 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.081 -1.012 . . . . 0.0 110.33 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.06 47.75 1.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.111 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 9.2 p30 -83.14 -18.01 40.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 110.238 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.48 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 80.13 -5.0 64.27 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 110' ' ' ASP . 7.4 m-85 -145.5 135.79 23.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -1.184 . . . . 0.0 109.876 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.0 mt -82.84 120.77 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.04 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 6.9 p-10 -87.84 176.65 7.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.158 -0.964 . . . . 0.0 110.324 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -69.72 -40.62 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -0.81 . . . . 0.0 110.126 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 11.7 mt-10 -54.29 -48.86 70.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.021 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' OE2' ' HB2' ' A' ' 107' ' ' LYS . 3.5 mt-10 -53.3 -50.25 65.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.687 HD23 HG23 ' A' ' 134' ' ' ILE . 0.8 OUTLIER -58.28 -39.74 80.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.313 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.53 -73.99 0.34 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 14.5 pt-20 -54.85 -44.77 74.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.213 -1.169 . . . . 0.0 110.573 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 125' ' ' THR . 10.9 mt -53.01 -56.02 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 110.241 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.84 -54.59 32.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -55.99 -39.67 72.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.076 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -53.05 -20.22 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.253 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 121' ' ' ILE . 12.2 p -86.35 -1.95 57.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.12 81.37 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . 0.2 OUTLIER -79.32 0.5 28.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -1.112 . . . . 0.0 110.237 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 41.97 45.75 3.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.46 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 127' ' ' GLU . 14.8 t -77.86 155.22 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.199 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' O ' HG13 ' A' ' 130' ' ' ILE . 20.7 pt -114.96 138.27 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 110.409 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ILE . 8.9 mt-10 -41.02 -43.44 2.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.478 -0.764 . . . . 0.0 110.588 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HB2' HG13 ' A' ' 130' ' ' ILE . 1.5 mm-40 -40.72 -38.53 0.92 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.303 -0.873 . . . . 0.0 110.6 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.84 -48.96 8.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.921 . . . . 0.0 109.659 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.687 HG23 HD23 ' A' ' 118' ' ' LEU . 13.3 mt -58.12 -39.45 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.441 -0.787 . . . . 0.0 109.46 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.863 ' HA ' HD11 ' A' ' 115' ' ' ILE . 4.5 tt0 -66.79 -41.6 87.36 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.589 -0.695 . . . . 0.0 110.021 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.81 -42.26 75.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.968 . . . . 0.0 110.086 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -36.43 78.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 31.2 tpp -61.64 -40.5 95.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.894 . . . . 0.0 109.875 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -59.12 -49.42 77.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 110.104 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -68.19 -41.38 81.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.031 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.54 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -73.99 -63.97 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.144 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 138' ' ' MET . 9.7 t0 -45.41 97.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 110.444 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -82.14 -24.22 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.431 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 10.3 m-80 -107.76 14.78 25.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.887 . . . . 0.0 110.161 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.15 47.7 19.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 110.329 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 51.1 p30 -105.32 25.57 10.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 110.091 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 44.33 35.46 3.82 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 86.6 mtt180 -157.91 121.35 4.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.54 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.2 mt -83.62 118.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.432 ' OD2' ' OE2' ' A' ' 153' ' ' GLU . 41.0 p30 -97.18 -179.78 4.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 110.445 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -59.27 3.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.403 -0.811 . . . . 0.0 110.43 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.02 -61.12 2.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.33 -0.856 . . . . 0.0 110.496 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 157' ' ' MET . 16.7 mt-10 -60.73 -39.95 90.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.366 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' A' ' 98' ' ' LEU . 21.5 t80 -59.68 -33.09 71.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.304 -0.872 . . . . 0.0 110.975 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 155' ' ' LEU . 25.1 mt -74.3 -46.45 40.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 110.974 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 157' ' ' MET . 63.5 mttt -66.67 -49.41 66.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.161 -0.962 . . . . 0.0 110.834 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.73 -50.51 7.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.015 -1.053 . . . . 0.0 110.372 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.467 ' HB2' ' SD ' ' A' ' 157' ' ' MET . 9.8 ttm -101.04 64.07 1.03 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.43 75.44 8.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 110.35 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.68 -47.66 2.78 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.696 HG22 ' HG2' ' A' ' 162' ' ' GLN . 12.2 p -49.61 122.9 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -1.146 . . . . 0.0 110.295 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.696 ' HG2' HG22 ' A' ' 161' ' ' VAL . 81.4 mm-40 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.198 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.222 0.534 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 12.4 t70 -110.51 -16.45 13.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 0.0 110.22 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 66.7 114.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 110.387 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -116.09 48.44 1.24 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.0 110.065 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.27 -47.52 1.01 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' HG3' ' HG2' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -92.89 107.71 19.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 110.085 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -59.72 139.56 57.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.889 . . . . 0.0 110.524 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 94' ' ' SER . 17.8 tt0 -43.61 -46.47 7.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.946 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 1.1 tp10 -50.42 -39.25 46.87 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.356 -0.84 . . . . 0.0 109.941 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HG2' ' HG3' ' A' ' 93' ' ' LYS . 6.3 tp10 -49.8 -66.32 0.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.119 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.3 OUTLIER -50.1 -45.62 52.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -47.81 -42.65 26.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.375 -0.828 . . . . 0.0 110.27 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 104' ' ' ILE . 42.4 m-20 -48.1 -46.19 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 0.0 110.5 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 m -78.21 -25.67 47.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 0.0 110.904 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -52.95 -62.65 1.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -0.999 . . . . 0.0 110.729 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -57.15 -27.98 62.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.264 -0.897 . . . . 0.0 110.92 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 100' ' ' ASN . 45.6 mm -61.42 -26.3 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.026 -1.046 . . . . 0.0 110.464 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -85.13 -29.21 24.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.273 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -79.87 117.24 20.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.079 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.17 -11.47 15.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.184 -0.947 . . . . 0.0 110.289 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 109' ' ' ALA . 56.6 m-80 -116.34 16.11 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.302 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 43.98 79.42 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.17 -33.13 5.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.365 -0.834 . . . . 0.0 110.23 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.519 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 111.85 -14.35 26.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.519 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 18.7 m-85 -149.93 141.25 23.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -1.087 . . . . 0.0 109.826 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 44.4 mt -82.81 130.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.247 -0.908 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 8.2 p30 -95.17 -176.87 3.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -0.873 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.1 tt -79.18 -44.98 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 110.508 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.605 ' N ' HG23 ' A' ' 115' ' ' ILE . 21.6 pt-20 -48.99 -35.13 14.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.103 -0.998 . . . . 0.0 110.14 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' N ' ' HG3' ' A' ' 116' ' ' GLU . 43.2 mt-10 -69.12 -42.31 76.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.029 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.622 HD23 HG23 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -57.36 -37.88 73.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.31 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -57.11 -72.95 0.5 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.4 pt-20 -53.95 -44.63 70.86 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -1.127 . . . . 0.0 110.701 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.2 mt -45.05 -56.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.086 -1.009 . . . . 0.0 110.481 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.716 ' O ' HG22 ' A' ' 125' ' ' THR . 15.7 mt -66.24 -52.31 48.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.684 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -48.71 -30.93 6.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 0.0 110.681 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.45 -56.62 18.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.0 110.743 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.716 HG22 ' O ' ' A' ' 122' ' ' LEU . 2.3 t -63.2 -10.15 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.137 -0.977 . . . . 0.0 110.559 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 128' ' ' HIS . . . 111.52 -29.1 8.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 129' ' ' VAL . 4.2 mm-40 -52.24 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.466 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 126' ' ' GLY . 8.1 m80 -67.32 76.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 109.975 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 127' ' ' GLU . 13.3 t -84.29 136.85 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.47 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 ' HB2' ' A' ' 133' ' ' ASP . 17.2 pt -90.97 143.59 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -42.95 -46.96 5.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 110.454 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -48.03 -27.23 2.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.458 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.486 ' HB2' HG13 ' A' ' 130' ' ' ILE . 0.2 OUTLIER -89.68 -41.89 11.66 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.619 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.622 HG23 HD23 ' A' ' 118' ' ' LEU . 36.7 mt -65.64 -37.97 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 109.915 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.16 -48.46 73.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 109.91 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 12.8 t0 -55.57 -45.94 77.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -57.7 8.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.975 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 2.0 ttm -56.18 -20.88 19.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -72.89 -44.75 60.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -0.835 . . . . 0.0 110.428 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -73.94 -34.48 64.33 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.244 -0.91 . . . . 0.0 110.716 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -74.04 -63.14 1.28 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.056 -1.027 . . . . 0.0 110.547 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 138' ' ' MET . 23.2 m-20 -41.89 96.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.483 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -72.84 -3.81 27.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.044 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.31 22.57 2.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 110.121 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 48.94 86.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.86 . . . . 0.0 110.337 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' OD1' ' CG ' ' A' ' 142' ' ' ASP . 17.6 p-10 -139.94 17.81 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 48.32 32.16 9.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 45.5 mtt180 -158.19 121.69 3.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.189 . . . . 0.0 110.454 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.8 mt -83.53 123.71 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.667 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 23.1 p30 -103.94 -177.44 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.617 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.89 ' CE2' HD11 ' A' ' 155' ' ' LEU . 29.7 t80 -49.95 -62.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.0 110.629 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.512 ' HA ' HD12 ' A' ' 155' ' ' LEU . 0.3 OUTLIER -48.83 -57.61 6.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.367 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.472 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 79.7 mt-10 -59.94 -39.63 86.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -0.968 . . . . 0.0 109.989 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 33.0 t80 -63.34 -51.48 65.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.211 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.89 HD11 ' CE2' ' A' ' 151' ' ' PHE . 37.3 mt -47.53 -54.06 12.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.213 -0.929 . . . . 0.0 110.452 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . 31.7 mttt -60.55 -51.2 70.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.609 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.506 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.1 ptm -48.75 -47.54 41.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.595 ' HB3' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -95.66 32.91 1.73 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.406 -0.809 . . . . 0.0 110.117 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 156' ' ' LYS . 5.3 tp10 -76.7 126.01 30.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.875 . . . . 0.0 110.262 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.63 50.67 6.4 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.7 t -59.99 138.13 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -1.139 . . . . 0.0 110.222 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.2 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.224 0.535 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 52.9 m-20 -132.12 -77.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.218 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 89' ' ' ASP . . . -178.21 158.47 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 110.412 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -177.62 142.46 0.32 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 0.0 110.033 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.63 -22.06 56.77 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -71.23 130.81 42.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -1.193 . . . . 0.0 110.306 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 95' ' ' GLU . 4.1 m -94.92 150.35 20.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.232 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 94' ' ' SER . 3.2 tm-20 -42.34 -38.53 1.86 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.872 . . . . 0.0 110.196 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 95' ' ' GLU . 3.4 mt-10 -41.7 -61.76 1.03 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.308 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -51.39 -62.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.964 . . . . 0.0 110.079 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -47.78 -62.18 1.58 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 110.06 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -44.91 -47.37 11.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -0.877 . . . . 0.0 110.109 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 1.8 m-20 -50.88 -52.71 39.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -18.54 39.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 110.131 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 16.0 t80 -55.06 -55.87 26.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.305 -0.872 . . . . 0.0 110.247 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -57.06 -42.89 81.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -0.885 . . . . 0.0 110.636 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 1.2 mp -57.21 -41.71 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.135 -0.978 . . . . 0.0 110.273 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.455 ' CE2' ' HE3' ' A' ' 158' ' ' MET . 10.9 m-85 -72.11 -43.64 64.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 0.0 110.486 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -73.64 102.58 3.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.059 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -84.14 -44.34 14.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 110.475 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -68.09 -8.04 34.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 110.226 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 50.47 24.77 1.69 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 112' ' ' PHE . 4.0 p30 -68.16 -20.99 64.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 110.278 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.489 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 112.09 -15.77 25.52 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 9.7 m-85 -148.01 134.13 19.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -1.165 . . . . 0.0 110.208 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.5 mt -82.5 133.78 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.297 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 6.4 p-10 -107.28 -171.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.932 . . . . 0.0 110.141 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.4 tt -72.51 -43.42 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.942 . . . . 0.0 110.187 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.587 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -55.83 -35.6 66.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 110.131 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -74.97 -52.31 11.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 110.417 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -38.86 -30.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.46 -0.775 . . . . 0.0 111.065 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 117' ' ' GLU . . . -56.03 -43.76 88.18 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.518 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 11.4 pt-20 -49.28 -45.86 45.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.125 -1.22 . . . . 0.0 110.942 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.518 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 1.5 mp -60.26 -50.39 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.092 -1.005 . . . . 0.0 110.12 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.677 HD12 ' O ' ' A' ' 118' ' ' LEU . 4.3 mp -69.08 -52.26 30.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 110.034 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 24.9 mtp180 -49.64 -36.93 26.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.967 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.32 23.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 0.0 110.324 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.8 p -61.14 -40.37 93.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.244 -0.91 . . . . 0.0 110.392 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.29 -3.97 9.58 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -92.66 133.47 35.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -1.197 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.26 60.21 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 0.0 110.136 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.545 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 38.6 t -45.48 166.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.442 ' N ' HG12 ' A' ' 129' ' ' VAL . 31.9 pt -118.52 151.99 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.99 -48.44 3.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.382 -0.824 . . . . 0.0 110.78 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -48.88 -31.54 7.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.824 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.545 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.1 OUTLIER -83.19 -43.95 15.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 109.451 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.2 mt -66.2 -38.15 81.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.506 -0.746 . . . . 0.0 109.822 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.498 ' HA ' HD12 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.98 -53.18 44.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 110.536 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -45.98 -51.31 13.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 0.0 110.45 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.56 HD12 ' HE3' ' A' ' 157' ' ' MET . 1.5 mm? -50.58 -41.27 54.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.553 ' HE2' HD12 ' A' ' 149' ' ' ILE . 20.9 tpp -67.97 -48.96 64.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.158 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -48.21 79.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.63 -32.42 69.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.5 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 143' ' ' LYS . 2.1 t -92.99 -38.06 11.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' MET . 1.4 m-20 -51.99 88.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 8.3 tptm -74.63 -18.19 60.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.911 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 1.6 m-80 -117.77 10.68 13.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.331 -0.855 . . . . 0.0 109.989 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.0 m120 55.31 46.13 24.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -0.881 . . . . 0.0 110.322 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -107.04 16.12 24.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.037 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 51.52 34.96 35.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 5.6 mtm180 -157.63 124.82 5.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.136 -1.214 . . . . 0.0 110.223 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.553 HD12 ' HE2' ' A' ' 138' ' ' MET . 4.2 mt -83.94 128.55 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 0.0 110.131 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.451 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 53.3 p-10 -108.73 -170.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 110.087 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -63.5 -37.87 88.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.93 -51.85 35.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.433 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.451 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 46.8 mt-10 -59.7 -45.41 92.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.566 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 155' ' ' LEU . 1.9 t80 -50.61 -57.97 6.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.0 110.768 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.7 mt -39.92 -64.15 0.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.468 -0.77 . . . . 0.0 110.677 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.15 -30.97 66.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.56 ' HE3' HD12 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -65.5 -40.31 92.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.53 ' N ' ' HG3' ' A' ' 157' ' ' MET . 2.5 mtt -109.06 48.92 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 0.0 110.169 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -87.11 8.44 23.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 0.0 110.318 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -161.48 39.0 0.4 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 162' ' ' GLN . 15.0 t -120.99 158.17 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.235 . . . . 0.0 110.179 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 161' ' ' VAL . 3.2 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.247 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.231 0.539 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 45.1 p-10 -102.28 148.14 25.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.38 37.14 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.9 59.43 1.7 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.323 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.42 -82.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.422 ' CG ' ' HG ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -168.16 93.92 0.37 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -1.137 . . . . 0.0 110.163 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -97.82 -178.25 4.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -0.833 . . . . 0.0 110.202 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 94' ' ' SER . 2.7 mp0 -44.33 -52.11 7.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.185 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -49.63 -55.95 11.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 110.289 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 1.9 mt-10 -59.71 -54.01 51.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.701 HD22 ' HE1' ' A' ' 154' ' ' PHE . 14.1 mt -50.78 -64.13 0.91 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.216 -0.927 . . . . 0.0 110.111 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.89 -46.01 10.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.968 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 67.7 m-20 -56.01 -48.29 76.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.129 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 73.8 m -45.33 -29.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -44.89 -62.97 1.02 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.942 . . . . 0.0 109.82 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.39 -42.01 61.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -0.931 . . . . 0.0 109.768 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 21.0 mm -61.28 -39.27 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.0 -51.96 48.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.865 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 21.0 t0 -53.42 129.37 31.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.517 -0.739 . . . . 0.0 110.418 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt -98.29 -14.43 20.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 110.191 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 4.3 p30 -133.47 12.0 4.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 55.39 57.35 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 36.0 p30 -84.85 -14.57 47.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.164 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 110' ' ' ASP . . . 94.07 -10.52 71.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CB ' ' HD2' ' A' ' 148' ' ' ARG . 46.7 m-85 -151.41 136.42 17.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.114 -1.227 . . . . 0.0 110.635 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.9 mt -88.28 121.65 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.921 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' HG3' ' A' ' 117' ' ' GLU . 13.6 p30 -98.3 171.01 8.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.229 -0.919 . . . . 0.0 110.342 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -58.49 -36.7 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.451 ' N ' HG23 ' A' ' 115' ' ' ILE . 70.8 mm-40 -51.03 -54.04 28.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.877 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 51.6 mt-10 -56.38 -41.58 76.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.365 -0.834 . . . . 0.0 109.867 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.787 ' HG ' HD21 ' A' ' 137' ' ' LEU . 0.3 OUTLIER -54.73 -43.56 72.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.049 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -56.44 -75.47 0.25 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 16.1 pt-20 -42.35 -45.06 4.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.296 -1.12 . . . . 0.0 110.479 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.497 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 41.5 mt -55.22 -55.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.386 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.722 HD22 HG21 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -63.15 -53.67 49.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 110.442 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -48.82 -40.36 28.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.13 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.19 -34.39 22.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.286 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 36.4 p -70.01 -23.33 63.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.962 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.1 3.76 26.08 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.452 ' HB3' HG23 ' A' ' 129' ' ' VAL . 11.9 mt-10 -89.59 132.9 34.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.311 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -85.38 53.36 2.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.722 HG21 HD22 ' A' ' 122' ' ' LEU . 22.6 t -65.28 149.4 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.868 . . . . 0.0 110.518 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 132' ' ' GLU . 6.2 pt -113.76 153.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.079 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.8 tt0 -41.71 -53.02 3.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 110.544 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.536 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -44.32 -36.45 2.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.72 -42.05 22.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.182 -0.949 . . . . 0.0 109.099 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 17.0 mt -67.18 -36.53 77.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.52 -0.737 . . . . 0.0 109.565 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 138' ' ' MET . 2.8 tm-20 -56.26 -32.47 64.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 109.838 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -49.83 -62.42 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.815 . . . . 0.0 110.767 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.904 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.1 pp -56.88 -27.97 61.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.987 . . . . 0.0 110.651 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.436 ' N ' HD12 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -67.01 -46.82 73.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.03 . . . . 0.0 110.046 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.84 72.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.877 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -59.9 -36.37 76.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.552 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -86.11 -59.06 2.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.322 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 145' ' ' ASN . 53.9 t0 -43.44 92.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -92.3 -20.06 21.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 15.1 m-80 -104.74 6.4 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.03 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.0 OUTLIER 63.93 28.49 14.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 110.211 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -87.76 8.66 24.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.201 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.76 24.66 33.88 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.538 ' HD2' ' CB ' ' A' ' 112' ' ' PHE . 1.4 mtt-85 -147.69 142.58 26.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -1.155 . . . . 0.0 110.189 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.904 HD11 ' CD1' ' A' ' 137' ' ' LEU . 19.4 mt -90.65 121.48 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.372 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 36.4 p-10 -97.7 -156.32 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.897 . . . . 0.0 109.907 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -71.18 -55.79 7.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.31 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -59.32 -60.21 4.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.908 . . . . 0.0 110.548 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.49 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 26.6 mt-10 -48.02 -37.74 15.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.316 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.701 ' HE1' HD22 ' A' ' 98' ' ' LEU . 50.9 t80 -60.37 -61.04 2.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.308 -0.87 . . . . 0.0 110.514 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 154' ' ' PHE . 91.4 mt -41.76 -39.03 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -0.892 . . . . 0.0 110.435 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 152' ' ' ASP . 8.8 mttm -58.42 -45.48 88.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 110.365 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.863 ' HE1' HD13 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -64.17 -51.2 64.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.826 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.581 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -96.88 50.93 1.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.0 110.572 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.63 -20.2 17.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.098 -1.001 . . . . 0.0 110.349 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -88.14 -31.13 15.05 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 161' ' ' VAL . 13.8 p -50.09 133.07 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -1.162 . . . . 0.0 110.178 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.252 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.201 0.524 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -150.11 67.88 0.98 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 110.249 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.19 81.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 110.23 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.69 -151.16 0.48 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 93' ' ' LYS . . . -86.78 144.04 19.37 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 92' ' ' GLY . 36.4 mmtt 54.95 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.316 -1.108 . . . . 0.0 110.246 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -101.21 -178.4 3.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.935 . . . . 0.0 110.16 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.13 -40.88 64.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 110.236 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.12 -49.85 72.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.313 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -67.88 -52.97 30.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.287 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.509 HD22 ' HE2' ' A' ' 158' ' ' MET . 0.1 OUTLIER -52.15 -53.39 43.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.153 -0.967 . . . . 0.0 110.094 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.97 44.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.95 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -77.02 -46.0 25.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -49.01 -27.26 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.967 . . . . 0.0 110.092 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.626 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 2.3 t80 -42.08 -56.54 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -56.93 -34.12 67.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.326 -0.859 . . . . 0.0 110.99 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.61 -59.83 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.957 -1.089 . . . . 0.0 110.358 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.675 ' O ' HD11 ' A' ' 121' ' ' ILE . 3.0 m-85 -62.42 -38.37 89.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -85.76 62.24 7.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 0.0 110.229 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -35.43 10.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.182 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.424 ' HB3' ' OD2' ' A' ' 110' ' ' ASP . 1.5 t-20 -55.51 -21.26 15.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 110.123 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.02 47.18 25.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.138 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 108' ' ' ASN . 33.1 m-20 -106.94 -13.86 15.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.542 ' C ' ' CD1' ' A' ' 112' ' ' PHE . . . 97.87 -2.43 60.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 111' ' ' GLY . 63.5 m-85 -150.57 119.42 6.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.24 . . . . 0.0 110.273 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.409 ' HA ' ' OE2' ' A' ' 117' ' ' GLU . 15.7 mt -83.79 116.39 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.34 -0.85 . . . . 0.0 110.112 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -92.59 175.28 6.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.083 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.578 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.7 OUTLIER -57.05 -42.73 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.894 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.578 ' N ' HG23 ' A' ' 115' ' ' ILE . 4.5 mt-10 -51.01 -45.87 61.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.849 . . . . 0.0 110.093 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' HG13 ' A' ' 121' ' ' ILE . 4.4 mt-10 -58.47 -50.48 73.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.89 . . . . 0.0 110.127 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 137' ' ' LEU . 0.3 OUTLIER -52.1 -34.65 45.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 0.0 109.893 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -70.28 -69.25 1.43 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -48.52 -45.24 37.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.098 -1.237 . . . . 0.0 110.18 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.675 HD11 ' O ' ' A' ' 105' ' ' PHE . 47.3 mt -57.0 -50.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.864 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' A' ' 122' ' ' LEU . 12.9 mt -76.72 -53.98 7.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.965 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 9.5 mtt180 -49.07 -32.24 9.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.886 . . . . 0.0 110.098 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -57.15 -43.24 82.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 110.4 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 81.0 p -55.66 -43.57 76.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.932 . . . . 0.0 110.349 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 135.26 -39.37 1.69 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 129' ' ' VAL . 1.9 mt-10 -46.02 125.23 6.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.136 . . . . 0.0 110.321 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.56 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.3 OUTLIER -71.67 65.47 0.49 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 127' ' ' GLU . 5.3 t -64.67 148.68 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.207 -0.933 . . . . 0.0 110.155 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.47 145.24 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.393 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 132' ' ' GLU . 15.7 mt-10 -43.86 -50.16 8.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 110.326 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -42.51 -32.39 0.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.366 -0.834 . . . . 0.0 109.992 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.76 -47.0 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.647 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 118' ' ' LEU . 16.8 mt -59.69 -38.7 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.44 -0.787 . . . . 0.0 109.785 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -48.97 -48.79 42.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.392 -0.817 . . . . 0.0 110.273 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -51.24 -46.84 62.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 110.717 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 118' ' ' LEU . 10.5 mt -53.48 -52.92 58.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.005 . . . . 0.0 110.884 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 31.9 tpp -66.67 -52.35 45.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.065 -1.022 . . . . 0.0 110.167 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.73 -60.7 2.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.45 -0.781 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -55.24 -37.67 67.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.263 -0.898 . . . . 0.0 110.666 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.544 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.68 -55.4 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 110.557 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -46.74 91.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 0.0 110.593 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -80.81 -38.73 27.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.106 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -95.8 12.5 29.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -0.873 . . . . 0.0 110.082 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 2.4 m120 53.49 87.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.396 -0.815 . . . . 0.0 110.55 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 148' ' ' ARG . 6.8 p-10 -143.97 13.87 1.68 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.328 -0.858 . . . . 0.0 109.628 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.471 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 56.86 20.78 34.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HG3' ' C ' ' A' ' 147' ' ' GLY . 30.7 mtt-85 -149.77 133.83 17.12 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.995 -1.297 . . . . 0.0 110.607 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.544 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.9 mt -84.29 132.85 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.812 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 24.4 p-10 -112.55 -170.01 1.58 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.189 -0.944 . . . . 0.0 110.458 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.626 ' CE1' ' CD2' ' A' ' 102' ' ' PHE . 3.3 m-85 -59.38 -56.58 20.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.411 ' HA ' HD12 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -52.33 -59.17 4.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.225 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 157' ' ' MET . 54.2 mt-10 -57.39 -46.79 83.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 110.017 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.539 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 84.5 t80 -47.86 -32.24 5.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 110.233 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.532 ' O ' ' CE ' ' A' ' 158' ' ' MET . 27.7 mt -75.68 -50.64 14.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.166 -0.959 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -49.42 74.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.184 -0.948 . . . . 0.0 110.954 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -43.77 -47.61 8.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 111.245 -179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.532 ' CE ' ' O ' ' A' ' 155' ' ' LEU . 6.2 ptp -39.06 -29.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 0.0 110.616 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 157' ' ' MET . 9.6 mm-40 -51.46 146.16 7.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.96 . . . . 0.0 110.004 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.34 14.1 56.28 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 55.8 t -113.72 115.3 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -1.134 . . . . 0.0 110.235 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.204 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.204 0.526 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.46 -162.86 0.61 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 110.089 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -98.29 46.81 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.937 . . . . 0.0 110.12 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -71.86 -49.79 35.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 141.74 -121.59 1.86 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 97' ' ' GLU . 2.2 tppt? -142.8 165.6 26.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.99 169.31 9.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -0.862 . . . . 0.0 110.035 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -42.43 -44.05 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.182 -0.948 . . . . 0.0 110.203 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -50.92 71.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 110.483 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.461 ' HB3' ' HG3' ' A' ' 93' ' ' LYS . 2.8 tp10 -47.54 -46.92 28.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.866 . . . . 0.0 109.919 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.501 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 3.8 mm? -57.03 -48.54 78.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.999 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -49.08 -53.11 21.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.45 78.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.121 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -53.19 -19.2 2.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 110.178 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.479 ' HA ' ' CE2' ' A' ' 154' ' ' PHE . 44.3 t80 -50.5 -50.22 53.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 110.188 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -30.6 69.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.418 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 26.2 mm -56.89 -38.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -85.22 -11.85 53.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -91.24 106.6 18.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.078 -1.014 . . . . 0.0 110.119 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -9.29 33.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 110.338 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.488 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 66.4 m-80 -117.09 9.26 13.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.922 . . . . 0.0 110.312 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 44.02 43.49 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 10.8 m-20 -80.3 -22.43 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.36 -7.98 62.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 44.8 m-85 -151.81 125.06 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -1.157 . . . . 0.0 110.247 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 149' ' ' ILE . 2.9 mp -83.31 112.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 109.955 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 15.2 p-10 -92.97 -173.24 3.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.3 tt -69.69 -41.9 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.867 . . . . 0.0 110.523 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -53.81 -55.39 26.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 24.0 mt-10 -45.4 -55.05 6.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.355 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.746 HD23 HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -48.77 -54.01 16.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.089 -1.007 . . . . 0.0 110.359 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -47.39 -77.06 0.12 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.9 pt-20 -42.67 -47.9 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.502 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 117' ' ' GLU . 8.0 mt -47.29 -55.43 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.011 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.746 HD12 HD23 ' A' ' 118' ' ' LEU . 2.4 mt -76.63 -54.86 6.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.0 110.211 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -49.06 -36.37 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.899 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -48.88 -39.66 26.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.855 . . . . 0.0 110.052 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 69.9 p -66.76 -38.47 86.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.123 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 104.45 32.57 4.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 128' ' ' HIS . 8.6 mm-40 -97.02 7.08 47.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -1.173 . . . . 0.0 110.319 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 127' ' ' GLU . 14.5 m-70 43.58 72.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 122' ' ' LEU . 57.7 t -88.62 154.92 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.343 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 130' ' ' ILE . 17.6 pt -103.38 145.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 110.177 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.1 mt-10 -49.85 -41.05 44.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.377 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.1 tm-20 -41.69 -33.38 0.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 110.357 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -44.78 12.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 0.0 109.418 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.634 HG23 HD22 ' A' ' 118' ' ' LEU . 26.9 mt -65.59 -38.95 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.505 -0.747 . . . . 0.0 109.883 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 13.2 mm-40 -56.64 -50.52 71.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.47 -0.769 . . . . 0.0 110.277 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -47.93 -55.02 10.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.935 . . . . 0.0 110.408 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.464 HD13 HD21 ' A' ' 118' ' ' LEU . 45.3 mt -48.96 -52.95 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.496 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.513 ' HG3' ' HB2' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -71.08 -50.01 38.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.293 -0.88 . . . . 0.0 110.418 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 14.1 mttm -56.53 -39.7 73.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.424 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.43 -40.66 61.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.538 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -83.86 -52.19 6.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 110.653 -179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.513 ' HB2' ' HG3' ' A' ' 138' ' ' MET . 29.5 t0 -46.45 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.401 -0.812 . . . . 0.0 111.01 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 30.3 tttt -77.71 -23.93 49.31 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -99.35 -5.61 29.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.69 . . . . 0.0 109.636 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.469 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 1.5 m-20 59.84 24.86 13.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 110.457 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 20.6 p30 -85.17 2.58 43.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.065 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 75.94 38.73 35.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 14.7 mtm180 -159.14 133.45 7.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -1.177 . . . . 0.0 110.498 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 141' ' ' SER . 2.0 mt -97.81 123.89 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -105.48 -173.91 2.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 54.1 p90 -57.25 -43.49 83.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.97 . . . . 0.0 110.09 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.603 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -63.75 -51.4 65.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.877 . . . . 0.0 110.018 179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 53.5 mt-10 -65.16 -52.51 54.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.089 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 102' ' ' PHE . 5.9 t80 -46.72 -57.28 5.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 154' ' ' PHE . 71.3 mt -45.3 -63.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -60.69 -25.2 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 110.019 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.525 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -60.85 -38.03 84.13 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.262 -0.899 . . . . 0.0 109.148 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.525 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.2 OUTLIER -103.11 4.47 37.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.759 . . . . 0.0 109.985 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -89.84 -33.45 16.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -0.852 . . . . 0.0 110.157 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -134.92 48.8 0.92 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.3 t -52.06 130.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -1.069 . . . . 0.0 110.289 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.059 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.193 0.52 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 15.1 p30 -136.47 58.91 1.72 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.27 -0.894 . . . . 0.0 110.267 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 58.35 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.895 . . . . 0.0 110.221 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.3 -168.56 1.65 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.217 -0.927 . . . . 0.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . -113.47 22.63 14.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.461 ' HA ' ' OE2' ' A' ' 97' ' ' GLU . 10.5 mttp 43.45 68.52 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.174 -1.192 . . . . 0.0 110.035 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -51.11 163.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.3 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 94' ' ' SER . 21.3 tt0 -42.9 -47.45 5.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 110.424 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.71 -41.58 74.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.285 -0.884 . . . . 0.0 110.692 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -52.25 -49.69 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.472 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.635 HD12 ' CE ' ' A' ' 158' ' ' MET . 21.3 mt -53.0 -43.06 66.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 110.274 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.31 -61.0 2.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 0.0 110.37 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -55.41 -49.72 71.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.498 ' SG ' ' CE2' ' A' ' 105' ' ' PHE . 42.5 t -59.93 -19.95 54.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.327 -0.858 . . . . 0.0 110.495 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.65 -57.47 11.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.054 -1.029 . . . . 0.0 110.177 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -44.79 -37.09 3.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 104' ' ' ILE . 2.0 mp -67.88 -53.06 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.498 ' CE2' ' SG ' ' A' ' 101' ' ' CYS . 11.9 m-85 -54.03 -31.21 50.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.156 -0.965 . . . . 0.0 110.028 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 18.7 t0 -87.2 91.52 8.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -0.87 . . . . 0.0 109.906 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 -41.97 65.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 110.522 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 109' ' ' ALA . 32.8 m-80 -87.19 6.38 33.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.437 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 43.0 63.14 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.196 -0.94 . . . . 0.0 110.201 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -96.92 -11.79 24.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 110.301 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 90.78 -15.11 61.34 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 46.0 m-85 -147.35 125.02 11.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 110.074 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.84 131.13 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -96.95 -167.4 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 110.167 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.798 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.5 OUTLIER -72.49 -41.02 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.932 . . . . 0.0 110.131 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.506 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 1.6 tm-20 -57.03 -53.94 52.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.475 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 22.5 mt-10 -53.15 -38.2 62.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.33 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.461 HD11 HD22 ' A' ' 137' ' ' LEU . 0.9 OUTLIER -60.58 -51.35 69.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.26 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -50.1 -74.21 0.3 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.475 ' OE2' ' HA ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -42.47 -54.61 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -1.141 . . . . 0.0 110.671 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.441 HG13 ' CD ' ' A' ' 120' ' ' GLU . 17.1 mt -49.13 -53.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.133 -0.979 . . . . 0.0 110.18 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 122' ' ' LEU . 36.3 mt -69.1 -46.23 68.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.355 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.99 -39.4 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.92 -44.05 29.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 126' ' ' GLY . 32.9 p -55.55 -64.18 0.93 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.229 -0.919 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.455 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . 142.32 37.76 0.08 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.75 154.85 24.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.277 -1.131 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 128' ' ' HIS . 12.1 p-80 -90.01 63.5 5.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 110.645 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.2 t -82.49 135.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.139 -0.976 . . . . 0.0 109.737 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.0 pt -102.78 145.07 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.066 -1.021 . . . . 0.0 110.508 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.2 mt-10 -42.74 -53.97 4.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.313 -0.867 . . . . 0.0 110.41 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -40.49 -27.2 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.369 -0.832 . . . . 0.0 110.828 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -85.89 -51.24 6.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.77 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.0 mt -60.82 -41.31 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 109.699 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.798 ' HA ' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -50.03 -50.99 45.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.424 -0.798 . . . . 0.0 109.915 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -65.89 -36.85 84.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 118' ' ' LEU . 2.0 tt -50.35 -44.36 54.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.611 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 ttm -67.11 -42.43 84.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.172 -0.955 . . . . 0.0 110.507 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -64.19 -44.34 92.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -68.53 -36.81 79.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.187 -0.945 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.552 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.0 t -80.78 -49.8 10.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.94 . . . . 0.0 110.341 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.505 ' HA ' ' OE2' ' A' ' 153' ' ' GLU . 38.5 t70 -60.55 90.27 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 110.63 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.47 49.12 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.844 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 73.5 m-80 -147.61 -74.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.465 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 1.6 m-20 172.06 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.604 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 35.2 p-10 -41.54 -25.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 76.64 51.54 6.44 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 2.5 mtm180 -158.13 153.66 26.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -1.102 . . . . 0.0 110.35 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.552 HG12 ' CB ' ' A' ' 141' ' ' SER . 22.1 mt -88.97 114.17 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.901 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 26.5 p30 -105.9 -172.48 2.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.447 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 22.3 p90 -57.62 -37.07 72.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.378 -0.826 . . . . 0.0 110.757 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.612 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -70.44 -52.78 19.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' HA ' ' A' ' 142' ' ' ASP . 48.5 mt-10 -68.45 -43.74 76.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.927 . . . . 0.0 110.259 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.537 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 37.4 t80 -49.23 -33.88 13.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.538 ' O ' ' CE ' ' A' ' 158' ' ' MET . 94.8 mt -76.1 -42.02 48.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -69.15 -49.01 60.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.053 -1.029 . . . . 0.0 110.673 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.537 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -44.43 -48.24 9.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.213 -0.93 . . . . 0.0 111.056 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.635 ' CE ' HD12 ' A' ' 98' ' ' LEU . 5.8 ptp -41.74 -27.33 0.1 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.186 -0.946 . . . . 0.0 110.217 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 157' ' ' MET . 0.8 OUTLIER -103.06 87.65 2.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 110.203 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 124.8 10.8 4.67 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.657 HG22 ' OE1' ' A' ' 162' ' ' GLN . 9.9 p -111.97 125.83 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.26 -1.141 . . . . 0.0 110.203 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.657 ' OE1' HG22 ' A' ' 161' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.167 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.247 0.546 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.633 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER 65.37 148.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.862 . . . . 0.0 110.214 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 64.14 81.17 0.21 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 110.299 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.8 -161.32 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.288 -0.883 . . . . 0.0 110.239 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.48 129.47 5.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.64 133.02 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -90.97 161.93 14.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.202 -0.936 . . . . 0.0 110.355 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.861 ' HG2' HD22 ' A' ' 155' ' ' LEU . 7.6 tt0 -42.92 -52.61 5.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.361 -0.837 . . . . 0.0 110.271 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 1.6 mt-10 -49.33 -58.26 5.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 110.053 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -54.17 -55.74 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.292 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 154' ' ' PHE . 12.7 mt -51.53 -47.1 63.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 0.0 110.229 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -41.82 -58.9 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.312 -0.867 . . . . 0.0 110.314 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -65.57 -26.96 68.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.912 . . . . 0.0 110.335 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -74.89 -9.08 58.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.779 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -55.21 -47.62 75.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.019 -1.051 . . . . 0.0 110.013 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -60.43 -35.57 76.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.914 . . . . 0.0 110.013 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 18.0 mm -59.67 -32.59 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 110.005 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 107' ' ' LYS . 3.0 m-85 -80.22 -59.0 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -58.32 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.196 -0.94 . . . . 0.0 109.932 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -53.39 -43.34 67.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.34 -0.85 . . . . 0.0 110.563 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -94.13 -159.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.208 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.35 60.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.57 -32.4 12.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.186 -0.946 . . . . 0.0 110.159 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.537 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 99.74 -3.73 57.58 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 36.2 m-85 -153.35 123.92 7.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 113' ' ' ILE . 3.8 mp -83.58 122.38 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.309 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -95.77 178.47 5.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.1 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.636 HD11 ' HG2' ' A' ' 135' ' ' GLU . 2.2 tt -57.3 -42.7 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.027 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -51.82 -53.81 36.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.897 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 4.1 mt-10 -52.17 -47.21 65.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.959 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.566 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -54.77 -27.63 42.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.366 -0.834 . . . . 0.0 109.837 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.45 -68.71 1.51 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.566 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.3 pt-20 -49.89 -44.51 49.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.097 -1.237 . . . . 0.0 110.177 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.566 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 20.2 mt -49.28 -61.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.914 . . . . 0.0 109.945 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' A' ' 129' ' ' VAL . 1.0 OUTLIER -68.74 -43.7 75.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.926 . . . . 0.0 110.012 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -50.77 -39.47 52.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.399 -0.813 . . . . 0.0 110.222 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.18 -44.19 75.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -0.86 . . . . 0.0 110.381 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 p -60.89 -31.62 71.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.15 -0.969 . . . . 0.0 110.161 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.86 20.24 29.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 128' ' ' HIS . 2.2 mt-10 -88.9 23.13 2.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -1.162 . . . . 0.0 110.225 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.583 ' C ' HG23 ' A' ' 129' ' ' VAL . 1.5 t60 56.94 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -0.906 . . . . 0.0 110.643 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 122' ' ' LEU . 2.9 t 70.18 143.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.587 -0.696 . . . . 0.0 110.031 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.3 pt -123.18 146.85 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.137 -0.977 . . . . 0.0 110.491 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.64 -46.32 14.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 110.121 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.03 -28.93 1.85 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -0.839 . . . . 0.0 110.457 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.437 ' O ' HD12 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -92.7 -48.98 6.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 118' ' ' LEU . 22.6 mt -55.61 -39.29 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 110.074 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.636 ' HG2' HD11 ' A' ' 115' ' ' ILE . 7.0 mt-10 -58.28 -46.14 86.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.173 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -50.69 -52.11 43.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.6 OUTLIER -53.94 -43.27 69.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.089 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -71.08 -53.89 13.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.187 -0.946 . . . . 0.0 109.857 179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -59.57 4.46 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -49.7 -40.51 40.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 110.202 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.554 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.2 t -77.12 -57.32 3.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.469 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER -61.15 75.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 110.551 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.5 OUTLIER -79.66 4.12 17.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 109.713 179.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 144' ' ' ASN . 1.4 t30 -121.88 10.09 10.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.603 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.29 26.26 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 -1.82 18.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.359 -0.838 . . . . 0.0 110.209 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.436 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 60.97 17.07 50.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.469 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 1.1 mtt-85 -158.34 143.39 16.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -1.117 . . . . 0.0 110.33 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.554 HG12 ' CB ' ' A' ' 141' ' ' SER . 7.7 mt -87.63 116.66 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.74 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 154' ' ' PHE . 53.4 p-10 -101.42 -175.41 2.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 110.276 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -54.52 38.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 110.09 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.13 -62.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.349 -0.845 . . . . 0.0 110.367 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 154' ' ' PHE . 68.1 mt-10 -57.21 -50.82 71.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.164 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 98' ' ' LEU . 14.4 t80 -43.39 -56.18 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.869 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.861 HD22 ' HG2' ' A' ' 95' ' ' GLU . 96.0 mt -61.72 -51.34 68.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 159' ' ' GLU . 7.1 mmtt -53.69 -50.56 65.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.501 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -50.93 -46.13 60.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.501 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -105.61 43.91 1.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.616 -0.678 . . . . 0.0 110.099 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -112.82 159.72 18.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.229 -0.92 . . . . 0.0 110.218 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.94 56.51 6.41 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.69 138.87 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -1.186 . . . . 0.0 110.067 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.171 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.219 0.533 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.51 151.08 19.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.125 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 91' ' ' LYS . . . -65.62 -144.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 110.017 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 90' ' ' ALA . 8.4 mttt -43.98 118.37 1.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.053 -1.03 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 93' ' ' LYS . . . -63.26 152.11 47.48 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER 37.94 -156.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.642 -0.916 . . . . 0.0 110.776 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -177.01 176.62 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.431 -0.793 . . . . 0.0 110.01 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -54.19 -35.44 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 110.108 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -42.45 -71.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.241 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.98 -48.82 42.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 109.805 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.536 ' CD1' ' HB3' ' A' ' 158' ' ' MET . 2.2 mm? -51.38 -61.45 2.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.039 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.11 -51.93 16.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.922 . . . . 0.0 110.228 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 71.6 m-20 -51.23 -34.04 30.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.822 . . . . 0.0 110.143 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.41 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 61.0 m -68.19 -15.09 63.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 110.215 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -56.24 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.311 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 100' ' ' ASN . 6.8 ptp180 -52.47 -37.67 57.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.289 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.444 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 13.0 mm -57.8 -45.76 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 110.261 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -53.95 34.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 0.0 110.141 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.21 146.52 54.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.453 -0.779 . . . . 0.0 110.509 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -125.49 -47.1 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.977 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 66.2 m-20 -79.04 2.76 19.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 110.156 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 56.45 59.35 3.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.879 . . . . 0.0 110.174 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -91.7 -21.52 20.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.166 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.451 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 98.23 -15.99 60.62 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 40.5 m-85 -153.09 130.06 11.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -1.086 . . . . 0.0 110.043 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.45 125.1 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.893 . . . . 0.0 110.626 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -104.27 -157.81 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 109.825 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.458 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -75.5 -37.39 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.133 -0.98 . . . . 0.0 109.976 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.458 ' N ' HG23 ' A' ' 115' ' ' ILE . 57.1 mt-10 -55.71 -44.4 77.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -63.78 -44.46 93.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.668 HD12 HD12 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -56.76 -33.98 67.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.391 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -65.89 -74.21 0.54 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -42.12 -59.87 1.63 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.222 -1.163 . . . . 0.0 110.961 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 120' ' ' GLU . 4.2 mt -43.69 -50.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.001 -1.062 . . . . 0.0 109.974 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.845 HD13 HG11 ' A' ' 129' ' ' VAL . 11.1 mt -77.4 -42.45 36.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.398 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 44.6 mtt180 -55.68 -32.85 63.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.94 48.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.0 110.125 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.8 p -77.14 -157.66 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.274 -0.891 . . . . 0.0 110.248 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.92 58.12 0.69 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.06 164.48 26.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -1.137 . . . . 0.0 110.506 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.12 94.01 7.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.881 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.845 HG11 HD13 ' A' ' 122' ' ' LEU . 4.0 t -109.73 72.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.327 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 19.0 pt -62.57 159.73 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 132' ' ' GLU . 2.2 tt0 -46.19 -49.5 16.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.503 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 2.4 mt-10 -40.99 -35.8 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.334 -0.854 . . . . 0.0 110.381 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.31 -47.46 8.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.661 ' CG1' HG12 ' A' ' 129' ' ' VAL . 17.6 mt -60.14 -41.03 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HG2' ' HG2' ' A' ' 131' ' ' GLU . 4.9 mm-40 -57.6 -36.79 72.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.513 -0.742 . . . . 0.0 110.051 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -51.25 -50.32 59.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.845 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.1 OUTLIER -56.68 -43.91 80.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.924 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.405 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -68.24 -43.84 77.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -0.857 . . . . 0.0 110.043 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -64.9 -43.46 92.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.225 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.42 -33.21 69.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 0.0 110.327 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.523 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.9 OUTLIER -86.03 -61.95 1.63 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.935 . . . . 0.0 110.394 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 60.6 t0 -41.14 99.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.559 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 76.4 tttt -99.18 2.5 45.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.825 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.525 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 0.6 OUTLIER -134.41 16.85 3.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.326 -0.859 . . . . 0.0 109.662 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 8.9 m-20 48.01 51.53 14.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.443 -0.786 . . . . 0.0 110.341 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -104.61 4.57 32.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.034 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.88 11.18 60.22 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . 6.0 mtp180 -147.56 146.43 29.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.142 -1.211 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.678 HG21 ' CE ' ' A' ' 157' ' ' MET . 4.7 mt -89.72 113.83 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.364 -0.835 . . . . 0.0 109.998 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.49 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 48.8 p30 -90.02 179.18 6.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.569 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.422 ' O ' ' HG ' ' A' ' 155' ' ' LEU . 16.8 m-85 -42.82 -59.19 2.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.349 -0.844 . . . . 0.0 110.28 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.94 -56.89 15.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.49 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 45.8 mt-10 -57.36 -46.9 82.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.275 -0.891 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.901 ' HA ' ' HE3' ' A' ' 157' ' ' MET . 35.5 t80 -59.53 -56.36 22.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.18 -0.95 . . . . 0.0 109.536 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 151' ' ' PHE . 32.4 mt -45.74 -48.67 15.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -0.912 . . . . 0.0 109.661 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 -57.92 6.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.365 -0.834 . . . . 0.0 110.081 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.901 ' HE3' ' HA ' ' A' ' 154' ' ' PHE . 1.3 ptp -47.45 -50.77 22.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.715 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.57 ' N ' ' CG ' ' A' ' 157' ' ' MET . 13.1 mmt -66.88 -32.19 73.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.424 -0.798 . . . . 0.0 110.352 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 160' ' ' GLY . 9.0 tt0 -86.99 157.66 19.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.045 -1.034 . . . . 0.0 110.085 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 159' ' ' GLU . . . 45.05 56.37 6.0 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 158' ' ' MET . 20.4 t -84.11 143.37 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -1.133 . . . . 0.0 110.245 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.246 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.193 0.521 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -93.78 -49.81 5.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.158 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.14 -168.97 3.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.839 . . . . 0.0 110.094 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -124.01 52.19 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 110.243 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . -97.66 104.31 2.98 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER 44.23 -157.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.204 -1.174 . . . . 0.0 110.049 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m 179.8 157.65 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.98 . . . . 0.0 110.444 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.553 ' HG2' HD21 ' A' ' 155' ' ' LEU . 1.3 tt0 -50.03 -49.26 51.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 110.071 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.12 -51.05 34.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 110.229 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -48.59 -60.14 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 110.342 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.556 HD12 HG13 ' A' ' 161' ' ' VAL . 28.5 mt -58.96 -58.54 8.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -42.47 -40.39 2.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.0 110.144 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 90.8 m-20 -62.34 -35.63 79.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.12 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 98' ' ' LEU . 71.8 m -67.57 -36.54 81.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 43.0 t80 -42.67 -56.34 3.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 110.22 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -44.53 61.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -62.82 -54.55 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.339 -0.851 . . . . 0.0 109.913 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -58.63 -43.2 89.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 109.934 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.456 ' OD1' ' OE1' ' A' ' 117' ' ' GLU . 14.0 t0 -85.19 109.02 18.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -122.08 -28.92 4.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.602 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.449 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 5.6 p30 -97.15 -44.33 7.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 110.332 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -87.54 -42.24 12.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.169 -0.957 . . . . 0.0 109.887 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 7.6 m-20 47.93 23.96 0.55 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.389 -0.82 . . . . 0.0 109.866 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.42 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . -142.83 -36.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 76.7 m-85 -149.63 136.94 19.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -1.101 . . . . 0.0 109.856 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.42 ' CD1' ' CD1' ' A' ' 154' ' ' PHE . 24.3 mt -82.56 131.5 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.178 -0.951 . . . . 0.0 110.101 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.48 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 28.4 p30 -119.11 -162.74 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 110.24 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.623 HD11 ' HG2' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -83.05 -42.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.577 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -52.49 -41.57 63.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' OE1' ' OD1' ' A' ' 106' ' ' ASP . 2.2 mt-10 -64.93 -37.93 89.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -65.82 -46.24 79.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.972 . . . . 0.0 110.242 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -46.01 -75.66 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 119' ' ' GLY . 5.1 pt-20 -43.24 -47.76 6.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -1.125 . . . . 0.0 110.615 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.94 -55.42 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.128 -0.983 . . . . 0.0 110.113 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.69 HD22 HG11 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -63.14 -43.16 99.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.986 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -38.92 64.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.274 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.81 -30.86 6.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.187 -0.945 . . . . 0.0 110.265 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.2 p -73.85 -29.85 62.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.77 53.84 1.88 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.7 mm-40 -129.71 148.47 51.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -1.13 . . . . 0.0 110.214 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 128' ' ' HIS . 23.2 p80 -71.3 58.34 0.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.13 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 122' ' ' LEU . 4.5 t -75.9 151.81 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 110.274 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.0 pt -139.61 155.94 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.885 . . . . 0.0 110.138 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.474 ' CA ' ' OE1' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -48.03 -47.88 33.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 3.6 mm-40 -42.11 -38.22 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -48.84 7.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 10.6 mt -61.46 -43.27 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -0.865 . . . . 0.0 109.748 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.623 ' HG2' HD11 ' A' ' 115' ' ' ILE . 3.5 mm-40 -53.11 -49.06 67.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.822 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 135' ' ' GLU . 12.5 t0 -43.75 -53.86 5.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.825 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 141' ' ' SER . 0.2 OUTLIER -50.66 -57.67 7.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.48 ' HE1' ' HA ' ' A' ' 114' ' ' ASP . 1.4 ttm -58.05 -34.86 70.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.178 -0.952 . . . . 0.0 109.583 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -70.56 -51.51 28.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.194 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -67.97 -40.36 83.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.372 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -57.69 -46.76 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.196 -0.94 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 141' ' ' SER . 0.4 OUTLIER -44.36 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.235 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.6 OUTLIER -93.59 2.69 56.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.145 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.441 ' HB2' ' CG ' ' A' ' 146' ' ' ASP . 4.2 m-80 -141.32 21.45 2.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.076 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.69 24.44 10.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.352 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 144' ' ' ASN . 42.3 m-20 -69.95 -11.79 61.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 0.0 110.192 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.456 ' C ' ' HG3' ' A' ' 148' ' ' ARG . . . 79.6 -6.47 57.99 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.456 ' HG3' ' C ' ' A' ' 147' ' ' GLY . 45.3 mtt180 -149.49 162.2 40.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -1.154 . . . . 0.0 110.011 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 141' ' ' SER . 20.3 mt -85.27 126.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 0.0 110.0 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.462 ' N ' ' OE1' ' A' ' 153' ' ' GLU . 13.0 p-10 -109.01 -163.98 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CZ ' HD11 ' A' ' 155' ' ' LEU . 56.2 t80 -57.81 -57.66 11.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.285 -0.885 . . . . 0.0 110.5 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -62.95 1.31 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.212 -0.93 . . . . 0.0 110.549 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' A' ' 150' ' ' ASP . 4.0 mt-10 -57.29 -43.93 83.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.934 . . . . 0.0 110.581 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.458 ' O ' ' HG2' ' A' ' 157' ' ' MET . 82.6 t80 -48.41 -50.58 30.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 110.059 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 95' ' ' GLU . 11.6 mt -57.25 -54.15 50.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.337 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -60.33 -40.1 89.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.304 -0.873 . . . . 0.0 110.735 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.484 ' HG2' ' SD ' ' A' ' 158' ' ' MET . 0.6 OUTLIER -49.98 -40.46 44.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 109.647 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.801 ' CB ' HG21 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -64.21 -6.95 7.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.558 -0.714 . . . . 0.0 110.543 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 158' ' ' MET . 1.2 mt-10 59.28 139.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.357 -0.839 . . . . 0.0 110.428 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.41 25.07 69.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.801 HG21 ' CB ' ' A' ' 158' ' ' MET . 42.5 t -106.88 155.06 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -1.102 . . . . 0.0 110.268 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.28 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.303 0.573 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 90' ' ' ALA . 12.3 m-20 53.95 -166.2 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.175 -0.953 . . . . 0.0 110.081 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 89' ' ' ASP . . . 44.3 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.241 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -43.05 123.61 2.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.293 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 142.63 145.62 4.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 17.4 pttm -166.66 157.76 12.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -1.123 . . . . 0.0 110.215 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.9 175.14 6.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.268 -0.895 . . . . 0.0 110.37 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.03 -54.18 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.341 -0.85 . . . . 0.0 110.2 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.83 -65.82 0.46 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.292 -0.88 . . . . 0.0 110.147 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 93' ' ' LYS . 19.3 mm-40 -52.23 -45.24 65.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.199 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.466 ' HG ' ' HE2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -46.73 -61.78 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 110.277 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -41.55 -57.95 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -70.13 -53.78 15.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.1 m -47.99 -22.28 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.2 -0.938 . . . . 0.0 110.521 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 151' ' ' PHE . 59.2 t80 -51.7 -51.93 52.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -26.69 63.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.316 -0.865 . . . . 0.0 110.648 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 37.1 mm -68.13 -58.73 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.037 . . . . 0.0 110.332 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -51.31 -34.16 32.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 13.8 t0 -73.39 89.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.269 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -83.25 -20.38 34.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.292 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.683 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 7.9 p30 -114.47 -1.29 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.183 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 66.73 69.77 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.327 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 4.3 p30 -108.72 -22.13 12.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 110.183 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.551 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 91.35 -3.64 79.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 6.9 m-85 -152.72 129.23 10.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -1.148 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 113' ' ' ILE . 3.4 mp -82.9 114.53 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.126 -0.984 . . . . 0.0 109.8 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 116' ' ' GLU . 3.1 p30 -88.1 -176.16 5.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.582 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.9 tp -65.47 -40.78 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 110.09 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.543 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -54.71 -52.49 62.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.336 -0.853 . . . . 0.0 110.27 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 52.2 mt-10 -51.91 -44.58 63.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.327 -0.858 . . . . 0.0 110.344 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.727 HD12 HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -53.11 -52.47 58.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.109 -0.994 . . . . 0.0 110.27 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.538 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -58.99 -66.69 2.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.8 pt-20 -48.06 -45.69 32.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 110.457 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.542 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 12.2 mt -52.97 -60.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.008 . . . . 0.0 109.973 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.651 HD13 HG11 ' A' ' 129' ' ' VAL . 16.8 mt -63.98 -38.67 91.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -64.4 -41.94 96.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.413 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.22 69.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.266 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 121' ' ' ILE . 24.9 p -55.95 -19.75 13.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.325 -0.859 . . . . 0.0 110.301 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 98.21 30.42 7.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -119.9 167.46 12.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -1.16 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 128' ' ' HIS . 51.7 p-80 -113.03 75.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 110.301 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.651 HG11 HD13 ' A' ' 122' ' ' LEU . 5.6 t -83.06 133.1 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 110.039 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.84 HD12 ' HB2' ' A' ' 132' ' ' GLU . 17.8 pt -85.42 152.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.469 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 2.3 mm-40 -52.53 -38.51 59.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.277 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.84 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.6 OUTLIER -40.25 -38.04 0.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.377 -0.827 . . . . 0.0 110.686 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.94 -45.66 9.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.123 -0.986 . . . . 0.0 109.636 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.727 HG23 HD12 ' A' ' 118' ' ' LEU . 40.1 mt -57.68 -38.36 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -0.798 . . . . 0.0 109.734 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 2.9 mt-10 -68.34 -36.33 79.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -58.51 -48.76 79.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.162 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 118' ' ' LEU . 97.2 mt -49.15 -44.38 42.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 0.0 110.199 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.629 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -68.94 -48.64 62.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 110.063 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -55.32 -35.5 65.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.964 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.29 -27.4 59.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 110.324 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.558 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -106.37 -60.75 1.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.861 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 138' ' ' MET . 14.7 t0 -38.24 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.77 . . . . 0.0 110.79 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.0 OUTLIER -86.57 -40.53 15.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.633 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.475 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 13.9 m-80 -92.19 17.7 9.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.015 . . . . 0.0 110.753 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 49.49 25.46 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.286 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 11.1 p-10 -78.66 2.8 18.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.132 -0.98 . . . . 0.0 110.187 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.92 30.98 79.43 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.1 129.75 6.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 110.192 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.629 HD12 ' CE ' ' A' ' 138' ' ' MET . 1.2 mt -83.39 129.33 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.899 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.54 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 1.5 p-10 -100.45 -163.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.013 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.456 ' CE1' ' CZ ' ' A' ' 102' ' ' PHE . 73.9 m-85 -69.22 -51.1 41.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 110.407 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -50.12 70.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 110.632 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.54 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 72.9 mt-10 -56.92 -44.75 82.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.118 -0.989 . . . . 0.0 110.533 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -52.97 -66.09 0.45 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.971 -1.081 . . . . 0.0 109.984 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 154' ' ' PHE . 20.1 mt -43.87 -32.48 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.955 . . . . 0.0 109.626 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -28.98 55.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.415 -0.803 . . . . 0.0 109.928 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.548 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -61.85 -37.59 85.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.275 -0.891 . . . . 0.0 109.356 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.548 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.0 OUTLIER -109.01 43.35 1.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.51 -0.744 . . . . 0.0 109.779 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -104.23 -38.27 6.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 110.547 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.34 17.01 29.21 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.95 144.27 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -1.141 . . . . 0.0 110.188 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.241 -179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 88' ' ' GLU . 2.0 mp0 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.235 0.541 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' GLU . 2.3 p30 -55.59 -164.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.87 . . . . 0.0 110.092 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.29 117.65 26.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.02 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.32 -34.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.258 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.35 104.12 2.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 45.99 83.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -1.139 . . . . 0.0 110.43 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.52 ' N ' ' HB2' ' A' ' 97' ' ' GLU . 0.3 OUTLIER -63.08 162.53 11.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.995 . . . . 0.0 109.974 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' O ' HD21 ' A' ' 155' ' ' LEU . 8.7 mt-10 -46.32 -52.44 12.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 110.161 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -68.44 -42.05 79.41 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.0 109.751 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.52 ' HB2' ' N ' ' A' ' 94' ' ' SER . 58.9 mm-40 -58.32 -36.03 72.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.373 -0.829 . . . . 0.0 109.708 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.868 ' CD2' HD23 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -84.52 -45.7 12.34 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.361 -0.837 . . . . 0.0 109.265 179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 151' ' ' PHE . . . -47.43 -34.61 7.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.093 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.61 -40.28 19.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.863 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.51 ' HG ' ' HE1' ' A' ' 105' ' ' PHE . 0.7 OUTLIER -54.21 -21.4 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.0 109.993 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.45 -64.71 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.988 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -51.06 -39.2 55.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.77 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 104' ' ' ILE . 1.6 mp -57.55 -50.35 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.289 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.797 ' HB3' HD13 ' A' ' 113' ' ' ILE . 4.7 m-85 -60.31 -52.06 66.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 109.546 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -67.61 87.53 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 109.428 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.8 mttp -88.79 -34.04 17.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.357 -0.839 . . . . 0.0 110.804 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 110' ' ' ASP . 17.3 p30 -81.2 4.48 20.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.059 -1.026 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 51.16 84.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.456 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 2.3 p30 -128.1 -34.16 2.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.204 -0.935 . . . . 0.0 110.18 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.452 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 118.3 -24.47 8.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.501 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 67.3 m-85 -148.93 126.72 11.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.27 -1.135 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.797 HD13 ' HB3' ' A' ' 105' ' ' PHE . 42.5 mt -83.58 126.96 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -105.05 -178.29 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.355 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 2.8 tp -56.09 -39.99 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 4.0 mm-40 -56.97 -58.12 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 110.184 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.599 ' OE1' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -46.31 -34.98 4.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.201 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.628 HD13 HG23 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -70.59 -155.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 68.65 -80.72 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -51.04 -55.02 19.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -1.12 . . . . 0.0 110.428 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.431 ' C ' ' O ' ' A' ' 120' ' ' GLU . 10.4 mt -42.09 -44.76 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 110.43 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 122' ' ' LEU . 45.8 mt -72.28 -49.71 32.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -48.69 -35.78 14.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.277 -0.889 . . . . 0.0 110.538 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.08 -42.29 60.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 32.1 p -68.03 -7.35 28.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.319 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' O ' ' OE2' ' A' ' 127' ' ' GLU . . . 81.09 41.67 10.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -121.69 140.78 51.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -1.172 . . . . 0.0 110.223 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.479 ' H ' ' CD2' ' A' ' 128' ' ' HIS . 23.0 p80 -82.16 111.78 18.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.287 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.6 t -126.12 156.18 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 0.0 109.867 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 132' ' ' GLU . 12.9 pt -130.39 158.07 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 110.282 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.428 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 2.7 mt-10 -47.92 -49.77 29.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 110.227 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 0.2 OUTLIER -42.65 -36.98 1.56 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.89 -48.07 8.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.29 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.628 HG23 HD13 ' A' ' 118' ' ' LEU . 22.9 mt -54.23 -36.45 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.482 -0.762 . . . . 0.0 109.694 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.497 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 51.8 mt-10 -60.89 -47.15 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -51.14 -39.52 56.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.0 mp -61.74 -46.77 88.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 0.0 110.21 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.486 ' CE ' HD12 ' A' ' 149' ' ' ILE . 30.4 tpp -65.05 -48.21 74.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.965 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.88 85.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.382 -0.824 . . . . 0.0 109.943 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -68.89 -33.17 73.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.114 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.483 ' CB ' HG12 ' A' ' 149' ' ' ILE . 6.9 t -84.1 -56.02 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 15.0 m-20 -42.32 103.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 110.57 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -79.74 -16.49 55.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.157 -0.964 . . . . 0.0 109.706 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 2.1 p30 -124.82 14.84 8.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.872 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.17 73.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 110.391 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 147' ' ' GLY . 10.0 p-10 -128.28 22.58 6.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -0.834 . . . . 0.0 109.805 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.434 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 43.17 36.6 2.9 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -157.9 120.84 3.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -1.166 . . . . 0.0 110.474 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.486 HD12 ' CE ' ' A' ' 138' ' ' MET . 7.1 mt -83.69 120.79 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.474 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 6.7 p-10 -90.06 -152.02 0.25 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 110.239 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.426 ' CZ ' ' HB1' ' A' ' 99' ' ' ALA . 49.5 t80 -82.08 -39.51 23.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.329 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.18 -56.69 4.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 0.0 110.691 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.474 ' CG ' ' OD1' ' A' ' 150' ' ' ASP . 29.8 mt-10 -46.75 -36.07 6.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 110.495 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.454 ' O ' ' HG2' ' A' ' 157' ' ' MET . 32.6 t80 -56.2 -56.42 21.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.868 HD23 ' CD2' ' A' ' 98' ' ' LEU . 2.6 mt -52.42 -54.07 36.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.401 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.34 -38.44 58.68 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.233 -0.917 . . . . 0.0 110.475 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.512 ' CG ' ' N ' ' A' ' 158' ' ' MET . 1.2 ptm -65.88 -49.0 69.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.512 ' N ' ' CG ' ' A' ' 157' ' ' MET . 3.9 mtt -95.62 37.06 1.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -0.926 . . . . 0.0 110.284 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -95.73 -34.16 12.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.238 -0.914 . . . . 0.0 109.759 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.13 38.56 2.28 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 12.5 p -57.75 152.57 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -1.109 . . . . 0.0 110.595 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.17 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.229 0.538 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -96.92 42.17 1.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 110.189 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.42 110.56 1.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 110.294 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.28 17.36 2.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 110.237 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.64 -142.08 15.41 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -72.65 82.94 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -1.135 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.71 162.75 27.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.151 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -51.55 -50.4 60.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.238 -0.913 . . . . 0.0 110.264 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -47.95 -46.57 32.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.127 -0.983 . . . . 0.0 110.125 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.4 tp10 -58.91 -55.69 31.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.307 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 0.4 OUTLIER -61.85 -56.7 16.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -45.24 -39.57 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.685 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -54.46 -46.31 73.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.884 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 98' ' ' LEU . 1.1 m -52.28 -41.01 62.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.326 -0.859 . . . . 0.0 109.88 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' A' ' 101' ' ' CYS . 14.9 t80 -43.83 -51.73 7.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.758 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -60.66 -36.27 78.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.811 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.8 mm -66.6 -43.58 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.832 ' CD2' HD13 ' A' ' 121' ' ' ILE . 1.3 m-85 -71.96 -40.06 68.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.873 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -79.19 88.38 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -45.85 68.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.37 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -70.47 -11.44 60.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 110.425 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.19 51.09 16.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.11 -27.19 22.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.48 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 128.53 -20.3 5.53 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 98.4 m-85 -151.21 134.15 15.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -1.178 . . . . 0.0 110.28 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.7 mt -82.75 149.46 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.399 -0.813 . . . . 0.0 110.174 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 -164.03 0.89 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.188 -0.945 . . . . 0.0 110.213 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 116' ' ' GLU . 2.5 tt -77.38 -38.68 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.186 -0.946 . . . . 0.0 110.463 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 95.5 mt-10 -60.76 -61.43 2.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.72 ' O ' HD12 ' A' ' 121' ' ' ILE . 20.9 mt-10 -42.55 -38.97 2.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.265 -0.897 . . . . 0.0 110.409 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.824 ' HB3' HG23 ' A' ' 134' ' ' ILE . 3.5 tp -60.05 -31.12 69.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.211 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 123' ' ' ARG . . . -73.03 -72.17 1.0 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.867 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 12.7 pt-20 -42.49 -43.49 3.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.184 -1.186 . . . . 0.0 110.509 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.832 HD13 ' CD2' ' A' ' 105' ' ' PHE . 27.5 mt -57.93 -50.46 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -0.838 . . . . 0.0 110.662 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.852 ' HB3' HG21 ' A' ' 129' ' ' VAL . 20.4 mt -67.74 -69.89 0.29 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.913 . . . . 0.0 110.873 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 119' ' ' GLY . 2.4 ptm180 -49.88 -24.09 2.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.227 -0.921 . . . . 0.0 110.651 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -54.54 -44.19 72.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 110.008 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.789 HG23 ' HG3' ' A' ' 127' ' ' GLU . 1.8 t -80.91 9.34 6.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.328 -0.857 . . . . 0.0 110.468 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.2 17.7 58.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.789 ' HG3' HG23 ' A' ' 125' ' ' THR . 46.6 mt-10 -84.05 121.2 27.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -1.136 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 87.24 2.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.873 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.852 HG21 ' HB3' ' A' ' 122' ' ' LEU . 3.4 t -109.61 146.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 110.238 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' GLU . 31.7 pt -119.55 159.7 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.145 -0.972 . . . . 0.0 110.205 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' ILE . 4.8 tt0 -41.43 -49.86 3.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.36 -28.91 13.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 0.0 110.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -43.38 11.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.824 HG23 ' HB3' ' A' ' 118' ' ' LEU . 30.0 mt -67.92 -38.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.545 -0.722 . . . . 0.0 110.312 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -67.07 -36.87 82.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.39 -0.819 . . . . 0.0 110.421 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.83 -52.4 65.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 0.0 110.681 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.635 ' HB3' HD21 ' A' ' 118' ' ' LEU . 1.4 mp -49.86 -44.27 49.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.308 -0.87 . . . . 0.0 110.899 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.485 ' O ' ' N ' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -64.83 -48.04 75.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.056 -1.028 . . . . 0.0 110.053 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.77 -60.1 3.41 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.318 -0.864 . . . . 0.0 110.62 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.47 -33.21 67.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.0 110.766 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.547 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.4 t -85.7 -62.47 1.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.146 -0.971 . . . . 0.0 110.717 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 138' ' ' MET . 0.5 OUTLIER -47.4 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.621 -179.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 ttpp -89.4 -3.81 58.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.0 109.814 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -120.69 12.03 11.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 109.905 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 51.23 39.26 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.417 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -101.37 23.06 11.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.212 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 142' ' ' ASP . . . 44.98 35.58 4.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 19.4 mtt180 -158.35 128.32 5.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -1.21 . . . . 0.0 110.458 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.547 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.5 mt -84.21 167.26 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 110.091 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 48.2 p30 -149.13 -163.68 1.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.025 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -56.07 16.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 0.0 110.403 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -56.74 17.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.656 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 141' ' ' SER . 84.8 mt-10 -59.53 -44.53 93.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.211 -0.93 . . . . 0.0 110.515 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.511 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 21.6 t80 -54.62 -52.0 63.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.095 -1.003 . . . . 0.0 110.132 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 159' ' ' GLU . 27.4 mt -57.34 -42.16 81.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -54.2 -60.29 3.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.6 OUTLIER -48.26 -52.81 19.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.025 -1.047 . . . . 0.0 109.551 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -104.72 52.97 0.74 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.411 -0.806 . . . . 0.0 110.227 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 4.5 tp10 -92.34 -53.82 4.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -103.09 32.99 6.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.81 149.22 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -1.167 . . . . 0.0 110.121 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.263 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.284 0.564 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.29 -49.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -104.72 152.15 22.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.919 . . . . 0.0 109.9 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -68.08 111.83 4.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.087 -1.008 . . . . 0.0 110.298 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.63 -139.85 5.26 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.573 ' CD ' ' N ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -173.74 31.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.243 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -46.63 167.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.141 -0.974 . . . . 0.0 110.121 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.546 ' HA ' HD22 ' A' ' 155' ' ' LEU . 0.4 OUTLIER -42.62 -45.19 4.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.895 . . . . 0.0 110.326 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -49.25 -54.31 17.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 110.224 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 93' ' ' LYS . 4.8 mm-40 -52.94 -58.56 6.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.297 -0.877 . . . . 0.0 110.58 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD11 ' SD ' ' A' ' 158' ' ' MET . 20.2 mt -50.97 -60.75 2.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.0 110.289 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.68 -50.74 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.322 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -55.15 -50.5 69.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.948 . . . . 0.0 110.246 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.92 -9.61 31.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.367 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 83.3 t80 -50.96 -61.69 2.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -0.952 . . . . 0.0 110.287 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.57 ' CG ' HD12 ' A' ' 104' ' ' ILE . 12.3 ptp180 -57.12 -36.04 70.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 110.458 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.57 HD12 ' CG ' ' A' ' 103' ' ' ARG . 1.0 OUTLIER -58.72 -34.06 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.665 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 107' ' ' LYS . 4.9 m-85 -83.65 -35.48 24.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 109.87 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 109' ' ' ALA . 48.1 t0 -67.78 59.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -46.6 -41.03 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 110' ' ' ASP . 46.8 t30 -69.51 -13.62 62.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.21 -0.931 . . . . 0.0 110.159 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HA ' ' OD2' ' A' ' 106' ' ' ASP . . . 45.49 54.98 7.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.857 . . . . 0.0 110.231 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.473 ' HB3' ' ND2' ' A' ' 108' ' ' ASN . 23.5 p-10 -108.65 -3.23 18.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 110.2 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.509 ' C ' ' CD2' ' A' ' 112' ' ' PHE . . . 101.49 -19.4 50.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD2' ' C ' ' A' ' 111' ' ' GLY . 95.8 m-85 -153.17 123.69 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -1.2 . . . . 0.0 110.434 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.87 132.28 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 110.304 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -102.71 -179.6 4.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.168 -0.957 . . . . 0.0 110.081 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.7 tt -59.94 -36.82 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.227 -0.921 . . . . 0.0 110.195 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -50.94 -52.69 39.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 110.285 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.442 ' O ' ' HB ' ' A' ' 121' ' ' ILE . 15.3 mt-10 -57.66 -54.74 43.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.405 -0.809 . . . . 0.0 110.311 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.561 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.1 mp -43.15 -39.78 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.108 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.515 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -59.75 -80.31 0.09 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.482 ' OE2' HG13 ' A' ' 121' ' ' ILE . 0.7 OUTLIER -48.3 -50.7 29.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -1.19 . . . . 0.0 110.297 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 125' ' ' THR . 10.3 mt -44.93 -55.07 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 110.137 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.1 mt -68.37 -62.28 1.47 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 110.51 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -48.76 -39.97 27.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.84 -52.27 57.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.927 . . . . 0.0 110.212 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 121' ' ' ILE . 31.1 p -54.75 -32.44 59.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 110.084 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.59 -1.36 23.39 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . 23.4 mm-40 -58.66 -17.02 18.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -1.164 . . . . 0.0 110.056 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 18.2 t-160 46.38 57.21 5.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.216 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 127' ' ' GLU . 14.8 t -89.56 153.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.244 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 132' ' ' GLU . 19.6 pt -98.06 154.85 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 110.2 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 132' ' ' GLU . 68.9 mt-10 -49.44 -51.41 35.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.539 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.5 OUTLIER -41.81 -34.27 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.635 -179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.28 -48.16 9.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.44 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.561 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 18.1 mt -55.52 -40.03 56.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.077 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -58.03 -53.89 53.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.626 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -45.03 37.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.962 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -37.19 67.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 110.106 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 19.1 tpp -69.95 -44.76 68.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.394 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 -51.27 62.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.396 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -55.34 -31.27 61.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.325 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.543 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -87.9 -51.2 5.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.374 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.7 OUTLIER -42.56 95.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 110.532 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.8 OUTLIER -76.2 -1.51 26.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.963 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.505 ' ND2' ' OD2' ' A' ' 146' ' ' ASP . 1.5 p30 -153.8 27.48 0.49 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 43.78 75.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 110.501 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.505 ' OD2' ' ND2' ' A' ' 144' ' ' ASN . 3.8 p30 -121.28 -0.29 9.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 109.997 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 70.88 24.16 77.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.154 -1.179 . . . . 0.0 110.154 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 5.4 mtt-85 -158.67 135.43 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.059 -1.259 . . . . 0.0 110.449 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 141' ' ' SER . 16.6 mt -91.06 136.13 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.478 ' OD1' ' CG ' ' A' ' 153' ' ' GLU . 26.7 p-10 -112.44 -173.03 2.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.922 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 42.2 p90 -68.07 -28.41 67.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 110.392 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.428 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -78.14 -42.21 32.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.639 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.513 ' OE1' ' HA ' ' A' ' 149' ' ' ILE . 89.4 mt-10 -69.71 -37.15 76.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.122 -0.986 . . . . 0.0 110.513 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.462 ' O ' ' HG2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.04 -33.29 51.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.964 . . . . 0.0 110.351 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 95' ' ' GLU . 81.8 mt -70.61 -62.56 1.34 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.509 ' HA ' ' HG2' ' A' ' 159' ' ' GLU . 21.4 mttm -53.4 -34.92 59.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.907 . . . . 0.0 110.566 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.536 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -53.79 -49.72 67.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.229 -0.919 . . . . 0.0 110.571 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.593 ' SD ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -99.37 -9.95 22.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.913 . . . . 0.0 110.447 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.509 ' HG2' ' HA ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -43.09 129.58 4.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.147 -0.971 . . . . 0.0 110.318 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 159' ' ' GLU . . . 43.28 63.84 1.96 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.0 p -82.96 150.97 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -1.125 . . . . 0.0 110.305 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.097 179.95 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.202 0.525 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.727 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -157.49 137.31 12.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.491 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 69.95 162.88 0.24 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.877 . . . . 0.0 110.75 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.74 133.53 47.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.849 . . . . 0.0 110.227 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' LYS . . . -99.72 159.37 19.68 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HG2' ' OE2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER 44.08 81.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -1.141 . . . . 0.0 110.25 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 93' ' ' LYS . 6.5 m -43.46 146.06 0.54 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.167 -0.958 . . . . 0.0 110.023 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.66 ' OE1' HD22 ' A' ' 155' ' ' LEU . 58.1 mm-40 -40.86 -40.35 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 0.0 110.456 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 95' ' ' GLU . 30.0 mm-40 -42.01 -40.45 2.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 110.385 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.474 ' OE2' ' HG2' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -60.46 -56.86 16.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 4.3 mm? -59.69 -51.44 69.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 110.228 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.34 -44.24 3.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.318 -0.864 . . . . 0.0 110.266 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 1.0 OUTLIER -51.78 -47.16 64.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 110.106 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.0 t -61.81 -31.79 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CZ ' HD12 ' A' ' 113' ' ' ILE . 18.1 t80 -51.45 -42.07 61.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.933 . . . . 0.0 110.086 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -41.04 99.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.263 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 104' ' ' ILE . 30.6 mm -59.0 -49.09 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 110.076 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -57.49 -35.48 70.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.756 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -91.91 113.14 25.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.326 -0.859 . . . . 0.0 109.661 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -109.12 6.33 24.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.408 ' O ' ' OD1' ' A' ' 108' ' ' ASN . 2.5 p30 -131.41 22.61 4.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.435 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 108' ' ' ASN . . . 50.3 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.78 -37.39 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.434 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 92.21 -7.29 78.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 53.2 m-85 -153.13 125.62 8.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -1.152 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 2.7 mp -83.7 125.49 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.319 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -104.91 -176.04 2.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.328 -0.858 . . . . 0.0 110.052 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.835 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -63.46 -37.77 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 109.854 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.405 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 9.2 mm-40 -59.0 -56.3 23.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.289 -0.882 . . . . 0.0 109.982 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 15.9 mt-10 -45.5 -54.06 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.308 -0.87 . . . . 0.0 109.829 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.734 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.2 tp -51.19 -27.94 10.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.32 -75.64 0.35 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 17.2 pt-20 -45.52 -44.39 12.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -1.183 . . . . 0.0 110.571 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.546 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 48.5 mt -48.43 -70.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.251 -0.906 . . . . 0.0 110.496 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.833 ' O ' HG22 ' A' ' 125' ' ' THR . 97.6 mt -48.76 -49.89 36.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -0.893 . . . . 0.0 110.577 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -52.89 -38.41 61.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.977 . . . . 0.0 110.537 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -48.05 -59.97 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 110.528 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.833 HG22 ' O ' ' A' ' 122' ' ' LEU . 7.4 t -59.38 -26.06 64.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.132 -0.98 . . . . 0.0 110.396 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 92.02 37.54 5.98 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -86.79 -10.43 53.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -1.218 . . . . 0.0 110.029 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.71 82.16 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.11 166.14 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 110.166 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 132' ' ' GLU . 4.7 pt -117.13 146.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.102 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.474 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 2.9 pt-20 -39.57 -42.92 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 0.0 110.858 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.481 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -43.4 -40.08 3.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.105 -0.997 . . . . 0.0 110.328 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.44 -44.44 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 118' ' ' LEU . 66.8 mt -56.75 -35.72 46.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.674 0.75 . . . . 0.0 109.509 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.835 ' HA ' HD11 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -68.6 -39.58 80.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.692 -0.63 . . . . 0.0 110.239 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.29 -50.29 72.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.139 -0.976 . . . . 0.0 110.356 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.451 ' HB3' HD21 ' A' ' 118' ' ' LEU . 1.3 mm? -45.63 -50.73 13.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.021 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.552 ' CE ' HD12 ' A' ' 149' ' ' ILE . 3.3 ttm -67.22 -46.6 73.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.923 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.31 -53.55 6.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.396 -0.815 . . . . 0.0 110.29 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.6 -49.98 73.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.551 ' CB ' HG12 ' A' ' 149' ' ' ILE . 3.1 t -69.72 -64.47 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.239 -0.913 . . . . 0.0 110.457 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.491 ' HB2' ' HG3' ' A' ' 138' ' ' MET . 30.5 t0 -43.19 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.506 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 141' ' ' SER . 3.3 tptm -96.9 -13.64 22.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.2 -0.938 . . . . 0.0 110.165 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.467 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 6.2 m-80 -101.42 16.36 25.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 52.43 18.81 1.01 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -0.853 . . . . 0.0 110.462 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 16.9 p30 -80.94 -0.18 38.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.051 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . 62.18 28.27 70.44 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 9.9 mtt180 -152.58 135.12 15.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.158 -1.201 . . . . 0.0 110.373 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.552 HD12 ' CE ' ' A' ' 138' ' ' MET . 5.9 mt -83.65 116.3 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.92 . . . . 0.0 109.86 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -97.77 -170.36 1.98 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.106 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -52.99 -58.78 5.82 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.249 -0.907 . . . . 0.0 110.366 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.06 -64.94 0.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -0.955 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.473 ' OE2' ' N ' ' A' ' 143' ' ' LYS . 44.9 mt-10 -50.65 -51.98 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.376 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.472 ' O ' ' HG2' ' A' ' 157' ' ' MET . 42.0 t80 -50.53 -56.74 10.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.168 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.66 HD22 ' OE1' ' A' ' 95' ' ' GLU . 46.9 mt -42.52 -51.31 5.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 0.0 110.345 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -62.2 -46.98 86.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 110.745 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.518 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.5 ptm -43.27 -46.5 6.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.183 -0.948 . . . . 0.0 109.85 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.518 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.8 OUTLIER -92.93 47.89 1.31 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 110.195 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -98.35 118.63 35.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 110.391 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.69 11.27 80.59 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.49 155.0 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -1.181 . . . . 0.0 110.117 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.229 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.568 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 89' ' ' ASP . 1.9 m-20 -89.65 55.85 3.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.42 -136.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 110.061 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.95 -17.56 27.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 0.0 110.361 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.98 70.64 1.28 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HG3' ' CD ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -64.42 126.06 26.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.206 -1.173 . . . . 0.0 110.36 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.66 172.87 6.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.95 . . . . 0.0 110.21 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -49.51 -48.96 47.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 110.138 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -43.72 -49.38 7.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.173 -0.955 . . . . 0.0 109.894 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.417 ' CD ' ' HG3' ' A' ' 93' ' ' LYS . 0.8 OUTLIER -54.65 -54.59 39.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.944 179.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 3.5 mm? -50.52 -49.38 55.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.881 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -53.55 -57.02 12.2 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.326 -0.859 . . . . 0.0 110.258 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -48.57 -50.16 33.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.102 -0.999 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.82 -20.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.893 . . . . 0.0 110.08 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.517 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 56.6 t80 -53.85 -51.24 64.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 110.486 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -29.19 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.163 -0.961 . . . . 0.0 110.489 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.5 -27.92 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 110.121 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.475 ' HD1' HD13 ' A' ' 121' ' ' ILE . 2.5 m-85 -84.9 -55.73 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 110.336 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -50.82 131.62 26.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.394 -0.817 . . . . 0.0 110.259 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -123.03 2.22 9.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.184 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 109' ' ' ALA . 73.5 m-20 -125.02 26.41 7.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.356 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.93 49.44 5.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -93.32 -31.75 14.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.382 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.473 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 96.41 -14.51 64.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.473 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 27.2 m-85 -147.7 131.7 17.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -1.078 . . . . 0.0 109.924 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 mt -82.95 116.05 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 110.631 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.487 ' OD2' ' HB2' ' A' ' 116' ' ' GLU . 3.8 p-10 -100.87 175.9 5.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.808 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.2 tp -53.48 -41.56 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.56 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -51.48 -54.96 21.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.923 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 121' ' ' ILE . 31.8 mt-10 -56.8 -56.23 24.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.776 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -44.1 -38.62 3.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.992 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.506 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -59.74 -78.29 0.15 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -51.21 -45.99 62.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.0 110.259 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.55 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 14.9 mt -42.55 -61.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.385 -0.822 . . . . 0.0 110.38 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.855 HD22 HG21 ' A' ' 129' ' ' VAL . 4.2 mt -59.34 -56.87 16.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 0.0 110.433 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -48.67 -34.58 12.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.085 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -51.93 -40.83 61.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.7 p -66.59 -17.42 64.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 0.0 109.989 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.38 20.34 13.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -103.49 154.29 19.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -1.141 . . . . 0.0 110.386 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -107.37 70.21 0.78 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.852 . . . . 0.0 109.661 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.855 HG21 HD22 ' A' ' 122' ' ' LEU . 15.6 t -79.27 123.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.522 -0.736 . . . . 0.0 110.703 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.506 HD12 ' HB2' ' A' ' 132' ' ' GLU . 47.3 pt -75.33 159.71 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.28 -32.22 68.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.987 . . . . 0.0 110.556 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.506 ' HB2' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -48.75 -35.59 14.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.989 . . . . 0.0 110.497 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.02 -51.2 6.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.652 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 118' ' ' LEU . 7.3 mt -55.76 -43.5 74.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.508 -0.745 . . . . 0.0 109.472 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HG2' HD11 ' A' ' 115' ' ' ILE . 2.9 mm-40 -62.05 -38.75 89.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.656 -0.652 . . . . 0.0 109.955 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.13 -51.88 66.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 110.208 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.2 mt -50.75 -42.09 57.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.229 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 42.9 tpp -66.96 -49.07 66.6 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 109.878 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -59.09 -41.98 89.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.27 -0.894 . . . . 0.0 109.946 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -25.73 68.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.571 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -97.54 -33.58 11.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 110.234 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.2 t0 -59.43 79.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 0.0 109.931 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -76.25 0.58 18.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.328 -0.858 . . . . 0.0 110.994 -179.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.471 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 0.5 OUTLIER -151.71 20.31 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.919 -1.113 . . . . 0.0 110.533 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.1 m120 55.35 71.21 0.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.662 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 7.6 p-10 -126.95 12.08 7.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.749 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 45.4 30.65 3.08 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' CD ' ' HB2' ' A' ' 112' ' ' PHE . 3.7 mtt180 -158.69 131.12 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 110.701 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.571 HG12 ' CB ' ' A' ' 141' ' ' SER . 8.0 mt -88.89 133.42 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.73 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 2.8 p30 -113.54 -164.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.436 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.6 -57.67 9.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.88 -57.7 11.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.619 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.471 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 73.2 mt-10 -54.25 -50.16 67.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.297 -0.877 . . . . 0.0 110.463 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 155' ' ' LEU . 64.2 t80 -49.68 -59.0 4.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.027 -1.045 . . . . 0.0 110.237 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 154' ' ' PHE . 9.8 mt -41.79 -66.06 0.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.315 -0.866 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -34.16 14.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.62 -37.97 73.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 109.854 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.513 ' N ' ' HG3' ' A' ' 157' ' ' MET . 0.4 OUTLIER -112.21 27.05 9.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 110.63 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.781 ' O ' HG23 ' A' ' 161' ' ' VAL . 1.6 mt-10 -90.45 -172.82 3.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 0.0 110.007 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 56.07 40.46 82.92 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 159' ' ' GLU . 19.2 t -129.96 157.52 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -1.168 . . . . 0.0 110.466 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.031 179.698 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.257 0.551 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.68 93.3 9.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -172.99 105.34 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.103 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -166.51 131.72 2.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.313 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.59 153.39 23.23 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -129.67 57.62 1.67 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.219 -1.165 . . . . 0.0 110.27 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -45.12 153.1 0.21 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.183 -0.948 . . . . 0.0 110.167 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 94' ' ' SER . 6.4 tt0 -42.9 -45.94 5.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -64.1 -48.32 76.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.965 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 2.5 tp10 -58.84 -41.31 86.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 93' ' ' LYS . 25.1 mt -61.66 -59.19 5.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.293 -0.88 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -45.29 -43.64 10.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.904 . . . . 0.0 109.953 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 22.0 m-20 -51.05 -45.98 61.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 102' ' ' PHE . 4.5 t -67.98 -22.86 64.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 110.003 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.501 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 14.1 t80 -42.31 -63.29 0.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.515 ' HG3' ' N ' ' A' ' 104' ' ' ILE . 4.7 ptt180 -62.23 -36.35 81.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.515 ' N ' ' HG3' ' A' ' 103' ' ' ARG . 31.6 mm -59.65 -33.93 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 110.277 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -79.57 -65.98 0.93 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.906 . . . . 0.0 110.344 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 105' ' ' PHE . 48.3 t0 -42.58 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 110.226 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 105' ' ' PHE . 10.7 mttt -75.97 -10.25 59.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.213 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -102.14 -165.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.153 -0.967 . . . . 0.0 110.302 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.4 4.25 14.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.172 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.537 ' O ' ' CE2' ' A' ' 112' ' ' PHE . 6.7 p-10 -66.37 -27.77 68.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.938 . . . . 0.0 109.898 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 90.32 15.98 56.28 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' A' ' 110' ' ' ASP . 38.0 m-85 -146.75 131.88 18.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.119 -1.224 . . . . 0.0 110.599 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.468 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 3.2 mt -83.16 131.74 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.406 -0.809 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 117' ' ' GLU . 24.3 p30 -100.52 -177.24 3.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.106 -0.996 . . . . 0.0 110.463 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.2 tt -64.93 -40.74 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 110.484 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.554 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -59.86 -52.02 67.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.038 -1.038 . . . . 0.0 110.183 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 24.9 mt-10 -48.55 -42.85 34.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.911 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.578 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -58.35 -27.02 63.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.805 . . . . 0.0 110.239 179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 123' ' ' ARG . . . -73.6 -72.87 0.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 7.4 pt-20 -41.91 -45.15 3.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.435 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 117' ' ' GLU . 42.6 mt -57.44 -57.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.431 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -73.82 -44.31 56.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 110.61 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.22 -36.72 75.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.985 . . . . 0.0 110.276 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 120' ' ' GLU . . . -47.72 -40.44 20.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.011 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.419 ' H ' HG23 ' A' ' 125' ' ' THR . 52.0 p -56.17 -28.36 57.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -0.846 . . . . 0.0 110.068 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.0 -31.52 6.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 129' ' ' VAL . 6.7 mt-10 -49.99 125.78 12.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -1.097 . . . . 0.0 110.231 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.566 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -70.11 62.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.448 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 127' ' ' GLU . 11.1 t -61.68 148.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.979 . . . . 0.0 109.886 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 131' ' ' GLU . 5.8 pt -121.72 147.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 110.359 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -39.02 -36.67 0.31 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.576 -0.703 . . . . 0.0 110.761 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.22 -35.43 62.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.687 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.06 -44.04 12.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.97 . . . . 0.0 109.697 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.578 HG23 ' HB3' ' A' ' 118' ' ' LEU . 15.9 mt -66.22 -36.96 78.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.387 -0.82 . . . . 0.0 110.138 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -60.17 -43.61 95.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -54.52 -53.38 55.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.904 . . . . 0.0 110.335 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 141' ' ' SER . 2.1 mp -47.58 -41.31 21.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 110.509 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -71.69 -53.78 12.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.935 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.68 -57.07 4.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 110.754 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.27 -40.5 90.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.152 -0.967 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.515 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -75.26 -54.35 7.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.163 -0.96 . . . . 0.0 110.5 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 146' ' ' ASP . 0.3 OUTLIER -55.09 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 110.965 -179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -69.95 -46.29 65.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.049 -1.032 . . . . 0.0 109.466 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 9.0 p30 -82.78 -7.45 59.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 5.6 m120 63.39 82.34 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.43 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.513 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 10.7 p-10 -130.25 5.46 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.884 . . . . 0.0 109.972 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 74.58 20.8 79.43 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 35.5 mtm-85 -158.31 140.44 14.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -1.134 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.515 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.5 mt -90.46 137.64 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 109.79 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 150' ' ' ASP . 36.2 p-10 -110.01 -151.13 0.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 110.524 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.761 ' O ' HD12 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -75.35 -55.51 5.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.589 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -54.7 43.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.881 . . . . 0.0 110.461 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.464 ' OE1' ' HA ' ' A' ' 142' ' ' ASP . 51.0 mt-10 -56.74 -53.48 57.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 110.554 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 153' ' ' GLU . 26.1 t80 -43.51 -51.54 6.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -0.908 . . . . 0.0 110.396 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 151' ' ' PHE . 4.6 mt -63.13 -55.16 27.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -46.27 -41.48 13.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.985 . . . . 0.0 110.655 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.405 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.55 -46.81 62.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.808 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.405 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -99.47 42.33 1.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.129 -0.982 . . . . 0.0 110.298 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.71 133.3 41.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.124 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.86 30.65 75.77 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 162' ' ' GLN . 70.5 t -45.58 140.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -1.097 . . . . 0.0 110.498 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 161' ' ' VAL . 51.3 mt-30 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.422 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.322 0.582 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 25.9 t0 -50.62 -51.46 48.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.359 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 89' ' ' ASP . . . 60.44 -173.2 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 110.298 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 74.96 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.922 . . . . 0.0 110.215 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.4 -51.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -144.96 140.25 28.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -1.149 . . . . 0.0 110.241 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.73 163.89 13.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.293 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HG3' ' CD2' ' A' ' 155' ' ' LEU . 33.9 tt0 -51.24 -43.48 61.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 110.276 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -44.59 -56.11 4.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.75 -56.19 17.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 110.451 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 99' ' ' ALA . 6.3 mt -56.9 -58.8 6.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.207 -0.933 . . . . 0.0 110.554 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -40.84 -52.49 3.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.383 -0.823 . . . . 0.0 110.529 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.41 -54.95 25.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.583 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 69.4 m -48.38 -24.16 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 0.0 110.715 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.497 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 47.0 t80 -45.23 -49.83 12.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.995 -1.066 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -57.16 -32.2 66.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.898 . . . . 0.0 110.376 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 43.7 mm -59.47 -40.4 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -78.17 -38.41 43.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 110.427 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -79.25 84.7 5.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -1.0 . . . . 0.0 110.303 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -32.02 22.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 110.229 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.427 ' OD1' ' CG ' ' A' ' 110' ' ' ASP . 4.2 p30 -100.6 14.87 29.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.157 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.11 69.31 0.69 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.117 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.427 ' CG ' ' OD1' ' A' ' 108' ' ' ASN . 3.6 m-20 -97.47 -17.16 19.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 110.23 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.48 40.81 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -150.45 146.49 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.031 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.4 mt -82.64 116.12 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 110.366 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -97.2 -178.54 4.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.858 . . . . 0.0 110.014 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.547 HG23 ' N ' ' A' ' 116' ' ' GLU . 3.8 tp -67.96 -39.43 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.096 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.547 ' N ' HG23 ' A' ' 115' ' ' ILE . 5.8 mt-10 -55.1 -52.8 62.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.373 -0.829 . . . . 0.0 110.235 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 120' ' ' GLU . 23.1 mt-10 -50.2 -45.3 53.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.398 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.563 HD22 HG23 ' A' ' 134' ' ' ILE . 0.5 OUTLIER -57.66 -34.18 69.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.574 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -66.54 -73.56 0.62 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' CD ' HG13 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -42.06 -49.44 4.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.293 -1.122 . . . . 0.0 110.561 -179.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.46 HG13 ' CD ' ' A' ' 120' ' ' GLU . 66.4 mt -55.07 -51.94 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.46 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.639 ' HB3' HG21 ' A' ' 129' ' ' VAL . 16.5 mt -64.71 -55.5 19.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.271 -0.893 . . . . 0.0 110.561 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.18 -36.71 73.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.887 . . . . 0.0 110.659 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.84 -30.93 4.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.428 ' H ' HG23 ' A' ' 125' ' ' THR . 30.9 p -66.23 -29.62 69.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.274 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.76 26.8 2.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -116.7 170.1 8.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -1.161 . . . . 0.0 110.397 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.39 62.68 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.712 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.639 HG21 ' HB3' ' A' ' 122' ' ' LEU . 5.5 t -65.57 126.82 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 134' ' ' ILE . 15.3 pt -81.15 154.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -41.76 96.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 110.676 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -47.83 -33.56 7.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.256 -0.902 . . . . 0.0 110.781 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 0.3 OUTLIER -83.23 -47.93 11.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 109.513 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.563 HG23 HD22 ' A' ' 118' ' ' LEU . 11.3 mt -58.26 -37.68 64.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.559 -0.713 . . . . 0.0 109.628 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.509 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . 32.8 mt-10 -60.37 -34.72 74.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.647 -0.658 . . . . 0.0 110.591 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 14.5 t0 -56.33 -55.02 38.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.924 . . . . 0.0 110.702 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -43.43 26.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.243 -0.91 . . . . 0.0 111.023 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.6 tpp -65.06 -51.58 60.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.096 -1.003 . . . . 0.0 109.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 139' ' ' LYS . 7.5 tmtm? -63.01 -39.25 94.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.4 -0.813 . . . . 0.0 109.953 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -67.27 -32.9 74.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.429 -0.794 . . . . 0.0 110.251 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.538 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.6 t -82.28 -64.28 1.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 110.487 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.426 ' OD2' ' HA ' ' A' ' 145' ' ' ASN . 45.6 t0 -44.36 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.395 -0.816 . . . . 0.0 110.48 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -89.26 -3.17 58.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.2 p30 -125.01 8.82 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.962 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.426 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 8.3 m120 59.26 39.27 22.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.875 . . . . 0.0 110.562 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.459 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 19.3 p30 -72.85 -13.63 61.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 110.076 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 148' ' ' ARG . . . 102.11 -11.77 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.495 ' CG ' ' O ' ' A' ' 147' ' ' GLY . 70.9 mtt180 -158.43 177.94 10.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -1.142 . . . . 0.0 110.152 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.538 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.6 mt -88.51 166.57 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 44.9 p-10 -144.35 -162.57 1.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.74 ' O ' HD12 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -73.26 -43.02 61.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.498 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -52.86 41.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.56 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 10.6 mt-10 -65.19 -39.98 93.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.212 -0.93 . . . . 0.0 110.542 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 3.5 t80 -54.75 -64.9 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 151' ' ' PHE . 8.1 mt -42.22 -52.86 4.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -59.74 -37.12 78.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.487 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -62.01 -47.04 86.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.487 ' N ' ' CG ' ' A' ' 157' ' ' MET . 11.4 mmt -81.02 -41.79 22.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.93 . . . . 0.0 110.43 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 38.0 mt-10 -50.17 101.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 0.0 110.136 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.71 25.49 29.81 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 161' ' ' VAL . 8.6 p -62.55 135.63 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -1.114 . . . . 0.0 110.368 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.196 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.318 0.58 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -111.15 -61.34 1.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.873 . . . . 0.0 110.183 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.74 84.03 4.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 110.398 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -152.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.099 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.73 -156.95 8.34 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -169.46 -179.37 3.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -1.115 . . . . 0.0 110.113 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.498 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -129.57 -175.67 3.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 0.0 109.922 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 17.7 mp0 -56.74 -37.43 71.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.964 . . . . 0.0 109.88 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 95' ' ' GLU . 10.8 tt0 -43.03 -62.62 0.98 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.953 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.36 -33.34 71.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.857 . . . . 0.0 110.264 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.677 HD22 HD23 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -67.06 -49.56 64.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 110.458 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.06 25.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.994 -1.066 . . . . 0.0 110.164 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -50.96 -43.41 60.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 110.276 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -56.01 -16.22 4.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.343 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -54.0 -64.78 0.72 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 110.893 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -31.52 63.44 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.042 -1.036 . . . . 0.0 110.669 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 35.1 mm -57.18 -43.27 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 110.418 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.754 ' O ' HD11 ' A' ' 121' ' ' ILE . 5.4 m-85 -75.03 -31.84 61.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.97 98.81 8.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 110.211 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 110.119 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 69.9 m-80 -95.17 -11.47 28.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.188 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 53.94 56.41 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.97 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.84 -12.9 29.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 110.46 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.517 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 117.06 -20.65 11.39 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.517 ' CG ' ' C ' ' A' ' 111' ' ' GLY . 65.5 m-85 -152.54 127.14 9.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.104 -1.233 . . . . 0.0 110.502 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 117' ' ' GLU . 12.6 mt -83.04 118.44 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.454 -0.779 . . . . 0.0 110.55 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 22.2 p30 -89.55 -172.88 3.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 109.708 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 116' ' ' GLU . 4.1 tp -63.28 -42.56 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.096 -1.003 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.579 ' N ' HG23 ' A' ' 115' ' ' ILE . 1.6 mt-10 -53.1 -55.27 25.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 110.247 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.585 ' HB3' HG23 ' A' ' 113' ' ' ILE . 23.7 mt-10 -50.6 -43.82 56.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -59.28 -29.27 67.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.58 -179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.02 -60.23 2.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.544 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.7 pt-20 -52.4 -44.63 65.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -1.141 . . . . 0.0 110.529 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.754 HD11 ' O ' ' A' ' 105' ' ' PHE . 94.6 mt -53.42 -48.22 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.135 -0.978 . . . . 0.0 110.017 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.2 -48.85 16.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.81 -32.72 9.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.331 -0.855 . . . . 0.0 110.342 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.14 -28.15 50.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.898 . . . . 0.0 110.307 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 127' ' ' GLU . 27.9 p -86.74 21.49 2.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.146 -0.971 . . . . 0.0 110.391 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 62.86 21.11 62.95 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HB2' ' OG1' ' A' ' 125' ' ' THR . 3.2 mt-10 -96.69 112.65 24.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -1.133 . . . . 0.0 110.187 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -74.15 81.94 1.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.9 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 134' ' ' ILE . 32.0 t -90.3 137.94 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.286 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.427 ' O ' ' C ' ' A' ' 131' ' ' GLU . 28.4 pt -104.93 155.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 110.108 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 134' ' ' ILE . 10.2 mt-10 -41.96 -46.67 4.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.0 110.302 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 4.6 mm-40 -41.0 -37.94 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 0.0 109.904 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.87 -47.33 7.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.422 -0.799 . . . . 0.0 109.43 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 118' ' ' LEU . 12.1 mt -58.94 -40.7 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.813 . . . . 0.0 109.726 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -59.11 -52.35 66.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.389 -0.819 . . . . 0.0 110.186 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -46.32 -45.9 17.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.229 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.4 mp -60.87 -54.75 41.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 110.035 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.646 ' CE ' HD12 ' A' ' 149' ' ' ILE . 2.2 ttm -67.0 -43.83 81.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 110.42 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -60.14 -43.42 95.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 110.314 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -68.46 -34.1 75.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 110.279 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.544 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -87.17 -62.78 1.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.526 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 138' ' ' MET . 21.8 t0 -50.94 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 0.0 110.728 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -82.13 -25.35 34.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.136 -0.977 . . . . 0.0 110.042 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.482 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 9.0 m-80 -90.16 16.17 8.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 0.0 110.21 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.18 38.02 3.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.202 -0.936 . . . . 0.0 110.074 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -97.27 14.16 27.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.0 110.138 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 51.46 37.92 41.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 6.6 mtt180 -158.68 125.9 4.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.163 -1.198 . . . . 0.0 111.008 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.646 HD12 ' CE ' ' A' ' 138' ' ' MET . 4.0 mt -87.28 129.27 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.201 -0.937 . . . . 0.0 109.214 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -110.58 -167.71 1.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.628 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -57.45 10.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.523 -0.735 . . . . 0.0 111.038 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.41 -64.3 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.191 -0.943 . . . . 0.0 111.335 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.482 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 65.4 mt-10 -47.29 -31.58 3.96 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.088 -1.007 . . . . 0.0 110.992 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.402 ' O ' ' HB3' ' A' ' 157' ' ' MET . 21.7 t80 -64.9 -59.02 4.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 0.0 110.533 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.677 HD23 HD22 ' A' ' 98' ' ' LEU . 3.7 mt -47.28 -54.5 10.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 110.272 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -24.9 58.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 109.922 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -70.03 -38.05 75.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.375 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.495 ' N ' ' HG3' ' A' ' 157' ' ' MET . 18.8 ttm -103.94 40.63 1.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.489 -0.757 . . . . 0.0 110.346 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.93 70.09 0.98 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 110.024 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 146.0 -20.75 1.77 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.435 ' H ' HG12 ' A' ' 161' ' ' VAL . 4.6 p -112.97 144.1 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.982 . . . . 0.0 109.967 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.278 -179.953 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.092 0.472 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -121.15 131.25 54.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.46 75.89 1.66 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 110.319 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 91' ' ' LYS . 0.5 OUTLIER -63.12 106.24 0.82 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.311 -0.868 . . . . 0.0 110.404 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.48 -37.44 0.49 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -151.6 139.68 20.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -1.098 . . . . 0.0 109.84 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 95' ' ' GLU . 2.0 m -126.22 160.69 29.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 110.562 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 94' ' ' SER . 4.9 tt0 -44.28 -46.29 9.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.75 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -47.75 -53.31 15.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.917 . . . . 0.0 109.624 179.526 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -55.34 22.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.613 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' A' ' 158' ' ' MET . 0.4 OUTLIER -64.18 -48.75 74.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.377 -0.827 . . . . 0.0 109.843 179.522 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.35 -53.43 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.781 . . . . 0.0 109.759 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 96' ' ' GLU . 68.7 m-80 -52.21 -38.96 59.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.4 -0.813 . . . . 0.0 109.923 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.49 -25.93 52.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.584 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 9.8 t80 -49.7 -58.16 5.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.262 -0.899 . . . . 0.0 110.486 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -66.9 -34.95 78.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 0.0 110.931 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.482 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 12.2 mm -68.33 -48.91 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.083 -1.01 . . . . 0.0 110.831 -179.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' LYS . 1.6 m-30 -71.27 -43.76 66.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.152 -0.968 . . . . 0.0 110.694 -179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -68.16 70.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.95 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.482 ' CD ' ' O ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -61.23 -35.63 77.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 110.298 -179.952 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 109' ' ' ALA . 13.4 t30 -75.9 -5.22 45.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.86 . . . . 0.0 110.036 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 42.29 76.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.3 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -124.08 -2.9 8.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.441 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.444 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 100.16 -21.96 42.21 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CG ' ' O ' ' A' ' 111' ' ' GLY . 92.6 m-85 -152.24 140.04 19.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -1.195 . . . . 0.0 110.375 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.446 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 29.5 mt -82.53 110.08 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.877 . . . . 0.0 110.117 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -87.89 -175.47 5.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.348 -0.845 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.12 -29.72 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.248 -0.908 . . . . 0.0 110.676 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -50.26 70.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.129 -0.982 . . . . 0.0 110.262 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.501 ' C ' HD12 ' A' ' 121' ' ' ILE . 8.4 mt-10 -57.55 -42.83 83.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.336 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.549 ' HB3' ' CG2' ' A' ' 134' ' ' ILE . 1.2 tp -52.67 -38.72 60.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.318 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.583 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -56.41 -72.84 0.51 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 26.3 pt-20 -51.76 -45.22 63.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -1.207 . . . . 0.0 110.785 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.539 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 40.9 mt -47.82 -46.79 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.97 -1.081 . . . . 0.0 110.23 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.0 mt -77.39 -51.87 10.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.224 -0.923 . . . . 0.0 110.195 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -48.45 -35.3 12.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -0.982 . . . . 0.0 109.488 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.61 -38.78 21.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 72.1 p -58.9 -55.29 37.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.897 . . . . 0.0 110.118 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.452 ' C ' ' HG2' ' A' ' 127' ' ' GLU . . . 139.11 41.25 0.09 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 129' ' ' VAL . 3.9 mt-10 -136.47 128.56 29.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.241 . . . . 0.0 110.072 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -65.74 66.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' GLU . 79.0 t -64.54 155.61 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.662 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 131' ' ' GLU . 17.5 pt -123.94 145.68 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.437 -0.789 . . . . 0.0 109.839 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 4.4 mt-10 -43.74 -45.95 7.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.884 . . . . 0.0 110.581 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -41.59 -43.9 2.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.192 -0.942 . . . . 0.0 111.01 -179.546 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 -48.6 12.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.583 HD13 ' HA2' ' A' ' 119' ' ' GLY . 20.3 mt -53.21 -35.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.552 0.692 . . . . 0.0 109.651 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.455 ' OE1' ' HA ' ' A' ' 132' ' ' GLU . 64.0 mt-10 -55.9 -52.26 64.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.536 -0.728 . . . . 0.0 110.602 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 50.4 t0 -45.25 -49.16 12.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 0.0 110.474 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.515 HD23 ' HE1' ' A' ' 157' ' ' MET . 0.1 OUTLIER -53.3 -43.78 67.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.152 -0.968 . . . . 0.0 110.393 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -40.31 68.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 0.0 110.398 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -60.06 -48.05 83.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.189 -0.944 . . . . 0.0 110.843 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.9 -33.82 75.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.798 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.55 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -76.66 -35.66 57.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 145' ' ' ASN . 0.4 OUTLIER -55.25 84.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 0.0 110.544 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' SER . 5.9 tttt -67.69 -8.36 34.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 109.953 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.45 22.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.172 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.474 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 8.5 m-20 51.22 64.75 1.71 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.331 -0.855 . . . . 0.0 110.785 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 142' ' ' ASP . 51.5 p-10 -112.72 5.77 17.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.192 -0.943 . . . . 0.0 109.97 179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 60.0 24.92 61.22 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 13.6 mtt-85 -158.13 130.71 7.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -1.163 . . . . 0.0 110.533 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.55 HG12 ' CB ' ' A' ' 141' ' ' SER . 6.1 mt -85.72 121.29 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.362 -0.837 . . . . 0.0 109.94 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.18 -173.6 2.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 110.411 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -53.7 -57.43 10.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 110.161 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -55.17 16.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.505 -0.747 . . . . 0.0 110.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 157' ' ' MET . 88.0 mt-10 -64.01 -57.94 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.207 -0.933 . . . . 0.0 110.53 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.572 ' CZ ' ' HG3' ' A' ' 158' ' ' MET . 38.6 t80 -40.83 -59.72 1.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.377 -0.827 . . . . 0.0 110.654 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 154' ' ' PHE . 81.5 mt -42.3 -65.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.345 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.84 -38.09 77.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 110.431 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 158' ' ' MET . 0.0 OUTLIER -66.97 -37.96 85.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.071 -179.639 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.73 ' HB3' HD21 ' A' ' 98' ' ' LEU . 3.2 mmt -83.81 13.76 4.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.537 -0.727 . . . . 0.0 110.514 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -111.51 143.58 42.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.032 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.55 -17.1 59.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.407 HG12 ' H ' ' A' ' 161' ' ' VAL . 7.7 p -84.76 145.42 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.398 -1.06 . . . . 0.0 110.192 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.289 -179.912 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.162 0.506 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.44 179.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.439 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 49.68 70.7 0.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.367 -0.833 . . . . 0.0 110.371 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.8 107.35 19.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.127 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -147.62 137.25 6.45 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.49 157.25 21.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -1.131 . . . . 0.0 110.344 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -103.76 150.28 24.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.951 179.621 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 94' ' ' SER . 2.5 mt-10 -42.19 -49.33 4.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -44.79 -56.35 4.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.278 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -57.73 -32.07 67.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.303 -0.873 . . . . 0.0 110.47 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.69 -51.07 9.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.509 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.7 -47.07 50.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.151 -0.968 . . . . 0.0 110.133 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -66.15 -33.12 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 110.447 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.8 m -65.16 -22.08 66.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.893 . . . . 0.0 110.829 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE1' HD11 ' A' ' 113' ' ' ILE . 71.7 t80 -49.25 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 0.0 110.391 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.53 -32.25 5.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 48.8 mm -68.33 -45.44 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.114 -0.991 . . . . 0.0 110.365 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.412 ' O ' HD11 ' A' ' 121' ' ' ILE . 17.0 m-85 -67.56 -24.94 65.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.25 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 109' ' ' ALA . 23.3 t0 -90.07 84.96 6.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -67.69 -32.16 72.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 6.0 p30 -93.87 -12.25 29.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 59.09 75.2 0.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.352 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 5.1 p30 -114.91 -6.39 12.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.269 -0.895 . . . . 0.0 110.091 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 86.28 -1.05 87.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 10.8 m-85 -146.8 124.01 11.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -1.142 . . . . 0.0 110.011 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.488 HD11 ' CE1' ' A' ' 102' ' ' PHE . 40.8 mt -85.83 124.59 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.261 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 116' ' ' GLU . 1.9 p30 -103.42 -176.19 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 110.249 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.3 tp -75.97 -31.68 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 0.0 110.317 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.452 ' HB2' ' OD1' ' A' ' 114' ' ' ASP . 1.3 mt-10 -58.22 -45.06 88.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.26 -0.9 . . . . 0.0 110.262 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 121' ' ' ILE . 37.1 mt-10 -59.91 -48.67 80.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 110.423 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.59 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -56.8 -34.59 67.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.152 -0.968 . . . . 0.0 110.13 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.578 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -57.98 -71.99 0.66 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.455 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 18.7 pt-20 -57.35 -44.49 84.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -1.171 . . . . 0.0 110.299 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.0 mt -47.06 -57.8 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.975 . . . . 0.0 109.87 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.425 ' O ' ' OG1' ' A' ' 125' ' ' THR . 0.3 OUTLIER -69.09 -49.18 59.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.093 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -53.92 -37.2 63.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 110.435 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.16 60.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.307 -0.871 . . . . 0.0 110.868 -179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 122' ' ' LEU . 61.5 p -54.65 -24.44 21.63 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.0 110.461 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.54 -27.4 6.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -75.79 134.05 40.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -1.122 . . . . 0.0 109.961 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -87.19 71.07 10.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.145 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.403 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 41.6 t -64.78 137.65 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 110.051 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' GLU . 9.4 pt -86.3 137.91 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 110.366 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.801 ' OE1' HD12 ' A' ' 134' ' ' ILE . 8.9 mm-40 -42.75 -38.28 2.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.26 -0.9 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -40.79 -39.46 1.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.385 -0.822 . . . . 0.0 110.551 -179.837 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -84.31 -45.38 12.87 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.174 -0.954 . . . . 0.0 109.425 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.801 HD12 ' OE1' ' A' ' 131' ' ' GLU . 23.6 mt -56.19 -35.67 43.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.493 -0.754 . . . . 0.0 109.535 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 131' ' ' GLU . 1.1 mt-10 -65.66 -37.46 86.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.523 -0.736 . . . . 0.0 110.227 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 9.2 t70 -52.06 -54.6 28.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.216 -0.927 . . . . 0.0 110.214 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 137' ' ' LEU . 25.3 mt -50.5 -39.57 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 110.418 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.668 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -65.18 -39.08 92.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 110.406 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -64.88 -52.31 57.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 110.571 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -66.2 -27.64 68.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 111.13 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.568 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -89.34 -65.05 1.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.018 . . . . 0.0 111.025 -179.292 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' SER . 18.5 t0 -41.69 98.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.895 . . . . 0.0 110.36 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.4 tppp? -94.51 -32.11 13.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.361 -0.837 . . . . 0.0 110.367 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.486 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 4.5 p30 -101.94 17.68 22.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.135 -0.978 . . . . 0.0 110.213 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 2.0 m-20 48.74 80.44 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.486 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 9.2 p-10 -134.77 11.1 3.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 62.1 14.51 46.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 147' ' ' GLY . 72.1 mtt180 -146.94 143.95 28.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -1.158 . . . . 0.0 110.481 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.668 HD12 ' CE ' ' A' ' 138' ' ' MET . 1.2 mt -93.14 123.09 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 109.948 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 153' ' ' GLU . 39.4 p30 -91.74 -165.06 1.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.805 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -54.93 15.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.23 -0.919 . . . . 0.0 110.393 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.26 -57.28 13.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.13 -0.981 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.504 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 92.6 mt-10 -48.54 -46.29 38.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -0.844 . . . . 0.0 110.577 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 1.5 t80 -54.16 -58.9 5.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 0.0 110.677 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 155' ' ' LEU . 31.4 mt -51.46 -59.39 4.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.841 -179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -42.65 44.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.256 -0.903 . . . . 0.0 110.775 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.474 ' HE1' HG21 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -65.21 -45.17 85.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.116 -179.509 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.527 ' HA ' HG21 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -86.57 3.44 44.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.202 -0.937 . . . . 0.0 110.446 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -79.0 142.83 36.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 0.0 110.317 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.57 31.67 80.84 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 161' ' ' VAL . 70.0 t -101.27 67.46 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.149 -1.207 . . . . 0.0 110.111 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.237 -179.767 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.315 0.579 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.55 102.24 13.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 110.281 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.04 159.88 4.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -133.87 124.45 26.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 110.104 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.63 -150.46 5.95 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -106.63 -169.9 1.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -1.13 . . . . 0.0 110.174 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -64.55 -13.73 54.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 110.351 -179.967 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 94' ' ' SER . 0.2 OUTLIER 73.88 -49.15 0.68 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.388 -0.82 . . . . 0.0 110.546 -179.571 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -42.81 -48.93 5.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.085 -1.009 . . . . 0.0 110.092 -179.929 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 21.3 mp0 -53.61 -56.48 16.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.887 . . . . 0.0 109.924 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 95' ' ' GLU . 3.1 mt -52.26 -57.83 8.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.95 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 102' ' ' PHE . . . -47.66 -41.96 23.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.059 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -55.46 -32.76 63.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.686 ' HA ' HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -77.7 -7.2 56.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.881 . . . . 0.0 110.577 -179.709 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 99' ' ' ALA . 2.5 t80 -60.86 -56.48 20.65 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.07 -1.019 . . . . 0.0 110.428 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.524 ' HG2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -52.16 -22.98 4.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.185 -0.947 . . . . 0.0 110.733 -179.764 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.686 HD13 ' HA ' ' A' ' 101' ' ' CYS . 2.0 mp -74.28 -47.93 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.061 -1.025 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -80.12 -49.9 11.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.308 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 108' ' ' ASN . 52.7 t0 -67.48 74.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.222 -0.924 . . . . 0.0 110.18 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -46.43 -39.19 10.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.7 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 106' ' ' ASP . 17.3 m-80 -103.54 165.01 11.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.081 -1.012 . . . . 0.0 109.988 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.25 63.89 7.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' GLY . 17.2 p30 -102.55 -18.43 15.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.072 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.575 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 74.91 5.81 76.43 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 52.8 m-85 -148.53 110.29 4.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -1.147 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.91 144.85 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 109.762 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.46 ' CG ' ' HG3' ' A' ' 116' ' ' GLU . 30.0 p30 -119.7 -163.78 1.02 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.122 -0.986 . . . . 0.0 110.76 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' A' ' 135' ' ' GLU . 1.2 tt -79.59 -45.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -0.841 . . . . 0.0 110.779 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.603 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -51.41 -27.28 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 110.152 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 9.2 mt-10 -76.55 -48.93 17.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 109.86 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.472 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -51.85 -44.07 63.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.372 -0.83 . . . . 0.0 110.038 179.783 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -48.63 -83.91 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 10.6 pt-20 -42.42 -45.35 4.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -1.17 . . . . 0.0 110.493 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 12.0 mt -50.3 -54.33 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.084 -1.01 . . . . 0.0 109.679 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 122' ' ' LEU . 19.6 mt -73.1 -47.48 43.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.755 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -49.89 -37.55 31.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 0.0 109.837 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.64 -31.56 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 109.868 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 43.0 p -69.25 -148.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 110.154 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -126.97 38.21 2.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -113.0 -157.52 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.175 -1.191 . . . . 0.0 110.331 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -145.11 53.72 1.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 0.0 110.034 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.451 HG12 HG13 ' A' ' 134' ' ' ILE . 46.8 t -61.18 162.58 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.832 . . . . 0.0 110.347 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 131' ' ' GLU . 13.7 pt -139.18 152.02 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.3 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -41.27 -53.62 3.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.431 -0.793 . . . . 0.0 110.361 179.993 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 2.1 mt-10 -43.44 -36.65 2.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.005 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -45.1 11.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 109.465 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 118' ' ' LEU . 21.1 mt -62.81 -38.9 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.513 -0.742 . . . . 0.0 109.623 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.608 ' HG2' HD11 ' A' ' 115' ' ' ILE . 2.0 mm-40 -58.74 -45.05 90.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 110.12 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 140' ' ' ASP . 4.8 t70 -44.0 -50.02 8.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 110.265 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 141' ' ' SER . 31.6 mt -58.4 -40.27 81.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.444 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 34.5 tpp -65.34 -48.44 73.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.609 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -64.8 -37.16 86.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.576 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 2.9 t0 -72.19 -36.98 69.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.469 -0.769 . . . . 0.0 109.974 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.558 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -85.43 -46.65 10.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 110.136 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.454 ' HA ' ' CD ' ' A' ' 153' ' ' GLU . 29.3 t0 -61.82 86.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.395 -0.815 . . . . 0.0 110.45 -179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 -8.1 58.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.828 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -119.45 19.55 12.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.429 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 34.1 m120 46.97 41.9 11.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.111 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -82.9 -9.33 59.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.31 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.43 60.95 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.436 ' CD ' ' HB3' ' A' ' 114' ' ' ASP . 55.9 mtt180 -146.2 162.18 38.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.257 -1.143 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.558 HG12 ' CB ' ' A' ' 141' ' ' SER . 3.3 mt -84.38 118.77 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.288 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 2.9 p30 -94.39 -178.08 4.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.932 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 0.0 110.169 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.98 -61.26 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 110.051 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.454 ' CD ' ' HA ' ' A' ' 142' ' ' ASP . 94.1 mt-10 -59.42 -44.89 92.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 10.6 t80 -46.27 -66.98 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.957 . . . . 0.0 110.207 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 154' ' ' PHE . 10.0 mt -44.52 -56.86 3.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.133 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -37.52 72.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.582 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.525 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.0 ptm -54.76 -49.51 70.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.672 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.525 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -63.61 -17.33 62.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 109.989 179.818 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -72.39 106.76 4.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.331 -0.856 . . . . 0.0 110.104 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 117.28 -25.69 8.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.49 159.0 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 110.19 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.152 -179.965 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.278 0.561 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.53 -54.14 3.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 110.298 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.71 132.88 9.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.909 . . . . 0.0 110.391 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -108.7 2.31 21.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 110.139 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.89 -151.04 49.79 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 175.08 8.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.149 -1.207 . . . . 0.0 109.949 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 95' ' ' GLU . 72.6 m -95.42 142.38 27.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 110.327 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 94' ' ' SER . 3.5 mt-10 -43.38 -40.52 3.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.36 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -43.48 -45.51 6.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.711 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.0 -51.15 71.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.719 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 98' ' ' LEU . 4.1 mm? -46.68 -56.75 5.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -45.04 -55.13 5.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 110.225 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -52.1 -43.43 63.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.314 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.46 -24.52 60.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -53.83 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.98 . . . . 0.0 110.073 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -55.37 -38.01 68.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.142 -0.974 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.468 ' HA ' HD13 ' A' ' 104' ' ' ILE . 12.2 mm -62.5 -39.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 0.0 109.946 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.417 ' CE2' HD13 ' A' ' 121' ' ' ILE . 1.4 m-30 -84.33 -46.08 12.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.173 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 6.7 t0 -82.42 96.24 7.92 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.335 -0.853 . . . . 0.0 109.838 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -105.83 -27.4 11.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.187 -0.946 . . . . 0.0 110.904 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.461 ' CG ' ' N ' ' A' ' 109' ' ' ALA . 3.1 p30 -104.26 -45.19 4.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.014 -1.054 . . . . 0.0 110.77 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 108' ' ' ASN . . . -86.12 -39.76 16.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.991 . . . . 0.0 110.016 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 2.9 m-20 45.3 27.17 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 109.962 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.565 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . -152.33 -36.99 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 20.9 m-85 -151.57 112.32 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.433 -1.039 . . . . 0.0 109.322 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.429 HG23 ' CB ' ' A' ' 117' ' ' GLU . 5.0 mt -82.77 118.84 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.681 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.473 ' OD2' ' N ' ' A' ' 116' ' ' GLU . 4.5 p-10 -92.66 -155.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' A' ' 135' ' ' GLU . 3.0 tp -78.73 -33.63 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.0 110.248 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.473 ' N ' ' OD2' ' A' ' 114' ' ' ASP . 1.7 mm-40 -57.16 -59.32 5.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.305 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 1.9 mt-10 -44.23 -48.46 9.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.917 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.571 ' HA ' HD12 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -58.53 -31.98 68.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.338 -0.851 . . . . 0.0 110.103 179.811 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -60.44 -75.83 0.26 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 10.9 pt-20 -42.43 -45.58 4.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.258 -1.142 . . . . 0.0 110.44 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 118' ' ' LEU . 45.7 mt -47.21 -53.66 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.142 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.409 HD12 HG12 ' A' ' 134' ' ' ILE . 72.1 mt -75.14 -36.87 61.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.328 -0.858 . . . . 0.0 110.249 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 120' ' ' GLU . 6.6 mtm180 -62.96 -36.51 83.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 110.162 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.82 -40.43 41.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.322 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.2 p -61.96 -36.24 80.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 110.213 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.74 11.07 27.44 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -89.98 148.0 23.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.25 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -85.52 83.16 8.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 109.941 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' A' ' 133' ' ' ASP . 2.3 t -93.56 114.34 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 110.274 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 9.1 pt -73.28 146.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.239 -0.913 . . . . 0.0 110.05 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 130' ' ' ILE . 1.7 mt-10 -41.13 -49.34 3.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.864 . . . . 0.0 110.439 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.08 -26.68 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 0.0 110.264 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB3' HG12 ' A' ' 129' ' ' VAL . 0.1 OUTLIER -81.02 -50.01 10.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.309 179.636 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.557 ' CG2' ' HB3' ' A' ' 118' ' ' LEU . 6.4 mt -66.22 -42.55 91.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.463 179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.492 ' HA ' HD11 ' A' ' 115' ' ' ILE . 8.3 mt-10 -45.81 -42.61 12.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.0 110.052 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.14 -51.78 68.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.876 . . . . 0.0 110.246 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' A' ' 137' ' ' LEU . 2.7 mm? -48.63 -44.87 37.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.217 -0.927 . . . . 0.0 110.371 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 11.0 tpp -64.58 -45.96 84.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.759 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -46.21 74.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -0.835 . . . . 0.0 110.284 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 110.561 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.531 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -89.48 -63.75 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.985 . . . . 0.0 110.459 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 148' ' ' ARG . 1.7 t0 -47.82 91.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.026 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 141' ' ' SER . 1.1 mttt -84.53 -26.02 28.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.162 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 11.6 m-80 -86.63 -3.94 59.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 0.0 109.744 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.3 OUTLIER 67.26 15.08 9.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.331 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -60.63 -15.79 32.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.1 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.15 -5.94 82.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.521 ' N ' ' OD2' ' A' ' 142' ' ' ASP . 0.4 OUTLIER -137.9 146.4 43.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.069 -1.254 . . . . 0.0 110.486 179.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 141' ' ' SER . 5.8 mt -83.77 137.12 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 154' ' ' PHE . 29.4 p-10 -121.15 -160.83 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.852 . . . . 0.0 109.741 179.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.864 ' O ' HD12 ' A' ' 155' ' ' LEU . 49.5 p90 -68.17 -41.83 80.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.033 -1.042 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 1.0 OUTLIER -68.38 -56.88 6.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.499 -179.857 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' HA ' ' A' ' 142' ' ' ASP . 59.1 mt-10 -58.35 -48.53 80.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 57.4 t80 -46.55 -54.42 9.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.927 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.864 HD12 ' O ' ' A' ' 151' ' ' PHE . 6.2 mt -66.62 -47.06 73.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 0.0 109.984 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -48.32 -55.78 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 110.143 179.927 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.573 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -58.28 -52.47 65.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 109.72 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.573 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.9 mtm -89.96 39.81 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.075 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 4.8 tt0 -96.96 105.15 17.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 110.265 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 44.07 55.49 5.67 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 162' ' ' GLN . 60.6 t -53.99 168.89 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -1.137 . . . . 0.0 110.306 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.511 ' N ' HG12 ' A' ' 161' ' ' VAL . 5.8 mt-30 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.092 -0.956 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.144 0.497 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -166.65 93.69 0.49 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.563 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.55 -176.98 6.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 109.706 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 54.14 2.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.022 -1.049 . . . . 0.0 110.195 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -165.11 127.45 1.63 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -152.87 162.52 41.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.323 -1.104 . . . . 0.0 109.97 179.916 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.552 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -107.14 -169.22 1.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.807 -179.354 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -53.07 -46.11 68.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.453 -0.779 . . . . 0.0 110.844 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 95' ' ' GLU . 1.5 tt0 -38.31 -64.37 0.42 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -0.781 . . . . 0.0 110.819 -179.409 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.01 -55.93 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.943 . . . . 0.0 110.328 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD12 ' O ' ' A' ' 94' ' ' SER . 3.0 mt -58.61 -53.28 60.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.335 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 102' ' ' PHE . . . -49.17 -51.92 29.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 110.361 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -51.43 -50.61 59.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 0.0 110.305 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.42 ' O ' ' C ' ' A' ' 102' ' ' PHE . 5.2 m -53.03 -42.08 65.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.247 -0.908 . . . . 0.0 110.713 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 99' ' ' ALA . 87.3 t80 -42.28 -65.16 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 110.603 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -39.58 70.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.193 -0.942 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 mm -60.87 -32.78 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 0.0 110.581 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -75.1 -48.92 21.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.102 -0.999 . . . . 0.0 110.416 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.79 101.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -75.48 -45.88 35.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.201 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 69.3 m-80 -69.43 -15.3 63.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -0.879 . . . . 0.0 110.095 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 108' ' ' ASN . . . 59.37 42.93 17.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.45 ' OD2' ' O ' ' A' ' 112' ' ' PHE . 6.7 p-10 -84.07 -16.56 43.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.085 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.483 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 113.23 -16.05 22.57 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 3.4 m-85 -148.37 135.46 20.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 110.404 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 22.9 mt -85.26 119.36 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.852 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 23.8 p-10 -90.98 -175.76 4.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.0 OUTLIER -68.25 -38.85 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.814 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.492 ' N ' HG23 ' A' ' 115' ' ' ILE . 17.7 mt-10 -58.04 -55.2 38.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.135 -0.978 . . . . 0.0 110.332 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' A' ' 113' ' ' ILE . 7.2 mt-10 -46.62 -40.36 12.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 109.818 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.515 ' HB3' HG23 ' A' ' 134' ' ' ILE . 1.1 tp -61.16 -49.03 78.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 110.063 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -51.94 -69.85 1.05 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 121' ' ' ILE . 12.6 pt-20 -47.47 -45.96 26.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -1.189 . . . . 0.0 110.179 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 122' ' ' LEU . 6.5 mt -48.28 -65.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.986 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.699 ' HB3' HG21 ' A' ' 129' ' ' VAL . 44.4 mt -61.76 -44.83 96.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.467 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.495 ' HG2' ' NH1' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -55.21 -36.46 65.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.9 . . . . 0.0 110.731 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -47.55 -28.32 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 109.997 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.1 p -81.07 -47.31 13.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 110.007 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.32 35.51 1.45 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 5.1 mt-10 -99.88 16.6 23.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -1.204 . . . . 0.0 109.99 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 127' ' ' GLU . 44.5 p-80 38.24 43.89 0.63 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.627 -0.671 . . . . 0.0 110.49 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 122' ' ' LEU . 20.1 t -61.09 117.11 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.301 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.472 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.3 pt -77.74 148.63 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.298 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -45.34 -47.45 13.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.232 -0.917 . . . . 0.0 110.329 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HB2' HG13 ' A' ' 130' ' ' ILE . 4.8 mt-10 -41.24 -36.32 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -0.863 . . . . 0.0 110.477 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -43.81 15.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.673 HD13 ' HA2' ' A' ' 119' ' ' GLY . 26.6 mt -64.11 -38.48 82.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.396 -0.815 . . . . 0.0 109.588 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -50.45 73.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.488 -0.757 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 136' ' ' ASP . 9.2 t0 -45.47 -49.29 13.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 141' ' ' SER . 1.7 tp -51.65 -38.89 56.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.163 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 142' ' ' ASP . 0.6 OUTLIER -73.02 -57.58 3.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 110.055 -179.993 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 138' ' ' MET . 2.9 mmtm -43.34 -63.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 110.469 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -54.01 -20.43 6.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.796 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.547 ' CB ' HG12 ' A' ' 149' ' ' ILE . 0.6 OUTLIER -101.85 -62.32 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 0.0 110.424 -179.842 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 138' ' ' MET . 24.0 t70 -56.29 81.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 110.519 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -89.8 31.33 0.96 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.575 179.546 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -149.07 17.65 0.96 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.454 -0.779 . . . . 0.0 109.847 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 55.3 21.88 4.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 110.257 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 147' ' ' GLY . 1.4 t70 -85.58 4.57 35.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.855 . . . . 0.0 109.896 179.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . 41.57 38.97 2.34 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -158.31 124.55 4.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -1.211 . . . . 0.0 110.325 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.547 HG12 ' CB ' ' A' ' 141' ' ' SER . 13.5 mt -83.76 106.88 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 154' ' ' PHE . 44.8 p-10 -100.78 -140.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.135 -0.978 . . . . 0.0 110.37 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -76.46 -61.64 1.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 0.0 110.729 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.32 -56.02 13.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.654 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -60.53 -53.54 56.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.676 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.495 ' CB ' ' O ' ' A' ' 150' ' ' ASP . 44.9 t80 -43.98 -49.23 8.65 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 43.6 mt -64.68 -36.55 84.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.203 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -46.37 69.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.887 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.551 ' HG2' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -61.08 -42.33 98.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.846 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.551 ' N ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER -109.03 42.53 1.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 0.0 110.05 179.77 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.77 94.43 9.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.338 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 44.82 41.94 7.5 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 162' ' ' GLN . 23.1 t -47.17 133.94 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -1.169 . . . . 0.0 110.187 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 161' ' ' VAL . 3.1 mm100 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.287 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.394 0.616 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 89' ' ' ASP . 54.0 t0 -143.53 60.57 1.39 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' LYS . . . -102.44 60.82 0.83 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.388 -0.82 . . . . 0.0 110.893 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 90' ' ' ALA . 10.7 tttt -178.47 175.68 1.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.129 -0.982 . . . . 0.0 110.74 179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 91' ' ' LYS . . . 60.64 144.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -76.1 0.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.413 -1.051 . . . . 0.0 109.878 179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER 57.82 160.38 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.461 -0.774 . . . . 0.0 110.91 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 94' ' ' SER . 16.1 mt-10 -39.26 -40.26 0.73 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.485 -0.759 . . . . 0.0 110.745 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -45.71 -71.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 110.532 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -55.97 -38.38 70.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.211 -0.931 . . . . 0.0 109.991 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.511 ' HA ' HD23 ' A' ' 98' ' ' LEU . 9.5 mt -57.14 -53.97 52.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -44.65 -65.61 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.845 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 41.5 m-20 -52.07 -31.28 29.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 110.421 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -71.87 -9.85 58.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.208 -0.932 . . . . 0.0 110.378 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -58.99 -54.04 51.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 0.0 110.748 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -31.45 72.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.249 -0.907 . . . . 0.0 110.838 -179.378 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 mm -57.26 -29.31 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.036 -1.04 . . . . 0.0 110.125 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -80.53 -32.85 36.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.0 110.338 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.86 79.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.264 -0.897 . . . . 0.0 110.246 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -86.97 39.38 0.85 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.7 -179.878 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.625 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 27.9 t30 -128.96 -98.44 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 108' ' ' ASN . . . 174.8 27.81 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.984 -1.073 . . . . 0.0 111.041 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.4 p30 -113.45 -10.92 13.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.825 179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.78 13.7 81.97 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.457 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 51.2 m-85 -141.6 139.75 33.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 110.6 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.478 ' HA ' ' OE1' ' A' ' 117' ' ' GLU . 51.0 mt -85.37 126.32 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.542 -0.724 . . . . 0.0 109.384 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.49 -179.23 3.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.011 -1.056 . . . . 0.0 111.046 -179.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -65.3 -44.31 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.39 -0.819 . . . . 0.0 110.519 -179.64 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.541 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 2.6 mt-10 -60.17 -51.15 70.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.997 -1.064 . . . . 0.0 109.907 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.534 ' O ' HD12 ' A' ' 121' ' ' ILE . 14.6 mt-10 -49.76 -36.53 26.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.607 HD23 HG23 ' A' ' 134' ' ' ILE . 5.0 tp -60.71 -51.24 70.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 0.0 110.531 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . -42.43 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 19.2 pt-20 -42.08 -45.81 4.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -1.18 . . . . 0.0 110.628 -179.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 117' ' ' GLU . 37.6 mt -56.23 -58.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.99 -1.069 . . . . 0.0 109.72 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.033 HD13 HG11 ' A' ' 129' ' ' VAL . 49.1 mt -60.7 -44.63 96.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 0.0 110.103 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -59.74 -37.77 79.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.126 -0.984 . . . . 0.0 110.264 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.87 64.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.987 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.8 p -62.74 -23.31 67.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 110.228 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.57 47.43 15.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.53 13.44 20.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -1.109 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 55.77 47.71 19.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.0 110.307 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.033 HG11 HD13 ' A' ' 122' ' ' LEU . 71.8 t -79.88 86.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 110.107 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.1 pt -57.79 149.86 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.981 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 132' ' ' GLU . 3.8 mm-40 -50.32 -44.54 54.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.367 -0.833 . . . . 0.0 111.142 -179.309 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -39.43 -40.37 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.328 -0.857 . . . . 0.0 110.896 -179.474 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -47.3 21.6 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.307 -0.871 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.607 HG23 HD23 ' A' ' 118' ' ' LEU . 6.6 mt -59.71 -39.48 79.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.666 -0.646 . . . . 0.0 109.611 179.143 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.63 ' HA ' HD11 ' A' ' 115' ' ' ILE . 1.3 mm-40 -55.27 -42.33 73.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.03 -38.62 86.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.404 -0.81 . . . . 0.0 109.843 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 134' ' ' ILE . 0.6 OUTLIER -49.69 -41.98 44.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 110.947 -179.505 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.477 ' CE ' HD12 ' A' ' 149' ' ' ILE . 49.2 tpp -70.36 -43.8 69.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.921 -1.112 . . . . 0.0 110.173 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -62.74 -43.83 97.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.88 -18.77 64.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -99.07 -63.99 1.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.573 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.2 m-20 -40.05 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.552 -0.718 . . . . 0.0 110.798 -179.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 141' ' ' SER . 15.2 tttt -79.66 3.88 17.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.046 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 6.3 p30 -141.51 8.38 1.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.935 . . . . 0.0 110.053 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 144' ' ' ASN . 62.3 m-20 58.18 61.9 2.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 110.29 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 56.7 p30 -102.05 -5.03 25.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.936 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.466 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 87.71 -5.18 85.34 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.466 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 18.0 mtm-85 -152.35 157.03 40.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.971 -1.311 . . . . 0.0 110.79 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.477 HD12 ' CE ' ' A' ' 138' ' ' MET . 3.8 mt -89.28 144.87 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 152' ' ' ASP . 1.0 OUTLIER -121.01 -162.54 0.96 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.102 -0.999 . . . . 0.0 110.454 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.502 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 6.8 t80 -64.42 -52.92 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.136 -0.977 . . . . 0.0 111.112 -179.208 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.5 OUTLIER -60.2 -56.74 17.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.952 -1.092 . . . . 0.0 110.686 -179.397 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -58.02 -44.47 87.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.047 -1.033 . . . . 0.0 110.096 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.49 ' O ' ' HG2' ' A' ' 157' ' ' MET . 81.5 t80 -49.23 -54.99 14.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.208 -0.933 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 155' ' ' LEU . 35.3 mt -51.81 -51.42 56.65 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.316 -0.865 . . . . 0.0 110.357 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -46.99 -58.17 4.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.271 -0.893 . . . . 0.0 110.739 -179.74 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.565 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -47.53 -51.66 20.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.175 -0.953 . . . . 0.0 110.335 -179.586 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 1.073 ' O ' HG23 ' A' ' 161' ' ' VAL . 12.3 mmt -60.83 -36.38 78.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 0.0 110.385 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 158' ' ' MET . 0.0 OUTLIER 39.85 36.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.327 -0.858 . . . . 0.0 111.335 179.334 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 159' ' ' GLU . . . 42.44 41.71 4.19 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.439 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 158' ' ' MET . 59.7 t -55.49 125.3 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -1.11 . . . . 0.0 110.478 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 161' ' ' VAL . 25.7 mt-30 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.49 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.209 0.528 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.5 136.82 15.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.054 -1.029 . . . . 0.0 110.29 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.15 -164.47 1.44 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.301 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.85 125.5 47.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.852 . . . . 0.0 110.048 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.8 56.9 3.19 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.23 135.88 36.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -1.174 . . . . 0.0 110.595 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.4 m -76.59 138.91 40.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.671 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -47.62 -32.85 5.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.925 . . . . 0.0 110.284 -179.654 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -42.26 -52.12 4.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 110.302 -179.909 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -68.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 99' ' ' ALA . 7.6 mp -47.96 -61.92 1.72 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.01 -42.72 2.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.429 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -73.82 -57.9 3.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.595 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 62.9 m -48.93 -27.26 2.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.879 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -46.38 -50.32 16.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.989 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 -56.55 -42.59 78.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.425 HD12 HG23 ' A' ' 104' ' ' ILE . 20.0 mm -57.01 -43.3 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 110.635 -179.434 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -66.15 -38.45 88.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 110.175 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -67.19 89.74 0.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.097 -1.002 . . . . 0.0 110.091 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -62.78 -27.64 69.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 109.599 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.439 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 17.3 m-80 -104.78 -169.1 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.559 -0.713 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.14 65.41 0.82 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.365 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -114.44 -32.1 6.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 110.165 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.94 6.98 48.29 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.582 ' HB2' ' HD3' ' A' ' 148' ' ' ARG . 5.3 m-85 -152.09 128.88 10.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -1.203 . . . . 0.0 109.861 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.0 mp -83.28 141.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' OD2' ' OE2' ' A' ' 117' ' ' GLU . 3.9 p30 -106.88 173.32 6.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.253 -0.904 . . . . 0.0 110.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 116' ' ' GLU . 3.3 tt -56.4 -42.93 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.076 -1.015 . . . . 0.0 110.209 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.595 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.7 OUTLIER -55.2 -59.39 4.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.901 179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.598 ' C ' HD12 ' A' ' 121' ' ' ILE . 20.7 mt-10 -47.75 -43.93 27.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.668 179.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.762 ' HB3' HG23 ' A' ' 134' ' ' ILE . 2.5 tp -45.46 -31.23 1.64 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.612 -0.68 . . . . 0.0 110.719 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -73.41 -74.5 0.81 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 5.5 pt-20 -42.05 -50.04 4.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.2 -1.177 . . . . 0.0 110.476 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.598 HD12 ' C ' ' A' ' 117' ' ' GLU . 7.9 mt -48.33 -65.29 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.825 ' O ' HG22 ' A' ' 125' ' ' THR . 17.9 mt -59.67 -56.6 19.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 110.234 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -48.56 -30.99 5.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 110.453 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 121' ' ' ILE . . . -54.85 -53.78 50.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.302 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 122' ' ' LEU . 4.4 t -67.47 -139.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.973 179.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.448 ' N ' ' OG1' ' A' ' 125' ' ' THR . . . -118.34 11.75 12.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.828 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.3 mm-40 -81.61 97.32 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -1.066 . . . . 0.0 111.046 -179.477 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -66.06 93.25 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 127' ' ' GLU . 3.4 t -103.98 146.6 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.894 -178.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 131' ' ' GLU . 12.4 pt -112.71 159.0 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.239 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 130' ' ' ILE . 0.3 OUTLIER -42.89 -48.19 5.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.413 -0.805 . . . . 0.0 110.914 -179.703 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -47.28 -32.53 4.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.309 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.06 -48.3 8.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.463 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.762 HG23 ' HB3' ' A' ' 118' ' ' LEU . 22.8 mt -60.28 -42.74 91.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -59.01 -60.46 3.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.482 -0.762 . . . . 0.0 109.848 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -51.19 -45.39 61.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.431 -0.793 . . . . 0.0 110.217 179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -48.25 -43.98 32.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.812 -179.79 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.594 ' HA ' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -62.27 -48.44 79.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.782 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.04 -36.02 69.52 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.434 -0.791 . . . . 0.0 110.093 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.85 -17.9 65.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.835 . . . . 0.0 110.412 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.549 ' HB3' HG12 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -102.77 -62.32 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.127 -0.983 . . . . 0.0 110.803 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 141' ' ' SER . 2.6 t0 -37.69 109.01 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.671 -0.643 . . . . 0.0 110.731 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -83.51 -11.41 57.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.504 -0.748 . . . . 0.0 109.86 179.843 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 146' ' ' ASP . 1.7 p30 -132.08 4.69 4.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.151 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.439 ' OD1' ' N ' ' A' ' 145' ' ' ASN . 2.9 m120 60.83 48.19 7.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.458 -0.777 . . . . 0.0 110.772 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.45 ' HB3' ' OD1' ' A' ' 144' ' ' ASN . 45.9 p-10 -81.82 -10.2 59.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 179.557 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . 93.94 8.5 60.41 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.582 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 10.2 mtt180 -158.34 139.98 13.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -1.177 . . . . 0.0 110.296 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 138' ' ' MET . 3.6 mt -83.56 122.36 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -101.68 -174.24 2.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -53.32 -56.42 16.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.362 -0.837 . . . . 0.0 110.95 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.68 -63.5 1.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.745 -179.293 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 143' ' ' LYS . 21.1 mt-10 -55.76 -36.57 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.932 -179.392 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -63.24 -55.56 23.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.914 -1.116 . . . . 0.0 109.977 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 159' ' ' GLU . 12.8 mt -54.6 -41.83 70.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 110.388 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -58.93 -62.86 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 110.821 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.8 OUTLIER -57.43 -50.83 71.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 0.0 110.832 -179.43 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' MET . 6.1 mmt -62.09 -31.08 71.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.333 -0.854 . . . . 0.0 110.485 -179.722 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 155' ' ' LEU . 38.6 tt0 -66.72 76.97 0.11 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.458 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 110.47 36.01 1.99 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 162' ' ' GLN . 6.1 p -72.72 163.14 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -1.041 . . . . 0.0 110.785 -179.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.445 ' N ' HG22 ' A' ' 161' ' ' VAL . 1.8 mt-30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.259 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.245 0.545 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.39 125.13 47.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.117 179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -174.87 -179.33 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 0.0 110.462 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 6.1 ttmt 63.89 88.26 0.1 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.317 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -115.83 -141.63 7.34 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.439 ' HE2' ' HG2' ' A' ' 97' ' ' GLU . 0.7 OUTLIER -93.4 120.82 34.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.263 -1.139 . . . . 0.0 110.093 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -92.0 157.36 16.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.261 -0.899 . . . . 0.0 110.28 -179.826 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 94' ' ' SER . 0.4 OUTLIER -43.66 -50.34 7.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 110.205 179.898 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 4.5 mp0 -44.95 -57.35 3.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 110.244 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' HG2' ' HE2' ' A' ' 93' ' ' LYS . 5.9 tp10 -48.2 -59.97 3.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.263 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 155' ' ' LEU . 6.0 mt -57.99 -45.98 85.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' A' ' 102' ' ' PHE . . . -42.36 -59.29 1.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.242 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 101' ' ' CYS . 3.7 m120 -50.02 -54.11 22.36 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.897 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.457 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.2 m -43.6 -32.59 0.98 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.908 179.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' A' ' 99' ' ' ALA . 13.0 t80 -42.93 -63.93 0.71 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 110.345 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -63.68 -29.63 70.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 101' ' ' CYS . 23.0 mm -60.84 -50.77 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.487 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.4 -13.7 14.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.908 . . . . 0.0 110.271 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -89.42 118.49 29.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.09 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -110.66 -11.91 14.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.348 -0.845 . . . . 0.0 110.196 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -109.71 15.09 23.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.505 -0.747 . . . . 0.0 110.611 -179.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 45.25 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 0.0 110.239 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -126.55 -27.88 3.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.436 179.989 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 112' ' ' PHE . . . 101.95 -19.47 49.33 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 62.0 m-85 -153.23 128.24 9.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.326 -1.102 . . . . 0.0 110.068 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.499 HG23 ' OE1' ' A' ' 117' ' ' GLU . 1.4 mp -82.51 123.52 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 -179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -102.21 -168.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.249 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 116' ' ' GLU . 2.8 tt -65.14 -40.47 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 110.328 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.555 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -51.38 -52.38 46.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.435 -179.693 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.499 ' OE1' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -56.97 -44.62 82.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.903 . . . . 0.0 110.28 -179.767 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.631 ' HB3' HG23 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -48.47 -34.19 10.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.171 -179.971 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -58.36 -85.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 15.7 pt-20 -42.43 -43.89 3.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.15 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.45 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 15.5 mt -52.61 -48.98 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.877 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 122' ' ' LEU . 10.8 mt -70.32 -47.1 62.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 110.097 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -51.96 -42.42 62.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.187 -0.946 . . . . 0.0 110.208 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.04 -31.6 5.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.432 -0.793 . . . . 0.0 110.548 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.3 p -68.87 -35.91 77.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.244 -0.91 . . . . 0.0 110.363 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.91 49.24 2.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.45 -7.55 8.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -1.166 . . . . 0.0 110.206 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 59.29 84.05 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 110.039 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 133' ' ' ASP . 9.1 t -108.69 149.58 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.318 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' O ' ' C ' ' A' ' 131' ' ' GLU . 16.2 pt -113.44 154.82 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.126 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 130' ' ' ILE . 10.2 mt-10 -39.41 -51.0 2.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.436 -0.79 . . . . 0.0 110.777 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -42.3 -34.89 0.86 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.208 -0.932 . . . . 0.0 110.074 -179.991 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . 0.3 OUTLIER -88.37 -44.75 10.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.503 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 118' ' ' LEU . 33.3 mt -63.26 -38.3 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.811 . . . . 0.0 109.894 179.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -54.04 -53.73 49.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.778 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -45.26 -48.73 12.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.013 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.575 HD22 HD21 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -53.09 -49.01 67.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.855 . . . . 0.0 110.377 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 26.4 tpp -66.11 -50.43 64.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -41.83 93.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.398 -0.814 . . . . 0.0 110.093 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -66.77 -35.58 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.539 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.4 t -80.54 -48.83 12.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' MET . 0.4 OUTLIER -49.23 90.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.508 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 141' ' ' SER . 17.5 tttt -80.09 -19.21 47.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 145' ' ' ASN . 0.2 OUTLIER -122.48 0.91 9.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.401 -0.812 . . . . 0.0 109.901 179.68 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 64.96 52.07 1.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.872 . . . . 0.0 110.564 179.727 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 146' ' ' ASP . 50.7 p-10 -93.7 0.02 56.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 0.0 109.968 179.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.61 11.58 84.34 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -152.79 139.1 18.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.144 -1.21 . . . . 0.0 110.434 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' A' ' 141' ' ' SER . 10.2 mt -83.63 134.76 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.154 -0.966 . . . . 0.0 109.751 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 152' ' ' ASP . 2.1 p30 -118.6 -166.27 1.21 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 110.144 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 152' ' ' ASP . 41.1 p90 -70.02 -34.98 73.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 -179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.594 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -66.0 -49.0 69.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.315 -179.909 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 141' ' ' SER . 74.8 mt-10 -71.92 -56.61 5.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.0 110.38 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.446 ' O ' ' HG2' ' A' ' 157' ' ' MET . 69.6 t80 -45.29 -45.17 11.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.968 . . . . 0.0 110.117 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 98' ' ' LEU . 13.1 mt -55.62 -40.93 72.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.149 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -55.11 36.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.56 ' CG ' ' N ' ' A' ' 158' ' ' MET . 0.3 OUTLIER -47.17 -49.73 22.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 109.588 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.56 ' N ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -66.77 -29.89 69.96 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.37 -0.831 . . . . 0.0 110.363 179.947 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 158' ' ' MET . 0.4 OUTLIER 42.82 -148.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.994 . . . . 0.0 110.277 -179.933 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.23 38.52 3.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.7 p -46.09 151.31 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -1.13 . . . . 0.0 110.271 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.244 -179.954 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.189 0.518 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.73 171.77 11.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.354 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.501 ' O ' ' CB ' ' A' ' 91' ' ' LYS . . . -123.4 34.67 5.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.328 -0.858 . . . . 0.0 110.262 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 3.6 tptp 70.11 69.18 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.264 -0.897 . . . . 0.0 110.56 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 93' ' ' LYS . . . 107.86 64.54 0.58 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER 64.64 113.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 110.376 179.608 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 95' ' ' GLU . 1.5 p -74.7 142.18 44.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 109.942 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.697 ' HG2' HD22 ' A' ' 155' ' ' LEU . 4.7 mt-10 -41.14 -44.91 2.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.79 -44.59 28.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 110.062 179.845 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.433 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 3.0 mt-10 -55.42 -60.1 3.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -0.894 . . . . 0.0 110.462 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.652 HD13 ' HE1' ' A' ' 158' ' ' MET . 0.2 OUTLIER -51.21 -54.79 22.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.317 -0.864 . . . . 0.0 110.443 -179.847 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -41.32 -48.52 3.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.412 -0.805 . . . . 0.0 110.134 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.44 -43.65 71.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.064 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 74.8 m -63.9 -18.81 64.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.285 -0.885 . . . . 0.0 110.192 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -53.15 -55.76 21.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 110.122 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -55.82 -33.75 64.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.907 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.03 -39.44 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 110.065 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -66.54 -51.51 55.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.099 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -72.56 123.77 23.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.165 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.471 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 19.6 mttp -93.99 17.19 12.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.424 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 50.3 m-80 -148.68 173.99 12.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 110.424 -179.485 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.5 40.6 1.0 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.283 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.424 ' OD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 p30 -88.13 -23.2 23.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.18 18.71 63.07 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -153.28 117.3 4.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.307 -1.114 . . . . 0.0 110.294 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 36.9 mt -84.1 132.05 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 110.32 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -107.34 -164.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.346 -0.846 . . . . 0.0 110.136 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.585 HG23 ' N ' ' A' ' 116' ' ' GLU . 1.1 tp -78.65 -43.93 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.085 -1.01 . . . . 0.0 110.236 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.585 ' N ' HG23 ' A' ' 115' ' ' ILE . 31.2 mt-10 -51.78 -53.07 43.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.0 109.826 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 120' ' ' GLU . 76.2 mt-10 -57.37 -44.58 84.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -50.48 -44.98 56.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.351 -0.843 . . . . 0.0 110.27 179.919 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.535 ' HA2' ' CD1' ' A' ' 134' ' ' ILE . . . -42.64 -83.39 0.02 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.471 ' OE2' ' NZ ' ' A' ' 107' ' ' LYS . 11.7 pt-20 -47.06 -44.44 20.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -1.158 . . . . 0.0 110.33 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.459 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 17.8 mt -48.18 -57.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.916 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 125' ' ' THR . 18.2 mt -68.85 -47.63 65.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.95 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.32 -37.87 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.856 . . . . 0.0 110.147 179.756 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.3 -31.33 43.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 122' ' ' LEU . 65.7 p -52.9 -34.55 55.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.88 . . . . 0.0 110.18 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.19 24.71 5.86 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -120.83 169.89 10.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 110.156 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -92.35 76.5 5.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.879 . . . . 0.0 110.139 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.38 149.17 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.188 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' ' 131' ' ' GLU . 7.2 pt -133.26 149.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.253 -0.905 . . . . 0.0 110.085 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 130' ' ' ILE . 2.1 mt-10 -41.55 -49.39 4.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.56 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 10.8 mt-10 -42.42 -40.39 2.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.037 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.39 -47.92 10.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 109.175 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.64 HG23 HD13 ' A' ' 118' ' ' LEU . 10.4 mt -55.2 -39.08 49.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.4 -0.813 . . . . 0.0 109.272 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -54.59 -42.18 70.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.527 -0.733 . . . . 0.0 109.948 179.49 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -56.85 -50.72 71.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 110.245 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.6 mp -54.63 -35.53 63.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.417 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.493 ' O ' ' N ' ' A' ' 142' ' ' ASP . 2.1 ttm -74.64 -55.53 5.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 110.396 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -47.54 -55.54 8.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 0.0 110.235 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.61 -33.39 69.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.883 . . . . 0.0 110.278 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 2.0 t -84.9 -62.34 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.0 110.344 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 138' ' ' MET . 3.4 t0 -40.44 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.406 -0.809 . . . . 0.0 110.694 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 141' ' ' SER . 2.9 mttt -76.66 -27.86 55.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.935 . . . . 0.0 109.617 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.416 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 8.4 m-80 -104.24 1.44 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 109.796 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.39 17.57 7.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.41 -0.806 . . . . 0.0 110.314 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.23 -14.32 17.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 110.048 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.494 ' C ' ' CG ' ' A' ' 148' ' ' ARG . . . 97.41 9.21 55.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.494 ' CG ' ' C ' ' A' ' 147' ' ' GLY . 32.2 mtt85 -150.69 142.81 24.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.379 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 4.4 mt -83.7 137.62 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.048 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -111.74 -179.99 3.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.131 -0.981 . . . . 0.0 110.112 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.577 ' CG ' ' N ' ' A' ' 152' ' ' ASP . 30.8 p90 -51.64 -42.49 62.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.226 -0.921 . . . . 0.0 110.625 -179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.577 ' N ' ' CG ' ' A' ' 151' ' ' PHE . 1.9 m-20 -67.0 -58.48 4.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.283 -0.885 . . . . 0.0 110.892 -179.434 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.416 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 39.6 mt-10 -59.46 -38.33 80.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.209 -0.932 . . . . 0.0 111.031 -179.321 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.488 ' CD2' ' SD ' ' A' ' 157' ' ' MET . 25.7 t80 -58.99 -57.38 13.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.041 -1.037 . . . . 0.0 110.619 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.697 HD22 ' HG2' ' A' ' 95' ' ' GLU . 64.6 mt -40.74 -50.07 3.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -0.882 . . . . 0.0 110.317 -179.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -39.11 90.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.964 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.513 ' CG ' ' N ' ' A' ' 158' ' ' MET . 2.2 ptm -55.85 -46.52 78.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.362 -0.836 . . . . 0.0 109.869 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.652 ' HE1' HD13 ' A' ' 98' ' ' LEU . 1.7 tmm? -69.09 -14.74 63.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.515 -0.74 . . . . 0.0 110.158 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.03 -24.14 30.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -136.89 45.24 1.09 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 87.7 t -52.57 111.09 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 0.0 110.128 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.435 ' CB ' ' O ' ' A' ' 161' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.219 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.228 0.537 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -81.09 134.53 35.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 0.0 110.168 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -153.88 34.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.063 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 40.33 1.28 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 110.153 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -137.81 -178.64 16.22 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -101.67 101.25 11.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -1.132 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -76.35 158.36 31.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.0 110.118 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -41.93 -44.38 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 110.298 -179.961 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -59.62 -44.11 93.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -0.906 . . . . 0.0 110.52 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.49 -62.57 1.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 110.737 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.514 HD21 ' HG2' ' A' ' 158' ' ' MET . 16.0 mt -46.61 -53.75 10.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.246 -0.909 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' LEU . . . -42.45 -37.51 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -75.36 -42.74 53.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 110.623 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -55.17 -24.61 27.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.968 . . . . 0.0 110.544 -179.704 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 101' ' ' CYS . 15.6 t80 -42.82 -54.57 4.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -67.13 -37.51 83.96 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.194 -0.941 . . . . 0.0 110.0 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.7 mm -57.53 -39.96 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.938 . . . . 0.0 110.29 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.676 ' CD2' HD13 ' A' ' 121' ' ' ILE . 2.4 m-85 -83.59 -26.08 30.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -80.76 98.48 7.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.222 -0.924 . . . . 0.0 110.252 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -75.81 0.94 16.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.289 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -132.27 167.53 19.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -0.858 . . . . 0.0 110.244 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.79 29.07 0.94 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.418 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.534 ' O ' ' CD2' ' A' ' 112' ' ' PHE . 8.8 p30 -76.26 -24.0 54.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -0.906 . . . . 0.0 110.271 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.538 ' O ' ' CD1' ' A' ' 112' ' ' PHE . . . 80.03 7.46 88.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 111' ' ' GLY . 38.7 m-85 -153.07 133.75 13.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -1.175 . . . . 0.0 110.241 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.33 129.48 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.345 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 117' ' ' GLU . 35.4 p30 -101.99 -179.01 3.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.076 179.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.563 HG23 ' N ' ' A' ' 116' ' ' GLU . 0.5 OUTLIER -58.82 -43.47 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.064 179.937 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.563 ' N ' HG23 ' A' ' 115' ' ' ILE . 19.3 mt-10 -52.21 -51.93 55.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.073 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' HA ' ' CD ' ' A' ' 120' ' ' GLU . 1.5 mm-40 -57.56 -39.19 76.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 0.0 110.367 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.511 HD22 HD11 ' A' ' 122' ' ' LEU . 0.9 OUTLIER -60.01 -50.95 71.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 110.537 -179.68 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.498 ' HA2' HD13 ' A' ' 134' ' ' ILE . . . -49.64 -74.45 0.27 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' CD ' ' HA ' ' A' ' 117' ' ' GLU . 5.6 pt-20 -42.31 -47.7 4.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.434 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.676 HD13 ' CD2' ' A' ' 105' ' ' PHE . 6.1 mt -51.86 -58.37 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 110.013 179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.511 HD11 HD22 ' A' ' 118' ' ' LEU . 64.7 mt -60.67 -47.1 87.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 110.289 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -36.78 66.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.201 -0.937 . . . . 0.0 110.39 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.13 -42.22 28.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -0.862 . . . . 0.0 110.497 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.2 p -54.86 -48.44 72.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 110.359 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 126.4 35.97 0.55 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.05 147.75 48.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.389 -1.065 . . . . 0.0 110.129 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.574 ' O ' ' CG ' ' A' ' 128' ' ' HIS . 0.1 OUTLIER -82.96 59.94 5.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 110.301 -179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' A' ' 122' ' ' LEU . 7.9 t -61.7 156.81 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.407 HG13 ' HB2' ' A' ' 132' ' ' GLU . 12.4 pt -125.67 148.2 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.32 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 132' ' ' GLU . 4.3 mt-10 -45.99 -47.72 16.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.022 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 131' ' ' GLU . 1.9 mt-10 -42.58 -35.0 0.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 0.0 109.877 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.03 -43.63 12.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.498 HD13 ' HA2' ' A' ' 119' ' ' GLY . 14.1 mt -64.13 -40.04 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.454 -0.779 . . . . 0.0 109.633 179.36 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.8 -48.45 72.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.402 -0.811 . . . . 0.0 109.848 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -47.83 -53.79 14.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.76 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.537 ' HG ' ' HE2' ' A' ' 157' ' ' MET . 0.4 OUTLIER -50.76 -43.02 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.876 179.613 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -69.26 -53.69 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.615 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.36 -53.76 46.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.079 179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -57.59 -40.28 78.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 110.107 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.549 ' CB ' HG12 ' A' ' 149' ' ' ILE . 1.8 t -76.32 -59.03 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.207 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 138' ' ' MET . 4.1 m-20 -52.57 87.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.831 . . . . 0.0 110.533 -179.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 141' ' ' SER . 0.3 OUTLIER -68.25 -18.93 64.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.589 179.611 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.425 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -121.74 11.58 10.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.804 . . . . 0.0 109.801 179.664 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 20.8 m-20 51.8 86.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -130.54 13.11 5.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.332 -0.855 . . . . 0.0 110.017 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . 58.4 23.58 54.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 112' ' ' PHE . 3.0 mtt85 -158.3 123.71 4.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 110.424 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 141' ' ' SER . 5.7 mt -84.52 122.33 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 109.817 179.682 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -101.58 -175.09 2.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.995 . . . . 0.0 110.541 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -49.26 -57.79 6.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 110.552 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -61.55 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.691 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.425 ' OE2' ' ND2' ' A' ' 144' ' ' ASN . 96.0 mt-10 -56.72 -33.15 66.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.935 . . . . 0.0 110.645 -179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.464 ' O ' ' HG2' ' A' ' 157' ' ' MET . 13.1 t80 -60.65 -64.34 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 110.614 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.1 mt -46.66 -58.07 4.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 110.443 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -47.11 -38.77 12.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.963 . . . . 0.0 110.409 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.537 ' HE2' ' HG ' ' A' ' 137' ' ' LEU . 0.9 OUTLIER -67.66 -48.71 65.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.291 -0.881 . . . . 0.0 110.152 -179.957 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.524 ' N ' ' CG ' ' A' ' 157' ' ' MET . 4.3 tpp -87.73 21.0 2.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.369 -0.832 . . . . 0.0 110.411 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.99 125.17 41.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 110.132 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.76 55.8 4.8 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.7 t -76.28 129.13 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -1.19 . . . . 0.0 110.367 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.152 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_